entity,frequency
CLL,18852
#,7114
#CLL #,2715
Chronic,2003
FDA,1281
AstraZeneca,970
BTK,721
today,714
#CLL #leusm #,658
MD,599
#leusm #,590
first,553
Venetoclax,537
–ö–ê–õ–ö–í–ï–ù–°,523
–æ–ø–∏—Å–∞–Ω–∏–µ,523
#cll,444
3,440
#CLL,418
Calquence,406
2,403
SLL,399
@medivizor,395
MRD,379
adults &amp,373
Imbruvica,362
#lymphoma #,352
‚ö™‚ö´,335
#leukemia #,292
@MDAndersonNews,278
EU,278
Lymphoma,277
VS,276
1,241
Ibrutinib,227
obinutuzumab,226
#lymsm #,225
Rituximab,221
#Leukemia #,220
CALQUENCE,218
ClinicalTrial,211
17p,200
rituximab,200
UK,194
ASH,194
Jeff Sharman,191
0,189
Roche,183
2019,182
4,179
@LeukemiaMDA,179
Today,177
2017,168
PhD,168
one,168
#oncology #,165
two,160
NHL,158
ChronicLymphocyticLeukemia,157
AML,155
Venclexta,153
CLL &,151
2018,151
second,147
US,145
FCR,141
Chronic Lymphocytic,141
cll,140
TorneoClausura,140
Leukemia,139
#CLLsm #,137
Obinutuzumab,136
non-Hodgkin,136
CME,135
AbbVie,130
MabTherea,129
#leusm,125
IMBRUVICA,123
Here Comes the Sun,120
2020,118
Scan,117
Nicole Lamanna,115
MCL,114
#ASH18 #,113
12,112
5,111
1st,110
First,110
2016,110
Mantle Cell Lymphoma,109
@US_FDA,107
tomorrow,104
#Leusm #,102
CLLsm,101
AIM,100
via @medivizor,99
Lymphocytic Leukemia,97
#pharma #,96
U.S.,96
at least one,94
Bruton,92
Cello Health PLC,89
Lamanna,88
AZN,87
RNS,87
Keating,87
#leukaemia #,86
American Society of Hematology,86
John Gribben,86
#cancer,85
OncoAlert,85
Hematology,83
#ASH18,83
Peter Hillmen,82
Genentech,82
2015,82
un,81
BCR,81
Richard Furman,80
9,80
@ASCO,80
Barbara Eichhorst,80
Mantle Cell,79
Jennifer Brown,78
Jennifer Woyach,77
Reuters,75
about #CLL,75
Europe,74
10,74
EHA,74
@Medivizor,72
#Lymphoma #,71
8,71
Furman,70
IMBRUVICA¬Æ,69
#cllsm #,68
#CLL &,68
three,68
One,67
William Wierda,67
MURANO,66
Arzerra,66
2nd,65
2x,65
6,65
@NEJM,65
AZ,64
ASCEND,63
ASCO19,63
Brian Koffman,63
#Chronic #,62
#Leukemia,62
this week,61
CML,61
BCL-2,60
Susan Leclair,60
14,59
15,59
19,58
this morning,58
#KnowledgeIsBestRx,58
TGTX,57
Paolo Ghia,56
CancerNews,56
@LLSusa,55
#lymphocytic #,55
#mmsm #,55
Karina Vega,55
II,54
CLL/SLL,54
PFS,53
Two,53
Duvelisib,53
Idelalisib,53
tonight,52
#CML #,52
#UNIDASPORELOBJETIVO,52
four,51
Canada,51
Ireland,50
NEJM,50
Arnon Kater,50
year,49
#ibrutinib #,49
ASCO16,49
ERIC,49
Ofatumumab,49
Michael Keating,49
Learn,48
MedEd,48
US FDA,48
ASCO20,48
NOTCH1,48
Stephan Stilgenbauer,48
First-Line Treatment,48
VENCLEXTA¬Æ,48
CI,47
FL,47
Jacqueline Barrientos,47
CDC,47
myeloid,47
Wierda,47
1.713.535.7176,47
this year,46
Cancer,46
CONGRESS,46
Annual,46
Susan O'Brien,46
Saturday,46
Zydelig,46
Japan,45
90%,45
Twitter,45
BloodCancer,45
7,44
EHA24,44
DYK,44
@wwierda,44
#charity #,44
LibertadoresFem,44
Verastem,44
#lymphoma,43
Acerta,43
Relapsed/Refractory,43
#chronic #,43
KnowledgeIsBestRx,43
1L,42
ORR,42
India,42
RNA,42
ASH2020,41
European,41
#bloodcancer #,41
Anthony Mato,41
CLLSA,41
#COVID19 #,40
FDA Approves Acalabrutinib,40
#ASH17 #,40
Hairy Cell Leukemia,40
17,40
@QMBCI,40
LYMPHOCYTIC,40
Cello Group plc's,40
Chemotherapy,39
Danielle Brander,39
ASCO18,39
Relapsed/Refractory Chronic,39
#CLL Program,39
#UU Perspective,39
ITunes,39
Australia,38
ABBV,38
30,38
#ASH19 #,38
Kerry Rogers,38
Q&amp;A,38
GCLLSG,38
September,37
11,37
üôè,37
Leukemia &,37
Michael Hallek,37
PowerfulPatient,37
#cancer #,36
Davids,36
@MDAndersonNews @LeukemiaMDA,36
Roundup,36
John Seymour,36
non-Hodgkin‚Äôs,36
20,36
Liz Pe√±a,36
#MCL #,35
EMA,35
Non-Hodgkin,35
#ASH16,35
Survival Benefit of Venetoclax,35
Relapsed/Refractory CLL Persists Out,35
"December 5, 2020 - Patients",35
Anna Schuh,35
Commissioned Lay Leader,35
CALQUENCE¬Æ,34
Congrats,34
@WVCancer,34
the Treatment of Patients,34
1b,34
@MDAndersonNews #,34
ATM,34
Zanubrutinib,33
Friday,33
BTKinhibitors,33
week,33
the United States,33
#ChronicLymphocyticLeukemia #,33
MS,33
John Pagel,33
Susan O‚ÄôBrien,33
DvoCapiata VS,33
Fabiola Sandoval,33
Edinburgh,33
Synergy,33
BCLLatlas,33
#UNIDASPORELOBJETIVO #,33
APTO,32
about #,32
CR,32
NGS,32
Lymphocytic,32
Combination,32
dans,31
Blood,31
John Byrd,31
18,31
ImmunoOnc,31
#NHL #,31
UNITY,31
German,31
Chemoimmunotherapy for Chronic Lymphocytic Leukemia,31
Ublituximab,30
China,30
#bloodcancer,30
Follicular Lymphoma,30
Sharman,30
Canadian,30
ASCO,30
annual,30
John Allan,30
#ERIC2020 #,30
London,30
Q&amp;A. Register,30
@ASCLS,30
yesterday,29
COVID19,29
Pembrolizumab,29
Woyach,29
#EHA25 #,29
#Ibrutinib #,29
#ASH15 #,29
CARTcells,29
5-year,29
Thompson,29
Cll,29
Global Chronic Lymphocytic,29
@LeukemiaMDA &,29
Condition Summary,28
#endcancer #,28
95%,28
24,28
EndCancer #,28
25,28
13,28
#FNCE #,28
SanLorenzo,28
USD $2000,28
535,27
ACE,27
PD,27
100,27
George Follows,27
ClinicalTrials,27
#CLL $,27
CAPTIVATE,27
#ASH20 #,27
Scotland,27
CARTcell,27
Chronic Lymphocytic Leukemia Treatment,27
#hemeonc #,27
RT PhysRelations,27
Marketed,27
#PBL,27
Umbralisib,26
2013,26
CALQUENCE+obinutuzumab,26
0.06,26
FREE,26
#ASH2019 #,26
#EHA24 #,26
William G. Wierda,26
Spanish,26
watch &,26
#hematology,26
NYC,26
Tait Shanafelt,26
JobOpening,26
#Bioinformatics #,26
Sept 6,26
Portland,26
Global Clinical Trials Review,26
Thomas Kipps,26
Bcl-2,25
Kipps,25
Peninsula,25
#CLL Treatment,25
#health #,25
Multiple Myeloma,25
2011,25
#idelalisib,25
FISH,24
#iwCLL2019,24
Tomorrow,24
Matthew Davids,24
Bendamustine,24
Webinar,24
https://t.co/gAW4eNMxrc,24
#ASH20,24
CLARITY,24
Register,24
Venclyxto,24
each year,24
Chris Fegan,24
Liza Larrea,24
Pipeline Review,24
RiverPlate,24
Dominic LeBlanc,24
AgingData,24
PatientCafe,24
2021,23
2014,23
Thursday,23
CNS,23
1/2,23
next week,23
TN,23
Health Canada,23
26,23
the day,23
Blood Advances,23
#cancerfree #,23
Leusm,23
40,23
#WorldCancerDay,23
DRG,23
Tanya Siddiqi,23
Small Lymphocytic Lymphoma,23
RESONATE-2,23
MabThera,23
Sunday,23
Pepex,23
Lucha,23
Brown,22
La,22
Oxford,22
monthly,22
32,22
@SeattleCCA,22
Philip Thompson,22
@columbiacancer,22
$TGTX #,22
PeerView,22
Alessandra Ferrajoli,22
USD $,22
35,22
BCell,22
Loophole,22
FDA Approves New Drug,22
60,21
‚Å¶@BloodJournal‚Å©,21
Tuesday,21
third,21
16,21
#AndrewScottTV #,21
ASH2018,21
27,21
#ASH17,21
Priority Review,21
Othman Al-Sawaf,21
Hodgkin,21
Constantine Tam,21
#rituximab #,21
Nitin Jain,21
#venetoclax,21
MM,21
Ublituximab in Combination,21
Share,21
Chronic Lymphocytic #Leukemia,21
Lymphoma &,21
Laurie Cristaldo,21
Hairy Cell,21
Gilead,21
Cello Group,21
Forecast,20
Relapsed/Refractory CLL,20
Tx,20
COVID-19,20
ICMR,20
PI,20
M.D.,20
daily,20
10%,20
CAR,20
this weekend,20
20%,20
22,20
Myeloma,20
duvelisib,20
Atlanta,20
Andrew Zelenetz,20
MedicBoard,20
transcription,20
Jennifer R. Brown,20
non-Hodgkin's,20
French,20
Philip A. Thompson,20
PLCG2,20
Acute,20
May,20
@bloodwise_uk,20
Blood Journal,20
GralCaballero,20
"LuchaLibreChilena
- #NAGERO5taRegi√≥n",20
ASCO17,20
#iwCLL2017,20
#ASH16 #,20
#strategy #,19
#marketing,19
Efficacy,19
50%,19
NIH,19
Healthcare,19
FDA Approves,19
@ClevelandClinic,19
#ASCO18,19
Japanese,19
#ASH15,19
@IrishCancerSoc,19
#MPN #,19
Copiktra,19
Medicare,19
Kostas Stamatopoulos,19
31,19
#Leukaemia #,19
Rai,19
Kanti Rai,19
‚ö™‚ö´ https://t.co/iNSCkmDUoI,19
Fecha 13,19
Melanoma,19
Insights &gt;&gt;&gt,19
Marc,19
#ReadByQxMD,19
U.S. FDA,19
GBX,19
nunca falla,19
sino el,19
GANAR,19
#AcademiaCLLFUTBOL,19
PBL,19
JNJ,18
Brukinsa,18
linfoc√≠tica cr√≥nica,18
Three Years,18
covid-19,18
Jan Burger,18
2010,18
Buena,18
el c√°ncer,18
Coca Cola,18
James,18
#CLLsm,18
Irish,18
100%,18
#NonHodgkinsLymphoma,18
Chinese,18
RHHBY,18
Lymsm,18
RxWiki,18
Lymphoma Society,18
Natural Prevention and Treatment of Chronic,18
CD200,18
Venetoclax Plus Rituximab,18
Drs,18
MBL,18
#CLL Patients,18
years,18
5th,18
Rituxan,18
2023,18
Acute Myeloid Leukemia,18
Carsten Niemann,18
Florence Cymbalista,18
Phillip Thompson,18
#EHAtrending #,18
Javier Pinilla-Ibarz,18
Griselda Garay,18
Leukemia Drugs,18
Torneo clausura - 2da Fecha,18
Fecha 11,18
Venclexta plus Gazyva,18
#Venetoclax #,18
Venetoclax‚ÄìRituximab,18
https://t.co/rnLJTZJPY8,18
https://t.co/aFnbeaJMOU https://t.co/XbsSHnAti0,18
FreeCME,18
Johnson &,17
Monday,17
#healthcare #,17
Richters,17
#calquence #,17
#clinicaltrials,17
noticia para pacientes de,17
#OncoAlert #,17
#myeloma #,17
Overman M* et al,17
Project Orbis,17
Mato,17
Calquence Wins FDA Approval,17
TLS,17
morning,17
Yesterday,17
Three,17
#lymphoma &,17
#AgingData #,17
CancerPatients,17
@anthonymatomd &,17
CIT,17
Chronic Lymphocytic #,17
the year,17
BCL2,17
"#ESHCLL2020
",17
#ALL #,17
29,17
Emili Montserrat,17
BSI,17
JT,17
Watch &,17
#leukemia #leusm #,17
#chemosucks,17
30-minute,17
Smudge,17
Orlando,17
Carmen Ben√≠tez,17
UAA,17
#StandUpToCancer #,17
EurekaMag,17
#mpn #,17
https://t.co/8vMhXebPhN,17
Lacroix,17
140,16
John,16
40%,16
#medicine #,16
Calquence Showed Improvement In Small Group Of Hospitalized,16
Skills Challenge,16
TOMORROW,16
30%,16
Second,16
Waldenstr√∂m,16
PI3KŒ¥,16
15ICML,16
#ASCO19,16
Barrientos,16
#lymsm #leusm #,16
21,16
ASH17,16
La EMA,16
Steven Coutre,16
TG Therapeutics,16
Haematologica,16
Four,16
myeloma,16
Houston,16
Spain,16
Germany,16
Epidemiology,16
Paul Barr,16
Impressive,16
@IMFmyeloma,16
Acute Lymphocytic Leukemia,16
Non-Hodgkin's,16
Janssen,16
EC,16
BTKInhibitors,16
#BeLegendary #,16
ST,16
"Olimpia

‚è±",16
Torneo clausura - 4ta Fecha,16
RSP,16
9na,16
LivingWell,16
Eight,16
#FlashbackFridays #,16
FinnCap,16
#iwCLL2017 #,16
Video Update,16
NCCN Publishes New Patient Education Resources for Patients,16
England,15
ChronicLymphocyticLeukaemia,15
Europa,15
Ian Flinn,15
Btk,15
Covid,15
Australian,15
@MoffittNews,15
March,15
#ClinicalTrials #,15
AF,15
Therapy,15
23,15
The US Food and Drug Administration,15
28,15
healthcare,15
HemOnc,15
80%,15
#MDS #,15
Town Hall,15
Facebook,15
NHS,15
BIRC3,15
this summer,15
Turmeric,15
CART,15
Immunoglobulin,15
Myeloid,15
@NYLCandCLL,15
the Treatment of Chronic Lymphocytic Leukemia,15
#rituximab,15
#lymfekr√¶ft #,15
62nd,15
Hematolog√≠a,15
Gribben,15
ESHCONFERENCES,15
#MultipleMyeloma #,15
Ibrutinib Plus Venetoclax,15
American,15
IgHV,15
MedscapeEdu,15
Michael Choi,15
Status,15
@DrRaulCordoba,15
EPAR,15
Damia Cortaza,15
‚öΩ 0-0,15
Non-Hodgkin Lymphomas,15
Torneo clausura - 1ra,15
"LuchaLibreChilena
- #NAGERO5taRegi√≥n #",15
the Chronic Lymphocytic Leukemia Society,15
Denver,15
tumorimmuno,15
132,15
TG Therapeutics Announces Orphan Drug Designation,15
#H2 #,15
#KnowledgeIsBestRx #,15
@AnnaSchuh3,14
Leuk√§mie,14
#news #pharma #,14
contra,14
36,14
#DLBCL #,14
AE,14
üëâ,14
81%,14
#leukemia,14
Waldenstrom,14
Mark,14
1%,14
#ASH,14
San Diego,14
IgM,14
CancerResearch,14
Linfoma,14
August,14
50,14
PatientPower,14
Koffman,14
Patient Power,14
HARMONY,14
#CLLsm #Leusm #,14
#ibrutinib plus,14
uMRD,14
#CART #,14
2 years,14
MZL,14
Adaptive Biotechnologies Receives Expanded FDA Clearance,14
37,14
Genmab,14
@MDAndersonNews &,14
June,14
Western Europe,14
NovelTherapy,14
HL,14
https://t.co/ot4xB84i0N,14
Michele Nadeem-Baker,14
SpotLeukaemia,14
SCT,14
#Hodgkin #,14
‚ö™‚ö´ https://t.co/i4XNcCIu0r,14
‚ö™‚ö´ https://t.co/Y23kRL4nhv,14
‚ö™‚ö´ https://t.co/2mMAhLbDTZ,14
@UniBarcelona,14
–õ–µ—á–µ–Ω–∏–µ,14
–ª–∏–º—Ñ–æ—Ü–∏—Ç–∞—Ä–Ω–æ–π,14
Clemens Wendtner,14
@UniofOxford,14
Jeffrey Jones,14
USD $2500,14
The Future of Chronic,14
Andrew Zelenetz - individualizing,14
BRIEF-Janssen,14
FiercePharma,13
MPH,13
Christmas,13
#Acalabrutinib,13
B1,13
John C. Byrd,13
EndCancer,13
@TheUSONetwork,13
Bruton‚Äôs,13
Medical News,13
Truxima,13
@UTSWNews,13
#clinicaltrials #,13
five,13
#BloodCancer #,13
6 months,13
HemeOnc,13
88%,13
Lymphomas,13
Mantle,13
Zelenetz,13
New York,13
the CLL Society,13
the week,13
Gene Mutations,13
First-Line,13
#cml #,13
TGR-1202,13
@genentech,13
IGVH,13
MDS,13
Wednesday,13
5 years,13
Boston,13
Elias Campo,13
43,13
ROG,13
MCC,13
HELIOS,13
#MRD,13
TatPremiers,13
U.S. FDA Approves,13
New Drug Application,13
Market Size,13
day,13
non-Hodgkin #,13
BMT,13
0-3,13
Joana Galeano,13
Paola Genes,13
#chemo #,13
CLLHZ19,13
Torneo clausura - 5ta Fecha,13
Vit D insuff &,13
Gazyva,13
Current Research &,13
Glasgow,13
Present Results,13
Przewlek≈Ça #,13
bia≈Çaczka limfocytowa w pigu≈Çce,13
the International Workshop on Chronic Lymphocytic Leukemia,13
#Lymphoma,13
Nike+,13
#SFC,13
Calquence¬Æ,12
Size,12
"Calquence, BeiGene's",12
Coronavirus,12
#leusm  ,12
cancer drug,12
#SOHO2020,12
Randomized Trial of Acalabrutinib,12
SYK,12
Lynparza,12
#treatment #,12
Astra Zeneca,12
f√∂r,12
MD Anderson,12
93%,12
70%,12
$RHHBY $,12
Phase 3,12
NDA,12
#Cancer #,12
Waldenstrom Macroglobulinemia,12
#EHA23 #,12
This week,12
Ensayo,12
Linfocitica,12
Hillmen,12
charityTuesday,12
Carol Preston,12
#HemOnc #,12
Journal of Clinical Oncology,12
Chronic Lymphocytic Leukemia,12
Chelsea,12
#mds #,12
4-Year Results and Evaluation of Impact of Genomic Complexity,12
Brander,12
John M. Burke,12
#blodkr√¶ft #,12
SF3B1,12
U2,12
#patientpower #,12
CLL Study Group,12
Matt,12
Davide Rossi,12
Cirmtuzumab,12
Farrukh Awan,12
Kater,12
Assess Minimal Residual Disease,12
George Duke,12
eBook,12
#crypto #,12
Cello Health,12
Rod Humerickhouse,12
Prognostic Factors,12
Andy,12
Leeds,12
@USAToday,12
#chemo,12
Chicago,12
France,12
#gerionc #,12
Con Tam,12
the International Workshop,12
#cancersucks,12
David Maloney,12
CardioOnc,12
the Feinstein Institute for Medical Research:,12
600%,12
Torneo clausura - 3ra,12
Lee Swanson,12
Moon Shot,12
Kay,12
CLLHeroes,12
Media Group,12
Roundup Chronic Lymphocytic Leukemia,12
Lymphoma Daily,12
Verastem Announces Clinical Data,12
#Venclexta #,12
Westin Galleria,12
üèÄ,12
Leukemia Treatment-,12
Peel Hunt,12
CureClick,12
https://t.co/R65ihudmhd,12
The Force to Fight #CLL,12
TeamDiabetes,12
2025,11
BM,11
#acalabrutinib #,11
BioSpace,11
200,11
#covid19 #,11
#CLLsm #leusm #,11
3rd,11
month,11
Alessandra Tedeschi,11
usado,11
@TheLancet,11
last week,11
obinutuzmab,11
7%,11
Un,11
British,11
@JanRynne,11
USA,11
BTK Inhibitors,11
Bcell,11
12%,11
Wang,11
RR,11
Phillips,11
DLBCL,11
The Food and Drug Administration,11
ASH16,11
Orphan Drug,11
Promise of Acalabrutinib,11
the Management of #CLL,11
Love,11
geriheme,11
last year,11
Catherine Wu,11
FollicularLymphoma,11
Sat,11
HemaSphere,11
Docs,11
#AML,11
Mazyar Shadman,11
Minimal Residual Disease,11
4th,11
#hemepath #,11
üëà,11
Richter,11
#MMSM #,11
#medtwitter #,11
Non-Hodgkin‚Äôs,11
Multiple Phase 3 Studies,11
this afternoon,11
PB,11
MB,11
lymphomas,11
#haematology,11
November,11
Venetoclax &,11
#blood,11
half,11
CLL Society,11
Bcl-2 Inhibitor,11
Oncology Access Program,11
April,11
CLL14,11
#ibrutinib &,11
39,11
@DRGinsights #CLL #,11
B-Cell,11
#chronic,11
Mayo Clinic,11
Chemotherapy-Free Combination Regimen,11
Alliance,11
Demonstrate Progression-Free Survival,11
Ang√©lica V√°zquez,11
Nicholas Chiorazzi,11
$CLL #,11
#DesdeLasCanchasEc,11
Dan Landau,11
PubMed,11
CAMBIO,11
GOOL,11
July,11
#CME #,11
December,11
#LeuSM #,11
RT EHA_Hematology,11
54%,11
Kolibaba,11
#LivingWell #,11
#KEY #,11
Leukemia Daily,11
ASCOU,11
#ASCO17 #,11
N+1 Singer,11
2016-2020,11
PowerfulIn2016,11
digifest15,11
Malignancies,10
Interferon,10
Calquence Fails Pair of,10
MT,10
#Oncology #,10
APG-2575,10
f√°rmaco,10
Bendamustine/Rituximab,10
European Hematology Association,10
RCT,10
Acerta Pharma,10
Cancer Network,10
PharmaScrip,10
Lisocabtagene Maraleucel,10
rel/ref,10
62%,10
+ rituximab,10
Novartis,10
#chroniclymphocyticleukemia #,10
NSCLC,10
Tam,10
2026,10
92%,10
#CLLsm #Leusm,10
AstraZeneca Outlook: Calquence for Mantle Cell,10
Myloma,10
Tonight,10
FDA Breakthrough Therapy Designation,10
#all #,10
#science #,10
@AACR,10
65%,10
RareDiseaseDay,10
70,10
AKT,10
#books #,10
#Cll #,10
Supporting Emergent Literacy,10
#dlbcl #,10
Manuel A. Santiago,10
EYFS,10
January,10
YouTube,10
#Chronic Lymphocytic,10
Phase 2 Trial,10
@LeukemiaMDA #,10
the last decade,10
44,10
Brian Hill,10
@fredhutch,10
this evening,10
#nonhodgkinslymphoma #,10
the European Research Initiative,10
Ferrajoli,10
#endcancer,10
Coutre,10
FoxMemorial,10
Brian,10
BUS,10
11q,10
PDQ,10
AskTheExpert,10
Times,10
#freedomdevice #,10
Paris,10
Fludarabine,10
101,10
"AmericaDeCali

‚è±",10
Stephenie Lacoste,10
72,10
@KebleConference #,10
#AdvancedNursing #,10
Tom Kipps,10
Future Implications,10
John Terry,10
SummerFest,10
Ham-Wasserman Lecture -,10
Control Chronic Lymphocytic Leukemia,10
HALO,10
SOHO18,10
https://t.co/sVZw9yJECB,10
EHA18,10
Stilgenbauer,10
CURE Media Groups Strategic Alliance Partnership Program,10
przewlek≈ÇƒÖ bia≈Çaczkƒô,10
metalmec√°nicos,10
#PowerfulIn2016,10
https://t.co/mb0X5nTOSX,10
Leukemia - #,10
#ASH14,10
New England Journal of Medicine Online Publication,10
Rituximab Shows Clinical Response,10
Patient Stories-How,10
Phase II,9
#pharmaceutical,9
#pharma,9
New CALQUENCE,9
3 years,9
kan,9
CRS,9
Astrazeneca,9
AZ‚Äôs Calquence,9
October 21,9
#ASCO20 #,9
420,9
BTK Inhibitor Acalabrutinib,9
Una,9
RA,9
25%,9
GoogleAlerts,9
#ASH19,9
@NHSGGC,9
ASH19,9
24 months,9
@CllSociety,9
Acala,9
Breakthrough Therapy Designation,9
#ASCO2019 #,9
83%,9
Ash2018,9
Neil Kay,9
Mantle Cell Lymphoma Patients Benefit,9
IR,9
AstraZeneca Snags Quick FDA OK,9
@UniversityLeeds,9
Dutch,9
PhD &,9
mRNA,9
R. Gregory Bociek,9
@UvA_Amsterdam,9
#marijuana #,9
eight,9
41,9
@anthonymatomd,9
acute myeloid,9
MSCE,9
Acute Lymphoblastic Leukemia,9
Zusia,9
afternoon,9
Haematology,9
Barcelona,9
GC,9
Paul M. Barr,9
#ASH2020 #,9
@QMUL,9
500,9
clinicians,9
next year,9
@Roche,9
MBBS,9
Venclexta/Venclyxto,9
types &,9
WGS,9
PI3K Inhibitor Therapy,9
#CLL Society,9
Robin Fo√†,9
Adrian Wiestner,9
Watch and Wait,9
Michele,9
Vitamin D,9
EBMT,9
Graeme Fraser,9
#Leukemia #Leusm #,9
Rheumatoid Arthritis,9
last night,9
ICU,9
Ben Kennedy,9
GA101,9
age 67,9
Bruce G. Raphael,9
AbbVie Inc.,9
#EYtwittertagteam #,9
Carol Moreno,9
Congress,9
56th,9
many years,9
199,9
#RT,9
Andrew Schorr,9
Seattle,9
microRNA,9
The International Workshop,9
AttentionMining,9
#mpnsm #,9
Texas,9
MSK,9
Extended Follow,9
89%,9
#ASH19 @ASH_hematology,9
Griselda L√≥pez,9
next month,9
@nature,9
Verastem Oncology,9
CLL Horizons,9
#blooducation,9
BloodCancerAwarenessMonth,9
Carlo Croce,9
#cancerhumor,9
Petra Langerbeins,9
#LymSM #,9
#Frontline #,9
#Research4ACure #,9
#CancerMoonshot #,9
@LLSusa @LeukemiaRF @LMCongress,9
#blockchain #,9
#cancercongress,9
Hematologic &,9
#duvelisib,9
Sept 27,9
#EHA2018 #,9
#CLL #ChileLuchaLibre #,9
Ill.,9
challenges &,9
#WatchWaitWorry,9
#Wrestlemania #,9
Media Group Partners,9
#CancerCare #,9
FIEBRE,9
BGSConf,9
19.16%,9
mpncll16,9
#lympocyticleukema #,9
1000km2016,9
https://t.co/XCyjRcuZ9I Trillium Wins,9
#ConnectedDash #Dash4Charity #,9
#lifelonglearning #,9
#ASCO15 #,9
FDA - WallStreet,9
Aberrant Epstein-Barr,9
NICE,8
1L #CLL,8
Solidarity,8
17P,8
Johnson,8
$JNJ $,8
Calquence Approved,8
Seymour,8
Imfinzi,8
@WHO,8
#biotech #,8
$AZN #,8
The European Commission,8
PrecisionMedicine,8
IV,8
PET/CT,8
pembrolizumab,8
Bruton Tyrosine Kinase,8
VEN,8
Science Immunology,8
LEUCEMIA LINFATICA CRONICA:,8
el Acalabrutinib,8
@tobyeyre82,8
lymsm,8
obinutuzumab versus chlorambucil,8
38,8
1/,8
Journal,8
sll,8
72%,8
TGA,8
#healthcare,8
#hemeonc,8
PhIII,8
LymphocyticLeukemia,8
IL,8
AstraZeneca PLC,8
BJH,8
24%,8
#stateofscience #,8
IBRUTINIB,8
Jacobs,8
weekly,8
67%,8
Demonstrates Activity,8
75%,8
Potential Lymphoma Blockbuster Calquence,8
Following PhIII,8
@unisouthampton,8
Relapsed/Refractory #,8
Orphan,8
#Lymphocytic #,8
STAT3,8
61-year-old,8
2 weeks,8
James Gerson,8
2027,8
evening,8
Memorial Sloan Kettering,8
2005,8
#DisabilityInfo #,8
February,8
@ZuckerSoM,8
TrialUpdate,8
#WatchAndWait,8
Florida,8
the Phase 3 GENUINE Trial,8
BRAF,8
this Friday,8
Brazil,8
@bloodcancer_uk,8
Jeff,8
PDQ Cancer Information Summaries,8
CTSM,8
Leukemia Cells,8
MD &,8
Follicular,8
71-year-old,8
#ImmunoOnc #,8
Danilov,8
5-Year Analysis,8
season,8
#ChronicLymphocyticLeukemia #CLL #,8
Combined Data,8
Disease-Free Survival Data,8
October,8
@landau_lab,8
Terry,8
"100,000",8
‚Å¶@sloan_kettering‚Å©,8
Deborah Sims,8
53-year-old,8
Manchester,8
Matthew S. Davids,8
Rheumatoid,8
Liverpool,8
6:30 AM,8
the Recurrent Gly101Val Mutation,8
Manitoba,8
Acute Myeloid,8
CellTherapy,8
VSTM,8
Connected Learning Live,8
#Dr.,8
NewJersey,8
3%,8
Dad,8
Signal Line Cross,8
@LeukemiaMDA @MDAndersonNews,8
Indian,8
#Imbruvica #,8
FDA Approves Venetoclax,8
#Duvelisib #,8
#eyfs #,8
Gazyvaro,8
March 28th,8
Tcell,8
#twofingersuptocancer,8
Andrew,8
Healio,8
this month,8
Super,8
#successfulstudents #,8
Hundreds,8
VENCLEXTA,8
lymphoma &,8
Measure Minimal Residual Disease,8
#ESCNJ #,8
#Follicular #,8
Time,8
12/10,8
Jain,8
0-5,8
Teva Pharmaceuticals,8
42,8
2006,8
√ëA√ë,8
the XVIII International Workshop,8
BloodCancer Awareness Month,8
CLl,8
Ibrutinib-Rituximab,8
‚öΩ 0-2,8
CancerCare,8
ICML15,8
Sarah,8
The Changing Face of,8
Alicia Bobadilla,8
Amsterdam,8
#Leuk√§mie #,8
#CancerTreatment #,8
Burke,8
Abbvie,8
Chemotherapy-Free Combination Regimen for Previously Untreated Chronic,8
PowerfulPatients,8
14th July,8
#ASH18  ,8
Resource Center,8
MRDFocus,8
Therapy Vs,8
@Ericllorg #,8
May 2017,8
#EHA23,8
Keating &,8
Glenn,8
USES,8
IL-23R/IL-23,8
CharityTuesday,8
March 24th,8
Common Drug,8
Britain,8
CC @anthonymatomd,8
Quality of Life Experience,8
#biotechnology #,8
#NAGLuchaLibre #,8
acto de presencia en otras,8
The Mike Paetzold Daily,8
https://t.co/e7DofYPnxe,8
VIDEO:,8
Blood Advances Talks,8
Viva La,8
5/14,8
Safety &,8
@Northwell_EM,8
#AskTheExpert #,8
Castro,8
#PowerfulIn2016 #,8
FDA Approves Ibrutinib,8
Penn Study,8
Nearly 80 Percent,8
BloodJournal,8
Novel Treatments of Special Cases,8
Wallonie,8
#SFC #,8
Randall Goskowicz,8
73%,7
ICYMI,7
recent years,7
Acalabrutinib,7
all day,7
https://t.co/W83AqqbUX8 Learn,7
three years,7
CALQUENCE Shows Long-Term Efficacy and,7
StockMarket,7
Phase 2,7
Remdesivir,7
the Treatment of Chronic,7
AstraZeneca Pharma,7
Ghia,7
TX,7
PBS,7
#BloodCancerAwarenessMonth #,7
el medicamento,7
la tormenta de citoquinas,7
Lymphoid,7
three days,7
82%,7
Richard R. Furman,7
Blood Cancer Drug Calquence,7
Phase III,7
Rocky Mountain Cancer Centers,7
Gracias,7
w,7
#mantlecelllymphoma #,7
DOR,7
P3,7
400,7
NCI,7
12 months,7
FDA Approves Calquence,7
78%,7
46,7
NCCN,7
ARQL,7
E451,7
#MCL,7
65,7
NonHodgkin,7
AstraZeneca Reports,7
Lugano,7
https://t.co/Xnq2hWyaIM,7
Linfoma Mantellare,7
Black Swan Intelligent Insight,7
New Combo Treatment,7
https://t.co/exmVf8WSl5,7
a Breakthrough Therapy,7
Gaithersburg,7
$ABBV $,7
ONO-4059,7
#endlymphoma #,7
#bigdata,7
Shuo Ma,7
HSCT,7
webinar,7
#CardioOnc #,7
Eosinophilic,7
every day,7
Nick,7
#Immunotherapy #,7
#MultipleMyeloma &,7
#HemOnc #Leusm #,7
Lydia Scarf√≤,7
English,7
13q,7
George,7
#COVID19nCancer #,7
Relapsed/Refractory Mantle Cell,7
13%,7
1-hour,7
Exposition,7
IgG,7
Lymphocytic Lymphoma,7
57%,7
First-Line Treatment for Patients,7
Kirsten Fischer,7
35%,7
U.S. Food and Drug Administration,7
TG Therapeutics Announces Publication of Phase 2,7
7 AM PST,7
December 4,7
MultipleMyeloma,7
Cologne,7
Nashville,7
J. Brown,7
@andrewschorr &,7
84%,7
#MedEd #,7
Katy Rezvani,7
#patienter,7
#aml,7
Dr Brian Koffman,7
New Chronic,7
night,7
Scans,7
Treatments,7
#cll #,7
@MayoCancerCare,7
NF,7
Review,7
#sundpol #,7
John Burke,7
#bmtsm #,7
Burger,7
Lisa,7
Idelalisib for Treatment of Relapsed Follicular Lymphoma,7
Brad Kahl,7
Krebs,7
Melbourne,7
summer,7
https://t.co/O27fLx4Ywh,7
#CLL Sessions,7
Cello Health plc,7
#CE #,7
Myelogenous Leukemia,7
CancerNetwork,7
Autoimmune,7
MF,7
QoL,7
#ibrutinib,7
RT,7
American Society of Clinical Oncology Annual Meeting,7
Oxford Academic,7
Philadelphia,7
#CFC #,7
HIF-1Œ±,7
CD49d,7
Hematologic Malignancies,7
Jennifer A. Woyach,7
10 years,7
Justin Taylor,7
üìö,7
Curcumin,7
Download,7
#BreastCancer #,7
This morning,7
Wilmot Cancer Institute,7
ACCC,7
Follicullar Lymphoma,7
about one,7
Venetoclax-Rituximab,7
1995 to,7
Bearish List,7
#lymsm,7
#research,7
Venclexta¬Æ,7
0-1,7
PML,7
MDAndersonNews,7
0-4,7
Leukaemia,7
#FDA #,7
Segundo,7
Monthly,7
Combo,7
#Bcells #,7
Bruce D. Cheson,7
Roundup Weed Killer,7
#anxiety #,7
up to,7
OvarianCancer,7
#iwCLL2019 #,7
Weill Cornell Medicine,7
Birmingham,7
ASHMHM19,7
Leukemia Awareness Month,7
#AML #,7
VenG,7
Prognostic Score and Cytogenetic Risk Classification,7
Key Insights,7
LymHubSS,7
#chronic lymphocytic,7
ALLIANCE,7
fifth,7
"1,2,3 Retracement Bearish",7
#venetoclax #,7
CancerMoonshot,7
Post-Treatment Follow-Up,7
#lakelouise #,7
@LLSusa #,7
Token,7
@cancertrials_ie,7
Paolo Strati,7
Prof Peter Hillmen,7
#ash18 #,7
RWE,7
#worldcancermeet #,7
#Paris #,7
#CARTcells #,7
Western,7
First-Line Therapy,7
ExceptionalResponder,7
25 years,7
IntegrativeMedicine,7
IgVH,7
Bcells #,7
Value and Innovation to News,7
Media Consumption,7
#CryptoLiveLeak,7
Chris,7
Cyclacel,7
CYC065 CDK Inhibitor Demonstrates Synergy With Venetoclax By Dual Targeting Of Chronic,7
#VivaLaBotch #,7
Spurgeon,7
VLA-4,7
Diet,7
Paul Henderson,7
https://t.co/xqyJtshM3B,7
CURE Media Group Partners,7
a Research and Development Event,7
Esanex Announces First Patient Dosed,7
#SOHO17 #,7
HittaMiz,7
Novel SF3B1,7
HodgkinLymphoma,7
2500,7
BTK Inhibitor BGB-3111,7
Bgb-3111,7
Global Clinical Trials Review H2,7
Big News,7
Fred Hutch,7
SIOG16,7
MPNCLL16,7
#PowerfulPatient,7
New York State Approval,7
Unique NGS Panel,7
https://t.co/SsL7cxx3gV,7
La Verne,7
European Commission Approves,7
First-Line Treatment of Patients,7
May 14th,7
ASH15,7
#ASH2015P2,7
Venetoclax Receives Breakthrough Therapy Designation,7
http://t.co/854Sswa4R2,7
Disease-Related Genes,7
T-Cell Dysfunction,7
TMJ,7
FoodAllergies,7
Type II,7
Knees,7
Nodality Launches PathPro,7
Wales,6
Five,6
$AZN $,6
17%,6
Tagrisso,6
monoterapia,6
üìΩ,6
La UE,6
@ChandnaHimani,6
two weeks,6
Ph.D.,6
RichtersSyndrome,6
Italy,6
SCI,6
hours,6
75,6
@MDAndersonNews #Leukemia,6
Cancer Research,6
AcertaPharma,6
Lancet,6
f√°rmaco Acalabrutinib,6
97%,6
un f√°rmaco ya,6
Dr,6
Trump,6
MedTwitter,6
Bethesda,6
2012,6
Pharma,6
Article,6
Clinicaltrial,6
Cambridge,6
BGNE,6
8%,6
Antitumor Potency,6
the American Society of Hematology,6
WM,6
Nice,6
Lampson,6
ProjectOrbis,6
19%,6
IBR,6
C481,6
69%,6
Siddiqi,6
Therapie,6
La FDA,6
Kerry A. Rogers,6
81,6
Role,6
3-year,6
several years,6
P2,6
3 #CLL,6
CLLsm Tues,6
9:45-12:45 - Chairs,6
Bartlett &,6
#CancerResearch #,6
Neil E. Kay,6
MD Anderson Cancer Center,6
Another BTK Inhibitor    Active,6
#CTSM #,6
Ibrutinib &,6
87%,6
BGB-3111,6
@sehh_es,6
AstraZenecas Calquence,6
#ngs #,6
Approved,6
PreviouslyTreated Mantle Cell Lymphoma Available,6
at least 1,6
The U.S. Food and Drug Administration,6
BTK &,6
Read Blog,6
38%,6
ACP-196,6
Relapsed/Refractory #CLL,6
2a,6
Jacqueline Claudia Barrientos,6
DO,6
4-year,6
#MM #,6
Oxidative,6
Rogers,6
AP,6
John Hayslip,6
ESH,6
3 days,6
Monday 15 February,6
3:30pm,6
Notch,6
66,6
WorldCancerDay,6
Mark Silverstein,6
@wwierda @MDAndersonNews,6
Epstein-Barr,6
Plus Rituximab,6
rituximab-arrx,6
https://t.co/Hd5Yskv3Fd,6
@Hemato_Vhebron,6
the years,6
Erlene Seymour,6
Post-Treatment in Previously Untreated Patients,6
Jan A. Burger,6
Myeloid Leukemia,6
1.25 #,6
TRANSCEND CLL 004,6
RWD,6
PI3Ki,6
clonoSEQ,6
Hematologist,6
Piers Blombery,6
@chadinabhan,6
Tedeschi,6
the Tumor Microenvironment,6
Driver Mutations,6
ESHCLL2020,6
The Mithralog EC-7072 Induces,6
Alexey Danilov,6
Ian W. Flinn,6
Lymphoid Leukemia,6
COVID‚Äê19,6
LymphomaMatters,6
ITP,6
WednesdayWisdom,6
Barr,6
Dana-Farber Cancer Institute,6
#lyle_dk #,6
Thanksgiving,6
Andreas Agathangelidis,6
European Research Initiative,6
#sll #,6
PFS &,6
Langerhans,6
Betty,6
@LymphomaCanada,6
Frontline,6
Prognosis,6
Dual Inhibitor,6
Swedish,6
Acute myeloid,6
#chroniclymphocyticleukaemia #,6
MPN,6
September 11,6
#blodcancer,6
O'Brien,6
Bone Marrow,6
#AML &,6
Alterations,6
the #FDA,6
ASCO &,6
Adaptive,6
Aspergillus,6
TatProud,6
American Society of Clinical Oncology,6
Lorna Warwick,6
ASCO 2020,6
CL,6
the last few years,6
20 years,6
Steve,6
Bearish Centerline Cross,6
#cancertreatment,6
300,6
Constantine S. Tam,6
Arthritis,6
CLL Forum,6
the European Commission,6
#indianchieftain #,6
#oncology #mm #,6
#chroniclymphocyticleukemia,6
WBC,6
Non-Hodgkin Lymphoma,6
Lori A. Leslie,6
ASCO 2019,6
Data Trial,6
Lymphoma Hub,6
Analysis,6
autoimmune,6
a Primary Endpoint,6
AndrewScottTV,6
Bob Azopardi,6
"Mantle Cell Lymphoma
Primary Central Nervous System",6
#blodkr√¶ft,6
Yanina L√≥pez,6
Dr Jennifer Woyach,6
Expert Perspectives,6
"more than 35,000",6
33,6
45,6
GralDiaz,6
"Leukemia, Lymphocytic",6
0-6,6
36%,6
Hallek,6
The Steinberg Law Group,6
90,6
6‚Äâyears,6
Linfomas,6
Outlook,6
Arzerra¬Æ,6
#BCell Malignancies,6
18th,6
Annual International Workshop,6
@Ericllorg,6
#geriheme #,6
9/22,6
Claudia Romero,6
Clinical Pearls and Future Directions,6
https://t.co/0p9udHOw2w,6
#LEUsm #,6
10am-2pm,6
#gerionc #geriheme #,6
üî¨ Ibrutinib-Rituximab,6
N Engl J Med,6
üî¨ Shanafelt TD,6
#follicular #,6
67,6
58,6
July 31st,6
MondayMotivation,6
#survivor,6
The Untold Story of the Longest Persisting CAR-T Cells,6
#LymphomaMatters #,6
Erkrankung,6
GIMEMA,6
OverallSurvival,6
STIM1,6
2009,6
#PeerView #,6
Venclexta Plus Gazyva for People With Previously Untreated,6
May 14,6
Minneapolis,6
23rd,6
Nick York,6
TipTuesday,6
#RT &,6
Treatment Options,6
@KarolinskaUnsju,6
@cardinalhealth,6
AbbVie/Roche,6
U.K.,6
Standard Fludarabine,6
Non-Hematologic Adverse Effects,6
VENCLYXTO¬Æ,6
Guest @GlennSabin,6
#NHL,6
Wesley Bishop,6
@UCSDnews,6
#prowrestling #,6
chroniclymphocyticleukemia,6
Benzene,6
@ColumbiaMed &amp,6
PD-1 Expression,6
#melsm #,6
#Advocacy #,6
Rituxan Hycela,6
$CLL,6
the Era of Novel Agents,6
Nora Larson,6
5-Year,6
@TheUSONetwork &,6
WestminsterHall,6
17th,6
8q24/MYC,6
#Ch #,6
SoundCloud,6
Oral Pres,6
NY,6
N.B. MP,6
Personalized Era,6
#BSH2017 #,6
10-year,6
SupportiveCare,6
#CLL #ChileLuchaLibre,6
RockFighter,6
@Pharmacyclics,6
May 20th,6
APWA,6
2017-2018,6
https://t.co/8Bj7Do9qmp https://t.co/g4wrEO527r,6
Feb 18th,6
https://t.co/mQ7MAYy5np,6
January 10th,6
#CLL Treatment Options,6
Delta,6
F Caligaris-Cappio,6
DCLLSG16,6
CLL News,6
New Data,6
#Rio2016 #,6
JPN,6
HealthNews,6
Families &,6
Care Partners,6
https://t.co/SzZaYNyqPq,6
Normal B Cells,6
#learning #,6
#CLL #ASH15 #,6
Basquet,6
CLLMDA,6
2015-2019,6
Multiplicom,6
Carlos Lucas Lopes - Equita√ß√£o,6
Przewlek≈Ça,6
Najnowsze,6
leki w,6
Recommended,6
Single Cell Network Profiling,6
#msn #mmsm #CLL #,6
James Berenson,6
@IPPOSI,5
Einstufung,5
prima,5
„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquence¬Æ,5
WHO,5
#AstraZeneca #,5
Clive Zent,5
Dec 7,5
Kanser,5
LEUCEMIA LINFATICA CRONICA,5
para la,5
the European Union,5
Kombination,5
AstraZeneca Pharma India,5
AXL,5
Idelalisib Plus Rituximab,5
Bijal Shah,5
FACP,5
OpenAccess,5
Green Light,5
CytokineStorm,5
Los,5
BI,5
la leucemia,5
4 years,5
un f√°rmaco,5
Waldenstroms,5
Investigadores,5
el uso del medicamento,5
el tratamiento de,5
El Acalabrutinib,5
Prueban,5
qui,5
Studie,5
#Health #,5
#Acalabrutinib #,5
ASTRAZENECA'S CANCER DRUG CALQUENCE,5
Sun,5
Lenalidomide,5
COVID„Éº19,5
Jahren,5
#clinicalresearch,5
OncologyTribune,5
Forbes,5
#COVID-19 #,5
#news #,5
Det,5
Obinutuzumab Plus Chlorambucil,5
STELLAR,5
Awan,5
CALQUENCE Significantly,5
the Time Patients Lived Without Disease Progression or Death in Previously Untreated Chronic,5
Calquence Sets Sights,5
5%,5
4%,5
#jobs #,5
Frontline CLL,5
SCL,5
FDA Approves Calquence for Adults,5
Annual Meeting,5
10th,5
#CLLSM #,5
&gt;&gt,5
EHA2019,5
#bloodcancers,5
#ICML19 #,5
New Post,5
Disease Progression,5
Calquence Phase III,5
#melanoma #,5
Daten,5
Without Obinutuzumab,5
Tregs,5
WaldenstrÔøΩm's,5
LC-MS/MS,5
Mantle Cell #,5
–ê–∫–∞–ª–∞–±—Ä—É—Ç–∏–Ω–∏–±,5
#ngs,5
BTKinhibitor,5
The #FDA,5
more &gt;&gt,5
US FDA Accepts Regulatory Submission for Acalabrutinib,5
Grants Priority Review,5
FDA Awards Acalabrutinib Priority Review,5
FDA Priority Review,5
@DRGinsights #,5
https://t.co/KP1fuSI20Y,5
como medicamento hu√©rfano,5
New England Journal of Medicine Demonstrates Acalabrutinib,5
16ICML,5
#leukaemia,5
Wu,5
xenograft,5
@BritSocHaem,5
Dr Love,5
AMC,5
Bruton's Tyrosine Kinase,5
Esther Schorr,5
Matt Davids,5
the MD Anderson Cancer Center,5
UK CLL,5
@DKFZ,5
836826,5
AbbVie Pharmaceuticals,5
1 year,5
Universit√§t zu K√∂ln,5
Info,5
Hematology Review,5
2018;14(2):63‚Äì4,5
LRF,5
British Columbia,5
@UniCologne @LLSusa,5
"Lymphoma Society 
https://t.co/ZTl8OqnlVU",5
idelalisib-rituximab,5
Medifocus Guidebook,5
the era of next,5
Matutes,5
LLS,5
WhatsApp,5
Jonathon Cohen,5
#cancer &,5
TRANSCEND,5
Annual Scientific Day,5
https://t.co/k4dKwtqNDo,5
CA,5
IL-10,5
Poland,5
RNAseq,5
11th,5
5PM,5
#hemonc #,5
Health Canada Approves,5
VEGF,5
Hairy,5
Pneumocystis,5
Adolescents &,5
Young Adults,5
"Jan 12, 2021",5
5:00 PM CET/ 11:00 AM EST,5
MCL1,5
1b/2,5
@waynemedicine,5
84,5
12/16,5
four years,5
34%,5
#MPN,5
7th,5
Lilly Announces Updated Data,5
Andrew Roberts,5
MEI,5
Pinilla-Ibarz,5
#CLL Management,5
O‚ÄôBrien,5
the Phase Ib/II Study,5
#Venetoclax,5
CT,5
Lindsey Roeker,5
the next few months,5
@OHSUSOM,5
POT1,5
Last week,5
this day,5
Dr Neil Love,5
HOVON,5
Wnt5a,5
Lydia Scarfo,5
FNCE,5
ALL,5
2008,5
COMPLEMENT1,5
TBT,5
IPS-E,5
üëã,5
@VJHemOnc,5
decades,5
@UKNEQAS,5
#openaccess #,5
Quality of Life,5
Susan M. O‚ÄôBrien,5
BloodCancers,5
Chemo,5
33%,5
#research #,5
Ed,5
Brazilian,5
GP,5
RNA BM742401,5
Tumor Lysis Syndrome,5
LPL,5
Oct. 10,5
Comparison of Treatment Outcomes,5
noon,5
9/12,5
34,5
52,5
Study,5
California,5
Temadag,5
some #CLL,5
CCR2,5
@WVCancer &,5
Shanafelt,5
TatReserves,5
Front-Line Therapy,5
71,5
Sand Grove Capital Management:,5
PDF,5
GENUINE,5
68-year-old,5
ROR1,5
@Rigshospitalet,5
51%,5
600,5
Ed Bradley,5
TG Therapeutics Announces Final Results,5
@abbvieuk,5
Joshua Brody,5
#RareDiseases #,5
one day,5
TG Therapeutics Announces,5
MedscapeLIVE,5
Postdoc,5
1.0 #CMEcredits,5
CombinationTherapy,5
#Imbruvica,5
1494,5
Cello Health Group,5
International Prognostic Score for Asymptomatic,5
@drjgauthier,5
FT596,5
https://t.co/BiIhiTd9Ib,5
https://t.co/3uwdFT0BlI,5
Americans,5
MYC,5
#patients,5
65 years,5
531,5
The Number of Signaling Pathways Altered,5
cancer &,5
the weekend,5
EAD,5
"more than 20,000",5
#livelive #,5
Great day,5
PBAC,5
#steinberglawgroup #,5
OnkoLogisch,5
BH3,5
Health,5
2024,5
about one-quarter,5
KOLs,5
17p-deletion,5
BET,5
CGT,5
New Data Demonstrate,5
Blood Cancer Journal,5
8:15 AM,5
Steering Committee,5
Routine Clinical Practice,5
70 years,5
0-8,5
Galway,5
#CLL Patient,5
Washington,5
rituximab maintenance,5
CLLuster,5
#CFC,5
Javier Pinilla,5
Natalia Pe√±a,5
Griselda,5
Berlin,5
TG Therapeutics Announces Data Presentations,5
Yakult Honsha Co.,5
CLLPatients,5
StemCells,5
60th,5
Leveraging Next-Generation #BTKInhibitors,5
#PI3K,5
#BCAM #,5
Eichhorst,5
The Importance of Minimal Residual Disease Negativity,5
#LymphomaHub #,5
Brian Parkinson,5
Dublin,5
#CancerTherapy #,5
#HL #,5
Marrow Transplant Research Report,5
the B Cell Receptor Underlies Dysfunctional Signaling,5
#remission #,5
#cancerhumor #,5
al,5
Myeloma 2018,5
August 6,5
11 AM Pacific/2 PM Eastern,5
Ruxience,5
Alemtuzumab,5
TrialTuesday,5
Jacqueline C. Barrientos,5
non-Hodgkin B-cell,5
#immunotherapy #,5
150,5
DUO,5
Westwood,5
Azithromycin Resistance,5
Pharmaceutical,5
#frontline #,5
Damia,5
#cll  ,5
2 #,5
Massachusetts General Hospital,5
Dana-Farber,5
#blooducation #,5
about #CLL #,5
@DrMatasar @anthonymatomd,5
"VivaLaBotch

#",5
50 years old,5
Lisa Henley-Durcan,5
Lisa &gt,5
#bonemarrowtransplant #,5
#stemcelltransplant #,5
Venclexta Plus Gazyva for Previously Untreated Chronic,5
Oregon,5
Read &,5
Emma,5
Roche‚Äôs,5
Jordan Gauthier,5
@MDAndersonNews #leusm #,5
congress,5
Venetoclax-rituximab,5
First Non-Chemotherapy Combination Regimen for Treatment-Na√Øve Patients,5
2007,5
the past month,5
Analysis of &gt;100 primary,5
Differentiation,5
Jose Martin-Subero,5
Response and Resistance,5
Joseph Melenhorst,5
2016-2026,5
2b,5
12/4/18,5
7:30-9:15a,5
up to Seven Years,5
DrBrown #DrBurger,5
Enhancer Architecture,5
#ASH18 üá∫,5
Saar Gill,5
David Porter,5
@MattKalaycioMD,5
David,5
@APHP,5
weekend,5
#AbbVie #,5
TNF,5
Larry Saltzman,5
Mark Scott,5
#BCL2 #,5
#hemonc #hemeonc #,5
#relapsed/#refractory #,5
7/23,5
#support #,5
MorphoSys Presents Clinical Data,5
#friends #,5
Kathleen D. Hoffman,5
John F. Seymour,5
Hematogenix Laboratory Services,5
#Wrestlemania #WWE #NEWORLEANS #,5
Mother's Day,5
–õ–µ—á–µ–Ω–∏–µ–≤–ò–∑—Ä–∞–∏–ª–µ,5
Mantle Cell Lymphoma Misdiagnosed,5
https://t.co/1bDN7LP6WJ,5
#running,5
Current Approaches to Diagnosis and Risk Stratification,5
Akt,5
Repost,5
CLL @MDAndersonNews,5
UKGov,5
bloodcancer &,5
Boxer,5
Campaigns,5
Susan Ash-Lee,5
#HiddenCancer #,5
#MP &,5
83 Percent,5
1 hour,5
60-second,5
GCLLSG16,5
Turtle,5
Ian Pollard,5
#PowerfulPatient #,5
Read more&gt;&gt,5
#Liverpool #,5
Leclair,5
Month 6,5
EHA22,5
#ICML2017 #,5
The Largest International Assembly,5
Kicks Off,5
mantle cell,5
30+ yrs,5
The Association of Dyslipidemia With Chronic Lymphocytic Leukemia,5
Checkpoint Inhibitors,5
Franco Cavalli,5
Southampton,5
TG-1101,5
#chlorambucil,5
July 2016,5
https://t.co/h81Jh8XJl5,5
BeiGene Presents Updated Clinical Data,5
Karen,5
H2,5
January 30,5
MPLN,5
#LlavaTeam #,5
CPT,5
2016 to 2022,5
#soho_2016 #,5
2016 to,5
HealthcareMarketing,5
GAV,5
#PPLC16 #,5
Cancer Genetics,5
@WeillCornell #CLL #,5
Bendamustine &,5
Estrov,5
#TeamDiabetesCDA #,5
Frontline Imbruvica Improves Survival,5
https://t.co/854SswrFIA,5
#KnowledgeIsBestRx @MDAndersonNews,5
IPH2201,5
Interphase Cytogenetics,5
Iowa,5
Companies &,5
1987,5
limfocytarna limfocytowa - nowo≈õci w leczeniu,5
16097,5
About 10 percent,5
Advance of the Year,5
#Gazyva sBLA,5
Data Demonstrates Efficacy in Previously Untreated,5
Marc Auckland,4
LYMSM,4
Amgen Inc.,4
$AZN $JNJ $,4
CALQUENCE Met Primary Efficacy Endpoint,4
LLY,4
NEW YORK,4
Studiendaten,4
CADTH,4
obinutuzumab/chlorambucil,4
Oncology,4
solidarity,4
World Health Organization,4
Day 3,4
the Treatment of Relapsed or,4
52%,4
#AI #,4
Jim,4
https://t.co/8JwlIjSHTd,4
Biotech,4
#comitatoimalatiinvisibili #,4
Terapia,4
11%,4
1/3,4
#CLL #Ibrutinib #,4
WHO Solidarity,4
Oct 21,4
11/2020,4
Healthy Subjects,4
BTKÈòªÂÆ≥Ëñ¨acalabrutinib„ÅåCLL/SLL„ÇíÂØæË±°„Å´Áî≥Ë´ã,4
@CRCTU,4
Michael Wang,4
bloodcancerawarenessmonth,4
Steve Coutre,4
https://t.co/pDysrG92ZC,4
dem,4
AstraZeneca Calquence,4
acalabrutinib &,4
#caxtx,4
EHA25,4
Without Obinutuzumab vs Chlorambucil/Obinutuzumab,4
Ruxolitinib,4
Alan Skarbnik,4
48%,4
Response,4
vakalarƒ±nda potansiyel,4
Han,4
53,4
48,4
EAMS,4
üòÜ,4
#BTK,4
SLE,4
Cancer Institute,4
peor de la enfermedad,4
May 31,4
PO,4
EPS,4
AstraZeneca Announces,4
15%,4
the U.S. FDA,4
EFS,4
fda,4
#Pharma #,4
Netherlands,4
TODAY,4
Ohio State,4
the coming days,4
Corona,4
Kinase Inhibitors,4
acala,4
PancreaticCancer,4
#mclsm #,4
@Bannermdandersn,4
obinutuzumab + chlorambucil,4
94%,4
#PubMed #,4
#obinutuzumab #,4
ArQule,4
47%,4
Clinical News,4
Bruce Cheson,4
ASH2019,4
Session 642,4
Fda,4
Horizon,4
the U.S. Food and Drug Administration,4
ü§£,4
@hemonctoday,4
Five-year,4
44%,4
Acalabrutinib Key Clinical Data,4
ACP-319,4
last month,4
nonHodgkin,4
P. Ghia,4
SoC,4
#EHA24,4
CLL Study,4
RS,4
RareDisease,4
#ASH #,4
OncoEmatologia,4
idelalisib,4
ASH18,4
B-Cell Malignancies,4
#MantleCell #,4
Brian T. Hill,4
üëë,4
Ryan W. Jacobs,4
#MantleCellLymphoma #MCL #,4
LOXO,4
14022018,4
Jerry,4
Versus Ibrutinib,4
ÈòøÂèØÊõøÂ∞º,4
Owen O'Connor,4
#ASH17 Oral,4
pat,4
28%,4
#genomics,4
Biologics,4
Avella,4
#ssbmt #,4
5 #,4
WuXiAppTec,4
@MDLinx,4
Clock,4
Another day,4
Pharma Giant AstraZeneca PLC,4
two days,4
Comparison,4
Ibrutinib-Intolerant CLL,4
SLL #,4
AstraZeneca Early Data Demonstrate Clinical Activity of Acalabrutinib,4
32%,4
#USAN #,4
#CLL #MCL #,4
recomienda Acalabrutinib,4
su designaci√≥n,4
"Venetoclax, Acalabrutinib Active",4
55%,4
MSN,4
APRN,4
#FL #,4
PROFILES,4
at least 2,4
SuppOnc,4
Second-Generation Selective Covalent Inhibitor,4
Listen &,4
BRUIN,4
481,4
CLL Research,4
Tissue,4
Oncology &,4
#clinicaltrials &,4
Greece,4
Norway,4
CMO,4
GI,4
ActiveMonitoring,4
Coevolution of Leukemia and Host Immune Cells,4
Ublituximab + Ibrutinib,4
#„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„Éñ #,4
63,4
David Ozor,4
5 Million,4
Treatment Type,4
1 week,4
CRISPR,4
125,4
BigData,4
the US Veterans Health Administration System,4
Danish,4
Sharon,4
BloodCancerAwareness,4
This year,4
https://t.co/bilFPSiimI,4
CACHE EYE,4
#reading,4
Optimal,4
MYD88,4
#TrialUpdate #,4
Thousands,4
Hematological Malignancies,4
MD &gt;&gt,4
Colorado,4
annually,4
#Ibrutinib plus,4
#cart,4
LGL,4
#ASH2020 Update,4
750,4
CTsm,4
Riabni,4
DelveInsight,4
3 months,4
Fixed-Duration Imbruvica-Venclexta Combo,4
Mabtas,4
Israel,4
John M. Burke &,4
ASHKudos,4
Loxo Oncology,4
SMC,4
BC,4
@TGTherapeutics,4
46%,4
NA,4
BeiGene Announces Data,4
BGNE BeiGene Announces Data,4
15s,4
SEQUOIA,4
Weirda,4
Phil Thompson,4
Novel Agents,4
HodgkinLymphom,4
Anmeldung,4
#SOHO2020 #,4
seven,4
Mass Cytometry: Application,4
5 year,4
Join Drs,4
@ClevelandClinic &,4
@CIBERONC,4
#publiHUCA #,4
Jeff Folloder,4
Hoffman,4
Silvia Deaglio,4
Norwegian,4
6q,4
Dec. 4,4
https://t.co/X5KZjUZQtl,4
REGISTER,4
Vietnam,4
Modulates,4
Signaling,4
Targeting TRAF4,4
PR,4
FCR #,4
SVP,4
Freda Stevenson,4
"176,200",4
https://t.co/IZP0myDLnZ,4
18F,4
#mantlecelllymphoma and,4
Diagnostic,4
@NormaFoleyTD1,4
CXCL13,4
Mantle Cell #Lymphoma,4
#hematology #,4
the #,4
UK &,4
Robin Katz,4
Pulmonary,4
Seema A. Bhat,4
this weeks,4
Ulrich J√§ger,4
Ibrutix,4
Schongewusst,4
kurz #CLL,4
Four-Year,4
10am,4
EOT,4
SWOT Analysis,4
@muni_cz,4
Tom Henry,4
Chornobyl,4
Virtual Support Group,4
@JackMAiello @LLSusa,4
Leukemia Patients https://t.co/phmGGEIsEa,4
#imbruvica #,4
212Pb-NNV003,4
Andrew Evens,4
@SidYadavMD,4
Chaudhry,4
1991,4
1.25,4
Chronic Lymphocytic Leukemia &,4
Moreno,4
CDT,4
Roger Strair,4
BCAM,4
every year,4
DM,4
AML &,4
#ublituximab,4
#trademarks,4
https://t.co/0USWqp3C8I,4
"September 6th, 2020",4
McRaven,4
Ian W Flinn,4
IND,4
@SeattleCCA &,4
T&amp;C,4
https://t.co/erfwLzfKU4,4
Cello Health PLC:,4
Technological Innovation,4
Hoffmann-La Roche Ltd.,4
Teva Pharmaceutical Industries Ltd.,4
Johnson Services ‚Äì,4
Medic Report,4
ALS,4
#idelalisib #,4
#obinutuzumab + #,4
REVIEW,4
3/4,4
7/22,4
MCL-1,4
Pneumonia,4
"https://t.co/doxJ4fltQN
#",4
HLA,4
Rajat Bannerji,4
Polish,4
Expansion Breakout,4
43%,4
9th,4
Lynn,4
Adverse Events,4
Prof Gribben,4
#Hematology #,4
the Era of Next Generation Sequencing,4
60 Minutes,4
AI,4
Clinical Kidney Journal,4
Skarbnik,4
3 years ago,4
Cello,4
Cello Signal,4
#imbruvica,4
https://t.co/DsU5Lhmg3L,4
RAS-BRAF-MAPK-ERK,4
Spartans,4
Xerxes,4
1B,4
Cationic,4
ClL,4
plus rituximab,4
#pharmacy #,4
May 2,4
a few days,4
Ofatumumab/Lenalidomide,4
The Connect CLL Registry,4
Pfizer,4
Elderly,4
Korean,4
#bioRxiv,4
2/2,4
April 27th,4
Ritux,4
NFL,4
Forecasts,4
https://t.co/7IAZR25b6M @TNOncology,4
#UK #,4
HighRiskCovid19,4
Brad S. Kahl,4
"over 35,000",4
#Agenparl #,4
Key Players,4
Copenhagen,4
Karina,4
Michael,4
CancerSurvivor,4
freedomdevice,4
Informationen,4
#LUCHAlibreChilena #ElMejorBotazoDeChile #,4
#wrestler #,4
Haploidentical Blood,4
Bien,4
notre article,4
#Salute #,4
SocialNetwork,4
#CLL Research,4
#monsanto,4
IPI,4
Hematuria,4
the Chronic Lymphocytic Leukemia,4
#wrestler#wrestling #,4
Adequate Activating Signaling,4
Ohio,4
@ZPWLC,4
four-year,4
MN,4
Kahl,4
Deletion 17p,4
@AbdelWahablab,4
$TGTX $,4
ANP-BC,4
Trabectedin,4
@AmericanCancer,4
"20,940",4
Expert,4
Anna DeVeaux,4
"https://t.co/wfbRZOFthA

#",4
Anderson Cancer Center,4
CFDT,4
CFTC,4
77%,4
Stephanie Lacoste,4
642,4
4 #CLL,4
#education,4
NitinJainMD,4
1/4,4
0-2,4
Nairelis Guti√©rrez,4
"Karina Vega ‚öΩ

",4
Genome Discovery,4
F. Hoffman-La Roche,4
ClinicalUpdates,4
Oslo,4
December 6,4
T√©l√©chargez,4
#leuc√©mie #,4
12/2019,4
SP VS,4
#G4M,4
Droplet Digital PCR,4
Oncologists,4
PCR,4
#bmtsm,4
1799,4
AskAlex,4
PrecisionOncology,4
Alex Rolland,4
#CLLHZ19,4
HemOnc Times,4
Monsanto,4
Lenalidomide Restore NK Cell Function,4
about our #,4
Relapsed/ Refractory B-cell,4
#ClinicalResearch #,4
iwcll2019 Edinburgh,4
Torneo clausura - 6ta,4
DvoSantani,4
#CLLHZ19 #,4
Personalized Management,4
2e,4
Paradigm Shift,4
HDAC6,4
about #cll,4
Backyard Roundup Use,4
1996,4
SAT 9/14 Session XIII,4
PhysRelations,4
#Brno #,4
Sept 17th,4
more than 500,4
#career #,4
Outcomes,4
@WeillCornell &,4
PatientEducation,4
#PatientCare #,4
Natalia,4
https://t.co/GUe9czEdfK,4
Denise,4
üòî,4
2 days,4
Ibrutinib + Rituximab,4
#Press,4
Sept (Edinburg,4
Italian,4
‚û°Ô∏è https://t.co/6FlZvW1kFX,4
this September,4
Turkey,4
BriefedUp - UK Stock Market News,4
https://t.co/Y9vWeE7kra,4
Without Idelalisib Followed,4
Bearish Engulfing,4
Entstehung,4
#15ICML #,4
KI,4
#VamosGUMA #,4
LA Sutton,4
Maloney,4
Prof Hallek,4
miR-15a,4
miR-16-1,4
#fatigue #,4
CNSmasterclass,4
Presents Data,4
Venetoclax Chemotherapy-Free Combination Regimen,4
Flinn,4
61%,4
3 year,4
‚ö™‚ö´ https://t.co/F3gfK5ZWIn,4
S2E05,4
Mass.,4
302,4
Venclexta-Gazyva,4
$ABBV FDA,4
Kari Vega,4
a decade,4
OLIMPIA VS #,4
May 1,4
QOL,4
#prowrestling,4
RBC,4
Gnocchi,4
Idela,4
Antigen Drive,4
@UCSDHealth &,4
2.2019,4
Leukemia2019,4
Clonal Relatedness,4
IBB,4
@ZuckerSoM @CllSociety #,4
#Crypto #,4
CellularTherapy,4
neceista la ayuda,4
Jonathan Cohen,4
Centre,4
#mondaymotivation #,4
Worry,4
Andrew Brunner,4
the Center for Leukemia,4
1968,4
IMBRUVICA(R,4
#luchalibrechile #,4
Facebook Live,4
CYC065,4
CLL Reference EpiGenome,4
DrBrown,4
Clinical Trend,4
2003,4
Jennifer,4
SickleCell,4
LBA-4,4
@eaonc E1912 - Shanafelt,4
Prof Seymour,4
#realestate #,4
the age of 60,4
Combination of Lenalidomide &,4
Mutated IGHV &,4
Daniel Catovsky,4
Small Lymphocytic #,4
the University of Texas,4
Rick Furman,4
#CDDFworkshop #,4
$ROG $,4
progression &,4
Patrick Thornton,4
#ECM,4
INFI,4
at least two,4
3pm ET,4
12 pm,4
https://t.co/0oWf5Xg5S3 &,4
#g2mdripfeed #,4
https://t.co/Ev1xS6K1QB #leusm #,4
IDonc,4
the last day,4
Sept. 22,4
Prague,4
MPNCLL18,4
7 #,4
MYELOMA,4
Christopher Fox,4
#laboratory #,4
Dr Mato,4
@NHSEngland,4
https://t.co/X94xXwJIbH #,4
#ibrutinib #idelalisib,4
IgLV3-21,4
"#AllStarWeekend

",4
LuchaLibre,4
@cardinalhealth &,4
CheckOrphan,4
"June 3, 2018",4
78-year-old,4
75-year-old,4
NewWork,4
Follicular Lymphoma Opportunity,4
Verastem Oncology Reports,4
#luchalibre #,4
621,4
Predicting Mechanisms of Ibrutinib-Resistance,4
#charity,4
Obinutuzumab &,4
Help Tess,4
#erc20 #,4
Health Canada Approves RITUXAN,4
#ChronicLymphocyticLeukemia #leusm #,4
Social Studies,4
Daratumumab and Ibrutinib in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia,4
#CLLsm #leusm #hemeonc #,4
Less Effective #,4
Promise,4
#devops,4
Thurs,4
3/15,4
IWC,4
#germancheerdad #,4
Bloodcancer,4
WeCanICan,4
PLoSOne,4
CD44v6,4
#ibrutinib @BloodJournal,4
#charity #boost4charity #London #,4
Westminster,4
Oceans,4
#EHA2017,4
Christopher Oakes,4
CTL019,4
Aliki Xochelli,4
https://t.co/mhzeGaRTj4,4
Ulrich Jager,4
#flashbackfridays,4
EHA17,4
Dr Furman,4
315,4
Chronic Lymphocytic Leukemia Treatment Options,4
USD,4
Two #CLL Couples,4
CLLOrigenes,4
31072017,4
#CLL Retreatment,4
23 September,4
RockyMountainCancerCenters,4
10072017,4
Lymphocyte &,4
LaVerne,4
Dr O'Brien,4
Feinstein Institute Scientist Recognized,4
30052017,4
france,4
@unimelb &,4
Roundup &,4
31052017,4
#VamosLuciano #,4
Personalized Cell Therapy Combined with Ibrutinib,4
New Data Presented,4
ASCO 2017,4
Finds IMBRUVICA¬Æ,4
PennMedicine,4
TG Therapeutics Announces Positive Data,4
HomoloGene,4
Homininae,4
CLLU1,4
#ASCO17,4
Ibrutinib Achieves Complete Remission,4
lucha,4
Michele Nadeem-Baker's,4
Significant Comorbid,4
#iwcll2017 #,4
Cameron Turtle,4
#BGSConf,4
#lra #,4
@ChelseaFC,4
Leukemia Market,4
#NAGERO5taRegi√≥n #,4
Choice &,4
Idelalisib Plus Ofatumumab,4
15 March,4
Adding Idelalisib,4
Topline Data,4
DanaFarber,4
"#BioAsia2017
",4
PharmaCity,4
SurbhanaJurong,4
ABT,4
@BurrisSkip,4
the Era of Oral Targeted Therapies,4
TGR1202,4
Spleen Tyrosine Kinase,4
Signal Transduction Pathway,4
https://t.co/8kseO5CTrW,4
OA,4
prostate &amp,4
#chileluchalibre,4
Jasmin Bahlo,4
Management of Chronic Lymphocytic Leukemia,4
New Agents to Treat Chronic Lymphocytic Leukemia,4
CARE,4
PPLC16,4
Hexa #,4
#getleads #,4
ASH2014:,4
130,4
CHC2016,4
Jennifer Abraham,4
#JLL #,4
Hawaii,4
Dr Eichhorst,4
Success,4
Chronische,4
Onclive,4
Function,4
Dr Gribben,4
#LaCr√≠ticaDelAmor #,4
#EHA16,4
#EHA2016,4
an Effective Target,4
101 Chronic,4
Open Day,4
#AskTheDoctor,4
Leukemia https://t.co/7m16Q0gmAk #,4
Jorge Cortes,4
European Regulators Accept Applications,4
New Drug Approvals Bring Hope,4
PM,4
#ASH15 https://t.co/2MFGNZUrs2,4
360WiseNews,4
CAL-101,4
Infinity Announces Completion Of Target Enrollment,4
Adap,4
EntrepreneurMindset,4
"DRIVER

Salary - 1850 + 250 + OT

INTARVIEW AUG'",4
"4TH

#",4
0766805908,4
Kiko,4
706,4
Blood Test Results,4
#caturlifelive #,4
the Best Care and Support,4
Richter's Transformation After Transplantation Failure,4
#uniofyork #,4
ZYDELIG,4
Treats Cancer,4
Follicular B-Cell,4
SAR245408/XL147,4
Agonist,4
Splenomegaly,4
Sandra Smith,4
Sanlam Securities,4
Single Cell Network Profiling S,4
Practica,4
#Basquet #,4
#Practica #,4
#construction #,4
Pirtobrutinib,3
KTE,3
nella,3
Three years,3
BrainSights,3
2L,3
das,3
refrattaria,3
Durvalumab,3
Comparing,3
@CALQUENCE,3
#biotech #lifesciences #,3
Uni√≥n Europea,3
@AstraZeneca,3
Day 2,3
Ô∏é,3
»òPƒøI“¨≈ö FINŒõNCIŒõL,3
BTKis,3
DOH,3
Pembrolizumab Plus Acalabrutinib,3
Zulassung,3
2PM,3
Oncology News,3
Coronavirus Study,3
AstraZenca,3
CALAVI Phase II,3
#BayArea #,3
El f√°rmaco,3
AstraZeneca Plc,3
#comitatoimionlus #,3
#ChronicLymphocyticLeukaemia $,3
pembrolizumab vs pembrolizumab &,3
UroToday &gt,3
@AmericanCancer @TiansterZhang @MRHarrisonMD,3
nuova,3
CCL,3
the World Health Organization,3
@LLSusa &,3
Read,3
ETHealthworld,3
Medscape Hematology-Oncology,3
a Systematic Review,3
Proton Pump Inhibitor,3
@OncNursingNews,3
#leukemiamarket #,3
11/16,3
Condition Summary: Lymphoma,3
IL-6,3
IL-1,3
Maintenance rituximab,3
LLC,3
@SarahCannonDocs,3
Condition Summary:,3
Louis Staudt,3
AACRcovid,3
BID,3
#Calquence #,3
9%,3
Examine Acalabrutinib,3
"April 15, 2020",3
Matthew Fowler,3
#CCC19 #2019nCoV #,3
NCT04346199,3
Prof Paolo Ghia,3
New Drug,3
provoca la propagaci√≥n de la Covid-19,3
Especialistas,3
los,3
el Per√∫,3
Lymsm #,3
del trabajo,3
#BTKinhibitor #,3
4/8,3
Ma√±ana,3
US Oncology Research,3
Novo Nordisk‚Äôs Rybelsus,3
HealthDay,3
Nuovi,3
che un,3
ben tollerato ed efficace,3
nella terapia del,3
U,3
ScienceMagazine,3
COVI,3
m√°s graves de la #,3
la reacci√≥n hiperinflamatoria,3
UCI,3
salute,3
probaron con,3
Ahora,3
EEUU,3
un f√°rmaco usado,3
#Science #,3
the National Cancer Institute,3
MedNews,3
#coronavirus,3
PST,3
BTK-Inhibitor,3
2/8,3
PCT,3
Calquence de AstraZeneca,3
PhII,3
#SARS_CoV_2 #,3
Leslie,3
zero,3
@FiercePharma,3
#BTK #,3
œÑŒ± œÄœÅœéœÑŒ± Œ¥ŒµŒ¥ŒøŒºŒ≠ŒΩŒ± Œ±œÄœå œÑŒ∑ œáœÅŒÆœÉŒ∑,3
Astra Zenecas,3
almost half,3
#lifesciences #,3
CV UPDATE,3
6%,3
Astra,3
FTSE,3
#US #,3
Acalabrutinib &,3
the Phase 3,3
DCGI,3
Ryan,3
Oncology Learning Network,3
OhioState,3
last month's,3
@TheLancetHaem,3
Waldenstr√∂m‚Äôs,3
"20,000",3
71%,3
42-month,3
mejora la supervivencia libre de progresi√≥n,3
Calquence Steps Up,3
First-Line CLL,3
Merck,3
#News #,3
#Research #,3
CLLpatients,3
BTK C481S,3
Amgen,3
Benjamin Lampson,3
TN CLL,3
@anthonymatomd of @sloan_kettering,3
US Food and Drug Administration,3
Givlaari,3
#lylcl #,3
ECM,3
#–Ω–æ–≤–æ—Å—Ç–∏ #,3
#HematologyConferences #,3
USFDA,3
"Calquence, GLYC's",3
FYI,3
#acalabrutinib,3
98%,3
Indirect Comparisons,3
004,3
#mcl,3
DS-8201,3
Keytruda,3
@UCLAJCCC,3
Bruton‚Äôs Tyrosine Kinase,3
85%,3
https://t.co/Kni0UJD0Np,3
LeucemiaLinfociticaRecurrente,3
ICML19,3
Toronto,3
anticanc√©reux acalabrutinib,3
The ASCO Post,3
migliora il,3
idela,3
#Business #,3
#ChronicLymphocyticLeukaemia #,3
12-month,3
23%,3
the Time Patients Lived,3
@UofCalifornia,3
ACALABRUTINIB,3
#CI #,3
over 90%,3
#ASH18 @ASH_hematology,3
LymphoidNeoplasia,3
#ÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ #,3
76%,3
1y,3
Leuk√§mie-Studie,3
Bijal D. Shah,3
#Moffitt #,3
Perth,3
Novit√†,3
#leusm https://t.co/LA3kiEgLMk,3
novo,3
j√° tenham,3
October 2017,3
https://t.co/1wik5C1ZVm,3
Macroglobulinemia,3
the Efficacy of Ibrutinib and Acalabrutinib in Patients With,3
aprobaci√≥n de la FDA,3
Jia Ruan,3
7501,3
Ryan Jacobs,3
#btk,3
Discusses Acalabrutinib,3
AstraZeneca Reports Boost In,3
4 percent,3
the fourth quarter,3
$5.49 billion,3
#MantleCellLymphoma,3
Wang et al - acalabrutinib,3
CRR,3
12mo,3
@EFPIA,3
3 #,3
#malaysia #,3
#Treatment #,3
ASH2017,3
Drugs &,3
Cheson,3
155,3
Highlight Its Commitment to Blood Cancers,3
American Society of Hematology Annual Meeting,3
https://t.co/25kaG0uyEY,3
US FDA Approves,3
https://t.co/nHmUjMiC5A,3
https://t.co,3
#retweet #,3
#Mantle #Cell #,3
Previously-Treated Mantle Cell Lymphoma,3
rel/ref #,3
Order at Biologics I,3
#bigpharma #,3
"#Calquence*),new #",3
#pharmacy,3
AstraZeneca Pharmaceuticals,3
MRK,3
„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆACALABRUTINIB„ÄÅÁ±≥ÂõΩÈ£üÂìÅÂåªËñ¨ÂìÅÂ±ÄÔºàFDAÔºâ„ÅåÊâøË™çÁî≥Ë´ã„ÇíÂèóÁêÜ„ÄÅÂÑ™ÂÖàÂØ©Êüª„Å´ÊåáÂÆö,3
Earlier this week,3
„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆACALABRUTINIB„ÄÅ„Éû„É≥„Éà„É´Á¥∞ËÉû„É™„É≥„ÉëËÖ´Ê≤ªÁôÇËñ¨„Å®„Åó„Å¶Á±≥ÂõΩÈ£üÂìÅÂåªËñ¨ÂìÅÂ±ÄÔºàFDAÔºâ„Çà„ÇäÁîªÊúüÁöÑÊ≤ªÁôÇËñ¨„Å´ÊåáÂÆö,3
#biotech,3
linf√°tica cr√≥nica,3
Q3,3
#clinical #,3
recomendado,3
NewsCancer,3
https://t.co/FFuSMABt49,3
Acerta Pharma's,3
ACP196,3
Shows Efficacy,3
cont,3
Harry Potter,3
61,3
only one,3
#Relapsed #,3
pati,3
Jennifer Boyer,3
COVIDvaccine,3
79%,3
#iwCLL2021,3
medicare,3
EOMES,3
RCC,3
@Haematologica,3
the Functional Assessment of Chronic Illness Therapy-Fatigue,3
Vit D insufficiency &amp,3
"3, 2010]",3
#CLLsm #leusm,3
Gleevec,3
Danielle Roberts,3
FLAIR,3
CXCR7,3
Carlo Moreno,3
el equipo,3
#LacasaLitner #,3
https://t.co/4ORpORcPAU,3
#lymsm #CLL,3
@clonoSEQ,3
BTK Inhibitor,3
Randomized Controlled Trials,3
Leukaemia Care,3
Amjad Hayat,3
Richter‚Äôs Syndrome,3
winter,3
The University of Iowa/Mayo Clinic,3
Dr Brown,3
68,3
#celltherapy,3
the Tumor Microenvironment: What Do We Need to Consider When Treating Chronic Lymphocytic,3
Challenges,3
one year,3
PTCL,3
IKAROS,3
76,3
AFib,3
CMS,3
Florida Cancer Specialists &,3
The Lancet Haematology,3
PAX5,3
Richard Rosenquist Brandell,3
Chemotherapy &,3
TN Patients With CLL Undetectable Minimal Residual Disease,3
doc,3
@MicheleNadeemB,3
CDK9,3
Laura,3
Bruton Tyrosine Kinase Inhibitor,3
Lymphocyte,3
2 pm ET,3
IG,3
#PrecisionMedicine #,3
Sweden,3
Crohn,3
Roundup¬Æ,3
30s,3
#melanoma,3
#CLLSociety #,3
@unibirmingham,3
#IAmAndIWill #,3
Rockefeller University Press,3
Lymphocytosis,3
Haematologica #,3
Call Office of Patient Recruitment,3
Lymphoma Society Universit√§t zu K√∂ln The Leukemia &,3
Six,3
millions,3
Leukemia B Cells,3
72-year-old,3
17pdeletion,3
BTEC CPLD,3
170,3
2030,3
new &,3
CLL Society‚Äôs,3
Steve Martin,3
PatientExperience,3
@UWMedicine,3
Blanca Espinet,3
8 am CST,3
"Lymphoma Society 
AbbVie",3
#iwCLL2021 #,3
"27, 2020] @LRoekerMD et al",3
Checkpoint Blockade,3
Jay Blatt,3
Zusatznutzen,3
2-[18F]-FDG PET,3
Meeting &,3
ROS,3
Fixed-Duration Ibrutinib-Venetoclax,3
https://t.co/dpg3RKudEk,3
medtwitter,3
Vaccines,3
Sara Tinsley,3
Moffitt Cancer Center,3
Norah,3
Stacey Gray,3
John G. Gribben,3
XPO1,3
SOC,3
Novel Agents Could Chemoimmunotherapy,3
6610,3
1-year,3
DSc,3
Aggressive Progression,3
JLB,3
#Bcell #,3
Subcutaneous Masses,3
Unusual Manifestation of Relapse,3
26%,3
frailty,3
77,3
Key #,3
Stefano Molica,3
3-4,3
Chl,3
Jennifer Crombie,3
Leukemia/Small Lymphocytic #,3
#CLL #leusm,3
@WeiDing3,3
Richter's Transformation,3
Every day,3
Day 1,3
ITT,3
74%,3
Algorithm,3
Murano,3
CK,3
Ven,3
five-year,3
$ABBV #,3
1:1,3
12:30 PM ET,3
BeiGene,3
MDAnderson,3
the New Era,3
Treatment-Na√Øve,3
18%,3
16%,3
#CCO #,3
"@LLSusa
https://t.co/Go2BZDQP8i",3
Bob,3
GIBB,3
Neil Love,3
Mike,3
Peer Perspective,3
"15,000",3
B Cell Malignancies,3
Oppezzo,3
GenQA,3
Ennio,3
Merkel Cell Carcinoma,3
Alexey V. Danilov,3
Robin Weinick,3
November 10,3
Serum,3
postdoc,3
94,3
Umbralisib Plus Ublituximab,3
Hill,3
Miami,3
Venetoclax Plus,3
Beg√ºm Alankus,3
J√ºrgen Ruland,3
#leukemias #,3
10 minutes,3
@sloan_kettering,3
A Case Report,3
#CLL #MM #,3
DNAmethylation,3
PIM,3
OncoAlert Prognostic,3
ANP-C,3
WeChat &,3
age 40,3
VirtualHem2020,3
#targetedtherapy #,3
#clinicalperspectives,3
#exhibitions #,3
Annals of Oncology,3
LyLe,3
ER,3
#watchandwait,3
John Allan‚Äôs,3
Peer Exchange,3
Health Care Resource Utilization,3
#sequencing #,3
the past 5 years,3
Khan,3
https://t.co/SsdSY4ShkK #leusm #,3
SCIENTIFIC RATIONALE FOR LOWER DOSE OF,3
Clinical Advances in,3
#Hematolog√≠a #,3
Pete,3
CLL Treatments,3
Richter‚Äôs Transformation,3
Sportskred,3
≈†√°rka Posp√≠≈°ilov√°,3
RichterTransformation,3
the ERIC 2020 Virtual Meeting,3
next Tuesday's,3
96%,3
de novo,3
the U.S.,3
#BloodCancerAwareness Month,3
Speaking Out,3
"60,300",3
"4,510",3
the 2018,3
Sloan Kettering,3
Buenos Aires,3
56,3
@pbachi,3
Earlier this year,3
T-Cell Dynamics,3
Deborah,3
CLL Campus,3
#trademark,3
World Lymphoma Awareness Day,3
1988,3
@IMBRUVICAUSHCP,3
Clinical Trials,3
2y,3
CLL Care,3
Predictive Molecular Biomarkers,3
#Ascentage #,3
Sept. 9,3
HPV,3
Month,3
European Commission,3
#blood #,3
V√©ronique Leblond,3
next week's,3
Assess MRD,3
MEDICARE,3
POOR &,3
Courtney DiNardo,3
Scott,3
#EducatedPatient webinar,3
WBW,3
Allo,3
#HemeOnc #,3
FDA Clears,3
Jason Butler,3
Unity,3
Chair,3
9/11,3
Is It Time to Treat Your CLL,3
https://t.co/NGhv2u1qiV #,3
79-year-old,3
https://t.co/hqvU35f2vq #,3
109,3
PTCMA Virtual,3
August 2020,3
#BloodCancers #,3
six,3
@NEJM #,3
#lenalidomide,3
Expectations,3
BreastCancer,3
#Leusm @OncoAlert,3
Jenn,3
Comparison of Access to Novel Drugs for Lymphoma,3
MILLENNIUM PARTNERS,3
approximately one third,3
Jacob Soumerai,3
#obinutuzumab in,3
@RWJbarnabas,3
@VerastemOncolog,3
PI3KŒ¥/CK1Œµ,3
Treg,3
Aquatechnics,3
JAK2 Inhibitor Therapy,3
#CMCX #,3
6 month,3
1/1b,3
July 13,3
Seth Cohen &,3
Robert Grossman,3
#idelalisib &,3
59,3
Virtual,3
Mum,3
Montserrat,3
#venetoclax &,3
Only 2 weeks,3
New 52,3
Cirmtuzumab ROR1 Antibody for Treatment of Mantle Cell Lymphoma,3
Helen Knight,3
6/29,3
Chroniclymphocyticleukemia,3
SNSS,3
#DNAsequencing #,3
ALC,3
NOTCH,3
Shadman,3
Costs Among Commercially Insured,3
128,3
cirmtuzumab,3
PF-Fund,3
@CEITEC_Brno,3
#IOM #,3
BeiGene Announces,3
#CLL @BloodJournal,3
months,3
üí•,3
Mitochondrial Genome-Derived,3
Oncogene,3
Covid_19,3
CLL Update,3
#CART,3
#leukemie,3
123,3
IB,3
"Jan 17, 2020]",3
Jennie Crews,3
#fun #,3
wanna,3
$CELG Phase,3
16.69,3
Tennessee Oncology,3
#MZL #,3
Paul,3
Jackie Broadway,3
Estamos,3
#Genmab #,3
Megakaryocytic,3
the Acute Phase of Chronic,3
Lymphoid Malignancies,3
1.50,3
the U.S. #FDA,3
"April 21, 2020",3
#ibrutinib +,3
@JADPRO,3
Profiling and,3
@RoswellPark,3
1995 to 2017,3
Duvelisib Promising,3
AsktheExpert,3
#19-C-0024,3
"over 40,000",3
#stocks #,3
73,3
Chase,3
8th,3
the 1st,3
#oa #,3
#coquitlamlittleleague #,3
BSI Connected Learning Live,3
Last day,3
Nature Communications,3
#CLL14 #,3
Precision Medicine Management of,3
AbbVie News Center,3
Medical Independent Sales Representatives,3
Medical Distributors,3
#relapse #,3
#payasos,3
#Clown #,3
Lincoln,3
https://t.co/3Eo7wJgaeF,3
IL-27,3
TN - Attend,3
#fundraising,3
the Era of Targeted Therapies,3
Lymphoma Coalition Global Patient Survey,3
9 years ago,3
Israeli,3
VigiBase,3
@wwierda of,3
Leukemia Non-Hodgkin,3
SMYD3,3
Hematologist-Oncologist,3
Lymphoma Department,3
John Theurer Cancer Center,3
Hackensack Meridian Health,3
December 2019,3
Complex Karyotype,3
the Polish Lymphoma Research Group,3
Charles Berry,3
Geriatric Clinic,3
#Glasgow #,3
Jitka Malƒç√≠kov√°,3
ProstateCancer,3
HME,3
#bayer #,3
#leukemia #nhl #,3
#thesteinberglawgroup,3
2000,3
Blossom,3
March 1st,3
#venetoclax plus,3
the American Society Hematology,3
CeMM,3
Hofland T,3
#glyphosate,3
MachineLearning,3
5hmc,3
@Patients_Videos,3
#phdlife #,3
Liver,3
OGT,3
#sequencing,3
New Treatments for Chronic,3
#APs #,3
Attention Mining,3
#CryptoLiveLeakToken #,3
Amy Pierre,3
Single,3
Frontline Ibrutinib/,3
Ibrutinib/Rituximab Combo Retains PFS Advantage Over FCR,3
#BRNA #,3
Geroge Follows,3
üëç,3
Siempre,3
March 20-22 2020,3
Efficacy and Safety of Tenalisib,3
pan-Canadian,3
Neha Godiwala Goyal,3
1000,3
MissionMonday,3
del a√±o,3
James Kaye,3
FANCA,3
#multiplemyeloma #,3
#SUD #,3
Gene Promoter,3
#RWE #,3
6pm,3
those older than 70 years,3
MedicalSecrets,3
VenR &,3
Show Efficacy and Safety,3
Dana-Farber's,3
#ASH19 #leusm #,3
Discovery,3
#Janssen #,3
61st,3
3052,3
Fischer,3
AVO,3
#CLL morning,3
115,3
Lymphocytic Leukaemia,3
M.B.,3
#xnl #,3
47,3
Meta,3
Cannabis,3
Fixed-Duration Chemotherapy-Free Regimen,3
Afghanistan,3
@LornaWarwick,3
Rituximab Provides Superior Clinical Outcome Compared,3
New Recombinant,3
Adjuvanted Herpes Zoster Vaccine,3
Waldenstr√∂m Macroglobulinemia Treated,3
"Stephanie Lacoste ‚öΩ

",3
Gilead Sciences,3
Fo√† of @SapienzaRoma,3
Clive James,3
SCIG,3
#CLL Drug,3
FIVE YEARS,3
‚úå,3
symposia,3
#hemophilia,3
Mantle-Cell,3
59%,3
0-18,3
Less than a week,3
Occitanie,3
SNU,3
FO,3
UNSA,3
29%,3
HSMN,3
FAAAS,3
FASCO,3
28 days,3
2004,3
Comparison of Time to Next Treatment,3
Costs,3
0-13,3
0-11,3
SaturdayMorning,3
#lymfekr√¶ft,3
Francesc Bosch @Sidnavigare,3
Charlotte,3
earlier this year,3
6-year,3
New Treatments &,3
#CancerAwareness #,3
London &,3
rel/ref #CLL,3
11/2019,3
Sloan Kettering Cancer Center,3
#iwCLL,3
Manali Kamdar,3
GSK,3
PrimeView,3
CancerAwareness,3
Wegener Granulomatosis,3
#cell,3
Christina Fisher,3
"Transforming Leukemia Research https://t.co/uVKpQcbwZX @MDAndersonNews ""Jain",3
#mddigitastv #,3
Woyach https://t.co/YsOSXJryYC,3
Research,3
The Times Are A-Changin,3
Tanzania,3
#pancreaticCancer #,3
#breastcancer #,3
Prof Anna Schuh,3
VPA Research Prices,3
Verastem Oncology Announces,3
GeneticTesting,3
#letstalkaboutbloodcancer #,3
info &amp,3
FOUR,3
https://t.co/67pqbdQyMe,3
CLLAN,3
NEW LymphoQuant,3
Internal Controls,3
LymphoTrack,3
Low Positive Control for Minimal Residual Disease,3
Behandlung von #,3
Onsite,3
#aml #,3
"CancerMedMDA 
PhysRelations",3
Cllsm,3
@statnews,3
#science,3
#Ibrutinib Plus,3
#clinicalpearl #,3
Ang√©lica,3
VisualAbstract,3
9/7,3
Bond,3
https://t.co/jIoJLXHbfX,3
WT,3
Intense Uptake of Liposomal Curcumin,3
Red Blood Cells,3
Revision,3
Week 1,3
Potential Upside Indicated,3
SpringerLink,3
ISS,3
#cheflife #,3
https://t.co/FemFwnmne3,3
#oncology,3
Harvard Medical School,3
the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide,3
https://t.co/jIoJLXHbfX #,3
CCR,3
TWIMH,3
Mayo,3
van Bruggen JAC* et,3
CD8&lt;sup&gt;+&lt;/sup&gt,3
AB Science SA,3
Celgene Corporation,3
Dynavax Technologies Corporation,3
#perspective,3
el tratamiento de la #,3
RichtersTransformation,3
#CML,3
https://t.co/9ZvRol20ky,3
#venetoclax + #,3
Roberts,3
2017-2026,3
@ACCCBuzz,3
Gauthier,3
Venclexta Improves Outcomes Among,3
asco19,3
Instagram,3
CLL Tokens,3
7 years,3
MVA,3
#medicalbills,3
#lymphocyticleukemia #,3
a few years ago,3
Thornton,3
June 22,3
KOL,3
SC,3
GCLLSG @UKKoeln,3
Carl June,3
Bangladesh,3
@NewstalkFM,3
+ Rituximab,3
Front,3
@IKNL,3
NKRdata,3
New Study Identifies Patterns of Growth,3
news &,3
#humorfightscancer #,3
#lls,3
the New England Journal of Medicine,3
Fixed,3
1 #,3
#malignancies,3
@renalmyeloma,3
@DrHKantarjian,3
https://t.co/O8OZtEvxmd,3
Bel√©n Ben√≠tez,3
@harvardmed,3
‚ö™‚ö´ https://t.co/pkJOxiyzEs,3
Gran,3
Join,3
TuesdayThoughts,3
Crowdsourced Stock Ratings,3
Genentech Inc.,3
#Gazyva,3
the US FDA,3
‚ò∫,3
May 15,3
April 2019,3
Talha Munir,3
Diana Salinas,3
almost 50%,3
Leawood,3
KS,3
Gary,3
#FL #MCL #,3
Leucemia Linfoc√≠tica Cr√≥nica,3
GDUHem2019,3
#transplant #,3
@NCCNnews,3
‚Å¶@DanaFarber‚Å©,3
Summer,3
BSH2019,3
Brussels,3
Dustin,3
Co-Existing Medical Conditions,3
#CLLsm #LeuSM #,3
Frankfurt,3
37%,3
linfocitica cr√≥nica,3
Czech,3
#MayoCLL,3
Dr George Follows,3
FreeCrypto,3
#ERC20 #,3
üë®üèª‚Äçüî¨ Sharma S,3
Dr Wierda,3
@jeff_sharman,3
FBXW7,3
Barbara Andersen,3
#Relapsed/#Refractory #,3
JCAR014,3
@MyPeakChallenge,3
Sue,3
First Chemotherapy-Free,3
NCCN Guidelines Insights,3
marrow &amp,3
#MDedgeChats,3
Nursery,3
SET,3
Imran Khan,3
Pa.,3
Catherine,3
@JNCCN,3
Lymphoma Working,3
LymphomaConf,3
Aristotle,3
#ASH18 #leusm #,3
the EBMT Chronic Malignancies,3
New York's,3
ERIC International Meeting,3
the Spring of 2017,3
Transcriptional Profiles,3
Lamanna &,3
#CLL Medscape,3
Patient Cafe¬Æ,3
BTKC481S-Mediated Resistance to Ibrutinib,3
CCL3,3
#flu season,3
Lymp,3
Interpreting Chronic Lymphocytic Leukemia Prognostic Markers,3
the Novel Treatment Era,3
Gill,3
#cryptoliveleak #,3
Combination Regimen Significantly Improved Survival Versus the Chemoimmunotherapy FCR,3
80 Percent,3
ASHsm,3
Obinutuzumab Showed Significant Improvement,3
Progression-Free Survival Compared to,3
@VicompcancerCr,3
11:30am,3
@Celgene,3
Dr Woyach,3
bendaka,3
#ASH18 Paolo,3
MarriottMarina Pacific,3
#amlsm #,3
üé•,3
#patient,3
Slide,3
I√±aki Mart√≠n-Subero,3
‚ô°,3
Healthcare Marketing,3
non-17p,3
@TDTCML,3
Frank Mercer,3
Rupert Beazley,3
49,3
David Innes,3
Segunda Semifinal,3
CDDFworkshop,3
3000researchers,3
4 NOVEMBER,3
#forum,3
#regulators,3
@Genentech,3
November 19th,3
Lymphocytes,3
https://t.co/Unq3XaxzpH,3
#I√±akiMartinSubero,3
#CLLRooted #,3
Top-Line Pivotal Data,3
@CRGenomica,3
Antineutrophil,3
CRG,3
#Biomarkers #,3
Andrew Lipsky,3
NYSE,3
National Comprehensive Cancer Network,3
Verastem Oncology‚Äôs,3
Distinct Activities of,3
Rezvani,3
Last year,3
#hemonc,3
us &amp,3
60+,3
https://t.co/jalxkAqEXi,3
https://t.co/NtFSQEu44Z,3
University,3
AJH,3
#nursery #,3
12 pm PT,3
6th,3
#cancerevent  ,3
a Fixed Duration for Patients,3
$tgtx #,3
#cryptonews #,3
Comprehensive Safety Analysis,3
#CLL @MDAndersonNews,3
#SpotLeukaemia #,3
The United States,3
Susan M. O'Brien,3
42%,3
1st day,3
Comparison of Tumor Staging Systems for Cutaneous Squamous Cell Carcinoma,3
#CLL Horizons,3
Widespread Intronic PolyAdenylation,3
Cancer PathoGenesis,3
Christine Mayr,3
CELG,3
https://t.co/I62Jpv3SWK,3
9/23,3
John Fox,3
First-Line Approach,3
info,3
Bristol,3
https://t.co/ucrspSsB1V,3
#hematologymeetings,3
Leamington Library,3
Everyone‚Äôs,3
https://t.co/NtFSQEu44Z #,3
#BSH2018 #Leusm #,3
https://t.co/ygv8jmWazP,3
https://t.co/V8pVuy0qBL,3
Niagara Falls,3
#ASCO18 #,3
Value-Based Care for Patients,3
CLL FORUM,3
Bloodwise,3
WorldCare Consortium,3
#BigData,3
Jes√∫s Mar√≠a Hern√°ndez Rivas,3
#novel #,3
https://t.co/dwNFePSB2z,3
#EHA2018,3
EHA2018,3
#EHA23  ,3
https://t.co/7hibikeSvr,3
over 4000,3
coming weeks,3
Stockholm,3
CBFB,3
Hallek M. #,3
EHA 2018,3
Jackie Broadway-Duren,3
Venclexta/Rituxan,3
Pennsylvania,3
#CLL Register,3
University Hospital Cologne,3
Stemness Signatures,3
Lymphocyt,3
Lymphocytic Leukemia &,3
#Socrates #,3
NORTH CHICAGO,3
#NHL #Hodgkin #,3
MMSM #,3
https://t.co/7P1AAZRCyk,3
Patrick,3
Farrukh T. Awan,3
Rituxirel 500,3
Patientenleitlinie,3
EGRX,3
between #CLL,3
May 23,3
2 year,3
"148,000",3
Analyst and,3
Investor Day,3
Veterinarians,3
John 9,3
Some #CLL,3
Notes &,3
AACR18,3
BBC,3
WaitWaitWorry,3
#FridayFeeling #,3
the X International Meeting,3
#plasmacelldisorders #,3
Duvelisib NDA,3
#Manchester #,3
$VSTM #,3
Stephen Spurgeon,3
"Leukemia, Acute #Lymphoblastic Leukemia",3
#Non-Hodgkins #,3
USMLE,3
International CLL Group,3
CLLGlobal,3
VR,3
2-year,3
#ethereum,3
CancerSucks,3
UCSF,3
#InicioDeTemporada,3
MothersDay,3
the Potential Utility of Biosimilars,3
TPECS,3
Mars,3
#pathology #,3
John Gribben @QMBCI,3
Daratumumab and Ibrutinib in Treating Patients With Symptomatic Chronic,3
MoA,3
Updates/Advances,3
PLX51107,3
Dave,3
UBLITUXIMAB,3
#CampLakeLouise #,3
#hcsm,3
BBC News,3
Madrid,3
Simon Cox,3
#cancers #,3
Journey,3
#hiddencancer #,3
2:30 pm,3
integrin,3
a Therapeutic Target,3
2:30pm,3
Advocacy Officer,3
BladderCancer,3
Jan. 3,3
age 84,3
Robert Frasca,3
w @anthonymatomd,3
Oncology/Hematology,3
Mohit Trikha,3
Venetoclax Active,3
Ibrutinib-Refractory CLL,3
the New Year,3
C6,3
#mpnsm,3
#diet #,3
28112017,3
Soy,3
David Matthews,3
#rangers,3
#germancheerleader #,3
#charity #boost4charity #,3
LeBlanc,3
#cheerlabellangenfeld #,3
Dr Keating,3
ITGB2,3
#ASH17 -,3
Haem,3
ARCTIC,3
Deletion,3
https://t.co/VAe01Lg427,3
#ICML17 #,3
Jeff Sharman - watch,3
#ICML17,3
this Saturday,3
Elisa ten Hacken,3
Andrea Sitlinger,3
Non-Hodgkin‚Äôs Lymphoma(NHL,3
"Multiple Myeloma
",3
Gr√®ve,3
#SNU #,3
CllFighters,3
Nitin Jain @MDAndersonNews,3
#BSH17,3
12.00,3
only two,3
22082017,3
#leukaemia #health #boost4charity #,3
Mutated IGHV4-34 Receptors,3
Distinct Immunogenetic Features,3
the XVII International Workshop,3
#cancerandi #,3
Global Clinical Trials Review H1,3
CRO,3
LymphomaExpert,3
https://t.co/6IDvwYIEZA,3
Leclair &,3
Chronic Lymphocytic Leukemia(CLL,3
Webinar Replay,3
PersonalizedMedicine,3
@uni_ulm,3
IgG Levels,3
Invariant NKT,3
Barbara Eichorst,3
#EHA22 #,3
Uppsala,3
Crete,3
#diabetes #,3
Chornobyl Cleanup Workers,3
NEW PhII Study,3
10 Commandments for,3
#powerpoint #,3
Leukemia CLL,3
Pipeline Review H1,3
More Targeted Approach,3
Month 5,3
Dose-Escalation Study,3
4 #,3
Baseline,3
Therapeutic Challenge,3
lymsm v√≠a @lymphomahub,3
NR,3
quercetin,3
SLL &,3
131,3
#NHL &,3
31032017,3
#ChoosingWisely #,3
Brad Adams:,3
#Phase III,3
TG Therapeutics Announces Positive,3
#Leukemia Risk,3
Ibrutinib Therapy,3
https://t.co/dKxeEGjW8o,3
Venetoclax (Venclyxto,3
B-Cell Lymphocytic Leukemia,3
"May 12-15, 2017",3
Antigen,3
SIOG: Management of Chronic,3
@ImedexCME,3
@SIOGorg,3
#Ad #,3
https://t.co/1Q9EhTyFgD,3
Grow,3
Obinutuzmab,3
Cont,3
UPenn,3
Management of Chronic,3
#bendamustine &,3
IDH,3
Korea,3
https://t.co/HIwC2fIT9K https://t.co/Jr1xPFP1qO,3
https://t.co/IF2bGhGYnP,3
Federico Caligaris-Cappio,3
CLL-,3
"Opportunity, Growth",3
Honokiol,3
https://t.co/nfe0BoSc8q,3
Global Chronic Lymphocytic Leukemia Treatment Options,3
Belgrade,3
Nitin Jain @LeukemiaMDA,3
#NCT02756897 #,3
#MPNCLL16 Horizons,3
https://t.co/eFsM9YB8,3
Niemann,3
Weill Cornell,3
10/20,3
BatamPort,3
Ibrutinib Linked,3
https://t.co/1VIHvhhbEi,3
"Obinutuzumab, Ibrutinib &",3
1L &,3
Rel Chronic Lymphocytic Leukemia,3
Jeff Jones,3
MayoClinic,3
Tadeusz Robak,3
#New #,3
60 seconds,3
Descifradas las mutaciones gen√©ticas,3
New Upfront Treatment Algorithm Emerges,3
#business #,3
@PatientPower &,3
https://t.co/M9ixvIbhPW,3
CUB,3
@CONCACAF #,3
Consolidation Appears Effective,3
Treatment of Chronic,3
‚Ä¢ Infection,3
Second-Line Treatment,3
Non-Hodgkin #,3
Dr Barr,3
Dr Alyea,3
GILD,3
@Novartis,3
@Columbia,3
2020 - Analysis,3
Technologies &,3
https://t.co/3bFIXqqP48,3
Acute Lymphoblastic Leukemia and Potential for Chronic Lymphocytic Leukemia,3
Los Lobos,3
https://t.co/Cwr7g6c7Gy @roche #,3
Hepatotoxicity,3
Roche‚Äôs MabTherea,3
#EYTalking,3
VAT,3
Anfield,3
Venclexta Approved,3
"Biologics, Inc.",3
Market Forecasts,3
Rela,3
polatuzumab vedotin,3
Allele May Worsen Outcomes,3
#CLL #relapse,3
@UCCancerCenter &,3
23 April,3
Hodgkin‚Äôs Lymphoma,3
CLL Are Newest Patient Guidelines,3
Treatment Advances Change,3
Fort Saskatchewan,3
https://t.co/92t3TAIhMD,3
RT PatientPower #,3
The US Food and Drug Administ,3
Lake Louise,3
Hodgkin Lymphoma,3
Hodgkin Lymp,3
Front-Line Chemoimmunotherapy,3
#1000km2016 #,3
under 65's,3
Complete,3
Obinutuzumab Monotherapy,3
Ofatumumab May Be Safe,3
April 2015,3
Generic Bendamustine,3
#ASH15 Idelalisib,3
#ASH15 Ibrutinib,3
ScienceSwitzerland,3
#Patient #,3
#interview #,3
Farhana,3
Rituximab Shows Superior Efficacy,3
CAMBRIDGE,3
Imbruvica Phase III,3
https://t.co/GSjQWyjCNC @AbbVie,3
6 to 8 p.m.,3
Ibrutinib Therapy Linked,3
#IMBRUVICA #,3
#idelalisib +,3
#learning,3
@Bannermdandersn #,3
@Bannermdandersn @MDAndersonNews,3
Supplemental New Drug Application for Treatment,3
Supplemental New Drug Application,3
#soho_2015 #,3
Clustering of Expression Data,3
Improve In Patient Pool,3
CLL Airport,3
SAUDI ARABIA,3
2200+OT,3
1800+300+OT,3
1800,3
#MOGA15 #,3
#owen #,3
Drug Profiles,3
GenArray,3
Hockey Star,3
#BloodJournal #,3
ChristineLeeTIC,3
9-10 year old,3
#District9,3
#champions,3
#OnToTheNext #CLL #,3
PracticeUpdate,3
#KnowledgeIsBestRx @LLSCanada,3
Multiplex PCR-Based,3
#CLL http://t.co/bVgZOoa75s,3
#EHA2015 #,3
@LosLobosBand,3
#CLL @Roche,3
leczenie rokowania,3
Combination With Ofatumumab Improves Progression-Free Survival,3
New Ibrutinib Combination Regimen Shows Substantial Benefits,3
GML,3
Janet O'Brien,3
WallStreet,3
Susan Novick,3
dx'd CLL,3
First-Line Treatment Selection,3
Upfront Treatment,3
#construction #CLL #,3
#horse #,3
#mpn #mmsm #,3
"RT 
",3
Sold Out,3
#FF #,3
Happiness,3
AV,2
Mumbai,2
the Treatment of Previously Untreated Mantle Cell Lymphoma,2
Argentina,2
TGTherapeutics,2
Lesen Sie,2
Beitrag,2
@OHSUNews,2
chez les,2
d‚Äôune,2
#h√©matologie #,2
The European Medicines Agency Review of Acalabrutinib,2
the Treatment of Adult Patients,2
testa,2
testa contro,2
linfocitica,2
AbbVie‚Äôs,2
BioPharma Dive,2
Eli Lilly,2
"AZN
Read",2
‚ñ∂ dpa-AFX,2
Goldman,2
FINANZTREFF,2
"AstraZeneca Plc - Calquence Met Primary Endpoint Against Ibrutinib
Calquence Met Primary Efficacy Endpoint",2
a quarter,2
The PFS,2
https://t.co/W83AqqbUX8 CALQUENCE,2
762,2
25.9 months,2
linfoc√≠tica cr√≥nica @AstraZenecaES,2
https://t.co/c60KOMIBJt,2
gagamitin sa,2
Maria Rosario Vergeire,2
https://t.co/3vVU2IFbFi,2
Dr Michael Wang,2
Paolo,2
#news #pharma,2
#ChronicLymphocyticLeukaemia https://t.co/4HC742Om8,2
CALQUENCE Data Across,2
CV,2
#refractory,2
ABIM #,2
Solidarity Therapeutics Trial,2
#WM,2
1 to 3 days,2
ESMO20,2
@sonpavde,2
CALQUENCE Connections,2
November 21,2
„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquence(R)ÔºâEU„Å´„Åä„ÅÑ„Å¶„ÄÅÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„ÅÆÊ≤ªÁôÇËñ¨„Å®„Åó„Å¶ÊâøË™çÂèñÂæó,2
Medicina,2
la,2
ilacƒ± koronavir√ºs,2
koronavir√ºs hastalarƒ±nƒ±n,2
ama√ßlanan kan kanseri,2
NP,2
Meet its Primary Endpoint,2
P-II Studies,2
Otro,2
–≤ –∫–∞—á–µ—Å—Ç–≤–µ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω–æ–≥–æ –º–µ—Ç–æ–¥–∞,2
https://t.co/SrcSOm7lDb,2
olduƒüu,2
#Calquence,2
Medicamento,2
SFBN Feed:,2
TUMORI,2
Calquence OK'd,2
US Market News,2
AstraZeneca Announced Calquence Approved,2
#bladdercancer #,2
Platinum-Resistant Metastatic Urothelial,2
@EngIPM,2
Sakigake-Designated HAE Med Berotralstat,2
SOLIDARITY,2
Update,2
a few #StocksToWatch,2
CAPIOT Software,2
$6.34 m,2
ThePrint,2
a few weeks,2
para ayudar,2
CALQUENCE Drug Profile,2
Anna,2
UPLC-MS/MS,2
A Phase 2 Trial of Acalabrutinib,2
Relapsed/Refractory Primary,2
the Role of Acalabrutinib,2
102,2
Australians,2
7NEWS,2
"More than 1,000",2
@AstraZeneca Calquence,2
https://t.co/NpogHWRyGO,2
DanaFarber LeedsHospitals #,2
UrothelialCancer,2
Suivi,2
https://t.co/iHQfe4XEof #,2
The European Medicines Agency,2
80 percent,2
50 percent,2
Study to Evaluate Effects of Proton,2
Inhibitor on Acalabrutinib Capsule,2
Healthy Participants,2
Study to Evaluate Relative Bioavailability,2
AstraZeneca PLC Calquence,2
zanubrutinib,2
symptoms &,2
QD,2
SEC,2
#q1 #,2
https://t.co/P8mymhjYba,2
idelalisib + rituximab,2
#EHA2020 #,2
https://t.co/gmDxRW3W9Y,2
JNCCN 360,2
IndustriaFarmac√©utica,2
Dra Adriana Scheliga,2
HUMIRA,2
18 months,2
rituximab plus idelalisib,2
bendamustine+rituximab,2
Reapertura de centros,2
La #OIT,2
de un,2
provoca la propagaci√≥n,2
para el tratamiento,2
https://t.co/7yCq8gDLTQ,2
linfatica cronica,2
la prote√≠na,2
@ScienceMagazine,2
0%,2
el momento,2
el tratamiento,2
Cytokine,2
ONT,2
https://t.co/bGfm4ujn9Y,2
#Qu√©dateEnCasa #,2
#Lenalidomide,2
Truxima¬Æ,2
Congresso,2
Coronavirus Can Set Off a ‚ÄòCytokine Storm,2
UU,2
dieron,2
al descubrimiento de la prote√≠na,2
la enfermedad,2
la prote√≠na BTK,2
el coronavirus,2
Parece,2
ya no se necesitan,2
las vacunas,2
al virus,2
Tocilizumab,2
m√°s graves de la COVID-19,2
more than four years,2
EstadosUnidos,2
un f√°rmaco de AstraZeneca,2
Hallada,2
üíä,2
Coke,2
#Doctors,2
üá∫,2
el tratamiento de algunos c√°nceres,2
SmartNews,2
d√≠as,2
de la,2
#SARSCoV2 #,2
Jan Burger @MDAndersonNews,2
de Bruton,2
el linfoma y,2
Network,2
@NIH,2
Complex Event Analysis,2
Der Bruton-Kinase,2
zur Behandlung,2
Lymphome,2
wurde,2
#COVID19 $,2
72.7%,2
FDA Approved Drug,2
Nuevo,2
#SARSCoV2,2
Pakistan,2
June 5,2
Health News,2
kommer,2
el #,2
#health #pharma,2
Zenecas,2
ASTRAZENECA'S CANCER DRUG CALQUENCE SHOWS INITIAL SIGNS OF HELPING HOSPITALISED COVID-19,2
VR-EPOCH,2
Visita El Post En,2
de crecimiento,2
las c√©lulas del sistema,2
al menos otro medicamento de quimioterapia,2
ASCENDstudy,2
Bemcentinib,2
Medi3506,2
Zilucoplan,2
IDELA,2
de d√©tresse,2
95,2
Begin Calquence Study for Coronavirus Treatment,2
TKI,2
pharma,2
#vaccine #,2
#biopharma #,2
#COVID-19,2
Burton,2
Calquence &,2
Cambridgeshire,2
AstraZeneca Initiates CALAVI Study Evaluating Calquence,2
#covid19,2
contra la,2
#haem #,2
Calquence mot covid-19,2
Lapatinib,2
Dasatinib - Ph+,2
@UTSWNews #,2
Lori Leslie,2
24-month,2
Chaitra Ujjani,2
Obinutuzumab Superior,2
Front-Line Treatment,2
AstraZeneca Pharma India Ltd,2
Relapsed/Refractory Mantle Cell Lymphoma,2
Pembro,2
Cancer Care,2
https://t.co/VRbNrLtOG7,2
‚â•1,2
Exciting Data With Acalabrutinib,2
Lancet Haematology,2
de Waldenstr√∂m,2
36 months,2
Roger Owen,2
106,2
Leukeran,2
Sant√©,2
alla chemioimmunoterapia standard,2
#onkoloji #,2
OLN,2
November 2019,2
AstraZenica,2
"AstraZeneca Co., Ltd.",2
LeucemiaLinfaticaCronica,2
allontana la,2
progressione.#ASH19,2
#tumore #,2
Jeff P. Sharman,2
Nuevas,2
Oxbryta,2
el tiempo,2
https://t.co/WfqQGa9IGb,2
42 months,2
Hand,2
#ASH19 $,2
Pada 2017 Food and Drug Administration U.S. Government,2
12.5%,2
the first day,2
KnowNow,2
93,2
Fly,2
MRD Neg,2
G-Chl,2
the Treatment of Ibrutinib-Intolerant Mantle Cell,2
Preliminary Safety and Efficacy Results,2
Treatment-Naive Chronic,2
#smalllymphocyticlymphoma,2
#hematologist #,2
"Thursday, November 21",2
210259,2
Deferasirox,2
210945,2
NDA #,2
Xcopri,2
12:00:00,2
the Treatment of Patients With Chronic,2
LeucemiaLinfatica,2
12:00:00 AM,2
Interactions &,2
$BIIB $,2
PS,2
Jen Woyach,2
CLL Indication,2
https://t.co/dy5ApexyNR,2
Orbis,2
NEUTRAL,2
7700p,2
#SLL #,2
US Food &,2
Drug Administration,2
Pipeline,2
CALQUENCE Approved,2
The #,2
Refractory Chronic Lymphocytic Leukemia,2
Pascal Soriot,2
Managing Adverse Events,2
MDACC,2
obinutuzumab + #,2
CALQUENCE¬Æ Data To Show Improved Progression-Free Survival In Phase III Front-Line Chronic,2
Cohen,2
obinutizumab,2
2020-2023,2
max,2
@SWOG,2
@eaonc,2
Herbert A. Eradat,2
JP,2
Farxiga,2
‚ûï,2
"Calquence
https://t.co/2JBkVPMkyK",2
Sameem Abedin,2
CLL https://t.co/iJoCDUxkkA,2
Only 2,2
78,2
Dans,2
DAEPOCHR,2
con rituximab en combinaci√≥n,2
con idelalisib o bendamustina,2
https://t.co/Kni0UJD0Np #,2
Shows Good Tolerability,2
Helen,2
AstraZeneca Calquence CLL Data Sets It Up For Regulatory Submissions,2
Woyach Highlights Long-Term Acalabrutinib/Obinutuzumab Data,2
PIP,2
"#comitatoimi
",2
"#comitatoimionlus
",2
insights &gt;&gt;&gt,2
EHA Congress,2
Zeneca,2
acalabrutinib„ÅØÂÜçÁô∫„ÄÅÈõ£Ê≤ªÊÄßCLL„ÅÆÂ¢óÊÇ™„ÄÅÊ≠ª‰∫°„É™„Çπ„ÇØ„ÇíÊó¢Â≠òÊ≤ªÁôÇ„Çà„Çä69ÔºÖ‰ΩéÊ∏õ,2
Universit√† Vita-Salute San Raffaele,2
IdR,2
ASCO Annual Meeting,2
„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquence,2
ÂâçÊ≤ªÁôÇÊ≠¥„ÅÆ„Å™„ÅÑÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„ÇíÂØæË±°„Å®„Åó„Åü Á¨¨‚Ö¢Áõ∏ELEVATE-TN,2
https://t.co/T2MNAjADbt,2
@pharmaphorum,2
the Pharmacokinetics of Acalabrutinib,2
2%,2
„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„Éñ„ÄÅÂÜçÁô∫„Åæ„Åü„ÅØÈõ£Ê≤ªÊÄßCLLÂØæË±°„ÅÆP3Ë©¶È®ì„Åß‰∏ªË¶ÅË©ï‰æ°È†ÖÁõÆÈÅîÊàêÔºçËã±AZ - QLifePro,2
FortySeven,2
TargetedTherapy,2
Pha,2
Headache,2
Response Assessment,2
Hematologist/Oncologist,2
CHOPR,2
PHOENIX,2
#solvecancer,2
OSU,2
Recorded,2
Shine,2
250,2
Anvisa,2
#oncologia #,2
New Post: Calquence Shows Durable Responses,2
rituximab alone,2
Aprovado,2
Confira,2
5% to 6%,2
#Lymphomas #,2
297,2
298,2
Tycel J. Phillips,2
KEY,2
#biologics,2
#blood_cancer #,2
MCL &,2
Sprague,2
Dawley,2
Biotransformation,2
#thursdaythoughts #,2
Christopher R. Flowers,2
ü§©,2
üë¢,2
DBL3001,2
Simon Rule,2
https://t.co/H9Qe69z3R7,2
63%,2
#WM #,2
ü§î,2
TWTR,2
@SitemanCenter  #,2
–ø–æ–∫–∞–∑–∞ https://t.co/hyEHP2nI1D,2
ABC,2
@Carolinas,2
Small Lymphocyt,2
@AndreGoyMD,2
Colorectal Cancer Charity,2
#HOPA18,2
https://t.co/v3AtrDJdeU,2
432,2
#precisionmedicine #,2
124,2
#cancertreatment #,2
10/31/17,2
+0.3%,2
ibrutinib+R,2
22%,2
ASH17 @DrMichaelWang,2
American Society of Hematology Annual Meeting - First,2
NB,2
1975,2
FDA Approves New Treatment for Adults With Mantle Cell,2
"Tuesday, October 31",2
Prexxartan,2
Zegerid,2
la aprobaci√≥n acelerada de acalabrutinib,2
–ï—â–µ,2
https://t.co/EfrTUEFftj,2
Ibruvica,2
10/31,2
#mantlecelllymphoma @AstraZenecaUS,2
Calquence - David SalazarThe,2
un nuevo oncol√≥gico de AstraZeneca,2
Previously-Treated Mantle Cell,2
OncoPharm,2
Order at Biologics,2
AmericanCancer,2
#lymphoma  ,2
#orphandrug #,2
#mantle #,2
"Calquence
https://t.co/rQ4FAiNVdf",2
Halloween,2
#lymphome √†,2
Mantle Cell Lymphoma Treatment,2
Tumor Control,2
Combination of Acalabrutinib,2
Vistusertib in Subjects With Relapsed/Refractory,2
BreakthroughTherapy,2
2.7B,2
https://t.co/ztg8YJ1QAU,2
Potential of Acalabrutinib,2
J Woyach,2
#duvelisib #,2
Early Data Demonstrate Clinical Activity of Acalabrutinib,2
only 5,2
#Acalabrutinib &,2
1H17,2
@anthonymatomd @MattKalaycioMD,2
Hematology News,2
Acerta Pharmas Acalabrutinib Recommended,2
EMA - Bidness Etc,2
4B,2
https://t.co/XCyjRcuZ9I Acalabrutinib Challenges Ibrutinib,2
Lee,2
Mirada,2
DTN Pharma News,2
Pharma News,2
https://t.co/KoFTin4LRz,2
Espa√±a,2
Followup,2
StemCells News,2
Amy Johnson,2
#organic #,2
GMOfree,2
#cacao #,2
Glutenfree,2
#nutrition #,2
#GreenLiving #,2
#spice #,2
New England Journal of Medicine Demonstrates Acalabrutinib ACP,2
I-II,2
GLI1,2
Daniel O. Persky,2
https://t.co/sOGl82JHHn,2
Submit,2
JAK-Src/STAT3,2
mAb,2
March 23rd,2
fourth,2
@LeukaemiaCareUK &amp,2
@UkCll,2
Dohner,2
an Active Role,2
@huntsmancancer &,2
"April 15, 2021",2
TFR,2
Heidi Yates,2
New BTK Inhibitor,2
4q,2
Chromosome,2
one week,2
CME/CE/CPE,2
Hun Ju Lee,2
The Truth Behind Aging,2
#PatientReporter #,2
March 30,2
0.5%-1%,2
an estimated 2% to 10%,2
Blood Journal 2014,2
Zusia https://t.co/bttRX7IkK9,2
12 PM MT,2
Mississippi,2
IKZF3,2
Receiving BTK Inhibitor Treatment: Considerations,2
#AdvancedPractitioners #,2
March 11th,2
Cathy Wu's,2
18th March,2
#HealtheVoicesLIVE #,2
CXCL12,2
LEF1,2
Signaling Pathway,2
@LVV2016 &,2
Abstracts,2
Alvaro Alencar,2
New Research Paper Published Using SCF Equipment,2
Andrea Pepper,2
the Sussex Cancer Fund,2
#BloodCancer#Leukaemia #,2
Loxo,2
Digital Advocacy,2
Health Equity,2
Ibrutinib Alone,2
Fantastic,2
Cancer Center,2
March 20,2
#ClinicalCaseSeries,2
Meta-Analysis,2
Nivolumab,2
PGR,2
GeneTherapy,2
Sandy Peterson,2
10am PT,2
Shane Coleman,2
#hvhebron #,2
Genetics,2
Effect of Digital Health Coaching Program,2
Brad Adams,2
Damian Kovalovsky,2
@GreatDebatesHem,2
Syed Ali Abutalib,2
CLL Ireland,2
Immune Dysfunction in Patients,2
TONIGHT,2
1461,2
Smudge Cells,2
Clinical Significance,2
COVIDVaccine,2
Anna Puiggros,2
@FacebookWatch,2
CLL-1,2
Research Institute,2
TG Therapeutics Announces Publication of Final Results,2
Solman IG,2
Blum LK,2
Burger JA,2
Kipps TJ,2
healthcare professionals &amp,2
May 2020,2
NKX2-3,2
LRIF1,2
1er,2
APR-246,2
Phd,2
Geoff Grubbs,2
February 19th,2
Siena,2
Acute Lymphoblastic,2
HHD2021,2
8am,2
‚û°Ô∏è  Advances in,2
NurseTwitter,2
her Research Project,2
#researchproject,2
Cerebral Invasive Aspergillosis,2
over 130,2
the Lymphoma Research Foundation,2
webinar Update on Oral Therapies for,2
February 10th,2
Emory University,2
CLL Helpline,2
800-500-9976,2
Michael Bishop,2
the UK,2
rituximab regimens,2
February 16,2
CLLSociety,2
NFAT5 Regulated,2
BCL6,2
Current Treatment of Refractory,2
Phoenix,2
about 10 years,2
Test Before Treat,2
#blodkr√¶ft #patienter,2
#cml #cmml #,2
more than 100,2
#NCT03737981 #leusm,2
Krakow,2
EYP,2
https://t.co/ZOz3kolPKr,2
.@wwierda,2
@CancerCare,2
tertiary,2
DrugSensitivity,2
Prof Ghia,2
2/5,2
Randall Davis,2
#HCCwebinar #,2
"20,720",2
"3,930",2
50 years,2
Sloan,2
Resource-Limited Center,2
January 27th,2
Marc Hoffman,2
CLL Cells,2
OXPLORED,2
Cause of Death in Patients,2
@DONJAZZY,2
Impfstoff,2
Superb,2
https://t.co/aBqLcfFNtO,2
post-ASH,2
Clinical Cancer Research,2
FDA &,2
Inactivated STAT5,2
100th,2
3 hours,2
Jane,2
65-74,2
TLR,2
"more than $100,000",2
@rubinstein_md,2
Annals of Hematology,2
biosimilars,2
Hinweis,2
Allgemeinzustand,2
2020/2021,2
$CYCC $,2
A Very Rare Case Presentation of,2
Patkar Salil,2
Panchal Harsha,2
Asha Anand,2
Patel Apurva,2
"Parikh Sonia

Read",2
Central Nervous System Involvement,2
the new year,2
John N. Allan,2
https://t.co/4AcDWy2gjy,2
ADCC,2
#malignant #,2
#AKT,2
Gene Expression Profiling Predicts Sensitivity,2
HDAC7,2
Wiestner,2
#hematologist,2
StayHome,2
Polatuzumab Vedotin,2
#COVID„Éº19,2
the holiday season,2
APs,2
PSA,2
‚ùì,2
#oncologist #,2
LYLE,2
30 years,2
VenR,2
#chroniclymphaticleukemia #,2
+91)9837605768,2
Clinical Relevance,2
Meghan Thompson &,2
Allison Winter,2
Randomized,2
Immune-Based Therapeutic Interventions,2
Dr Barrientos,2
#CryptoLiveLeak #,2
#EndCancer #,2
#ash20,2
@GOVUK,2
the Clinical Development of APG-2575,2
Der,2
Machen Sie,2
FRACP,2
Danelle James,2
M.A.S.,2
#ASHFromHome #,2
umbralisib plus ublituximab,2
Carla,2
üëÅ,2
A Phase 1/2 Study,2
"Therapeutics, Inc.",2
Venclexta &,2
five years,2
bendamustine &amp,2
Intolerant,2
Zinzani,2
Anthony,2
NE,2
Neutropenia,2
https://t.co/GSZaTHkKIS,2
CK1Œµ,2
83.3%,2
Combination with Ibrutinib for Patients,2
$LLY Loxo Oncology,2
Das,2
Venclexta/Venclyxto Based Combination,2
#AbbVie Presents,2
L-902688,2
Janssen Reports,2
#Clinical #,2
#ASHFromHome,2
METTL3,2
Pat,2
Jim Dean,2
IMHO,2
641,2
68%,2
del 17p/,2
Jacob D. Soumerai,2
4 year,2
25 months,2
$RHHBY Genentech,2
RocheInnovation,2
December 05,2
12:45:00,2
#ASH20 Education,2
‚Å¶@sloan_kettering‚Å© #ASH20,2
Doris üëã,2
Jeremy Abramson,2
https://t.co/GSZaTHkKIS #ASH20,2
#CLLSociety +,2
pre-ASH 2020,2
OnlineFirst,2
12/4,2
7-10 am PST #,2
"TG Therapeutics, Inc.",2
this Sunday,2
Immune Response Dysfunction,2
7 AM PST - Mapping,2
Pagel,2
https://t.co/mbZeJFRGYC,2
PI3KŒ¥ Inhibitor Therapy,2
TG Therapeutics Initiates Rolling Submission of Biologics License Application,2
Infos &,2
Newest,2
Cleveland Clinic,2
27%,2
58%,2
Dec 4,2
BLA,2
Susan,2
Clemens Wendtner von der,2
TME,2
a 2020 Platinum Seal of Transparency,2
Key Findings,2
400%,2
Global Chronic Lymphocytic Leukemia Treatment Market,2
businessNews,2
Inhye E. Ahn,2
MA,2
Dimitar Efremov,2
Three-year,2
Biobank,2
the U.S. Watch,2
"WALK
Leaders",2
105 days,2
CCND1,2
FT819,2
Adrian Bloor,2
1970,2
Translational Research E-Conference,2
Translational Research Conference,2
Applying Data,2
2 DAYS,2
@rightrelevance,2
"Sep 20, 2020]",2
üì∞ NEWS,2
Ferran Nadeu,2
18 years ago,2
@ESHaematology,2
DuoBody-CD3xCD20,2
the Management of #,2
Guest,2
GeneReviews,2
Nathan Tirey,2
a year,2
about #ASH20,2
SHC014748M,2
#mascara,2
Murine Model,2
Oncologist/Hematologist,2
CARTCellTherapy,2
Tailored Immunotherapy,2
New Targeted Agents,2
10:00 AM EDT,2
Ross Salvaris,2
Immunology,2
Veronika Ecker,2
https://t.co/2JD5PGqBvb,2
Canadians,2
MOC,2
ERK1/2,2
‚Å¶@CllSociety‚Å©,2
five year,2
Oct. 27,2
13 years,2
30+yrs,2
Thorsten Zenz,2
Molecular Marker,2
$10K,2
TG Therapeutics Reports,2
#h√¶matologisk #,2
@cancer_dk #,2
@USFDA,2
Leukemia - Treatment Breakthroughs,2
Onc,2
Venex,2
Diagnosis and Treatment of Chronic,2
the Treatment of Hematological Malignancies,2
#apl #,2
@QMUL &,2
BP,2
Tatjana Stankovic,2
CLL @Ericllorg,2
5 years ago,2
Annual National Patient Conference,2
CNE,2
RANKL,2
kills murine,2
51,2
This month,2
CLL Treatment: Finding the Best Option for YOU,2
SOHO State,2
the Art Updates,2
Ti'ara,2
Caregiver Educational Forum,2
60-year-old,2
Therapieerfolg,2
ICP-022 Versus Chlorambucil Combined With Rituximab,2
the Treatment of Untreated CLL/SLL,2
Hematology &,2
#mantle_cell_lymphoma #,2
#cancermedicine,2
Meet Pete,2
the last several years,2
1pm ET,2
ŒùŒ≠Œ±,2
NCT01889186,2
@wwierda &,2
Growth Opportunities,2
#leukemia #ChronicLymphocyticLeukemia #,2
Drs Neil,2
@UCIrvineHealth,2
Panagiotis Baliakas,2
Andrew Rawstron,2
Noah,2
Jan,2
"the Stromal Microenvironment: Direct Contact, Soluble Factors",2
Extracellular Vesicles,2
"Tuesday, September 29",2
CLL Treatment,2
BCMA,2
Oct. 6th,2
#bendamustine plus,2
Understanding Chronic Lymphocytic #Leukemia,2
UCI Health's,2
Clive Zent &,2
Atrial Fibrillation and Bleeding in Patients With Chronic Lymphocytic Leukemia Treated with Ibrutinib,2
the Veterans Health Administration,2
9-year,2
MarketsandMarkets,2
https://t.co/lXrSblY0SD,2
IL-21,2
#ÂÅ•Â∫∑1+1 #,2
JoJo,2
Cancer Hallmarks,2
Exosomes,2
#NordicNanovector #,2
96,2
#BCAM,2
How Can You Access the Latest #CLL Treatment Options,2
Tuesday 10/6,2
1pmET,2
1 pm ET,2
0.01%,2
NeoGenomics,2
FIRST,2
chlorambucil &amp,2
obintuzumab,2
@CommLivLondon,2
Kay NE,2
Hillmen P,2
MD CLL Society Inc.,2
#NonHodgkinLymphoma #,2
Astrid Pavlovsky,2
@HallekMichael,2
CLLsm  Register,2
the Community: Improving Outcomes,2
the Latest Clinical Advances,2
FACT,2
Katrine Melvold,2
Claudia,2
MolecularTumorBoard,2
6:45 AM CST,2
BS,2
the EC‚Äôs Marketing Authorization for Previously Untreated Patients,2
Rituximab for Previously Untreated Patients with,2
8 pm ET,2
#rockville #potomacmd #dmv,2
#maryland #,2
#hepatitisb #,2
OrphanDrug,2
@JNJNews,2
#fuckcancer #,2
Register Now:,2
@kostareli,2
https://t.co/62jAi90got,2
#WLD20 #,2
@SeemaAliBhat1,2
@AboulafiaMd,2
@VirginiaMason,2
@SummitCancerCen,2
Progressive,2
Deborah M. Stephens,2
20th,2
more than half,2
#bloodcancerawarenessmonth #letstalkaboutbloodcancer #,2
#lyle_dk  ,2
a day,2
https://t.co/cvfYV3Etjz,2
Richard Rosenquist,2
#bloodcancer #leusm #,2
Steve Gschmeissner,2
#anatomy #,2
Connect,2
Nephrology,2
#intenttouse,2
Join Erlene Seymour,2
RR #CLL,2
Expert Access,2
University of California Irvine,2
Medical Oncologist,2
https://t.co/HbVqRbVfUh,2
"U.S.,#GMAB",2
NVS,2
U.T.,2
IVO,2
1pm,2
Better Understand the Patient Experience,2
StatPearls,2
#amchelsinki #,2
Is It Time to Treat Your #,2
ITGA4,2
UberEats,2
#allogeneic #,2
@ASTCT,2
Lymphoma Australia Virtual Conference,2
Deb Sims,2
4 PM PT,2
9 AM Aug 18,2
Leukemia https://t.co/bJS3l7D3sP,2
@CochraneHaem,2
August 14,2
1st month &,2
2nd month,2
#BTK &,2
Pitavastatin,2
ASHMHM20,2
Genabschnitt,2
sein kann,2
Vergleich,2
#Covid19 #,2
ZTE,2
5G Network,2
Arvind Chaudhry,2
Katy,2
Protein LC3,2
#trialmatching,2
Virtual #,2
"Barbara Eichhorst üéâ

Click",2
Dose-Escalation,2
"30, 2020] Burger @NEJM",2
this August,2
#FUL #,2
https://t.co/l6tksZ6Suy,2
Got2Adapt,2
the Hospital Clinic of Barcelona,2
Lymphoma Research Foundation,2
Los Angeles,2
Duke,2
Achilles,2
Review Article,2
4th September,2
https://t.co/ipLLAKBv3C #,2
üëâhttps://t.co/ZvqLbmqK6,2
"Barbara Eichhorst

Register",2
The New England Journal of Medicine: Search Results,2
Hematology\Oncology&gt;&gt;https://t.co,2
@Pelotonia,2
Resistance-Associated Mutations,2
CLL #,2
#AMO #,2
Vitamin,2
‚Å¶@NEJM‚Å©,2
#Leukemia #Leusm,2
Jul 2014] Whitaker et,2
UGT2B17,2
Haitham Khogeer,2
SSBD,2
July 29,2
5 p.m. ET,2
Reddy,2
JackColvinPark,2
7/29,2
August 14th,2
Mouse Model,2
Dressler,2
#Dog #,2
ISO,2
#pharmaceuticals,2
#nutraceuticals #,2
#plantextracts #,2
CLL Patients,2
$TGTX Phase 2 Evaluate,2
Glenn Sabin,2
Cody Steeves,2
Manuel A. Santiago &gt;&gt,2
Paparoa Park,2
Section 1,2
Law Alert,2
#CTsm #,2
#patientvoice #,2
the Lazio Region,2
BARCLAYS PLC,2
806,2
@JanRynne @NYLCandCLL,2
‚Å¶@wwierda‚Å©,2
‚Å¶@TapKadia‚Å©,2
#TTA #,2
#JWNG #,2
2.30pm,2
Numbers,2
Frontline Chemoimmunotherapy,2
Tammi,2
Cohort Study,2
CDK,2
üèÜ,2
MABLE,2
TF,2
Central,2
South,2
Kathy Toomey,2
14 &,2
EQA,2
coordinator@cllsupport.org.uk,2
https://t.co/oJM14OqTvn,2
Tumor Board Series,2
April 2020,2
This Thursday,2
July 2,2
#HAYD,2
MTR,2
SSTY,2
#IIT #,2
don‚Äôt,2
David Allsup,2
#obinutuzumab and,2
SLAMF1,2
Mary Ann Anderson,2
Healthy Korean Individuals With Lymphocytosis,2
2020 - 2026,2
https://t.co/7dKuDX9z7Q,2
The Royal Marsden,2
Immunoglobulin Gene Analysis,2
Sonali Sharma,2
Andy Rawstron,2
Oncoalert,2
Gianluca Gaidano,2
VENICE,2
Expression Level,2
Suspected Disease Progression,2
#UTLE #,2
Alexy Danilov,2
CLL Answers,2
#CLL Society‚Äôs,2
Virtual Community Meeting,2
June 18,2
Kimberly Hanson,2
the European Hematology Association,2
PB uMRD,2
June 16th,2
12 PM EDT,2
University of Eastern Piedmont,2
Uhr LIVE-Stream,2
KML-Videoberichte,2
EHA25 mit LIVE-Diskussion zu,2
HodgkinLymphom aus dem K√∂lner Studio,2
moderiert von @HallekMichael,2
https://t.co/FfP8OUKmuA,2
https://t.co/O27fLx4Ywh #,2
Prognosis Factors,2
https://t.co/H5HAihTROz #,2
Jetzt,2
1/5,2
73-year-old,2
$ARQL $,2
AnCan/Throwing Bones Blood Cancers Virtual Support Group,2
6/10,2
Mount Sinai Hospital,2
Manhattan,2
Chart,2
Assessing Minimal Residual Disease,2
SLL Who Have Been Treated With Venetoclax,2
Mike Boston,2
Nationwide Epidemiological Study,2
Autoimmune Hemolytic Anemia,2
@GMWatch,2
üîú,2
Heme,2
the Protective Bone Marrow Microenvironment,2
American Society of Clinical Oncology Educational Book,2
Waldenstrom Disease Infected With,2
STAT3-Induced Wnt5a,2
a few minutes,2
https://t.co/I5OPN9JBf3,2
Pancreatic Involvement,2
RUNX1,2
3y,2
0.33,2
AGM Statement,2
#healthbook #,2
OpenBiology,2
2019-20,2
120,2
next Thursday,2
#storytime #,2
last night's,2
Marina Lukas,2
@ThorstenZenz,2
Egyptian,2
Bearish Signal Line Cross,2
#EuroBloodNet,2
Jing Fan,2
UW2020,2
RN,2
BSN,2
these days,2
https://t.co/AXpJ5dS71h #,2
A Diagnostic Dilemma and Treatment Challenge,2
Professional Version - National Cancer Institute,2
¬øPensando,2
nuestros #,2
con los que podr√°s #,2
#profesional de #,2
#Formaci√≥nOnline #,2
a full year,2
Impulsa tu carrera,2
ApacheSpark,2
memoria,2
Comenzamos,2
Junio,2
https://t.co/Huj173Omn8,2
8 PM ET,2
#RareDisease #,2
Piers Patten,2
Kings College London &,2
2B,2
6B,2
acute &amp,2
#umbralisib + #,2
DAPK3,2
Learn More:,2
Unusual Manifestation of Chronic Lymphocytic Leukemia,2
#mmsm #mpnsm,2
JCO,2
Fungal Infections,2
CAP,2
KML-Experten,2
Neil Kay &,2
#pharmacist #,2
1 month,2
the CARES Act,2
Functional Differences,2
the 2nd,2
Annual Report and Notice of AGM,2
Herpes Simplex Necrotic Lymphadenitis,2
Capnocytophaga,2
OSUCCC,2
Participate &,2
Venetoclax and Ibrutinib,2
Chemo-Antibody Therapy,2
PCAT,2
AdvancedPractitioners,2
the Safety and Pharmacokinetics of ABT-199,2
NCT01328626,2
AVM0703,2
Non-Hodgkins Lymphoma,2
#Cancertreatment #,2
Payment Date:,2
22/05/2020,2
Session 1,2
@kotharishalin,2
An Updated Perspective on Current Prognostic,2
Predictive Biomarkers,2
the Context of Chemoimmunotherapy and Novel Targeted Therapy,2
#prognostic #,2
IL-15,2
the Phase Ib/II Clinical Study,2
#MultipleMyeloma,2
First Person Treated,2
one month,2
FATE(21.07,2
Plasmablastic,2
Binet,2
Acute Pancreatitis,2
Complications of Influenza A,2
April 2018,2
the 15th,2
w Venetoclax,2
up to 5.5,2
#transplant,2
Iranian,2
85,2
at least 5 years,2
@RuthClifford5 @DrHealeyBird,2
3/28,2
PDQ¬Æ,2
AskDrH,2
12 weeks,2
Company Usability Profiles,2
Market Sizing &,2
Mollie Moran,2
German CLL Study Group,2
NEDD8,2
21 years,2
"https://t.co/XgnDiO75ft

#",2
Leukemia @LLSusa,2
"@LeukaemiaCareUK 
",2
AbbVie News,2
Arthralgias/Myalgias in Patients With Chronic Lymphocytic,2
2975,2
Lee Greenberger,2
Brad S. Kahl MD,2
Chronic  Lymphocytic Leukemia,2
Flood,2
EMBL,2
Seattle Cancer Care Alliance,2
DTHSTR,2
#prime #,2
full-year,2
Resistance to Therapy,2
OncLive,2
Mabthera,2
8 years,2
#patientpower,2
Mitochondrial Respiration Correlates,2
Jan &,2
III Alliance,2
https://t.co/YX7YLZYAs3,2
Personalized CLL Care,2
Acute Myocardial Infarction,2
https://t.co/HitHnmlQpX,2
Tampa,2
#bcsm,2
Jennifer A. Woyach MD,2
Eugen Tausch,2
Department of Internal Medicine III,2
Ulm University,2
buparlisib,2
p70S6K,2
Presentation and Review of Literature,2
"Chronic Lymphocytic Leukemia &gt;10,000",2
#FightBloodCancer #,2
Classic,2
Wanna,2
Ace Cafe,2
#instaclown,2
#instaChile #,2
#LUCHALIBRECHILENA,2
Karla Plevova,2
Differential Expression Profile,2
miR-27b,2
@NCCN,2
July 2019,2
EUCancerPlan,2
@eurordis,2
the Development of Targeted Therapy and Immunotherapy Approaches for Chronic Lymphocytic Leukemia,2
Wnt,2
#patients w,2
Unilateral Blurred Vision,2
the Sole Presenting Symptom,2
Bruce Raphael,2
Diop,2
BIRC3 #,2
March 5th,2
11:30 AM Pacific/2:30 PM Eastern,2
14 years ago,2
Hemato Oncology Key Points,2
#prowrestler#chileansWrestler #,2
#NHL Patients,2
SureSeq,2
#leukaemia #cnv,2
Carolyn Owen,2
Obinutuzumab May Benefit CLL,2
Obinutuzumab Versus Delayed,2
Redhill Local Councillors,2
Cerebral Metastases,2
A Case Report and Review,2
fridaythoughts,2
los √∫ltimos,2
Non-Coding Regulatory Regions,2
0.48%,2
GAN,2
MPNsm,2
CutaneousLymphoma,2
Google,2
IBM,2
el segundo,2
Prognostic Testing and Treatment Patterns,2
LL-37,2
10k,2
#PatientExperience #,2
NKcells,2
6.3%,2
Pulsar,2
EPIC,2
MAPK-ERK,2
Trametinib,2
Autoimmune Cytopenias,2
Focus on Molecular Aspects,2
#legalhelp #classaction #,2
Adam Olszewski,2
CART20,2
M√§nner,2
https://t.co/ZoDaujjYko,2
The European Medicines Agency‚Äôs,2
Grand Rounds,2
Nicht,2
@POG_LRC,2
Lymphoma Coalition,2
#weeds #,2
#nhl,2
Onkologie #,2
https://t.co/2vynEIqqi6,2
Lilly Presents Interim Clinical Data,2
Dose Escalation Trial,2
#SingleCellSequencing,2
Christoph Bock‚Äôs Group,2
Que,2
Cuando,2
üêª,2
@Genmab,2
Prof John Gribben,2
468,2
between 1989 and,2
Endstra S,2
de Weerdt I,2
Fakhri,2
Statistics,2
#law,2
#classaction #,2
Columbus,2
0/1,2
#NFC #,2
#talk #,2
#CLL Paradigm,2
CLL Progression and Persistence,2
The Newest Treatments,2
Lung,2
Medical Care,2
https://t.co/JppYZywasC,2
Wojciech Jurczak,2
ATH,2
5 days,2
CPG,2
Tues,2
@i_ringshausen,2
non-Hematology,2
#THR #,2
CNV Panel,2
Signal,2
@AEAL,2
#lawyer #law #legal #,2
Updates in Hematologic Malignancies,2
Stephen M. Ansell,2
myeloma &amp,2
SEATTLE,2
Blitzima,2
Dr Siddiqi,2
Lymphozyten,2
Small Lymphocytic Lymphoma/,2
MPAC,2
Sandra E. Kurtin,2
Adaptive Biotechnologies Receives,2
TEG,2
#p53 #,2
FOXO3,2
SUBMIT,2
1st Translational Research Conference,2
STAT5,2
new year,2
Samoan,2
#cmml #,2
LYMPHOMAS,2
#NUCLEAR #,2
#CASE #,2
Prognostic Value of,2
Baseline Total Metabolic,2
4-Year Update,2
#Herbal #,2
3 weeks,2
1995,2
integrin Œ±IIbŒ≤3,2
Science News,2
Thoracic,2
"üì∏ @cba_perez
",2
Doug,2
#ASHAwards #,2
Raman,2
ExerciseOncology,2
Anthony R. Mato MD MSCE,2
Isabel Cunningham,2
#PPC #,2
Texas Oncology--,2
a few hours,2
3D,2
Video,2
Messy,2
Smith,2
Murano Study Confirms Sustained Benefit of Time-Limited Venetoclax-Rituximab,2
Garc√≠a-Mu√±oz,2
Feliu J,2
"about 21,000",2
"6,000",2
#myeloma #mmsm #,2
AUS,2
Edward Faber,2
CGC,2
23rd January,2
Dana-Farber‚Äôs,2
NordicNanovector,2
Gene Expression,2
4287,2
Bionano #WholeGenomeImaging,2
#Richter syndrome,2
6-8pm,2
Combination Therapy Data,2
lifetime,2
Pan-BTK Inhibitor,2
Yue Lynn Wang,2
the Treatment of #,2
el ST,2
BeiGene Announces Clinical Data,2
#combinationtherapy #,2
Leusm @LeukemiaMDA,2
Catherine J. Wu,2
Dr Rai,2
Alexa,2
MRD Negativity,2
#teamCLL #,2
Hypertension in Patients Treated With Ibrutinib,2
NHLBI,2
#iNHL #,2
the hour,2
Ibrutinib + Venetoclax,2
#ibrutinib + #,2
BCL2 &,2
Approved &,2
Hall D,2
07:30am ET,2
Venetoclax Added,2
CLL Achieves,2
B.S.,2
12/8 8:30 AM,2
"14, 2019",2
Allergy and Clinical Immunology,2
SE,2
EM,2
Discover Verastem Oncology‚Äôs,2
Booth 601,2
Taliban,2
Navy,2
6 PM EST,2
Important week,2
GivingTuesday,2
Serologic Response,2
"0-5

#UNIDASPORELOBJETIVO",2
"0-4

#UNIDASPORELOBJETIVO",2
SLAM,2
Rixathon,2
New Options,2
Banerji,2
Speaking &,2
Listening Resources,2
https://t.co/ZgQyTUh5mu,2
#earlyliteracy #,2
#earlyyears,2
#listening #,2
90 minutes,2
Maureen Connolly,2
Ruth Schorr,2
Cure,2
FDA Approves New Treatment for Chronic Lymphocytic Leukemia,2
NewMonographMonday,2
umbralisib,2
@lymphomaphilia,2
20112018,2
2027SummaryChronic,2
CLL International Statistical Classification,2
Jamie,2
FDAapproves,2
@TGAgovau,2
Bio-Path Holdings Announces Clearance of Investigational New Drug Application,2
#writing #,2
#eyfstwitterpals #,2
Dr Goede,2
Molica,2
Zhu HY,2
Xia Y,2
Wu YJ,2
Wang L,2
10.08 pm,2
#nurseryrhymes #,2
Galway University Hospital,2
Post-Transplant Cyclophosphamide,2
134,2
#weedkiller #,2
a full day,2
CCO,2
BetaThalassemia,2
#cllsm,2
#PGIT #,2
EGCG,2
GreenTea,2
https://t.co/9Z2eYXMJi4,2
ITV,2
#Advertising,2
Ad Space,2
Polish Lymphoma Research Group Real-Life Analysis,2
#lymphome #,2
Relapse/Refractory Chronic,2
"600,000",2
information &,2
Ardilaun Hotel,2
PET/Computed Tomography,2
gi2019,2
Over 50%,2
5√®me,2
19 months,2
Pr√≥ximo,2
#MNL #,2
UMRD,2
40 years,2
#oncology #detection #,2
#CD19 #,2
nyc,2
NZ,2
Dallas,2
Bologna - 2nd,2
1979,2
#patients &,2
Sordo-Bahamonde C,2
1995-2017,2
PCR webinar,2
Michael J. Keating,2
Dec. 6,2
Ibrutinib or Chemoimmunotherapy,2
#Bologna,2
Angela Brooks,2
0-17,2
Angeles Portillo,2
0-16,2
0-12,2
0-10,2
Jeanne Schaffer,2
the 11th November,2
#all #cml #,2
HappyHalloween,2
Adult Leukemia Study Group,2
@VHIO,2
#N4P #,2
@GVAsanitat,2
J Brown,2
#escnj #,2
JohnTerry,2
#CRISPR #,2
Functional Perspective,2
Week,2
@CTOAM,2
NYP &,2
Last month,2
FDA Panel,2
el Atahualpa,2
Farissa C√≥rdoba,2
EMPIEZA EL 2DO,2
C√≥rdoba,2
LIZ PE√ëA,2
#CancerPatients #,2
Plasma B-Cell,2
21 months,2
only 1,2
#CLLsm #genetictesting,2
"https://t.co/LGm8qN6Kxh
",2
"AmericaDeCali

üîÅ",2
"‚öΩ 0-1

",2
204,2
Kirsty Sadler,2
CIMAGO,2
@GEPAC,2
#cancerawareness #,2
LasGumarelas,2
Mrs HTG,2
University of Colorado,2
A Fortunate Turn of Events,2
Verastem Oncology Announces Dosing of,2
FAQ,2
Table,2
Adam Kittai,2
NRAS,2
#biosimilar,2
Valerie,2
#phonics,2
October 30,2
4.5mln,2
#JLG #,2
#TFW #,2
UCL,2
Listen,2
Susie,2
U-MRD,2
Valentin Goede,2
Families,2
#balding #alopecia #,2
#BladderCancer #,2
the @HarmonynetEU 4th General Assembly,2
Firenze,2
@HospitalLaFe @IISLaFe @IBSAL_IIS,2
https://t.co/yFLJAew0e9,2
Ffrangeg,2
meithrin prynhawn,2
ac yn,2
Corff,2
#diwrnodieithoeddrhynglwadol #,2
21%,2
@UKCLL,2
Stamatopoulos,2
Africa,2
#obesity,2
https://t.co/BWwwRC8R4R,2
About 5,2
@OxfordHaem,2
about #MRD,2
Payment Date,2
#MakeBloodCancerVisible,2
Secondary Malignancies,2
Fixed Duration,2
Inaki Martin-Subero,2
Judith,2
ESMO,2
Fegan,2
Leukemia Linked,2
almost a year,2
ChronicLeukaemia,2
Lawsuit,2
@CLLAN,2
Belle,2
David Bond,2
neoplasia,2
Lawsuit Claims,2
Fact or Fiction,2
Cancer Awareness Month,2
about 20,2
SOHO19,2
#DIGS #,2
#tumor #,2
ARZERRA,2
#bloodcancerawarenessmonth #,2
32th,2
Landshut,2
8:45 AM,2
Case Presentation,2
SAT 9/14 Session XIV,2
10:50 AM,2
Andrea Lenartova,2
Sept. 20-23,2
#SOHO2019 #,2
Manuel Fuentes,2
#SF3B1 #,2
The Roundup Options Help Center of,2
LiveTracker,2
1st Line,2
Hackensack University Medical Center #,2
#sciencejobs #,2
https://t.co/bk0QlmJiRv,2
17-year-old,2
Friesian,2
1-month,2
#JT26,2
ACCC Educational Opportunities: Addressing Disease States,2
Blastic NK-Cell Lymphoma,2
470,2
1960s,2
4ta,2
"üìÜ

",2
Torneo,2
Aarhus,2
#lyle_dk,2
#BloodCancerAwarenessMonth,2
melsm,2
Blood Cancer Awareness Month,2
Leukemia Research,2
Statin Use,2
https://t.co/wiRVDUgkTA,2
a busy month,2
FightBloodCancer,2
Paul M. Barr MD,2
Hallek M,2
Torneo clausura - 2ra,2
√Ångeles Portillo,2
Hot Topic,2
Curt Hanson,2
between 1998 and 2018,2
EPAR Venclyxto,2
Leukemia Lymphocytic,2
Maura,2
#medical #,2
America,2
Guarani,2
Complex,2
VideoWebinars,2
1.0 #,2
CMEcredits,2
#LMS #,2
ACA,2
Innovative Science Solutions,2
Quantium Cast Episode,2
#QRT #,2
"SOLG
Out",2
#Scotland #,2
#NHS #,2
Anne,2
Oncologist,2
#‰∏âÈáçÁúå #‰ºäÂã¢Â∏Ç #‰ºäÂã¢ #,2
#„ÇÑ„Åæ„Å†„Åø„Çâ„ÅÑlab #ÁöáÂ≠∏È§®Â§ßÂ≠¶ #,2
One week,2
seven days,2
Older Patients,2
statin,2
Malignant lymphomas,2
Lymphosarcoma,2
Giant,2
MOMENT,2
Lymphoma Hub Satellite Symposium,2
quarterly,2
HLA-B27,2
Icahn School of Medicine,2
The Mount Sinai Hospital,2
Trend Analysis,2
"Challenges, Competitors Overview",2
Jo,2
the Management of Lymphoma,2
four decades,2
#2013,2
GeorgeDuke,2
#musichistory #,2
#thisdayinhistory,2
10s,2
Chemoimmunotherapy for Chronic Lymphocytic Leukemia | NEJM,2
@CancerTodayMag,2
Chemoimmunotherapy for Chronic Lymphocytic,2
NFkB,2
#digitaltv #,2
#MRDNegativity #MRDPositivity #Leusm #,2
@Daily_Experts,2
EHG,2
ERK,2
Zytostatikum verbessert,2
Drug Combo,2
0.17,2
0.35,2
the Mayo Clinic,2
Last days,2
8/6,2
MyLCI,2
Cincinnati,2
NEW,2
JAK Inhibitor Therapy,2
#XPD #,2
#therapy #,2
Russia,2
Doc,2
Unsolicited Advice,2
Rituximab Followed,2
de la d√©cada del 2000,2
los primeros reg√≠menes de #,2
quimioterapia,2
Billy,2
#wbw #,2
Yucai Wang,2
#GastricCancer #,2
7/27,2
Great Wolf Lodge,2
2501,2
Mason 45040,2
1-866,2
#MRDNegativity #,2
Jon,2
#lovethisplace,2
"https://t.co/wlqAoeRDZi
",2
US News,2
Venetoclax Combo Effective,2
@proactive_uk @CelloHealthplc,2
PhosphoFlow,2
https://t.co/Qf4WCMUEp2,2
obinutuzumab &,2
LymphomaManagement,2
Prof Richard Rosenquist Brandell,2
Genomic Medicine Sweden,2
PET,2
#TAP #,2
@STATnews,2
https://t.co/dN8hrKfY63,2
Umbralisib in Subjects With Chronic Lymphocytic Leukemia,2
Study to Evaluate Impact of Ibrutinib,2
the Quality of Life,2
AbbVie/Roche) Drug Report,2
https://t.co/PKkRYb0ulD,2
The Kansas Society of Clinical Oncology,2
the summer,2
HematologicalMalignancies,2
Subcutaneous Rituximab,2
2019-2025,2
Clinical and Molecular Evidence of Atovaquone,2
CLL Points,2
the CLL Society Tribune,2
PMA,2
Krebsforschung,2
#nurses,2
üìπ VIDEO,2
ChemoFree,2
TTNT,2
Cathy Skinner,2
#SNR #,2
#raredisease,2
@ALLIANCE_org,2
KML,2
#indolenteLymphome und,2
ZNSL von der,2
https://t.co/SVrUiS9gbt,2
#chronicillness,2
NEWS,2
Ergebnisse,2
Darwin,2
Congratulations,2
21st July,2
#CLL-,2
Optimizing Treatment Approaches,2
2.,2
#MedscapeEdu #,2
the Royal Marsden,2
Immunosuppressive Treg,2
the past year,2
Darryl,2
CLL Genetics,2
YoungEHA,2
Technology Research News,2
17:30-19:00,2
Anderson,2
TP0903,2
Phase 1/2 Study,2
TRANSCEND CLL,2
June 15,2
Rod Humerickhouse MD,2
#amandavscancer #kickcancerinthedick #,2
ZUMA-8,2
Broad Institute,2
CCP,2
Making Sense of CLL,2
Genetic Research,2
Nordic CLL,2
https://t.co/mSxczpWUdH,2
#CLL 101,2
‚Å¶@OncLiveSOSS‚Å© #,2
DEL PT,2
Lion,2
Neue,2
Krebs #,2
Venclexta in Combination with Gazyva for Chronic Lymphocytic Leukemia Presented,2
$CELG $,2
Hematologic Malignancies‚Äî,2
CARTtherapy,2
#immunotherapy,2
#Libertad-,2
LasGumarelas #,2
‚ö™‚ö´ https://t.co/HMaKIxmFEN,2
each day,2
around 80%,2
about 10%,2
#NCSD2019 #,2
https://t.co/O8OZtEvxmd #,2
Upfront,2
"Caring for Every Patient, Learning from Every Patient",2
"~115,000",2
the U.S. Ibrutinib,2
#SSBMT #,2
The Magic of Normal,2
#LymSM,2
Denny,2
Cathy Wu,2
NEJM #,2
@kanagalshamanna,2
Harvard,2
Epigenetische Signale,2
Sysmex,2
eurekamag,2
#CTO #,2
about #clinicaltrials,2
üì∏,2
Vishva Dixit,2
Fiorela Mart√≠nez,2
UC Irvine,2
Related Articles,2
Moscow,2
Akhtar et,2
AAPA19,2
2pm,2
#Bullish #,2
1L de la #,2
Venclexta + Gazyva,2
@Roche @abbvie,2
Barrett,2
@unisiena,2
Anglica V√°zquez,2
M√≥nica Vega,2
Stacey Worthy,2
Aimed Alliance,2
EPAR Arzerra,2
#DevOps #,2
first half,2
@proactive_uk,2
Jim Judges,2
Dean Howes,2
IO120,2
@NYLCandCLL &,2
https://t.co/vE6KAGkoGV,2
Mechanisms of PI3K Inhibitors,2
Dir.,2
Institute Physician,2
3010,2
Alison Duffy,2
@UMGCCC,2
States,2
Leukemia and Lymphoma Society,2
April 2017,2
'99,2
TNT,2
the Field Heading,2
https://t.co/yjsYonpY5d @LeukemiaMDA #,2
Tamar Tadmor,2
LCE,2
Cerro,2
Cambio,2
#SingleCell #,2
HealthInsurance,2
@aimedalliance &,2
Eliot Finkelstein,2
this 18 minutes,2
Biosimilar rituximab,2
TBD,2
https://t.co/yZ3n5Fab3e,2
Marc Hoffmann,2
"Therapy, Development, Growth, Demand and New Technology",2
Top Key Player,2
Cancer-Free World Podcast,2
https://t.co/DXmtr5nH5a,2
9.90,2
Anil Awesti,2
0-19,2
50s,2
https://t.co/6MNxNZPfxc #leusm #,2
La Carral,2
Solsona,2
Amy,2
Sonali Smith,2
the Treatment of Non-Hodgkin's,2
Blood Journal https://t.co/NANAYO165f,2
ten,2
LivingwithLymphoma,2
@WeillCornellMed,2
https://t.co/aU1xylg7QE,2
Follicular #,2
#CLL Community Advisory Board,2
LCE #,2
#CLL CAB,2
#Imbruvica plus,2
https://t.co/dYJb9OZZ3,2
three-year,2
April 9th,2
the 18th,2
Eisai,2
HBV,2
@haematologica,2
EBMT19 Annual Meeting,2
Types,2
https://t.co/vBi6nR2QUQ,2
Growth Drivers,2
PBC,2
earlier this week,2
G3-4,2
Foundation,2
41%,2
@ACTcharity &,2
David Lauder's,2
PatientReporter,2
United,2
LiveStream,2
Duvelisib: New Treatment for Relapse Refractory CLL,2
CNSMasterclass,2
14 July,2
Mulligan,2
SCS,2
NKp30 Receptors,2
Cancer Discovery,2
#ISAT #,2
Chronische lymphatische,2
Sudanese,2
AttentionMine,2
UtilityToken,2
#EarnCrypto #,2
https://t.co/LKjvGfBq4u,2
March 07,2
TCTM19,2
tomorrow night,2
SmartPatients,2
Sharma S* et,2
#Research4ACure,2
New Transcriptional Patterns,2
#cancerfree,2
Annual International Congress on Hematologic Malignancies,2
March 9,2
Ethereum,2
#chemo - #,2
Society of Hematology,2
Cancer Journal,2
JEM,2
Dr Davids,2
Mary Cahill,2
Emma Lane,2
Spencer Gibson,2
Sat 2 March,2
USD 9.1 Billion,2
https://t.co/nPSItvHjcb #,2
Spring,2
Lili Wang,2
#lymphoma and,2
#AttentionMining #,2
üå≥,2
TestBeforeTreat,2
Belgium,2
William Wierda MD,2
The Latest Advsnces,2
#MOHC19  ,2
#MDAnderson #,2
The Latest Advances on Chronic Lymphocytic Leukemia,2
Medical Oncology &,2
Ada,2
https://t.co/nTyhStdiIY #,2
hermano seria de gran,2
Le C√©gep,2
https://t.co/pgKbhiKSSN,2
Regional Cancer Care Associates,2
https://t.co/IXkxJ1GyMH,2
Teaching Fellow,2
#VitaminD,2
about #depression,2
16th,2
#patients #,2
@EFPIA @EU_H2020,2
Chronic Lymphocytic LeukemiaÔºçCase Report,2
L-Selectin Expression Is Influenced by Phosphatase Activity,2
BEZ,2
@JanssenUK,2
Article - Europe PMC,2
https://t.co/fJVZ8UZ24H,2
Imbruvica-Gazyva,2
El√≠as Campo,2
The Ohio State University Medical Center,2
#leukemia #CLLsm #,2
Hematologists,2
https://t.co/IT814ZkWXS,2
#LEUSM #,2
#EYFS #,2
#MDedgeChats #,2
Cancer Guide,2
the 1970s,2
about one-third,2
Cathy Hamilton,2
7 pm ET,2
1/31,2
First Non-Chemo Combination Therapy,2
@GENbio,2
4 days,2
Imbruvica + Gazyva,2
Louis-H√©bert,2
#obinutuzumab,2
Ibrutinib Superior to Chemoimmunotherapy for Progression-Free Survival,2
Jean Koff,2
Helen Marr,2
december,2
"Thursday, January 31",2
Advanced Medicine,2
Post,2
Dozens,2
12p,2
New Zealand,2
depression,2
#NCC #,2
Czech Republic,2
KIR,2
year',2
Osso Bucco,2
Lago Restaurant,2
AntibodyTherapy,2
D.C.,2
D.C. Area CLL Patient Support Group,2
the ‚Å¶@TheEBMT‚Å© Chronic Malignancies,2
Ibrutinib Plus,2
Younger Chronic Lymphocytic,2
the next couple years,2
#ASH18 &,2
Christopher Fegan,2
#3000researchers #ROC #,2
#dermpath #,2
Time-Limited Therapy With Drug Cessation Feasible,2
360,2
the CLL Research Center,2
#CLL #lesum #,2
less than 6,2
First-Line Therapy for Older Patients With,2
Lymphoma Working Parties,2
FactFriday,2
State,2
the morning,2
this spring,2
Criteria,2
2018_ReCap_May,2
ECOG-E192,2
@NatureMedicine https://t.co/GjtL2qBSXh,2
https://t.co/GpRjqMAUKG,2
the last month,2
#giveblood #,2
Dr @jeff_sharman 's,2
https://t.co/DHSqUj4dPp,2
DrBurger @MDAndersonNews,2
CPD,2
#MRDNegativity #MRDPositivity #PatientEducation #Leusm #,2
Fatigue,2
GeneticMutations,2
Watch Day 3,2
#ASH18 Daily Wraps,2
Dr Hallek,2
the Ham-Wasserman,2
https://t.co/G9DXWfh6zS,2
@LeukemiaMDA @MoffittNews &,2
Lymphomatoid,2
https://t.co/QtlMO9vQX0,2
Regimens,2
https://t.co/WvhiKvcPxP,2
Roundup Lawsuit Blames Glyphosate Exposure,2
Standard of Care,2
Blombery,2
#ASH18 Update,2
Federal Practitioner,2
AVAHO,2
@SitemanCenter,2
Alter von,2
Genetics101,2
https://t.co/3zBpm8pz73,2
39%,2
#ASH18 https://t.co/DyZWHJ2ofF,2
Nicole Lamana,2
#Mutation,2
#lymsm #ASH18 #,2
Robert Z. Orlowski,2
#ASH18 PatientPower,2
#chemoimmunotherapy #,2
Venetoclax Leads,2
#MedOnc #,2
Nordic Nanovector,2
Late Breaking Abstracts,2
2-day,2
Dennis,2
up to 7 years,2
Dr Lamanna,2
UM,2
Celgene,2
JanssenOncology Medical Affairs,2
Paula Cramer,2
#Ibrutinib + #,2
#ASH2018 #,2
MabThera¬Æ,2
Bendamustine Plus Rituximab,2
@UNIMORE,2
the Rai Staging System,2
#HistoryofBloodCancer #,2
#ash2018 #,2
Bruton‚Äôs Tyrosine Kinase Inhibitor,2
A Phase II Trial,2
LBA-7 - Acquisition,2
Progressive Chronic,2
8:30am,2
Pacific BR,2
@MarriottMarina Pacific,2
Daniel DeAngelo,2
#ASH18!,2
#LeuSM #LymSM #,2
immunoOnc,2
TCR,2
JanssenOncology,2
clinical &amp,2
7:30,2
Plenary,2
Murine,2
#ASH18 12/1,2
Firstline Treatment of Pts w/,2
https://t.co/pXA6X2zTgt,2
This weekend,2
FCR) Chemoimmunotherapy,2
Lymphocyte Leukemia,2
LymphomaStory,2
9.2bn,2
1.8%,2
Blwyddyn,2
Dr @jeff_sharman,2
Willamette Valley Cancer Institute and Research Center,2
the Treatment of CD37,2
miR-34a,2
1Ô∏è‚É£ week,2
Eva Kimby,2
@Ericllorg #ERIC18 #,2
Beatrice,2
Get,2
3x,2
Wallenberg Clinical Scholar,2
Week Closing Low,2
OncoPath,2
THC,2
Pratice,2
BeiGene Initiates Global Head,2
Trustee,2
October 2015,2
#YouMadeItHappen #,2
#MondayMotivation #,2
#IMsupported #,2
#workplaceofchoice,2
#thankYouLORD #,2
CURE Media Group,2
Host First Annual Gala,2
Dr Versha Banerji,2
#Ofatumumab #,2
Spinal Muscular Atrophy,2
Von Hippel-Lindau,2
#SunAWARE,2
Ann,2
MUT IGVH,2
https://t.co/8ei0Gapp0I,2
https://t.co/AWXfEHapQf,2
Day 10,2
#miRNA,2
https://t.co/BW6FxBDTA2 #,2
the past decade,2
@pole_emploi,2
the Association of Ibrutinib and Daratumumab in Relapsed/Refractory Chronic,2
MedOnc,2
Over 300,2
BIOEurope,2
#Bcl2 #,2
Flair,2
AbbVie-Roche,2
#discussion,2
Kahl Highlights Frontline Considerations,2
a Fixed Duration of Treatment in Patients,2
Non-Hematologic Adverse,2
Mark &,2
CarePartner Nelia,2
Moffitt,2
#Hematology #Leusm #,2
Transplant,2
#LLC,2
ClinicalResearch,2
the final day,2
PatientCare,2
MedGenome launches Genetic Test,2
Study to Evaluate Ibrutinib Retention,2
"Condition Summary: Leukemia, Lymphocytic",2
RRMM,2
data &amp,2
IvoGut,2
EliasCampo &,2
31%,2
Merkel,2
#sunAWARE,2
@VerastemOncolog #CLL,2
Combination Trials Signal Next Wave of Treatment,2
Arizona,2
Louise O'Driscoll,2
LymphomaMyeloma2018,2
Less than two weeks,2
LiveBroadcast,2
Eagle Pharmaceuticals,2
J Gribben,2
Parikh SA,2
Ren√©e Beekman,2
Pilot Study,2
Leukemia #CLL,2
Oct. 17th,2
#trading #,2
#competition #,2
half-year,2
almost 10%,2
the first 90 minutes,2
pl2018,2
#KangaExchange #,2
Cyclacel Pharmaceuticals,2
Molecular Prognostic Markers,2
Their Clinical Relevance,2
days,2
#nbnews #,2
https://t.co/FRTowbwd94,2
@MDAnderson,2
Wolverhampton #,2
3'UTR,2
#Leukemia #LeuSM #,2
#World #,2
the Management of Chronic,2
Chuck Pagano,2
@RocheCanada,2
@LymphomaAction #,2
A Review of Standards of Care,2
1yr,2
Prof Pete Hillmen,2
Francesc Bosch,2
Richters Syndrome,2
3 pm ET,2
Relapse,2
Prof Robin Foa,2
12pmPT,2
WAIHA,2
Max J. Gordon,2
Imbruvica @Pharmacyclics,2
Copiktrap,2
@drugscom,2
#fatigue plus,2
Duvelisib FDA,2
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,2
#golf #,2
NHL &,2
MiR-34a,2
DCLLSG,2
"BloodCancerAwarenessMonth 
https://t.co/UV7oeOTJBY",2
Individualized Lenalidomide Plus Chlorambucil,2
Rituximab May Be Feasible,2
#cryptotradealert,2
#blockchain #tokenfestboston #,2
IDP,2
APH,2
EKT,2
QXT,2
ECK,2
Survival,2
phase2,2
Comprehensive Safety Analysis of Venetoclax Monotherapy for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia,2
WES,2
#tcellrx #,2
8:45 AM - Dr.,2
'Case Study: A Case of CK,2
SOHO18 - Saturday 9/15,2
#EORTC #,2
QLQ-C30,2
#EORTC,2
#tokenfest,2
#boston #,2
#peertopeer #,2
RT &,2
#SOHO2018 @SocietyofHemOnc,2
#tokenfestboston #,2
Venetoclax FDA,2
12 PM PT,2
SOHO18 -,2
cll@patientpower.info,2
#WednesdayWisdom #,2
pts w,2
#gerionc #geriheme #leusm #,2
55-Year-Old Female,2
‚â•75 years,2
#Rituximab #,2
RESONATE-2 #,2
@CllSociety &,2
Virtual Tumor Board,2
Information Day,2
9/9,2
Purva Lad &,2
Vamos,2
Pericardial Involvement,2
Pharmacy Times Continuing Education,2
NovelAgents,2
combinations &,2
"üëà

#",2
Pipeline Insight,2
TWO,2
MRDNegativity,2
@maggiesglasgow,2
https://t.co/6ZaDaaRVi7,2
2+2 degree,2
two years,2
Office of Patient Recruitment,2
1-800-,2
@warwickuni,2
11am,2
Zinc,2
#fridayreads #,2
600 percent,2
PatientAdvocate Carol Preston,2
five other #CLL,2
ROC,2
#Leukemia #leusm #,2
6.30,2
5.00,2
Sandra,2
Nuneaton Library,2
more than 40 years,2
https://t.co/cjabQ4lUQp @LeukemiaMDA,2
William G. Wierda's,2
LighttheNight,2
#oncologymeetings #,2
Bantay Bata 163,2
#cancerpatient #,2
"Multiple Myeloma
Aplastic Anemia",2
Mediterranean,2
French Innovative Leukemia Organization,2
Everyone,2
https://t.co/JpsPvBijGd #leusm #,2
#inform #,2
#ChemoFree #,2
SmallMolecules,2
https://t.co/ZiyZOx0e2F,2
https://t.co/vHIHwePkEq #leusm #,2
Florence Cymbalista @APHP,2
PatientSupport,2
Andy Buclaw,2
Land's End,2
John O'Groats,2
#InflectionBiosciences,2
ClinicalData,2
GeneticTests,2
Elias Campos,2
25 July,2
Lymsm #Leusm,2
$tgtx $,2
University of Texas,2
Mauro,2
Moxetumomab,2
NOTCH1 Aberrations,2
CLL Summer Social,2
#StemCellTransplant #,2
Phas,2
#relapsed/#refractory,2
#EYFS,2
member &amp,2
Ecuador,2
"https://t.co/bJINb5OiJm
",2
#CancerSucks #,2
Wolverhampton,2
CD-20,2
Samuel Ng,2
Medical Review Series,2
Filomena De Falco,2
Beatrice Del Papa,2
Erica Dorillo,2
Elisa Albi,2
5k,2
https://t.co/QKHdBB14GK,2
Venclexta + Rituxan,2
esos,2
Tambi√©n,2
@LenkoSins_Xnl,2
#wrestling #,2
https://t.co/mLvIcU0Tk1 #,2
the Spanish Group,2
19.4%,2
Hematology Hub,2
Leukemia @genentech,2
70 years old,2
https://t.co/zvfV0qmxOQ,2
Medikamente,2
Chancen,2
ARN-LHR-SFO-PHX,2
#FemSmaHus #,2
Fraietta,2
Lina,2
https://t.co/BlOWGqlwhA,2
JanssenGlobal,2
Pete Hillmen,2
Victoria Hall,2
11.45,2
Roundup Lawsuit,2
Years,2
Vishva,2
16.15,2
$MOR Presents,2
Presents Clinical Data,2
Leukemia Medical Director &,2
Stockholmsm√§ssan,2
#BIFF #,2
https://t.co/DcIMgtGJHK @LeukemiaMDA,2
FDA #,2
June 14th,2
Hillmen of @LeedsHospitals,2
Roche Announces,2
FDA Approves Treatment,2
@mamartirenom,2
#hope,2
IBO,2
#bounty #,2
#Ethereum #,2
FBLive,2
LISTEN,2
Camp Lake Louise,2
Adam Sklar,2
ASN002,2
umbralisib (TGR-1202,2
Children‚Äôs Oncology Group,2
https://t.co/wlZs1i1jio,2
E450,2
9:45 am,2
E450 #,2
#CAR #,2
76-year-old,2
Melenhorst,2
Dean,2
Ibrutinib/Obinutuzumab Combo Improves PFS,2
"https://t.co/8oTumrpANz
#CLL #",2
ABBVIE,2
#personalizedmedicine,2
Patients Met Primary Endpoint,2
ONSCongress,2
OCN,2
AbbVie‚Äôs Imbruvica,2
#lymphoma $,2
IWCLL,2
200 #CLL,2
62-year-old,2
IL-6/STAT3,2
Cryptoliveleak #,2
#altcoin #,2
OFA,2
Cuneo,2
Derek Clarke,2
Biomarker,2
Haematology &,2
1986,2
State University,2
#relapsed #,2
Nanay,2
Erica,2
Response &,2
Prof Hillmen,2
Update on Signal Inhibitors,2
Venetoclax Found Effective,2
VSTM Verastem Oncology Reports,2
2012-2018,2
PR Newswire,2
Venetoclax and Ibrutinib in Treating in Participants With Chronic Lymphocytic Leukemia and Ibrutinib Resistance Mutations,2
New Blog Post,2
National #,2
Amy Seung,2
"Leusm
https://t.co/345qZFuQml",2
#Rituxan #,2
AssistRx,2
next month's,2
two-thirds,2
CLLLive,2
Intro Camp,2
#forkdelta #,2
Auckland,2
#Patients #,2
QXT #,2
NANO,2
24th May,2
IRAK4,2
Grade,2
this past summer,2
Rt HarmonynetEU 2nd day,2
Lisa Minkove,2
John Cena Sucks,2
Anas Younes,2
One month,2
IAH,2
Session 2,2
Venclexta-Rituxan Combo Reduced Disease Progression,2
3250,2
15% - 30%,2
El Dr.,2
#defaulttoken,2
Venclexta-Rituxan Delays Disease Progression,2
3.9%,2
Cohesin RAD21 Gene Promoter Methylation,2
Lars Bullinger ChariteBerlin,2
#Myelodysplastic Syndromes,2
StateofScience,2
#BMT,2
Graeme Fraser's,2
EBM,2
2 rituximab,2
HealthCanada,2
#subcutaneous,2
@LeukemiaMDA @LLSusa,2
Justin Kline,2
"16,000 feet",2
https://t.co/kbqrC0FmeW #PowerfulPatient,2
Esther,2
#EBMT17,2
#York,2
ForkDelta,2
#DNA,2
#AACR18,2
2010-2014,2
Hamblin Prize,2
#MothersDay,2
MRD+,2
Health and Social Policy,2
The Role of Rituximab,2
ŒòŒ≠œÉŒ∑ ŒµœÅŒ≥Œ±œÉŒØŒ±œÇ,2
ŒïŒΩŒ¥ŒπŒ±œÜŒ≠œÅŒøŒΩœÑŒøœÇ,2
œÉœÑŒø œÄŒªŒ±ŒØœÉŒπŒø,2
Œ†œÅŒ¨ŒæŒ∑œÇ,2
Nora Larson https://t.co/bOZ9duvJ7B @andrewschorr,2
MultipleSclerosis,2
Hematologic Malignancy,2
Farmers,2
@TheUSONetwork @WVCancer,2
#FlashbackFriday,2
CLL Airdrop,2
Kyle,2
#PowerfulPatient Chris,2
Habte Yimer,2
#RareDiseaseDay,2
#warwickuni #,2
Visits Helpful,2
Kathryn Kolibaba of @CompassOncology,2
Combinations Continue,2
CD4CD8,2
Zaborsky N,2
Gassner FJ,2
Maura Murray-Reeve,2
saturday,2
20h00,2
#ASH17 https://t.co/90LRO7UcVN,2
Zeev Estrov,2
O'Brien Covers Evolution,2
Marijuana Help Alleviate,2
#lymfklierkanker #,2
Factors Affecting Prognosis and,2
Gulcin Ozer,2
@AndrewSchorr,2
PALG - CLL4,2
@univienna,2
XVII International Workshop,2
May 12--15,2
#cllsm #hemeonc #,2
mAbs,2
#Venetoclax &,2
Radio 4,2
#diagnostics,2
Simon,2
#mutations,2
30 minutes,2
Yondelis,2
This Very Encouraging in,2
Vitro Data,2
Mouse Models,2
the Front Line,2
NASDAQ,2
another few years,2
Q4,2
@BBCRadio4,2
BBC News - Have,2
Future Implications - LWW Journals,2
the Treatment of Patients With Chronic Lymphocytic Leukemia With Progressive Disease on Single Agent Ibrutinib,2
@AbbvieUK,2
Leukemia Drug,2
Clinical Practice Recommendations,2
#Fight #,2
UW,2
2016-0900,2
A Phase II Study of Venetoclax in Combination,2
@NovartisPharma  @Genmab,2
@proactive_uk @CelloGroup,2
#CompassOncology #,2
PRIME,2
JUNO,2
#leukemia #hemeonc #,2
more than 80%,2
Model,2
23rd March,2
@Eastfield_EN3,2
"https://t.co/UQQAZxEeQ0  

#",2
Tissino,2
#BloodCancer Care,2
as many #MPs,2
NowPlaying,2
#Ireland üáÆüá™,2
health &,2
Matthews &,2
Michael Boxer,2
Robert ‚ÄúBob‚Äù Frasca,2
Zimmer Gunsul Frasca,2
FAIA,2
January 3,2
the age of 84,2
#Ireland,2
https://t.co/YGLwam06bK,2
ScienceNews,2
2022,2
"https://t.co/ZsH2tD6at6

",2
@FrimleyHealth,2
#LCSM #mmsm #,2
"@WVCancer
https://t.co/m7DkcBGHZE",2
dabigatran &amp,2
#ASH17 Daily,2
@Aurora_Cancer &,2
#mmsm #mpnsm #,2
dabigatran,2
@anthonymatomd (@PennMedicine,2
CLL - Cancer Network,2
SA,2
#PatientsAreWaiting #,2
"Detect, Identify and Treat Subtypes",2
Thrombocytopenia,2
membiak,2
#sicklecellsc,2
#sicklecellthalassemia #,2
#leukemie #,2
Michel van Gelder @MaastrichtUMC,2
Mark-David Levin,2
Kijken,2
Registreer,2
The Oncology Journal,2
#leusm #hemeonc #,2
UMBRALISIB,2
NFATC1,2
1632,2
6-8PM,2
C202,2
#NSCLC #,2
Olga,2
#mpnsm #mmsm #CLL #,2
#ash17 #,2
VSTM Verastem Announces Clinical Data,2
Education Program,2
3024,2
Lenalidomide Discontinuation,2
Strati,2
8PM,2
3002,2
BCA-1) Plasma Levels Are a Useful,2
Sivina/Burger,2
6PM,2
Aberrationsl',2
Unsere Rangers,2
Marie Scully,2
9 Dec. #,2
TTP,2
Sunday 10,2
Genomics &,2
12:30 PM,2
A Phase II Trial',2
Noon - Burger - 427 ',2
Randomized Trial of Ibrutinib Versus Ibrutinib Plus Rituximab,2
@doctorpemm,2
OBR,2
Dec.,2
#webleedblue,2
Hem News,2
ALERT,2
#max1049news,2
Federal Fisheries,2
Fisheries &,2
#MDS #MPN #,2
@MDAndersonNews @LeukemiaMDA @WVCancer,2
Camp Lake Louise Swag Bag,2
#webleedblue #,2
Small,2
Event and Live Webcast,2
December 10th,2
815 PM ET,2
PubSaludMurcia Monosomal,2
https://t.co/GOUfRi7Axn #ASH17,2
@NNUH,2
Decoding Monoclonal Antibodies,2
#Elderly #,2
Benda,2
IISLaFe HospitalLaFe,2
sehh_es #,2
GEPAC,2
GVAsanitat,2
26.8%,2
50e,2
NPDROCK,2
@Pathologists,2
1:00 PM,2
Nov. 14,2
7 p.m.,2
Italia,2
https://t.co/RQMpN0SQIv,2
Lewis Backler,2
#L #,2
–ó–¥–æ—Ä–æ–≤–∞—è,2
#Secondary #,2
PublicHealth,2
LM2017,2
Ireland Analysis Of Outcomes,2
Cancer During Cold and Flu Season,2
Leukemia Symptoms,2
Lekemia(CLL,2
OpenLabel Study,2
Rossi,2
Hairy Cell Leukemia(HCL,2
1k,2
#CLK #,2
Lenalidomide Maintenance Therapy Reduces Progression Risk - Cancer,2
Black Swan Intelligent,2
Dave Danchuk,2
#FO #,2
Columbia,2
CHC17,2
#Leukemia Restrictions,2
17q,2
#PatientEngagement #,2
@CCCNHS,2
930A,2
830A #CLL Session,2
8A #CLL Session,2
the Art Update #,2
7A,2
#CLL Expert,2
VOTE,2
8A,2
Joe Crisara,2
Inhye Ahn @NIH,2
MicroRNA-155,2
Hotel Michelangelo,2
Society of Geriatric Oncology Task Force,2
LeClair &,2
B Cell Chronic Lymphocytic,2
CLL)-Mayo Clinic,2
Richard Houlston,2
The Stromal Microenvironment Modulates Mitochondrial Oxidative Phosphorylation,2
#JImmunol Ibrutinib,2
Don Fresco,2
"#ÊóßÂéü‰ªò È¢®
",2
"#jdm
",2
"#crazylowlife
",2
Emili Monsterrat,2
#GAV #,2
Market Research,2
#leukemia #CLL #,2
CarePartner,2
https://t.co/HdTv9cY6mR,2
@UCSDNews &,2
"https://t.co/OUiioOOgy5

#",2
New Treatments For Chronic,2
Pharmacy Forum,2
Burke #,2
USD $1250,2
Pase Ib/II,2
spring 2018,2
Exercise,2
0.7%,2
90mth,2
ABVD,2
https://t.co/7G5xtUD1Tj,2
con parte de lo vivido,2
Kipps &,2
"RockFighter

Siguiendo",2
#CLL w,2
Ublituximab/Ibrutinib Beneficial in Patients With Chronic Lymphocytic,2
Idealisib,2
USD $1500,2
#CRO,2
Claire Dearden,2
#IgG Levels,2
Lynn Ingram,2
@UTSC,2
Celtaidd,2
Year 3LlD,2
Celtic,2
$juno #,2
Sunesis Pharmaceuticals Announces First,2
WNT,2
Pronounce Chronic Lymphocytic Leukemia,2
#bcra #,2
Medical Simulation,2
"Hairy Cell Leukemia
Lymphocytic Lymphoma",2
VENCLYXTO,2
Venclexta/Venclyxto Effective,2
#EHA22,2
#rituxan #,2
@DRGinsights,2
CLL Powerpoint,2
#MCL https://t.co/2bVySpACCL,2
@gnubila_fr,2
#EHA17,2
Less than a quarter,2
2016-0785,2
1063,2
$3 #,2
Henderson &,2
M Hallek,2
Less Than A Quarter of Patients With CLL,2
#2017 #,2
Restores Fludarabine Sensitivity,2
30042017,2
BRIEF-Beigene,2
MiR-16-1,2
C Tam,2
"September 22, 2015",2
Deborah Henderson,2
E354b,2
https://t.co/BUIdsAIBNJ,2
the Janssen Disease Lens,2
Efficacy and Safety Data,2
ASCO 2017 Show Sustained Survival Rates,2
ASCO Show Consistent Progression-Free Survival Benefit,2
Hall A. #,2
45%,2
Penn,2
van de bijeenkomst,2
CTL119,2
"üòè

#",2
Lymphocy,2
https://t.co/RukrlPSOBh,2
Viva La Botch,2
Diagnosis and Initial Treatment,2
Town Mtg,2
Selective Bruton‚Äôs,2
#johnterry #,2
Wierda &,2
https://t.co/OHF8gztJLS,2
smIL-4R,2
#JT #,2
Outcomes Data,2
Three Phase 3,2
#iwCLL17 #,2
iwCLL2017,2
Hallek #,2
‚â•8 consecutive days,2
&lt;8 days,2
10.9 months,2
#endocrine,2
Biennial Meeting,2
ONO,2
B Cell Chronic,2
Pan,2
1903,2
2day,2
the EMA CHMP,2
The Multiple Myeloma Daily,2
The Welcome Invasion of Drones,2
#APWA #,2
Con,2
4155,2
ON,2
Nivolumab-NSCLC &,2
Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects,2
CD49d Expression Associated With Lymphadenopathy,2
AACR17,2
WhaTech,2
ONO/GS-4059,2
Dicer,2
Drosha Expressions,2
Kinase Inhibitor,2
Drs Keating,2
APSHOexperts,2
Martin Dyer,2
United States,2
Bonus Resources Included,2
Allen Melan√ßon,2
#elderly #,2
RDW,2
https://t.co/Oz0QK6UVDS https://t.co/UZRYlCi5A6,2
https://t.co/8JCUs5Mh7y,2
Exhausted CD8(+,2
the Glasgow Know Your Lymphoma,2
25 March,2
Thoracic Complications,2
https://t.co/WGr8r6JfNT,2
https://t.co/MiCsCtoeIP,2
#Chemo Improves,2
TG1101,2
#Leukemia Drug,2
Clonal,2
CalgaryMarathon,2
TomKipps,2
#claremont #,2
Pollyanna,2
Negativity,2
@ONAcom,2
#findcures #,2
Five-Year,2
Promoter Hypomethylation and Expression Is Conserved,2
Mouse,2
#Cy #,2
Happens,2
https://t.co/oGdtioYClT,2
#Therapy #,2
"February 18, 2017",2
Shynron,2
New Study,2
Luego de un,2
#PowerfulPatient Deborah‚Äôs,2
#NGS #,2
Better Treat,2
Prognostic,2
NYP,2
Market Insights,2
https://t.co/Y6mQU8LclI,2
HaemOnc,2
New Pharmacotherapies,2
#MM,2
#Lepaf #,2
IntelligentMedicine,2
#CLL @Lankenau,2
#Early #,2
#ASH16 -,2
SIOG Task Force,2
ASH https://t.co/107G6X2EQA,2
https://t.co/TMzPN3I9Rr,2
New Cancerwise,2
Black Swan Intell,2
Jan. 12th,2
7pm ET,2
Feb. 18,2
#TGR1202 for,2
Ublituximab Plus Ibrutinib,2
Refractory Chronic Lymphocytic,2
#Financial #,2
#ZAP70,2
TGTX Orphan Drug Designation,2
Rac1,2
Drug Holidays,2
ASH2014: Management of #,2
Jones,2
National Cancer Institute,2
Ibrutinib Promising,2
ASH2016,2
#CheckpointInhibitors &,2
Multiple  Myeloma,2
65 Years &,2
52 Month,2
the Elderly,2
International Society Geriatric,2
https://t.co/vnVAkuJfMJ,2
#ASH16 Daily Wrap,2
ASBMT,2
Tumor-Microenvironment Interactions,2
29-year,2
PatientCaf√©,2
#Dating and,2
Pipeline Review H2,2
Transposon Mutagenesis Reveals Fludarabine Resistance Mechanisms,2
CLL Maintenance,2
Phase-III,2
#instalucha #,2
#Combo #,2
#CLL -,2
UAB,2
October 2016,2
2CK,2
9e,2
p184,2
TreatmentResistant,2
Demands,2
Jose Leis,2
@Pharmacyclics &,2
T4,2
Mechanism of Action &,2
Clinical-Grade Expansion/Differentiation,2
Richter's,2
Transformation &,2
@IRBBarcelona,2
https://t.co/1znyp2MWyQ,2
https://t.co/aFnbeb1nGs,2
CDF,2
@jonasasouza,2
givingtuesday,2
#gerionc #leusm #,2
Landscape &,2
the Management of Chronic Lymphocytic,2
"January 30, 2017",2
#DLBCL #HL #,2
#luchalibrechilena,2
Ya estamos,2
de los pacientes,2
#free,2
#1 #,2
#ofatumumab #,2
#CLL https://t.co/W6BEQyWj2J,2
#beatcancer #,2
LeukemiaAwareness,2
about #venetoclax &,2
Derek Caine,2
https://t.co/rfUnPq7pqt,2
Work of International Workshop,2
the age of 48,2
Global Relapsed Chronic,2
https://t.co/I9B0QDREou,2
@ICESOntario,2
‚óà,2
#CME,2
https://t.co/vtJSRnyz0M,2
#Regulatory,2
Pharma @abbvie @Roche,2
Niemann @Rigshospitalet,2
Innovation,2
https://t.co/R7WeN8F1TE,2
the next 15-20 years,2
Competi,2
Ke,2
https://t.co/V5ktbFSgpd,2
https://t.co/QU8aydQMxr,2
Live Webinar,2
https://t.co/RBjKw7Qhoi,2
w #CLL,2
ESMO16,2
eUpdate,2
10/7,2
#Transplant Be,2
JLL &lt;3,2
8 oct 2016,2
FST,2
üòè,2
#11thCheerAndLead #,2
12th,2
U.S,2
Marke,2
PAL,2
https://t.co/tWywgscwOf,2
#ASHMHM16,2
ASHMHM16,2
Weltlymphomtag,2
przewlek≈ÇƒÖ bia≈Çaczkƒô limfatycznƒÖ,2
@Jasoncology,2
Lipoprotein,2
https://t.co/11U1msyY5E,2
Guest Blog My Experience With,2
Medical Insurance Billing &,2
Doctor Office Visits,2
#Cancer @power4patients,2
"PatientCafe
https://t.co/3om3JW9TCb",2
El d√≠a de hoy,2
Competitive Strat,2
#wiright #p2 #,2
GEN,2
BMF Super-Enhancer Polymorphism,2
Ofatumumab Active for Induction and Maintenance,2
Patient Cafe,2
CLL Patients Responded to Influenza Vaccine - Patients,2
"Children
#",2
#teamdiabetescda #,2
Dm,2
NewEvidence,2
Lawrence Boise,2
Hcsm,2
UKR,2
76.565,2
"75.441
4.Belyavskiy #",2
RUS,2
Andrew Zelenetz -  ,2
30.666,2
30.608,2
30.566,2
30.166,2
#LoEstelardelaGimnasia #,2
1ra,2
1.Whitlock #,2
GBR,2
15.875,2
15.766,2
15.266,2
"15.133
#",2
Spleen and,2
Hilar Nodes,2
Antibodies,2
#mytulsatech #,2
@CONCACAF,2
#ASCO2016 #,2
#ASCO2016,2
#Targeted #,2
NEETPG,2
$RHHBY #,2
CLL Study Group's,2
#campuslive #,2
#financialassistance,2
Eliot,2
July 19th,2
Varied,2
Newly Diagnosed and Recurrent,2
May 12-15,2
Month 3,2
CJ Chris-,2
3 Years,2
#MultipleMyeloma +,2
Francesco Forconi,2
@CLLdoc,2
#fencing #,2
#Maintenance #,2
MRD-Negative Status,2
Pipeline Review 2016 ‚Äì Research and Markets,2
#In,2
5 months,2
#EHA2016 #,2
#EHA2016 Poster,2
#fairmontcll,2
FCR Regimen Confirmed,2
Standard Frontline Regimen,2
Sydney,2
JC Barrientos,2
#ASCO16 #,2
as many #CLL,2
PRT,2
CLL PRT,2
https://t.co/2ZwWoSSrAO,2
spoonie,2
ZURICH,2
#jadprolive #,2
TestTuesday,2
https://t.co/cOQlnhZ0I1,2
AbbVie/Roche's,2
CD-20 Antibodies,2
2.1,2
Dit,2
#cameralibra,2
@Beatrixzkh,2
https://t.co/5EfA44XPAW,2
JCIInsight Chronic,2
May 19th,2
https://t.co/HNKKBWWuXJ,2
AACR16,2
Wierda @wwierda,2
Janice,2
European Medicines Agency Issues Positive Opinion,2
Wierdas,2
Watch PatientPower,2
WeillCornell,2
Senegal,2
EV,2
Travel-,2
Lymphocytic Leukemia and Invasive Ductal Carcinoma Presenting,2
https://t.co/QlCw8jmpnE,2
Adding Targeted Therapy to Chemoimmunotherapy,2
2016-2018,2
Laura Crowe,2
DotScan,2
#haem2016!,2
haem2016,2
55,2
Abbott,2
LLS Welcomes FDA Approval,2
Venclexta to Treat Certain,2
The US Food and Drug Administr,2
‚óà FDA,2
el venetoclax,2
el tratamiento de la leucemia linfoc√≠tica cr√≥nica,2
deleci√≥n 17p,2
Roches Venclexta,2
Small-Molecule Inhibitors: Ibrutinib,2
@UCCancerCenter,2
Maintenance Lenalidomide Has Limited Feasibility,2
#Aviate #,2
3/23/16,2
#Supplements @MDAndersonNews,2
#hospital,2
Arresting the Inflammatory Drive of,2
IGHV1,2
Lymphom,2
#PowerfulIn2016  ,2
SweetsSyndrome,2
#Kixx #TeamDiabetesCDA #,2
LLL,2
el pr√≥ximo,2
@CelloGroup,2
#Monoclonal #,2
GBX 120 PT,2
1999,2
#PowerfulPatients,2
Early this month,2
https://t.co/MG9nYszXMC #,2
Adverse Outcomes,2
oftalmologia,2
High LEF1,2
Shari,2
5680 feet,2
Jasper,2
#BlitzSnowShoe,2
Leukemia Patient-Friendly Guides Put Out,2
month two,2
Leukemia Drug Priority Review,2
The Relationship Between Genetic Testing and Targeted Therapy,2
Bill Plunkett,2
#allogenicbmtransplant #,2
nadir,2
The Value of CT Scans,2
Januario Castro,2
FCR Immunochemotherapy,2
#Healthcare #,2
#estoeslucha #,2
H2 2015,2
ForTheFunOfIt,2
@MDAndersonNews -Combining New and,2
Venetoclax Safe,2
SLL With Poor Prognostic Features,2
#ASH15 - #,2
Lisa Hicks,2
Venetoclax/Rituximab Combo Gains,2
https://t.co/5Xijte3Ah2,2
Alberta,2
Innate,2
nikeplus,2
#Inhibitor Treatments Forever,2
@UFMedicine,2
20-year,2
Ofatumumab FDA,2
Extended Treatment,2
Ublituximab Is Combined With #Ibrutinib,2
Venetoclax Plus Rituximab Receives Breakthrough Therapy Designation,2
LLSinthenews Marking,2
Estov,2
CLL8,2
Barrientos @JacquieBarr,2
#1000km2016 #NoPotsy,2
6.00 km,2
@Roche @AbbVie,2
#Second-#Line #,2
#1000KM2016 #,2
Utilizing Maintenance Therapy,2
Home Run,2
#ASH15 News #,2
#collegetour #,2
A Case of Complete and Durable Molecular Remission of Chronic Lymphocytic Leukemia,2
Lemanne,2
CD126,2
Gribben @QMBCI,2
Wierda @LeukemiaMDA,2
Dinaciclib Demonstrates Potential Activity,2
#ASH15  ,2
Bespoke Human Immune Cell,2
Alemtuzumab Active,2
Therapeutic Combinations and Sequences,2
https://t.co/A7SphPE4Ky,2
https://t.co/NlSITppSL8,2
https://t.co/aKiirMocg9,2
Diego Villa,2
https://t.co/6RmH0ImcXw,2
#untreated #,2
nearly 80%,2
Black Swan Intelligent Insi,2
GM,2
J Sitra Dior,2
New England Journal,2
3 RES,2
Helena,2
Targeting BCL2 with,2
Relapsed/Refract,2
GMOfree Mining,2
Relapsed/Ref,2
Drs Jeff Sharman,2
Kanti Rai &,2
Oncolog√≠a,2
#London #,2
Xose de Puente Mon,2
#PowerfulPatients Save,2
#UUD #,2
#KnowledgeIsBest Rx #,2
#positivevibes #,2
"Nov. 17, 2015",2
#Novel #,2
Afternoon,2
#blog,2
Anca Prica,2
MBL #,2
This Week,2
Pfisiopatologicos,2
ACPMA,2
Positive &,2
Roman,2
#York #Learning #,2
Vemurafenib May,2
the 40 miles,2
ASU,2
Heinz,2
TESL Canada,2
#TESL2015 #,2
ReseachBib,2
Idelalisib Plus Rituximab Highly Active in,2
80 to 90 percent,2
Byrd,2
http://t.co/Wij4c7tJ4w,2
Supplemental NDA Submitted,2
Email care@leukaemiacare.org.uk,2
Fortschritte,2
A5,2
Robert Azopardi,2
ONS Meeting - Gazyva¬Æ,2
Relapsed/ Refractory Chronic Lymphocytic Leukemia,2
Insights,2
@dwodarz,2
KnowledgeIsBestRx @MDAndersonNews,2
#Priority #Review,2
Ofatumumab as Maintenance Therapy for,2
$NVS $,2
anti-cd37,2
Supplemental New Drug Application for Treatment-na√Øve,2
SNDA,2
Pan PI3-kinase,2
mTOR,2
http://t.co/mm3KsmnJJ7,2
Haemato-Onc Relaunch,2
Chronic Lymphocytic Leukemia Reveals New Molecular Subdivisions,2
Ritz,2
the PD-1 Checkpoint,2
18.52%,2
4-plus years,2
Global Industry,2
http://t.co/6iuQyVKuu3,2
Study of Idelalisib in Combination,2
Dyer,2
Pennine,2
http://t.co/ROdhZXWMl2,2
Leukemia http://t.co/pV3HasUnJZ,2
Epstein-Barr Virus MicroRNAs,2
#CollegeStation #,2
Route of Administration and Type of Molecule,2
#Hematolog√≠a MUTATIONS,2
Pilaralisib,2
Giovani,2
"#MOGA15
#",2
"#MOGA15
#CLL",2
Sue Zurface,2
#cute,2
Two years ago,2
Therapeutics Pipeline Report,2
Pipeline Review and Overview,2
Annotated Research Guide,2
Arzerra sBLA,2
CLL Cello Group,2
MD Anderson Hematologic Malignancies Retreat,2
2015/16,2
Stem Cell,2
#allstars #,2
#creativewriting,2
Fred Hutch:,2
TechJobs,2
CGIX,2
#Progression-#free #,2
WA,2
@Unsworth_CC,2
Optimal First-Line Therapy for Previously Untreated Chronic,2
Ublituximab (TG Therapeutics) Phase II With Ibrutinib Effective,2
Vienna,2
#Ofatumumab/#Chemo,2
Austria,2
GMCL,2
#ASCO15 #leusm #,2
#CLL #ASCO15 #,2
Tx Thwarts,2
Heywood,2
U15,2
IVGH,2
#ASCO2015 #,2
#Biothera #,2
The CARE #Hematology Session,2
Kuruvilla,2
Warburg,2
Clinical Review],2
#MOREoncology,2
1989,2
Sudhir Manda,2
Evolving Therapeutic Landscape,2
#ASCO15 $,2
Venetoclax Receives FDA Breakthrough Designation,2
WallStreet OTCChronic,2
CLL Molecular Onc Tumor Board,2
CancerFDA,2
Killing,2
Education &,2
#Empowerment Meeting,2
MabTheraSC,2
RIP140/NRIP1,2
Molecular Oncology Tumor Boards,2
La librairie,2
Poitou-Charentes,2
@HeysideCC,2
http://t.co/MLMWejUj1L,2
3year,2
StemCell Transplant http://t.co/rPwZOjCtfc,2
Nodality Launches PathPro Chronic,2
Roach,2
1.2015,2
TEL,2
Ublituximab + #,2
#66ers #,2
#VSCOcam #,2
#cavalo,2
TR,2
Novel Biologic Agents,2
NonHodgkin Lymphoma,2
AMAZING,2
Plaza Monumento,2
IFN,2
Leukemia - http://t.co/PQYhZdCUTh,2
@jisc,2
Rodney Brown,2
UWI,2
Super Crazy,2
#WWE #,2
las chicas,2
http://t.co/53ep96DvAp,2
GBX 105 PT,2
Harry Moore,2
the Moon Shots Program,2
Clifton Road,2
#machines #,2
MT @ASCO,2
#ride,2
Cancer Genetics',2
Quien Al #,2
04264352565,2
about #WorldCancerDay,2
Initial Presentation and Diagnosis of Chronic,2
http://t.co/RZAlLZeIhs,2
Myron Czuczman,2
Bett2015,2
Aberrations http://t.co/mBvZ6iLqFf,2
CELLO,2
94p,2
Leukemia http://t.co/I7fXDHtuLB,2
https://t.co/eJ6m4QpC5P,1
https://t.co/gg0G9At23N,1
#AstraZenecas #,1
Haematologica https://t.co/Z2kCLZaX0D,1
https://t.co/6OuJptLCIN #lymsm,1
#oncology #drugapprovals,1
https://t.co/Sxve6NGGX3,1
Superstar,1
@cancertrials_ie @CllSociety,1
https://t.co/murr3KPhsZ,1
Optimal Management of High-Risk CLL,1
19 March 2021,1
7.00 pm - 8.30,1
2 - Group Captain,1
"Pune

Chair",1
"Mumbai
Moderator:",1
@SWBH_RandD @Oncology_at_AZ,1
Thursday 18th March,1
The National Institute for Health and Care Excellence,1
https://t.co/ntYG8VLKyZ,1
Thursday 18 March 2021,1
https://t.co/nLoyYbepRA,1
#pharma #lifesciences,1
#ClinicalResearchNews #,1
#LifeSciencesNews #MedicalNews #,1
PharmiwebNews,1
https://t.co/tW2zAInOlp,1
@DaiichiSankyo,1
Nilemdo,1
Sky News,1
@bloodcancer_uk https://t.co/Sh0iIDgKel,1
https://t.co/NrxD4YK0zm,1
@CHANEL,1
Astra-Zeneca,1
TiP,1
KRT-232,1
Janssen Vaccines &,1
Prevention B.V.,1
Pharma B.V.,1
AstraZeneca AB,1
"Apremilast
Lanadelumab
Abatacept-remdesivir-infliximab-mesilato de cenicriviroc",1
Maria,1
Ibrutinib FDA,1
Brexucarbatagene Autoleucel FDA,1
https://t.co/klsjuwWfDM,1
https://t.co/l7qRcv0uDS,1
primario de eficacia en,1
Physician Views Preview,1
https://t.co/m89J49LBfC,1
CLL Research: Acalabrutinib,1
Mantle Cell Lymphoma Survival Likely Affected,1
CALQUENCE Beneficial,1
#calquence #CLL #,1
#rarecancer #,1
#TCTM21 #gvhdsm,1
Mantle Cell Lymphoma Treatment Market,1
Forecast Data,1
In-Depth Analysis,1
2028,1
rel/ref CLL,1
HTA ID:,1
20063,1
National Centre for Pharmacoeconomics,1
#Arzt #,1
#Immuntherapie #,1
#Therapie #,1
Dr Danilov,1
Dr Graff,1
Calquence Meets Primary Efficacy Endpoint,1
#digitalhealth,1
Lyfebulb,1
#leusm https://t.co/oYihNdET4I,1
"| @AstraZeneca 
https://t.co/m89J49LBfC",1
Imbruvica https://t.co/AAQF9Btz5m,1
https://t.co/1oki6GxPjP,1
News| Acalabrutinib,1
AMMH√©mato,1
Findrugs,1
#innovation #,1
#mantle cell,1
"Tuesday, January 26, 2021 - Roundup - MM&amp;M - Medical Marketing",1
"Calquence

@Merck @statnews",1
@moderna_tx @AstraZenecaUS @pfizer,1
https://t.co/2n8KV2Mhza,1
https://t.co/pbHwvaRtai,1
CALQUENCE met Primary Efficacy Endpoint,1
Trial Against Ibrutinib,1
https://t.co/HSRYADWja1,1
#CALQUENCE Met Primary Efficacy Endpoint,1
#Refractory #,1
https://t.co/3dDltqR7h2,1
https://t.co/0xCbBETtfM,1
„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç´„É´„Ç±„É≥„Çπ,1
Quick Takes,1
Comirnaty,1
Hong Kong,1
Albireo and Iterum,1
#OncologyTopNews #,1
https://t.co/kBg8DCFFmB,1
- Jain - - American Journal of Hematology - Wiley Online Library,1
Topline,1
https://t.co/ShghMeIhrE,1
https://t.co/m6YkcM0N8A,1
$AZN $JNJ,1
https://t.co/rmkHEDOpXj,1
"CALQUENCE Met its Primary Efficacy Endpoint

Related Tickers",1
https://t.co/2zmD10ekY5,1
https://t.co/rYM3dexyjU,1
https://t.co/bjLnjYzuBe,1
#leukaemia #pharma #,1
Calquence zur Behandlung,1
AKTIENCHECK,1
https://t.co/cEd42RpVQ7,1
https://t.co/qIzMgrqDqg,1
ATRIAL FIBRILLATION,1
Calquence',1
LiveSquawk,1
Calquence Met Primary Endpoint,1
ASTRAZENECA PLC - CALQUENCE MET PRIMARY ENDPOINT,1
New CALQUENCE¬Æ Data,1
#CALQUENCE #,1
https://t.co/fdzRB6KRVD,1
https://t.co/fIrPpYDHI0,1
Mit Acalabrutinib kam,1
Dezember ein,1
Bruton-Tyrosinkinase(BTK)-Hemmer auf den,1
Markt,1
Der Neuling,1
https://t.co/XTWA2Bz5NB,1
Global Acalabrutinib Market In-Depth Analysis Report,1
Global Manufacturers¬†Analysis,1
quanto nella malattia,1
https://t.co/R1CPilGRTH,1
Rai III,1
Ô∏èhapto,1
https://t.co/l6wzhD0nPv,1
Condition Summary: Primary Central Nervous System Lymphoma,1
PCNSL,1
Health Technology Assessments,1
sull‚Äôutilizzo di #,1
della leucemia linfatica cronica,1
con risultati significativi,1
Francesca Romana Mauro,1
Phase 2 #,1
an average of 22 months,1
12/17,1
„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquence¬ÆÔºâ„ÄÅ4„Å§„ÅÆË©¶È®ì„Éá„Éº„Çø„Å´„Çà„Å£„Å¶„ÄÅÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„ÅÆÊÇ£ËÄÖ„Åï„Çì„ÅÆÂøÉË°Ä... https://t.co/UAxtcYBcaN,1
„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquence(R)Ôºâ„ÄÅ4„Å§„ÅÆË©¶È®ì„Éá„Éº„Çø„Å´„Çà„Å£„Å¶„ÄÅÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„ÅÆÊÇ£ËÄÖ„Åï„Çì„ÅÆÂøÉË°ÄÁÆ°ÂÆâÂÖ®ÊÄß„Éó„É≠„Éï„Ç°„Ç§„É´„ÇíË©ï‰æ°,1
#ad https://t.co/613omF99rh,1
AZN LR OP Multiple,1
"Lynparza, Calquence, Enhertu",1
WHO Solidarity Trials,1
Investigaci√≥n üîé,1
üîé Los datos de #,1
https://t.co/1bPqyNA0km,1
Kinumpirma ng Department of Health,1
gagamitin sa World Health Organization,1
only seven,1
https://t.co/w4nltTQFJF,1
"Calquence
https://t.co/8JwlIjSHTd",1
Avigan bilang gamot sa,1
sa Pilipinas,1
gamot kontra COVID-19,1
sa mga gamot,1
kasama sa,1
Nagbigay,1
https://t.co/BogahKfYMH,1
bilang bahagi,1
sa paghanap ng gamot,1
para sa COVID-19,1
ÈòøÂç°ÊõøÂ∞º Â≠üÂä†ÊãâËÄÄÂìÅÂõΩÈôÖÈ¶ñ‰ªø,1
https://t.co/PkC83TF1kq,1
Los datos de Calquence de 4,1
#ad https://t.co/o9G2s6XEMh,1
#ad https://t.co/koo80IGjvP,1
Leucemia linfatica,1
l‚Äôottimo,1
nell'ambito,1
Acalabrutinib+R-CHOP,1
ND #,1
#ASH20 https://t.co/IF9eYVa8,1
Early Intervention With Acalabrutinib in Patients With High Risk CLL,1
Monday 11 January 2021,1
https://t.co/QRGsgACUdd https://t.co/IDZTWq5Bhk,1
Targeted¬†Oncology https://t.co/xwPSwP0ij8,1
#ad https://t.co/DljdCKTD7E https://t.co/aQD1ULX1AC,1
Management of Waldenstr√∂m Macroglobulinemia,1
https://t.co/43pVoOkpdi,1
#ROR1inhibitor #MDM2inhibitor #,1
#acalabrutinib #zanubritinib #,1
Refractory Autoimmune Hemolytic Anemia in Patients With Chronic,1
https://t.co/dmm83g8Osj,1
venetoclax+obinatuzumab,1
#ASH2020 https://t.co/zpspQNy8y1,1
CARAMEL,1
https://t.co/oGzpJRnaOf,1
#pharmatopnews #,1
https://t.co/gBB1X0TTK1,1
MCL https://t.co/xuH2beSMTw,1
2947 Phase 2 Study,1
Shows Long-Term Efficacy and,1
#ad https://t.co/kpqsMVmGLQ,1
Less Than 1%,1
https://t.co/bDMcZaWJHo,1
https://t.co/fpte97uDSd,1
MCL https://t.co/JvHjWIyvfe,1
ACE-LY-004 Phase II,1
Calquence - https://t.co/b8JIeZLF4S,1
obinutuzumab https://t.co/MRBDl9AdeQ https://t.co/WLy1gaofTm,1
https://t.co/FOL47mRFbO VIŒõ,1
MCL https://t.co/4DdzNkc7tO,1
#LatestPharmaNewsDec7 #,1
"LatestAstrazenecaNewsDec7 
https://t.co/GQHZzUJ6BW",1
#mantlecelllymphoma $,1
https://t.co/2Dd7CdJ1D8,1
Calquence and BeiGene‚Äôs,1
https://t.co/nb6TYqWit2 #,1
#competitiveintelligence #marketing,1
https://t.co/5Cn35fMGtb,1
üì∞ NEWS ALERT,1
Johnson - ASH,1
Fintech Zoom,1
ICO,1
#mantlecelllymphoma     ,1
Nicola Lamanna,1
https://t.co/fNEYyoTxW3,1
La Agencia Europea de Medicamentos,1
el tratamiento de leucemia linfoc√≠tica cr√≥nica,1
de las,1
#EMAapproval #,1
https://t.co/2RBCWL3esZ https://t.co/vzIq0g7ih1,1
https://t.co/obEDJId2i5 #,1
https://t.co/jPQIHPtq14,1
https://t.co/Xbm1MDi8nb,1
https://t.co/Q8tBJWRh5Z,1
https://t.co/b3IjDBRMXt #,1
https://t.co/x2KyjOQZlA,1
https://t.co/17s9RWLeha,1
Solidarity Trial,1
#covid19 #SARSCOV2 #,1
https://t.co/q96D7TjXSI,1
#ad https://t.co/KaW6GaAICw https://t.co/cBv8eK4Wia,1
kommt das,1
Behandlungsoption,1
https://t.co/xDWay9czSg,1
#ad https://t.co/1tKQmxDMwR,1
https://t.co/TXh0hAdz2e #,1
üëâüèºhttps://t.co/Zl0uXxvp4o,1
üëâüèºhttps://t.co/2RKhq2kkb0üëàüèº,1
https://t.co/S2SmE1Pygl,1
Contribuez,1
https://t.co/XnVrEkV7eG,1
https://t.co/LhC0IinxYC,1
https://t.co/PNKGq59aCR,1
#ad https://t.co/G2Fg3POnie,1
https://t.co/6GuNjqcsvx,1
UE,1
2020Âπ¥11Êúà20Êó•„Äê„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´ÔΩúÊó•„Äë„ÄéÊñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç§„É´„ÇπÊÄßÂëºÂê∏Âô®ÁóáÁä∂„ÇíÊúâ„Åô„ÇãÂÖ•Èô¢ÊÇ£ËÄÖ„Åï„Çì„ÇíÂØæË±°„Å®„Åô„Çã„ÄÅ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquence,1
ÂëºÂê∏‰∏çÂÖ®Êú™Áô∫Áóá„ÅÆÁîüÂ≠òÊÇ£ËÄÖ„ÅÆÂâ≤ÂêàÂ¢óÂä†„Å®„ÅÑ„ÅÜ‰∏ªË¶ÅË©ï‰æ°È†ÖÁõÆ„ÇíÈÅîÊàê„Åõ„Åö,1
https://t.co/X1PEde9Spp,1
Danilov &,1
https://t.co/ZfRmfV1CaW,1
14-day,1
#COVID-19 https://t.co/NssVAZ1vEt,1
https://t.co/5spf24Oa3A,1
https://t.co/mUPuCji8bG,1
Platinum-Resistant Metastatic #,1
https://t.co/Z41GBayMa9,1
https://t.co/MUsCSBQ2xR,1
https://t.co/ai5FkMGUan #,1
#ad https://t.co/6bmCbv2QBe,1
https://t.co/OPcVZAmkG5 #MCL #lymsm #,1
https://t.co/hX0lvkywy5,1
Die Europ√§ische Kommission,1
Behandlung von chronisch,1
https://t.co/OpBRvSmVBf,1
11/20,1
Êñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç§„É´„ÇπÊÄßÂëºÂê∏Âô®ÁóáÁä∂„ÇíÊúâ„Åô„ÇãÂÖ•Èô¢ÊÇ£ËÄÖ„Åï„Çì„ÇíÂØæË±°„Å®„Åô„Çã„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâCALAVIÁ¨¨‚Ö°Áõ∏Ë©¶È®ì,1
#ÂâµËñ¨ #,1
Êñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç§„É´„ÇπÊÄßÂëºÂê∏Âô®ÁóáÁä∂„ÇíÊúâ„Åô„ÇãÂÖ•Èô¢ÊÇ£ËÄÖ„Åï„Çì„ÇíÂØæË±°„Å®„Åô„Çã„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâCALAVIÁ¨¨‚Ö°Áõ∏Ë©¶È®ì... https://t.co/Ow7fO1u2g6,1
https://t.co/rbKwKoPKxV,1
https://t.co/r0X9hV6lu8,1
#ad https://t.co/u5RPyBDiXu https://t.co/lIjfV8mulj,1
COVID-19 https://t.co/o59KhfbzC0,1
üëâ https://t.co/GuoOZZsthw,1
Safety Data,1
https://t.co/KOFeTLi4vu,1
CURE &,1
#ad https://t.co/AwWPF5P1Uw,1
https://t.co/LUQkyCKbpS,1
#ad https://t.co/d7p49HxVT0,1
BTKÈòªÂÆ≥Ëñ¨acalabrutinib„ÄÅÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„ÇíÈÅ©Âøú„Å´EU„ÅßÊâøË™çÂèñÂæó,1
CLL Treatment Research,1
BTKInhibitor,1
https://t.co/mHoYUVp33s,1
https://t.co/PFF4wchuFG,1
https://t.co/fdHqNuMcQa,1
#ad,1
#ad https://t.co/YeEPWJi7Zo,1
https://t.co/QpX0aHM2Jw,1
https://t.co/MEUHtZquhl,1
#ad https://t.co/qmsGJjYjxw https://t.co/C9fS13op8b,1
Oncology News Update,1
https://t.co/LFwoRUAzFn,1
¬ÆÔºâEU„Å´„Åä„ÅÑ„Å¶„ÄÅÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„ÅÆÊ≤ªÁôÇËñ¨„Å®„Åó„Å¶ÊâøË™çÂèñÂæó,1
11/17,1
2020Âπ¥11Êúà17Êó•„Äê„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´ÔΩúÊó•„Äë„Äé„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquence,1
https://t.co/ucdmgUqyxu,1
https://t.co/ugOJpW32Rp,1
AZÁ§æBTKÈòªÂÆ≥Ââ§Calquence„ÅØ„ÄÅÂÖ•Èô¢ÊÇ£ËÄÖ„Å´ÂäπÊûú„ÅåË™ç„ÇÅ„Çâ„Çå„Åö„ÄÅ„Ç≥„É≠„Éä„Ç¶„Ç§„É´„Çπ„ÅåÂºï„ÅçËµ∑„Åì„ÅôÈáçÁØ§„Å™ÁÇéÁóáÂøúÁ≠î„Å∏„ÅÆBTKÈòªÂÆ≥Ââ§„ÅÆÂäπÊûú„Å´ÁñëÂïè„ÅåÊåÅ„Åü„Çå„Å¶„ÅÑ„Çã„ÄÇIL-6ÈÅÆÊñ≠Ëñ¨„ÅÆ‰∏≠Ê≠¢„ÇÇ„ÅÇ„Çä„ÄÅEli LillyÁ§æ„ÄÅRegeneronÁ§æ„ÄÅAZÁ§æ„ÅÆÊäó‰ΩìËñ¨„Å∏„ÅÆÊúüÂæÖ„ÅåÁõ∏ÂØæÁöÑ„Å´È´ò„Åæ„Å£„Å¶„ÅÑ„Çã,1
https://t.co/eNkelaGsec,1
#„Ç®„Éê„É™„É•„Ç®„Éº„Éà #,1
NOVITA,1
NEL,1
LEUCEMIA LINFATICA CRONICA - Approvato #Calquence,1
Newsletter Xagena,1
Xagena #,1
Join CURE &,1
Becky,1
MedLancr,1
Reduce Mortality or Respiratory Failure,1
la recomendaci√≥n de la EMA,1
Comisi√≥n Europea,1
BioPharma,1
Costco - AstraZeneca's,1
Fintech Zoom - https://t.co/4Vh6i9S9UF @FintechZoom,1
con la vacuna de la COVID-19,1
supervivencia sin progresi√≥n,1
los pacientes,1
OncoReporte,1
AstraZenaca,1
#clinicaltrials #pharma #,1
https://t.co/oatqNMeiOm,1
COVID-19 https://t.co/tR4HCzw6p9,1
#pharmanews,1
ElonMusk,1
el tratamiento de adultos con leucemia,1
COVID_19,1
ARD,1
https://t.co/suakSAViL0,1
onder ziekenhuis,1
https://t.co/Y7QNmOM5PD,1
The European Union,1
@EMA_News https://t.co/bDkVq0albN,1
https://t.co/4SwJZEsdoE,1
@Yahoo,1
11-12-2020,1
the White House,1
NO funciona en evitar,1
el posicionamiento de #,1
ila√ß ≈üirketi AstraZeneca tarafƒ±ndan,1
kan kanseri,1
kullanƒ±lan Calquence,1
korona,1
olduƒüu a√ßƒ±klandƒ±,1
SONDAKIKA,1
BioSpace https://t.co/q38xyvY6wD,1
Moderna,1
para la leucemia,1
linfoc√≠tica cr√≥nica  https://t.co/lSNumf738L,1
Kristin Jensen,1
$RHHBY $NVS $SNY $,1
Medicago,1
PhII/III,1
https://t.co/Qfi1j64IVG,1
"https://t.co/vLlIRsRpEn
#",1
https://t.co/9jSZcmL7hJ,1
FPRX,1
roughly 20%,1
–∫–æ–≤–∏–¥–∞ –Ω–µ –æ–ø—Ä–∞–≤–¥–∞–ª–∞—Å—å,1
Small¬†Molecules https://t.co/MrdhwD6Ori,1
https://t.co/OXdA2K2e5E #,1
COVID-19 - https://t.co/QALAuDCaMK https://t.co/2V4uqnPUe7,1
COVID-19 https://t.co/E1hk6OO6uH,1
https://t.co/VgnlrmYWLz,1
https://t.co/bb8v28s70i,1
https://t.co/Md0aLh039H Update,1
https://t.co/DC9zF468BR,1
https://t.co/6AG4vdmRqf,1
#Calquence disappoints,1
Apr√®s Novartis,1
la semaine derni√®re,1
c'est d√©sormais,1
d'AstraZeneca qui,1
Did Not Meet Primary Endpoint,1
AstraZeneca Announced Calavi Phase Ii Trials for Calquence in Patients Hospitalised With Respiratory Symptoms,1
"Did Not Meet Primary Endpoint

Related",1
contra la leucemia calquence,1
los ensayos,1
FinancialPersonal,1
COVID-19 https://t.co/oJIhIIKdFS,1
"https://t.co/wEgFGEEhwu
#",1
LA COMMISSIONE,1
https://t.co/tPMvNlXCJJ,1
LA CE,1
el linfoma linfoc√≠tico peque√±o,1
Combinado,1
el riesgo de progresi√≥n de enfermedad o muerte,1
https://t.co/sT6RLUGiOT,1
üò∂,1
@Nasdaq,1
Europa https://t.co/cRBFtXG0es,1
Salud de @Notimex  https://t.co/50siJTwS2x,1
Zdravilo Calquence,1
odobreno za,1
@ASTRAZENECAUK,1
sia,1
sia dopo ricaduta,1
AMM,1
Europa https://t.co/TRqsGUerUm,1
nella malattia,1
https://t.co/KiOjg4LE39,1
1.4,1
PAP Support,1
#LatestPharmaNewsNov9 #,1
https://t.co/avIAqF4wqr,1
Samiran Panda,1
#cancernews #,1
Calquence https://t.co/gGhPz9jTzu,1
Nasdaq News - https://t.co/fWUdbvKdVL,1
the Eu for the Treatment of Chronic,1
European Union,1
#AZN Calquence,1
#pharma $,1
"singlestockETPs
https://t.co/66gsMtTizU",1
Safety Study Supports Acalabrutinib Alone or in Combination for CLL,1
M.D,1
Versus Zanubrutinib,1
https://t.co/Pfxw71m0h9,1
60%,1
28.6,1
22.0,1
AZ‚Äôs Acalabrutinib Clear PAFSC Review OrphanPacific‚Äôs,1
https://t.co/07SVDclr7q,1
@RichardFurmanMD https://t.co/aGOKuhaL3W,1
CI Andy,1
https://t.co/YWghVa35x3„ÄÅÈÖ∏ÊÄß„Å´„Åó„Å™„ÅÑ„Å®Ê∫∂„Åë„Å™„ÅÑ„ÅÆ„Åß„Ç≥„Ç´„Éª„Ç≥„Éº„É©„Å´Ê∫∂„Åã„Åô„Å£„Å¶Ëçâ‰∏çÂèØÈÅø,1
a Phase Ib/II,1
Obinutuzumab zeigt,1
Vergleich zu anderen,1
Frontline-Behandlungen,1
Fludarabin nicht,1
https://t.co/emB9IkutHU,1
Try Calquence,1
4 months,1
#icmr #,1
#cdsco,1
#remdesivir #,1
Calquence https://t.co/AOQm5shPsd,1
AZ‚Äôs,1
PAFSC Review,1
Oct. 30,1
OrphanPacific,1
"Oct 7, 2020]",1
COVID19nCancer,1
„Ç´„É´„Ç±„É≥„ÇπÔºà‰∏ÄËà¨ÂêçÔºö„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºâ„Äç„Åå30Êó•ÈñãÂÇ¨‰∫àÂÆö„ÅÆÁ¨¨‰∫åÈÉ®‰ºö„Å´„Å¶„ÄåÂÜçÁô∫„Åæ„Åü„ÅØÈõ£Ê≤ªÊÄß„ÅÆÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ,1
Bemcentinib Capsule,1
1Bn,1
"#remdesivir üò≤
2",1
#COVID19 https://t.co/bIkImDLTJs,1
https://t.co/wqjckSh6BX,1
DoktorNews,1
"https://t.co/tlTVZ4LpgC
üëâYouTube-https://t.co/6BEykx8TIS
",1
#India #AstraZenecaPharma #,1
Daycosecurities https://t.co/vMB5Ueasl8,1
#astrazenecanews #acalabrutinibcapsules,1
"60,950",1
63.4 ‡§≤‡§æ‡§ñ,1
‡§Æ‡•á‡§Ç ‡§ñ‡§∞‡•Ä‡§¶‡•á‡§ó‡•Ä,1
#stockmarket #,1
#finance,1
#financenewsdaily #,1
#india,1
Exclusive Morning Market News &,1
Drugs Controller,1
March 12,1
#... #,1
frontpage_app https://t.co/ZWrZzX1Djd,1
https://t.co/hpLXR0Dz8r,1
KPMG,1
October 8,1
UPL,1
Mauritius - UPL Corporation,1
"October 21, 2020
Alert: Calquence Medicine Is Used To Treat Adults With Mantle Cell",1
Launch Calquence,1
"October 21, 2020",1
#Pharmaceutical,1
ASTRAZEN - Launch Of Acalabrutinib 100Mg Capsules,1
CoronaVirus,1
‡§ö‡§æ‡§π‡§§‡§æ,1
‡§™‡•à‡§®‡§≤,1
CoronaUpdates,1
#letsBeatCorona #,1
IndiaFightsCorona,1
"#coronavirusindia
https://t.co/RKoQzwYv3j",1
ETIndustryNews,1
#YoSoyJabali,1
‚Å¶@ICMRDELHI‚Å©,1
#Covid-19,1
https://t.co/7fFdSZXi55,1
https://t.co/ie6LhZnlYd,1
https://t.co/gcwXoOtYRh,1
Indian Council of Medical Research,1
the World Heath Organization‚Äôs,1
MCL  https://t.co/RWNWKsAMdD,1
ICMR  ,1
@ETHealthWorld App,1
https://t.co/LgSxxma0As,1
#ICMR #Dexamethasone #,1
https://t.co/kxXbva00S8,1
cllsm,1
ÈÄÇÁî®‰∫éÂ•óÁªÜËÉûÊ∑ãÂ∑¥Áò§ÊÇ£ËÄÖÔºåAcalabrutinibÊòØ‰∏ÄÁßçÊøÄÈÖ∂ÊäëÂà∂ÂâÇÔºåÈÄöËøáÈòªÊñ≠ËÇøÁò§ÁªÜËÉûÂ§çÂà∂ÂíåËΩ¨ÁßªÊâÄÈúÄÁöÑÈÖ∂ÂèëÊå•ÁñóÊïà„ÄÇ‰Ωú‰∏∫Á¨¨‰∫å‰ª£BTKÊäëÂà∂ÂâÇÔºåÁõ∏ÊØî‰∫éÁ¨¨‰∏Ä‰ª£ÁöÑBTKÊäëÂà∂ÂâÇ‰ºäÂ∏ÉÊõøÂ∞ºÔºåÂâØ‰ΩúÁî®Êõ¥‰Ωé„ÄÇ https://t.co/P9MEjeTKYq,1
ÈÄÇÁî®‰∫éÂ•óÁªÜËÉûÊ∑ãÂ∑¥Áò§ÊÇ£ËÄÖÔºåAcalabrutinibÊòØ‰∏ÄÁßçÊøÄÈÖ∂ÊäëÂà∂ÂâÇÔºåÈÄöËøáÈòªÊñ≠ËÇøÁò§ÁªÜËÉûÂ§çÂà∂ÂíåËΩ¨ÁßªÊâÄÈúÄÁöÑÈÖ∂ÂèëÊå•ÁñóÊïà„ÄÇ‰Ωú‰∏∫Á¨¨‰∫å‰ª£BTKÊäëÂà∂ÂâÇÔºåÁõ∏ÊØî‰∫éÁ¨¨‰∏Ä‰ª£ÁöÑBTKÊäëÂà∂ÂâÇ‰ºäÂ∏ÉÊõøÂ∞ºÔºåÂâØ‰ΩúÁî®Êõ¥‰Ωé„ÄÇ,1
ÈÄÇÁî®‰∫éÂ•óÁªÜËÉûÊ∑ãÂ∑¥Áò§ÊÇ£ËÄÖÔºåAcalabrutinibÊòØ‰∏ÄÁßçÊøÄÈÖ∂ÊäëÂà∂ÂâÇÔºåÈÄöËøáÈòªÊñ≠ËÇøÁò§ÁªÜËÉûÂ§çÂà∂ÂíåËΩ¨ÁßªÊâÄÈúÄÁöÑÈÖ∂ÂèëÊå•ÁñóÊïà„ÄÇ‰Ωú‰∏∫Á¨¨‰∫å‰ª£BTKÊäëÂà∂ÂâÇÔºåÁõ∏ÊØî‰∫éÁ¨¨‰∏Ä‰ª£ÁöÑBTKÊäëÂà∂ÂâÇ‰ºäÂ∏ÉÊõøÂ∞ºÔºåÂâØ‰ΩúÁî®Êõ¥‰Ωé„ÄÇ https://t.co/WFYCvmUUC9,1
https://t.co/mpaCAFP9AC #,1
Naj√≠t,1
#SolidarityTrial #,1
#CZECRIN #,1
#SUKL #remdesivir #,1
#lymphomahub https://t.co/x01M51QIyN,1
RESONATE-2 &,1
‚ÜîÔ∏è,1
‚è© U-MRD,1
NCT04488016,1
"BTKÈòªÂÆ≥Ëñ¨acalabrutinib„ÅåCLL/SLL„ÇíÂØæË±°„Å´Áî≥Ë´ãÔºö„Åå„Çì„Éä„Éì
#",1
SLL„ÇíÂØæË±°„Å´Áî≥Ë´ã,1
El Instituto Nacional del C√°ncer,1
el COVID-19,1
el estudio,1
@Notimex,1
Amy Burd,1
PhD @LLSusa &,1
COVID-19 - Healio https://t.co/1oHiaow5BJ,1
#ClinicalTherapeutics #Physicians,1
acalabrutinib drug,1
Briton Tyrosine Kinase,1
@FLOTUS,1
WeLoveTrump,1
Hydroxychloroquine,1
Jakafi,1
Ilaris,1
Mavrilimumab,1
Decepticon,1
Randomized Trial of Acalabrutinib -,1
Caluquence,1
"Keep Inspiring"" campaign!üé®üñåÔ∏è",1
#keepinspiring,1
#newcampagintheme #,1
#interestingmarketing,1
#q2 #,1
#Leukemia and,1
Lymphoma AwarenessMonth,1
Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect,1
Acalabrutinib Tablet,1
Protonpump Inhibitor Effect,1
Randomized Trial of Acalabrutinib https://t.co/kIjnP9UMSX,1
@KingsCollegeNHS &amp,1
@UHSFT,1
@AnnaSchuh3 @tobyeyre82,1
https://t.co/NVTHDy8sej,1
https://t.co/f1ksnRFLUe,1
MD @michaelwangmd @MDAndersonNews Durable,1
Nicole,1
Dr Rafferty,1
@CRCTU @AnnaSchuh3,1
JPBA  https://t.co/xftxi4xax4,1
https://t.co/LQnpqdJCLd,1
$APTO #,1
https://t.co/uq0qTyN2qL,1
https://t.co/a18Y9JBNDR,1
@SocietyofHemOnc #SOHO2020 -,1
WCC,1
Teamhaem,1
CHMP,1
Trials in China,1
M 56,1
8.4x16cm,1
RCHOP/RDHAP,1
Deauville,1
Acalabrutinib?(off-la,1
B-R &,1
2019-1141,1
NCT04505254,1
https://t.co/5pwMeDrN3q #leusm,1
Drs Seema,1
1600,1
the Pharmaceutical Benefits Scheme,1
Federal Health,1
September 1 Keytruda,1
PMBCL &amp,1
Calquence (Acalabrutinib,1
#lime4lymphoma #,1
World Lymphoma Awareness,1
https://t.co/R1LDo3H4xe,1
https://t.co/n2sBRUKDa3,1
September 1,1
https://t.co/X1JNjpukbd,1
https://t.co/RZPyIWgYyH,1
Pr√®s de 100%,1
the Clinical Journal of #Oncology Nursing,1
the Clinical Journal of Oncology Nursing,1
Improve Outcomes,1
Patienten,1
Urothelkarzinom,1
Jovelle Phillips,1
Javier Munoz,1
"over $14,000",1
half a billion dollars,1
https://t.co/ok68flYykp,1
Per√∫,1
al Covid,1
Plasma,1
"Ivermectina
Mavrilimumab
Ruxolitinib
Acalabrutinib
Hidroxicloroquina
Tocilzumab
Solidaridad",1
Only three,1
D.,1
ONSCJON,1
#CalquenceÔºà#„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºâ„ÅåÊ¨ßÂ∑ûÂåªËñ¨ÂìÅË©ï‰æ°ÂßîÂì°‰ºö„Çà„ÇäË£ΩÈÄ†Ë≤©Â£≤ÊâøË™ç„ÇíÂèñÂæó,1
IO,1
https://t.co/1oRQIihY5,1
üëâ https://t.co/13efSsgXZd,1
IDATwitter,1
ActusHemato,1
Laly Nsiala,1
C√©cile Tomowiak,1
https://t.co/mV65g3AHBR @PRTIMES_JP„Çà„Çä,1
2019-0565,1
Phase II Study of Acalabrutinib,1
https://t.co/DNN1X8krFo @PRTIMES_JP„Åã„Çâ,1
„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâ„ÄÅÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„ÅÆÊ≤ªÁôÇËñ¨„Å®„Åó„Å¶„ÄÅÊ¨ßÂ∑ûÂåªËñ¨ÂìÅË©ï‰æ°ÂßîÂì°‰ºö„Çà„ÇäÊâøË™çÂãßÂëä„ÇíÂèñÂæó,1
EUA,1
EMA Recommends Marketing Authorisation for Acalabrutinib,1
Bruton #,1
zur Zulassung als,1
Ein,1
B-Zell-Rezeptor-Signalweg,1
Bruton-Tyrosinkinase,1
Position einnimmt,1
https://t.co/gDm17XsgCK,1
Janssen/Pharmacyclic's,1
https://t.co/uu2e3JxXwJ,1
https://t.co/aIcSF7pvHl,1
Calquence Recommended,1
‚Å¶@CDCgov‚Å©,1
https://t.co/HhSWrNaJVD,1
Hoffnung,1
Zulassung von zwei,1
Krebsmedikamenten,1
Europ√§ischen Union,1
Arzneimittelagentur,1
Zulassung von #Calquence,1
von #Imfinzi,1
#Pharmazie https://t.co/ipMaM9B8Zq,1
"BTKÈòªÂÆ≥Ëñ¨acalabrutinib„ÅåCLL„ÇíÂØæË±°„Å´Ê¨ßÂ∑û„ÅßÊâøË™çÊé®Ëñ¶Ôºö„Åå„Çì„Éä„Éì
#",1
Condition Summary: Bioavailability,1
‚òÖÁ¶èÂ≤°Â∏ÇÊù±Âå∫„ÉªÊ≠ØÂë®ÁóÖ„Éª„Ç§„É≥„Éó„É©„É≥„Éà„Éª„ÅÇ„ÅπÊ≠ØÁßë„ÇØ„É™„Éã„ÉÉ„ÇØ„ÄÄ,1
„Åæ„ÅüASCENDË©¶È®ì„Å´„Åä„ÅÑ„Å¶„ÄÅÂÜçÁô∫„ÄÅÈõ£Ê≤ªÊÄß„ÅÆCLL„Å´ÂØæ„Åó„Å¶acalabrutinib„ÅÆÂçòÂâ§Êäï‰∏é„Åå„ÄÅÂåªÂ∏´ÈÅ∏ÊäûÊ≤ªÁôÇÔºà„É™„ÉÑ„Ç≠„Ç∑„Éû„ÉñÔºãidelalisib„Åæ„Åü„ÅØ„É™„ÉÑ„Ç≠„Ç∑„Éû„ÉñÔºã,1
https://t.co/y1HGygavJm,1
Astra Zenecas Calquence,1
Calquence Receives Positive CHMP Opinion,1
"singlestockETPs
https://t.co/T9kVQk5qRY",1
the EU - https://t.co/FS5KISZ8XS #,1
#Stocks #Ratings,1
CLL https://t.co/gDwZuApse9,1
LEUCEMIA LINFOCITICA CRONICA,1
"https://t.co/3uiVwlALY8
#",1
https://t.co/70ijGqm752,1
AIFA,1
#IFNŒ≤1a,1
ABX464,1
Calquence for CLL,1
Improving Adherence,1
NEOPLASIE,1
DI BTK DI NUOVA GENERAZIONE ACALABRUTINIB,1
https://t.co/i1x5uoxQfi,1
AACRCovid https://t.co/76To59DM7H,1
Covid -19,1
Lymphoma BTK,1
monocytes &amp,1
https://t.co/RJ6m59jbJZ,1
AACRCovid,1
Louis M. Staudt,1
https://t.co/jMCQCjzOod,1
Virtual Congress - CALQUENCE¬Æ,1
https://t.co/vTUN73Iibi,1
#EHA25 #CALQUENCE #ChronicLymphocyticLeukemia,1
El Medicamento Acalabrutinib,1
la la,1
Tirosina quinasa de Bruton,1
asocio,1
reducci√≥n de las,1
respiratorias y de la respuesta,1
Muerte de los,1
criticos,1
el COVID,1
https://t.co/edRIrfc4ow #MCL #,1
https://t.co/zfs8VEb1Tm,1
https://t.co/1klHGyZlma,1
Acalabrutinib for,1
Covid https://t.co/TdcUZ1WPMA,1
‡§ï‡•ç‡§≤‡•Ä‡§®‡§ø‡§ï‡§≤,1
‡§ï‡•Ä ‡§ú‡§ó‡§π,1
@ChandnaHimani ‡§ï‡•Ä,1
Acalabrutinib for Covid,1
"14,000",1
üáÆ,1
more than 40,1
Covid https://t.co/VCB0RKTrZv,1
ÿßŸÑÿ£ÿØŸàŸäÿ©,1
ŸäÿπÿØ ÿ£ÿ≠ÿØ ÿ£ŸÉÿ´ÿ±,1
ÿ¥ŸäŸàÿπÿßŸã,1
"https://t.co/CQcIWHiHR1

#",1
#BeDrEffective #COVID19 #covid #,1
https://t.co/8kfKqrqvu3,1
ÿ£ÿ≥ÿ™ÿ±ÿßÿ≤ŸäŸÜŸäŸÉÿß,1
https://t.co/iB9tDcT55Y,1
con k de queso,1
AZN.PLC,1
https://t.co/Aq78S6L61K,1
@HackensackUMC https://t.co/mgV1wMfxOt,1
Calquence for CLL/SLL,1
the first quarter of 2020,1
#chroniclympoidleukemia #,1
#lymphomamarket #,1
mid-20E,1
Sunny Kim @OHSUNews,1
LEUCEMIA LINFATICA CRONICA RICADUTA/REFRATTARIA,1
CLL/SLL: Acalabrutinib,1
https://t.co/KoCrWCjkQC https://t.co/xI2Pvvmdwp,1
https://t.co/50HX3pDMUn,1
2020 https://t.co/kpfdsfMbyA,1
coronavirusdrug,1
https://t.co/zKPivWw07e,1
"#RichtersSyndrome

",1
ChurchillHospital,1
OncoAlert Clinical,1
https://t.co/xWbCHTYSM4,1
"„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÄÅÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖÊ≤ªÁôÇËñ¨Calquence„ÅÆË©¶È®ìÁµêÊûú„ÇíÁô∫Ë°® 
       #PULSEBEATNEWS",1
presentaron,1
el Congreso Anual de la Asociaci√≥n Europea de #,1
https://t.co/h7zQvVwF6p https://t.co/tPRu8P4RsE,1
Calquence/IMBRUVICA,1
2021+,1
https://t.co/lAwMx7tSX5,1
Jak/Stat,1
#Baricitinib &,1
53 months,1
https://t.co/nrUJjwIYUU,1
#eha25 #,1
de progresi√≥n recidivante,1
linfoc√≠tica cr√≥nica refractaria - ecancer,1
AscentagePharma,1
https://t.co/GGgDVMP0o7,1
https://t.co/BvIksG5Rvy,1
https://t.co/RilbUfWbor https://t.co/bcAk6zRmDG,1
https://t.co/KATk86qNZW,1
Thomas Witzig,1
15 2019,1
267449,1
Naive CLL,1
less than 10%,1
idelalisib+rituximab,1
Idr,1
mutations.#lymsm,1
della leucemia linfatica cronica rendendolo un‚Äôinteressante,1
Alessandra Tedeschi https://t.co/9MqOD8Ki3b,1
FORCEtrial,1
d'un essai exploratoire de  l'inhibiteur de BTK #,1
https://t.co/lby1Mro6xp,1
IgE,1
humanized_mouse_model,1
CaretasEnCasa La,1
la azitromicina,1
el ritonavir y la ivermectina,1
para,1
los √∫ltimos d√≠as,1
el acalabrutinib,1
#SevereCOVID19,1
8/11,1
just a week,1
han publicado,1
Demiurge AI-,1
052_2020,1
Acerta Pharma B.V.,1
Da Paolo Ghia,1
ASCEND presentato ad #,1
https://t.co/mImMIrwJW0,1
CARETAS,1
con la reactivaci√≥n econ√≥mica,1
La OIT,1
de un dr√°stico,1
provoca la propagaci√≥n de la #,1
Esto,1
#CaretasSeQuedaEnCasa https://t.co/mWgAkNLbUA,1
#COVID„Éº19 infection &,1
Inhibition of Bruton,1
https://t.co/a6MkBjv4PQ,1
"https://t.co/YKJhqYRoGQ
",1
https://t.co/hhMwlN4jUm,1
"https://t.co/1AzS3lWsaM.
#Acalibrutinib",1
M√©dicos del hospital,1
Walter Reed,1
Maryland (Estados Unidos,1
han,1
el medicamento #,1
only 20%,1
Idelalisib/Rituximab,1
zonder obinutuzumab,1
https://t.co/z6srMQx1p5,1
#hipoxia #,1
muy graves,1
Baselga,1
#COVID19 #hypoxia #,1
#gene #,1
days 11,1
12.A,1
"June 12, 2020
Physician's",1
https://t.co/Mwo4Heh0s4,1
#Truxima¬Æ,1
#BCellLymphoma #,1
6Êúà 11Êó•,1
rituximab biosimilaire,1
√™tre efficace et bien tol√©r√©,1
Nieuwe,1
Neue Phase-II-Daten,1
Vertr√§glichkeit,1
Wirksamkeit des Therapieschemas,1
Rituximab-Biosimilar,1
Lenalidomid und Acalabrutinib,1
bei rezidivierten/refrakt√§ren,1
indican,1
el r√©gimen de Truxima¬Æ,1
de rituximab,1
el linfoma de,1
https://t.co/HTs71PxfDj,1
rituximab biosimilare,1
K https://t.co/2RFTDtDzgg,1
de la COVID-19,1
Sciece,1
precisa un ensayo cl√≠nico,1
Êñ∞Ë¶è‰ºöÂì°ÁôªÈå≤„ÅØ„Åì„Å°„Çâ,1
https://t.co/B4h7V9FGym,1
https://t.co/IEWipcmYu7,1
Staudt,1
TalkingHeads,1
DIMOSTRATA,1
studi,1
al 25,1
https://t.co/5icYzjSfzZ,1
https://t.co/IEWipcmYu7 https://t.co/wEPezSbrco,1
dimostrata affidabilit√†,1
air &,1
https://t.co/s85O4KrPx9,1
https://t.co/0feXholQVk,1
Celebrating Inclusion and Diversity,1
LGBTQA Pride Month,1
‡§ï‡•Ö‡§®‡•ç‡§∏‡§∞'‡§µ‡§∞‡•Ä‡§≤,1
‡§ú‡§æ‡§£‡•Ç‡§®,1
obinutuzumab vs chlorambucil,1
https://t.co/SHFBlo7hIb https://t.co/5KkX3QKQb4,1
LaSexta Noche,1
6 AEs,1
SPM,1
DoR,1
https://t.co/YrkK8dHKrd,1
Proponen al f√°rmaco,1
para frenar la respuesta,1
hiperinflamatoria mediada,1
citoquinas,1
https://t.co/Grvzcw7qtf,1
https://t.co/iV55cdheri,1
https://t.co/YR07QfR6m4,1
https://t.co/d4k6YU0E2J https://t.co/98MxSOoTIE,1
Estados Unidos,1
con un f√°rmaco que vence las formas m√°s graves de la #,1
https://t.co/b1hYh7pqJD,1
https://t.co/WGwiZmzceu,1
Se encuentra,1
https://t.co/3goXN6VKY8,1
https://t.co/U31nNmV3fs,1
üì∞Inhibition of Bruton,1
PruebanF√°rmaco,1
Se trata del Acalabrutinib,1
8 minutes,1
Cohort 1,1
TC Bec,1
Thanks to Research Nurses Sian,1
Jess,1
Dr Fox,1
the Phase II ACE-CL-001,1
https://t.co/a0eoVTEGY2,1
dimostrata l‚Äôefficacia,1
requirieron hospitalizaci√≥n,1
god vid,1
#leukemi #,1
#lifesciencesweden #,1
del 97%,1
prolungato,1
pretrattati,1
della #,1
la forma pi√π,1
https://t.co/LiLN9rBM5,1
rendesivir,1
hidroxicloro,1
el virus,1
descubrimiento da,1
@MoHFW_India,1
muestran,1
el Acalabrutinib un,1
de la tirosina,1
el tratamiento de casos,1
Leyendo,1
la inflamacion provocada,1
el covid haran estudios con pacientes de,1
Panam√°,1
https://t.co/mQp8bOc5f5,1
Monticelli,1
"Penrose, &amp",1
Medical Staff,1
Penrose-St. Francis,1
de Covid,1
BarricadaNews,1
@LaVanguardia,1
https://t.co/shKoC6pEZS,1
Hidroxicloroquina,1
escena pero el numero de muertos se incrementa dia,1
de Covid-19,1
Evan Kirstel,1
u! &amp;gt,1
‚Å¶@IrmaRaste‚Å© https://t.co/oympDvMcSm,1
medicamento para,1
reacci√≥n inflamatoria descontrolada,1
un f√°rmaco Acalabrutinib,1
SI SE SALVA ALGUNA,1
CREYENDO EN LA COMUNIDAD CIENTIFICA,1
ÿßŸÑÿ¥ÿØŸäÿØ - ÿµÿßŸÑÿ© ÿßŸÑÿ£ÿ∑ÿ®ÿßÿ°https://t.co/arS4FqSv7k,1
grubundaki hastalarƒ±n √ßoƒüunda,1
iltihaplanmada,1
https://t.co/2XzrVgtlf1,1
M√©dicos en Estados Unidos,1
El estudio fue desarrollado,1
el bloqueo de la prote√≠na,1
el resultado cl√≠nico,1
"cr√≠tico
https://t.co/1UnxBxIHDQ",1
de las c√©lulas,1
m√°s agudas de la enfermedad,1
el nuevo medicamento,1
https://t.co/POnUgfSRVJ,1
el producto es bienvenido,1
Benjam√≠n N√∫√±ez Vega,1
https://t.co/qrj8qjft8i,1
la tormenta de citoquinas ocasionada.,1
https://t.co/z94VtZcH58,1
uso del Acalabrutinib,1
El uso del Acalabrutinib,1
F√°rmaco,1
PUFA,1
https://t.co/6mcTdgJrOX,1
#„ÅäÁü•„Çâ„Åõ #„Åì„Åì„Çç„Ç∑„Çß„Ç¢ #,1
#ÂÖ¨Èñã #,1
@JosepCorbella https://t.co/E4US1tduHI,1
mejora la oxigenaci√≥n,1
PhillyVoice,1
de @AstraZeneca especialmente dise√±ado,1
regula toda la tormenta de citoquinas,1
provoca el coronavirus,1
https://t.co/ueDs3U8aH7,1
mejora su capacidad,1
sin mostrar,1
https://t.co/RntusFFsKY https://t.co/RdL1Upszv7,1
para luchar,1
https://t.co/Qum7LuDw0i,1
ŸÉŸàŸÉÿß,1
ÿπŸÑÿßÿ¨ÿßÿ™,1
Clar√≠n,1
CocaCola,1
‚Å¶@Pepsi,1
‚Å¶@IrmaRaste‚Å©,1
https://t.co/ww4MLv4SXR,1
BGR,1
CRP &,1
lymphocyte,1
@WilsonWyndham,1
Calquence with Coca Cola,1
Javier A. Pinilla-Ibarz,1
https://t.co/6fck4rcckU,1
https://t.co/XMiMye2az6,1
disminuy√≥,1
https://t.co/0MCLbszgy7,1
üë®üèª‚Äçüî¨üíä,1
5 June 2020,1
https://t.co/tdREH3Y2bJ,1
Se,1
https://t.co/Nep51XW8ux,1
https://t.co/Sp1UnLsQ1p,1
"https://t.co/R48LRRQ3GG

Rapid",1
The US Oncology Network,1
https://t.co/ayZNgVCG5Y,1
JDQ - https://t.co/71TzbuBmIj,1
Hospitalized,1
"#kawasaki
https://t.co/cv2Cx2WfzY",1
JCO„ÄëÂÜçÁô∫Èõ£Ê≤ªÊÄßÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„Å´ÂØæ„Åô„Çãacalabrutinib„ÅÆÁ¨¨‚Ö¢Áõ∏Ë©¶È®ìÁµêÊûú https://t.co/AZVAyVPFWn,1
#Clinical Improvement Found After Administration of Acalabrutinib,1
Social Reach:,1
#COVID19patients,1
qu'il,1
"2020,driven",1
Faxiga,1
https://t.co/bZ8qL4JvrO,1
https://t.co/76FoFU1Yfk,1
el covid 19 escuch√≥,1
Las Ketchup,1
Calquence Shows Promise,1
los hallazgos del estudio,1
Science Immunology Referencia,1
Acalabrutinib - Wikipedia https://t.co/3tQah5qwyj,1
severos de coronavirus,1
fue probado con buenos,1
faltan estudios m√°s,1
muy caro,1
LDN.If,1
Fenebrutinib,1
https://t.co/uCRKEFYMOa,1
Study for Hospitalized COVID-19 Patients,1
Calquence + BSC,1
https://t.co/lzkmxekDRT,1
the National Cancer Institute.https://t.co/UVSRcpBTEe,1
https://t.co/E3pGcrD0xL,1
"AZ‚Äôs Calquence
https://t.co/rWDxsq9bYh",1
https://t.co/0MGBm1KjYz,1
VidaySalud,1
las c√©lulas,1
https://t.co/MLJzktFGKi,1
–∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ —Å–≤–æ–µ–≥–æ Calquence,1
–≥–¥–µ,1
–ø—Ä–æ—Ç–∏–≤ —Ä—è–¥–∞,1
20–ö,1
https://t.co/MeSAnCQGnO,1
#COVID-19 https://t.co/gUVJHTE7oi,1
https://t.co/SpoZCayGak #CancerResearch,1
https://t.co/7EcSqfwmuf,1
https://t.co/Zh5v477cD6,1
4.0,1
https://t.co/Tve7YR7yZb,1
https://t.co/cYJNu5oPWe https://t.co/J2cw4tA8gW,1
https://t.co/v9IqfrXRlS,1
CORONAVIRUS ASTRA PHARM- DRUG POTENTIAL,1
Forbes &,1
#covid19cytokinestorm #,1
https://t.co/n7inOLPL7E,1
AstraZeneca $,1
"Study for Hospitalized COVID-19 Patients @AstraZeneca 
https://t.co/kZgK6o8qHf https://t.co/OZxRYC1XBq",1
20200608 0501,1
germany,1
republican,1
https://t.co/ak8PuuZcMi,1
#healthnews,1
"cv19
Read",1
ForbesTech,1
https://t.co/9tAJRjHR2q,1
https://t.co/y0huYKDaq4 https://t.co/3b6jzL8NkG,1
"ResearchHighlight
Acalabrutinib",1
#Covid_19,1
https://t.co/thjpKfekqr,1
20200608 0401,1
"covid-19,medical",1
Science Immunology den,1
Zytokinsturm,1
https://t.co/bXm7mZ9WVY,1
Wirkung,1
#Studie #,1
BTKInhibitor https://t.co/gIjOWSo39E,1
https://t.co/Trz3xB9leY,1
„Å´Êñ∞„Åü„Å™ÊúâÂäõÂÄôË£ú„ÄÇËã±„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´Á§æ„ÅÆCalquence(‰∏ÄËà¨Âêçacalabrutinib„ÄÅ#„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„Éñ)„Åå„Éï„Çß„Éº„Ç∫2„Å´ÈÄ≤„ÇÄ‰∫àÂÆö,1
https://t.co/wXLrZu72VW,1
‡§Æ‡§π‡§§‡•ç‡§§‡•ç‡§µ‡§æ‡§ö‡§Ç ‡§∏‡§Ç‡§∂‡•ã‡§ß‡§®,1
‡§∞‡•Å‡§ó‡•ç‡§£‡§æ‡§Ç‡§®‡§æ,1
@Clinical Trials Arena,1
ŸÖŸÜ ÿßŸÑÿßÿØŸàŸäŸá ÿßŸÑŸÑŸä,1
ŸÉŸàŸÅŸäÿØ-19,1
ÿßŸÑÿßŸàŸÉÿ≥ÿ¨ŸäŸÜ,1
8 ŸÉÿßŸÜŸà,1
ÿπŸÑŸâ ÿßŸÑÿ™ŸÜŸÅÿ≥,1
ÿÆÿßÿµÿ© ÿπŸÜÿØ ÿßŸÑÿ™ÿØÿÆŸÑ ÿßŸÑŸÖÿ®ŸÉÿ±,1
#„Éû„ÇØ„É≠„Éï„Ç°„Éº„Ç∏ #,1
„Åå„ÄÅ19‰∫∫„ÅÆÈáçÁóáÊÇ£ËÄÖ„ÅÆ„Äå„Åª„Å®„Çì„Å©ÂÖ®Âì°„ÅßÔºìÊó•„ÅßÂäπ„ÅÑ„Åü„ÄÅCRP„ÇÇIl6 „ÇÇÊøÄÊ∏õ„Åó„Åü„ÄÅÂçäÊï∞ÊäúÁÆ°„Äç„Å®Â†±Âëä„ÄÇ‰ªäÂ∫¶„ÅØ„Åª„Çì„Å®„ÅÜ„ÅÆ„Äå„Ç≤„Éº„É†„ÉÅ„Çß„É≥„Ç∏„É£„Éº„ÄçÔºüÔºüÔºöNCI,1
Calquence - BTK,1
#blocked,1
#bruton,1
#btk #,1
@AUThackeray,1
@Cipla_Global Medi3506,1
Outbreak News,1
https://t.co/lcZFR7J0Va,1
https://t.co/4SLsugVdqu,1
Respiratory Distress,1
zdravljenju pacientov z,1
Zdravilo inibira encim,1
ki,1
vlogo pri,1
tako da,1
potrebo,1
Health Tips,1
Estudio revela,1
https://t.co/89Q9LHlZB5,1
"Lactobacillus rhamnosus,,,https://t.co/GJDd8FvFPh",1
https://t.co/KtTfyfOx8k #COVID19 #Calquence #FE,1
Study Shows That Acalabrutinib,1
Roschewski et,1
drdaveoncall,1
Cacncermedicinen Acalabrutinib,1
Liten,1
ska nu g√∂ras,1
https://t.co/lv7FOG4CCl,1
19 #COVID,1
https://t.co/mn4y3xVVxo,1
22:40,1
Bolsa de Nueva York,1
el c√°ncer de AstraZeneca,1
#COVID19 https://t.co/xNKWNGFLPj,1
Para,1
visitanos,1
inhibiteur s√©lectif de la BTK,1
donne des r√©sultats spectaculaires,1
el proceso inflamatorio mejor,1
con cuadros severos,1
ClinicalStudy,1
https://t.co/6GJzCchfw9,1
Eleven,1
10-14 day,1
#funops #,1
Dampen #Cytokinestorm,1
Covid19treatment,1
#HealthyLife #COVID„Éº19 #,1
#Coronavid19 #,1
CoronaLockdown #,1
ET HealthWorld,1
Stefan Wermuth/File Photo,1
Ludwig Burger,1
AstraZeneca‚Äòs,1
https://t.co/C8PCrdcGXD,1
Tecnolog√≠a - Estudio,1
#Noticias #,1
TendenciasTech,1
1-3 days,1
https://t.co/0vcdNoyVX0,1
https://t.co/jSjG8WsYyl,1
https://t.co/eNgLbGgmYL  Acalabrutinib Dosis,1
al d√≠a,1
https://t.co/MFTvnWl2zW https://t.co/OZywtnS7Mg,1
BTK„ÅÆ„Ç∑„Ç∞„Éä„É´„ÇíÂãâÂº∑„Åõ„Å™,1
Calquence de #,1
peor de la enfermeda,1
Patients https://t.co/tLwxkZhANS &gt;&gt;&gt,1
de la farmac√©utica brit√°nica tienen,1
el respaldo de Institutos Nacionales de Salud de Estados Unidos,1
Patients https://t.co/Jt52Df1gjU,1
v√§rd att l√§gga,1
Nu n√§r det,1
kritiska,1
Calquence de¬†@AstraZeneca¬†mostr√≥ indicios de que,1
ÿ≠ÿµŸÑ,1
ÿßŸÑŸÉŸàÿ±ŸàŸÜÿß ÿπÿßŸÑŸÖŸäÿß,1
ÿ¨ÿØÿß,1
"#Acalabrutinib 
Selective Bruton",1
los tratamientos,1
AstraZeneca‚Äôs Calquence Showed Improvement In Small Group Of Hospitalized Covid-19 Patients,1
https://t.co/0CseAI21K1,1
peor de la enfermedad https://t.co/WT4nLolAz0,1
EDNInforma El,1
#medicamento #,1
#hospitalizados #COVID19 #,1
Erkrankungen,1
https://t.co/PINNZDtK3q,1
-mab,1
Actemra,1
"singlestockETPs

https://t.co/T2iB6cbSXg",1
kliniska f√∂rb√§ttringar,1
av de 19,1
kliniska,1
"https://t.co/txIcCvqJYM

#COVID #",1
#QuaratineLife #,1
Covid 19,1
https://t.co/kPovNedv44,1
14:34,1
https://t.co/jBxMKsyaMT,1
https://t.co/W4G1vN2PRm,1
https://t.co/d4k6YU0E2J,1
$QQQ #,1
Cancer Drug Calquence,1
calmar,1
la respuesta,1
inmunitaria de la tormenta de citocinas,1
asociada con,1
#lymSM,1
CLLsm https://t.co/xN8tolLK5W,1
#mantlecelllymphona #,1
https://t.co/S4kSerUdCX,1
El aca,1
#allergen,1
Randomized Trial of,1
Idelalisib Plus,1
Nebulised Heparin,1
"Zilucoplan
@rajeshtope11 @drharshvardhan @ArvindKejriwal @CMOMaharashtra @AUThackeray",1
"Zilucoplan
#",1
"Calquence, Bemcentinib",1
https://t.co/w2bwAvReqp,1
co19,1
Azithromycin,1
@WCM_MeyerCancer,1
8064,1
@wwierda @LeukemiaMDA,1
"CLL Update

Ibrutinib",1
Randomized Trial of Acalabrutinib Vs Idelalisib,1
Bruce,1
the Expert Review of Clinical Pharmacology,1
Jurczak,1
https://t.co/7IOeXBgvq6 #lymsm https://t.co/eGOCRpOhqA,1
#SARS_CoV_2,1
Marisol Urbieta,1
Oncologie France,1
l'acalabrutinib va,1
la lutte contre de SRAS-CoV-2,1
Nicolas VIUDEZ AstraZeneca,1
#industrie #pharma #,1
https://t.co/I5bLQHbcUU,1
OS &amp;safety,1
https://t.co/SQVwCnqcsv,1
Novedad,1
Ver√≥nica Saladrigas,1
Menda Lerenda,1
"@Paz_G_Polledo

M√°s de 3200",1
de Ab,1
ABG,1
ethanol y acalabrutinib,1
Consulta,1
$982m(+56%,1
$462m,1
397m(+67%,1
88mÔºà+100%,1
Drug-Drug Interactions,1
https://t.co/4Vjh1flhqJ,1
CI 0¬∑26‚Äì0¬∑95,1
https://t.co/jv1VOSCEa2,1
Vergleichsstudie,1
Bruton-Kinase-Inhibitor Acalabrutinib,1
√úberleben von,1
Anteil,1
1Q 12%,1
Guide,1
United Kingdom-Buy,1
"Enhertu, Roxa china",1
Farxiga HF,1
la supervivencia libre de progresi√≥n sobre la,1
#chroniclymphocyticleukemia https://t.co/Ap23cGpAFk,1
„Åß„ÇÇ‰æ°Ê†º„ÅÆÈ´ò„ÅÑ„ÅÆ„Å´„Å≥„Å£„Åè„Çä,1
"#MAGA2020 

",1
Politico,1
Baricitinib &,1
Favipiravir,1
#Power Belongs,1
„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´Ê†™Âºè‰ºöÁ§æ„ÄÅ„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâ„ÄÅÊñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá„ÇíÂØæË±°„Å®„Åó„ÅüCALAVIË©¶È®ì„ÇíÈñãÂßã https://t.co/lqv0RUY8T7,1
https://t.co/xmWRVEodKU,1
TNË©¶È®ì,1
https://t.co/Vqdop6jbFU,1
#acalabrutinib #COVID19 #,1
https://t.co/SpBHYegp1P,1
https://t.co/p7EW4DgLAz,1
https://t.co/bqn0wJXzHi,1
https://t.co/d8l9NbuSyi,1
https://t.co/WzFPBuDITt,1
Francis Collins,1
just 1%,1
https://t.co/eK7d3bZEAR,1
@AmericanCancer Society,1
Collins,1
https://t.co/9gaMMBghGy,1
Nurse Times üî¥ Nurse Times Coronavirus,1
la tempesta,1
Lo,1
Sanit√†,1
NurseTimes,1
Apr. 20 - Lancet: Acalabrutinib,1
PNN,1
JournalWatch,1
Selektif Bruton‚Äôs,1
about $APTO's,1
pan-BTK,1
https://t.co/XfXjoXGb1M,1
"COVID-19ÂÖ•Èô¢ÊÇ£ËÄÖ„ÇíÂØæË±°„Å®„Åó„ÅüAcalabrutinib„ÅÆÊúâÂäπÊÄß„Å®ÂÆâÂÖ®ÊÄß„ÅÆÁ¨¨2Áõ∏ÁÑ°‰ΩúÁÇ∫ÂåñÊØîËºÉË©¶È®ì
428Âêç„Ç™„Éº„Éó„É≥„É©„Éô„É´",1
@_atanas,1
@DNA_RNA_Uni,1
Article #1,1
"https://t.co/LR7B2NztHD
",1
Article #2,1
Article #3,1
"https://t.co/rLWUh8wZnu

#",1
ThisWeek,1
PharmaForecast,1
AstraZeneca Initiates CALAVI Clinical Trial With Calquence Against COVID-19,1
@Karyopharm @AhlstromJenny,1
https://t.co/HoOeykDHqH,1
Overheden kunnen,1
maar doemdenken,1
Binnekort,1
kansrijke therapie√´n beschikbaar,1
Dit kunnen stuk,1
stuk gamechangers,1
AstraZeneca Begins Clinical Trial of Calquence,1
obin-chl,1
https://t.co/cs6nWSsE35,1
https://t.co/IshVv6d7Og,1
@TheLancet      ,1
Dr Sharman,1
CLLsm https://t.co/ChV4h7kJp2,1
https://t.co/VBhe2rZaLD,1
Medicamento Calquence,1
AstraZeneca Initiates Calquence Clinical Trial,1
#COVID19 https://t.co/ImCxhfKkRv,1
April 14,1
Forbesbr - Medicamento Calquence,1
"https://t.co/gqcXva6WJo

",1
@YouTube„Åï„Çì„Åã„Çâ,1
BioPharma Dive https://t.co/X2MdJ7tOdA,1
covid19 https://t.co/l5xcV16tup,1
https://t.co/qQrr3dtLpy,1
https://t.co/fj8Ptad1pS,1
#pharmashots #,1
evidencia cient√≠fica,1
respalda el papel de la v√≠a,1
la producci√≥n de citocinas inflamatorias,1
COVID19 Trial Launching https://t.co/7nIKQz8Hyt,1
Cancer Drug #Calquence,1
the National Cancer Institute gave Calquence,1
Korona,1
Calquence   #,1
https://t.co/gfy6iNb0EL,1
ONCONEWS,1
el coronaviru - https://t.co/qDSGKhDP2d,1
Bruton TKI,1
‚Å¶@LeedJulia‚Å©,1
haematology,1
COVID-19ÊÇ£ËÄÖ„Å∏„ÅÆAstraZeneca„ÅÆBTKÈòªÂÆ≥Ââ§Calquence„ÅÆÂ§ßË¶èÊ®°Ë©¶È®ì„ÅåÂßã„Åæ„Çã https://t.co/IfuzZkjWcA,1
#NewsInTweets #WorldNewsInTweets #,1
https://t.co/c9UUZXzRsq,1
Wirkung des Krebsmedikaments Calquence,1
https://t.co/A2y3hnqo7P,1
https://t.co/V3x9EAcBjZ https://t.co/iK61334a27,1
COVID19 Trial Launching https://t.co/AhbQfGJ6us,1
COVID19 Trial Launching https://t.co/pP1vFJWJH0,1
#COVID19pandemic,1
AstraZeneca Launches Drug,1
#Coronavirus Treatment,1
AstraZeneca Initiates Clinical Trial with Calquence,1
https://t.co/uWWeMIVS2G,1
MemberCompany,1
#cllsm @astrazeneca,1
#Covid19,1
"COVID-19 Taskforce Starts With Calquence Trial
",1
https://t.co/2AasDTn6tC,1
ÿ®ŸÖÿß,1
Ÿäÿ™ŸÑŸÇŸàŸÜ,1
"Ÿàÿ≠ÿØÿßÿ™ ÿßŸÑÿπŸÜÿßŸäÿ© ÿßŸÑŸÖÿ±ŸÉÿ≤ÿ©
",1
https://t.co/hqGILm5KKV,1
allvarligt,1
#CoronaVirusSverige #,1
https://t.co/Jmac3oC6tM,1
https://t.co/J0SweHPD5r,1
https://t.co/J0xgcDPK4W,1
CALAVI,1
"CytokineStorm

https://t.co/BHHo1OMiay",1
"https://t.co/ZEFg2FtIKq
",1
https://t.co/uwM8f5XnU9,1
ÿßÿ≥ÿ™ÿ±ÿßÿ≤ŸÜŸäŸÉÿß ÿØÿÆŸÑÿ™ ÿπŸÑŸä,1
Gl https://t.co/2t7Skv99dQ,1
@ThisIsMoney,1
#tweetuk #,1
Astra Zenica,1
britanska,1
farmaceutska,1
kompanija,1
CALQUENCE za,1
Ovaj,1
koristi protiv,1
tipova LEUKEMIJE/ cancera,1
https://t.co/LiJCCoZDf8,1
#trending #,1
#COVID-19 https://t.co/QcSj1rn5RN,1
https://t.co/h2Z2pSATHm,1
+0.4%,1
https://t.co/u3ASQJf2EC| #pharma #,1
#covid19india #,1
https://t.co/byq81K0jQn,1
C.E. ELABOREAZA,1
1PLAN,1
DE RELANSARE EC,1
1500,1
VANDUT DE ASTRAZENECA SUB NUMELE DE CALQUENCE,1
DR.DIDIER,1
CRITICAT,1
inicia el ensayo cl√≠nico,1
https://t.co/l9qqtn5eBr,1
#LifeatBJ #,1
EXCLUSIVE,1
https://t.co/PjBLleVwdz,1
+6%,1
üñäÔ∏èDan Grote,1
#investment #,1
https://t.co/gbEp8ZqJhc https://t.co/UzNSLhfE0e,1
https://t.co/VOtn2oTtVX,1
https://t.co/ZNltaCYH2Y,1
https://t.co/a9kvetE43Y,1
https://t.co/5oIsiwH3BW,1
HeartNews,1
https://t.co/rrgYEl6TJb,1
@HLInvest https://t.co/Se4mYe2q99,1
Calquence drug‚Äôs,1
https://t.co/yLU6NVAbKW,1
try &,1
payday,1
https://t.co/hJmFeOF9y2,1
som verkar kunna,1
inflammatoriska,1
skapar stora,1
Calquence for COVID-19 https://t.co/vOG53jfbBy,1
#global #,1
#immuneresponse #,1
#respiratory,1
#mortality #,1
#clinicalbenefit #,1
#ICU,1
the early days,1
CoronavirusUpdates,1
DANGEROUS &,1
SOMEONE,1
testar cancerl√§kemedel mot,1
senaste hoppet f√∂r,1
l‚Äôautorisation de tester,1
15000,1
Euros,1
https://t.co/dvbEQo3dr7,1
MEDICIN,1
https://t.co/FeV2SUvhYQ,1
AZN +6%,1
"@CisionSverige

#COVID„Éº19 #COVID19 #",1
https://t.co/ywMQbymq3Y,1
https://t.co/85pc16E0ns,1
att det,1
"lyckas

https://t.co/nXo8wbAsvW",1
late #COVID19 #COVID #,1
72 hours,1
30-year,1
Coca-Cola,1
knew.#COVID19,1
$50M,1
tAPTO 806,1
https://t.co/T7aJx4h78E,1
#analytics #,1
APTO - Interesting,1
https://t.co/z7nrycMbAE,1
https://t.co/kyV9361Vsi,1
Forbes https://t.co/Hkyaz44o1V,1
Suffix,1
Calquence in CLL,1
https://t.co/kcxtRrMcMG,1
https://t.co/MDIdDAhptk,1
https://t.co/ENyjZNSW9M,1
AGN,1
~May 2020,1
mid-2020;SKYRIZI,1
Benjamin L. Lampson,1
"Calquence, Gazyva",1
"@LoriLeslieMD @JTCancerCenter
https://t.co/EtAGmyy9MZ",1
¬øPara,1
"https://t.co/xKMp6ZDSId

#leusm #",1
95.8%,1
91.5%,1
79.2%,1
87.2%,1
42-Month Follow-Up,1
Krista Isaac,1
CMAR,1
TN Study,1
@SeattleCCA University of Washington,1
Fred Hutchinson Cancer Research Center,1
Pharma India,1
Calquence-Acalabrutinib,1
#dcgi #,1
"Calquence
https://t.co/1u4Gv7zWPY",1
DCGI - Equity Bulls https://t.co/37bLpiVSKh &gt;&gt;&gt,1
Bec,1
Rumpel-Leede,1
https://t.co/7y1FPF4ebL,1
Utilizing Acalabrutinib,1
#RD360 #,1
@Aiims1742 https://t.co/Dl2KLC1YnY https://t.co/pjsUKRzNDs,1
https://t.co/cPc8kJxcFl,1
@michael_overman &,1
CalquenceÊòØ‰∏ÄÁßçÊøÄÈÖ∂ÊäëÂà∂ÂâÇÈÄÇÁî®‰∏∫È¶ñÊé•ÂèóËá≥Â∞ë‰∏ÄÁßç‰ª•ÂâçÊ≤ªÁñóÊàêÂπ¥ÊÇ£ËÄÖÊúâÂ•óÁªÜËÉûÊ∑ãÂ∑¥Áò§(MCL)ÊÇ£ËÄÖÁöÑÊ≤ªÁñó„ÄÇhttps://t.co/jAc5A1r1iV,1
https://t.co/cwOKHJ03Y4,1
https://t.co/4SokVIWW9U https://t.co/9qqGOipuAj,1
MCL Mantle,1
the STELLAR Site Initiation for @Derriford_Hosp,1
CLTAP,1
van Waldenstr√∂m https://t.co/1Jrkhn1V7P,1
Value-Based,1
#„Éô„Éç„ÇØ„É¨„ÇØ„Çπ„Çø #,1
Acalabrutinib Monotherapy Active,1
Waldenstr√∂m Macroglobulinemia,1
https://t.co/1bSTTvnefE,1
Desempe√±a un,1
de las c√©lulas B. Ejemplos:,1
Calquence) Indicaci√≥n: linfoma de,1
75+ yo Pt,1
SAVR &gt,1
2 yrs ago,1
ASA 81 mg + apixiban 5,1
#CardioOnc @datsunian,1
AntiCD19 CAR Tcell Therapy,1
#TCL #,1
"https://t.co/5iKhNWAeem

#leusm #",1
Macroglobulinemia with &gt;80%,1
PhI/II,1
Southampton &,1
Ston,1
Lukanol,1
con un perfil de seguridad manejable en pacientes sin,1
Lancet Haematol,1
95% and 92%,1
32% and,1
94% and 88%,1
4.6m,1
Great UK,1
https://t.co/ke65HwO1Tj,1
Only 1%,1
G3/4 AEs,1
neutropenia &amp,1
The UK CLL Forum Paper of the month,1
92,1
45-month,1
https://t.co/stGAuYf3B0 #leusm #,1
AstraZeneca Canada,1
Actualit√©s https://t.co/Pj9NTahYLw,1
the Clinic: Acalabrutinib for Adult Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma https://t.co/UjOFSwmUfE,1
https://t.co/QJi4wmgbnu,1
https://t.co/f3zyare1Ia https://t.co/NW2trSjNbL,1
#KINASEINHIBITORS #,1
https://t.co/SomdeXvDId,1
the @Pelotonia Institute of Immuno-Oncology,1
https://t.co/enyqjKAW3d,1
KASIM - ARALIK 2019,1
FDA ONAYLARI,1
#crizanlizumab #,1
#givosiran,1
#hematoloji #hematolojiistanbul #kansertedavisi #,1
#memorialata≈üehirhematoloji,1
https://t.co/C9VArh4lhZ https://t.co/9d7gW8mi5Q,1
obinutuzumab versus obinutuzumab  plus,1
#rtor #,1
https://t.co/92OLNYdyiZ,1
The Twitter,1
2-3,1
the Lymphoma Calquence,1
kayak,1
Relative Selectivity of Covalent Inhibitors Requires Assessment of Inactivation Kinetics,1
https://t.co/9cMtYAPHm5,1
https://t.co/jvF4dIWERO,1
wmsm,1
mmsm,1
#lymsm https://t.co/uVY0Y3XawM,1
#thelancethaematology #,1
2019Âπ¥12Êúà19Êó•„Äê„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„Äë„Äé„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâ„ÄÅÊú™Ê≤ªÁôÇ„ÅÆÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖÊÇ£ËÄÖ„Åï„Çì„ÅÆ,1
https://t.co/pAr8H4xAXa,1
Richard Furman‚Äôs,1
#leukemia #wednesdaywisdom #,1
#ELEVATETN,1
James N. Gerson,1
ECM https://t.co/rSq7DmM4Q3,1
#NewIndicationNotification Calquence,1
#oncology #leusm #,1
https://t.co/Qgeg8bzbOB https://t.co/7wt3ZfrqR4,1
questa,1
donne l‚Äôacalabrutinib dans,1
Chlorambucil https://t.co/n9z9W093ix,1
DI BTK DI NUOVA GENERAZIONE,1
LA PROGRESSIONE SIA,1
Zanubrutinib ASH,1
https://t.co/e2a66VSV26,1
I. Someone,1
aprobadas para,1
https://t.co/ePtvIR2uiB,1
https://t.co/EqXn48xcpV,1
"Calquence, Vascepa",1
#chemistry,1
#med #,1
https://t.co/18bBhrSIK7,1
https://t.co/u2m8NKykTy,1
https://t.co/zqG1rFbQXY https://t.co/uEkk3DzAkY,1
https://t.co/Kt4cha4sHu,1
https://t.co/67PsPfokCT,1
https://t.co/ojY4fAOXax,1
https://t.co/HqltJaENt8,1
90% to 95%,1
los resultados,1
https://t.co/pGHr9hdmG2,1
Presentaci√≥n de @AstraZenecaES,1
Merck Lilly,1
J&amp;amp;J&amp;39;s Imbruvica,1
AstraZeneca&amp;39;s Calquence,1
EliLilly,1
los #,1
https://t.co/ghxHUC6vG3,1
#oncology #clinicaltrials #,1
L,1
inhibiteur de la kinase,1
ligne dans la leuc√©mie lympho√Øde,1
42-Month,1
the US Oncology Network,1
obinutuzumab https://t.co/jWSGXqjb1h,1
Calquence Sets Sights on Imbruvica https://t.co/5ydRguKBtQ,1
only 8,1
75.0%,1
16 #CLL #,1
https://t.co/poApfwhNAe,1
Nicholas Richardson,1
https://t.co/awR35ls4ZU https://t.co/FK5HrqOvEY,1
Imbruvica https://t.co/l3RVp4UcHp,1
https://t.co/nDmId0TMJk,1
TN Study for Previously Untreated,1
Hems/Oncs,1
Breaking Data,1
https://t.co/9e83mxwuXo,1
https://t.co/Ci6tDaKNeq #,1
28.3 months,1
https://t.co/phcLrjtTAJ,1
https://t.co/P38I9sweml https://t.co/nzIetmecKd,1
Êñ∞ÁùÄË®ò‰∫ã]„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâÁ±≥ÂõΩ„Å´„Åä„ÅÑ„Å¶ÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖÔºàCLLÔºâÊàê‰∫∫ÊÇ£ËÄÖ https://t.co/kw8lXThhka,1
2019Âπ¥12Êúà09Êó•,1
https://t.co/d1Vsi7bknx https://t.co/SszdMPvxvB,1
LDH,1
pts w/progression,1
#ASH19 https://t.co/HuReauElCm,1
lymsm https://t.co/8qW1DyRnEK,1
Dr Woyach - BTK C481,1
obinutuzumab mejora la,1
ScienceLink,1
16.7%,1
Healio https://t.co/lxQsVdtkT9 https://t.co/hfU6aOhrMw,1
a few weeks ago,1
Frontline CLL https://t.co/EJLSOd7K3E,1
AstraZenecaÔºà„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´Ôºâ„ÅÆ„Éñ„É´„Éà„É≥„ÉÅ„É≠  https://t.co/04RdmI8tIy,1
AstraZeneca„ÅÆBTKÈòªÂÆ≥Ââ§Calquence„ÅÆCLLÂàùÊ≤ªÁôÇPh3„ÅÆ2Âπ¥ÈñìÁÑ°Â¢óÊÇ™ÁîüÂ≠òÁéáÁ¥Ñ90ÔºÖ,1
CLL https://t.co/tVrvgjeQJc &gt;&gt;&gt,1
https://t.co/FlRbROlerI,1
15 months,1
"@NYLCandCLL @JanRynne
https://t.co/fPndDe6G9q",1
@TheUSONetwork https://t.co/hdV3PYRFzd,1
Location,1
Ben Lampson,1
Wayne,1
4x4 square https://t.co/lQuMqY6Vis,1
https://t.co/OZ0f7r3JzC,1
Qollor,1
"Venclexta
2",1
35-40%,1
"Calquence, Imbruvica",1
#ASH19 $NVS $,1
Obinutuzumab #,1
#ASH19  ,1
2-yrs‚Ä¶.very,1
overl;y,1
CLL&gt;,1
4-5,1
obinutuzumab - starting w/acala,1
x1 month,1
C4,1
Around 48%,1
BM uMRD &,1
#lymsm https://t.co/nDQM5oiv2A,1
15/31,1
C8,1
C16,1
obinutuzumab unclear,1
the Time Patients Lived Without Disease Progression or Death in Previously,1
Lymphocy..,1
Treatment-Naive CLL,1
7:30AM,1
@wwierda @LeukemiaMDA #,1
28.3,1
VS.acala,1
Obinutuzumab + Chrorambucil,1
G-Acala,1
OFS,1
GChl,1
https://t.co/UsjT6ZoCtW,1
the Treatment of Ibrutinib-Intolerant Mantle Cell Lymphoma,1
the Treatment of IbrutinibIntolerant Mantle Cell Lymphoma,1
de Calquence,1
Canadiens,1
ProjetOrbis,1
M√©dicamentsetinstrumentsm√©dicaux,1
17p or 11q,1
https://t.co/5rXsTUjcTU,1
IYCMI,1
"#LeuSM
",1
a million,1
The Food and Drug Administration‚Äôs,1
los datos del ensayo Fase III ELEVATE-TN de Calquence,1
https://t.co/lkVSg0TsoX,1
https://t.co/Mag7sKKUdF,1
https://t.co/fbTwRrlBIc,1
los primeros datos de 'Calquence',1
#Industria,1
https://t.co/RLlvWaEW7q,1
"https://t.co/fbTwRrlBIc

",1
https://t.co/RLlvWanlfS,1
#esalud #MarketingParaMedicos #,1
SaludDigital,1
https://t.co/4EpVAx0JNt,1
https://t.co/xW4L1k1CIw,1
Weekly Drug News,1
https://t.co/VNjHyX2Zx4 https://t.co/DliUfyWoMT,1
Calquence https://t.co/SyjyiEotth,1
SLLCategory,1
CLL/SLL„ÅåÊù•Âπ¥„ÅÇ„Åü„Çä„Åã„ÇâÊÖå„Åü„Å†„Åó„Åè„Å™„Çä„Åù„ÅÜ„Å™‰∫àÊÑü,1
Calquence Receives FDA Approval,1
SLL https://t.co/97L2lAh3tY,1
FDA Approves Calquence as Treatment Option for Adults,1
the Treatment of Patients With Chronic Lymphocytic,1
Fda approva,1
https://t.co/6lCKmOCB3P #,1
CLL ÿå SLLhttps://arabmedical.pro/other/oncology/calquence-%d8%a7%d9%84%d9%85%d8%b9%d8%aa%d9%85%d8%af%d8%a9-%d9%84%d8%b9%d9%84%d8%a7%d8%ac-cll-%d8%8c-sll-2/,1
SLL https://t.co/sRlWTndsWY,1
SLL Category,1
Health News Created,1
SLL https://t.co/gt0TbYowFi,1
https://t.co/rtzt8ywINp,1
SLL https://t.co/lxY7icQz2B,1
@WeillCornell @nyphospital,1
#lymphoma https://t.co/gZ31vPKvep,1
Project Orbis Collaboration,1
https://t.co/QE0VlPBeqy https://t.co/xq1TXka26z,1
ÿ¥ÿ±⁄©ÿ™ ÿßÿ≥ÿ™ÿ±ÿßÿ≤ŸÜ⁄©ÿß,1
https://t.co/d80osJyYZo,1
https://t.co/4FcnvQySR3,1
FDA Approves Acalabrutinib to Treat CLL,1
CancerConferences,1
SLL https://t.co/zu2MUWcGE3,1
Calquence under Project ORBIS,1
ViiV,1
Neon,1
SK Bio,1
WuXi,1
NTGN https://t.co/7WoT0Q5Sfj,1
https://t.co/jrzd6RVUHy,1
SLLhttps://arabmedical.pro/other/pharmacy/calquence-%d8%a7%d9%84%d9%85%d8%b9%d8%aa%d9%85%d8%af%d8%a9-%d9%84%d8%b9%d9%84%d8%a7%d8%ac-cll-%d8%8c-sll/ https://t.co/OpizpDVmUT,1
Efficacy and Safety of a BTK,1
Adult Patients with Previously Treated Mantle Cell Lymphoma,1
Fleming,1
"Dec. 3, 2019",1
Jason McDonald,1
801,1
971-8823/,1
The U.S. FDA,1
SLL - https://t.co/bSJJiAOPoX,1
Key FDA,1
#metoodrug,1
#thebarislowforFDAapproval #,1
cllsm üôÑhttps://t.co/8xhGUEgNfr,1
FDA Nod,1
https://t.co/5ZfLZnmWcU &gt;&gt;&gt,1
@AstraZeneca's Calquence,1
Six months,1
https://t.co/UgUPHYvoZj https://t.co/yyiRuyscvX,1
@TGAgovau &,1
#Singapore #,1
HealthSciencesAuthority &,1
Switzerland,1
#lymsm @AstraZeneca,1
@ZacharyBrennan @RAPSorg,1
https://t.co/wTPMKqH71S,1
#ChronicLymphocyticLeukaemia https://t.co/uQ4JMXzJoI,1
Pharma Industry News,1
#PharmaIndustryNews #,1
#Zydus #,1
Calquence CLL,1
BUY,1
CLL Calquence,1
the US FDA‚Äôs Approval,1
https://t.co/VnTitz1CDI,1
"November 21, 2019",1
https://t.co/lIr9ivAJ2o,1
11/21,1
GLYC,1
Intra-day,1
ONTX,1
$SNY $,1
https://t.co/vD1PSjePOF,1
Project Orbis FDA,1
"November 29, 2019",1
https://t.co/0uH9fZjP0b,1
https://t.co/VkpiGnAX0I https://t.co/PvBTMzlaxc,1
el tratamiento de la LLC,1
"Nov 21, 2019",1
SLL https://t.co/k5EPVurrDc,1
tolerabilityCALQUENCE,1
https://t.co/TERzXBu169,1
#drugnames #,1
https://t.co/2OFENMrtRy,1
CLL/SLL https://t.co/32pTdmkWeF,1
Copy/Paste,1
Any Grade AEs,1
Gr3+ AEs,1
https://t.co/8mQCj2u9Ek &gt;&gt;&gt,1
https://t.co/M9BYqi8QNy,1
https://t.co/4iqEKFBeaA,1
#obinutuzumab + #chlorambucil,1
https://t.co/1xaSOxXvpM #,1
TuesdayNewsDay,1
https://t.co/uGsPmf1uVY,1
https://t.co/IQLswQovyE,1
La Chine,1
l'Europe,1
#USA #Pharma #,1
Brukinsa @AstraZeneca,1
https://t.co/QHdyGgmC46,1
BeiGene FDA,1
AbbVie&amp;39;s Imbruvica,1
obinutuzumab vs obinutuzumab + #,1
"#ASH19

",1
1L 91%,1
n=13,1
Nice wk @Maryam_Yazdy #,1
"al
BTK MUT",1
"PLCG2 MUT

103/105",1
3-6,1
MUT,1
31.6,1
3 AEs,1
#acalabrutinib + #,1
2019„ÅßÁô∫Ë°®,1
https://t.co/0IbudsECrt,1
CALQUENCE¬Æ #,1
Data To Show Improved Progression-Free Survival In Phase III Front-Line Chronic Lymphocytic Leukemia,1
Meeting¬†¬†Business Wire,1
https://t.co/3ww46CFbAd,1
30-mos,1
Acala+ O,1
year-end,1
Calquence 1L,1
6th Nov Roxadustat,1
PIII CV,1
ASN,1
8th Nov,1
SABCS,1
#drugandmeddevice #,1
Sant√© Canada,1
#m√©dicamentsetinstrumentsm√©dicaux #,1
https://t.co/AtJ4b6mifs,1
#pharmaceutical https://t.co/CWJgGpZIC4,1
HOPE,1
https://t.co/bKpxftUYBK,1
50% to 63%,1
Dr. Rogers,1
Julie Durocher,1
https://t.co/jR2kMwVX0d,1
McGill University,1
about 2 weeks ago,1
Eric Kader,1
Montr√©al morning,1
Paul Vardanis,1
SVB Leerink's Porges,1
the best decade,1
Sovaldi,1
#cllsm #mclsm #,1
August 2019,1
@MDAndersonNews Lymphoma &,1
AstraZeneca Canada‚Äôs Calquence,1
https://t.co/aNTeb3HU74,1
#leusm https://t.co/FMmh08RNuY,1
@UCLAHealth,1
Eradat Discusses Data With Acalabrutinib,1
Comparison of Three Chemotherapy Regimens,1
Bendamustine/Rituximab/HighDose Cytarabine,1
Bendamustine/#Rituximab/HighDose Cytarabine/Acalabrutinib,1
10/3/19,1
"81%
43%",1
"PET
mDOR",1
|#lymsm,1
CLL Konkurrenz,1
Rituximab +,1
la designaci√≥n de terapia innovadora de acalabrutinib,1
https://t.co/hh99rUIRy4,1
RelapsedRefractory Bcell NonHodgkin Lymphoma,1
Condition Summary: Non-hodgkin,1
"Calquence
FDA",1
Pascal Soriot PS,1
3.5,1
benda,1
72% and 65%,1
Roxa,1
"Lynparza, Roxa and Calquence",1
assets inc tezepelumab,1
Epanova,1
DS8201,1
#RMELiveWM #,1
polatuzumab vedotin + obinutuzumab + lenalidomide,1
+ pembrolizumab,1
Leukemia https://t.co/7W8HU7ffiQ,1
Study of Acalabrutinib Versus Chlorambucil Plus Rituximab,1
API,1
AZ‚Äôs Calquence for Export,1
https://t.co/eCh1YU10dA,1
691,1
https://t.co/CYaWFJaGad,1
ÈòøÊñØÂà©Â∫∑ÔºàAstraZenecaÔºâËøëÊó•ÂÆ£Â∏ÉÔºåÁæéÂõΩÈ£üÂìÅÂíåËçØÁâ©ÁÆ°ÁêÜÂ±ÄÔºàFDAÔºâÂ∑≤Êéà‰∫àÈù∂ÂêëÊäóÁôåËçØCalquenceÔºàacalabrutinibÔºâÁ™ÅÁ†¥ÊÄßËçØÁâ©ËµÑÊ†ºÔºàBTDÔºâÔºå‰Ωú‰∏∫‰∏ÄÁßçÂçïËçØÁñóÊ≥ïÊ≤ªÁñóÊÖ¢ÊÄßÊ∑ãÂ∑¥ÁªÜËÉûÁôΩË°ÄÁóÖÔºàCLLÔºâÊàê‰∫∫ÊÇ£ËÄÖ„ÄÇCLLÊòØÊàê‰∫∫ÊúÄÂ∏∏ËßÅÁöÑÁôΩË°ÄÁóÖÁ±ªÂûã‰πã‰∏Ä,1
https://t.co/mdTAmKRms6,1
#CLLsm #Calquence,1
#wins,1
AstraZeneca Calquence Gets FDA's,1
Breakthrough Status,1
Lynparza Imfinzi,1
Fasenra and Symbicort,1
CVRM,1
Lokelma,1
Brilinta,1
Roxadustat,1
Bruton-TKI,1
https://t.co/1aGfEThx22 #CLL #,1
Calquence https://t.co/vPGNRpte7L,1
Breakthrough Therapy Designation for Calquence,1
#ChronicLymphocyticLeukaemia,1
https://t.co/FBvyAKkTQa,1
https://t.co/2uMEYvr13b,1
Calquence marks,1
#Calquence https://t.co/KkzYpSq4Bs,1
BTK inhibitor.@PallawiTorkaMD,1
https://t.co/OxpXA1nEpF,1
Two Phase III Successes,1
https://t.co/3HdSw7Oy29 https://t.co/om4thlcEzu,1
Calquence ‚Äì Endpoints News,1
Calquence - https://t.co/jAeBwMscVF,1
2012/13,1
@AstraZenecaUS https://t.co/vqcF14Onm4,1
Granted,1
the US Food and Drug Administration FDA,1
Calquence https://t.co/eLC0pDHj5A &gt;&gt;&gt,1
https://t.co/EfWXIfBFbV,1
Calquence - https://t.co/DuxwsnuPCG https://t.co/edRzUs0fei,1
https://t.co/rn49u1dQVe,1
the US FDA‚Äôs,1
Calquence https://t.co/8gyBUXYxuq,1
https://t.co/KCBenjX3VQ Calquence,1
AstraZeneca plc Calquence,1
https://t.co/vopqywk1bc,1
the Potential Future of Acalabrutinib,1
Headaches https://t.co/9G2MDw6qiW,1
23E,1
c23%,1
https://t.co/6WjVVbvq0e,1
MD https://t.co/iJoCDUxkkA,1
@MedicalCollege,1
Abedin Discusses,1
RSP https://t.co/kMyhhNYH3a,1
the BJH Single,1
Spriano,1
lymphomas - Spriano,1
$FGEN 2,1
"al
Zanubrutinib",1
b.d.,1
G3 bleed+1,1
96.2%,1
üóû Le,1
#EHA24 https://t.co/f3TyHYAb6,1
"SpringerLink
https://t.co/gumnmKIf5G",1
Karmali,1
https://t.co/r0wN6J4aeO #,1
EHACongress,1
#EHA24  #,1
#TrialsLink #,1
I. Mechanistic,1
3-Year Follow-Up of,1
Obinutuzumab Combo,1
AstraZeneca/Acerta,1
Global Drug Overview,1
2017-2019,1
AstraZenecaAcerta Overview,1
AstraZeneca/Acerta) Overview,1
ACE-LY-004,1
https://t.co/W7F0mjLKQd,1
Gem/Abraxane + Ibrutinib,1
Ibrutinib + Durvalumab,1
https://t.co/ABFqj9DDG6 #,1
@AstraZenecaES,1
@aecc_es #,1
anuncia los resultados,1
del ensayo llamado,1
@AstraZenecaES @_SEOM,1
@aecc_es  ,1
Leucemia Linfatica Cronica,1
prolunga,1
il,1
https://t.co/A2OgiD1ETn https://t.co/PF65zQWSK0,1
@NewfusionApps #Science News,1
AMSTERDAM,1
Calquence @StrathScience #,1
https://t.co/eH4RcSmahb,1
https://t.co/r59LTw315,1
https://t.co/rNgNfxaooI,1
la supervivencia,1
linfoc√≠tica cr√≥nica recurrente o refractaria https://t.co/k2CqiDA3ED,1
obinutuzumab showcase,1
lylcl https://t.co/ltEOofPOP9,1
Catalyst,1
Roxat,1
#lylcl https://t.co/FgOweV8gsh,1
Woyach Highlights Long-Term Acalabrutinib/Obinutuzumab,1
https://t.co/4aVW7JT0QY https://t.co/WKBv4Kf69v,1
Paediatric,1
#ICML19 https://t.co/XlYyTPHJAh,1
the Mantle Cell Lymphoma Program of Excellence,1
"#comitatoimalatiinvisibili
",1
https://t.co/vud2dkQjxA,1
#LucidQuest #,1
arma terapeutica,1
che,1
l‚Äôuso,1
#Ibrutinib -intolerant,1
Kerry Roger,1
#EHA19  ,1
#ICML2019 #,1
@SanRaffaeleMI,1
https://t.co/eH9RgjNpZn,1
Vose,1
#ICML #,1
BTKIs,1
https://t.co/uYVaLW3taL,1
Kerry A Rogers,1
https://t.co/fUZKCjfleZ,1
https://t.co/rJt6N1UvrT https://t.co/Gslb9ycKHO,1
Forty Seven,1
Acerta Collaborate to,1
https://t.co/tNpPuCpcG6,1
https://t.co/BJtpJpSpmS #healthcare #,1
#drugtrial,1
RR-CLL #,1
https://t.co/kuXLKCfkH4,1
https://t.co/BAoZEXD3gm &gt;&gt;&gt,1
#leusm https://t.co/I0LNGKosxn,1
linfoc√≠tica cr√≥nica refractaria,1
https://t.co/JWuRFHlgKw AZ',1
https://t.co/A21zBFUTl5,1
https://t.co/OwlLHn6dti,1
Johnson‚Äôs Imbruvica,1
Calquence Phase III Clinical Trials - https://t.co/jAh7zQOH2o,1
AbbVie/J&amp;J‚Äôs,1
https://t.co/8mOcx1zEuo,1
maggiori,1
Calquence https://t.co/7lpxFTnpQa,1
#AZN #,1
https://t.co/lkBouGD2YI,1
Babcock,1
Serco,1
"Calquence
https://t.co/IAQfIg2KId",1
Calquence - https://t.co/l1xoVuGxz4,1
ÔºàÊó•ÁµåBPÔºâ https://t.co/lLUQy5nwmO,1
https://t.co/tGDwEO9L7,1
https://t.co/cfUxjByRMv,1
l'acalabrutinib allonge la survie,1
"https://t.co/T2MNAjADbt
#leusm #",1
#PI3Ki &,1
#CIT,1
https://t.co/jvkv4FddyD https://t.co/dn5erTvsyX,1
https://t.co/sKfbJkHXnC,1
16mo,1
80+%,1
https://t.co/DVSvGr0E1P Calquence,1
K Maddocks,1
#Primary #,1
https://t.co/VXxry0lycd,1
12:30 PM CEST,1
https://t.co/jvkv4FddyD,1
Paolo Ghia: Acalabrutinib,1
#ASCEND #,1
@CiceriFabio @massdomi,1
@albertomussetti,1
LB2601,1
39-month,1
94.4%,1
"https://t.co/T2MNAjSe31
#",1
https://t.co/C4manYB8gV,1
Ibrutinib / Calquence,1
ÂâçÊ≤ªÁôÇÊ≠¥„ÅÆ„Å™„ÅÑÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„ÇíÂØæË±°„Å®„Åó„Åü Á¨¨IIIÁõ∏ELEVATE-TNË©¶È®ì„ÅÆ‰∏≠ÈñìËß£Êûê„Å´„Åä„ÅÑ„Å¶‰∏ªË¶ÅË©ï‰æ°È†ÖÁõÆ„ÇíÈÅîÊàê https://t.co/tBTBiY400B,1
sonid√©gib https://t.co/tavWkHY5Bw,1
L'√©tude de phase 3,1
de l'adulte https://t.co/SmIEa5z80c,1
en ensayo cl√≠nico de Calquence https://t.co/15GhuoKCTi https://t.co/2Nd0v1RUU1,1
@USI_en,1
Calquence #,1
https://t.co/WitzYAStvx https://t.co/jJ2P5QmPnZ,1
#MantleZoneLymphoma,1
#WM @WMIWMF,1
Calquence Meets Endpoint,1
Calquence in Phase III CLL,1
L‚ÄôEND POINT,1
$AZN https://t.co/PYWnA8sZoW,1
https://t.co/fVoUrvbPAF @PharmaTimes,1
III,1
III https://t.co/32N0gAlEHl,1
AbbVie https://t.co/KeZQTnXLo1 $,1
https://t.co/JwEYT7eNSu,1
Calquence Hits Endpoint,1
AbbVie - https://t.co/1tif0r99Vw,1
jargon,1
BusinessNews https://t.co/ZFABnktREQ,1
PharmaShots,1
AbbVie https://t.co/xUiFKFmn6C &gt;&gt;&gt,1
https://t.co/wxTvmXE8ir,1
Leukemia  https://t.co/Xt7Ryf8KVa #,1
https://t.co/TNhN7GGFx4,1
AbbVie - https://t.co/tSrMvwTDeE,1
AbbVie https://t.co/KeZQTnXLo1,1
https://t.co/aLYjSyKAHJ,1
https://t.co/WU5YYxRPLR,1
"f√∂r Calquence
https://t.co/KrXv06WwrD",1
f√∂r Calquence - https://t.co/ifFoQ95cNE,1
https://t.co/WevZPwBOsT #pharma,1
#calquence,1
chemo+obi,1
Ibrutinib P3,1
https://t.co/av9MnLBprZ https://t.co/2mwMlOTJGn,1
AstraZeneca Calquence Phase III ELEVATE-TN,1
"https://t.co/T2MNAjADbt
#",1
El aca‚Ä¶ https://t.co/TK9TBd4G08,1
#ASCO2019„Ç≠„É£„É≥„Éö„Éº„É≥ #ASCO2019 #,1
obinutuzumab - Woyach - 71%,1
obinutuzumab - Woyach - https://t.co/MiXW5St1sc,1
obinutuzumab - Woyach - Responses,1
3yr,1
obinutuzumab - Woyach - https://t.co/LMSdFatbMi,1
obinutuzumab - Woyach - https://t.co/sFlJzjsZCY,1
obinutuzumab - Woyach - https://t.co/hBZVgKsWP8,1
#lungcancer #,1
Astrazeneca drug CALQUENCE https://t.co/tCYWB28xSl,1
CALQUENCE https://t.co/JvtBNFNNXl https://t.co/NhXcIoDjIR,1
https://t.co/av9MnLBprZ https://t.co/TYD9U25X14,1
Investigate,1
Condition Summary: Hepatic Impairment,1
Hepatic Insufficiency,1
#bloodwise_uk https://t.co/kFcbTPERmy,1
"al
-Acalabrutinib+Obinutuzumab",1
ANC,1
G3,1
#Blooducation #,1
https://t.co/Q4WwASmNJ1 https://t.co/iGh6UDJN2,1
Imbruvic,1
https://t.co/JaSYc1URfz https://t.co/r6DWa8ose0,1
https://t.co/NagDFQSmyB $,1
https://t.co/J2TuUqMvor &gt;&gt;&gt,1
https://t.co/7SMmLfv3qC,1
https://t.co/lMc3dXzvjM,1
https://t.co/qC6j58LEtN,1
@PRTIMES_JP„Åã„Çâ,1
nonHodgkins,1
@Blood Advances https://t.co/fK8xqP6RTE,1
ŸÖŸÜ ÿßŸÑÿ™ÿ¨ÿ±ÿ®ÿ© ÿßŸÑÿ≥ÿ±Ÿäÿ±Ÿäÿ©,1
Venetoclax and Acalabrutinib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma,1
https://t.co/oHnVytaxln https://t.co/BH0tWAJXvj,1
Jose Baselga,1
Leukemia https://t.co/qpR1HQ0Cwo,1
AcertaPharma &,1
5F9 + #rituximab + #,1
#antibody 5F9,1
AZ Imbruvica Rival Reports Positive Trial Results,1
Rare Disease Drug,1
#drugapproval #,1
https://t.co/cOKIo4AlJv #,1
#leusm https://t.co/tm6bypVMhi,1
#lymphocyticleukaemia #drugtrials #,1
ThePMI19,1
Phase 3 #CLL,1
https://t.co/5jri6chsMI,1
https://t.co/8dld7cndsa,1
https://t.co/1OreI2H634 &gt;&gt;&gt,1
AstraZeneca Announce Calquence Phase III ASCEND,1
https://t.co/TfYyx6NwsB,1
‚ñ∂ UBS,1
Kursziel von 5400,1
$AZN $GILD $,1
https://t.co/URyU7iLapi $,1
Phase III CLL,1
AstraZeneca - Company,1
AstraZeneca Plc Calquence Phase III,1
https://t.co/ZscbUpjqbN - $AZN,1
https://t.co/PgmYYjRwpf,1
https://t.co/q1LlBsyJ9l,1
Calquence PhIII,1
Phase III ASCEND,1
"Calquence
https://t.co/WgwCwzFHFe",1
Study of Acalabrutinib,1
Malignancies https://t.co/bx74WCwAvr,1
Condition Summary: Phase I: Relapsed or Refractory B-cell,1
Ref,1
M.D. #Lymphoma @michaelwangmd @MDAndersonNews,1
#BTK Inhibitors,1
https://t.co/6iPXKw66Cc,1
https://t.co/cXq2Ol5dwR,1
the Oncology Nursing Society Congress,1
ONS Congress,1
#ONSCongress #,1
Oncology Nursing Society Congress,1
Anaheim,1
Without Acalabrutinib in Patients With Newly,1
https://t.co/kjPEwFRE69,1
Lynparza Calquence,1
@SenSanders,1
Headaches https://t.co/UeW7VXtcEp,1
Xagena,1
#Acalabrutinib - #,1
Aggiornamenti,1
Xagena - #,1
EmatologiaOncologica,1
FarmaciEmatologici,1
https://t.co/qVz7YcgjMr &amp,1
https://t.co/SzpkCOFleZ &amp,1
Database,1
Ematologia &,1
#healthcare#MedEd #,1
Xagena: Acalabrutinib - Aggiornamenti,1
Xagena - WEB,1
https://t.co/SzpkCOFleZ,1
"Versus
 Chemoimmunotherapy",1
age 18,1
"CALQUENCE 

https://t.co/U4ZLjLiqNd",1
MCL  @michaelwangmd,1
acalabrutinib w PBMCs,1
"Tregs
@TiansterZhang",1
SHINE,1
Juno/Celgene Car T,1
Echo,1
Bendamustine-Rituximab-Acalabrutinib,1
Bendamustine-Rituximab-Placebo,1
546,1
https://t.co/ucVjIot5dE,1
Podoll et,1
Bioavailability,1
"Journal of @OfTreatment 

",1
"20th February, 2019",1
copanlisib,1
Astrazeneca drug CALQUENCE - https://t.co/4LKkAmOf7l,1
Astrazeneca drug CALQUENCE:,1
Astrazeneca drug CALQUENCE https://t.co/HDFIF6RWtw https://t.co/x9NjbKMRVv,1
CALQUENCE https://t.co/1vGXPhGGjx https://t.co/lTbL3HKr00,1
indicado para o tratamento de pacientes,1
LCM,1
tenham,1
pelo menos,1
Confira &gt,1
#oncologiabrasil #,1
NCT02477696,1
Shagun Arora,1
Up @michaelwangmd https://t.co/5Pz77118rl,1
Patel Discusses,1
Mantle Cell Lymphoma @MDAndersonNews,1
https://t.co/GgtLTGJ9xJ,1
MCL Data,1
Tycel Phillips,1
the Safety of Acalabrutinib Plus Bendamustine/Rituximab,1
#ASH18 https://t.co/XGwDLOWp7u,1
https://t.co/wsvy5lhoMw https://t.co/oQg8SX15Ig,1
Wang Discusses,1
Robert Dean,1
Phase 1/2 Trial https://t.co/XqLFQzewwW,1
Headaches https://t.co/j31N9klSVZ @MDAndersonNews,1
Headaches https://t.co/9G2MDw6qiW https://t.co/XZjhMOXL4F,1
https://t.co/av9MnLBprZ https://t.co/8OJC9tIxqy,1
Efficacia di Acalabrutinib,1
https://t.co/34NjYPrK5k,1
#revistamedicinasa #,1
#anvisa #medicamento #,1
@MDAndersonNews https://t.co/T3wKtzI7Ys,1
"https://t.co/Gh1eQdD3eH
",1
#MCL #lymphomas,1
Headaches https://t.co/ogrAMMQa2O,1
the BTK Inhibitor Acalabrutinib,1
Active Metabolite,1
Healthy Volunteers,1
https://t.co/73S1LmuTvR,1
"https://t.co/NDZ87SLB49 
",1
https://t.co/7GrL6pmpci,1
https://t.co/rm9X2JVD0M Listen,1
last year‚Äôs,1
https://t.co/V1lZmWCV3z,1
#Acalabrutinib Regimen Highly Active,1
November 2013,1
4 years later,1
https://t.co/huPwAK0ThO,1
CLL https://t.co/vTeEuQmyNU,1
Jackie Barrientos,1
692,1
Cosentyx,1
Keytruda 1L,1
AD,1
MCL Confirms Efficacy &,1
„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâ„ÄÅÊñ∞„Åü„Å™Èï∑Êúü„Éá„Éº„Çø„Çí2018Âπ¥Á±≥ÂõΩË°ÄÊ∂≤Â≠¶‰ºö„ÅßÁô∫Ë°® - PR TIMES,1
https://t.co/kob3WoN7bu,1
„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„ÉñÔºàCalquenceÔºâ„ÄÅÊñ∞„Åü„Å™Èï∑Êúü„Éá„Éº„Çø„Çí2018Âπ¥Á±≥ÂõΩË°ÄÊ∂≤Â≠¶‰ºö„ÅßÁô∫Ë°®,1
https://t.co/Nm6QZvUIgQ,1
https://t.co/hlF7UwfxiG &gt;&gt;&gt,1
#ASH18 https://t.co/GgtLTGJ9xJ,1
https://t.co/VLj59jhpKm,1
#ASH18 #MCL #,1
Calquence at ASH 2018 https://t.co/Ix6al2x3dg,1
#ASH18 @CancerMedMDA  https://t.co/GgtLTGJ9xJ,1
Safety and Efficacy of Acalabrutinib Plus Bendamustine,1
#MCL #ASH18 https://t.co/NhrCaUdI72,1
Relapsed/Refractory Mantle Cell Lymphoma https://t.co/cuEczbzlgt,1
Ujjani,1
https://t.co/V9vYJcj1FX #,1
https://t.co/Yy7K9jj9Yk,1
https://t.co/ue5jQVu99C,1
#lylsm #,1
https://t.co/av9MnLBprZ https://t.co/uRi6IQamil,1
Humans,1
https://t.co/JsjTOWd4xC,1
#MassSpec #,1
DMD,1
An Application to Pharmacokinetic Study,1
JPBA,1
La monoterapia,1
della macroglobulinemia,1
Waldenstr√∂m https://t.co/66cdyLdupV,1
https://t.co/vpXIyZuoIh,1
Hep B reactivation,1
65 years of age,1
"16,800",1
VelosBio,1
$58M,1
Dave Johnson,1
multibillion,1
https://t.co/av9MnLBprZ https://t.co/kNmG4OB829,1
Bruton Kinase,1
#iwNHL18 #LymSM #,1
y suele,1
el primer mes de tratamiento,1
La absorci√≥n de acalabrutinib,1
el uso de omeprazol,1
Shah Compares Toxicity Profiles of Ibrutinib and Acalabrutinib @MoffittNews,1
Shah Compares Toxicity Profiles of Ibrutinib and Acalabrutinib,1
https://t.co/T5R0RHghDF,1
https://t.co/av9MnLBprZ https://t.co/YFs1wgP4sR,1
https://t.co/IhxxZ6S6j0 #EHA23,1
Combination for Follicular Lymphoma,1
https://t.co/aBujkZyx0,1
https://t.co/rWyXK4XNPF,1
#mcl https://t.co/iJrys8dyon,1
Dr Shah,1
https://t.co/chqFhgycR7,1
Xagena: Acalabrutinib,1
1igr,1
üíÑ,1
üòâüéì,1
Waldenstrm,1
WEEKEND,1
Pip Nicolson,1
Prof Steve Watson,1
https://t.co/quzZGdGH3d,1
https://t.co/LygKlQrmST,1
@PipNicolson,1
GPVI' - https://t.co/3sdz1wiYrA,1
Watch now,1
Owen,1
LOL,1
https://t.co/v8ADpRWX8c #,1
WM https://t.co/mnfYrw6cJ8,1
#Waldenstromsmacroglobulinemia #,1
Zuma-2,1
https://t.co/iPMH1kDHPZ,1
#BehindTheLens,1
#MantleCellLymphoma and,1
#wmsm #,1
Zanubrutinib #,1
Ibrutinib.#EHA23 https://t.co/Zc9evhknz8,1
+ ACP-319,1
–ø–æ–∫–∞–∑–∞ https://t.co/jDIuVarh1o,1
Macroglobulinemia Waldenstr√∂m,1
resposta duradoura,1
Novas,1
https://t.co/NLMlaZRdv0,1
OncolinesProfiler,1
NTRC,1
162,1
Herceptin¬Æ,1
SUMOylation,1
–ø–æ–∫–∞–∑–∞ https://t.co/6gLyxXLuX9,1
blinatumomab,1
#AbbVie Inc,1
Calquence Set,1
$5bn Drug,1
Calquence Vs Imbruvica,1
#lymsm https://t.co/dxwqdpm1oy,1
Another BTK Inhibitor Active,1
Macroglobulinemia https://t.co/AkCAAvgTEr,1
Peter Martin,1
https://t.co/e8iWTXdFsW,1
#Diabetic #,1
https://t.co/bLusNoiUZd,1
"@WHEREISTHEOUTRAGE
üí©üí©üí©",1
#ASC018 #,1
BOPA,1
Communicated,1
ASC018 Abst,1
Oral Abstracts Hematologic Malignancies Lymphoma,1
"CLL
Abstract",1
Waldenstroms Macroglobulinemia,1
–ø–æ–∫–∞–∑–∞ https://t.co/KJbYEDFhdo,1
tonight 18:15 CEST,1
–ø–æ–∫–∞–∑–∞ https://t.co/IhCJYlT0Xv,1
üò∑üò∑‚ò†Ô∏è https://t.co/Ul4G6ZvSmi,1
Dyer et al,1
CR #lymSM Btk,1
https://t.co/fUSQQ4aChd,1
https://t.co/Y90b60vjrD,1
Imbruvica $ABBV,1
–ø–æ–∫–∞–∑–∞ https://t.co/ChRoYFdUEm,1
–ø–æ–∫–∞–∑–∞ https://t.co/ykuJeW3pnK,1
–ø–æ–∫–∞–∑–∞ https://t.co/zwEsawfg6I,1
https://t.co/kNTATey2yq,1
ref,1
#ASCO18 https://t.co/Y2wxgOC87A,1
https://t.co/Y2wxgOC87A,1
–ø–æ–∫–∞–∑–∞ https://t.co/k86CCYG9iU,1
–ø–æ–∫–∞–∑–∞ https://t.co/w53vQCFGc5,1
Dyer et al - acalabrutinib,1
rel / ref DLBCL,1
Only 21,1
GCB,1
https://t.co/sbfQjg4k8,1
@Carolinas https://t.co/dys5DIGyUd,1
https://t.co/Qn1koAoAzi,1
https://t.co/qTFEw6bdT0,1
MCL @Carolinas,1
https://t.co/knzNbw47iC,1
–ø–æ–∫–∞–∑–∞ https://t.co/NGemW5FmBs,1
https://t.co/oO62YDbvHn,1
CCND1 Negative,1
https://t.co/Y0yPRT8FKY,1
–ø–æ–∫–∞–∑–∞ https://t.co/qfoKjiNvOx,1
John Theurer Cancer,1
–ø–æ–∫–∞–∑–∞ https://t.co/tmCCR6oCNW,1
–ø–æ–∫–∞–∑–∞ https://t.co/m8DYNQsL68,1
Goy Shares Insights on Acalabrutinib and Ibrutinib Data,1
–ø–æ–∫–∞–∑–∞ https://t.co/1M3m43eo35,1
https://t.co/GC5ivTrOYw https://t.co/ffri2MbjYG,1
–ø–æ–∫–∞–∑–∞ https://t.co/k6kOmJq16l,1
https://t.co/mxpJtP7PEy,1
Standard DLBCL,1
New Post: Phase 2,1
–ø–æ–∫–∞–∑–∞ https://t.co/6rcPx9RxGL,1
–ø–æ–∫–∞–∑–∞ https://t.co/GepH6xz64A,1
–ø–æ–∫–∞–∑–∞ https://t.co/2o0N18bVAP,1
–ø–æ–∫–∞–∑–∞ https://t.co/J35eqUu1LK,1
–ø–æ–∫–∞–∑–∞ https://t.co/RFB8Z61sij,1
–ø–æ–∫–∞–∑–∞ https://t.co/HVfkdwIh0q,1
–ø–æ–∫–∞–∑–∞ https://t.co/Z8IPWUhL0y,1
–ø–æ–∫–∞–∑–∞ https://t.co/rAuFHzttB2,1
–ø–æ–∫–∞–∑–∞ https://t.co/O12yOmOlwf,1
–ø–æ–∫–∞–∑–∞ https://t.co/x25Lepqt9x,1
https://t.co/iz2rodNPAQ,1
–ø–æ–∫–∞–∑–∞ https://t.co/8GYMa2hXZV,1
#MantleCellLymphoma #,1
–ø–æ–∫–∞–∑–∞ https://t.co/xGikVVcnWq,1
–ø–æ–∫–∞–∑–∞ https://t.co/xgOQ6LCex2,1
–ø–æ–∫–∞–∑–∞ https://t.co/waFfx1vlVU,1
–ø–æ–∫–∞–∑–∞ https://t.co/AudFdDSmKA,1
–ø–æ–∫–∞–∑–∞ https://t.co/brTT1aCtWd,1
–ø–æ–∫–∞–∑–∞ https://t.co/H2L4BSEovB,1
–ø–æ–∫–∞–∑–∞ https://t.co/x97FW2vcYw,1
–ø–æ–∫–∞–∑–∞ https://t.co/dKXq0hz9BD,1
–ø–æ–∫–∞–∑–∞ https://t.co/CR1wqDnPaz,1
https://t.co/s17oegRIHN,1
–ø–æ–∫–∞–∑–∞ https://t.co/zzG36yfUSL,1
–ø–æ–∫–∞–∑–∞ https://t.co/vqRubSyGNP,1
–ø–æ–∫–∞–∑–∞ https://t.co/mN97xyvwSg,1
–ø–æ–∫–∞–∑–∞ https://t.co/8JqK5NMc8C,1
–ø–æ–∫–∞–∑–∞ https://t.co/IimfFgbE1d,1
–ø–æ–∫–∞–∑–∞ https://t.co/urscyLXArr,1
–ø–æ–∫–∞–∑–∞ https://t.co/pbWC1gHbxq,1
–ø–æ–∫–∞–∑–∞ https://t.co/o1POjimz1d,1
https://t.co/yiUOwYyLzF,1
–ø–æ–∫–∞–∑–∞ https://t.co/M5FuVZOGfk,1
–ø–æ–∫–∞–∑–∞ https://t.co/KSlXp7HBFW,1
–ø–æ–∫–∞–∑–∞ https://t.co/2CRtzYSUg6,1
https://t.co/cEYqSBueS4,1
https://t.co/AXZBkAMg3M,1
–ø–æ–∫–∞–∑–∞ https://t.co/pcEwrcQKen,1
https://t.co/BbzXsdIYfT,1
–ø–æ–∫–∞–∑–∞ https://t.co/eMIIOfpO8A,1
–ø–æ–∫–∞–∑–∞ https://t.co/q6VSsBv00,1
–ø–æ–∫–∞–∑–∞ https://t.co/RBQaLVHPAw,1
–ø–æ–∫–∞–∑–∞ https://t.co/71z6fjP5qT,1
–ø–æ–∫–∞–∑–∞ https://t.co/8mCDFMqQXE,1
–ø–æ–∫–∞–∑–∞ https://t.co/xYXXQW7q9k,1
https://t.co/fnPdQ0yfJi #MantleCellLymphoma #,1
–ø–æ–∫–∞–∑–∞ https://t.co/bGoIkqOBnC,1
–ø–æ–∫–∞–∑–∞ https://t.co/wfvFNOG0vt,1
–ø–æ–∫–∞–∑–∞ https://t.co/BHtnp4D3Ts,1
https://t.co/CVhFBGIUcT,1
–ø–æ–∫–∞–∑–∞ https://t.co/xJ0zK8fdqx,1
VA Heme,1
https://t.co/v5oBhK5WtR,1
https://t.co/t4wBqGWeP1,1
–ø–æ–∫–∞–∑–∞ https://t.co/hKyAV3hIJn,1
–ø–æ–∫–∞–∑–∞ https://t.co/0J5lztBguL,1
–ø–æ–∫–∞–∑–∞ https://t.co/sbBxyx3ul9,1
https://t.co/93oSPqUyTE,1
–ø–æ–∫–∞–∑–∞ https://t.co/v6FgyMqITt,1
–ø–æ–∫–∞–∑–∞ https://t.co/cS80p6lmem,1
https://t.co/NSjDf1Thpv #MantleCellLymphoma #MCL #,1
–ø–æ–∫–∞–∑–∞ https://t.co/azRWi8PZw3,1
–ø–æ–∫–∞–∑–∞ https://t.co/2fJIqZwXaQ,1
https://t.co/udagVQPQDA,1
–ø–æ–∫–∞–∑–∞ https://t.co/bXZdT6uyn5,1
–ø–æ–∫–∞–∑–∞ https://t.co/46tZl9Fd0a,1
https://t.co/OzvtljczSS,1
–ø–æ–∫–∞–∑–∞ https://t.co/igjdVtMhQs,1
https://t.co/2LFUJLmnOv,1
–ø–æ–∫–∞–∑–∞ https://t.co/eTVhPN5srf,1
–ø–æ–∫–∞–∑–∞ https://t.co/621CV6lSua,1
–ø–æ–∫–∞–∑–∞ https://t.co/NzI1sKNYV6,1
–ø–æ–∫–∞–∑–∞ https://t.co/VmPBLh2qVM,1
–ø–æ–∫–∞–∑–∞ https://t.co/HZRXMK645K,1
–ø–æ–∫–∞–∑–∞ https://t.co/MkbPuTWxXG,1
–ø–æ–∫–∞–∑–∞ https://t.co/bamcwtBTpu,1
–ø–æ–∫–∞–∑–∞ https://t.co/EMgdWiALpB,1
–ø–æ–∫–∞–∑–∞ https://t.co/R79ansL1jo,1
–ø–æ–∫–∞–∑–∞ https://t.co/lZIE1geic2,1
–ø–æ–∫–∞–∑–∞ https://t.co/DEJbglPQ2,1
–ø–æ–∫–∞–∑–∞ https://t.co/7anyygyQjv,1
–ø–æ–∫–∞–∑–∞ https://t.co/jC5Qpkseng,1
https://t.co/UikjN8HUKl,1
–ø–æ–∫–∞–∑–∞ https://t.co/bovtfonyhi,1
–ø–æ–∫–∞–∑–∞ https://t.co/ytUuynifx0,1
https://t.co/W2RCWUn6xE,1
–ø–æ–∫–∞–∑–∞ https://t.co/0cnCAaKhsN,1
https://t.co/DK7PMDQ0Pj,1
–ø–æ–∫–∞–∑–∞ https://t.co/hZVviUX6Md,1
https://t.co/dBDCSmiEoz,1
–ø–æ–∫–∞–∑–∞ https://t.co/AFBhlscrXT,1
https://t.co/V2olyGM6rZ,1
–ø–æ–∫–∞–∑–∞ https://t.co/vZ0By9lpjc,1
https://t.co/pGxhb58Zzk,1
https://t.co/30qAxmJ1DO,1
–ø–æ–∫–∞–∑–∞ https://t.co/x4zFBt2zTS,1
–ø–æ–∫–∞–∑–∞ https://t.co/zmaArUnovd,1
–ø–æ–∫–∞–∑–∞ https://t.co/rO2ofBk0Wp,1
–ø–æ–∫–∞–∑–∞ https://t.co/Q02GdUpTIg,1
–ø–æ–∫–∞–∑–∞ https://t.co/VprLC9dvlk,1
–ø–æ–∫–∞–∑–∞ https://t.co/0bXshaja7C,1
–ø–æ–∫–∞–∑–∞ https://t.co/KbJe9G52kc,1
–ø–æ–∫–∞–∑–∞ https://t.co/kHgxym2DZM,1
https://t.co/QnhtXsWt9z,1
–ø–æ–∫–∞–∑–∞ https://t.co/zUt78ZAylL,1
–ø–æ–∫–∞–∑–∞ https://t.co/deQ8hyyHgJ,1
https://t.co/ZiUvGqdQ2M,1
–ø–æ–∫–∞–∑–∞ https://t.co/9158xYzqnu,1
–ø–æ–∫–∞–∑–∞ https://t.co/3cIkl0UvIx,1
–ø–æ–∫–∞–∑–∞ https://t.co/B94bcwBO9G,1
–ø–æ–∫–∞–∑–∞ https://t.co/eD6Ux2ixfR,1
–ø–æ–∫–∞–∑–∞ https://t.co/xcTXii6QRh,1
–ø–æ–∫–∞–∑–∞ https://t.co/EazGgIlT5C,1
–ø–æ–∫–∞–∑–∞ https://t.co/J5hGsDnvmm,1
–ø–æ–∫–∞–∑–∞ https://t.co/qgTpB1JJmF,1
–ø–æ–∫–∞–∑–∞ https://t.co/kIEULkD8WE,1
–ø–æ–∫–∞–∑–∞ https://t.co/qWRC1nM6IC,1
https://t.co/J8yQGVv5Yv,1
–ø–æ–∫–∞–∑–∞ https://t.co/f3aSYyGDXv,1
–ø–æ–∫–∞–∑–∞ https://t.co/k5iHJaC19,1
–ø–æ–∫–∞–∑–∞ https://t.co/9PxEX0U9Gv,1
https://t.co/wwDBbmAbUT,1
–ø–æ–∫–∞–∑–∞ https://t.co/AKolJhEP9K,1
https://t.co/hqRSGX6usQ,1
https://t.co/awpVw7mWDU,1
–ø–æ–∫–∞–∑–∞ https://t.co/zbZzN0A7O1,1
–ø–æ–∫–∞–∑–∞ https://t.co/IodeoutTmm,1
–ø–æ–∫–∞–∑–∞ https://t.co/80YWRV1Rlu,1
–ø–æ–∫–∞–∑–∞ https://t.co/o4vDFsXZ5,1
https://t.co/yJcgWm28TS,1
–ø–æ–∫–∞–∑–∞ https://t.co/akvldBCQe1,1
–ø–æ–∫–∞–∑–∞ https://t.co/odJpgZOMDN,1
–ø–æ–∫–∞–∑–∞ https://t.co/gHyVazHt7u,1
https://t.co/w1g7uxUNom,1
Ibrutinib and Acalabrutinib,1
Zanubrutinb,1
–ø–æ–∫–∞–∑–∞ https://t.co/rDNInsGTGP,1
–ø–æ–∫–∞–∑–∞ https://t.co/hLhqBdpOdI,1
–ø–æ–∫–∞–∑–∞ https://t.co/odkeUz7KrP,1
–ø–æ–∫–∞–∑–∞ https://t.co/STmsEq1dJH,1
–ø–æ–∫–∞–∑–∞ https://t.co/4Fw89OdUjd,1
–ø–æ–∫–∞–∑–∞ https://t.co/F8Wnn5qATe,1
https://t.co/1QMs5b1Pq9,1
–ø–æ–∫–∞–∑–∞ https://t.co/7NMpc2StL4,1
https://t.co/cUJenKyCR3,1
–ø–æ–∫–∞–∑–∞ https://t.co/fqKkvPP3pC,1
https://t.co/e5uaLiqT77,1
–ø–æ–∫–∞–∑–∞ https://t.co/lVd2hb4uHO,1
https://t.co/KBF7CGuJnc,1
https://t.co/F9mrsNSpkW,1
https://t.co/27A6PybUD3,1
–ø–æ–∫–∞–∑–∞ https://t.co/l896XHUxiw,1
https://t.co/oaNTY4gB68,1
–ø–æ–∫–∞–∑–∞ https://t.co/t6zTZThJsx,1
–ø–æ–∫–∞–∑–∞ https://t.co/mRx3iY9IPI,1
–ø–æ–∫–∞–∑–∞ https://t.co/xnlrD5HPuv,1
–ø–æ–∫–∞–∑–∞ https://t.co/FsdtIpvyKp,1
–ø–æ–∫–∞–∑–∞ https://t.co/oJ2rINL8b0,1
–ø–æ–∫–∞–∑–∞ https://t.co/fbqLwNm1QR,1
–ø–æ–∫–∞–∑–∞ https://t.co/b0VZVGpmqB,1
–ø–æ–∫–∞–∑–∞ https://t.co/J9KkW2yYXw,1
–ø–æ–∫–∞–∑–∞ https://t.co/rbSZlNV0UM,1
https://t.co/dN2bZrfArJ,1
–ø–æ–∫–∞–∑–∞ https://t.co/naqQ9sqtSc,1
–ø–æ–∫–∞–∑–∞ https://t.co/bV9CZn9uFX,1
https://t.co/ng12wtde0k,1
–ø–æ–∫–∞–∑–∞ https://t.co/4dKQ7QZBHE,1
–ø–æ–∫–∞–∑–∞ https://t.co/feCClEEd7,1
–ø–æ–∫–∞–∑–∞ https://t.co/mZ6nAHwKO6,1
–ø–æ–∫–∞–∑–∞ https://t.co/TTJItLKo2P,1
–ø–æ–∫–∞–∑–∞ https://t.co/eYnViedq8c,1
–ø–æ–∫–∞–∑–∞ https://t.co/ztZ01cGj0i,1
–ø–æ–∫–∞–∑–∞ https://t.co/J2Bfxonabb,1
–ø–æ–∫–∞–∑–∞ https://t.co/U63YqX7gsO,1
–ø–æ–∫–∞–∑–∞ https://t.co/zrUxw5JvcQ,1
–ø–æ–∫–∞–∑–∞ https://t.co/m74fXo4DNR,1
–ø–æ–∫–∞–∑–∞ https://t.co/YOXir9vaJT,1
https://t.co/8FD84NeO6Q,1
–ø–æ–∫–∞–∑–∞ https://t.co/aDGc2p1MuR,1
–ø–æ–∫–∞–∑–∞ https://t.co/xKKoMYDUBl,1
–ø–æ–∫–∞–∑–∞ https://t.co/fzFYcO1RQ6,1
https://t.co/HAliaRouZj,1
–ø–æ–∫–∞–∑–∞ https://t.co/FlOukL2wo4,1
https://t.co/IrUonKTN4d,1
https://t.co/2NVWspgBbQ,1
https://t.co/vlds48TnJX,1
Barrientos Discusses Acalabrutinib,1
–ø–æ–∫–∞–∑–∞ https://t.co/8EGhl34kjG,1
–ø–æ–∫–∞–∑–∞ https://t.co/9doH347ivH,1
–ø–æ–∫–∞–∑–∞ https://t.co/eS1bm0pKyS,1
https://t.co/TykXy4i5H2,1
–ø–æ–∫–∞–∑–∞ https://t.co/TNGPgPwXXL,1
–ø–æ–∫–∞–∑–∞ https://t.co/3Fb5XMpLa5,1
–ø–æ–∫–∞–∑–∞ https://t.co/l3ImnrMAsJ,1
–ø–æ–∫–∞–∑–∞ https://t.co/GazDIuGbDF,1
–ø–æ–∫–∞–∑–∞ https://t.co/KkceMgXNjA,1
–ø–æ–∫–∞–∑–∞ https://t.co/3iHVTbTbDS,1
–ø–æ–∫–∞–∑–∞ https://t.co/TmdsgN8xQz,1
–ø–æ–∫–∞–∑–∞ https://t.co/J5JOq2jBH4,1
–ø–æ–∫–∞–∑–∞ https://t.co/IY6MouawQw,1
–ø–æ–∫–∞–∑–∞ https://t.co/HkGZRDbB2p,1
https://t.co/PPagEi8nLO,1
–ø–æ–∫–∞–∑–∞ https://t.co/TGp3X3J7cN,1
https://t.co/0960pwq9bl,1
–ø–æ–∫–∞–∑–∞ https://t.co/RFZ8clqomV,1
–ø–æ–∫–∞–∑–∞ https://t.co/odGqGQ8pER,1
–ø–æ–∫–∞–∑–∞ https://t.co/vtTWu42rPg,1
https://t.co/YX6GyTKU4u,1
–ø–æ–∫–∞–∑–∞ https://t.co/x4EE25UO2P,1
–ø–æ–∫–∞–∑–∞ https://t.co/s8IcXj9Fws,1
–ø–æ–∫–∞–∑–∞ https://t.co/U8J3zthed4,1
–ø–æ–∫–∞–∑–∞ https://t.co/5cCzqCzUlX,1
–ø–æ–∫–∞–∑–∞ https://t.co/tQA31kg7I6,1
–ø–æ–∫–∞–∑–∞ https://t.co/WpSg5mkMM2,1
–ø–æ–∫–∞–∑–∞ https://t.co/dJk8Osam64,1
–ø–æ–∫–∞–∑–∞ https://t.co/yIAzuQHeIa,1
–ø–æ–∫–∞–∑–∞ https://t.co/TN4dDy6VZM,1
–ø–æ–∫–∞–∑–∞ https://t.co/KhykiP6NXb,1
–ø–æ–∫–∞–∑–∞ https://t.co/zgUTXH4Rnh,1
https://t.co/xSRfCH2wxO,1
https://t.co/BhlgsnJSgk,1
–ø–æ–∫–∞–∑–∞ https://t.co/St3tgcJaD5,1
–ø–æ–∫–∞–∑–∞ https://t.co/pOSZ3konXA,1
https://t.co/AVKe25vHOO,1
https://t.co/eVeM3x7pXj,1
https://t.co/EQK5ruNLiY,1
–ø–æ–∫–∞–∑–∞ https://t.co/QsCoO1a2Tk,1
–ø–æ–∫–∞–∑–∞ https://t.co/MeJOPQxRjf,1
–ø–æ–∫–∞–∑–∞ https://t.co/yLPetDiTtc,1
–ø–æ–∫–∞–∑–∞ https://t.co/INRNSQnqoN,1
–ø–æ–∫–∞–∑–∞ https://t.co/4GVheCvM11,1
–ø–æ–∫–∞–∑–∞ https://t.co/xtX11Slw5B,1
https://t.co/Dg2eCoJdhI,1
–ø–æ–∫–∞–∑–∞ https://t.co/1QoNGZnKRY,1
–ø–æ–∫–∞–∑–∞ https://t.co/ZccRDIb976,1
–ø–æ–∫–∞–∑–∞ https://t.co/77BpMipHrc,1
–ø–æ–∫–∞–∑–∞ https://t.co/MdVQZs19Fa,1
–ø–æ–∫–∞–∑–∞ https://t.co/VDBgypZpXm,1
https://t.co/aSuOXcq1OE,1
–ø–æ–∫–∞–∑–∞ https://t.co/kbCm04Z6FL,1
https://t.co/sOe5q1qRUH,1
–ø–æ–∫–∞–∑–∞ https://t.co/4PTdOIcoML,1
–ø–æ–∫–∞–∑–∞ https://t.co/0Oy8AbJxBW,1
–ø–æ–∫–∞–∑–∞ https://t.co/Hq0Ubrhl9,1
–ø–æ–∫–∞–∑–∞ https://t.co/BlKSi9fXfH,1
https://t.co/0F0kheEQya,1
–ø–æ–∫–∞–∑–∞ https://t.co/xbXp9BHmMA,1
–ø–æ–∫–∞–∑–∞ https://t.co/1NlrGqw6Zm,1
–ø–æ–∫–∞–∑–∞ https://t.co/rqzhGZJCVS,1
–ø–æ–∫–∞–∑–∞ https://t.co/fa1yJ1SEkB,1
–ø–æ–∫–∞–∑–∞ https://t.co/cV4fDXV4Ns,1
https://t.co/VvGDNZspx3,1
–ø–æ–∫–∞–∑–∞ https://t.co/IFdW8cpFj9,1
–ø–æ–∫–∞–∑–∞ https://t.co/WVpkVtpjyg,1
–ø–æ–∫–∞–∑–∞ https://t.co/Z3UGQhkHb4,1
–ø–æ–∫–∞–∑–∞ https://t.co/WvDtonxfp3,1
–ø–æ–∫–∞–∑–∞ https://t.co/OxAWa4ujly,1
https://t.co/czAUXbGi2,1
–ø–æ–∫–∞–∑–∞ https://t.co/ZX5yJ6AeOE,1
–ø–æ–∫–∞–∑–∞ https://t.co/18kjyZh43d,1
https://t.co/ezdktmTCBm,1
–ø–æ–∫–∞–∑–∞ https://t.co/J2HRwdVTtC,1
–ø–æ–∫–∞–∑–∞ https://t.co/FJwmjBbeyz,1
–ø–æ–∫–∞–∑–∞ https://t.co/t2jGNyobxK,1
–ø–æ–∫–∞–∑–∞ https://t.co/7YvyGZX3tC,1
–ø–æ–∫–∞–∑–∞ https://t.co/KjgDLnyoSD,1
https://t.co/8sDpKQr9RQ,1
–ø–æ–∫–∞–∑–∞ https://t.co/0QYIIF0DPs,1
–ø–æ–∫–∞–∑–∞ https://t.co/3phz8NcJ9a,1
–ø–æ–∫–∞–∑–∞ https://t.co/LhSAy8W5zj,1
–ø–æ–∫–∞–∑–∞ https://t.co/7zJhXG31ix,1
–ø–æ–∫–∞–∑–∞ https://t.co/GPCj1jMjIF,1
–ø–æ–∫–∞–∑–∞ https://t.co/uE9aFIVcOL,1
–ø–æ–∫–∞–∑–∞ https://t.co/ToRcYtBcAS,1
–ø–æ–∫–∞–∑–∞ https://t.co/qhhT5e5klo,1
–ø–æ–∫–∞–∑–∞ https://t.co/9Y18AjVfEb,1
–ø–æ–∫–∞–∑–∞ https://t.co/oUL4GYuvSy,1
–ø–æ–∫–∞–∑–∞ https://t.co/89if2SvT1f,1
–ø–æ–∫–∞–∑–∞ https://t.co/HLI62SXRbd,1
–ø–æ–∫–∞–∑–∞ https://t.co/Gt7PJFWl96,1
–ø–æ–∫–∞–∑–∞ https://t.co/upE5ISECey,1
–ø–æ–∫–∞–∑–∞ https://t.co/iDUqueBxW6,1
https://t.co/tc02UU9NjS,1
–ø–æ–∫–∞–∑–∞ https://t.co/TeYjDscPX5,1
–ø–æ–∫–∞–∑–∞ https://t.co/sTyXvW6rve,1
–ø–æ–∫–∞–∑–∞ https://t.co/gp8U4g0ieK,1
BMO $ABBV,1
Mavyret,1
Humira,1
Rova,1
–ø–æ–∫–∞–∑–∞ https://t.co/lI7gpTYZ98,1
–ø–æ–∫–∞–∑–∞ https://t.co/C4ErIEy2CQ,1
–ø–æ–∫–∞–∑–∞ https://t.co/TvARDJtWFP,1
–ø–æ–∫–∞–∑–∞ https://t.co/j7Y3XnMejX,1
–ø–æ–∫–∞–∑–∞ https://t.co/GVhz8EWkqr,1
–ø–æ–∫–∞–∑–∞ https://t.co/opQGrDr0b6,1
https://t.co/CpX0pBynkj,1
–ø–æ–∫–∞–∑–∞ https://t.co/baZcKXSUVk,1
–ø–æ–∫–∞–∑–∞ https://t.co/Nmz1JRsDkN,1
–ø–æ–∫–∞–∑–∞ https://t.co/CQad4KdIEk,1
–ø–æ–∫–∞–∑–∞ https://t.co/ANti9XAwVq,1
–ø–æ–∫–∞–∑–∞ https://t.co/hy4NBXpecb,1
–ø–æ–∫–∞–∑–∞ https://t.co/Vk3OFrW57x,1
–ø–æ–∫–∞–∑–∞ https://t.co/2BCOxHp6l7,1
HOPA18,1
#MCL https://t.co/xvMKduyQ4d,1
Andre Goy,1
#lymsm https://t.co/EGIawkeOE7,1
USD $1500 -,1
Insight,1
Logan,1
Dr Kay,1
hypertension &,1
https://t.co/VE4fsJfxDF,1
Kay Discusses,1
#leusm https://t.co/KlMH7MU44i,1
https://t.co/04TK6WMK8J,1
Acalabrutinib Therapy for Mantle Cell Lymphoma,1
4)Acalabrutinib‰ΩµÁî®„ÅØÊú™Ê≤ªÁôÇÔºèÂÜçÁô∫ÁôΩË°ÄÁóÖ„Å´ÂÆâÂÖ®„Åã„Å§ÊúâÂäπ,1
@michaelwangmd,1
under a year,1
https://t.co/LRJy9Raj8U,1
https://t.co/ILEtZvgIvb,1
Efficacy &,1
Safety of (Acalabrutinib,1
Relapsed/Refractory CLL &,1
Intolerant of Ibrutinib Therapy,1
2/2020,1
https://t.co/NEuiL5e5zL,1
#INFOS #,1
TRAITEMENT,1
#Linfoma del,1
sin rama control,1
Plaquetas,1
Ibrutinib al,1
https://t.co/lFDL34hE5W,1
Read Trends,1
@MSDNederland,1
Life Sciences Industry,1
https://t.co/k6oXsDt7wW,1
"14,260",1
Calquence https://t.co/YIFGo16IBR,1
Calquence https://t.co/okU7eVZDPY,1
https://t.co/N9BpfnaTqw,1
https://t.co/cs575CgccV,1
https://t.co/0bMhcSPc1M https://t.co/e0GKsaXDh7,1
El 31,1
para el,1
#linfoma de,1
Aprenda,1
la aprobaci√≥n,1
the Q3 2017,1
Lymphoma SnapShot,1
#AgingData #NACDA_Aging #,1
@JTCancercenter,1
498,1
#oncogenomics #,1
https://t.co/XXi3AkHvPK,1
#MantleCellLymphoma #MCL #FingersCrossedAgain,1
FingerCrossedAgain,1
O'Connor,1
Acalabrutinib Versus Ibrutinib,1
RISULTA MOLTO EFFICACE,1
Acerta/AZ's Acalabrutinib,1
1/2 134,1
the Overall Response Rate,1
CLL https://t.co/MY5cGJlG7c,1
#lymsm #leusm @BloodAdvances,1
https://t.co/X78EuZop4Q https://t.co/QeZeCli7YA,1
Next Steps With the Ag,1
IRB,1
Lawrence Kaplan,1
#ASH17 Oral Abstract,1
#155 Read,1
Wang #,1
lymsm https://t.co/FlNtiIx1iF,1
the Clinic: Acalabrutinib in Previously Treated Mantle Cell,1
https://t.co/YBUba11Y7N,1
DidyouKnow,1
https://t.co/nm2s1j5whX,1
lymsm https://t.co/FlNtiIfpU5,1
Times &,1
The Sunday Times,1
https://t.co/nwmZbNeSRp,1
https://t.co/AtwhFr6NMi,1
Bioimpact News,1
Êñ∞BTKÈòªÂÆ≥Ââ§Acalabrutinib„ÅåÂÜçÁô∫,1
Lancet Article,1
https://t.co/FfzVowykgv,1
Wang Discussed Acalabrutinib Activity,1
#ASH17 @CancerMedMDA  ,1
#thelancet,1
#lymphomedumanteau #,1
essai de phase 2,1
just 6 weeks,1
@TheLancet https://t.co/QS6yjvA78B https://t.co/nw2q5lTb6I,1
#ASH17 https://t.co/nVsIy46s8i,1
https://t.co/4BHYrOugpY,1
#Syria,1
Acalabrutinib Highly Effective for Refractory MCL,1
Calquence - https://t.co/ipF8u2ecgi #,1
#medicinal #,1
https://t.co/tnjLdrLeEm https://t.co/JvvRgXyKu5,1
Dr Byrd,1
1stL&amp;RR,1
2yPFS 90%,1
19 de novo,1
Obino,1
C2,1
https://t.co/NP1uvXG30A https://t.co/fH07rG87cb,1
Neil Berinstein,1
Calquence https://t.co/Fi9QEHV8uR,1
Relapsed/Refractory Mantle Cell Lymphoma - Cancer Therapy Advisor,1
TCSC https://t.co/tAJZGfJJJg,1
AstraZeneca Announces CALQUENCE Demonstrates Activity,1
Pharma Cos News AstraZeneca‚Äôs,1
https://t.co/tCwREMjRgS,1
https://t.co/B5W7DiUZdJ,1
https://t.co/I2a1bVjw0P,1
#laboratoire #,1
ASH17 Acalabrutinib,1
https://t.co/8TD8mIQCPY,1
https://t.co/9o0DQiFSEs,1
https://t.co/1CX459cmyB,1
AstraZenecas,1
Wang et al,1
#ASH2017 #,1
https://t.co/WAJXXrAEUR,1
ASH17 @DrMichaelWang nice,1
Dr Wang,1
MCL 40%,1
12mPFS 67%.https://t.co/9YQnL0Cuu1 https://t.co/pZiO2N40D9,1
Obat Baru Untuk,1
https://t.co/5mHSYEilDa,1
https://t.co/WD2j9gBgVW,1
Safety of #Acalabrutinib Monotherapy,1
#ASH17 https://t.co/6FFo7zW4Nh,1
https://t.co/QiQxBayv0M,1
Efficacy and Safety of #Acalabrutinib Monotherapy,1
Study https://t.co/9WoPJKVKu3 https://t.co/iIKz1LBQPN,1
https://t.co/bZUxue6iSO,1
https://t.co/oxv34M6TQi,1
#Acalabrutinib #MCL #,1
#TheHinduPatrika,1
Lymphoma RX,1
Angelica Welch,1
Dr O‚ÄôConnor,1
CR 40%,1
The Delaney Clause,1
Calquence https://t.co/UPldurcIRa,1
cancer drug win,1
https://t.co/JZA3eEIArj,1
https://t.co/32YU5lSmoP,1
JR Brown,1
#Richter @1stpostgraduateCLLconference,1
https://t.co/InO9OjPBY4,1
Lymphoma https://t.co/JJl7h0i1ek,1
https://t.co/Xnq2hWyaIM https://t.co/4ciLwzMHgF,1
BMO $,1
https://t.co/ApTbjWtLEH,1
https://t.co/R74ZW3oeBU,1
#NonHodgkinLymphoma,1
Calquence https://t.co/A5WG8oWJQ0 $,1
Linfoma de C√©lulas,1
Manto,1
https://t.co/8JMR7nAU0e,1
FDA Clears CBC Test for Office Use,1
G-CSF Priming,1
ClinicalEdg,1
https://t.co/tLtdJPKHmD,1
Calquence Treatment for Treatment of,1
Calquence https://t.co/GthCzqexDo $,1
https://t.co/mh54XHKevN,1
https://t.co/BzXpSYaVKR,1
https://t.co/vsQGpU57km,1
Calquence https://t.co/qlAR44ELCv $,1
Calquence https://t.co/2i3nzuKEA8 $,1
https://t.co/99krVFacAa,1
Calquence https://t.co/KMvfIJLHmt $,1
https://t.co/bEHWGan1H6,1
Nieuws,1
#apothekersassistent,1
#apotheker,1
#apotheek #,1
https://t.co/VA61VVBj07,1
2017/11/07,1
Â∞èÈáéËñ¨‚Ä¶ https://t.co/srzDaM18YF,1
RxWiki https://t.co/pSWAV5XGBX,1
https://t.co/AAKnA5Vr7K,1
RxWiki https://t.co/H3clkiserb,1
approvalsWatch News,1
ŸÑÿπŸÑÿßÿ¨ ÿ£ÿ≠ÿØ ÿ£ŸÜŸàÿßÿπ ÿ≥ÿ±ÿ∑ÿßŸÜÿßÿ™ ÿßŸÑÿØŸÖ ÿßŸÑŸÜÿßÿØÿ±ÿ©,1
Organon Kinase,1
GeneNominator,1
Behandlung von Mantelzellenlymphomen bei Erwachsenen,1
several months ahead,1
https://t.co/Xnq2hWyaIM https://t.co/99YdfYNuya,1
Calquence https://t.co/bb6pt3fnZh,1
https://t.co/4prOqRMtjI,1
https://t.co/2twGDHmplI https://t.co/cxc6xoHNke,1
https://t.co/RPPEaUEjqP,1
Calquence https://t.co/oTAkRmoPCW $,1
Calquence https://t.co/jOeV4zE0CA $,1
https://t.co/tzM7fx5evP,1
Medli,1
Calquence https://t.co/G5QLcIoUbf $,1
Calquence https://t.co/9Oj5WCUXvD $,1
https://t.co/w7jttipd8O,1
Calquence - Drug Store News https://t.co/cEDzxWXKXx ‚Ä¢ https://t.co/MmJAa7KXeT,1
FDA Aprova Acalabrutinib,1
Linfoma Folicular,1
Mantle Cell Lymphoma https://t.co/F4Xx3C46aG,1
#Wellness #,1
#kanser #,1
#hematoloji,1
2017ACCP,1
https://t.co/vJPhnnX60Q,1
#MantleCellLymphoma $,1
https://t.co/Izd3L0BtsN,1
@Kemivarlden @Kemisamfundet,1
https://t.co/aWrjA6G5Tv,1
"Calquence
@PharmaCompass",1
https://t.co/WYpiGqOsl4,1
Mantle Cell Lymphoma Category,1
Mantle Cell Lymphomahttp://www.medicinenet.com/script/main/art.asp?articlekey=207987,1
#RhythmHealth #,1
DrBotha,1
Potential Lymphoma Blockbuster Calquence  https://t.co/rAt6OV6fYm,1
https://t.co/OHgaYAzMxS,1
"Calquence
$",1
Mantle Cel,1
https://t.co/7F5GGHV0QU,1
https://t.co/bU22GYVdHA,1
https://t.co/sODNeHtQXr,1
Snags Quick FDA OK,1
https://t.co/00N4iU15Q9,1
"Order at Biologics, Inc.",1
https://t.co/1Iev3Dt8a0,1
#lymphoma https://t.co/971Nz1i5cP,1
Biologics: https://t.co/rTEEnGPTIS https://t.co/jv9ejJSOaA,1
https://t.co/1ROMbt1H1f,1
Hours,1
https://t.co/hgOfDAeM8E,1
https://t.co/Xnq2hWyaIM https://t.co/HFv4DGylCt,1
SanJose,1
Calquence https://t.co/Wy0mGgi4c8,1
https://t.co/fJd3a3BxEq https://t.co/GnqpYM5uXD #,1
https://t.co/5lUHtYHU6,1
https://t.co/yYF6niWO3o,1
"MCL
https://t.co/QDqH2Kw3bE",1
SF,1
Votre Argent,1
"1,6%",1
https://t.co/f092cym3vW,1
https://t.co/CpNaTqcp2S,1
Mantle Cell Lymphoma https://t.co/2DucHtTl2l,1
BTK inhibitor &,1
Potential Lymphoma Blockbuster Calquence https://t.co/qxwkDBC0R2,1
FDA„ÅåÊàê‰∫∫„Éû„É≥„Éà„É´Á¥∞ËÉû„É™„É≥„ÉëËÖ´„Å´acalabrutinib„ÇíÊâøË™ç,1
1.5B,1
Calquence - https://t.co/YGsPqOwyHQ,1
Calquence ‚Äì ENDPOINTS NEWS https://t.co/kWKe7jQYXk,1
Calquence https://t.co/QLCNHzeu9M,1
https://t.co/CJFJVpcuqJ,1
Calquence https://t.co/cqAlrXip2G #,1
Calquence https://t.co/TceHChm7p1 #,1
Mantle Cell Lymphoma - Medscape,1
#health #news #NewsAssistant,1
https://t.co/UY1EDeW9S3,1
https://t.co/7owkjN3m2O,1
Calquence https://t.co/QLCNHzeu9M #,1
"Oct. 31, 2017",1
HealthDay News,1
Lymphoma - https://t.co/CeOljlHOrg - #Nutrition,1
Acal RR,1
$CPRX $,1
MRNS,1
Calquence https://t.co/ksq7ANt5S0,1
https://t.co/OHMqZUd3ck https://t.co/73tgukRsmv,1
Lymphoma https://t.co/MaLTrvLBdp,1
https://t.co/Z55l6I0xpD,1
AstraZeneca plc,1
@medscape„Åï„Çì„Åã„Çâ,1
#spx #,1
https://t.co/0EFW9nRYml,1
Calquence https://t.co/4Hw620WxRS,1
https://t.co/5y6yNnGTbI,1
https://t.co/m1wxAl4hZZ https://t.co/QcD53XtqFa,1
https://t.co/k1gsLyXun5,1
https://t.co/mHpTCCmmek,1
https://t.co/9vaA1v90qH,1
https://t.co/Z9rC2RxZNs https://t.co/S10BFpTqRI,1
RT Reuters,1
https://t.co/lEhllg1miL https://t.co/8kO7m7DkcQ,1
BTK FDA,1
Calquence - https://t.co/WgfiHyrNRc,1
Calquence at $,1
"14,259",1
https://t.co/2YfrUb8mfL,1
Grace Guthrie,1
Jane Huang,1
@frazierhealth,1
Brian Lannutti,1
Amy Peterson,1
Calquence https://t.co/JCG75xiuEL,1
Calquence - FiercePharma,1
Calquence https://t.co/LURcRRQFbv #,1
https://t.co/nyX6UdCbhM,1
https://t.co/D2WeUf6xHA,1
Aggressive Mantle,1
#inhibitor #,1
https://t.co/YAAd7Ae4G4,1
LONDON,1
Calquence https://t.co/20iQSyvigp https://t.co/2fo8T6I07n,1
Drug Administration - Interactive Investor,1
Black Swan Intelligen,1
https://t.co/mcI3Pv1o7O,1
Calquence https://t.co/QKSCVWEc0Q https://t.co/Jk0El8Y8L5,1
https://t.co/acAlc2zZMK https://t.co/cRfVlL9Tez,1
https://t.co/sQ92UWPUcf,1
https://t.co/pMw8UH3sSB,1
MCL https://t.co/vkyQT8XBjn,1
# https://t.co/5rn3z90Sxb,1
patienter med tidigare behandlad,1
mantelcellslymfom https://t.co/u2ZAdBCjtA,1
HealthNews FDA,1
Grow Taller,1
https://t.co/db7VhVndOd,1
https://t.co/mPd9r7jCc8,1
https://t.co/sLcR1tCxfH,1
BREAKINGNEWS,1
https://t.co/0ezusI3NAu,1
https://t.co/77a9rzWg2n,1
73%-87%,1
20+ months,1
1.9 months,1
#acalabrutinib #mantlecelllymphoma #,1
Lymphoma https://t.co/D27SvakUi7,1
https://t.co/0c0Ko5FhG4,1
Calquence - https://t.co/eUQqMlStSi,1
https://t.co/33NP4wsdUR,1
The U.S. Food,1
https://t.co/ArHjrzvteQ,1
https://t.co/QHrccnrvKn,1
PDUFA,1
New Treatment for Adults With Mantle Cell,1
$AZN Calquence,1
https://t.co/PAcwEIW8TK,1
CALQUENCE label https://t.co/fEIYxHnIx6,1
"https://t.co/kiOImqVILu 
#",1
Falsified Data on Acalabrutinib https://t.co/IxtAgtOlwM,1
#astrazeneca #,1
#preclinical #,1
#AZ #accalabrutinib #,1
https://t.co/0wDOX1adUe,1
https://t.co/a0IRyqiml8,1
Ê≠§ÂâçÊúâÂàÜÊûêË°®Á§∫ÔºåFDAÁöÑÁ™ÅÁ†¥ÊÄßËçØÁâ©ËÆ§ÂÆöËÉΩÂä†Âø´ËØ•Êñ∞ËçØÁöÑÂºÄÂèë‰∏éÂÆ°ËØÑÔºåÊúâÊúõÂä†ÈÄüËøôÊ¨æÁî®‰∫éÊ≤ªÁñó‰∏•ÈáçÁñæÁóÖÁöÑÊñ∞ËçØÁöÑ‰∏äÂ∏ÇÊµÅÁ®ã„ÄÇËÄåAcalabrutinib‰∏ÄÊó¶ÊàêÂäü‰∏äÂ∏ÇÔºåÈÇ£‰πàÈòøÊñØÂà©Â∫∑ÂèØ‰ª•Ë°å‰ΩøÂÖ∂30‰∫øÁæéÂÖÉË¥≠‰π∞Acerta,1
PharmaÊòØ‰∏ÄÂÆ∂‰Ωç‰∫éËç∑ÂÖ∞ÁöÑ„ÄÅ‰∏ìÊ≥®‰∫éË°ÄÊ∂≤Â≠¶ÁñæÁóÖÁ†îÁ©∂ÁöÑÁîüÁâ©Âà∂ËçØÂÖ¨Âè∏„ÄÇ2015Âπ¥ÔºåÈòøÊñØÂà©Â∫∑‰ª•40‰∫øÁæéÂÖÉÊî∂Ë¥≠‰∫ÜAcerta,1
ÊçÆÂà∂ËçØË°å‰∏ö‰∏ì‰∏öÂ™í‰ΩìPharmafileÊä•ÈÅìÔºåÈòøÊñØÂà©Â∫∑ÂèëÁé∞ÔºåÂÖ∂ÊéßËÇ°ÂÖ¨Âè∏Acerta,1
PharmaÂú®Á†îÂèëÊñ∞ÂûãÂÆûÈ™åÊÄßÊäóÁôåËçØÁâ©AcalabrutinibÁöÑËøáÁ®ã‰∏≠‰º™ÈÄ†‰∫ÜÈÉ®ÂàÜ‰∏¥Â∫äÊúâÊïàÊÄßÊï∞ÊçÆ„ÄÇËØ•ËçØÁâ©Âú®‰ªäÂπ¥8ÊúàÂàöÂàöË¢´ÁæéÂõΩÈ£üÂìÅËçØÂìÅÁÆ°ÁêÜÂ±ÄÔºàFDAÔºâÊéà‰∫à‰∫ÜÁ™ÅÁ†¥ÊÄßÁñóÊ≥ïËÆ§ÂÆö,1
PI3KŒ¥ Inhibition with Acalabrutinib &,1
ACP-319 Improves Survival &,1
Mouse Model https://t.co/uvmovtH8Wi,1
Ascerta &,1
FDA Revis√£o,1
the FDA Awards Acalabrutinib Priority Review,1
FDA News,1
the Month of August,1
ONCOLOGY,1
ESMO17,1
https://t.co/6Uy5Y9uUYk,1
https://t.co/bvDd8Uzc7k,1
https://t.co/INqdiYL1DU,1
ACCEPT,1
Salute Domani - Linfoma,1
https://t.co/ftRqGXmlC4,1
https://t.co/fHFhrc2qc7,1
https://t.co/vddfgIXsS9,1
Lymphoma Treatment Acalabrutinib Receives,1
FDA https://t.co/Fio9Y1R2fL,1
LCM https://t.co/njHPPTASxB,1
https://t.co/GiF8D2B9so,1
Potential Mantle Cell,1
https://t.co/4tjlMHhyVd,1
Clinical Trials Acalabrutinib,1
US #FDA,1
Grants Priority Review -  https://t.co/LliVW9guuZ,1
the Treatment of‚Ä¶,1
FDA Awards,1
#MCL https://t.co/MKK9zjKNIE,1
#Breakthrough #,1
ACE-LY110,1
NDA Priority Review,1
https://t.co/Uv9Ms522Li,1
US FDA Accepts Regulatory Submission,1
Priority Review https://t.co/z7Y8yUXJzq,1
https://t.co/VgVMyp83aM $WX,1
https://t.co/Qw3ZW4Yvnr $WX,1
https://t.co/TQlPNGNVaQ,1
2017/08/04,1
https://t.co/E7YwpZ1UTP,1
„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆACALABRUTINIB„ÄÅÁ±≥ÂõΩÈ£üÂìÅÂåªËñ¨ÂìÅÂ±ÄÔºàFDAÔºâ„ÅåÊâøË™çÁî≥Ë´ã„ÇíÂèóÁêÜ„ÄÅÂÑ™ÂÖàÂØ©Êüª„Å´ÊåáÂÆö https://t.co/9svzGMIBll,1
„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆACALABRUTINIB„ÄÅÁ±≥ÂõΩÈ£üÂìÅÂåªËñ¨ÂìÅÂ±ÄÔºàFDAÔºâ„ÅåÊâøË™çÁî≥Ë´ã„ÇíÂèóÁêÜ„ÄÅÂÑ™ÂÖàÂØ©Êüª„Å´ÊåáÂÆö - PR TIMES,1
„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆACALABRUTINIB„ÄÅÁ±≥ÂõΩÈ£üÂìÅÂåªËñ¨ÂìÅÂ±ÄÔºàFDAÔºâ„ÅåÊâøË™çÁî≥Ë´ã„ÇíÂèóÁêÜ„ÄÅÂÑ™ÂÖàÂØ©Êüª„Å´ÊåáÂÆö https://t.co/Hm80ev8fM9,1
„Ç¢„Çπ„Éà„É©„Çº„Éç„Ç´„ÅÆACALABRUTINIB„ÄÅ„Éû„É≥„Éà„É´Á¥∞ËÉû„É™„É≥„ÉëËÖ´Ê≤ªÁôÇËñ¨„Å®„Åó„Å¶Á±≥ÂõΩÈ£üÂìÅÂåªËñ¨ÂìÅÂ±ÄÔºàFDAÔºâ„Çà„ÇäÁîªÊúüÁöÑÊ≤ªÁôÇËñ¨„Å´ÊåáÂÆö - PR TIMES,1
#PriorityReview to,1
pts w. mantle cell,1
#mantlecelllymphoma #MCL,1
https://t.co/Orkc9JSFCg,1
AstraZeneca FDA,1
https://t.co/lktGQfYbri,1
https://t.co/BB5ywaxmGt RT https://t.co/GdpJCdkXDf,1
"MCL
https://t.co/jsiymd9P0M",1
https://t.co/C6tUKMrJgv,1
https://t.co/GFvPmyxHdE,1
https://t.co/wPp9Soc0Tl,1
dall'Fda,1
US FDA Priority Review,1
https://t.co/rzzWpbBNOy,1
#lymphoma https://t.co/rqfYWbSkVL,1
#lymphoma https://t.co/X4G9mdWQ9u,1
#Company_News,1
https://t.co/2xRBabWAz9 https://t.co/kyGahW4Ngk,1
https://t.co/n7X2rHNEmF,1
WX,1
https://t.co/miqH8SxeDj,1
InvestingFrance,1
Journal of Hematology &,1
#Radiology,1
#Pediatrics,1
#Neurology,1
FDA Accepts Acalabrutinib Filing &,1
https://t.co/JQMLb3sDar,1
FDA Breakthrough Designation,1
ACP196) https://t.co/FbyfaVRSCD,1
https://t.co/GuK6xFGaMm,1
https://t.co/Kw6mTMxfn8,1
https://t.co/UNP42nPEFB,1
prioriterad,1
https://t.co/ypaeQ9rxLO,1
https://t.co/SbFQqc66QJ,1
https://t.co/mYWWktX3cj #pharma #,1
AZN Acalabrutinib FDA,1
1.5bn,1
#Cardiology https://t.co/pwUiXEhTMD,1
FDA Grants Acalabrutinib Breakthrough Therapy Designation for the Treatment of Mantle Cell Lymphoma,1
US FDA https://t.co/b34xWGx1cb,1
MYSTIC,1
2 days - durvalumab,1
https://t.co/viMHXcqqPq #,1
https://t.co/BiKxYgVSXz,1
Bl,1
https://t.co/s2eauWFPAZ,1
ACP196) https://t.co/0lOQy12Ywb,1
#acertapharma https://t.co/9gP2g2Of1l,1
#lymphoma https://t.co/wWiPr0uJ71,1
https://t.co/BB5ywaxmGt,1
BTD,1
The Treatment Of Patients With Mantle Cell,1
https://t.co/NahZjRsfBe,1
https://t.co/srulQdF6Po,1
LOXO &,1
REDX,1
AstraZeneca - negative MYSTIC-Studiendaten,1
https://t.co/WBp17jxC4c https://t.co/xBH0335Tlv,1
https://t.co/iXNfStBE1d,1
https://t.co/XW2lFHgNsT,1
the Acerta BTK,1
https://t.co/QMYpW05AJI,1
2H17,1
Bydureon,1
Comparison of Acalabrutinib,1
Chronic Lymphocytic L,1
Vistusertib,1
week of June,1
GEMP,1
PBYI,1
PTI,1
RARX,1
mo https://t.co/XVnI9YYJxB,1
The Bruton Tyrosine Kinase,1
"‚ë°ÔºöËâæËäùÂØ∂
‚ë¢ÔºöÊó•ÁõõÂ•àÁ±≥ÁîüÊäÄÊúâÈôêÂÖ¨Âè∏",1
cl√≠nico para,1
Leucemia Linfocitica Cronica,1
https://t.co/1WYcoD9a1A,1
https://t.co/zK31mAXOJY,1
https://t.co/aEHc4lrzR7,1
transformation &,1
SRC,1
#ibrutinib than #,1
Richter's transformation &,1
https://t.co/PUYWPRTuA5,1
https://t.co/OJiyOFGHck https://t.co/HLXGiIcrzn,1
https://t.co/ixOx4a5sS9,1
Ibrutinib-Intolerant CLL/,1
SLL https://t.co/LADNZwYmeV,1
https://t.co/UwjRruqlWA,1
#Ibrutinib-#Intolerant #,1
one #BTKinhibitor,1
DifficulttoTreat Chronic Lymphocytic L,1
ASH16 https://t.co/1v5grK1mxS,1
https://t.co/KBJcTa7mtd,1
Astrazeneca plc Early Data Demonstrate Clinical Activity of Acalabrutinib,1
https://t.co/Dmx7JOPjnK,1
Business Wire https://t.co/FxuetwrHan,1
Dr Awan,1
#ASH16 $,1
#ASH16 Words,1
38.1%,1
ash16,1
ASH16 Dr Hillman,1
200bid,1
https://t.co/i4pD10QihV,1
https://t.co/MkvubnfL9e,1
Upcoming Trials,1
"Obinutuzumab, &amp",1
CheckpointInhibitor,1
ÂïÜÈ°ò2016-120630,1
#Trending $,1
4Q16 https://t.co/HYTZ6mV5Vw,1
Andrew Davies,1
ASH16 Next-Gen,1
AstraZaneca,1
jaar van start-up,1
FD,1
VCS2016,1
Checkpoint Inhibitor https://t.co/r43HF0hY0,1
@ScrippsHealth @UCIrvineHealth,1
oncolog√≠a con lanzamiento de 6,1
Para hematolog√≠a,1
https://t.co/21fbhyZv5G,1
#tyrosine,1
#spebrutinib,1
GS-4059,1
#inhibitor,1
#ACERTA #,1
#Wallonia,1
MedicBoard https://t.co/0OhxGwQEZv,1
Leucemia linfatica cronica,1
https://t.co/vuX34bvUSO,1
Pembro + Acalabrutinib,1
Durva + Ibrutinib,1
LCC,1
https://t.co/J0lwJvD42Y,1
Aka Acalabrutinib,1
Acalabrutinib Challenges Ibrutinib,1
#Acerta,1
https://t.co/xOsufNP1y1,1
https://t.co/Bmw69C9bSE,1
Intolerant of Ibrutinib,1
GaithersburgJobs,1
"Marketing, Acalabrutinib Team:",1
https://t.co/Vnf9LRU0eu,1
Europa Lee,1
https://t.co/CBT1NbvTS9,1
#onmedic #,1
esalud,1
para su designaci√≥n,1
https://t.co/stRh4GT2nP v√≠a @IMMedicoHosp,1
https://t.co/u9VfZz5Wsm,1
ClashofClans News La EMA,1
NewsSalud,1
LA,1
DI FARMACO ORFANO PER ACALABRUTINIB,1
#Acerta #,1
#pharma #clinicaltrials #,1
astrazeneca https://t.co/3PDZGSyu0v,1
https://t.co/A8oBOpZcpc,1
https://t.co/OJrloGF08D,1
los BTK de segunda,1
"Orphan"" Drug Status",1
#medtech #,1
https://t.co/O6Tc4oIQx8,1
The European Medicines Ag,1
https://t.co/f2eL6qoAKZ,1
International Business Times,1
India Edition,1
https://t.co/MkUIaTfMuy,1
@ibtimes_india,1
https://t.co/LERc1amLWT,1
Orpan,1
3 Haem,1
3 haem,1
Article &gt,1
https://t.co/EUiXAbFjtU,1
#Acalabrutinib Recommended for OrphanDrug Designation,1
Three #Cancer,1
–ü—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤—ã–π,1
$4 Billion,1
https://t.co/DYt2qvRL0a,1
https://t.co/KWohETqKgG,1
https://t.co/kz1YlFraXp,1
https://t.co/SzW3gmwKjY,1
Acerta Acalabrutinib,1
https://t.co/HYmPwV6N4a,1
https://t.co/R7WEbIRX9q,1
https://t.co/jLCidt8mxH,1
BRIEF#AstraZeneca,1
EUROPE,1
THREE,1
https://t.co/XkqaSuf5fD,1
#MG https://t.co/KiKYfhgjBf,1
25 February,1
https://t.co/t2wOhmifkx,1
EU Orphan Designation,1
Indications,1
AstraZeneca #,1
Risultati,1
BTK di,1
New Leukemia,1
https://t.co/BwrtQLZSV1,1
„Éñ„É´„Éà„É≥Âûã„ÉÅ„É≠„Ç∑„É≥„Ç≠„Éä„Éº„ÇºÈòªÂÆ≥Ââ§acalabrutinib„ÅØÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖÊ≤ªÁôÇ„Å´„Åä„ÅÑ„Å¶ÂÆâÂÖ®„Åã„Å§ÊúâÂäπ  ,1
#gan,1
#„Åå„Çì #,1
https://t.co/whpHAw0vat,1
ARRIVA IL,1
[News] Acalabrutinib,1
Bruton @NEJM New,1
Strong Responses,1
https://t.co/uFd35JUjpz,1
#ACP-#196,1
Acaba,1
ya tenemos,1
puertas otro inh,1
https://t.co/GHjE7vGPpP,1
CLL https://t.co/jUL2aVcYpI,1
nuevo f√°rmaco,1
Ojal√°,1
$7 billion,1
Acerta Pharma Phase III BTK,1
https://t.co/cDVeSyTDYa,1
https://t.co/ymcUSScyC8,1
https://t.co/EHE6QK9JpY,1
Imbruvia,1
H2/2016,1
https://t.co/JK90imYons,1
$4B #,1
https://t.co/8J6ewRk4Vo,1
https://t.co/g2HRsaST8K,1
6‚É£,1
3‚É£,1
nearly $5 billion,1
Dutch #,1
#abbv #,1
NEJM https://t.co/bUS78gtUjE,1
5bn,1
https://t.co/XP9TVMgwWj,1
2nd-gen,1
MPTMeetings,1
CME/CE,1
#adult #,1
https://t.co/rFoPHcEOl6,1
https://t.co/bvbddzZEC5,1
https://t.co/76K2MNaavu,1
https://t.co/WF9zvR1xaE,1
https://t.co/mvCVHoVDGq,1
Today The new drug,1
https://t.co/bZ1prKYSjk,1
GB,1
The Prognostic Significance of del6q23,1
https://t.co/n6unRgGqFB #,1
Lymphocytosis Exacerbated,1
https://t.co/9EL9SZS9Ey,1
https://t.co/612S6QKjN3,1
COVIDvaccine &,1
MRNA,1
PK,1
Efficacy of Tafasitamab,1
Ublituximab Plus Ibrutinib vs Ibrutinib Alone for Patients With Relapsed or Refractory High-Risk #,1
Insights https://t.co/cDbjcookN5,1
GetVaccinated,1
https://t.co/CHnoN6339b,1
Only 17%,1
https://t.co/EZherPDQIv,1
#leusm https://t.co/Ulet2pWHMF,1
March 8th,1
NP-C,1
Deborah Stephens,1
The Treatment Landscape: Learn,1
Advocating for Your Care,1
10 am CT/11 am EST,1
@LurieCancer &,1
#Interferon Signaling,1
Leukemia Cells Contributes,1
Signaling Pathway https://t.co/7rKmGSZRL9,1
Oncology + Eternal = Oncternal Therapeutics,1
Covid 6 weeks ago,1
"1, 1975] Rai, Sawitsky",1
Cronkite,1
Chanana,1
Levy,1
https://t.co/MQX8T19Kgj,1
THE GIMEMA WORKING GROUP,1
#edtech #education #,1
https://t.co/dUIKb1HPOd,1
more than a year,1
MHQ,1
CLLsm https://t.co/xc9pkNa7jo,1
https://t.co/YqYb37BjYV,1
May 28th &,1
"https://t.co/8c9rbRpETx
#",1
30sËÉ∂ÂõäÁî®‰∫éÊ≤ªÁñóÂ•óÁªÜËÉûÊ∑ãÂ∑¥Áò§ÂíåË°ÄÊ∂≤ÁôåÔºàÊÖ¢ÊÄßÊ∑ãÂ∑¥ÁªÜËÉûÊÄßÁôΩË°ÄÁóÖÔºâÔºåÁîü‰∫ß,1
Study of TG-1801 Alone,1
MARCKS,1
https://t.co/A9OHjhyQLL,1
GenomeWeb https://t.co/QEqbWHx3PG,1
Blood Cancers,1
#leusm https://t.co/VejSFle8HY,1
the Global Bridges Core Lecture Series Heme Malignancies Block,1
https://t.co/En0oicVvP6,1
https://t.co/312kq8cxcM,1
https://t.co/1FlUXM3UaY https://t.co/7ailILaUHG,1
Tuesday 3/30,1
CLLsm https://t.co/ps4CIyLOZo,1
https://t.co/oqwWIBuh8q,1
"https://t.co/QK47Y8Nvon 

#",1
https://t.co/GiNBVNbrbj,1
Study to Evaluate Adverse Events,1
"Activity, Movement of Oral",1
$12 billion,1
12.7%,1
the forecast period,1
https://t.co/7k2rd8dieg,1
#leusm https://t.co/MNkLE58g6J,1
6 weeks ago,1
Astra Zeneca's,1
"Saturday, March 20",1
@LurieCancer,1
3-hour,1
Drs Shuo Ma,1
Debbie Stephens,1
about #SCT &,1
#BoneMarrowFailures,1
ASOVASNA,1
June 2021,1
"GOLDMAN INTERNATIONAL RESEARCH AWARD
Fund",1
‚û° https://t.co/8KH2KetAXH,1
@aamdsif,1
Education Council,1
#bmt,1
Umbralisib and Ublituximab,1
New this week,1
EHA Unplugged,1
Jos√© Cabrera-Serrano,1
HeidiYates,1
Cohort 4,1
AmbassadorsChallenges,1
#STEM #CLL #Humanities,1
#Arts #,1
#PersonalDevelopment https://t.co/icRXgSRYls,1
https://t.co/JmCTrFjCbm,1
https://t.co/lSepFCQ1wC,1
Noxxon,1
NOX E36,1
Nephropathy,1
"Multiple Myeloma
NOX",1
"#OneCancerVoice 
",1
https://t.co/6LN7Ws1RaC,1
District,1
#MyHeartIsYellow #,1
HappyEmployees,1
#HappyCustomers #,1
ILoveWhatIDo,1
A Tissue Counterpart,1
#TheWiderWiserView,1
https://t.co/7jFrSZqkxK,1
@AACR https://t.co/Lg2GJLx5Hw,1
the ‚Äòwatch &,1
c.dunnion.1@nuigalway.ie,1
Cord Blood Derived,1
CAR-Engineered NK Cells,1
Universal Chimeric Antigen Receptor,1
Jim Dornan,1
Jamie Dornan,1
Dornan,1
Imbruvica Plus Novel,1
Mid-Atlantic Region,1
"@dukemedicine 

Register",1
https://t.co/hWO2wlED8y,1
https://t.co/z7Q98TGOml,1
Tanja Stankovic's,1
GNM,1
#languagedevelopment #SLCN #,1
#oncoalert #,1
https://t.co/LKoFaPIpKC,1
#leusm https://t.co/RuMN4hGKQ4,1
Reed&amp;Harbor,1
#reediculous #,1
#subtlegoodbye,1
Conjugate Pneumococcal Vaccine,1
@ChrisPe10544853,1
@andrea_pepper2 &,1
@EleniLadikou,1
#leukeamia,1
only 13%,1
@SeattleCCA https://t.co/fKbl19C9s2,1
March 17th,1
GRUBHUB Gift Cards,1
Diagnosis and Staging of Chronic Lymphocytic Leukemia,1
Chronic Lymphocytic Leukemia https://t.co/WVIixV8TdD,1
https://t.co/M5npea3Peu,1
https://t.co/IxzNruqz0n #CLL #leusm #,1
https://t.co/G24SqpTsAE #CLL #leusm #,1
Challenges and Solutions for Collecting and Analyzing Real World Data,1
Illustrative Example https://t.co/bQ4TmR1CxV,1
#leusm https://t.co/FDmQSzVHcO,1
The Leukemia Research Foundation,1
ConquerBloodCancers,1
World-Renowned Experts,1
https://t.co/HovY8JCGOm,1
https://t.co/pNdcjApiw8 #,1
#leusm https://t.co/0XZ7VBZYxO,1
https://t.co/M2fHHjwbj6,1
Bruton Tyrosine Kinase Inhibitors,1
the Frontline Treatment of Chronic,1
Register for @power4patients  webinar,1
https://t.co/cHfzErxOLU,1
@AnthonyMatoMD,1
las infecciones del paciente onco-hematol√≥gico,1
SB 2765,1
"https://t.co/Ks6QGXnkJs
",1
#MS #,1
5:00 PM ET,1
Steven Courtre,1
the Stanford University School of Medicine,1
Yeahhhhh,1
ga,1
Zooooo,1
#covid en,1
namelijk geen,1
https://t.co/16p9MXXjzf,1
#leusm https://t.co/wYeHOYQKHL https://t.co/8qmTzAwVY3,1
#ALLIN #,1
#weloveourcustomers,1
https://t.co/0fM98bcfgd,1
Kerry A,1
VAY736,1
#leusm https://t.co/Fbgtxmcp1y,1
Leukemia https://t.co/a8e39C17JX,1
Prayer Warriors,1
Cheryl,1
Missouri,1
March 23,1
Susan OBrien https://t.co/ek6GU1mGfG,1
Murali,1
Brown JR,1
Alan Ramsey,1
@KingsCollegeLon,1
Alexander Egle,1
https://t.co/94r2myhokX,1
Regimens https://t.co/zMVW23UosV,1
FOXO1,1
Congratulation,1
Allison Michie,1
I√±aki Martin-Subero,1
Centret f√∂r,1
Norden,1
#leusm https://t.co/yK3LgHSsRm,1
#languagedevelopment #,1
Bcr-Abl,1
Featured Click,1
https://t.co/kftWoGfQVp,1
knockin mouse,1
https://t.co/EF5ElkKxDl,1
Makes Splash,1
New CLL Drug,1
1.00pm,1
GMT,1
STATIC,1
acute #myeloid,1
https://t.co/NhDpBqGn20,1
https://t.co/4vhCMg7kQZ,1
UNITEGlioblastoma,1
#IntermittentFasting #,1
Development and Characterization of Venetoclax Nanocrystals for Oral Bioavailability Enhancement,1
#leusm https://t.co/RQtGm9o9bO,1
"June 11-13, 2021",1
Xueyan Cui,1
Mantle-Cell Lymphoma,1
4 month,1
Targeting Bruton,1
AYA,1
lymfatische leukemie',1
https://t.co/f22ID12Tz0,1
#laser #tSPL,1
@chuanzhenzhao,1
#1D &,1
#2D,1
70 year old,1
MC,1
iNHLs,1
‚Å¶@DanaFarber‚Å© https://t.co/LSjbAg2xF6,1
https://t.co/pDNp2LKPCC,1
#ASHC21 #,1
Scaffolds,1
Vitro Leukemia Model https://t.co/iNdKHC35g9,1
"The ""Dark Side Matter",1
Aberrant Expression,1
Chronic Lymphocytic Leukemia Patients https://t.co/XMAvafOOsj,1
Apoptotic Blocks in,1
BH3 Profiling,1
Monica D. Mead,1
#nonhodgkin #,1
#RareDisease,1
Wildgroei üñ• üîõ,1
nonhodgkin &amp,1
#jonge patienten,1
#BHSnursing @Stkstichting,1
ü§ó,1
üñ• webinar,1
#nonhodgkin &amp,1
#BHSnursing @VPPvzw,1
"15.03.2021,17:59",1
LymphoidNeoplasms,1
#16ICML,1
myeloma https://t.co/e29k4PfZRG,1
Raquel,1
con nosotros.,1
#Ortodoncia #,1
Valdemoro,1
Program,1
üèª‚Äçüíª Access,1
https://t.co/4JxrKi3ePR,1
@anthonymatomd et,1
@RoswellPark https://t.co/jdIPoFLVRo,1
https://t.co/luhJ5FFQ5x,1
https://t.co/28pTvRmTx5,1
üìöIl #CLL,1
Fondazione,1
Traduttori,1
Vittoriale,1
https://t.co/PatIJvALak,1
@TheLancet üëâ,1
https://t.co/FRjBYscj2n,1
a.k.a,1
üòâ,1
https://t.co/qRZpk3Z7g2,1
#leusm https://t.co/wp4xwWSTWQ,1
Initiative 65,1
Thursday 3/11,1
#SABmember,1
Christopher Flowers,1
MS of @MDAndersonNews,1
https://t.co/9kuUcDe8bd #leusm #,1
one million,1
@Labcorp,1
March 11,1
https://t.co/2uoWVrF2ZE #,1
Quercetin,1
the National Alliance for Caregiving,1
#caregiving #,1
"Ipilimumab, Ibrutinib",1
@CancerResearch,1
#leusm https://t.co/xEHyrre4ed,1
https://t.co/PgcEO8p15M,1
https://t.co/reRpOjiMAD,1
Agence @pole_emploi en centre ville de #Toulouse,1
"this Friday, March 5th",1
April 21 &amp;26,1
@NCCN #,1
https://t.co/mNkHktbD2n,1
the Pharmacy Grand Rounds,1
the last two years,1
MyeloidMaligancies,1
VWF,1
SCD,1
infections https://t.co/aRq6va2kRT,1
March 30th,1
https://t.co/uvrNKyxnbL,1
@LymphomaAction,1
19th March,1
https://t.co/DoswNPxofG #,1
https://t.co/T0ANwAeiys #CLL #leusm #,1
Mikhaila Rice,1
CaLLing Targeted Therapies: Advancements in Chronic Lymphocytic Leukemia,1
University Hospital Galway,1
Adrian,1
https://t.co/pGySo4GScX,1
2021Âπ¥(3Êúà1ÈÄ±ÁõÆ,1
APPS         #,1
AMRS                               ,1
ZM,1
"CRWD

 ‚Äª„Çµ„Éñ„É°„É≥„Éê„Éº",1
#U #,1
Chilblains,1
#leusm https://t.co/6GvSFogzWU,1
Legalization &,1
Licensing,1
Venetoclax10,1
Venetoclax100,1
#delhi https://t.co/FOYOmVsGA1,1
CLL Progression &,1
Leukemia https://t.co/1bGMTS5awd,1
Dinner,1
IgG-Aggregation,1
the Complement System in Patients With Chronic,1
mai kezel√©s√©nek interdiszciplin√°ris,1
#Duvelisib plus,1
decade,1
"https://t.co/RQmySolNol

#",1
https://t.co/yVn0BaZL6O,1
2:50 pm Eastern,1
Novel Approaches,1
@syed_abutalibmd,1
Drs Goy,1
Chanan-Khan,1
https://t.co/k2q2Z4YhzI,1
mon ennemi,1
ma richesse,1
@AsherChananKhan,1
‚Å¶@GCC_Cortes‚Å© @gotoper,1
‚Å¶@sloan_kettering‚Å© ‚Å¶@GACancerCenter‚Å© https://t.co/BeXnWR49Ya,1
N.a.v,1
ziektendag wil Evy,1
@Radiorgbe,1
Getuigenis,1
Quitter la maison le matin,1
Dieux t‚Äôaccorde,1
drague la beaut√©,1
https://t.co/eKnvWCOXYH,1
1 day,1
melena,1
discomfort &amp,1
#biology #,1
#cellulartherapy https://t.co/wPruzO2jbH,1
ATTN,1
May 28,1
#medicalconference #,1
@LymphomaAction @MPNVoice,1
https://t.co/121XzLjEkq,1
https://t.co/s5g6dwClfx,1
@gmcrotty üëèüëè https://t.co/ch5leN4uI2,1
Dr Gerard Crotty,1
Dr Crotty,1
#vaccine #COVID19 #,1
Immune #Dysfunction,1
Acta Haematol,1
Medifocus com Inc.,1
https://t.co/wVNVV3IyMC #CLL #leusm #,1
#Ability #,1
TCT2021: Update,1
Australasia,1
https://t.co/RzvISwFHAS #leusm #,1
TCT2021: Case,1
https://t.co/9Ij2J9DQVb  #leusm #,1
3 months ago &,1
ACCED,1
"https://t.co/GolAmLScSr

#",1
54yo,1
Recurrent CLL,1
Treatment of Hodgkin Lymphoma,1
#education #,1
OnlineLearning,1
Adenoid,1
12p EST,1
a big month of February,1
UKONIQ,1
late 1960s,1
Rossana Maffei,1
EKG,1
Epigenetic Trajectories,1
February 27th,1
5pm EST,1
Research Institute &,1
IL-17,1
IL-23,1
ECP2021,1
NRWHIP,1
Lymphoma Australia Ambassadors,1
this March,1
"6,900",1
#leusm https://t.co/8pemT7bYdH,1
2/24,1
the Era of Next Generation,1
https://t.co/cjb19yZT5e https://t.co/OycWUgXV7v,1
DCLL9718S,1
@MicheleNadeemB &,1
Feb 24 &,1
Jingyu,1
GOLDMAN INTERNATIONAL RESEARCH AWARD,1
Safety and Efficacy of CT125A Cells for Treatment of Relapsed/Refractory CD5+ Hematopoietic Malignancies,1
se discutir√°n las nuevas gu√≠as,1
el diagn√≥stico,1
Paolo Ghia Lydia Scarf√≥,1
Moritz F√ºrstenau,1
https://t.co/g74aulg1V2 #CLL #leusm #,1
Dean JP,1
James DF,1
Mongan,1
https://t.co/UsnDozPIZz,1
https://t.co/TpYvvCaj9q @wwierda #,1
OHC,1
James Essell,1
@LLS_TriState Surviving &,1
2/27/21,1
Essell,1
https://t.co/mgGYbckYbK,1
King's,1
ForeverKings,1
16:30,1
"the EHA Endorsement of @myESMO  Clinical Practice Guidelines for Diagnosis, Treatment",1
"today, Feb 22",1
"https://t.co/YK2v5l3L4y 

ICYMI",1
the last two days,1
#leusm https://t.co/ZaM1AZKEMd,1
t(14;18)(q32;q21,1
NVG-111,1
del nuevo,1
IPS,1
Tycho Baumann,1
adenopat√≠as para,1
@sehh_esüìÜSig,1
#PharmaceuticalsBiotech #,1
https://t.co/3A9bcOnLJL,1
his 60s,1
#Calgary #,1
https://t.co/BJbLmPYAj5,1
Laplace,1
Methylome and Persist through Disease Progression and Therapy,1
Therapeutic Options for Patients,1
Deficient Chronic Lymphocytic,1
Narrative Review,1
https://t.co/rCx8H2uLTo #CLL #,1
COVID19Vaccine,1
#leusm https://t.co/HHnrq3ASev,1
February 23,1
Early Intervention in Asymptomatic Chronic Lymphocytic Leukemia,1
Eli Muchtar,1
Sameer A. Parikh,1
April 13th,1
NCLLSG2021,1
@DONJAZZY https://t.co/Wdr429lQ01,1
Less than 1 week,1
Great Debates &,1
GDUHem2021,1
NEW ARTICLE,1
Feb 19,1
@Pharmacyclics Pharmacyclics,1
Inc. Pharmacyclics,1
"AbbVie Company 
https://t.co/kDbC7Uj5vx https://t.co/Z5ydcMBPMV",1
SCCA,1
Zoom,1
"March 9th, 2021",1
Feb 23-25,1
splenomegaly,1
Ophthopedia Update,1
Coronavirus Vaccines,1
#COVIDVaccine  ,1
Frontline Treatment Options,1
~75%,1
Mein Mann,1
Risikogruppe,1
#chronischlymphatischerLeuk√§mie #,1
Asthmatikerin,1
Ehefrau,1
Impfung,1
kann nicht,1
Homeoffice,1
https://t.co/VQainaPMzS,1
Feb. 19th,1
12:30PM,1
LLS Facebook Live,1
LivingWithCLL https://t.co/82d2tA6UOf,1
MedTwitter https://t.co/FHMrj6d5BY,1
Cardiotoxicity Claims Furthered,1
@huntsmancancer,1
"@MicheleNadeemB  
Register",1
hourly,1
#housing #,1
2:30pm EST,1
Big Difference,1
https://t.co/5vOL8YfMo0,1
PostdocPosition,1
TumourImmunology,1
@FondazioneTLS,1
@young_eha @SiicaI,1
Expanded Access Program for Participants Who Completed Study,1
Without Azacitidine,1
Mini-HCVD,1
the Treatment of Relapsed or Refractory Acute Myeloid,1
https://t.co/FlwUgRlz6W,1
ü§î Wondering,1
Jim Allen,1
9.6,1
J. Gribben,1
@DisabledWorld,1
June 18-22 2021,1
myeloma https://t.co/YaDV2WZZNQ,1
#bendamustine100mg,1
#KIGALI #,1
Douala #,1
Nairobi,1
Georgia,1
Idaho,1
CLLsm https://t.co/Log2hL2nVX,1
$IDRA $MGNK $,1
$XCUR $PHIO #,1
#TLR9 $,1
586,1
https://t.co/9EzykzugfH #,1
https://t.co/iofu8yUjnU,1
Envy,1
4‚Äêfactor,1
586 #CLL,1
Endoplasmic Reticulum,1
MIMIC,1
Chlorambucil,1
Alentuzumab,1
"Private Healthcare
Ibrutinib",1
#thecancergap #,1
#SpotlightOnHematology #,1
February 20,1
#MPN #MM #,1
Ask The Expert: Live Q&amp;A With,1
February 23rd,1
@OracleHealthSci,1
@DrugInfoAssn,1
https://t.co/Nxkh41fAO6,1
https://t.co/f9EJ4uSKA6,1
SMZL,1
https://t.co/L0hGGgVPJQ #CLL #leusm #,1
"@CancerTrialCork @cancertrials_ie
@EibhlinMulroe",1
https://t.co/fhmREaaNZ1,1
2020 Ireland,1
February 12th-27th,1
Patient Involvement,1
Research/ Delphi Projects,1
bigdataforbloodcancer,1
ChildhoodCancer,1
Andrea Visentin,1
Winter Hematology Update,1
65 years old,1
BcR,1
https://t.co/wKccKQuf3y https://t.co/qMT3UD6agN,1
https://t.co/9izwYLsPR5,1
12:15 PM ET,1
Immunogenicity and Safety of Commercially Available Vaccines,1
Patients With Hematologic Malignancies,1
üëâ https://t.co/JqnBYYLyxi #,1
The Design of BCL-2 Inhibitors for Treating Chronic Lymphocytic Leukemia,1
Shiyu Wang,1
#drugdesign #,1
#PatientPower nights,1
Hematologists Feb. 23,1
#FloridaCancerSpecialists #,1
CLLFlorida,1
First Past the Post,1
Maria Teresa,1
Bochicchio,1
Daniele Calistri,1
Advanced Practice,1
Neutropenia in Chronic Lymphocytic Leukemia,1
https://t.co/LamDzT0dNN,1
Feb 10th,1
https://t.co/d3id3PP13J https://t.co/p5FyZKxCY5,1
@Uchicago,1
@ASTCT @CIBMTR,1
#BMTsm #GvHD #,1
JNCCN36,1
up to 50%,1
nightly,1
979,1
696-6988,1
#daysinnbryancollegestation,1
#daysinn #,1
#hospitality,1
10th March,1
CLLForum,1
https://t.co/Lpr4OIPSZM,1
https://t.co/fB0NUCcrUK,1
LearningMondays,1
Prof Gunnar Larfors,1
https://t.co/c2ZskAhXuD,1
https://t.co/f0jYw88bRy,1
LungCancer #,1
https://t.co/UiGlIMs3I4,1
CNN,1
Ujjani &,1
https://t.co/vWzaoeDJut #CLL #leusm #,1
FACP/CLL,1
848,1
ZHX2,1
Focus on Novel Drugs - FullText - Acta Haematologica - Karger Publishers,1
1-10%,1
"Infections
Diarrhea
CVS AEs",1
as high as 40%,1
Robert Figlin,1
OBR Peer-Spectives,1
Aditi Choudhry,1
Pleasant Hill,1
Robert Galamaga,1
Stephen Goldfarb,1
Sierra Vista,1
#beyondASH21 #,1
"@anthonymatomd
@LRoekerMD",1
JustIn,1
https://t.co/YSgeJrNmkI,1
https://t.co/jt62QKlK3,1
SWATH-MS,1
Worldcancerday,1
#donateblood,1
Tara Graff,1
https://t.co/oLSCtcPKQs,1
Kesimpta,1
Op üéóÔ∏è#Wereldkankerdag lanceren,1
https://t.co/EKWK635n2c,1
OpenScience,1
WorldCancer Day,1
Idelalisib Is Not Associated With Increased Bleeding Risk in Patients With Relapsed,1
$10 billion,1
https://t.co/qV8jio7C97,1
#VerdensCancerDag #,1
#BloodCancerAwareness https://t.co/WcnqxGKHWW,1
https://t.co/mrPfQcJGDH,1
#IAmAndIWill https://t.co/cK41X9ep5I,1
#acuteleukemia #,1
#MMSM,1
#leukemia #mpnsm,1
Core Outcome Sets,1
An Unusual Case of Prolymphocytic Leukemia Transformation in a Patient With Chronic Lymphocytic Leukemia,1
Richter's + Dr.,1
TRANSCEND CAR-T,1
worldcancerday2021,1
https://t.co/EIetVOXQiB,1
70s,1
https://t.co/JIFsqBD2sy,1
#worldcancerday2021,1
@JanRynne https://t.co/EDDZtdbJs8,1
#IAmAndIWill https://t.co/DNATUWIw2z,1
https://t.co/y3muEmrTGr,1
https://t.co/Elx9xtUEUu,1
Journal of Experimental Medicine,1
"https://t.co/WwXcUfyFSb 

",1
https://t.co/rEsAlVoBKS #,1
https://t.co/9jaFWRmT8o,1
Telemedicine Activate More Remote Tools to Manage,1
https://t.co/bCEZ8pSJi4,1
#stories,1
#language #,1
#EYTagteam #EYtwittertagteam https://t.co/5Ow9xbB0Vs,1
https://t.co/yd5pgwQnmD #,1
#sprog #,1
#sprogdidaktik #CenterForSprogOgL√¶ring #CLL #,1
#DetNationaleCenterForFremmedsprog #,1
NCFF,1
BloodCancerAwareness https://t.co/avbG4Le2kZ,1
https://t.co/xCNEMTdenJ,1
Oncologist and Patient Preferences for Novel Agents,1
Disconnects,1
Bcells,1
Retrospective Analysis,1
Dose Reduction on Clinical Outcomes in Patients With Relapsed/Refractory B-Cell Malignancies,1
John Pagel‚Äôs,1
https://t.co/8BSKoarYuV,1
https://t.co/X0VN09q45q https://t.co/DSsvA8KlUh,1
https://t.co/jahOpJsmNa,1
Elliott,1
1400,1
#charity #fundraising #CLL #,1
onco,1
#mantlecell #,1
Syndrome,1
308,1
de m'assoir sur,1
5 millions,1
Crusader,1
Stern,1
https://t.co/p1I3FPmkrq #CLL,1
Notch Signaling Promotes Disease Initiation and Progression,1
CarePartner Nelia Pacheco,1
Current Perspectives,1
April 6,1
Therapy Sustains Efficacy,1
#LOXO-305 and,1
https://t.co/z9OtcYHAQW,1
Fastest,1
non-neurosurg journal,1
üò∞,1
NKTR-214,1
Young Adults With Recurrent or Treatment,1
Aberrant Methylation,1
Gene ADAM12,1
Chronic Lympocytic Leukemia Patients: Application of Methylation Specific-PCR Technique,1
Musashi 2,1
dasatinib tx,1
"Feb 23, 2021",1
16:30-18:00,1
Prof Eichhorst &,1
"the EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, &amp",1
@SeattleCCA @CllSociety,1
Serum Monoclonal Component,1
FL et al,1
NVAX,1
Rhapsody Music Notes,1
#haukuish,1
#BeyondTheCongress #,1
@MDAndersonNews @UTMDA_CPRTP https://t.co/C98wlbIC7I,1
Nurse-Like Cells,1
Tissue Microenvironments,1
https://t.co/lhZLetbYVC,1
Pulmonary Cryptococcosis,1
COVIDVaccination,1
CancerandVaccine,1
Squirrels,1
#EYmatters #,1
"https://t.co/rQiHFiTxlF

#",1
#physicaldevelopment #,1
https://t.co/dNxdwCb7I7 https://t.co/aS0flNRd7x,1
CART2,1
https://t.co/gqsApAmOME,1
https://t.co/qpUs7oFqu7 @CLLSociety https://t.co/v8j1oREaCw,1
@LeukemiaMDA  &,1
Attn,1
Wnt Signaling,1
HELQ,1
EGR3,1
Strength,1
RepublicDay,1
RepublicDay2021,1
#mmsm #realworldevidence #,1
NMA,1
Willliam Wierda,1
"Êó¢Ê≤ªÁôÇÈ´ò„É™„Çπ„ÇØCLL„Å∏„ÅÆ„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„Éñ„ÅØ„Ç§„Éñ„É´„ÉÅ„Éã„Éñ„Å´PFS„ÅßÈùûÂä£ÊÄß„ÇíË®ºÊòé„ÄÅÂøÉÊàøÁ¥∞ÂãïÁô∫ÁèæÁéá„ÅØÊúâÊÑè„Å´Ê∏õÂ∞ëÔºö„Åå„Çì„Éä„Éì
#",1
ÂÜçÁô∫„ÉªÈõ£Ê≤ªÊÄß„ÅÆCLL„ÇíÂØæË±°„Å´ÈÅ∏ÊäûÁöÑ„Éñ„É´„Éà„É≥Âûã„ÉÅ„É≠„Ç∑„É≥„Ç≠„Éä„Éº„ÇºÈòªÂÆ≥Ëñ¨„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„Éñ„ÅåÊâøË™çÔºö„Åå„Çì„Éä„Éì,1
https://t.co/bgrl5cpQce https://t.co/f45Mv2dE3G,1
Calcitriol/Vitamin D Receptor System Regulates Key Immune Signaling Pathways,1
HMGB1,1
KMT2D,1
kuASHreview,1
Ex Vivo Mitochondrial Respiration Parallels Biochemical Response to Ibrutinib,1
#lymsm https://t.co/uZkauyTEwv,1
1-Year,1
Placebo Following Ibrutinib/Venetoclax,1
https://t.co/qpUs7oFqu7 @CLLSociety https://t.co/ll9d3JycnF,1
storytime,1
https://t.co/Uc2DKVz2Uy,1
28 January,1
4.30 pm,1
Molecular Diagnostics,1
Guillaume Cartron,1
@LysaLymphoma,1
https://t.co/MUkBcbjpfd,1
@danafarber &,1
PressRelease,1
#March√© de la #leuc√©mie #,1
NoxxonPharma,1
MedImmune,1
Novartis - Jumbo News,1
https://t.co/yoyvhha70V,1
‚Å¶@wwierda‚Å© ‚Å¶@DrJasonWestin‚Å©,1
Neelapu,1
‚Å¶@wwierda‚Å© ‚Å¶@MDAndersonNews,1
ipc https://t.co/caI73oCDPi,1
our ‚ÄúYear,1
https://t.co/qPpbLOVXYj,1
plasma https://t.co/TtWFRlFyEe,1
https://t.co/jXJhq8ghsM,1
#Leusm https://t.co/YpFTsdmL8h,1
The Pivotal Role of Viruses,1
Pathogeny,1
IgG K Cryoglobulinemia,1
a Human Metapneumovirus Infection,1
Hematopoietic,1
https://t.co/qpUs7oFqu7 @CLLSociety,1
ERA PerMed,1
https://t.co/5ClYLo5kO1 https://t.co/rB3GAhd40K,1
https://t.co/oOWILHso7,1
#CLL https://t.co/XKdWt8RpD3,1
Adapter,1
NK-92,1
Late Epstein-Barr,1
Comparison of Outcomes of Transplant,1
the Novel Targeted Therapy Era,1
Leuk√§mieerkrankung bei Erwachsenen,1
langsam verl√§uft,1
jedoch bisher nicht,1
heilbar,1
#bendamustine100,1
"#rituximab
#bendamustine100",1
"#uses
",1
#bendamustine #,1
#ZIMBABWE #,1
#SOUTHAFRICA #,1
NIGER,1
https://t.co/yoyvhha70V @DRGinsights  ,1
‚Å¶@ASH_hematology‚Å© ‚Å¶@OncLiveSOSS‚Å©,1
ipc,1
#cartcr #,1
#JADPRO Review Article,1
https://t.co/nN5ZT2SsRj,1
https://t.co/yoyvhha70V #NHL #,1
#leusm https://t.co/9oP1tud9CC https://t.co/Nr6ZCwxRYD,1
BPK,1
Symbasis Sign MOU,1
Develop CLL Treatment,1
Freddie Fantastic,1
CME Event,1
https://t.co/0haIIwDmQm,1
impressions &,1
MyelodysplasticSyndrome,1
join &amp,1
2.8 de #CLinkLoyalty chez,1
SONAE,1
#CLLSociety‚Äôs,1
de @MDPIOpenAccess,1
btk,1
VaccineStrategy,1
https://t.co/72E15cCPbJ,1
Quickie,1
Tremfya,1
guselkumab,1
"MAB
B. IgG1",1
MAB,1
ü§îü§î,1
üëâhttps://t.co/NOWGQLZyAh,1
Bax/Bak,1
mPTP,1
Radon,1
P≈ô√≠bram,1
the Czech Republic,1
CLL Progresses,1
Enhanced Expression of miR-181b,1
B Cells of CLL Improves,1
#leusm https://t.co/yiWmtgaCgF,1
Practical Advice for Coping,1
GEP,1
Niamh Appleby,1
the @MedicalCollege of Wisconsin,1
https://t.co/dQpJ3E9HzO,1
CSO,1
Hans,1
Vliet,1
#bispecifics #,1
nnnnntknnnnsla o g olimpodebe,1
un n. N nnnnpH √± las g. Nn√± k9gnv lasnVB,1
n. Nn,1
https://t.co/oN1XJRtlif,1
https://t.co/vnmIakzflp,1
https://t.co/mXBRvY2Wl4,1
"30, 2020",1
PEITC,1
Watercress,1
3Í∞úÏõî,1
#Ï†ïÍ∏∞Í≤ÄÏßÑ  ,1
Bood,1
#CLL Rx,1
James D‚ÄôRozario,1
News| Health Canada,1
$ONCT #,1
@uktuebingen,1
"https://t.co/hpUZSWPM0c

#",1
Oct '17,1
Pharmacovigilance Evaluation of Bendamustine,1
Skin Disorders,1
the Japanese Adverse Drug Event Report Database,1
EMT,1
Zulassung #,1
Wirkstoff-Kombination,1
Peer Perspectives,1
TLR9 &,1
https://t.co/lqgttTS8LR,1
8 AM CST,1
EndCancer #leusm #,1
Corrigendum,1
112371,1
microRNA-125a,1
STAT3 and Bcl2,1
APR246,1
ConceptualModel,1
newarticle Impact of Oral Targeted Therapy on,1
Jean Lachaine,1
Catherine Beauchemin,1
#economicburden,1
American Society of Hematology https://t.co/K0hSKNjndj,1
#leusm https://t.co/qKgUHj24QS,1
‚Å¶@sloan_kettering‚Å© ‚Å¶Written,1
https://t.co/qWbZYsMdLr,1
Anthony Mato @anthonymatomd,1
Idelalisib Does not Increase Risk for Bleeding in Patients With,1
H.,1
üëâhttps://t.co/PmrpFz8oc7,1
post-#ASH20 #CLL,1
@hospitaldelmar,1
Saphyr,1
Cytoscan HD &,1
karyotype,1
$BNGO #,1
BionanoSymposium,1
#kroniklenfositiklosemi,1
#losemi #,1
#kokhucre,1
https://t.co/x13RUWvlpg,1
the Scientific Working Group,1
CLL/European Research Initiative,1
Jan. 13,1
https://t.co/p4z8g5tNvq,1
Leukemia https://t.co/q64yV8GFdS,1
#leusm @Annals_Oncology,1
The Eyes Cannot See What the Mind Does Not Know: Endocrinological Side Effects of Ibrutinib,1
TNDailyNews,1
Nguyen,1
@DimHien @MSSO,1
"2,293",1
https://t.co/jS28kwgwwG,1
@bagalbp,1
Super day,1
‚ÄòThe Gruffalo,1
First-Line Ibrutinib Effective,1
Condition Summary: Lymphocytic Leukemia,1
3 minutes,1
Intracranial,1
https://t.co/2AsC2PjEeY,1
Results &,1
Genomic Complexity &,1
#earlylanguage #,1
#ASH20#HemOnc #,1
Cancer Stat Facts,1
https://t.co/MD9a6UfKOT,1
Flexible Phase Behaviors,1
Aqueous Solution,1
Corticosteroids Contribute to Serious Adverse Events Following Live Attenuated Varicella Vaccination and Live Attenuated Zoster Vaccination,1
https://t.co/r8K0a0Sdr4 #CLL #leusm #,1
Greek,1
#vaccnations #covid #,1
the CSF3R T618I Mutation,1
Luxembourg,1
Emile Hemmen,1
98,1
@bnluxembourg,1
#FICE #,1
1/25,1
1/26,1
1/27,1
Hematol  ,1
MBL @gretnhe,1
FollowFriday,1
Control of Choroidal and Orbital Metastasis,1
Blood https://t.co/lDHxcljzET Well,1
Michael Chowen,1
#2ne1 #CLL #,1
MINZY,1
The American Journal of Forensic Medicine and Pathology,1
CLLsm https://t.co/awk3hrchNu,1
the 2021 International Workshop,1
George: https://t.co/kamXnWvh1x https://t.co/LaUS0QuVp2,1
CLLsm https://t.co/XQ4qRTfP0n,1
Prognostic Indices,1
a difficult year,1
BK,1
@DrHealeyBird,1
@RuthClifford5 https://t.co/9hY7g25lMm,1
@SEHH @VHIO,1
https://t.co/VA0naZSNMh,1
https://t.co/6H2QJGZ6R3,1
Second-Line Therapy,1
https://t.co/j3UWvblsT4,1
https://t.co/paX70V3bBI,1
0800 977 4396,1
https://t.co/UAUN7wphiX,1
@UniCologne,1
#leusm https://t.co/voSMYODf9d,1
https://t.co/XKC9uLr6tC https://t.co/F7SfnX8WWM,1
üëâ https://t.co/oFhIJEhZkm,1
@cancer_dk,1
A Time-Limited Approach,1
LEUKAEMIA CELLS,1
POLYMORPHONUCLEAR,1
Limitations,1
https://t.co/wC2p206OnY,1
CARTCellTherapy Market Size,1
US$ 8.92 billion,1
"Global Chronic Lymphocytic Leukemia Treatment Market Production, Capacity",1
https://t.co/IVMTClhsPT https://t.co/LhQWVlBo5Q,1
CLLsm https://t.co/sI0o8KMWjw https://t.co/LWNnWnCEGW,1
@NovantHealth Novant Health Cancer Institute,1
@kenderian_ss,1
#extracellularvesicles @MayoCancerCare,1
https://t.co/jjsuUYaP0M,1
70 Days,1
36.81,1
PsoriasisPhase,1
7.81,1
saglife,1
Goodman_heme,1
https://t.co/zCsAKU55nw,1
Microenvironment Remodeling and Subsequent Clinical Implications,1
https://t.co/xCb5UIvBq2,1
"Exposition
",1
https://t.co/7kxkWWRYLw,1
"https://t.co/eQBJyaiT6r

#",1
4.27,1
"#EHA2021 
",1
Minimal Toxicities for Poor Prognosis IGHV-,1
Maharaj D,1
Srinivasan G,1
Abreu MM,1
Ko MW,1
Jewett A,1
Gouvea J https://t.co/dGP861GuyV,1
https://t.co/SaavsmNhy6 https://t.co/gkwziBra9v,1
#CIPD +,1
@PracticalNeurol &,1
@bmj_company,1
https://t.co/J6JNzeJIlC,1
https://t.co/IgWPbYdYNY https://t.co/LA7aGKAwEv,1
Personalized Multi,1
Vaccination,1
Targeting Constitutively Active STAT3,1
Thrombin Generation Profile,1
https://t.co/vh0Jh05KIO https://t.co/SOrtIG2mZi,1
Annual Meeting Highlights for the Advanced Practitioner: Hematologic Malignancies,1
C3,1
LiveStream Package,1
Relapsed/Refractory Mantle Cell Lymphoma - BioSpace,1
prive pas de √ßa,1
Copanlisib Plus Ibrutinib,1
#leusm https://t.co/m0qaYKc30G,1
https://t.co/E3Ifw2lM0s,1
https://t.co/6AZnrazfiM,1
CLLsm https://t.co/lpmzyNwsvi,1
Victoria,1
8-hour,1
NHL/CLL,1
non-Hodgkin‚Äôs Lymphoma,1
Wegener‚Äôs,1
Promising First-Line Option,1
"Leukemia

https://t.co/uTYjo5gpLa",1
NHL/CLL Patients https://t.co/3LlAc6lszo,1
the MURANO Study for Relapsed/Refractory Chronic,1
the BRUIN Clinical Trial,1
CLL https://t.co/noIsE2YGyP,1
https://t.co/HAe91EuxWQ,1
#Molecular #,1
Minimal #Toxicities,1
Maharaj,1
Dicamba,1
https://t.co/ZZKV8Asi94,1
CLL Drug Trial,1
Demonstrates Efficacy,1
LOXO25,1
#GCLLSG https://t.co/OAFpOW7n26,1
PubSaludMurcia Clinical,1
@Area3Lorca,1
#COVID #,1
CLL ASH's,1
https://t.co/W7oAavcnyf,1
"1,it",1
Umbralisib/ublituximab,1
#oncologist #CLL #,1
#WonderWoman1984,1
https://t.co/5UZSsgJOXZ #CLL,1
#hvhebron #onco #,1
the Coronary Arteries,1
Accurate Assessment of Minimal Residual Disease,1
https://t.co/EknGuklKxD,1
"https://t.co/4E4FF2ynsz
@CllSociety @JanRynne",1
COVID-19 &,1
Mmmmm,1
#Nanaimo Cancer Clinic,1
Dapagliflozin,1
69yo,1
Gleason 7/ISUP 3,1
September 2021,1
#physician #,1
"@OncLiveSOSS 
https://t.co/2KvDv8MOg0",1
https://t.co/D0jTtht3b6,1
#COVID19nCancer #COVID19 #CLLsm,1
COVID19Vaccine n=30,1
Obinutuzumab Plus Bendamustine,1
1C,1
Up to 33%,1
DFCR,1
"Leukemia
https://t.co/mUsPU48ZXU https://t.co/XZ8QCzYfRb",1
the U.S. National Institutes of Health,1
#pesticide #,1
@JanRynne @CllSociety @CLLAdvocates,1
‚Å¶@sloan_kettering‚Å© https://t.co/mmJdEzNAbl,1
Network @knowyournodes Lymphoma Coalition,1
Our CLL Stories,1
"üëâhttps://t.co/heXMpjT6L1üëà

üìÖ",1
4 years ago,1
"al
28%",1
VR&lt;2y,1
"AE

Interrupt",1
https://t.co/VWzockK2jh,1
#CLL- Speakers,1
MD Anderson TX,1
PGIMER Chandigarh,1
New Delhi,1
7.00-8.30 PM,1
HemeMalignancies,1
@LeukemiaMDA @MathewsVikram @DrPMPGI https://t.co/dQzLk1r0lA https://t.co/LcIIiYybuT,1
just 90 minutes,1
885,1
8665,1
4693,1
Antonella Santoro &,1
Elisa Laurenti @SCICambridge,1
B Cell Derived Tumors-More,1
$TGTX #umbralisib #,1
"https://t.co/pUvHKcuXs3

#",1
#crowdfunding,1
#pleasehelp,1
https://t.co/QZXkZXfXgm,1
Medicine https://t.co/qj0HYuskId,1
CovidVaccine,1
CLL Doc,1
@ASCOPost,1
https://t.co/5Mi3IlILBz,1
@Amgen,1
https://t.co/Jxfzesv415,1
https://t.co/g34RZ5u7mP,1
Case Report: Chronic Lymphocytic Leukemia With a Rare Translocation t(14;19)(q32;q13) Involving IGH,1
HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy,1
https://t.co/VCDiwdLeKI,1
CLL Stories,1
"Nick,",1
Liz,1
https://t.co/9jRDz7C9tA,1
https://t.co/EdtOkiCDMM,1
American Society of,1
20 year,1
@MassEyeAndEar &,1
@QMBCI https://t.co/2AEH8Msaby,1
TNFAIP3,1
"ÊÑüÊüìËÄÖ„ÅØÊØéÊó•Êï∞ÂçÅ‰∫∫Ë¶èÊ®°„Å´„Å™„Å£„Å¶„Çã„Çì„Å†„Åã„Çâ„ÄÅ„ÇÇ„ÅÜÂ∞ë„ÅóËûçÈÄö„ÇíÂà©„Åã„Åõ„Å¶„Åª„Åó„ÅÑ„ÄÇ
ÊåÅÁóÖ„ÅåÁôΩË°ÄÁóÖ„Å†„Å®ÊÑüÊüì„Åó„ÇÑ„Åô„ÅÑ„Å´Ê±∫„Åæ„Å£„Å¶„Çã„ÅÆ„Å´",1
2Âπ¥ÂèóË®∫„Åó„Å¶„ÅÑ„Å™„ÅÑ„ÅÆ„Å®ÊãÖÂΩìÂåª„Åå„ÅÑ„Å™„Åè„Å™„Å£„Åü„Å®„ÅÑ„ÅÜ„Åì„Å®„Åß„ÄÅÁ¥π‰ªãÁä∂„Åô„Çâ„ÇÇ„Çâ„Åà„Åö„Å´Âú∞ÈÅì„Å´Êñ∞Ë¶è„ÅÆÁóÖÈô¢„ÇíÂΩì„Åü„Çã„Åì„Å®„Å´,1
https://t.co/tlyXQKLeQj,1
https://t.co/fl316mLXVw,1
@danafarber,1
ONE-HOUR,1
Telemedicine,1
Allan,1
https://t.co/auFOF38YD1,1
NCT04269902,1
EVOLVE,1
12/14/20,1
CTSU,1
Soliman DS,1
Al-Kuwari E,1
Siveen KS,1
Al-Abdull,1
https://t.co/rchW8lNuqk https://t.co/w7y6ziHwgj,1
https://t.co/aEXzC379VC,1
TGTX-1101,1
https://t.co/UuqljSNztg,1
A New Skin Manifestation,1
Immune Dysfunctions,1
ASH Highlights,1
16 December 2020,1
Immunchemotherapie,1
Welche,1
Nebenwirkungsprofil,1
Die Highlight-Studien,1
Ublituximab Doublet Bests Chemoimmunotherapy,1
#CLL #CryptoLiveLeakToken,1
all about #AttentionMining V1,1
@PhilippStaber,1
@MDAndersonNews https://t.co/pJ3CyRtYxw,1
https://t.co/SX5WdqIamE,1
CLL Clinical Trials Explained,1
ECG,1
@mydocwire,1
https://t.co/LzlH30bgUY,1
December 16th,1
"üëâhttps://t.co/Y3CaGd4sz3

#",1
#CLL https://t.co/mMmpIE8VHv,1
Versus Investigator's,1
19th Dec'20,1
"7 PM-08:30PM IST
Join",1
https://t.co/sSgqO4EA9Q,1
https://t.co/FVYfWYvrEg,1
Yvonne Gomez,1
#titanstaff #,1
#neverstoplearning,1
#titanpride,1
PSJAProud,1
the Latest Research in Combination Therapy and Immunotherapy,1
https://t.co/spfnfUyqsQ,1
Download] Kindle Medifocus Guidebook,1
https://t.co/oPyjbl4waS #,1
https://t.co/nJrTt5Ti2R,1
üëâhttps://t.co/Mdcwv8wUvEüëà,1
only 30%,1
DelveInsight https://t.co/aHq6tPYvoK https://t.co/74M0gpg2YU,1
https://t.co/EA816F71uW,1
DelveInsight https://t.co/C6zQXMHnJ2 https://t.co/sdOK7XMeEX,1
DelveInsight https://t.co/PVfuMlgjkp,1
PharmaceuticalsBiotech,1
https://t.co/VvrCbeeiFb,1
https://t.co/rDMa8sm1bF,1
the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease,1
more than 3 years,1
Cityof Hope,1
https://t.co/eyaoYEy6fE @CLLSociety,1
docs &amp,1
#mmsm #leusm #,1
Viktoria‚Äòs,1
Leukemia https://t.co/ESFdJ4tJv3,1
A Very Rare Case Presentation of Chronic Lymphocytic Leukemia Occurring,1
BNTX Phase 1 A Pilot Study,1
Without Low-Dose Cyclophosphamide,1
4-month,1
#vitaminD,1
4th January,1
C-MYC Amplification,1
Umbralisib + Ublituximab,1
CLL Society's,1
"https://t.co/gP022r5pdC
",1
https://t.co/CW6744fDh6 #ASH20,1
Fauci,1
https://t.co/uX3BkEy4Xv,1
ASh20,1
62 %,1
84 %,1
"@IrishCancerSoc
Episode 2",1
DecodingCancer,1
Feinstein Institutes for Medical Research,1
https://t.co/UY8EMk894e,1
#leukemiaawareness #BeatingCancerTogether #,1
Parexel Informatics',1
Clinical Relevance of,1
"Residual, Persistent &",1
Elongated Abnormal Sized Nodes,1
#Clinicaltrials #,1
diese,1
Leitlinie,1
Rezidiv Therapien,1
#ASHToday #,1
https://t.co/FthcH3i9iU,1
HEUTE,1
Uhr LIVE - KML-Videoberichte,1
H√§matologen von @UKKoeln,1
#Universit√§tsklinikum #,1
HamburgEppendorf,1
@debbiemstephens,1
ASHToday,1
Schwerpunkt #,1
Studien,1
"#BestOfASH 

#",1
Precision Medicine and Combination,1
"#PhD 
 ",1
CD49d expression https://t.co/oGh2ZfEKIO,1
Heitmann,1
Muller,1
Protecting &,1
Leading People During Reopening of Government,1
Dec 16,1
CLL Important,1
A Diagnostic Dilemma and Treatm,1
Regimen,1
#ASH20 -,1
https://t.co/1N2p3PfmpH @ASH_hematology,1
Ferran Nadeu @idibaps,1
#ASH20 @LundJenny,1
earlier year,1
#geriheme https://t.co/Ue6NX2fsro,1
@Pharmdca @pawcio2009,1
"the American Society of Hematology Annual Meeting
https://t.co/BXz4QgAnGP",1
https://t.co/XRRY9AyMfy,1
4pm PT / 7pm ET,1
@JanRynne @HSELive,1
@anthonymatoMD,1
Caveats,1
Plasma-Mediated Resolution,1
https://t.co/ERtFulbAgm,1
Up to $10 billion,1
#Roundup #,1
2 minute,1
The Scottish Medicines Consortium,1
NHSScotland,1
#Cornishlithium #,1
the American Society of Hematology Annual Meeting,1
MALT1,1
Umbralisib Ublituximab,1
https://t.co/hxvTvuJrIA,1
https://t.co/coLCirZMxv,1
Lymphocytic Leukemia &gt;&gt,1
https://t.co/KFjsgoiKAq,1
https://t.co/Yb4SzCmZ7M,1
https://t.co/lANKjnU5K1,1
CLL-1100,1
M-CLL,1
U-CLL,1
Arnon P. Kater,1
https://t.co/mgUIyq06h5,1
Rituximab Sustains Survival Benefit,1
5 Years,1
https://t.co/j7oH5qgAQ0,1
#ASH20 News,1
https://t.co/pHqbktziBu,1
D+V,1
https://t.co/zaf75dHkBb,1
https://t.co/2e45Z8bR6f,1
UNITY CLL,1
üì∞üìπüë®‚Äç‚öï,1
"@UBCIMP 
Hodgkin Variant",1
Canada American Society of Hematology https://t.co/M2U61N9qIb,1
Ash20,1
U2 #CLL,1
CLLsm https://t.co/YLJ1hpJTL0 https://t.co/0j52W7OPCW,1
"Only 28%, 11%",1
https://t.co/hWHrt9rU7b https://t.co/GJlck4NfHX,1
ASHHaiku,1
Luckily,1
LZTR1 #leusm #,1
https://t.co/RjAGbMwyLg,1
#leusm https://t.co/ohXjhJwXjU,1
https://t.co/9OCThjRAEZ,1
LLY Lilly Announces,1
SLL Data,1
#Umbralisib + #Ublituximab,1
Ohad Benjamini @SHEBA,1
CR 63%,1
MTD,1
JustAnnounced,1
TN &,1
O-Chl,1
19.5,1
@johngribben,1
31.9,1
17.9,1
68.7%,1
ND,1
Leukemia/Small Lymphocytic Lymphoma,1
https://t.co/t7Wr7HfuwF,1
Study of Oral Venetoclax Tablets in Combination With Intravenous Obinutuzumab Injection to,1
Lilly,1
AF&lt;1%,1
"the American Society of Hematology Annual Meeting
https://t.co/yJ7AQccuBS",1
https://t.co/4p9BZ00GZJ https://t.co/AKkOEDwRXS,1
ASHToday Satellitensymposium mit Meet &,1
Greet,1
14.15 - 15.00,1
Market Research Report,1
https://t.co/mb2c1yvqVr,1
$ABBV,1
https://t.co/mAW6w4R2fD VIŒõ,1
https://t.co/ryWn8VV3lH,1
International Prognostic Score,1
https://t.co/BxJnbgkxNT #CLL #leusm #,1
ASHToday Tracks,1
12.30 - 14.15,1
Schwerpunkt,1
@morningecfm,1
VIŒõ,1
https://t.co/uQssEcqHmS,1
Venetoclax-Obinutuzumab Significantly Improves Chronic,1
https://t.co/1ndNPFGrsq,1
VENCLEXTA/#VENCLYXTO,1
https://t.co/h5hSNNbVuS,1
about #mutations #,1
https://t.co/sT9IcrPeIo,1
https://t.co/cGQdqSqzNs,1
Monday 7 am PST,1
Benjamini,1
2020 Day,1
Anthony Fauci,1
MURANO &,1
https://t.co/eyaoYEy6fE https://t.co/nnukLCud4G,1
https://t.co/AxXsr2YDMY,1
obinutuzumab rx,1
https://t.co/LrkynSGRIm,1
#Clinical #Trials/Medical #,1
https://t.co/TWPggDRIm8,1
https://t.co/1QmW8euJIr,1
https://t.co/xcxiipOukf,1
https://t.co/A2bdQjUFQV,1
https://t.co/p7K7fPmEvF,1
# # # # # # # https://t.co/ZMOKOh7Z4K,1
Coexisting mut &amp,1
Intellasia East Asia News,1
https://t.co/gOrccCic2M,1
Previo https://t.co/epyf023JnR,1
Dr Lipsky,1
WT #,1
BGNE Announces Data,1
"Meeting
https://t.co/doxcGzWrbV",1
https://t.co/Z3N78BKiZi,1
#Lanalumab plus,1
üëâhttps://t.co/n3xTrNcBC1,1
#ASH20 - Venetoclax,1
@genentech @JanssenGlobal @Pharmacyclics,1
https://t.co/0BiQTkw938,1
https://t.co/AuKT86Sq2q,1
m6A,1
#zanubrutinib #,1
#obinutuzumab #lanalumab,1
#CLL #COVID„Éº19 #,1
7:30 AM,1
544,1
Agree,1
https://t.co/9giWeuwrRw,1
#ASH20 Worldwide,1
#lymphoma Drs/CNS,1
@dbrandnerMD,1
Therapeutic Develepment and Current Uses of BCL-2 Inhibition,1
#lymsm #leusm #mmsm #CLL #,1
https://t.co/ZPQSoCDbDc,1
https://t.co/GYxTsw74mO,1
Dec 5,1
Zero,1
Data For Fixed Duration Treatment Venclextavenclyxto,1
https://t.co/kh3O18KF9d,1
Fixed-Duration,1
@landau_lab @richardFurmanMD @chaligneRonan @AnnaEnim @WCMLymphoma @Columbiacancer See,1
#Janssen #ibrutinib #,1
https://t.co/YVKbiiAVmf,1
Kirsten Fischer @UniCologne,1
https://t.co/mKna3wG1bo,1
#CLL https://t.co/uhIJKoChB4,1
86,1
Mabs,1
#loxo-305 #,1
https://t.co/Fb40kWOrUG,1
"#ASH20
",1
#CLL TRT,1
#LRFGrantee,1
ASHTogether,1
BAX,1
3 pm PT,1
Session 604,1
Al-Sawaf #,1
~60,1
ASH2020 https://t.co/4tKxvmCnp5,1
AbbVie $ABBV Presents,1
Kater #,1
37.8%,1
82.1%,1
@Othman_Al_Sawaf,1
Obin-Ven CLL14,1
GCLLSG Dr Al-Sawaf,1
#ash20 Congratulations,1
MURANO f/u.,1
1)Don't,1
relapaed,1
the Changing Landscape,1
Clinical Trials Evaluating,1
#Richter @ASH_hematology,1
https://t.co/yToft0duNg,1
#Media #,1
#CLL 1st,1
Captivate,1
TAP Clarity,1
https://t.co/3sJ4022Lno,1
AbbVie Presents Extended Follow-Up Data for Fixed Duration Treatment,1
Business Wire,1
https://t.co/rqa2hfDYeh,1
Genentech Announces New Data Reinforcing,1
@Rfonsi1,1
Leukemia https://t.co/yCEaYzBw1D,1
MRD-negative #,1
Fraser et al - HELIOS,1
Ibrutinib + RB,1
578,1
BR - 14.3,1
0.23,1
0.18-0.29,1
0.61,1
0.46-0.82,1
Nescaf√©,1
Moreno &,1
ash20,1
identification &,1
2pm PT,1
https://t.co/gry52Mbqv6,1
1 pm PST/ 4 pm EST,1
register &amp,1
https://t.co/UwC7uPQA6j https://t.co/5j9tivTX4h,1
https://t.co/urQCqVazcJ,1
Club Success Mantra,1
Student Activities,1
SAL,1
Center,1
"Inter-University Aptitude Quiz Competition
Register",1
#NCU #,1
#ASH20 https://t.co/PsfIkVDNy4,1
Kirsten Fischer's,1
Education Book,1
@SeattleCCA @fredhutch @CllSociety,1
OncoAlert Approaches,1
Chronic Lymphocytic Leukemia &gt;&gt;RFP@,1
https://t.co/NRuFwi2Frw,1
"Susan M. O‚ÄôBrien
John Pagel",1
CLL Therapy Disease State,1
The American Journal of Surgical Pathology https://t.co/49lQy94NX3,1
the past 3 years,1
#MDS #BPDCN #CLL #,1
about 1st,1
12/5 9:30,1
"https://t.co/s1HSCea4VZ
#leusm #",1
just a few years,1
CLL https://t.co/8fgvJ6iCAI,1
https://t.co/GhEx3lH7u1,1
Relapsed/Refractory Small Lymphocytic,1
#leusm https://t.co/wLwLQOfjM7,1
https://t.co/v7wUKkkN4R,1
about #CLL #ASH20 #,1
ASH20,1
#VictoriesOverCancer #,1
6:00p EST,1
https://t.co/jTgbzVTZ6Y,1
üìñ,1
https://t.co/PdXC4ULUd1,1
488 #CLL,1
SMDH,1
https://t.co/NA2BcjohVw,1
https://t.co/KmChgFmqcH https://t.co/Gdr2pRwiw6,1
More than 200,1
MD Anderson CLL,1
#mdanderson #,1
https://t.co/kCeSkeyvyt,1
Combinations,1
Sequencing Therapy,1
‚Å¶@CllSociety‚Å© https://t.co/pEh1Vtifbn,1
Dec. 4Dr,1
John Gribben +,1
TGTherapeutics Announces Publication of Phase 2 Data,1
#PI3K #InhibitorTherapy,1
#EndCancer #leusm #,1
Five years ago,1
San Bernardino,1
https://t.co/yd5pgwQnmD https://t.co/S7BxFxdmjy,1
https://t.co/4yPv22PPsp,1
Monday Dec 7th,1
#leusm https://t.co/vZ2w0RWZZh,1
PI3K Inhibitor,1
https://t.co/67gSRCQI3A,1
NFCMonth https://t.co/7HQ4K4q2f9,1
Phase 2 Study,1
the Safety and Efficacy of Umbralisib in Patients,1
Leu https://t.co/9BOcnkMR31,1
K Inhibi,1
DEZ,1
Uhr LIVE-Diskussion,1
Lymphom-News,1
#CLL #Myelom #iNHL #,1
https://t.co/Bta8pMjPGT,1
#patients #UK https://t.co/lSMMVZTIlw,1
https://t.co/8dneegFdgR https://t.co/8s5dTHymAl,1
Food &,1
BTKi+7,1
"intol
2",1
Ix,1
Drs Flinn,1
HSCT Webinar https://t.co/Pu4oaDax4e,1
Top Abstract,1
https://t.co/0ehTnGJJlS,1
Obinutuzumab-Related Adverse Events,1
https://t.co/ryNzBdggHX,1
"COVID
Access",1
"@INFO_NCPE
Remote",1
@CillianDeGascun,1
Covid Vaccines &,1
anti-PD-1,1
"this Friday, December 4",1
Thompson https://t.co/GSZaTHkKIS,1
@Columbia University,1
Herbst Irving Comprehensive Cancer Center,1
https://t.co/INsWMtwhLV https://t.co/KxZ0ruUP1y,1
https://t.co/IgWPbYdYNY #CLLsm #,1
https://t.co/Z0ytBzRrQ6,1
SLL ‚û°Ô∏è,1
an Asymptomatic Immunocompromised Individual,1
https://t.co/yP1fBlk8Fn,1
Providers,1
https://t.co/vU1Jb2G8DC,1
https://t.co/MePMCPe5CE,1
6 feet,1
https://t.co/94xWOqAwZI,1
63yo M,1
Venetoclax-R. During,1
COVID,1
keratinocyte #,1
carcinomas,1
https://t.co/iO9lZ0OWAe,1
Eugen Tausch von der,1
Daten des #,1
#leusm https://t.co/IVSxvUl3tT,1
@fredhutch; &amp,1
"@QMBCI

Watch",1
üëâhttps://t.co/0cAYCd0Xgr,1
#LOXO305 #,1
BOTH,1
the stromal microenvironment,1
New Research: Method,1
the past 20 years,1
Industry Analysis,1
Emerging Technologies,1
"10,000",1
Focus on Novel Drugs,1
PNP,1
SAMHD1,1
50.00,1
https://t.co/pHlf5OLCqa,1
35.00,1
https://t.co/LK4aUzf6hV,1
10.00,1
one-hour,1
https://t.co/yfSOFPmwOS,1
2.50,1
Oncology Today,1
the Swedish Cancer Institute,1
"Dr Paul Barr

@Emer49034181",1
#productmarketing,1
https://t.co/N9hDXuaO65,1
#lymphomas,1
Four-year,1
Hypertension,1
Cause of Oliguric Acute Kidney Injury,1
https://t.co/6j5cRUAWfZ,1
Lindsey E. Roeker,1
https://t.co/doxJ4fltQN #lymsm,1
Fannie Mae,1
Freddie Mac,1
https://t.co/P1wEmpfpkl  #FannieMae,1
#FreddieMac #,1
Paolo Caimi,1
NEGATIVE,1
years/decades,1
https://t.co/d4ac90dFrm #leusm #,1
Gene Mutation,1
Lymphocyte/Monocyte Ratio,1
https://t.co/LJDfcxBLyV #CLL #leusm #,1
#Macrophage Polarization,1
Nurse-Like Cells Are the Caretakers of Leukemic Cells,1
https://t.co/XlzRmAP6Uu,1
Global Chronic Lymphocytic Leukemia Treatment Market Research Report,1
MGRS,1
70yr,1
https://t.co/oZ2JODIiH6,1
Week 8,1
#ucdavis #,1
#aggies #,1
#leadership #,1
https://t.co/v76qPulhsY,1
Daniel Catovsky +Estela Matutes,1
leumsm  https://t.co/5nBUdFKhGh,1
@UniversityofWA &amp,1
Susan Leclair Phd,1
https://t.co/dJRe0rIYez,1
#DHPSP #,1
INPST,1
#Blood #,1
BreakingData,1
#hemoncs,1
MyelodysplasticSyndrome &,1
RapidImpactReport,1
https://t.co/iXsEN3THfa,1
#CLL https://t.co/E1Z9QHh9jy,1
a couple of days ago,1
IGLV3-21,1
https://t.co/T7JfRmv6DD Driver,1
https://t.co/T7JfRmv6DD,1
January of 2017,1
#ASH20 ||,1
Focus on,1
‚Å¶@wwierda‚Å© #,1
‚Å¶  https://t.co/sMiWAz5Feo,1
‚Å¶@tobyeyre82‚Å© ‚Å¶@AnnaSchuh3‚Å©,1
Pigmentary,1
https://t.co/2ozgaenCwJ,1
more than 70 days,1
SARS- CoV-2,1
https://t.co/a50PGTLAc9,1
Murano Study Demonstrates Enduring Undetectable Minimal Residual Disease,1
CLLsm https://t.co/CdAXznrNYO,1
https://t.co/YJWSVmul5z #leusm #,1
"Friday, December 4th",1
"Monday, Nov 23",1
MRI,1
bloodwork &amp,1
Augmented Human Intelligence,1
Anderson @LeukemiaMDA,1
OTILT,1
Large B-Cell,1
~2-9%,1
#muggles #,1
#oncology #cancertalk #,1
https://t.co/JICNYhlLCz,1
AsktheDoctorDirectly,1
Raghuveer Ranganathan,1
Ranganathan,1
https://t.co/rpII9B7L9u,1
@jeff_sharman Join,1
https://t.co/4zxvvrkJDj,1
Bill Wierda,1
14:45,1
evolution &amp,1
"John Seymour
14:35 Live",1
#ESHCONFERENCES,1
1.50 #,1
Dr Moles,1
Elaine Willmore @UniofNewcastle &,1
Maggie Harnett @iiiglasgow,1
the last Day,1
the last 3,1
#ESHCONFERENCES https://t.co/nOUJzMJvF1,1
Jenny K &,1
Diwali,1
https://t.co/f9bZqy1Vsr,1
#CLLsm #ChronicLymphocyticLeukemia https://t.co/TgSdA8HHC8,1
https://t.co/hwxuJwXkTg,1
https://t.co/xzNAkfSeIg,1
#ESHCONFERENCES https://t.co/ToPT8MGvVq,1
"Peter Dreger
Discussants",1
Eric Eldering,1
"Stephen Schuster
Access",1
7:00 AM PT,1
SESSION VI,1
"Chairs M. Davids P. Dreger
Access",1
@WCMCLymphoma &,1
https://t.co/4VSCrXWfGn,1
üñ• CLL Management,1
25 November 2020,1
20:00 KSA time,1
Hypoxia,1
Article Title: Bilateral,1
#EdoriumJournals #,1
"Chylouseffusion

Article URL: https://t.co/UJt81fLM66 https://t.co/8TULHUKUz8",1
A Systematic Review,1
BH3 Mimetics,1
14:30CET,1
the 3rd Day,1
The ESH Translational Research E-Conference,1
Spend and hour,1
https://t.co/7k8eLZEILh,1
#hemepath #haempath #,1
https://t.co/LTc9XHmH6N,1
the Immune Microenvironment,1
Mutations and P53 Protein Residual Function,1
Single-Cell Transcriptomics,1
https://t.co/8taZpFmzXI,1
Cancer Risk/Mortality,1
TCGA Datasets With the Genetic Risk Score,1
Rush - PGY-1 Resident,1
Grand Rounds Presentation üíä,1
David Spaner - CLL Diagnosis,1
Managing Symptoms https://t.co/YWO7yw1W2y Excellent,1
43-minute,1
#Toronto,1
David Spaner,1
the 2nd Day,1
14:30,1
"https://t.co/ajhf5EMdRi 
Register",1
Alexey Danilov &,1
"Davide Rossi
Access",1
"https://t.co/apMlWgIaB2
Register",1
"#ESHCLL2020
#",1
https://t.co/SaBCoUEEHA,1
https://t.co/AhkhPQ6fV8,1
üì£Watch,1
"üëâhttps://t.co/Tnx9CZswudüëà

",1
https://t.co/lcCz962Gm0,1
at least 70 days,1
https://t.co/DJynVbdPnH,1
MD Anderson Cancer Center Untreated,1
21 years later,1
CD20 dim+,1
dim+,1
2R,1
86%,1
11q23.3,1
"13q, 17p",1
#hemepath #AMPath #Molpath #,1
https://t.co/YF6t6Spxel,1
https://t.co/5dXLwdH2GJ,1
20:30  SESSION III,1
Delmer,1
#PROMs,1
DigitalHealth,1
Dimitar Efremov &,1
https://t.co/MAtzfI0gis,1
@MDPIOpenAccess,1
Lunch &,1
https://t.co/mpZHLEhlwx,1
Matthew Davids &,1
"Alessandra Tedeschi
Agenda",1
"https://t.co/AwOkPN3uuD
Register",1
#ESHCONFERENCES https://t.co/vepALtW4AK,1
Hassan Jumaa,1
Andrew Steele,1
Anthony Mato &,1
#ESHCONFERENCES https://t.co/dLRrf6RoeD,1
Login,1
the next 3 days,1
"CLL 
Chairs",1
"Kostas Stamatopoulos
Access",1
https://t.co/YnUAkdSIWA,1
"@bloodcancer_uk
@INFO_NCPE",1
https://t.co/wOpj1GgsaD,1
13:50 Welcome,1
"C. Oakes
Access",1
Hellenic Group of Patients,1
Leukemia Greece,1
the CLL Advocates Network,1
https://t.co/POBsdVd8Gx,1
"Wednesday 25 Nov, 1pm",1
Dominic Pivonka @abbvieuk &,1
Rob Coster,1
"England- 

Venetoclax",1
J. Brown P. Ghia,1
13:50,1
Leukemia ‚Å¶@sloan_kettering‚Å©,1
Federico Paz,1
#strong #,1
Nov. 16-19 #,1
https://t.co/Dh5ZGLuTfj Register,1
https://t.co/GV7q4rH766,1
https://t.co/rWt2vbHsCm https://t.co/1HOiX1E92V,1
#Abtract #,1
#leukaemia #drugapprovals,1
Translational Research E,1
"Nov. 16-19,",1
https://t.co/xOCwfrdgCS #,1
Bone Metastasis,1
Mumbai Hematology Group,1
Chr,1
105(9):2205-2217,1
Julio Delgado,1
Dolors Colomer,1
https://t.co/Rhadc3eoYW,1
Manitoba Primary Care Providers,1
tomorrow 12-1 p.m.,1
Guest Expert,1
Mark Kristjanson,1
ONE,1
@CarrawayHetty @ClevelandClinic,1
Leukemia/Lymphoma IPC,1
530pm,1
Empowerment Resource Center,1
Thompson #,1
https://t.co/TwdooUNWNS,1
Recordatorio,1
Recordar el algoritmo de tratamiento de,1
@sehh_es @SCLHH1,1
https://t.co/xMq7QnnqSv,1
Marco Gonz√°lez,1
Jefe de Servicio @HematoCAUSA,1
Gu√≠as LLC de la SCLHH:,1
aproximaci√≥n cr√≠tica,1
Nitib Capsule,1
https://t.co/6Fc6g15kU2 https://t.co/5m7AGyP8A9,1
#supersquirrels #,1
#PSE #,1
NICE Recommends Venclyxto,1
Gazyva for Chronic,1
#VeteransDay 2002,1
AgentOrange,1
https://t.co/f8w7mREzxk,1
the Experts ‚Üí Register,1
Nov. 16-19,1
APTO CC,1
more than 1,1
https://t.co/AAmpWhGWjO https://t.co/b3b3fhYwSF,1
"more than 1,000",1
LOXO/Lilly Announces Details,1
"ASH2020 

‚ñ™Ô∏è#LOXO305",1
BTKin,1
NHLs,1
ORAL,1
Wed 3:30 ET,1
about $APTO,1
English #,1
Acute Kidney Injury,1
Ibrutinib-Induced Cardiac Tamponade,1
Non-Genetic Mechanisms of Resistance,1
#WonderWoman,1
Great News,1
@JanRynne @IPPOSI,1
@gmcrotty,1
Epcoritamab,1
#Genmab &,1
Kirkland,1
SARSCOV2,1
70* days,1
Genetic and Epigenetic disruption,1
Laia Coll,1
Cancer Epigenetics Group,1
Curcumin for Treatment of Chronic Lymphocytic,1
l'√Ängel Bistu√©,1
Functional Cytomics Group,1
https://t.co/E9AnQNcTqN,1
MHG,1
"Friday, 13th November 2020",1
"9 PM
",1
Versha Benerji,1
The Results Are In,1
#khakis https://t.co/C1HyOUb2HF,1
"‚§µÔ∏è
https://t.co/GkONVrJ163",1
routine healthcare,1
@utswcancer &,1
@MassEyeAndEar,1
@michelenadeemb &,1
Register Today,1
Life Goes On,1
Bio,1
#lifewithcancerisstilllife #,1
https://t.co/wqJyRG04qL,1
Zur Anmeldung,1
Chronischen Lymphatischen,1
ab der,1
Erstlinientherapie,1
Krebs #CLL,1
BCells,1
LAST üòÉ,1
@CIBSS_UniFR @UniFreiburgüëç,1
#rituximab |,1
"#ÈóòÁóÖ
",1
Zanubrutinib Plus Obinutuzumab,1
https://t.co/4uyKTHMwWb,1
https://t.co/JICgPE2JwR,1
Hossameldin - Zoom,1
#3meds #3medsonlinemedicine #3medsonlinepharmacy #,1
GAIA,1
https://t.co/NsPGhzjZFy,1
https://t.co/Sw2YbLVRGb,1
ÿßŸÑÿπŸÖÿ± ŸßŸß,1
ŸäÿπÿßŸÜŸä,1
‚ö™,1
"Giacopelli, Brian; Global DNA",1
THE LOWER EXTREMITIES IN,1
8 pm ET / 5 pm PT,1
@LLSusa @CureLeukaemia @LeukaemiaAus  @lymphomahub,1
@EPCALM,1
Jessica Marini,1
PGY2 Oncology Resident,1
https://t.co/Vt96dMobLd,1
The European Society for Medical Oncology,1
@myESMO #CLL #,1
https://t.co/IGfLiCEId3,1
https://t.co/JuKBynNeln,1
Pharmacokinetics of Venetoclax,1
Pyjamas,1
#memes #letstalk,1
#comedia #,1
#tvshow #,1
#quarintena #,1
Bo Zhang,1
the Development of Chronic Lymphocytic Leukemia,1
Yiming Wu,1
Integrative Transcriptome and Quantitative Proteome,1
69,1
Hispanic,1
non-Hispanic,1
3137,1
"Umbralisib, Ublituximab",1
543,1
Treatment Na√Øve &,1
"‚§µÔ∏è
https://t.co/5tQDDvT25K",1
ELISA,1
PIA,1
Notch1,1
https://t.co/6OVgWDCUyI,1
BMTsm,1
https://t.co/ZVrvjoRii8 https://t.co/MmihWAExJJ,1
https://t.co/OFHoKKlQxs,1
Ublituximab-Umbralisib Combo,1
Pallasch,1
University hospital of,1
Cologne @UKKoln,1
Wunderlich,1
MPI for Metabolism,1
Proliferative Signals,1
CNE/#CME,1
https://t.co/OlapBAaWiG,1
https://t.co/jqI4ZeZSww,1
interleukin-10,1
PLT&lt;100,1
@myESMO #,1
https://t.co/Na5MIH8w1r,1
nearly 37%,1
SACT,1
#haunting,1
https://t.co/Z7bjOo0uOg,1
GO28440,1
https://t.co/IgWPbYdYNY #CLLsm,1
https://t.co/sJsATbEIbu,1
ANCC,1
https://t.co/8RUmFIlBZJ,1
P53,1
WWP1,1
Jacbos,1
@sehh_es #,1
Vitamin C-,1
JECCR,1
Obinutuzumab Versus Fixed-,1
https://t.co/UcZoeZdDKC #,1
Bruton Tyrosine-Kinase,1
dysphagia,1
https://t.co/3H4AILtY55,1
https://t.co/g2K5cihRj2 #,1
CLLsm https://t.co/8NcOjaPU97,1
Slab,1
terry m√¢le,1
"@ChelseaFC 
La",1
"la connait
",1
#CAPTAIN #,1
Oncogenesis,1
#NonHodgkins #,1
BioXpress #,1
20wks,1
Jin Seung,1
CAPT_ACTP2020,1
Meet The Professor,1
1:00 PM ET,1
30th September,1
PatientAdvocacy,1
"https://t.co/gasZy8Frt3
@GioraSharf @felicebombaci @NYLCandCLL",1
"@Paschald
@NormaFoleyTD1",1
"Oct. 24, 2012",1
GBM4,1
VietnamVets,1
üß°,1
https://t.co/iCni1gycWw,1
https://t.co/J9WGTQ0ReI,1
FDA Fast Track,1
Chris D'Andrea,1
Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia,1
Erasmus MC,1
70-year-old,1
Gastrointestinal Involvement in a Patient,1
at least 72%,1
malignanciesvan Bruggen,1
Leukemia Concomitant,1
https://t.co/r2i3ifaXNE #CLL #leusm #,1
#mclsm #lysm #,1
Bob Levis,1
https://t.co/YWuuKtpWRu,1
Dr Bryan ‚Å¶@cure_magazine‚Å©,1
#educatedpatientsummit,1
https://t.co/gmoFYsp55S,1
Latin American,1
Circadian,1
https://t.co/d29MqIsDu6,1
R-,1
https://t.co/VQtTmxaEoh,1
november,1
#letscurethis #,1
18 and 20,1
Homeschool,1
@Education_Ire,1
https://t.co/HNnt1kbOD3,1
‚§µÔ∏è,1
198,1
71% and 63%,1
14 and 28 days,1
the Lymphoma Program,1
https://t.co/t0CBeeKZi3,1
Register for @power4patients webinar,1
Peggy,1
Coumadin,1
parthenolide &amp,1
Tetrahedron,1
@chembham,1
"OpenAccess 
https://t.co/DLeCqjmJVn",1
JGW Patterson Foundation,1
the ESH Translational Research E-Conference on Chronic,1
Inflection Biosciences,1
@Christinekw @m_adler7,1
ZachBreeding,1
@lgranichRDN,1
an awesome #,1
Magrolimab,1
Relapsed and Refractory Indolent,1
plasma levels,1
https://t.co/u4HoWMROGs,1
Fc-Engineered Antibodies,1
Enhanced Fc-Effector Function,1
Deb,1
Dublin Deb,1
Patient Power https://t.co/Ik87mCkKtC,1
@peixun_zhou &,1
https://t.co/IQ4bbUxeX8,1
‚ÅÉŒ≤2,1
‚ÅÉLDH &gt,1
"U/L.
",1
https://t.co/OGmJ6CBllS,1
sigue sin mostrar,1
https://t.co/wKmQHLKC1D,1
#oncology #regulatoryaffairs #,1
https://t.co/kVSwjoMFmR,1
Sandra Kurtin,1
#JADPROLive Virtual,1
FightCancer,1
November 16-19 2020,1
"Michael Hallek
Visit",1
"https://t.co/c73Pfgftfz 
#",1
Tero Aittokallio,1
Laszlo Zsombor,1
Patients Taking Oral Anti-,1
Medications https://t.co/27Hfrgcw87,1
https://t.co/PZ10psB1iA,1
Ipilimumab,1
multiplex CRISPR-edited,1
John Pagel's,1
Sameer Parikh,1
ùüÆ,1
@ErleneSeymour @karmanoscancer #,1
Birx Slammed,1
FDA Takes Back Power,1
Heartland COVID Crush - MedPage,1
@TGTherapeutics + umbralisib,1
@genentech/@Roche,1
https://t.co/ZiMEng9s9x,1
Ublituximab/Umbralisib Combo Fast Track Status,1
https://t.co/ZVjTmddrsH,1
TGTX AmpCard,1
https://t.co/4WSTDt3s8Z,1
Canada &,1
Only 8 hours,1
#ItsChemoTime,1
WearADamnMaskToProtectPeopleLikeUs,1
https://t.co/8RUmFIDdoj,1
Belfast City Hospital,1
https://t.co/Odtj1SuyEC,1
Kr√¶ftensBek√¶mpelse,1
Fast Track Designation,1
#stockstowatch #,1
#daytrading #,1
"TG Therapeutics,",1
https://t.co/jq1oBll7RO,1
TG Therapeutics Announces Fast Track Designation Granted,1
Catherine Holliday,1
Geneva,1
Neil Mathews,1
Sharon Winton,1
PBS &,1
UK/Aus,1
MC webinar,1
Peter Hillman @LeedsHospitals,1
https://t.co/Rzux4EHJF3,1
11.7%,1
Haematologica Journal Ferrata-Storti Foundation,1
10/2020)#Zusia,1
üåª‚òÄÔ∏èüí´ https://t.co/GmgTWXu7zs,1
#registrability #,1
https://t.co/qhpq4M1RuJ,1
New Article Alert,1
https://t.co/zzfDtadXc0,1
@dinamoMD,1
#cytopath #,1
https://t.co/jCt9jYwcFL,1
https://t.co/SLOR2wIB4R,1
Fluorescence in Situ Hybridization for Detecting Molecular Cytogenetic Abnormalities of,1
the IFN Response of Chronic,1
The Anti-Apoptotic Role of EBV-LMP1,1
Lymphoma Cells,1
https://t.co/zfxbma7zAh,1
https://t.co/S41MLWQMqT,1
fredag kun,1
#p√•r√∏rende,1
"#lyle_dk
V√¶r med til",1
Friday 30th October,1
1.00,1
Samir Agrawal,1
Consultant Haemo-Oncologist,1
https://t.co/TwaNqsjfKi #leusm #,1
#CLLsm #MCLsm #hemeonc #,1
https://t.co/erJyDsLEZX,1
Leslie Powell,1
Nathan‚Äôs,1
Nathan,1
https://t.co/7pnxhO7sve,1
10:15 am,1
ET &,1
Questions &,1
Register Here: https://t.co/TN2oxME2Rx https://t.co/hrhsmdjcNh,1
#fallball,1
#Ibrutix #,1
#‰æùÈ≤ÅÊõøÂ∞º #,1
ÿßŸÑŸÑŸàŸÉŸäŸÖŸäÿß https://t.co/DaSN7UFbUs,1
rituximab https://t.co/dnP0QGiMd1,1
ERIC),1
1st-3rd October 2020,1
#endoplasmic reticulum,1
Jan Burger of @MDAndersonNews,1
Developing Novel Agents,1
https://t.co/8kH3hsy14,1
https://t.co/Z2pDqO0rJt,1
the NHLBI #ClinicalTrial,1
DAP Kinase-Related Apoptosis-Inducing Protein Kinase 2,1
https://t.co/RlOlNmaHRA,1
10 and 15,1
https://t.co/azVoMp66nq,1
the Era of Targeted Therapies https://t.co/bpKRmNPFmg,1
WorldSeries,1
#LeukemicLungDisease #,1
POCUS,1
TimeFlies,1
1pm ET Register,1
Sort of a Plan,1
#nonhodgkinslymphoma  ,1
https://t.co/iZPwQkblBB,1
Virtual Light The Night,1
Mike Giannamore‚Äôs Light the Night Walk Fund Raising Page,1
Place Ninth Circuit En Banc,1
Stairway to Heaven‚Äù,1
#COWANLIEBOWITZ #,1
https://t.co/bheLRmlHf9 @LymphomaCanada,1
2 weeks ago,1
Patienten-Webinar,1
CLL des CIO K√∂ln,1
Referentin,1
Ober√§rztin,1
Klinik,1
The Shifting Paradigm,1
Alankus,1
Ruland @TU_Muenchen &,1
https://t.co/2JD5PGqBvb https://t.co/dzlhqGWFw1,1
Swedish Cancer Institute,1
W #,1
https://t.co/xU5gu5zG9x  #,1
BRAF Inhibitors,1
Ibrutinib Use Among,1
#heor #,1
1:2,1
SureSeq‚Ñ¢ CLL+CNV Panel,1
#cnv,1
Sandoval Sus,1
this Thursday,1
https://t.co/82lr036Ovb,1
10/17 1pmET #CLL #,1
https://t.co/lh8mb7AvUi,1
#ChronicIllness #,1
bcl-2,1
BICRollCall,1
@MSMEDU,1
üßµ https://t.co/4725aIYBh2,1
M. O'Brien,1
@DebbieMStephens &,1
TNFRSF13B,1
CLL Risk and Clinical Picture,1
Well as Expression of Their Products-APRIL,1
TACI Molecules,1
Awesome,1
169,1
CLL Society‚Äôs Global Virtual Patient &,1
"Saturday, October 10, 2020

",1
the next few weeks,1
#TheWiderWiserView https://t.co/WK8aRR3eCu,1
Cassin - - Hematological Oncology - Wiley Online Library,1
JNCCN360 https://t.co/LA2vNBCUaZ,1
https://t.co/HDODTNGmeA,1
Ask the Expert,1
https://t.co/fjzxRZ5jGr #Oncology,1
https://t.co/4E4FF2ynsz,1
@CllSociety @JanRynne,1
https://t.co/Hrz8xGob21 https://t.co/JNIsiKkRUR,1
New Research: Genetic,1
https://t.co/mkpJgnekfP,1
#revistes #,1
24/7,1
"2,167 #Cancer",1
üëâ Visit,1
https://t.co/Z2PqV1pg2W,1
"‚§µÔ∏è
https://t.co/CzXDq6glgm",1
Oct. 27th,1
200MA,1
6.40,1
$135M,1
PR Partial-Responses,1
52W-high $,1
9.25,1
Dec. https://t.co/KHpwqvz7Oz,1
https://t.co/xRGiCE0JbN,1
rs3751143,1
A week,1
Bestimmte Risikofaktoren,1
Krankheitsverlauf,1
Lebenserwartung von Menschen,1
https://t.co/uPF54ZCsHh https://t.co/9k6oCrUBA3,1
Oncology 6/2020,1
Journal of Clinical Oncology #,1
Dear Abby,1
the Lab Scientist,1
Hospice,1
Improved Patient Classification,1
#Ibrucent #,1
atoz-drugs.com,1
Troll,1
@EYTalking,1
the Treatment of Recurrent or Refractory,1
RCD Chemoimmunotherapy For Relapsed Chronic Lymphocytic Leukaemia,1
Berberine,1
#clltoolkit,1
#prime https://t.co/GW01xJIwIG,1
https://t.co/YveTM3gugp,1
https://t.co/ARi1ETXVL8,1
https://t.co/Gz5VFOlh7I,1
#leukemia https://t.co/FS0ffkoikI,1
#NMEDclinical #,1
15 minutes,1
"the ""How Can You Access the Latest #CLL Treatment Options",1
https://t.co/8AH8MgMoQc,1
https://t.co/iiNuv6SrdP,1
higienista m√°s veterana,1
acaba de,1
@TheMighty,1
Oct. 6,1
https://t.co/kzfhlkBoqu,1
https://t.co/pZfuzb2efA,1
the National Patient Conference,1
#professeurs,1
SPDP,1
journ√©e mondiale des enseignantes,1
May 2019,1
EMEA,1
Œ±ŒΩŒ¨œÄœÑœÖŒæŒ∑,1
Œ¥œçŒø Œ±ŒπŒºŒ±œÑŒøŒªŒøŒ≥ŒπŒ∫œéŒΩ  Œ∫Œ±Œ∫ŒøŒ∑Œ∏ŒµŒπœéŒΩ,1
ŒªŒµŒºœÜœéŒºŒ±œÑŒøœÇ,1
Œ∂œéŒΩŒ∑œÇ,1
Splenic Marginal Zone Lymphoma,1
https://t.co/3o1YDrZ89u,1
ALK,1
#CLL #COVID #,1
Catheter-Related Acromioclavicular Damage,1
Trichosporon,1
CART19-BE-01,1
1:45 pm ET/10:45 am,1
12:45 pm ET/9:45 am,1
üëâhttps://t.co/KS6Ku2V6gS,1
The ERIC CLL Database,1
"üëâhttps://t.co/ssFLwtncb4üëà

",1
https://t.co/AuIJovR37Q,1
#ERIC2020 @anthonymatomd,1
üëâhttps://t.co/ZOy0OMZ5cT,1
9 am PT/12 pm ET,1
Register Now,1
https://t.co/a30VRTWoGx,1
"Jennifer Woyach

",1
Global Chronic Lymphocytic Leukemia Treatment Market Recent Trends,1
Forecast By Application,1
##CLL,1
TODAY - Latest,1
Dave - In,1
Memoriam,1
"Friday, October 16",1
"Saturday, October 17",1
EXCEPT,1
Leukemia https://t.co/AG3nhO8NJu,1
"https://t.co/ag3OxI2as0

#",1
Lablogatory,1
"https://t.co/uypl9Zt5AJ

",1
Obinutuzumab vs Chlorambucil,1
https://t.co/AvcRE2jqUB,1
@CLLlacrosse,1
Coming Years,1
Financial Information,1
the California Teachers Study,1
Dr Jitka,1
#WomenInScience #,1
‚Å¶@OncLiveSOSS‚Å©,1
ipc ‚Å¶@SAStricklandMD‚Å©,1
‚Å¶@OhioState‚Å©,1
Cowan,1
Liebowitz &,1
Latman Alumna Shira,1
Appointed Register,1
https://t.co/lJZaOxBdGU https://t.co/WbHgxNSs36,1
8 pm Eastern - all,1
4y,1
0.19,1
0.41 95%,1
0.26-0.65,1
#CLLtreatment,1
#leusm https://t.co/MfxEh9eEuU,1
https://t.co/o2X4fAg75Z,1
CHIP,1
üëâhttps://t.co/yfDiTL27iC,1
"üëà

&",1
"üëâhttps://t.co/EHkvqPuzxNüëà

",1
the Canadian Lacrosse League,1
üëâhttps://t.co/69P6e2tQS9,1
https://t.co/fnk9sXf2X7,1
"üëâhttps://t.co/fKYCQP4zIeüëà

#",1
CLL https://t.co/svogvH9v11,1
"üëâhttps://t.co/O9p0vDBrzwüëà

",1
#communicationandlanguage,1
Human Chronic Lymphocytic Leukemia,1
"Soniya https://t.co/GbBSRxAgmv

",1
#researchpaper #,1
5/8,1
3/8).#CLL,1
the Determination of Idelalisib,1
Mice Blood,1
Pharmacokinetic Study,1
Jose Sandoval Sus,1
"VirtualHem2020 
View",1
Latest CLL Research,1
Michele Nadeem Talks Ibrutinib,1
https://t.co/NAvuRhmI0,1
"@FacebookWatch 
",1
CLLPatientInfluencer,1
https://t.co/wMQ91UTL2k https://t.co/PKWu1VDtmv,1
Fashion Law Institute,1
"Friday, September 25",1
https://t.co/E5qereWIAg,1
Bat3 Signal Transduction Molecules,1
Only a few days,1
Oct 6,1
https://t.co/DaYjccWFy5,1
improvements &,1
Belimumab Reinforces Small Molecule Inhibitor Treatment,1
Bhargava,1
Institute of Blood Disorders and Bone Marrow Transplant at,1
Fortis Hospital,1
Gurugram,1
Diagnosis and Treatment,1
HemaSphere #,1
https://t.co/FbVMiBMngR,1
just 4 days,1
This day 9 years ago,1
O1%,1
üëâ https://t.co/sXVcObJJ7C,1
Frontline #,1
Chemoimmunotherapy https://t.co/c0AePEDlhg,1
sd43,1
‚öæÔ∏èüèÄ‚öΩÔ∏èüèíü•ç,1
‚õ∑üèåÔ∏è‚Äç‚ôÇÔ∏è,1
Experimental,1
Novel Genotype Definition,1
the First Epidemiological Investigation of Canine Adenovirus Type 2,1
Dogs in Central China,1
Importance of Crosstalk Between Chronic Lymphocytic Leukemia Cells,1
#interne #,1
Classic #Chemoimmunotherapy for Chronic Lymphocytic #Leukemia,1
Juravinski Cancer Centre,1
https://t.co/TvXN0U0bsF https://t.co/Rfmbg8cRFM,1
#Leukemia #ChronicLymphocyticLeukemia #,1
Watch George‚Äôs,1
fbf via,1
The Hawaii Society of Clinical Oncology,1
just a couple of hours,1
Can We Tip the Scale Towards Better Outcomes,1
David Macdonald,1
@OttawaHospital,1
Jonathan Stevens,1
October 2020,1
https://t.co/yYnkJPaFhA,1
the EORTC QLQ‚ÄêC30,1
QLQ‚ÄêCLL17 Questionnaire #Abstract,1
https://t.co/geDp27ZOQj,1
1983-2012,1
https://t.co/SmTNpn5f3A,1
Laurie Sehn,1
BC Cancer,1
#BCCancer #,1
#raredisease #,1
https://t.co/9heCTlNAyj  #leusm #,1
Just one week,1
192,1
#tbtüîôüì∏ #ni√±o #,1
#huarazperu #,1
Huaraz,1
https://t.co/cC8uEnq5Wc,1
#degustacion,1
3i,1
Article Alert,1
#academictwitter #,1
researchmatters,1
https://t.co/1nv7YUyVpt,1
Every 3 minutes,1
about #AML,1
of@karmanoscancer,1
https://t.co/51yxmJVs3w,1
12:00 PM ET,1
COVID19 https://t.co/2zu84eFoFf,1
Collega Denise,1
Carolien van,1
Carolien,1
Venetoclax-Obinutuzumab,1
Ibrut,1
Alessandra Ferrajoli of @MDAndersonNews,1
üé•üë®,1
28 September,1
üëâ https://t.co/szSOQBULk5,1
https://t.co/kbr8POCzN7 #CLL #,1
#lymsm https://t.co/38rIngRnUR,1
@Healthgrades,1
https://t.co/pe4zNM1q5,1
https://t.co/N8d79Oih77,1
Monosomic,1
MIR15A/MIR16-1,1
Diverticulitis,1
"about #ChronicLymphocyticLeukemia 
",1
#ChronicLymphocytictreatment #,1
ChronicLymphocyticmedication,1
üëâhttps://t.co/DDG2rfnSQy,1
Aged Monoclonal Antibody Encephalitis,1
the Hawaii Society of Clinical Oncology,1
@UNMC,1
#leadingtheway #,1
Zusia https://t.co/I166E4vrLv,1
$CELG Phase 3,1
"Saturday, November 21",1
#HealtheVoicesLIVE  ,1
more than 20 years ago,1
#bloodcancerawareness,1
OurExpresssions,1
Janssen Research &,1
Development,1
https://t.co/oRQ4bu0Tel,1
"https://t.co/xHKvJwuWQE 

CD200+ CLL",1
https://t.co/3g4IJ3Hl5F,1
Partner Schools,1
YR #,1
The Impact of Age on Survival,1
https://t.co/EYuoLS1HGB,1
only 2 weeks,1
Learn More &,1
ÿßŸÑÿ¨ŸÖÿπŸäÿ© ÿßŸÑÿ≥ÿπŸàÿØŸäÿ©,1
9-10 pm,1
https://t.co/TbOdKKZJ0D,1
Isurus Oxyrhincus,1
Theater,1
Fox Grape,1
Wildflower Biopharma,1
https://t.co/Cy0yPZscqj,1
Myung Sun Kim,1
#BCAM #CLLsm #,1
Ô∏èÁôΩË°ÄÁóÖÁ†îÁ©∂ÊúÄÊñ∞ÁôºÁèæ,1
#Ë°ÄÁôå #,1
https://t.co/kkefclLi2e,1
https://t.co/xFZyzYnSsJ #CLL #leusm #,1
SRS,1
https://t.co/hEg73scoAD,1
a Negative Prognostic Factor,1
https://t.co/o3RRhS4p0,1
earlier last month,1
https://t.co/D7D5YB8Odg,1
Drs Carolina &,1
Miguel Pavlovsky @Fundaleu,1
Latin America,1
AlphaTherapy,1
Only two weeks,1
Level R1,1
5425,1
682,1
older than 19,1
"an estimated 21,040",1
BloodCancerAwareness Month,1
https://t.co/TiajdUp3WE,1
Zatta &,1
TeleMedicine,1
#LetsBeatCancerTogether https://t.co/C6Va4CY7IB,1
Jeffrey Zatta‚Äôs,1
Community Medical Center‚Äôs,1
Chirag Shah,1
https://t.co/dpKpcPEh0O,1
Ivanova,1
Saint Petersburg,1
14th_rgmm,1
#Chroniclymphocyticleukemia #,1
9/17,1
ONSBridge,1
https://t.co/liTqUxaVFi,1
https://t.co/RdyxEMMSmF,1
David L. Porter,1
#Leukemia #Leusm https://t.co/muRi7Zxtyo,1
Party,1
https://t.co/OohRJsi5Sk,1
CLLsm https://t.co/2WSaTDqbm1,1
Northwestern,1
LCSW &,1
LesliePowell,1
#NorthwesternMedical #,1
MLS,1
#sciencemajors #,1
#cancer #medtwitter #,1
WLD20 https://t.co/KbA3V8DOEp,1
"@BLLPHD
@CllSociety
https://t.co/XwBqB7jXbm",1
HEMATOLOG√çA - Scarfo,1
Register for Our Upcoming,1
How Can You Access the Latest CLLTreatment Options,1
@MDAndersonNews @LeukemiaMDA Emil J,1
‚è©,1
#SOHOITALY20 #,1
#AML #MM #,1
https://t.co/nPuTqdgPVZ,1
Breweries,1
https://t.co/dpOz3hfOyb,1
Register üëâ https://t.co/mqA88ESTdL,1
https://t.co/RLPDNnicZF #,1
This World Lymphoma Awareness Day,1
https://t.co/G1CF1dqRM5,1
Sept 15th,1
https://t.co/M2HtigP3nu,1
Ed Spuzello,1
19 September,1
9PM,1
KSA Time on SSBMT Webinar,1
University of Amsterdam &,1
Barts Cancer Institute,1
SaudiHematology,1
#LMIC as,1
thousands,1
several more decades,1
Oct. 10th,1
https://t.co/S4JoOpOp2K https://t.co/gZVyHNRzZV,1
Ven-Obi for PFS &,1
Al-Sawaf,1
"al
#venetoclax &amp",1
0.31,1
3y 82% vs 49%,1
CK &,1
CLL-&gt;,1
"#Mantle_Cell_lymphoma 
",1
#Small_Lymphocytic_Lymphoma,1
"#leukemiatreatment 
",1
"#ibrutix 
",1
#ibrutinib140mg,1
https://t.co/oRYLCqGcKX,1
@WeillCornell #leusm,1
The American Cancer Society Cancer Action Network,1
Hope Home,1
Bismarck ND,1
These Lights of Hope,1
kidney &amp,1
cancer &amp,1
LightsofHope,1
Last couple days,1
@SocietyofHemOnc Daily News,1
#SOHO2020 @VJHemOnc,1
Hoh HY,1
Barrientos JC,1
O'Brien S,1
Mulligan SP,1
"JC, Lal ID",1
Dean J‚Ä¶ https://t.co/a5axoHzuAq,1
HuR Affects Proliferation and Apoptosis of Chronic,1
Pathway,1
Fatal Mucormycosis and Aspergillosis,1
Mixed Invasive Mold Infections,1
What Influences the Choice of Ibrutinib-Rituximab vs,1
Classic Chemoimmunotherapy for Chronic Lymphocytic Leukemia,1
Regulating ADAR1,1
@Reebok,1
Wonder Women,1
Leukemia https://t.co/Aox64TqK4v,1
https://t.co/DOV9wBvqRo https://t.co/jCGXkWrByw,1
MD Swedish Cancer Institute,1
#iwNHL20,1
#OncoAlert #NHLsm #,1
5-fold,1
#ASHMHM20 &,1
the Steering Committee,1
https://t.co/67BIBYlpEj #lymsm #,1
https://t.co/s4Xb03aHuY,1
Tina,1
Achieving Innovation,1
"BTK Inhibitors: Selection, Safety",1
Continuum,1
Measuring Residual Disease,1
Watch Registry,1
"William Wierda,@wwierda",1
#lymsm https://t.co/lxCyQlYfj2,1
Nilanjan Ghosh,1
https://t.co/88duD5d0vy,1
#Ibrutix #Ibrutinib #,1
#lymphomasupport #,1
"Êú™Ê≤ªÁôÇCLL„Å´ÂØæ„Åô„Çã„Ç§„Éñ„É´„ÉÅ„Éã„Éñ„Å®„É™„ÉÑ„Ç≠„Ç∑„Éû„Éñ„ÅÆ‰ΩµÁî®ÁôÇÊ≥ï„ÅåÊ¨ßÂ∑û„ÅßÊâøË™çÔºö„Åå„Çì„Éä„Éì
#",1
the decades,1
AntiCancer,1
HematologyPharmacists,1
Nitin,1
#CLL17 #,1
KNOW,1
Sept. 16,1
@hampel_p,1
@AMPath,1
Y. Lynn Wang,1
Jimmy Lee,1
the past four years,1
Joseph Flynn,1
D.O.,1
Norton Medical Group,1
Norton Cancer Institute,1
Sept. 10,1
2:34 PM CST #,1
Session VI,1
Oct. 9,1
https://t.co/HrefufuO0v,1
https://t.co/UuKKwqY5CR,1
"ü§î
‚òÄ",1
ËßÄÁúãÈ¶ñÊí≠Ôºöhttps://t.co/nqq9bSaapJ,1
@biovitenskap,1
In Vitro Sensitivity to Targeted Therapies,1
the European Commission's,1
the 2020 American Society of Clinical Oncology Annual Meeting,1
the B Cell Lymphoma Micro-Environment,1
only 3 weeks,1
World LymphomaAwarenessDay,1
AllTrials,1
DiversityMatters,1
Mar√≠a Hern√°ndez‚ÄêS√°nchez,1
Teresa Gonz√°lez,1
https://t.co/9kZg8jth29,1
Colorectalcancer,1
"@SidYadavMD @hampel_p 

Register",1
@JackMAiello,1
8 pm EDT,1
@JackMAiello @LLSusa @CureLeukaemia @LeukaemiaAus https://t.co/9jBtNcOjG6,1
https://t.co/blXVseXYLo,1
Law Alert - Tiffany‚Äôs,1
$21 million,1
Summary Judgement,1
"Costco for Trademark Infringement Vacated on Appeal

https://t.co/gAd1X7C1aa",1
#trademarkinfringement,1
Parameswaran Venugopal,1
"Wednesday, Sept. 16",1
https://t.co/9XAObHdIyE,1
Seymour | Park,1
Rituximab for Previously Untreated Patients,1
"Jain @NitinJainMD 

Join",1
https://t.co/Q0YxOKKbd6 https://t.co/3VtCa7DEfW,1
less than 1 month,1
Glucocorticoid,1
#openaccess,1
VO,1
Venetoclax-Obinutuzumab For Untreated Patients,1
Managing BTK Inhibitor Toxicities,1
8:00 AM,1
10/6,1
CLLsm https://t.co/Oj2IdhrV5G,1
#marketingauthorisation #ibrutinib #,1
#efficacy #,1
"this Friday, September 11",1
FDA Grants Orphan Drug Designation,1
Priti Patel,1
BloodCancerAwarenessMonth https://t.co/dD5XT4bcFl,1
Janssen‚Äôs Imbruvica,1
+ Rituximab Receives,1
https://t.co/JTnuKehEwK #BloodCancerAwarenessMonth,1
https://t.co/qCUBHG5Qza,1
Ghoshdastidar et al.,1
ZYBT1,1
Janssen's,1
#ecapproved #,1
https://t.co/9LwfXKuf6N,1
"Sept 9,",1
Support Group,1
Richard Farmer &,1
https://t.co/WkfxknTzMI,1
"@ancan501c3 
",1
#NHL #MPN #,1
Meet Michele,1
Kenny &,1
Richard - AnCan/Throwing Bones Blood Cancers,1
Acute Myelocytic,1
Myelocytic,1
CELLFOOD,1
https://t.co/QaLWc5lY8K,1
Phonics &,1
2 years later,1
The Virtual Congress on Hematology #,1
22-23 October 2020,1
Pia Raanani,1
#clinicalperspectives #,1
Combination Obinutuzumab,1
Alloa,1
Paul Hampel,1
Molecular Tumor Board,1
7.15 AM PST,1
9.15,1
8 PM Nepal,1
https://t.co/Jp54LLHUTw,1
"https://t.co/uXt0p97yzi

#",1
@bagalbp @CTCTC_tmc,1
Seth Cohen,1
#WLD2020 #WLD20 #,1
#all #apl #cll,1
15¬†years,1
Meet Our Faculty,1
Third-Year,1
Hampel,1
https://t.co/Z4MMAVIjNs,1
September 9th,1
"Discover 
 ",1
#WLD20,1
SpotLeukemia,1
CLL.Thanks,1
#FragileNucleosome Seminars,1
Giacomo Corleone,1
Effie Kostareli,1
https://t.co/UjX9j534B2,1
over 10 million,1
#diseasecontrol,1
https://t.co/9mbaXvz7rd,1
Forgottenfamilies,1
https://t.co/YazbUIIQpq,1
#binutuzumab https://t.co/RFDR3OgqWJ,1
"735,000",1
#WLAD2020 https://t.co/ouIuwAsVRZ,1
3x5,1
#worldleukemiaday,1
The Ohio State University,1
https://t.co/XjUnIv8Z80,1
the Ed Durham Team,1
Blood Cancer,1
https://t.co/cfreRN9Suo,1
Ben je opmerkelijk,1
vaak verkouden,1
heb je opgezette lymfeklieren,1
je controleren,1
op leukemie,1
#12jaar,1
#maarikbenernog #,1
"#WLD20
",1
https://t.co/VzY2JDYAIL,1
"https://t.co/jnfx9foIkS
#",1
CMML,1
https://t.co/xsiBDQi3lk,1
Industry¬†Analysis,1
Two weeks later,1
#WorldLeukemiaDay #,1
Haematologica #CLL,1
the 13th,1
Scientific Working,1
World Leukaemia Day,1
Steven Treon,1
HEMATOLOG√çA - Mattsson M. et al - Increasing,1
OncoAlert Outcomes,1
‚Å¶@anthonymatomd‚Å© ‚Å¶@tobyeyre82‚Å© ‚Å¶@DrRaulCordoba‚Å©  https://t.co/r3VZMRZo6p,1
Raji,1
#retrotransposon #,1
#methylation #,1
#genom #,1
#patienter med  ,1
kr√¶ftdagen2020 https://t.co/aHoWlZZPfM,1
Case Report,1
#chroniclymphocyticleukemia #AmericanJournalofOphthalmologyCaseReports #,1
@SidYadavMD &,1
https://t.co/IuRO4lxMna,1
HealthcareCollaborator,1
#PatientAdvocate #,1
@MedscapeCME,1
MD S,1
CLL - Brian K...,1
Leukemia - Brian,1
#leusm https://t.co/GEsWyEaLjj,1
https://t.co/W0sjFOeHaV,1
SMURF1,1
https://t.co/0gDRnloSEK,1
Kappa and Lambda Immunohistochemistry,1
#headandneck #,1
#neuroendocrine tumours,1
https://t.co/XgB1YLje2Y,1
https://t.co/ul9SPAQjMr,1
https://t.co/jT1nnSSPfM,1
Learn More: https://t.co/m08Z2b9jRj https://t.co/gvNleVkjqH,1
https://t.co/HGZiHF9i69,1
#CLL Care,1
Patient Access Novartis Oncology,1
#CLL #HCL #,1
Le Creativity,1
https://t.co/Xt97tSnZMS,1
ASCO Top Pick,1
https://t.co/mtjy8KEgmL,1
October 10,1
https://t.co/EjiqKI2PqL https://t.co/PiDcwhb2pU,1
https://t.co/uZkauyTEwv,1
https://t.co/hDF9ZqBUez,1
MedscapeElevate,1
Developed in Partnership,1
@RockpointeCorp,1
Olivier Tournilhac,1
between 2009 and 2018,1
https://t.co/IUgJAY0g9Q,1
MRD Testing and Limited Duration Therapies,1
https://t.co/fiep8mL91M https://t.co/s8IqVn6K2N,1
Green Tea Extract,1
Extract of Green Tea https://t.co/SLwCguguqB,1
Rituximab-Bendamustine,1
OncoAlert Longitudinal,1
CLL Registry - Sharman - 2020 - eJHaem -,1
@SoniSmithMD,1
https://t.co/I6HGXhhbA4 #CLL,1
https://t.co/k3DShZfL9Y,1
https://t.co/133aJSKhvN #,1
IL-11,1
Portell,1
@Donnchadhol,1
Courtney D. DiNardo,1
1‚É£ more day,1
EBMT20Virtual,1
International Ultman Chicago Lymphoma Symposium,1
https://t.co/QP98hksMVt,1
#Leukemia #MPN #,1
#BloodCancers Hereditary,1
@PatientPower Founder,1
@MDAndersonNews Hereditary Hematologic Malignancy Clinic,1
Leukemia #COVID,1
Verb,1
recount &amp,1
https://t.co/I2OiEj7V1M https://t.co/yVFotLTZjO,1
HCV,1
üò∑ü©∏üôå,1
#WearAMask #,1
MaskWashing,1
@NCCONS,1
Pam Profusek,1
#NurseTwitter #,1
those days,1
https://t.co/JybcEBNh6h,1
1 pm PST/4 pm EST,1
A Phase 1/2 Study of Oral LOXO‚Äê305 in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,1
SCC,1
Watch More,1
Official Statement,1
"https://t.co/jxqq9oFv8j
",1
#soho2020 #,1
Day Two,1
Sept 10,1
https://t.co/IqNPdr1kp8 #,1
https://t.co/KJkeRtI9Ez,1
Relapsed or Refractory,1
Dr Wei Wang,1
Reviews BTK Inhibitors,1
FISHtest  #,1
#cllms https://t.co/Qal6MOoh9j,1
#itu,1
the past two decades,1
27th,1
1 pm PT/4 pm ET,1
https://t.co/p5RJsEMF7j,1
@LRoekerMD @anthonymatomd @tobyeyre82,1
2-y,1
NRM,1
bmt,1
al @BloodAdvances,1
pre allo &,1
https://t.co/pl8QJcsqBd,1
9/2,1
Learn More: https://t.co/qjEmygF2tF,1
https://t.co/MTdTMKi5CY,1
Morphologic Diversity of Merkel Cell Carcinoma,1
https://t.co/DalSkxE2rL,1
https://t.co/b7CJuxErrf #,1
#CLL Society Registration,1
Global Virtual Patient &,1
Richter‚Äôs,1
https://t.co/EjiqKI2PqL https://t.co/39ZZGcEJlI,1
@LeciaSequist,1
Leukemia@nresearchnews,1
SLAMF,1
https://t.co/zN1uMI8FK0,1
CLL Answers Now Program,1
1 PM PST/4 PM EST,1
#IGHV,1
#FishTest #,1
https://t.co/wRkjVeXkNM https://t.co/CRFLLgNrrL,1
OncoAlert The Impact of Age on Survival,1
#geriheme  https://t.co/b6FSOmd8d0,1
https://t.co/eDeg1awQqs,1
"over 13,000",1
https://t.co/r2YgJo4CYh,1
von Wenserski L,1
Schulthei√ü C,1
Bolz S,1
Schliffke S,1
Simnica D,1
Willscher E,1
Wolters-Eisfeld,1
Riecken K,1
https://t.co/GIiWxSO7Bp,1
64Cu,1
F(ab')2,1
Demographic,1
Calabar,1
South-South Nigeria,1
#ChronicLymphocyticLeukemia Patients,1
the Precision Oncology Alliance,1
#EducatedPatient Webinar,1
SoTimely,1
AHR,1
Promotes Tumor Progression,1
EDHM,1
https://t.co/I1lxmpP88L,1
Siteman Cancer Center,1
SchonGewusst,1
H√§matologie und Medizinische #,1
Onkologie e.V. #,1
Onkopedia Leitlinie,1
Untersuchungen,1
Risikofaktoren,1
Einleitung,1
Leukemia https://t.co/MdwsCsgjzS,1
https://t.co/pudoqxq4mS,1
16:23:22,1
GMAB NEW ARTICLE,1
https://t.co/zqZsHC8XnJ,1
GMAB Genmab Announces Plan,1
"GMAB 
Novartis",1
$30 million,1
16:06:59,1
energy &amp,1
#connotation #,1
https://t.co/sAiIfqLJRr,1
Chao Family Comprehensive Cancer Center,1
Virtual National Blood Cancer Conference,1
Register here &gt;&gt,1
https://t.co/Z0dTd0fKsX @UCIrvine,1
1st September,1
Dr Satarupa Choudhuri,1
the Royal Oldham Hospital,1
"Sunday, September 6th, 2020",1
https://t.co/sE39cuZxFD https://t.co/97RMPu61To,1
THIS FRIDAY,1
Career Development Award,1
Postdoctoral Fellowship Grantees,1
https://t.co/jggvQw2mFl #,1
A Phase II Study of Ibrutinib,1
https://t.co/VfX1PQswUW #CLL #leusm #,1
Phase II Study of Combination Obinutuzumab,1
Bezeichnungen,1
IGHV,1
mit der,1
lymphatischen #Leuk√§mie,1
Dieser Artikel,1
https://t.co/yaExsCnFBl #GemeinsamGrenzenVerschieben #Onkologie,1
NEJM Resident,1
https://t.co/IBhuRvhwVg,1
https://t.co/A6bcA5Cl7R,1
https://t.co/BUKvvJLu2p,1
Acute Leukemia,1
SNPJournalClub,1
up to $8k,1
A third,1
WEBINAR,1
10am PT https://t.co/8vlfIF2dUQ,1
Marty,1
https://t.co/wRs4DGDCLP https://t.co/BAzet7Thd4,1
"Journal of Clinical Oncology
https://t.co/SSDAnfT3nQ https://t.co/HQyKtWkdFX",1
between 1982 and 2013,1
https://t.co/ezH3jn58cQ,1
a couple of hours,1
11 am CST,1
https://t.co/zdBgpVQDJp #CLL #leusm #,1
CD5low Clones,1
Crystal,1
SPRY,1
#traineebms #,1
"@SidYadavMD, @AboulafiaMd",1
https://t.co/UOqaGrZLUC,1
Brighton &,1
Sussex Medical School,1
microfluidics,1
Quality of Life Significantly Lower,1
iPSCs,1
TRAC,1
Peter Anglin,1
Southlake Regional Health Centre,1
PL,1
Sanofi,1
#drugdevelopment #,1
#acquisition #RandD #,1
#BrutonTyrosineKinaseinhibitors  ,1
Follicularlymphoma,1
"Phase II Study of Combination Obinutuzumab, Ibrutinib",1
https://t.co/R5UrAYV0fO #CLL #leusm #,1
Das Vorliegen,1
Nichtvorhandensein von bestimmten,1
Merkmalen,1
Tempo,1
Hier,1
#Leuk√§mie https://t.co/eV7dB6h1wM,1
https://t.co/qbQTwhTa9b,1
Number Blocs,1
https://t.co/loKkRq29ve,1
Society 1/19/2020,1
https://t.co/IGM2h8yjqf,1
pasamos al 2do,1
Miniaturized Drug Sensitivity,1
https://t.co/K4XrDu76Fl #CLL #leusm #,1
https://t.co/V3yLPNo4v3,1
8/18,1
https://t.co/iQJ1OrLWjU,1
https://t.co/ShuyicWXwQ https://t.co/qK2v7TqXFy,1
Grandma Fantastic üëµ,1
EYFSSquad https://t.co/HaFjkdBt6M,1
the Treatment of Chronic Lymphocytic #Leukemia,1
"https://t.co/wcacaV9Wv0
#",1
BcellMalignancies,1
450,1
acute disease &,1
https://t.co/FQiRbs4AQr,1
Treatment Naive,1
Phase 1 Clinical Development Plan,1
#CLL/ #,1
#AML #leusm #,1
up to month 38,1
der bei der,1
https://t.co/f5od1VGhSx #,1
https://t.co/0Q6DXA3OK1,1
William Bensinger,1
Venugopal,1
https://t.co/Zwu1AC0aSJ,1
8 pm Eastern TONIGHT,1
@CalebLareau &,1
@NatureBiotech,1
Leukemia https://t.co/0USWqp3C8I #,1
https://t.co/fy6NQyVGXv,1
https://t.co/SaZAhX8Y8n,1
"GEORGE THOROGOOD

",1
Delaware,1
one dollar,1
Badder Than Ever,1
the Leukemia and Lymphoma Society of Canada,1
GEORGE THOROGOOD https://t.co/WpSbXgvKW2,1
Jonathon B. Cohen,1
71-year,1
"https://t.co/TFkZeJb9h6

#",1
"https://t.co/uUE0CFSutC
",1
#CLL #multicenter #,1
ICICLLE,1
Diploma in,1
Quality Management,1
https://t.co/YVcmdo3w77,1
141,1
https://t.co/rgagylmQSh #,1
Bei der,1
Risikofaktoren den Krankheitsverlauf,1
Lebenserwartung von Patienten,1
#GemeinsamGrenzenVerschieben #,1
https://t.co/xdw7uPYeH6,1
Summit Cancer Centers,1
"August 6th, 2020",1
Primary Immune Deficiency Disease,1
Kroger Specialty Pharmacy,1
August 22nd,1
"https://t.co/Oqrlh7Zeqj  
",1
Congrats Elias,1
Julio,1
Ferran &,1
Dolors,1
Abnormal Expression of,1
CTLA-4 Immune Checkpoint Molecules,1
CARD9,1
Coxsackievirus B3-induced,1
https://t.co/NmqbTvre1X #,1
https://t.co/YaAw77HBnx,1
FUNDSWIFT - https://t.co/zzZha7petd,1
the Section Head,1
the Department of Hematology/Oncology,1
the @VirginiaMason Clinic,1
Kenny,1
12 @ 8.00 pm Eastern - https://t.co/AY5xmKgpji #,1
last Wednesday,1
only #MECFS,1
"#YoungIndiansGAO 
",1
https://t.co/26T5fVm2B2 https://t.co/26T5fVm2B2,1
Relevant Securities in Issue,1
#leusm https://t.co/CtWxXpTWAd,1
https://t.co/pELslI86TD,1
Advanced Melanoma,1
EQ-5D-Derived Health State Utility,1
796,1
Utilities,1
Systematic Review,1
Brian Coffman,1
COVID-19 Severity and Mortality in Patients,1
SPA,1
ü©∏üò∑üôå,1
#WearAMask,1
Meet Lee,1
https://t.co/sE39cuZxFD https://t.co/8d6qpOsYAj,1
#Cancers #,1
https://t.co/xlrudRK985,1
el primer dia,1
üê≠,1
MRD Assay,1
https://t.co/mYZ1wvWe4,1
the Chronic Lymphocytic Leukemia Patient Management Simulator,1
#ARS #,1
#MAJE #MHPC #,1
SIGC,1
Join @RichardFurmanMD,1
8/12,1
"https://t.co/GspNgXqgWJ

#",1
ama,1
Aug. 12,1
4PM,1
ClonoSeq,1
https://t.co/XLLmXXig4o,1
Volunteer Network,1
https://t.co/I9i6nQVWxd,1
05/12 &,1
03/26,1
https://t.co/sE39cuZxFD https://t.co/YCBVf2dhRm,1
Leukemia https://t.co/SXPzulSXID,1
Placebo,1
Prospective Phase III Study Evaluating Efficacy,1
Safety of Panzyga,1
Cirmtuzumab Consolidation for Treatment of Patients With Detectable,1
#CLL CLL,1
ABO,1
Varanasi,1
Psychological Distress in Outpatients With Lymphoma,1
Lombardy,1
Lombardy Hematology Network,1
https://t.co/eyz44dnX8E,1
OncoAlert How We Manage Patients With Chronic Lymphocytic,1
‚Å¶@LeukemiaMDA‚Å©,1
end of,1
"July 30, 2020",1
#PDZ #,1
RCN,1
5 DAYS,1
Monday @,1
11am EST,1
8/18 1pmET #CLL #CLLsm Register,1
August 5th 2013,1
Frank Zappa,1
3rd #CLL,1
QLQ-CLL17 Questionnaire,1
https://t.co/6VDE2smnKi,1
#aalborg #,1
hotelhvidehus d.,1
okt,1
#f√•svarp√•sp√∏rgsm√•l #,1
https://t.co/qyVLyJTzA6,1
https://t.co/b8CrgA5Ldf,1
Christianity,1
https://t.co/98qH9gXHSk,1
https://t.co/iOH8llPqnJ https://t.co/p2GiSI7hzI,1
https://t.co/cj4elEqmr9,1
https://t.co/6o4oGx3lge,1
https://t.co/rtaP8vazJI,1
CGC2020,1
Fl√©ch√®re Fortin,1
https://t.co/eYARCtS6wx https://t.co/VBhdf30iGr,1
Norah Grant,1
Radio 4 Today‚Äôs Programme,1
Saturday 1 August,1
1 August,1
the Treatment of Chronic Lymphocytic Leukemia: Evidence,1
Expanded Clinical Phenotype,1
Oncological Associations,1
Immunopathologic Insights of Paraneoplastic Kelch,1
Encephalitis,1
https://t.co/DyjDVOQnAw #CLL #leusm #,1
@JanRynne @CllIreland https://t.co/xzKvLcMdIb,1
#BSI #,1
@CllSociety @CllIreland,1
only one month,1
Targeted Treatment of Lymphoma,1
Stephen Opat,1
https://t.co/6PUEdDiHpW,1
Dr. Yan,1
https://t.co/2Sp79DGUGm,1
https://t.co/Mg0CkE6VPk,1
Primer d√≠a de #,1
el Institut Pasteur,1
ansiosa,1
emocionada,1
todas son,1
#lovescience,1
Aug. 18,1
HDAC1,1
August 14 @ 9 am EST,1
https://t.co/ljJtWRThFN,1
Society https://t.co/V3B9V64mQm,1
Goodbye Boston,1
2 brilliant years,1
@uclcancer,1
https://t.co/AgSkLPgvQS,1
6.5 years,1
NEJM https://t.co/fpOjyMduA5 https://t.co/cfsEK8KTSq,1
Targeted Next Generation Sequencing Reveals Molecular Heterogeneity,1
Only 24 hours,1
Somatic Hypermutation,1
BLOOD,1
NATURE,1
https://t.co/lgJhn4mNnR https://t.co/QBvUmbSUtH,1
https://t.co/Mh8VcgQ9Rb https://t.co/Mh8VcgQ9Rb,1
ADE,1
OncPharm @MayoPharmRes,1
CLL https://t.co/BcrOlnMGRG,1
205,1
https://t.co/Mu2D80gpsB #CLL,1
https://t.co/JJRFsCGtbx,1
https://t.co/A9GJuxrd0M,1
HaroldMoodyPark,1
Glenora Rugby League Football Club - EST,1
1931,1
THREAD - Chronic Lymphocytic Leukemia,1
"üëâhttps://t.co/HOmPzO9M0eüëà
 
",1
#Leukemia #Leusm @OncoAlert,1
18th - 10,1
https://t.co/rseM6ErVNY,1
Clinical Pearls &,1
Morning Reports,1
#HematologyOncology #,1
"NEJM 
https://t.co/KU9VLoHKKx",1
@BLLPHD,1
Boomer Buy Setup,1
Pocket Pivot,1
#SO4,1
#GPSS #,1
#JAN #CVSG #,1
CEY,1
#ADAM #,1
#AFMC #VNET #,1
#BLP #,1
#OCT,1
#SENS #,1
https://t.co/URbb1OOX9K,1
https://t.co/n58vPA6Swy,1
Online Focus Group,1
Clinicopathological Role,1
https://t.co/LT9q2DB7Cf  ,1
AwayGame,1
Harold Moody,1
https://t.co/jshRcfppeD,1
@Swarnah_J14‚Å©,1
https://t.co/I7S00l8oQk,1
"Friday, July 31",1
Jill Vershel,1
PA-C,1
Aboard the Titanic,1
#leukemia #mask #facecovering #,1
super,1
Estimated Study Start Date  :,1
"August 3, 2020",1
69-Day Follow-Up,1
Challenges in CLL Management Webinar,1
Months,1
this final week,1
Riad El,1
Mervet Mattar,1
Mervat Mattar,1
Peter,1
#CLL https://t.co/8W8E35Vepz,1
CLL Management,1
SSBD https://t.co/Xqg3FDK5QY,1
FRIDAY,1
https://t.co/BOLk7je6i3,1
#CLL Webinar,1
August 18th,1
1 PM Eastern,1
10 AM PT,1
12 PM CT,1
Aug. 10 @ 11 am EST,1
https://t.co/FyKJedoxEq https://t.co/7ymU6L8UDi,1
SpiritsIndustry,1
https://t.co/lc8uA1DNuN https://t.co/mlf1hBwqI7,1
Determination of Venetoclax Using AQbD Principles,1
https://t.co/v2mNLX3YQj,1
TIM-3,1
Occupational Exposure to Pesticides,1
Chemokine Receptors CCR1,1
‚òÄ,1
miR-15a/16-1,1
miR-497/195,1
https://t.co/pVYlUenYmJ https://t.co/LSAZqKTtbv,1
"mdpijcm
#",1
31 March 2021,1
ACE-CL-001Ë©¶È®ì„ÅÆÂÖ®Â•èÂäπÁéá97ÔºÖ„ÄÅASCENDË©¶È®ì„Åß„ÅØÁóÖÂã¢ÈÄ≤Ë°å„ÅÆ„Å™„ÅÑÁîüÂ≠òÁéá„Åå82ÔºÖ,1
#leusm https://t.co/kbzS8WlToW,1
the Test Before Treat Survey,1
Influencer &,1
#CLL Reporting,1
https://t.co/JbDv5rZRDX  ,1
#PATIENTAdvocate #,1
#EHAtrending,1
Janssen Receives,1
Jack Colvin Park https://t.co/uSxrg9a1Kr,1
CURE¬Æ‚Äôs,1
https://t.co/lc8uA1DNuN https://t.co/wCr0shJExC,1
Gene Repertoire,1
@Haematologica  https://t.co/KZZ1UAdHNf,1
"11, 2015]",1
Strati &,1
FCFP,1
DABFP,1
$5.6 billion,1
Meta-Analysis Reveals Significant Sex Differences,1
Transgenic,1
One day,1
"12.45pm 
#",1
Jack Colvin,1
(few years ago,1
Reduction of Localized Subcutaneous Fat: Review of the Literature,1
Evidence,1
New Research: Increased Expression of Autophagy,1
Cannabis Industry,1
Hemp-Derived CBD,1
#cannabisindustry #,1
Leukemia ‚Å¶@sloan_kettering‚Å©  https://t.co/kGoOmO987e,1
Pleural,1
#JNCCN360,1
#leusm https://t.co/oVmb0LIr8A,1
https://t.co/0RuSzOtoHM,1
#MTGCLL #MTGO #,1
https://t.co/q66EEmpG72,1
#BSIPH #,1
https://t.co/jiRZT4SX6E,1
CLL Management Webinar,1
28 July 2020,1
19:30 KSA,1
¬øEst√°,1
de capacitaci√≥n,1
la gu√≠a,1
Marie,1
https://t.co/Q3pQhIqaHU,1
https://t.co/M2YMDsKjAM,1
#BSIUK #,1
18 August,1
Dana Farber Cancer Institute,1
Founder CLL Society USA,1
HOMEGAME,1
No.2,1
No.6,1
CancerCarer,1
CFR,1
Tx W,1
https://t.co/c6zWhFSGuy,1
Expert Review of Hematology,1
https://t.co/YFYsoeXdgp,1
Ibrutinib-Ublituximab Combo Leads,1
Better Outcomes for Patients,1
https://t.co/5CAvkXRSKM,1
@cure_magazine webinar,1
Educated Patient,1
"Wednesday, July 29",1
https://t.co/lc8uA1DNuN https://t.co/KRWe1iejaz,1
Block Listing Update &,1
Total Voting Rights,1
https://t.co/ey0FMjEHfH,1
Atypical Spindle Cell Lipomatous Lesion Resected From Patient With History,1
‚Å¶@sloan_kettering‚Å© ‚Å¶@tobyeyre82‚Å©,1
CRF,1
Ô∏èAge ‚¨ÜÔ∏èCIRS,1
Equiv,1
@anthonymatomd @LRoekerMD+others https://t.co/Klv4AYsOFh,1
"@anthonymatomd @tobyeyre82

https://t.co/bpPjzWGu2",1
#JCOOP #,1
Q1 2020,1
RadicalRemission,1
the early age of 28,1
https://t.co/42i4z5ITte https://t.co/kEE2jZDKsi,1
Kenneth Research Global Leukemia Treatment Market-By Disease Type,1
Fore https://t.co/gBJyPnEYPI,1
Refractory Acute Myeloid,1
79-Year-Old Man With,1
EducatedPatient,1
ÿßŸÑŸàŸäÿ®ŸäŸÜÿßÿ± ŸäŸàŸÖ ÿßŸÑÿ£ÿ±ÿ®ÿπÿßÿ°,1
5 ŸÖÿ≥ÿßÿ°Ÿã,1
ÿ®ÿßŸÑÿ™ŸàŸÇŸäÿ™,1
#PatientResources #,1
Nancy Torres,1
Clive Zent‚Äôs,1
https://t.co/dsMaqbxy6w,1
sundaythoughts,1
@Bharat_Ramlal,1
@Joseph A. DiGiusepp https://t.co/XFRfgeTZdU,1
MNDA,1
https://t.co/0wt4TI2e16,1
Howick,1
80 metre,1
GraemeMurdoch @,1
https://t.co/nhfBKZzEL7,1
Lymphocytic Leukemia(CLL,1
#recordingindustry,1
#musicindustry #,1
https://t.co/Ubc6Knx4qs,1
lymphocyte count &gt;15√ó109/L,1
https://t.co/rV6Pz9MPjG,1
#lympsm #leusm #,1
https://t.co/MRhpghrluD #,1
https://t.co/7Fvplil6bF,1
Pseudohypoxemia.,1
Aggressive Chronic Lymphocytic Leukemia,1
Atrial,1
Katelyn Brown,1
only 21,1
https://t.co/Nj91l3qpiu,1
Paparoa Park Howick,1
BeThere,1
16 30,1
.@SeattleCCA &amp,1
Waipareira,1
@FarrellyPhotos,1
GraemeMurdoch,1
https://t.co/YNHbUhCVma,1
Number 7,1
https://t.co/71OkPkF6dI,1
Number 8,1
https://t.co/hzfUsiqXLT,1
#‰∏≠ÁõÆÈªí„É™„É•„Éº„Ç∏„Éº„Ç∫ #,1
#‰ªäÂ∏ÇÈöÜ‰∫å #,1
ÔºàÁ¨ë,1
https://t.co/izPtszkGdg,1
Number 9,1
Law Alert - U.S.,1
Supreme Court,1
The U.S. Supreme Court,1
#SCOTUS #trademarks #,1
https://t.co/QZfMHQx07H,1
South China,1
Number 10,1
https://t.co/dwpynNjIOu https://t.co/EiLHF6lyS7,1
Number 11,1
https://t.co/t5fSzkXdJK,1
#COVID19 #SARS_CoV2 #,1
@myESMO @CDCgov,1
#DinnerWithTheDocs,1
https://t.co/GVSega8Omz,1
umbralisib (@TGTherapeutics,1
https://t.co/ycjWepYfjx,1
#lyle_dk i,1
#aalborguh #,1
#h√¶matologi #,1
#all #apl #cml #,1
Number 12,1
the US Veterans Health Administration,1
around 40%,1
Cases,1
#SapienBiosciences #Herbalmedicines #,1
one our,1
UpTheMightyRoosters,1
Platelet Function and Bleeding,1
Lymphoma Patients on Ibrutinib,1
166,1
RT-,1
#CLL https://t.co/8GgiEN2cvZ,1
‚Å¶@ksondermann‚Å© ‚Å¶‚Å©,1
the Stability and Degradation Pathways of Venetoclax,1
https://t.co/PPPtqAwtdH,1
20 - 16,1
Richmond Bulldogs Grey,1
Sign up &,1
nosh &amp,1
#powerfulpatients #,1
#OOUT,1
ADME,1
#AAS #RAI,1
#AAVC,1
#MAFL #SIGT #,1
https://t.co/ocjT3YsNed,1
Round 4,1
3  #,1
2020 summer,1
#oncology #covid #,1
#bloghopping #,1
@uni_copenhagen,1
#LeuSM https://t.co/lXjgLu5zFg,1
2.30 pm #,1
"#UpTheMightyRoosters 
",1
Richmond,1
Park https://t.co/S8YidVDcit,1
https://t.co/FUAIDQMzx7,1
CLL Campus  https://t.co/kJ6VhFon2e,1
#smm #,1
1PM EDT,1
TGTherapeutics Announces Publication,1
Blood Advances Describing Unique #Immunomodulatory Effects,1
#Umbralisib $TGTX https://t.co/wygSzhkBgO,1
Assess the Association,1
Asian,1
non-Asian,1
üèÜüèÜ,1
#MTGLegacy #,1
MTG #,1
https://t.co/zAl2zWSVSB,1
CTCF,1
"North,",1
https://t.co/rb1NJxe4mJ https://t.co/ZfGbgOtiUj,1
Chronic Lymphocytic #Leukemia Dinner,1
@RWJUH,1
#medicalmarketresearch,1
#takepart,1
#joinus #,1
BRB,1
Weekly,1
Rutger's CINJ,1
RWJBarnabas Health,1
200 mile,1
Donate,1
COVID-19 Trademark Alert - Protection,1
Counterfeit Face Masks,1
#covid19law #,1
BTK Inhibitor Zanubrutinib,1
glycosaminoglycan‚Äëplacental,1
https://t.co/E2qFUk7WFn https://t.co/VGYxfkqm1v,1
JCOGO,1
https://t.co/CiGo0LFeZj #,1
the past 30 days,1
AnCan/Throwing Bones Blood Cancers,1
July 8 @,1
8.00 pm EDT - https://t.co/SoxUhlEclW #,1
@JackMAiello @LLSusa https://t.co/Mqjl2QPpRv,1
umbralisib.,1
#HWG,1
#RMMC #,1
Kathleen Toomey,1
https://t.co/pP16ulJkOv,1
Barriers to Proceeding,1
Reduced-Intensity,1
the 2020 season,1
AcquiredArray,1
NTRK,1
#quality #,1
1pm 16th July,1
Efficacy of Ibrutinib,1
Adult Leukemia Study Group Observational Study,1
Astrid,1
lymsm https://t.co/VA2QuJshQl,1
https://t.co/rtrsQNtUb4,1
the Walter and Eliza Hall Institute,1
https://t.co/3xEk2ncj50,1
https://t.co/W4XKEyS3ay #CLL #leusm #,1
@Phari,1
MolecularDiagnosticsProgram,1
MolecularTechniques,1
#pathologist #,1
Lymphoblastic Leukemia,1
New Jersey,1
CLL Community,1
https://t.co/rb1NJxe4mJ,1
Dermatological Toxicities of,1
WEGO Health Awards,1
KEPT SECRET &,1
ROOKIE,1
YEAR,1
Between March and,1
GAIA/#CLL13,1
Grandpa,1
‚Å¶@LLSusa‚Å©,1
#JulyBirthday #,1
just 1.2%,1
the @CllSociety Tribune,1
#PandemicPoems #,1
https://t.co/01B1gi6SIm,1
https://t.co/Skm13mmkWq,1
"Influence of Rurality, Race",1
Southern,1
Northern #,1
Oncology Institute of Southern Switzerland,1
#JOG #,1
#TPT,1
#BME,1
https://t.co/AiAdVI1uUF,1
Week Closing High,1
#IKA #,1
IGG,1
PVCS,1
$DOW #,1
$BA #BA $M #M $,1
$KO #,1
#FB $,1
#RT $,1
Liberum  https://t.co/ltLxRmHVR3,1
eight year,1
@Blodkreft_Nor https://t.co/ZbmxLci2VU,1
161p,1
Marice Alcantara,1
@FionaElseyCRI - Mucosal-,1
Dr Alcantara,1
Immuno,1
the City of Hope centre,1
https://t.co/7wSxrH0tDD,1
"ü§î

Investegate |Arsenal Capital Mgmt Announcements",1
Arsenal Capital Mgmt,1
#HER2- #,1
David Lauterstein,1
"Nasty Pig, Inc.",1
Notable,1
Executive,1
Crain‚Äôs NY Business 2020,1
#PRIDE #,1
Orphan Drug Designations,1
ODD,1
#regulatoryaffairs #,1
"lymsm 
https://t.co/IN7h4LXDAJ",1
https://t.co/J3eW9z9pya,1
myeloma https://t.co/SIdfniLfia,1
ONCT Oncternal Therapeutics Announces Orphan Drug Designations,1
Cirmtuzumab ROR1 Antibody for Treatment of https://t.co/gd8BuxXJAL,1
Cirmtuzumab ROR1 Antibody for Treatment of Mantle Cell,1
June 30,1
Oncternal Therapeutics Announces Orphan Drug Designations,1
https://t.co/N4lyg3Fc4c https://t.co/NZo5dEMiMi,1
Chronic Lymphocytic Leukemia Treatment Market 2020 Analysis,1
Global Industry Revenue,1
Ch√©calo ya!,1
Anne Martens,1
@AnnaSchuh3 @OUHospitals,1
"https://t.co/4x5VEXuid2

@VJHemOnc",1
Lucius Pharma,1
https://t.co/E7Uz7x0mAY https://t.co/PWqRkutcqp,1
the webinar here &gt,1
CLL Society ASH,1
New Clinical Trial,1
CURE,1
Clinical Trial Corner,1
June 2020,1
Coronavirus Risks for People With Chronic Lymphocytic Leukemia,1
#EHA2020 https://t.co/oJY0Va5oF5,1
https://t.co/PmKMSgbMTP,1
Time-Limited Triplet Therapy Induces Rapid Undetectable,1
Polymorphisms,1
C. Niemann @uni_copenhagen,1
integration &,1
"more than 152,000",1
Montanans,1
Daines,1
#ublituximab plus,1
https://t.co/2jUodxdR7,1
https://t.co/o7fWNDIxBc,1
"August 10, 2011 - New England Journal of Medicine @NEJM",1
MercuryRetrograde,1
Lymphocytic Leukemia: Current Status,1
https://t.co/aa9OuMjqjp,1
https://t.co/rsfhiE0lHD,1
https://t.co/EW03Ksv69K /8,1
https://t.co/EGdfWE9hem,1
#OncoAlert Genetics,1
#EHA2020 https://t.co/gMj7mQklYU,1
https://t.co/pVYlUenYmJ,1
Selecting,1
#infringement #,1
@grpetersen1 https://t.co/hAxEnB9QBU,1
The Combination of Venetoclax,1
between 1990 and 2017,1
anti‚ÄêSARS‚ÄêCoV‚Äê2,1
https://t.co/QYsNu7oWx2,1
#Mosaic #,1
#T_cell #,1
https://t.co/jjgTwFWqcE https://t.co/yu1V7tbO4I,1
Self-Improvement,1
#covid #,1
#haircut #,1
Charlie Rogers',1
Gliotoxin Recovers,1
40(5,1
Korean Society for Laboratory Medicine,1
#Chronic_lymphocytic_leukemia #,1
https://t.co/Yp3rVNVcSV,1
https://t.co/NAZYardTFc https://t.co/kYvyFqXhKG,1
Therapeutics Market Tremendous Growth,1
@ASCO Virtual Scientific Program,1
EHA25: Advances,1
#foamed,1
CME https://t.co/HWBO36yniU,1
https://t.co/N4lyg3Fc4c,1
the Clinic: Ibrutinib in Combination With Rituximab,1
CLLD,1
Growth Factor,1
https://t.co/SAmEh76ghY,1
FDA Orphan Drug Designation,1
Restaurant Industry Insight - Registering a Descriptive Restaurant Name,1
#AACR20,1
Virtual Annual Meeting,1
Hemasphere,1
Nikos Sousos,1
LPD,1
HemaSphere https://t.co/ob67iYkIMY,1
iBTK,1
#eha #,1
the Era of Next Generation Sequencing - PubMed https://t.co/iyyjMsxkEe,1
the Era of Next Generation Sequencing - PubMed,1
#EHA25  ,1
"MedTwitter
https://t.co/IJIEdwz3Hi",1
FMC63-28Z,1
https://t.co/zpPvupSEVe,1
Summarize,1
Dr Moreno,1
Literacy,1
Hairy McClary,1
Gabriela Forestieri,1
Institute of Oncology Research,1
IOR,1
https://t.co/T72FL782xC,1
Brno University Hospital,1
Fabienne Meier-Abt,1
@UZH_en,1
trisomy12 &,1
https://t.co/7qlfNx5YfJ,1
Anne-Sophie Michallet,1
@UnivLyon1,1
ICLL07 FILO,1
PLCG2 Mutations,1
more than 2 years,1
@Dcollinsflynn https://t.co/L8m9Yjodv5,1
https://t.co/Skj8JUFfDk,1
the University of Eastern Piedmont,1
"üëâhttps://t.co/kt1tI31lz3 üëà

@VJHemOnc",1
"Obinutuzumab
Ibrutinib + Venetoclax",1
https://t.co/Gp72esLu3l #CLL #leusm #,1
"üëâhttps://t.co/CVX2x0dqGnüëà

@VJHemOnc",1
https://t.co/Kkh5vsG13V,1
@JanRynne @NYLCandCLL @CllSociety @CLLSupport,1
"Lymphocytic Leukemia, Advantages of Monoclones",1
13th,1
over $,1
"2,000.00",1
#leukemia #gibbons5k #,1
the era,1
#cirmtuzumab plus,1
Stuart Blakemore,1
Henzl,1
Secondary School Research,1
#CEITEC #,1
#SOC #,1
JCMM,1
CLL Care Finally Returning,1
Junyan Lu,1
Limited Evidence Offers Some Hope for Good Outcomes - Cancer Therapy,1
Wednesday 15th July,1
13:00,1
Clinical Presentation https://t.co/assMmFTTaJ,1
https://t.co/Vb7npszewa #leusm #,1
‚â•24 months,1
"the 2020 NCCN Virtual Annual Conference, Drs",1
Stephens,1
#BVIC #,1
IQE,1
Otto D. Trautz,1
Vermont,1
"June 4th, 2020",1
the UVM Medical Center,1
https://t.co/wTYvwVc53u,1
~50%,1
"anorexia

Respiratory/Chest/Bronchia/Lung: Cancer",1
FMC7%,1
https://t.co/JiOK6VCqD2,1
#foamed #medtwitter #,1
MRD remissions &amp,1
https://t.co/E9xj3Hvfgl,1
Henriette Huber,1
58.5%,1
42.1,1
80.5%,1
3+ mos,1
MERVENDALPS,1
Etsy,1
https://t.co/AyJNiDXSHh,1
https://t.co/iZG0hZ1pPd,1
https://t.co/ilbMD7k65F,1
ACRCaseinPoint,1
Frontline Therapy,1
Noonan Syndrome,1
Cryptococcal,1
Hetero Healthcare Launches,1
https://t.co/hlla0BIzY6 https://t.co/AvT2ahCh5U,1
#EHA2020 @Aptitude_Health,1
F Morschhauser üá´,1
Ansell üá∫,1
B Eichhorst üá©üá™,1
M Rummel üá©üá™,1
PL Zinzani,1
üáπ,1
@LoriLeslieMD,1
Andrew Ip,1
https://t.co/iejgqbUT8e,1
A Safety and Preliminary Efficacy Study of CC-99282 in Combination With Obinutuzumab in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic,1
Tirabrutinib in Combination,1
https://t.co/mVaNSf5NZY,1
Chronic Lymphocytic Leukemia Treatment Market Growth,1
https://t.co/S08uFwdTQx,1
https://t.co/jAt0MSpiZB,1
https://t.co/vfcrFOgWhc,1
https://t.co/ThF0Nn0zKt,1
#americanflag #,1
"al
#",1
ZanuO,1
"antiCD20
2",1
mFup,1
BTKinhibitors &,1
week‚Äôs,1
18:00 CEST,1
AIL,1
LE LEUCEMIE-LINFOMI E,1
Marsden,1
https://t.co/TsZIxGadBS,1
@CRCTU @tobyeyre82 #,1
#leusm https://t.co/TGYSY1Ngu6,1
Novara,1
#EHA25 #COVID #,1
less than 24 hours,1
https://t.co/ufOgtZsjZ8 #,1
Janice Gabrilove,1
Rawstron,1
"al
MRD",1
1st 2 months,1
"üëâhttps://t.co/5mm5VapMHyüëà

#EHA25Virtual",1
"al
BTK &",1
Michallet,1
BM MRD,1
-ve:&lt;0.01%,1
9-&gt;16,1
FC-obinx4,1
5-7 days,1
Weitere Infos &,1
"Catherine_J Lab, Apr 10, 2020",1
Global Oncology Trial Management,1
OncologyTrials,1
ü•ç,1
#finlax #,1
Integrin-Mediated Adhesion,1
Chemoresistance of Acute Lymphoblastic Leukemia Cells Residing,1
the Bone Marrow,1
the Central Nervous System,1
PD-L1/PD-1,1
Leukemia https://t.co/2NVABxmFS3,1
https://t.co/NA0mwmzJwa,1
@JanRynne https://t.co/h5dWLJSoHQ,1
https://t.co/YjlOB3RGMP,1
+5.4%,1
https://t.co/llGRmzmYqv,1
Heute Abend,1
los!,1
Unser,1
Ihnen,1
Beginn des #,1
hematologytoday,1
Sein Thema,1
"üëâ https://t.co/31FGy1hfs7
",1
https://t.co/7HG0YOd6I0,1
#CLLsm https://t.co/k1RYmh3ZSN,1
https://t.co/FLvNdtGBws,1
1st week,1
https://t.co/ehacRmeuxV https://t.co/XHtOm72xZq,1
spanish,1
https://t.co/U4riTte1ef https://t.co/4YnWHMIjP2,1
1q,1
Leeds Teaching Hospitals NHS Trust,1
"https://t.co/Wu2jITZYYu

Hosted",1
"Monday, June 29, 2020 --",1
7:30 PM ET,1
#accp #,1
Datos,1
#LLC #,1
el anciano,1
2.-25%,1
4.-La,1
6.-Cuando,1
mal,1
#DNA3 #,1
SYM,1
Matthias B√∂ttcher,1
Mougiakakos,1
#GCLLSG #EHA2020 #,1
the Presenting Complication of Hyperviscosity Syndrome,1
Cost-Effectiveness,1
Third-Line,1
CME https://t.co/c3tLfEJiTd,1
https://t.co/deryV1dUO8 #leusm #,1
TopTen,1
CarersWeek,1
#EHA2020 presentation,1
KLL14 √áALI≈ûMASI,1
#ASCO20,1
#hematolojiistanbul #kll #,1
#leukemia #leukemiatreatment #,1
#memorialata≈üehirhematoloji #,1
Video Chat,1
June 10 @ 8.00 pm Eastern - https://t.co/vDsHrQ7ZMD,1
https://t.co/bjWi5koNoc,1
#MedicalJournal #,1
#medicaleducation #,1
https://t.co/P2cICEGNI0,1
Contact - 8130290915 #,1
Indonesia,1
"canada,#Malaysia,#Thailand",1
"Hong Kong,#UAE",1
Iraq,1
Small Lymphocytic Lymphoma Mimicking Primary Cutaneous Marginal Zone,1
Colonization of Germinal Center Follicles,1
2:1,1
https://t.co/sY9d2osUsX,1
https://t.co/GfLl3NdVu7,1
Oxford Gene Technology,1
SureSeq CLL + CNV,1
https://t.co/9Rwu3zmHSO,1
June 11th,1
8 AM CEST,1
https://t.co/JNB8SZtDKV,1
Virtual Community,1
#tweeted #,1
"August 29, 2012",1
NationalCancerSurvivorsDay,1
the Batman Ears,1
Comparable AE,1
Ken Hill,1
Pinehurst,1
8-year,1
#NCSD2020 #,1
Ed Bradley Dead,1
The Evolution of Targeted Therapies,1
Popular #ASCO20 Research on,1
üëâ https://t.co/mQCBQZiSNt,1
#erRORneous #,1
between #BCR and ROR1/non-canonical #Wnt signaling!,1
https://t.co/W2Q8wNAAKC,1
APR-246 in Combination With Ibrutinib,1
Hodgkin Lymphomas,1
ü§Ø,1
#MPH #,1
#RCN,1
#HTCF,1
#UKW #,1
FDA Update: Ibrutinib + Rituximab,1
Watch #CLL,1
#chronicleukemia #,1
https://t.co/4Ttct433G1,1
Hodgkin Lymphoma-type,1
Fine-Needle Aspiration,1
https://t.co/8TzNrvXKf3,1
https://t.co/Tg4IwV7YDq,1
Access,1
#multiplemyeloma,1
lymphoma/#CLL,1
https://t.co/zD2UmMEEwe,1
https://t.co/Co5gR3s39P,1
2.8%,1
Advanced Binet,1
BeiGene Announces Approval Of BRUKINSA In,1
#COMy20 @COMyCongress https://t.co/uCAGlrgMEQ,1
@ASCO https://t.co/3On62tyEbR,1
https://t.co/uIXvDo3YBF,1
The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice,1
Radar,1
CLLÊÇ£ËÄÖ‰ºö‰∏ªÂÇ¨„Çª„Éü„Éä„Éº,1
Ibrutinib in Previously Treated High-Risk #,1
https://t.co/PeN7dywO6s,1
#carotenoid #,1
https://t.co/sHdllnGC6h @LeukemiaJnl https://t.co/KnZ0C9WFHe,1
mab +,1
https://t.co/32A1MQ1nbg,1
MRD-neg,1
about 50%,1
@ASCO 2020 Virtual,1
#twitterMoment,1
#NTBR #,1
and/or medical devices,1
https://t.co/n9PE0zLSjk,1
at least,1
#btc #,1
#digitalassets #,1
@cryptocom @Bitcoin https://t.co/NGEe8vs0hl,1
Carlos Carrasco,1
his 12th,1
#Abstract,1
https://t.co/83Idai08sM,1
https://t.co/kpWxtfsh53,1
June 4,1
John Allan &,1
https://t.co/qHaiiJdpnc,1
https://t.co/FgAmkXIDXs,1
Previo https://t.co/FqMyQurSD2,1
Nationwide,1
16-Year,1
#Clinical Progression,1
Immunol,1
01;203(11):3078-3085 Authors,1
Rozovski,1
https://t.co/KVWkHhHKY3 #leusm #,1
NOTCH1 Mutations Detection,1
Non-Aspergillus,1
WorldBloodCancerDay,1
1 March 2016,1
Unerm√ºdlichen,1
Krebsforschung Ma√üst√§be,1
Deutschen Krebspreis,1
Blick,1
Forscherleben,1
#MyCLLife,1
https://t.co/uGRzqCFHdX,1
a week and a half,1
Pharmacyclics,1
NuRD,1
m‚Äôn,1
Chemokuur,1
Over 3,1
Dankbaar &,1
CKJ,1
@kdjhaveri @LeukemiaRF https://t.co/Rfp61uGJTJ,1
Edelmann et al,1
105(5,1
1379‚Äì1390,1
https://t.co/93S7rSeD2j,1
#BBY #,1
MANO,1
#OSI #,1
https://t.co/C1r4EjmcsH #CLL #leusm #,1
HealingTouristry,1
4wd #cll/wssp,1
0139449473,1
12 Rx na√Øve 22,1
TN 86%,1
"MURANO
- Short",1
https://t.co/LaPPnzaRFv,1
@CllSociety co-founder,1
@TinaP_J #,1
#1percent #,1
#staysafe,1
NIAID Trial,1
#Remdesivir #,1
BJH Article: Protective Role,1
https://t.co/WTilWdxeDB,1
https://t.co/2xXpKR0Zcy https://t.co/PxrrQwnMdG,1
Sytuacja,1
choroby rzadkie w czasie,1
@_KLRwP,1
@ISPPAN @hematoonkologia,1
#chorobyrzadkie #,1
April 17th,1
Wait and Watch,1
COVIDnCancer Great,1
#COVID„Éº19 and,1
https://t.co/BciVpeuQDb,1
about 1 hour,1
the Care of Patients,1
OncoAlert International,1
https://t.co/AW8HNlkCtf,1
https://t.co/3lSLgxORvP,1
JT https://t.co/YxmamDGRWA,1
Cloud Lunch,1
Victor Rodrigues,1
May 25 2020,1
12 PM,1
UTC,1
#MSDevIRL #,1
https://t.co/hDF9Zqkjn1,1
charities &amp,1
Protective Role,1
#AbbVieUK YouTube,1
a good few years,1
https://t.co/6fLnU2rqsw,1
venG,1
8 #,1
5-6 PM,1
Register &gt;&gt,1
https://t.co/xMmUVXIqex,1
A Case of Hyperkalemia Versus Pseudohyperkalemia,1
151p,1
the current year,1
115p,1
Virus,1
Waldenstrom Disease Infected With COVID-19,1
New Research: Evaluation of Somatic Hypermutation Status,1
the Era of Next Generation Sequencing: Somatic,1
@YucaiWangMD &,1
@ab_pau &,1
@mikewdennis,1
https://t.co/EUmncZIxNa #CLL #leusm #,1
https://t.co/qMFUpA7uBu #CLL #leusm #,1
#BILN #,1
#ANCR #,1
RWA,1
https://t.co/yno3X5vI7Z,1
The EQA Summary Report and Individual Laboratory Report,1
ISPOR - REAL-WORLD HEALTHCARE RESOURCE UTILIZATION,1
ACP,1
https://t.co/d3LyebXEjp,1
Shielding,1
#Share #,1
#staysafe #,1
"FollicularLymphoma 

Read",1
"https://t.co/4ORpORcPAU

Oncology &",1
Management of Ibrutinib Toxicities,1
https://t.co/fKOXtdMtsd,1
May 2020: Please,1
Current Evidence in Management of CLL,1
#registernow,1
https://t.co/sIYJ8v8itF,1
https://t.co/SphdIC5jZn,1
CLL Heath Center:,1
https://t.co/H9jVjxDtDE,1
Self-Management for Patients With Lymphoma: Assessment of the Reach of Intervention,1
Chemical Lift-Off Lithography of Metal and Semiconductor Surfaces,1
"https://t.co/eTflDUqQ9e
",1
Drs @DrMDavids,1
https://t.co/deQBLmGi7d https://t.co/LWcaMhVTZw,1
@UofGCancerSci,1
Bourne,1
TeachingPoint,1
#trademarkapplicant #,1
Dominique Bron,1
CAR T-19,1
https://t.co/S0h6LtlrYW https://t.co/xKStAT8A5M,1
Protecting Cells,1
the Cytotoxicity of dGTP,1
rituximab plus chlorambucil,1
https://t.co/ks3a1JY9l6,1
the Severity of Chronic,1
#ASCO20 $,1
GENIUNE Phase 3,1
20% vs 5%,1
"UTX

Abstract",1
VIDEO CHATüö´,1
8pm Eastern 5/13 https://t.co/zFQZE6IeJb Free,1
@JackMAiello @LLSusa @CureLeukaemia,1
#TRI #,1
#DDDD #,1
#DIGS #PPH #RECI #,1
#BWY #,1
https://t.co/26nE3obeGy,1
New Treatments,1
#cancerGRACE #,1
https://t.co/U8qfPDjrEQ,1
PD-L 1,1
avelumab,1
May 13 @,1
the Biosimilar Rituximab (Riximyo,1
@SPONDYLITISCA,1
Chris Fletcher,1
https://t.co/ROtq1rYPDl,1
#cll https://t.co/3k7OxIlky7,1
https://t.co/8h5E6Yeh2r @CancerNetwrk,1
Deborah G. Kirkland,1
The Hoffberger Breast Center at Mercy,1
The Evolving Role of the Patient Navigator,1
#publishing #,1
Karsten Rippe,1
https://t.co/Si9lHGZ8Qw Mutations,1
#publiHUCA,1
@UWMedicine #MedscapeEdu,1
https://t.co/hosMvsnMZt,1
Ophthopedia Update: Ophthalmic,1
#Ophthalmology #Eye #,1
NutriSci,1
Metabolic,1
ÿ£ÿØÿßÿ© ÿ¨ÿØŸäÿØ ÿ™ÿ≥ÿßÿπÿØ ÿπŸÑŸâ,1
New Prognostic Tool,1
https://t.co/WMGsuhDrxa,1
https://t.co/O29ztmEK4Q,1
https://t.co/hsl7YC20bm #leusm #,1
radon,1
The Speckled Protein,1
#mbbs #medquiz #,1
#next #,1
#medvibes #,1
#thuglife,1
#sarcasm,1
#mcq #,1
#quotes #,1
#medcomics https://t.co/PbJ5BQOvqW,1
https://t.co/r2u4UJkEAg #,1
#leusm https://t.co/lvUyttx2K7,1
https://t.co/HYd0n3fFbJ,1
FieldofDreams,1
Manouchehri-Doulabi E,1
Faranoush M,1
Pak F,1
Barati M,1
Kokhaei P,1
Momtazi-Borojeni AA,1
12-Month,1
Utilizing Real-World Evidence,1
Improve Care,1
20 Years,1
Laura Michaelis,1
https://t.co/ah8vzk8Cm0 #,1
https://t.co/zTMgPtTOz1 https://t.co/6IISoqiBvI,1
The Challenge of Developing #ClinicalPathways,1
@ADVIhealth,1
https://t.co/8mq3tV7GVW,1
Cancer Update-Pandemic Edition,1
my final 4 months,1
Aug.,1
UNITYCLL Phase 3,1
#Ublituximab #,1
https://t.co/pMWO69IOeb,1
Sydney Hester,1
US National Institutes of Health Study,1
https://t.co/oBdxPYrVnN,1
Lower CRS,1
Dose Finding Study to Evaluate,1
NCT02406742,1
Melanoma Incidence and,1
Myelodysplastic Syndrome: A Matched Cohort Population-Based Study,1
July 26,1
"November 17-19 2020
Chairs: J Brown",1
Information https://t.co/lcf3gjNn3F,1
next 14th,1
The Venetoclax BTK Inhibitor Sequencing Question,1
#nca,1
#notcovid #,1
May 19,1
Otsuka,1
"#clinicaltrials
",1
OncoAlert Feasibility,1
https://t.co/PcGY6cDg0e,1
https://t.co/6Wd48Jo0iM,1
Across Canada,1
"approximately 1,745",1
#COVID19 https://t.co/sxECWL6muC,1
"https://t.co/arz9Ziz89K

@SarahCannonDocs @TriStarHealth",1
https://t.co/evqGZqR4on,1
1053,1
between 2007 and,1
https://t.co/USJSFDwXnB,1
East Africa,1
"COVID19 

Watch here &gt;&gt",1
Thks #,1
r4today,1
@BBCr4today,1
Ô∏è &,1
millions acres,1
Dicamba - Researchers,1
U.S. National Institutes of Health,1
Ublituximab Improves Progression-free Survival,1
tomorrow (7th May,1
Collectively Answering The Venetoclax BTK Inhibitor Sequencing Question,1
x3 peak,1
1.8B,1
6/1.8,1
5B,1
@EPA,1
CURE‚Äôs,1
webinar series,1
Farukh Awan,1
https://t.co/IgFZFPv8rd,1
Thursday 7th May,1
https://t.co/J56nVaySmG,1
First-Line Ibrutinib,1
12:36:21pm,1
Leukemia - https://t.co/rP4wz5LmeU,1
Leukemia https://t.co/hjt1ujkJsA,1
15.89,1
27.53%,1
Pascal Lefevre,1
#CLL https://t.co/orrMHrHfjZ,1
Kindle,1
DjVu,1
AudioBook,1
umbralisib &amp,1
May 6,1
https://t.co/X71ampNsus,1
cytotoxic #,1
16.20 PM Positive,1
TGTX(12.46,1
5.70,1
Trial Met Primary Endpoint,1
#premarket #,1
Leukemia Nasdaq,1
https://t.co/GtknsBHhi6,1
https://t.co/3XSXgPFnmY #CLL,1
Relapsed or Refractory Chronic,1
15 May,1
712k,1
CD4,1
https://t.co/wAXtQyakdx,1
Michal Smida,1
https://t.co/WpfWqY9IfG,1
https://t.co/MnpKfwmakM,1
Hematologic Malignancies-,1
Ash Research Collaborative,1
üëâ  https://t.co/OidOKhNkHU #lymsm,1
#Duvelisib #Copiktra #,1
#COVID19  ,1
@VerastemOncolog @danwpaterson,1
@SteveFDA @ScottGottliebMD,1
@bloodcancer_uk https://t.co/DxiBSfoEZT,1
@ChicagoIL - #,1
#She -,1
the Monterey Jazz Festival,1
https://t.co/4IrAwDOJFZ,1
https://t.co/O6zsGLAfsC,1
@UNC,1
@lzitella,1
Myalgia,1
Fatigue https://t.co/dPPgRK1M1C,1
Atrial Fibrillation,1
Bleeding/Bruising https://t.co/VudGfkXMKc,1
Cytopenias,1
NCCN¬Æ Guidelines https://t.co/hrtyOQIgOt,1
Optimizing the Use of BTK Inhibitors,1
15 highlights,1
https://t.co/P0NXLTMcII,1
para comenzar de nuevo,1
#CentroLasLomas #,1
only 12%,1
Inpts,1
32.5%,1
CLL Experts,1
#Stromal #,1
Tumor #Microenvironment,1
Lymphocytic Leukemia:,1
SPN,1
LEF-1,1
#ROL #,1
#VAL #,1
#RDT #,1
#copyright #,1
#postdoc #CLL,1
Coronavirus Turmoil,1
#NCICTEP,1
@eaonc @FDAOncology @Pharmacyclics,1
"lymsm 
https://t.co/DLLOlHmjav",1
#COVID-19 &,1
7th May,1
10AM,1
#UK CLL,1
https://t.co/KUhPmK2vdG,1
SIRT1/HIF-1Œ±,1
https://t.co/hMD7MyJI7z,1
Improved Patient,1
73 years old,1
CHO Anuba Lohe's,1
Phek Village SC-HWC,1
Phek district-Nagaland,1
CLL/Lymphoma Tweeps,1
1L/2L,1
https://t.co/d7E2ZICdzl,1
https://t.co/hP5anNFmgg,1
https://t.co/cgjEJW5ipr,1
5pm Irish time,1
April 28 10:00AM PDT,1
1:00PM EDT,1
nearly a month,1
17 days,1
Mary Hernandez,1
Read Mary's,1
mAbs rituximab,1
https://t.co/9tu5cZ8xHQ,1
https://t.co/yl1pi8DRrT #CLL #leusm #,1
MedTwitter #,1
the Additional Funding Package,1
#update #,1
#flu #influenza #,1
#pharmacist,1
#HER2 #,1
"https://t.co/HOwubiEsIz

#Leusm #",1
#healthjournalism #,1
Richard Bakst,1
Amir Steinberg,1
April 28,1
https://t.co/iP2kwfgNg0,1
Alison Mulholland,1
Amy Sheldrick,1
@sujeethemat,1
@ArijitBishnu,1
LRR,1
Multiple,1
#HealtheVoicesLIVE - HUGE,1
CathyKramer,1
Gratitude Breakout,1
https://t.co/r1xR7AhWBv,1
the European Medicines Agency,1
HealtheDinner,1
Middle Eastern,1
#HealtheVoicesLIVE #CLL https://t.co/dMueP4Xs3i,1
https://t.co/JQrQhXZPbb,1
https://t.co/u73zPVmrZ1 #CLL #leusm #,1
31-year-old,1
https://t.co/2griUox1pM,1
#AACR20 Annual,1
the @lymphomahub next week,1
https://t.co/PWhTINqrW7,1
LIVE-Webinar,1
10-11:30 Uhr zu #,1
√Ñrzte,1
Interessierte u.a.,1
@H_Einsele M. Dreyling,1
P. Borchmann,1
A. Engert,1
B Cell Tolerance,1
the IgM Fc Receptor,1
FcŒºR,1
https://t.co/8T7mLWb5qS,1
JAOAClinicalImage https://t.co/c3g8mbjw4k,1
"https://t.co/tzNZGUZzp4

#",1
https://t.co/fVFBs8KxPd,1
#hematologicmalignanices,1
Reaserch Advance on Inhibitor Targeting,1
https://t.co/giatCFd0Pc U.S. FDA Approves,1
OncoPharm Anyone,1
D1 &,1
900mg D2,1
Laura Patrussi,1
Nagaja Capitani,1
Cosima T. Baldari,1
@Pharmacyclics Imbruvica,1
FDAApproved,1
https://t.co/iTuOmaKUsC,1
@CruiseNorwegian #NCLH,1
#RareDisease FDA,1
HCPLive https://t.co/MXnANJfMAg,1
https://t.co/ueDxnOd2jT,1
rate=28%,1
rate=44%,1
64 months,1
Aktuelle Therapiekonzepte bei Lymphomen,1
#HodgkinLymphom #,1
nearly 6 weeks,1
https://t.co/BAhSKnwdiz,1
ÿ®ÿ¥ÿ±Ÿâ,1
ÿßŸÑŸÑŸàŸÉŸäŸÖŸäÿß ÿßŸÑŸÖÿ≤ŸÖŸÜÿ©,1
ÿßŸÑÿßŸÖÿ±ŸäŸÉŸäÿ© ÿπŸÑÿßÿ¨ ÿ¨ÿØŸäÿØ,1
ÿßŸÑŸÑŸàŸÉŸäŸÖŸäÿß ÿßŸÑŸÑŸäŸÖŸÅÿßŸàŸäÿ© ÿßŸÑŸÖÿ≤ŸÖŸÜÿ©,1
ŸàŸáŸà ÿÆŸÑŸäÿ∑ ÿØŸàÿßÿ° ÿßŸäÿ®ÿ±Ÿàÿ™ŸäŸÜŸäÿ® Ÿàÿ±Ÿäÿ™ŸàŸÉÿ≥ŸäŸÖÿßÿ®,1
ÿßŸÑŸÑŸá ŸäŸÜŸÅÿπ ÿ®Ÿá,1
https://t.co/9JWuG78NMX,1
https://t.co/DqZM35xJf3 https://t.co/zgAdJC0Zpj,1
The U.S. #FDA,1
https://t.co/jrkjFPAFxy,1
The Delaware County Daily Times,1
https://t.co/Tvd3GzA2fd,1
the Food and Drug Administration,1
#CLL)/small lymphocytic #,1
"more than 21,000",1
2/6,1
https://t.co/KwW3t9pA9Q,1
FDA https://t.co/J7A6tFw0cZ,1
#ProjectOrbis #,1
LLS Volunteer,1
#LLSVolunteer #,1
MRD Updates,1
https://t.co/lus5wLYSxO,1
#BDFACSMatters webinar,1
https://t.co/dumqVta90D,1
Brenda Eichelberger,1
earlier this month,1
#CARESAct #,1
https://t.co/DyLW8kKZea #,1
CMV,1
Dysfunction,1
https://t.co/2mN86CxrWF #CLL #leusm #,1
Iron Overload,1
Autoimmune Hemolytic Anemia: A Case Report,1
https://t.co/UGMmbaTkHj,1
PAGC19,1
#haemreg #,1
TEAMHAEM,1
Warm Autoimmune Hemolytic Anemia: Clinical Profile and Management,1
https://t.co/pT95lbSBF7 https://t.co/4eOVSHVIoY,1
https://t.co/cSD1RZMKYc #CLL,1
https://t.co/6JyfiylcIw,1
Holothuria,1
https://t.co/QQ4MmszDW8,1
5.48,1
12.11 am,1
11.13,1
pm https://t.co/OhFbvcgQB8,1
VAI,1
5.48 am,1
https://t.co/fhLLujNPNi,1
@Roivant CEO.,1
#efpvirtual,1
#EyeForPharma #,1
#EFPVirtual #Covid19 #EyeForPharma #,1
ERC Consolidator,1
https://t.co/7y7Z6ZE8d3,1
Long-Term Outcomes,1
https://t.co/QrteQFevCN,1
BSI Connected Leaning Live,1
https://t.co/cirX26IkMl,1
Leukemia @Pennmedicine,1
Kymriah https://t.co/0gksLqnKHV https://t.co/F8HZw9MvdN,1
"Tuesday, April 21st",1
7-8 p.m. CT,1
#CARESact #,1
Merkel Cell,1
BCL-2 Proteins in Pathogenesis and Therapy,1
2.4%,1
Version https://t.co/alrfnIo0aq,1
https://t.co/kHY7s8X74V,1
Christine Ryan,1
PJP,1
#stayathome #,1
#cancertips,1
Eight-year,1
NCA,1
"Friday, April 17, 2020",1
11 AM PT / 12 PM MT/ 1 PM CT/ 2 PM ET Register,1
AVM,1
https://t.co/NzMRUNPpRZ  ,1
1.00p,1
EyeForPharma,1
journey &amp,1
#rarediseases,1
#trademarkabandonment,1
https://t.co/VY7rt3Gkxa  ,1
the previous 2 decades,1
Ibrutinib-Associated Cardiac Tamponade with Concurrent Antiplatelet Therapy,1
@eyeforpharma,1
https://t.co/jNF1XnIfZW,1
6 week,1
HSE &,1
Tuesday 14th,1
8.30pm,1
preclin,1
Clin,1
Mucho,1
Hernandezlab,1
Cheers @stellardoc1,1
Pfizer Inc.,1
https://t.co/PcoPJx3BMP,1
"Cancer 
Learning",1
HeLa,1
https://t.co/pIVMLikOqK,1
#leusm https://t.co/N94d1bg4kG,1
New Coronavirus Webinars,1
Telehealth #,1
Telehealth,1
Cancer Patients,1
https://t.co/8zvucEyw2p,1
p66SHC,1
Leukemia https://t.co/we0RHeNMvO,1
https://t.co/VhN8Nvso3v,1
"Condition Summary: Lymphoma, Small Lymphocytic",1
https://t.co/uyKdoPwtD0,1
kontakt #lyle_dk,1
lyle@lyle.dk el,1
#cml #cmml #lymfekr√¶ft #,1
https://t.co/RHSnIOrfYV,1
#Observational Trial of Real-World #Treatment #Utilization,1
https://t.co/Yttv9KkdMP,1
HICCC,1
@nyphospital/@ColumbiaMed,1
https://t.co/iX78sD4j24,1
#BCL-2 Proteins,1
Magdalena Klanova,1
Pavel Klener,1
#diagnosed,1
#Blood https://t.co/rOAJvfGfol,1
#RSP #,1
#Respirator,1
N95 #corona,1
https://t.co/9iND9Ywg85,1
Up to half,1
M√©xico,1
International #Prognostic Score for Asymptomatic Early,1
https://t.co/2wNbtRuuIT,1
"April 3, 2020",1
https://t.co/VUD7JedVtd,1
Jumanji,1
COVID2019,1
Wei Ding,1
https://t.co/Q4szuhJcuv,1
#leusm https://t.co/v15zcoRfwE,1
Mexican,1
International Prognostic Score for Asymptomatic Early,1
https://t.co/sbFUaPqNye #CLL #leusm #,1
https://t.co/c3VWOQCFcq,1
8 pm,1
our 1st,1
https://t.co/C867lO1NJN,1
#ILLINOISsocialwork Community Learning Lab #CLL,1
"Facebook

#",1
Less than 30 minutes,1
NIH CC Office of Patient Recruitment,1
https://t.co/ePDGuZxgJg,1
specialist &amp,1
#stayhome,1
#Umbralisib/#Ublituximab/#Venetoclax,1
https://t.co/V55Mz4sJrX,1
April 8 @,1
8.00 pm EDT - Free,1
Patent &,1
Trademark Law Alert,1
CARES Act - U.S. Patent and Trademark Office Extends Various Filing and Fee Deadlines for Applicants Affected,1
#patents,1
#USPTO #,1
https://t.co/9gx7e4V3uT,1
the Treatment of Patients With,1
Hepatitis B Virus Reactivation Under ƒ∞brutinib Treatment,1
"Mark S. Lesney
https://t.co/PrVJkAgHmK",1
first quarter,1
COVID-19 Update,1
AnCan,1
Covid-19 &,1
Wednesday 8 April,1
3.15pm,1
Prof Fegan,1
care &amp,1
"#ÿ≥ÿ§ÿßŸÑ_ÿßŸÑŸäŸàŸÖ
",1
@Roche https://t.co/LWuVjFrPFE,1
@Lab_Rezvani,1
Leukemia https://t.co/spHUn7ebRh,1
https://t.co/0OpIho5VHK,1
34 and 42 months,1
https://t.co/ZZnuAUFAn0,1
info @ https://t.co/zFQZE6IeJb &,1
@Fundaleu,1
#NKcell #,1
9am PST/NOON EST,1
https://t.co/YdZ7apSMbu,1
#monoclonal #,1
GPA,1
#PV #,1
#biosimilarity #,1
#safety #,1
#oncology #cancers #,1
Histopathological Features of Tissue Alterations Induced by,1
Cryolipolysis on Human Adipose Tissue,1
https://t.co/sno8bqc5y4,1
Nxf1,1
@WaterfordMafia,1
Automotive,1
14 April 2020,1
the Disruptions Created,1
#COVID19 https://t.co/UOWRJF4kj6,1
PLEASANT,1
Dr Amir Steinberg,1
Dr Rich Bakst,1
@TischCancer,1
"130,000",1
https://t.co/YkLvd4vnAE,1
April 1 2020,1
#CLL #COVID19 #leusm #,1
https://t.co/3NHCxcvUaE,1
https://t.co/yyfQOqirlf,1
@Bloodjournal,1
Myelodysplastic Syndrome with,1
#covid19UK era,1
#COVID„Éº19 https://t.co/qJ0FzzLqes,1
CLL - https://t.co/UfncyhKLOa,1
‚Å¶@sloan_kettering‚Å© ‚Å¶@CllSociety‚Å©,1
#COVID„Éº19 #,1
Mom &,1
https://t.co/eRVFIDBdMu,1
The next couple week,1
"Pharmacists‚Äô Role in Managing Patients with Chronic Lymphocytic Leukemia""  @MDPIOpenAccess Thank you @KatieBPharmD for your co-mentoring",1
https://t.co/Wce8JGP8lg,1
Fight CLL International Workshop,1
The Many Facets,1
Tumor-Microenvironment Cell Interactions,1
https://t.co/XLVEdw3uS0 #MCL #,1
4800,1
Landlord,1
585.00,1
CancelRent,1
#CLLMonthlyMinutes #,1
https://t.co/xClz9Xx57M,1
üòÉ,1
@Roche https://t.co/IL0jdohBv6,1
Round Two!,1
"Friday, April 3, 2020",1
11:00a.m,1
MT/,1
1:00p.m,1
CT/,1
2:00p.m,1
American Cancer Society,1
30 days,1
a difficult month,1
https://t.co/0N4nVM6J9O,1
ICYMI‚ÄîClinical Picture,1
https://t.co/jTiXnjwV4s,1
Grant of Options,1
#Duvelisib #Copiktra #COVID19 #,1
Lymphoma T-Cell,1
#PI3K #inhibitor #,1
https://t.co/d0AWYsuvux,1
Monday 30 March,1
Balkan,1
Serbia,1
HSE,1
11 am live on,1
RTE News Now,1
Making Waves,1
https://t.co/D7SLgF0Q6i,1
https://t.co/Pq6UkuyOdL,1
@Orlaodo,1
EBV,1
#lymphoma #inhibitor #,1
#MZL,1
https://t.co/zUeglDR5OH,1
2.95p,1
Lab Scientist,1
Thomas Henry,1
https://t.co/XhEsKFroeQ,1
https://t.co/7q5B1QM99X,1
Serum Expression,1
Seven,1
VLA-4 Expression and Activation,1
#ForMyDad #,1
John‚Äôs Chemo Medication,1
https://t.co/YUdFNeHHn0 #,1
#covidaus,1
https://t.co/C2q59iIyzl,1
@anthonymatomd of @sloan_kettering https://t.co/p3C8OIWPwU,1
The Globe - https://t.co/ed1cLS3PBs,1
OfficialNIHR https://t.co/PsPWo1lWsS Full-length,1
Register: https://t.co/jJYHecC913 https://t.co/sPhruh1wrQ,1
the American Cancer Society,1
25 days,1
Thomas Baxter,1
March 15th,1
Vancouver Gen Hospital,1
Approximately 93%,1
zanubrutinib https://t.co/CJzYMDNV9z,1
IrishMed,1
https://t.co/LlJ9wlvYmL,1
#covid19 #mmsm #,1
Sam Matheny,1
#bsa,1
#bethere,1
#conference,1
#wildwest #,1
https://t.co/k1dsl6Vqt2,1
100000,1
Tennessee,1
Town hall,1
@tnonc,1
74,1
https://t.co/yvPSIZpWiL,1
Sean O Neill,1
https://t.co/lrvqgXpchV.,1
#littleleague,1
https://t.co/wxrboYxUMR,1
Market Forecast,1
WHO Classification,1
MedscapeEd,1
CNP,1
Shilpa Paul,1
@MDAndersonNews https://t.co/JCeJQlDYyo,1
https://t.co/L6q56uQ9p8,1
Sean O'Neill,1
BTK Inhibitors Transform Treatment,1
Constantine S. Tam MD,1
Crohns,1
RA &,1
#FlattenTheCurve,1
#VirtualLearning #,1
#StayHome #COVID19 #,1
Northern Ireland,1
#COVID19ireland #,1
Bay Area,1
Mark DeSaulnier,1
"https://t.co/gc9tnqtNWF

Please",1
First View Insight Prices,1
https://t.co/0oYn1O3Bbp,1
#askpatientpower #,1
Carol Butler,1
https://t.co/vvmLK5RJWb,1
https://t.co/wXqrcJk0zT #CLL #leusm #,1
rituximab-containing,1
Latest Advice On Coronavirus For People Affected By Blood Cancer,1
https://t.co/nhyLo30bRf,1
#CLL https://t.co/xL6SMBfIyU,1
Ô∏èN,1
"VEN

Reason",1
https://t.co/MFzBboZrma,1
Benign Hematology,1
WHNFT,1
BioTechniques,1
Heidelberg,1
"https://t.co/LdFhLIgnZe
Many",1
Methyl-COOM,1
An Anecdotal Case Report of Chronic Lymphatic Leukemia,1
NEAT1 Long Isoform Is Highly Expressed in,1
Juglans,1
NEAT1 Long Isoform Is Highly Expressed in Chronic,1
Tumor Suppressors,1
4 yrs ago,1
#COVID„Éº19 #COVID19 #,1
Larry Anderson,1
the 3%,1
3/19 11 AM PT/2 PM ET,1
https://t.co/USsJoanzhl,1
3/18 12:30 PM PT/3:30 PM ET:,1
#SF3B1,1
@ucsc &,1
@MIT &amp,1
https://t.co/ne85FjGGYq,1
2034,1
First View Insight,1
MD Medical Oncologist,1
https://t.co/lyWnUKGcSj,1
the next 12 weeks,1
https://t.co/WlMw6QaszY,1
Expression of CD163,1
Next week,1
#COVID19ireland and,1
SelfIsolation,1
Investigators Pursue LessToxic Treatment,1
#immunocompromised,1
https://t.co/2lVFr5hJY2,1
#EuropeanCommission #,1
#phaseIII,1
#disease #first #,1
#HighRiskCovid19 #,1
@USATODAY,1
Coronavirus Update,1
@WVCancer #,1
NorthernIreland &,1
Nfkbie,1
#TwinPetesInvesting #,1
#investing üé¢#,1
#stocks,1
#SPT #,1
$MSFT $,1
#DVO #,1
https://t.co/yQ45yIg615,1
the 80%,1
the other 20%,1
Hep C. Both,1
Ages 59 &,1
#HighRiskCovid19,1
O'Brien &,1
Stephan Stilgenbauer Ranges,1
#bloodbanks #,1
#Bonemarrowtransplant #,1
#StopCoronaVirus #,1
#hodgkin #,1
UKCLL Forum,1
Evaluate the Safety and Preliminary Efficacy of Ibrutinib,1
NCT03153202,1
Market Share,1
Competitive Landscape,1
the Unstimulated Cell Culture,1
#Covid_19 #,1
computer &,1
New UK,1
@RuthClifford5,1
New UK CLL,1
#CLL #lympsom #,1
#COVID2019uk https://t.co/rGVKxTnQkC,1
https://t.co/m6oJT53cQ8,1
Frontline Venetoclax/Obinutuzumab Approved,1
https://t.co/TgXMHLVwgr,1
AbbVie‚Äôs Dual Regimen Receives EC‚Äôs Approval for Patients with Previously Untreated Chronic Lymphocytic Leukemia,1
EC Approval,1
the Cervix Involving the Coronary Arteries Leading,1
Fmc7 Negativity,1
Low-Grade Nonhodgkin Lymphoma,1
Phase 1b Study of Tirabrutinib in Combination With Idelalisib or Entospletinib in Previously Treated Chronic Lymphocytic Leukemia,1
the Cervix,1
Friday 3/13,1
7am &,1
30 days ‚Ä¢,1
Scharff,1
Chiorazzi @NorthwellHealth Labs,1
Riccardo Moia,1
Andrea Patriarca,1
üëâhttps://t.co/t0hCiD8ou8,1
https://t.co/2bTFMDjZFs,1
El #CNAGCRG,1
al estudio #PanCancer,1
otras cosas,1
"https://t.co/LDRSvMDiKJ 

",1
Phase 1b Study of Tirabrutinib in Combination With Idelalisib or Entospletinib in Previously Treated Chronic,1
Without Chlorambucil,1
HCP,1
odettecancercenter @CPHO_Canada,1
Cellfree IgGaggregates,1
https://t.co/6jIy2Gutbv,1
12 year old,1
OskarStrong,1
#engagedcommunity #successfulstudents #CLL #,1
shareastoryeveryday,1
https://t.co/utK9s2FCKK,1
#usmle,1
"Saturday, March 28 
Registration",1
10:00 am Program,1
"11:00 am 
 
Our",1
#FLASCOEvents‚Äã #,1
Patient Power #,1
https://t.co/9PtHvWbKwG,1
https://t.co/8W55gXKJZb,1
Seattle #,1
Cancer Care Alliance,1
Important New #,1
https://t.co/abcufNHmPo,1
EpsteinBarr,1
#COVID19 &,1
home &amp,1
the 2020 Majors Dodgers,1
Claremont American Little League,1
JOHN TERRY,1
Krazyhorse Farmhouse,1
Matourian,1
#Ash #,1
SadafFazeli,1
Krazy Horse Farmhouse,1
Chipping North,1
#BeLegendary #cll,1
#UK #CLL #,1
6th March 2020,1
CO,1
mid April,1
PF-Share,1
#RNK(+13%);#AVG(+7%);#CPG(-14%,1
https://t.co/K1eJEjHzDZ,1
The Debate Over Early Intervention,1
Leukemia https://t.co/eqH2wUx4BY,1
Depression,1
Spine Plane,1
Neuralgia,1
Targeting Mitochondrial Apoptosis to Overcome Treatment Resistance,1
https://t.co/iUUBgduFqq,1
https://t.co/ecjU2exCft https://t.co/VzGPKfpZji,1
Saudi Arabia,1
Hematology Congress,1
https://t.co/fAfRUKAEJv,1
Watch Lynn,1
Bruce G. Raphael MD,1
https://t.co/sbEvshS8YF,1
@WorldBookDayUk,1
#COVID_19 #,1
Lamana &,1
Koffman @CllSociety @LumereHQ,1
PEs7TuMEBK,1
Join Drs Adrian Wiestner,1
Chris Pleyer,1
April 18,1
#scout #ftr1200 #,1
Motor,1
https://t.co/PtRtJVIxKL,1
about #WorldBookDay2020,1
Elmer,1
#WeLoveReading #ListeningAndAttention,1
@invitrogen,1
Ron J. Keller,1
Concise,1
SIU Press,1
#SIUDAY,1
#SIU #,1
AbrahamLincoln,1
Twitterstorians,1
The University of Texas @MDAndersonNews Houston,1
#leusm https://t.co/gX4wVzckYX,1
March 5th - Ask,1
#leukemia #patientpower https://t.co/lU1JM6paCA,1
ŸÖÿ≥ÿßÿ° ÿßŸÑÿÆŸäÿ± Ÿäÿß,1
64 year old,1
"64,000",1
mm¬≥,1
nearly 40 million,1
Mary,1
https://t.co/MGqKBHGbkr,1
https://t.co/zztrdw39S2 https://t.co/QkLFGXQc72,1
https://t.co/HBXo8zu6HK,1
Rebecka Svanberg,1
Carsten Niemann‚Äôs,1
Hemati M,1
Rasouli Nejad Z,1
Shokri MR,1
Ghahremanfard F,1
Mir Mohammadkhani M,1
Kokhaei,1
Autophagy Regulation,1
https://t.co/ZEsrszvoyL ‚Ä¢1.0 hr ACPE,1
@Haematologica about #DNAmethylation,1
12 #CLL,1
https://t.co/hc9mLZnb22,1
@dukemedicine https://t.co/ZjFgbuecnM,1
the Brighton Burn,1
#CLL).#drugdiscovery.https://t.co/ktPte3xPa0,1
CLLSpecialist,1
about #COVID19ireland,1
#WhatsYourUseCase,1
Patients Treated With Venetoclax,1
Determination of Blood Tumor Cells,1
Fortune Business Insights Come,1
Supply Chain Analysis,1
https://t.co/349FxBdoii,1
Hypertrophic Cardiomyopathy,1
scoutbobber,1
Patients Treated With Venetoclax - Cancer,1
DOCK10,1
Gareth Auckland,1
MKmarathon,1
JustGiving,1
https://t.co/Bx3sg8ZvCp,1
baseballalldayeveryday,1
Claremont American Little League https://t.co/XWA7DzrhCp,1
1925,1
#cll @CllSociety @huntsmancancer,1
https://t.co/drtUq4AnVp,1
HDAC3,1
https://t.co/2BtP0nzu5f https://t.co/anUIVhuWUf,1
https://t.co/Fl9sKDLQ9A https://t.co/zyEv0EPXZA,1
Starwars,1
"https://t.co/aTxcSSnsSz

#Leukemia #",1
CancerDiagnosis,1
RT EuropeanCancer,1
Doug Olson,1
BTK-,1
2020-2025,1
Clinico-Biological Implications of Modified Levels of Cytokines,1
#coronavirus #,1
COVID19 &,1
#free_software_community #tunisia #,1
JLL https://t.co/rXYoc19AEF,1
https://t.co/2cSsWnBPmF https://t.co/ixFJCOKcuC,1
SHOUTOUT #CancerSurvivors,1
SEX + CANCER,1
Feel Safe Asking,1
@PATIENT POWER SEGMENT,1
#DiffuseLargeBcell #,1
Bone Marrow Stromal Cells Drive Key Hallmarks,1
ISHBT ERIC,1
"Chandigarh
@IJMPOofficial #",1
https://t.co/CWTBD6xy8A,1
BCL-2 Inhibitors Reach New Milestones,1
https://t.co/zsS1wXq6i2,1
ENCLEXTA,1
"https://t.co/lcf3gjNn3F
#",1
Obinutuzumab Versus Fludarabine,1
@nyulangone,1
#stateofscience tonight,1
https://t.co/Hd5YskMEwL https://t.co/nHGdGvTz9y,1
"@Haematologica
https://t.co/b4NrHGO2Zk https://t.co/tNupsUFSHL",1
https://t.co/utc6Xq17IT,1
Leukemia and Lymphoma,1
Pharmacy Times,1
The Globe - https://t.co/G3TO5Gt796,1
Observational Study Relapsed or,1
Regimens Outside Clinical Trials,1
the Lake District,1
https://t.co/Fzt3tyvaj4,1
https://t.co/BiIhiTd9Ib #,1
The Very Hungry Caterpillar,1
UTW,1
#ASICSLDN10K,1
https://t.co/jKPq9yG1DI,1
DISCO Application for the Improvement of Financial Outcomes,1
BCR-ABL1 Positive,1
Plasma Cell,1
@tobyeyre82 @anthonymatomd &,1
"@Haematologica 
https://t.co/J7FgOGnEFP",1
Sept 2021,1
Combination With Zanubrutinib,1
Tislelizumab https://t.co/kQm1KEwLOY,1
HLA-Compatible Patients With Hematologic Malignancies,1
East Bourne,1
the early 1800,1
https://t.co/ozbcXqeKhf,1
lymsm https://t.co/WZYxJfpf48,1
one #CLL,1
"BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents",1
https://t.co/X5h03LDVYn https://t.co/EidEKqdrC0,1
Miami Leukemia Symposium,1
https://t.co/06y3Y7CAt7,1
Complications,1
RNA Lnc-IRF2-3,1
Generation and Validation,1
Canine,1
Diagnostic and Future Therapeutic Purposes,1
Rahmen,1
Krebsaktionstag,1
Betroffene,1
Angeh√∂rige,1
Menschen mit #,1
#wrestler #suplex #,1
https://t.co/LlajuHY1cJ,1
The Important Role of STAT3 in Chronic Lymphocytic Leukaemia Biology,1
https://t.co/3wyScHhpe5 https://t.co/Y6D8oyAY7M,1
Shanghai,1
later this year,1
#aml #mm #,1
Globe,1
https://t.co/75ZyXFkKN3,1
üòÉ | &amp,1
BSH2020,1
https://t.co/cWxuR1EcRz,1
lymsm‚û°,1
SMUDGE CELLS,1
f√ºr meinen,1
dem Motto,1
Zielgerichtet,1
Wirksam,1
Neue Kombinationen,1
https://t.co/pOLrgjuiAA @davidhenrymd @anthonymatomd https://t.co/9EV1haUWnm,1
Potential Milestone,1
#ÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ Ôºà,1
#CLLÔºâÊÇ£ËÄÖ„Å´ÂØæ„Åô„Çã,1
„Å®„ÅÆ‰ΩµÁî®ÁôÇÊ≥ï„Å®„Åó„Å¶„ÄÅ#„Éô„Éç„Éà„ÇØ„É©„ÇØ„Çπ,1
ABNORMAL,1
2.Follicular,1
3.S√©zary,1
6.Hairy,1
Pushing Through Cancer,1
Obinutuzuma/Ibrutinib https://t.co/P2xxtWIaIw Here,1
CNV,1
"https://t.co/BWhUyeixHz

#",1
https://t.co/gM3znmvIoT,1
FREE WEBINAR,1
433,1
Data and Health-Related Quality of Life,1
154,1
Relapsed or Refractory Disease,1
Blooducation üî¨ü©∏,1
https://t.co/iF0f3hgIL3,1
#Raman,1
C. Gobinet et al,1
@Tribvn_HC,1
https://t.co/L8CkLLThVi,1
Jennifer Specht,1
Los Angeles County,1
#cmll#AAA #,1
https://t.co/O7XHpF0jgw,1
≈Ωiva,1
https://t.co/7IAZR25b6M @TNOncology https://t.co/3djmIFIVR2,1
Checkout,1
Grateful to Patient Power,1
Town Hall Meeting,1
Cancer https://t.co/2eeie7Nkgs,1
Ofatumumab May Prolong Survival,1
https://t.co/iI8fjU863,1
28 Years,1
„Äç,1
#ÔºëÊó•ÔºïÂàÜ„ÅÆÂÖçÁñ´Â≠¶,1
#pharmamar #,1
HighRisk,1
#leukemia #patientpower https://t.co/pq7GsXyILA,1
https://t.co/0g54zuk079,1
Annu Rev,1
the Differential Diagnosis of Chronic,1
https://t.co/GUMV81lyMy,1
#MedCram,1
AAASmtg @aaas,1
Noon,1
20.00,1
#carolenash #,1
challenger‚Ä¶ https://t.co/j3HLYOfPSH,1
IL-17 Signaling,1
Time-Limited Treatments,1
MCN,1
FTR,1
1200,1
the Carole Nash Motorcycle,1
Lurbinectedin,1
https://t.co/Kt6S73iap7,1
Fulminant Acanthamoeba,1
Ibrutinib-Treated Patient,1
https://t.co/0nAyUzBoky,1
NCRI CLL210,1
Good News - https://t.co/t4b4dYoENl,1
13.8 months,1
#GHH #,1
#AV #,1
#SMSN #,1
OncoAlert Achieving,1
Post-Transplantation Cyclophosphamide,1
Javier Bola√±os,1
hemat√≥logo mexicano,1
https://t.co/leDKG1YBeY,1
ValentinesDay,1
https://t.co/kXopYpELww,1
@pfizer,1
linfoc√≠tica cr√≥nica üß¨en Pa√≠ses,1
Bajos,1
el √≠ndice de supervivenciaüòå,1
incrementado notablemente,1
#SWG #,1
https://t.co/aZ2VVxFdFS,1
https://t.co/HTJ46MScNL,1
#NonHodgkinLymphoma and,1
https://t.co/4G2QECHUyt,1
TMG,1
PTEC,1
KAZ,1
+4.6%,1
Early last week,1
IGLV3-21*01,1
Paula Soler,1
Martin,1
#3DGenome #,1
https://t.co/DP32O8k6LL,1
https://t.co/QlLjksijce,1
Rachel Thilssen,1
lornecancer2020 https://t.co/yBvCmd2e1r,1
PROUD,1
FlappyCrypto,1
#Ripple #,1
#Litecoin #,1
#BNB #,1
#monero #,1
#HEOR,1
#oncolytics,1
Pulse,1
scoutbobber‚Ä¶,1
https://t.co/IWIdCJJmvm,1
DIAGNOSTIC PANEL,1
CLL/HCL/SLL,1
8527233535,1
Paramount Spectrum Market,1
Crossings Republik,1
Ghaziabad,1
#dr_lal_path #,1
#crossings,1
#republik #,1
https://t.co/T6TDa2eEX8,1
Drs Woyach,1
WomeninScience,1
MDAnderson Novel Cell,1
Immunotherapy Produces #Results,1
James Dean MD,1
Sr Medical,1
"Pharmacyclics, Inc.",1
CLL @Pharmacyclics Pharmacyclics,1
AbbVie Company,1
#CLL @UofGCancerSci,1
#relaps #,1
MicheleNadeemBaker &,1
NicoleLamanna,1
#CLL)https://t.co/,1
ChildhoodCancer &,1
LymSM,1
GAIA/CLL13,1
FCR/BR,1
I+V+O.,1
https://t.co/LwePMJjJnD,1
MYF6,1
CLEAR,1
The Genetic and Molecular Basis for Canine Models of Human Leukemia,1
12 Feb.,1
pbs,1
NOTCH1 delCT,1
29 months ago yesterday,1
$TGTX Announces Completion of Target Enrollment,1
Gavyza + Chlorambucil,1
29 months &gt;26 months,1
Paolo Tambaro &,1
the Ongoing Alliance A041702 Trial,1
Caligaris,1
el #Rojo,1
"0 - 2 #CDMKJ

#",1
#DT #,1
#by,1
#CABLE,1
30cm #CLL #„Ç™„É§„Ç§„Éá #„Éë„ÉÉ„ÉÅ„Ç±„Éº„Éñ„É´,1
30cm CLL,1
Joni Casalis,1
"0 - 1 #CDMKJ

#",1
non-CLL,1
Sheila Hoff,1
#leukemia #patientpower https://t.co/fEVHjZUQTC,1
Lew et al,1
PB + BM,1
Value of BM uMRD,1
Cumplimos el,1
tenemos el,1
#LaBandaSigue #,1
Rochester,1
"obino,",1
#hemonc2020 #,1
Bart van Echteld,1
RGCON2020,1
The @knowyournodes Lymphoma Coalition Global Patient Survey 2020,1
age 18 and +,1
this past November,1
80k‚Ç¨,1
March 1,1
#ESHJGA2020,1
#ESHCML2020 @Dr_IlaPagani,1
16th Annual Conference,1
28 years,1
the Netherlands https://t.co/HIJMfWBfOg,1
"The 2020 Lymphoma Coalition @knowyournodes
 Global Patient Survey",1
Lymphomas &,1
https://t.co/6WLgXHNFRh,1
Leukemia Patients https://t.co/iIhVv8SJ0u,1
the Chemo-Free Treatment Paradigm,1
13q14.3,1
https://t.co/mW6tIzLKMU #,1
CGH,1
https://t.co/pwvnEp7Ga4,1
ACCC Quality Improvement Workshops Address the Need for Improved Chronic Lymphocytic Leukemia Care https://t.co/xxoAYjo28W,1
BlueCarpet,1
#PatientsMatter #,1
ùêÇùê®ùê¶ùê©ùê•ùêûùê≠ùêû ùêëùêûùê¨ùê©ùê®ùêßùê¨ùêû,1
https://t.co/akv6PyaGsu,1
#ai #ml #,1
TAK-077,1
k3C,1
7.1%,1
6.1%,1
BUR,1
HUR,1
3.1%,1
+4.85%,1
https://t.co/X5h03LDVYn https://t.co/HBtkfWGxZO,1
Serumlevels,1
Version 4.2020,1
NCCN Clinical Practice Guidelines in Oncology,1
PhD @MDAndersonNews,1
#ARK #,1
#HILS #GENL #,1
#FCIT #HOTC #ATST #FGP #,1
TENG,1
"Medication Adherence,",1
Health Care Utilization,1
Dabrafenib,1
K-RAS,1
James Beebe,1
Ralph Williams,1
two weeks later,1
Read Ralph's Story,1
#netde,1
@acmedsci,1
AMSSpringboard,1
#firstgrant #,1
@MHLSQUB,1
Zostavax,1
PBM,1
+2%,1
#MPAC &,1
#SFOR,1
K3C,1
Another good day,1
-7.5%,1
Allesanda Ferrajoli,1
#RNAseq #,1
‚Å¶‚Å¶@dalida_ray‚Å©  https://t.co/9xyuXhqkFE,1
JBH492,1
non-hodgkin's,1
@UTSWNews https://t.co/zme9DtcFQd,1
Learn more https://t.co/Sc2VD3XX39,1
up to 25%,1
10x,1
@CeMM on Ibrutinib,1
https://t.co/6gqMfuFfGs,1
Roundup Options Legal Center of Alabama Encourages Users of,1
the Steinberg Law Group,1
https://t.co/ORIh6smMw0 #,1
#weedkiller,1
#steinberg #law #,1
https://t.co/vFHdmUXxOo,1
#EYFSculturalcapital #,1
#worldcancerday,1
#lyle_dk #livskvalitet #,1
"Reddit

https://t.co/ZgxhsWpicr",1
Breakthroughs,1
https://t.co/YSvgibaSpy,1
CLL Support,1
"February 4, 2020",1
CancerSpecialist,1
#MagenDarmkrebs #,1
"Brustkrebs 
WHOUNOIO https://t.co/RxVJPqFjMZ",1
https://t.co/3XD0WfIdvI,1
#LanguageDevelopment #,1
https://t.co/5WM4FoeKAi https://t.co/5NDa7Ks7pb,1
Scripps Research,1
https://t.co/t86zMhdN3o https://t.co/ulMhIpbt2x,1
https://t.co/UJzcukitIs @MDAndersonNews,1
#patientpower https://t.co/Jogg3y08XO,1
#NCLLSG2020 #,1
https://t.co/1bzYJcYfWP https://t.co/gsIkQ8CV6D,1
Colds,1
CD147,1
https://t.co/0hkaSA4V70 #CLL #leusm #,1
#lymsm #CARTmeeting20 #,1
#gcllsg https://t.co/MQWwgCqBVM,1
https://t.co/S8Zu21ayMp,1
https://t.co/WttWkKETzT,1
ven+obinutuzmab,1
https://t.co/7ENWCldJfs,1
https://t.co/HGtg076GSM,1
YChromosom,1
Teil der Erbinformation,1
Von,1
Mehr Fakten,1
Small Molecules |,1
https://t.co/X5nVtOWNV6,1
Venex_100,1
https://t.co/tsEz9YpbYH,1
https://t.co/9nsT8W0JRk,1
Chemotherapy-Free,1
Fixed-Duration Treatment for Patients,1
Previous Treatment $ABBV,1
HSP70/HSF1,1
meded,1
Kollegerna,1
har producerat denna,1
#√•boakademi #kontinuerligtl√§rande #,1
Leukemia https://t.co/hdO6qxYr6x,1
https://t.co/LyfOmdv9Qi,1
https://t.co/O6PLwEYMBn,1
@CeMM_News,1
https://t.co/kqSt4VTcgV,1
B Cell Malignancies Centre of Excellence,1
SaudiBlood,1
@Medscape #,1
#Urology #,1
ECM https://t.co/KrMYcfZpoE,1
#ASH19 -,1
https://t.co/10LkeIzg9W https://t.co/9StB5YjPHs,1
Receives Positive CHMP Opinion,1
https://t.co/s6Jjfz578u #CLL #leusm #,1
Drittel,1
Zeitpunkt,1
Beobachten #,1
Mehr Infos,1
https://t.co/knQLCCjCfE,1
the Japan Snodgrass Bequest,1
#singlecell #cll,1
#scRNAseq,1
https://t.co/H5pvxTD6OO,1
Michael Taylor,1
https://t.co/ktORuUDqAK,1
https://t.co/NWIMrI5brE,1
M. Hallek - Paris,1
#ESHCLL2020 #,1
https://t.co/aEgYETnB46,1
LDT,1
reg https://t.co/b50aw9LClQ https://t.co/z6bskFjY7K,1
#lawyer #legal #law #,1
Finale Ergebnisse,1
PROLONG-Studie,1
Elena Georgieva,1
Bulgarian Lymphoma Association,1
Elena,1
https://t.co/5qUvDvHpik,1
Contact @NIHClinicalCntr Office of Patient Recruitment,1
Feb. 1st,1
Sitges üá™,1
https://t.co/HcBDxWgZBZ,1
Monoclonal Antibodies,1
https://t.co/s97rLuk5a9,1
#scRNAseq #,1
PDQ Cancer Information Summaries https://t.co/AkmgV3yvGR,1
https://t.co/XinCgwTPKi @NatureComms #,1
Blood https://t.co/0oE1hOwqVf,1
bienvenidas las,1
lo bueno,1
tiene el dolor,1
al placer de ganar,1
the last 10 years,1
https://t.co/J6F75Z0lPl #,1
https://t.co/HhERbFTeUi,1
Center for Lifelong Learning,1
@FerrumCollege,1
Delia Heck,1
#phoebeneedlescenterinc #,1
#phoebeneedlescenter #,1
#seniorprograms #,1
https://t.co/6lBRBFawZk https://t.co/Kp2akfHkHg,1
BCL-W,1
Burkitt,1
recent or years ago,1
shape &,1
#CharityTuesday,1
https://t.co/zTnXHseMZl,1
https://t.co/HP76OTRn5u,1
#NoMasShowFamiliar #xnl #,1
450k,1
80‚Äì98%,1
JBH492 Monotherapy,1
Practice-Changing Studies in Treatment-Naive CLL,1
11am-1pm EST,1
Jan 31st,1
https://t.co/3wyScHhpe5 https://t.co/xSVLURcS7X,1
#minidetectives #,1
@UWMedicine #MedscapeEdu https://t.co/DRAIzR3tjX,1
Autoimmune Complications,1
the Era of Targeted Drugs,1
https://t.co/Ah0Mcq0AgE https://t.co/PwrtDKmTgs,1
the early years,1
EEF,1
#todasparami #,1
üåπ,1
https://t.co/OMMIrcOjdS https://t.co/3mMSpFGlLQ,1
Gomes CKP,1
Bobkov,1
Riedl JA,1
Smit MJ,1
Eldering E,1
Levin,1
Genomic and Epigenomic Alterations,1
CRISPR/Cas9-,1
Flowers to Inhibit Proliferation of Acute,1
Adipocyte Differentiation,1
Silico Analysis of Interactions,1
#TheGreatExplorer #,1
2gether,1
#MoreOptionsMoreChances #,1
https://t.co/bckOXmAt1j,1
https://t.co/HcdMzcVjW0,1
Cardiff,1
Janice Rees,1
John Perkins,1
Sarah Draper,1
Royal Gwent Hospital,1
Surveillance,1
Imputation of Gene Expression Data,1
Fourth,1
11q23,1
#B-,1
@Roche @AmecoResearch,1
#legal #,1
#legalhelp #,1
#surgeon #,1
#MLW #,1
"Santiago, Chile",1
"#leusm
 ",1
@LornaWarwick  @LymphomaAction @CLLSupport,1
https://t.co/lN7ZOoS8V9,1
2+ years,1
Afib,1
the U.S. Radon,1
Efficacy and Safety of Duvelisib Following Disease Progression,1
Curcumin Therapy,1
https://t.co/tOCiQeMSEK,1
TERN,1
Everyday,1
a school day,1
#fabmentor #,1
#lovingmyplacement #,1
https://t.co/QawSwLrET3,1
the next 2 years,1
Prof Chris Fegan,1
#bloodcancerawareness #,1
Erweiterung,1
Anwendung,1
Beh√∂rden,1
Kombitherapie,1
Bita Fakhri,1
https://t.co/9FAgxRNKFi,1
Kanduri,1
5mc,1
#epitwitter #,1
https://t.co/mX06zpTgye,1
https://t.co/WGcQ8wNSNY B-cell,1
CancerCure,1
BBC News https://t.co/vPeAep0NWb,1
@KjetilTasken @TheSFPM,1
Rendeiro,1
Christoph Bock‚Äôs,1
Stratification &,1
BHSnursing @cancernurseEU,1
Royal Melbourne Hospital,1
colds &,1
#NWAC #,1
#cascadelittleleague #,1
#indoorbaseball #,1
over 50,1
https://t.co/azG6Q9BqOd,1
https://t.co/qtOFKDhgTL https://t.co/hfOJHzgR2K,1
#NDH #,1
Immunohistochemical Expression,1
Follicular Lymphomas,1
ASH2019 Annual Meeting,1
Indolent Lymphomas,1
1:45,1
#kuASHreview #,1
#HelpTeresaLive Medical Care,1
https://t.co/0VyEJhf5PK,1
https://t.co/g7zFaZ2WT5 #lymsm #,1
mAb sensitizes,1
96-year-old,1
#Bcellmalignancies,1
+2.3%,1
PF-Share +1.6%,1
+2.2%,1
#BLIN;#CLL,1
#UDG(-3%);#WIL(-2%,1
RCH,1
RNWH,1
Peter Napper,1
RUNX3,1
About 22k,1
nearly 1/4,1
that same year,1
the age of 50 years.(Memorial,1
üì∞ Read,1
about #idelalisib,1
#fridayfact #dyk #follicularlymphoma,1
#MedTech #,1
Minimal Residual Disease Assessment,1
Clinical Routine,1
der bei,1
WeltKrebsTag,1
l Nice,1
‚Å¶@ImmunologyUoB‚Å©,1
@ConversationUK,1
@i_ringshausen @SCICambridge,1
@OxfordGeneTech,1
ImmunoOncology Comprehensive,1
https://t.co/Osb23RPQBx,1
https://t.co/9jmaoknDEs,1
BTKÈòªÂÆ≥Ëñ¨,1
https://t.co/q81PzS4OkO,1
https://t.co/3IkCASobk7,1
$TGTX #JPM20 #,1
https://t.co/BXs2OQn7rI,1
Feast,1
#PPIX #,1
#MSYS #AURA #,1
Daratumumab and Ibrutinib for the Treatment of Relapsed or Refractory Chronic,1
https://t.co/WgIYYqphXA,1
https://t.co/dTW1xDQDW7 https://t.co/uJujRkbRMF,1
The Lymphoma Coalition 2020 Global Patient Survey,1
11 March,1
#LymphomaMatters,1
Brexit,1
CLL Signal,1
https://t.co/Dq6vWUqB6K],1
Raphael,1
https://t.co/0VgTff7sOl,1
"Daratumumab and Ibrutinib for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia, DIRECT Study",1
#leukemia #ash2019 #,1
https://t.co/GnfOwz3UiC,1
https://t.co/gPO0ta3Hmo,1
Togo,1
RNA-Seq,1
https://t.co/x5sGhHQhFi,1
@ASCO @SIOGorg @YoungSIOG @siognah,1
FFpaciente @GEPAC,1
steinberg,1
Warthin,1
#ENTPath,1
#HemePath #SurgPath https://t.co/7py5lGDcc7,1
ChadRobbins,1
@AdaptiveBiotech,1
#JPMHC20,1
#JPMorgan2020,1
@UWMedicine #,1
SureSeq CLL +,1
#leukaemia #cnv #,1
https://t.co/MDmMh7DKMz,1
https://t.co/vV0AafHskz,1
https://t.co/drF1Z6p9b1 https://t.co/RVAKuMmIte,1
LiquidBiopsy,1
https://t.co/SJNN3zio37,1
#fuckyoucancer #,1
https://t.co/AoV4K0Aqq6,1
"Jan. 13, 2020",1
Russell Powell,1
The Health Nexus: https://t.co/4hrtW9hWDL,1
Primary,1
Use clonoSEQ√Ç Assay,1
Jan. 13 2020,1
GLOBE NEWSWIRE Adaptive Biotechnologies Corporation,1
"Venetoclax

https://t.co/zBP7Q9bz3Y",1
https://t.co/GgVv4oOUel,1
Adaptive Biotechnologies Receives Expanded Medicare Coverage,1
https://t.co/TT8V8kXXzp,1
2 cents,1
Cardiac,1
Ô∏èLet,1
HFpEF,1
Frontline BTK Inhibitor Selection,1
Philadelphia Lymphoma Rounds,1
‚Å¶@sloan_kettering‚Å©  https://t.co/5OGeRdc0Xg,1
D - Mayo,1
D3,1
PRIMA-1MET cytotoxic effect,1
Ein Fehlen,1
Teils des Chromosom 17,1
Fortschreiten,1
Zellteilung,1
Tumorwachstum,1
https://t.co/dB7wwrnUd2,1
1 yr ago,1
Genentech &,1
#Abbvie‚Äôs,1
12-yr,1
Jamaica,1
#AA First,1
https://t.co/ILBIYATf26,1
Review @CellCellPress Snapshot,1
Adrian Krainer @CSHL,1
#scienceTwitter #medtwitter #,1
https://t.co/kQxRKbFOEn https://t.co/rVISEgz2vv,1
Mayo Clinic Hematologist,1
M.B.B.S.,1
https://t.co/a5ARcglvfN,1
"up to $8,400",1
PAN,1
https://t.co/c1rfrHAqLN https://t.co/udP8E9JVSV,1
Blutzellen aus dem,1
Leuk√§mieformen,1
#gemeinsamgrenzenverschieben #,1
https://t.co/rZkvhODcgC,1
27.3%,1
https://t.co/9RsY1eEKFO,1
Association,1
COMPLEMENT,1
Mech,1
0.28%,1
ISA,1
Cowen,1
ADPT,1
USD 17.1 billion,1
USD 12.3 billion,1
6.8%,1
https://t.co/d4Q61IJfab,1
REVIEW CASES,1
https://t.co/drymzDa3IO,1
#CLL Medicine,1
AlexeyDanilov https://t.co/7vuHirdMOk,1
Reward,1
@idibaps &,1
#PBLT #,1
#BATS #,1
#POLX #,1
PHI,1
#TED #,1
SXX,1
Zanubrutinib Faces Off Against Ibrutinib,1
https://t.co/QyI37Ms7uS,1
Woyach Highlights Progress and Next Steps,1
https://t.co/4RihmW9KmC,1
Cello Health #CLL,1
12y,1
'Board,1
Fwd PE~15x,1
Randomized Study,1
Sortilin,1
Novel Diagnostic,1
every six months,1
https://t.co/YMNG96iHC5,1
https://t.co/kXKhAON00q,1
https://t.co/450rtcfNXo,1
#EXPN #,1
#IBT #,1
#MAJE #IDOX #,1
https://t.co/4koEji25DF https://t.co/SVbZRY9zUU,1
"Trabectedin"" Targets Leukemic Cells and Restores Immune Cell Function in Models of Chronic Lymphocytic Leukemia",1
#health #medicine #,1
#marine,1
Ian W. Flinn @SarahCannonDocs,1
31st January 2020,1
Autoimmune Hemolytic Anemia After Relapse,1
20 weeks ago,1
the next 32 weeks,1
#MNO #,1
#UNG #,1
#SPR #,1
#DEMG #INPP #JSG #,1
https://t.co/zTT7J5BRTW,1
https://t.co/puZPJkP8eA,1
@AtriumHealth,1
March 20-22,1
M. Hallek,1
‚û°Scholarships,1
https://t.co/MSkfN1GOpv https://t.co/qcGyUgydvK,1
https://t.co/270OUPTVT2,1
https://t.co/1XLtAAfEHV,1
al #ASH19 #,1
al #ASH19,1
https://t.co/cvRmKOO95h https://t.co/42osgzQz2a,1
"al
Post",1
"CR

Nice",1
#patientpower https://t.co/meu3NyIRk3,1
https://t.co/aJxqcXTo6J,1
#ASH Review,1
"Feb 13, 2020",1
@LLSNJ @LLSusa,1
@TheLancetHaem International Advisory Board,1
#geriheme #CardioOnc #,1
Peri,1
https://t.co/N7GeSZ8LT8,1
The Year,1
MD @nih_nhlbi,1
William J. Archibald,1
TAM-M2,1
NLRP3,1
IL-1Œ≤,1
https://t.co/KNWMrFYajL,1
https://t.co/CrmeFfla2H,1
#pharmamar,1
#yondelis #,1
trabectedin,1
#leukemia #leukSM #,1
@cancerhealthmag,1
the Alliance A041702 Trial,1
The Ohio State University Comprehensive Cancer Center,1
https://t.co/HmUN344Dof,1
https://t.co/nlzW7cbwrz,1
https://t.co/q0WDyeAPyG,1
New Year 2020,1
#CryptoMedia #,1
Tezos,1
#CLL $CLL,1
https://t.co/pmOTbvSrR5,1
https://t.co/Mn5z4lywpY #CLL #,1
Modulating Cyclin D2,1
NY Lymphoma Rounds,1
2/5/2020,1
NewYear,1
7 25%,1
the CLL Global Research Foundation,1
https://t.co/0xZwUISl9C,1
https://t.co/74MHR8QPxr,1
OncLiveCountsDown2019 https://t.co/wjIFP75VBx,1
https://t.co/tR91x1ZK2Q,1
Godt Nyt√•r,1
#patientn√¶r #,1
https://t.co/fs9dZytbz4,1
Last day of 2019,1
#GVP #,1
"3, 2018",1
Original,1
Q&amp;A. https://t.co/c3llrRaldN,1
Anthony F. Daniyan,1
the Safety and Efficacy of Ibrutinib/Venetoclax,1
OncLiveCountsDown2019,1
"#ESHCLL2020 
",1
#ESHSCHOLARSHIPFUND #,1
üëâ https://t.co/Opi2SP2ZL6,1
"1,000",1
New Year,1
https://t.co/HoKkq84f4p,1
#mabs #,1
https://t.co/kEGHXUn4Zs https://t.co/9boshrLWT8,1
#bloodwise #,1
https://t.co/9rcYPp6zMA,1
https://t.co/d4y6v37HLo,1
The Dietary Inflammatory Index,1
the MCC Spain Study,1
#DMGT,1
#FIVE #,1
#MCT #,1
#BHI,1
#LSRG #,1
#CLL #CAML,1
#BRWM #PRTC #,1
Watch üéû,1
#ASH19 https://t.co/sApCQFsYGM,1
https://t.co/ywLyERNKSF,1
Leading Players,1
https://t.co/pw3BqwVH6h,1
https://t.co/tQmBXxNnsJ,1
Christian,1
Randomized Phase III,1
#„Ç´„É´„ÇØ„Ç®„É≥„Çπ #,1
quickly 9 years,1
Non Hodgkins,1
Garo hills,1
Meghalaya,1
https://t.co/NQuc20YSuW #,1
Treatment https://t.co/yKvMVwmjrm,1
https://t.co/tW5zPsJcAl,1
Teresa Smrecansky,1
Dave Kasanicky,1
Lynnda,1
#patientpower https://t.co/hxiBXciPPK,1
Winter Recess,1
"tomorrow,",1
Dec. 24 through,1
Jan. 1,1
"Thursday, Jan. 2",1
Demetri Kofinas,1
https://t.co/0xUUI1vuIm,1
Angioedema,1
van Oers et al Blood Cancer Journal,1
https://t.co/9J4sJZG0YL https://t.co/Ib7XKoJoTn,1
https://t.co/5SbwlwaD6k https://t.co/xkesytvlJ2,1
https://t.co/XYEeBrFa62 @gofundme,1
https://t.co/TAT1SzDeJE,1
https://t.co/CUnobgUJ3Z #,1
#ash2019 #cll,1
@MDPIOpenAccess - https://t.co/ELjgNr6AkD #,1
GS-5829,1
T Cells for Effective Immunotherapy,1
#„Ç∏„É¨„É≥„Éû,1
&gt;65 w follicular,1
FL) &,1
w idelalisib +,1
clin trials &,1
https://t.co/IGIzEn81vu #hemecsm,1
GVHD https://t.co/VYA9qxHDlB,1
NuView Academy,1
Frosty,1
Snowman,1
tambi√©n estar√© ah√≠ hermanito,1
ü§°,1
#instaclown #CLL #ChileLuchaLibre #,1
https://t.co/xvmtUVD0RF,1
https://t.co/6XjpCah43A,1
Epigenetics and Epigenomics,1
https://t.co/rWuHGib3V3,1
Triangle,1
140p,1
Health Marketing,1
https://t.co/0NQ4AYvTw9,1
#transcription,1
https://t.co/WTvSZUODzM,1
IDEL,1
https://t.co/N6ZMV9n6HR,1
Rigtig Gl√¶delig Jul og,1
Mange,1
LyLe_dk,1
#mds #cml #,1
@cancer_dk @sundpol,1
Advanced Malignancy,1
https://t.co/MSkfN1GOpv,1
"https://t.co/nSTh9kNyzz

#",1
https://t.co/q4SIoiZhIT,1
the Treatment of Relapsed or Refractory Hematologic Malignancies https://t.co/1ArnDEbcw4,1
https://t.co/EVreYHhfR9,1
https://t.co/JGl1wbmjAl,1
5‚Äâyears,1
https://t.co/ZzaWkJmY6R,1
https://t.co/FrUuLCUPNp,1
https://t.co/C5WdG7rcqy,1
1012,1
Tony Pogo,1
#instaclown #,1
#LUCHALIBRECHILENA #ChileLuchaLibre #,1
#autophagy #,1
LeukaemiaResearch,1
Andrew Steele‚Äôs,1
https://t.co/EMnhe7nBto,1
https://t.co/Kz6xC8GMjl,1
MedlinePlus,1
@NASA,1
#GRID #,1
#SIM #,1
detr√°s de mi ventana,1
Ya casi,1
the Center for Lifelong Learning's,1
Winter Concert,1
Winter Dreams,1
Alexia Without Agraphia,1
the Initial Manifestation of Progressive Multifocal Leukoencephalopathy,1
https://t.co/g7bOwZGX92,1
#ad https://t.co/HanAG4pOzS,1
retweet @ CERTHellas,1
CERTHellas,1
https://t.co/ReNAj9SM0i,1
van hacer,1
enanos cuando,1
#chileansWrestler #,1
#likeforlikes #,1
#„Éá„É¨„Çπ„ÉÜ #,1
Catherine Coombs,1
Jonathan Ferland,1
D2 des Faucons,1
https://t.co/vnEw1bhtT9,1
Lynn‚Äôs Story,1
Marsden day,1
Eradat,1
Rituximab Biosimilar,1
the Fixed Duration Trial for Ibrutinib/Venetoclax,1
@GWCancer,1
https://t.co/FmZNNSZ4en,1
via,1
https://t.co/kD5GNYSidw #„Éá„É¨„Çπ„ÉÜ #,1
Recomendamos el material de @villalbafede,1
Kari Vega @kariii_vega,1
campeona,1
m√°xima artillera,1
Myelin,1
estar√°s participando,1
el √∫ltimo,1
#a√±o #,1
https://t.co/4DSKfpcKlY https://t.co/yRz41ae3hR,1
https://t.co/lb76TtM7s1,1
SHIP1,1
adv/ref #CLL,1
https://t.co/qgBpEptb1y,1
rick simpson,1
Alexey,1
@RTIHS,1
2‚Äêdrug,1
https://t.co/rMLDoWxcFu,1
Viability,1
#ASH19 https://t.co/KQ7L8GVHLr https://t.co/rRSioxfqlF,1
TRANSCEND NHL,1
001,1
"MedEd 

Watch",1
only 0‚Äô07%,1
N√°jera MJ,1
Mar√≠n-Gorricho,1
https://t.co/2bIHiceNU5 #CLL #,1
BCL11B,1
cell).,1
#DrManojKumarSharma #,1
Carol&amp;#39;s Story,1
https://t.co/CSbfPV9NDE,1
#RBG #,1
#RECI #,1
https://t.co/dUe3t2maPC,1
#ASH19 - Data,1
James A. Kay @RTIHS,1
CLL @OxfordHaem,1
Otis Chapman,1
February 2003,1
1995 through 2004,1
https://t.co/lHcPTHcTFy,1
Pipa√≥n,1
the Severity of Chronic Lymphocytic Leukemia,1
https://t.co/A8RDUF6ztx #CLL #leusm #,1
"M. Hallek
Submit",1
"40,500",1
hemophilia,1
The Centre for Lifelong Learning,1
#MREI,1
Las,1
Gumarelas,1
consagran campeonas tambi√©n,1
del Clausura,1
La Huerta,1
nuevo t√≠tulo,1
lo ganaron de punta,1
@CLLPY,1
@SpringerOpen,1
https://t.co/89C8cVfsa2 #,1
HongKong,1
#LRD,1
GRK,1
MAF,1
Connections,1
DFW,1
https://t.co/vW6tV2JGQv,1
Pamela Crilley,1
Department of Medical Oncology,1
Communiqu√© Intersyndical National des Organisations Syndicales,1
FSU,1
#FO et,1
SOLIDAIRES de ‚Å¶@pole_emploi‚Å©,1
@OhioState &,1
@nationwidekids,1
COP,1
92.7%,1
86%-96.8%,1
@LRoekerMD,1
"https://t.co/TpjhHayjov
Join us &",1
ImmuneSuppression,1
#ImmuneModulation #,1
Macrophages @MDAndersonNews,1
#TRAIL #,1
#TAMs #,1
Catherine Gutierrez,1
MD/PhD,1
Cathy Wu‚Äôs,1
Wales https://t.co/wEEjv9WE1g,1
#kemofri #,1
#sundpol,1
https://t.co/8c3IjMRpd0 #,1
11 months,1
45.5%,1
https://t.co/bGkZqno51P,1
Amal Saidi,1
Plano,1
Health Monitor,1
#ZOO,1
#SHB #AMER #CLL #,1
#SCIN #,1
#ZOO #,1
#AAS #RHIM #,1
ARK,1
Scrip,1
https://t.co/CHMYZfr53G,1
Reihe LymphomKompetenz KOMPAKT,1
Videoberichten von,1
Kongress,1
#Lymphome #,1
CARTCells,1
Gru√üwort,1
Mrs Foley,1
#CLL üíö,1
#quartet,1
https://t.co/rIG8MDLK7O,1
Marie Benz,1
MURANO Study Confirms Sustained Benefit of Time-Limited Venetoclax-Rituximab,1
#ASH19 https://t.co/heOgMSoXzZ,1
Gonzalo Blanco,1
@gretnhe,1
@TxaviManCat,1
hospitaldelMar,1
2017-2027,1
Monoclonal B-Cell Lymphocytosis,1
lyle_dk,1
https://t.co/5SbwlwaD6k https://t.co/Vci8boOScz,1
https://t.co/KZLjZKxUoa,1
https://t.co/pBau8BWEej https://t.co/s7NUPR4Mca,1
#ASH2019 https://t.co/oubcLzsDmr,1
The Aurora Research Institute,1
Hall,1
Clare Gould,1
4290,1
the Wilson Grant,1
@snowdomeau,1
Blanca Espinet @hospitaldelmar,1
https://t.co/vqHF2cTkOO #CLL #,1
@YNHH,1
https://t.co/zBNjuMHOqW,1
CLL Prognosis,1
https://t.co/MsrcudzG4i,1
@anthonymatomd https://t.co/u1UHP5YIrp,1
CDK2/9,1
deletion 17p,1
https://t.co/22lqUWNEYr,1
48 months,1
Tanja &,1
@IcgsUob @unibirm_MDS,1
9.00,1
https://t.co/hsr7hfZ2Aw,1
#ASH19 Video,1
Jessica Okosun,1
164,1
per International Workshop,1
3:30,1
Johnsons Imbruvica Sales Beat Roches Rituxan,1
https://t.co/b8kepGuXye,1
Johnson‚Äôs Imbruvica Sales Beat Roche‚Äôs Rituxan In Chronic,1
W415,1
Elisa Ten Hacken,1
#singlecell #CLL,1
Sequioa,1
https://t.co/3aJOK5U983 https://t.co/R6p9l0DUL0,1
Stick,1
juliadonaldson https://t.co/kIbkZybRCP,1
lymphopenia&amp;neutropenia,1
humans&amp;dogs,1
#CLLsm https://t.co/xoV2VV7r22,1
Korea Biomedical Review https://t.co/l89EXnRSgw https://t.co/tIIuFLPWM4,1
Venetoclax) Combination in Patients,1
#Venetoclax Triple Combination Phase,1
4716,1
between 6 and 8 PM tonight,1
#ASH19 #creativity #,1
#ASH19 https://t.co/2mak3wOXVF,1
SLL         ,1
The end of day two,1
Seth Karol,1
üîÑ Liza Larrea,1
87.5%,1
#ASH19 https://t.co/C8M1vevUKu,1
BTK Resistance,1
BTK Intolerance,1
Three-quarters,1
#CAPTIVATE #,1
https://t.co/QheFlblzkT,1
Inici√≥,1
üîÑ Griselda Garay,1
#ASH19 https://t.co/HerA2q9zHU,1
CLL=77%,1
2.7mos,1
Dr Anthony Mato,1
Stockmarketnews,1
CLL14 &,1
2.5 yrs f/u),1
Prof Tam,1
#zanubrutinib #CLL #,1
2 - 92%,1
Fib,1
92.7 %,1
Dr C,1
‚ö™‚ö´ https://t.co/Abcyn0FrBp,1
Nairelis Gutierrez,1
Arranc√≥ el,1
rituximab vs fludarabine,1
#CLL &lt;70,1
https://t.co/zGIeVri7K7 https://t.co/jDoPQ6eL8h,1
#leukemia    ,1
Vegas,1
ASHP19,1
üë©üèª‚ÄçüíºRegister,1
"https://t.co/pXlVYCVYUw
üñ•Live",1
ACPE,1
Mechanisms of Response &,1
Resistance to Targeted Agents,1
https://t.co/QYtbmJb0QG,1
Ibru,1
https://t.co/9wHO0LUsys,1
https://t.co/A2c81qIiRw,1
Eichorst,1
Woyach üëå https://t.co/oDvA85xiP8,1
https://t.co/qiJPXj6Xhh,1
@anthonymatomd @tobyeyre82 @DrMiguelPerales,1
Avelumab,1
1558,1
hall,1
WomenInMedicine,1
#ASH2019 https://t.co/oZSxOAJfwc,1
@CyteirInfo,1
https://t.co/ozRmOafZs3,1
A.I.,1
iFCG,1
December 08,1
Hall E1,1
355,1
the Treatment  https://t.co/3rOXEO6Iyo,1
https://t.co/YRKaAnmACl,1
Chemotherapy-Free Treatment Combo Achieves,1
#ASH19 https://t.co/QWDmwXHVE1,1
Cellular Therapies,1
2449,1
12:45pm-1:15pm,1
5:30 pm EST,1
Patient Power‚Äôs Facebook,1
Deyi Zhang,1
1:15 in,1
the Treatment of #CLL,1
@CllSociety @JanRynne https://t.co/5Ya68hFoqs,1
23 months,1
"#MCL 
",1
#ASH2019 https://t.co/JrR573aePC,1
https://t.co/hp8mvka5QN https://t.co/KVWT5UJ73U,1
https://t.co/5PHQ9Y5TrN,1
Kirsten Fisher,1
venetoclax+obinutuzumab,1
high &,1
https://t.co/17QtDPdJ20,1
anti-BTK/BCL-2,1
https://t.co/nPCkmZt5EH,1
https://t.co/fqCGDISbO6,1
#ASH19 https://t.co/khmksAFMcK,1
https://t.co/aOqIi6T38A,1
I+V study,1
IHGV,1
Oncoalert https://t.co/dGLiRFI9pD,1
@LeukemiaMDA https://t.co/BN0YYgG2Hr,1
https://t.co/9HBJFwKCrt,1
mab,1
I+V,1
CD4 w/tx,1
@eaonc @EurekAlert,1
p53 mut,1
Tait Shanafel,1
(45 months,1
"oncoalert 
Older",1
#VictoriesOverCancer &,1
https://t.co/mC5CSGlreW,1
https://t.co/Ff8o4Rath4,1
48 month,1
Dr Lampson,1
the CLL Oral Presentation Session,1
#ASH19 https://t.co/BLtERzO7Zh,1
https://t.co/l1WFFyGbWX,1
8:45 AM ET,1
https://t.co/qlsiRiJPo7,1
#oncoalert https://t.co/fLzHgjJFWT,1
oncoalert,1
oncoalert https://t.co/IKgJZUBmTa,1
Epilepsia,1
https://t.co/n4Ylt30FKQ,1
B. https://t.co/U17NgcItlb,1
https://t.co/pMyf15YPLg #CLL #leusm #,1
1763,1
5:30-7:30 pm ET https://t.co/I10AlvOsyh,1
https://t.co/LGX2eItI8K,1
MedscapeLIVE https://t.co/s7d5QEesOu,1
MedscapeLIVE https://t.co/Yh8ONOHt2,1
pm EST,1
#MedscapeLIVE Presents,1
https://t.co/w9bTUdu1H6,1
Periscope,1
#MedscapeLIVE,1
#ASH19 https://t.co/OqfwuBmgZJ,1
BCJ,1
https://t.co/jEdncd99Pn,1
FOXO3a,1
203,1
https://t.co/oxdpUKNPat,1
Almost 8 years,1
Monoclonal,1
#prowrestler#chileansWrestler #ElMejorBotazoDeChile #,1
pisoton‚Ä¶ https://t.co/Jv7pp20XHT,1
https://t.co/qO1NSSrZ2,1
8 AM,1
First-Line Treatment of IGHV-Mutated CLL,1
Stephens @BloodJournal https://t.co/W1cia5WPdl,1
https://t.co/IiImswbiyh &lt;&lt,1
#CARTtherapy,1
@LevineCancer,1
later this week,1
https://t.co/pAfN1d7I5e,1
https://t.co/aI3tUXjkwv,1
Ibrutnib,1
$KDMN KD025,1
Ibrutinib KD025,1
Lindsey Roeker ‚Å¶@sloan_kettering‚Å©,1
3-1,1
"Liza Larrea ‚öΩ

",1
the National Comprehensive Cancer Network Volume,1
Empez√≥ el segundo,1
Inicia el,1
#SWEF #,1
#OVB #,1
APTO &,1
253 &,1
https://t.co/AYkQkUcpxA,1
https://t.co/JW1Ps4ISVO https://t.co/v7zaUusIJb,1
https://t.co/0LXXqk8M5P #CLL #leusm #,1
https://t.co/OPZ5mEFiv3 #,1
CLive James,1
1977,1
https://t.co/oqovrZ7bkv,1
https://t.co/hYivrDs9AE,1
Mitochondria,1
"46,000x",1
#GivingTuesdayCA #,1
ResearchMatters,1
four-day,1
https://t.co/tc47cJaGYm https://t.co/5fkVA6V3fO,1
#grandrounds #,1
ClinicalEpigenetics,1
https://t.co/0ZpbKId49a,1
ASH LIVE REVIEW,1
AML/#MDS,1
https://t.co/bjnASBa1Ck,1
https://t.co/qWHU0aRFyy,1
https://t.co/7AiebQxWpE,1
1/7,1
MedThread,1
https://t.co/5sl3cAA9k6,1
@LymphomaCanada  #CLL #,1
Dec. 10th,1
David - RIP,1
#massspecpub #,1
https://t.co/1km6ZGM1P8,1
"al
Longer",1
45m,1
"Trial

https://t.co/cKmLZpEXX3",1
the CLL Society on Giving,1
https://t.co/8d3MZLx1UJ https://t.co/lr0GlRoc8H,1
https://t.co/2IBJOL1b3r,1
üîÑ Neily Carrasquel,1
üîÑ √Ångeles Portillo,1
Fabiola Sandoval ‚öΩ,1
Arranc√≥ el segundo,1
#ASH19 @BloodJournal,1
BionanoGenomics,1
#WholeGenomeImaging #,1
INICI√ì,1
Nicolas Martinez-Calle,1
Unmutated IGHV &,1
KLHL6,1
Coexistence of Myeloid,1
Lymphoid Neoplasms,1
https://t.co/MT7s5RoNMa,1
https://t.co/SF7cFgaWrc,1
https://t.co/TFMSgi0vPY,1
üö®New Exchange,1
Pairs,1
CLL Treated With Bruton's,1
Tyrosine Kinase Inhibitor,1
S4,1
@TheKyleRees,1
@Velindre Cancer Centre,1
Outlander,1
Bone,1
Johnson https://t.co/0GdjO0IQYI https://t.co/Pw6r9EUexi,1
Renee Beekman,1
#AdvCompBio #,1
Keine M√∂glichkeit,1
K√ºrze,1
News zu Lymphomen,1
https://t.co/TsaCravWrZ,1
Irene Lopez,1
@FMugianesi https://t.co/LHZP57S1WP,1
@UniofOxford : https://t.co/ZWhhb3pYvU,1
#familia #,1
üá± @ Rootstock &,1
Vine https://t.co/69oZGiIz78,1
BuFlu,1
Paraguay,1
Review Article: Treatment,1
https://t.co/8Roh4JmBK8,1
A few years,1
@CllSociety @NYLCandCLL,1
CliveJames,1
#RIP #,1
#lmsm https://t.co/qtue5X1eiQ,1
International Program,1
#Treatment of,1
https://t.co/ns0sSqIn7,1
https://t.co/A6Ca3ER3Aq,1
#LymphomaResearch #,1
https://t.co/CreyKQlIrB,1
https://t.co/FHjiQ59xVf,1
4-0|,1
‚ö™‚ö´ https://t.co/WjKkML7PLk,1
#leukemia https://t.co/70N1RL1OL8 #,1
Jay,1
Few weeks,1
https://t.co/DZPMbAc3Uw,1
HealthResearch,1
isoform 3,1
Pn4CL3,1
CoA,1
"3,4",1
BCL-2 Inhibitors,1
Present and Future,1
Phosphatidylinositol 3 Kinase Œ¥ Inhibitors: Present and Future,1
https://t.co/HZnseYjzIh,1
https://t.co/VpZJ2z97LV,1
#lumilab #,1
About 10%,1
Pie Day,1
Thanksgiving Day,1
our first #Advertising,1
#CLL #CryptoLiveLeakToken $,1
Reward Users,1
Advertising Campaigns,1
"853,651",1
"Views
Clicks",1
"5,264",1
CTR,1
0.62%,1
"1,054",1
Ublituximab &amp,1
#leusm https://t.co/OB5oFwU76b,1
https://t.co/JpZSxXLjGV,1
https://t.co/dWeogwiuSq,1
1g,1
Second Malignancy Risk Higher,1
https://t.co/h7c5WYAfUM https://t.co/xqFj5Jj8xX,1
USD $3516,1
Ô∏è https://t.co/ovBOkuqEsF,1
AstraZeneca Leverages,1
RTOR &,1
"Dec 8, 2019",1
45-minute,1
"Sunday, December 8",1
https://t.co/rxyYLy1Ncm #,1
Watch Alessandra Ferrajoli,1
lymsm https://t.co/FJ118xf66,1
1-5,1
"1-5

#",1
üîÑ Claudia Romero,1
‚ö™‚ö´ https://t.co/Aphkrr4Alb,1
#FLUKE https://t.co/IQ805xWQhY,1
Sao Paolo,1
#wm https://t.co/8xxt0ZOGxo,1
Chemotherapy Foundation Symposium,1
#WCMDeptOfMed &,1
trastuzumab,1
#ISOPP2019 #,1
Jay Connolly,1
https://t.co/kqvi10EJFJ @andrewschorr #,1
#patientpower https://t.co/RWFxinUuzL,1
Read Betty‚Äôs,1
https://t.co/zvYYEzfahv,1
the Spanish Club,1
el Mensaje Period√≠stico',1
https://t.co/USm9xPHmbh,1
FDA Takes Second Action Under International Collaboration,1
Fatal Legionella pneumophila,1
https://t.co/7AczHMlx6I #CLL #leusm #,1
FDA Approved New Treatment Option for Patients,1
https://t.co/YdUanq2sUF,1
AmericanCancerSociety,1
https://t.co/5SbwlwaD6k https://t.co/nYThJktxSI,1
Ibrutinib and Hypertension,1
Risks,1
https://t.co/VI9nWiuZQ3,1
https://t.co/Cu1sYPiKF5,1
https://t.co/4drrzoRO6l,1
"https://t.co/vyh7yXLojp

#",1
@CACHEORG EYE,1
#CLL #EYtwittertagteam @earlyyearsefc,1
l https://t.co/mUR4y9v36K,1
https://t.co/1yxjd5lN3,1
#patientpower https://t.co/tLpT2PQ5tC,1
https://t.co/OlSVBezXES,1
FREE @RCGP,1
#bloodcancer modules,1
https://t.co/6hcv2uPWUv,1
https://t.co/kqqdbBOWXZ,1
Quality Assurance of Secondary Immunodeficiencies,1
SID,1
CLL/MM Patients,1
PHEDRA,1
https://t.co/UzFdewRC7K #,1
Systematic Synthetic Phonics,1
B1 #EYtwittertagteam #,1
#BiomedChrom #,1
MassSpec,1
¬°Ya se juega el segundo,1
@UCSD #,1
#RCN #ESP #STX #,1
GENIUNE,1
older than 80y,1
#preceptorship #,1
Dr Al-Sawaf,1
"https://t.co/xAtYP5TIvh

#",1
Staying Positive While Living With a Chronic Illness,1
Halfway,1
SLL @,1
üß¨,1
Meu,1
Rap de Blumenau,1
#racioc√≠niohumano #,1
#rapnocruzeiro #,1
https://t.co/GacDBGGeij,1
Zou YX,1
Li XT,1
Miao KR,1
Zhao SS,1
Xu W,1
Intraepidermal Nerve Fiber Density,1
The Metabolic Profiles in Hematological Malignancies,1
HOLISTIC,1
ON - Molica - - Hematological Oncology - Wiley Online Library,1
@FabienneMackay,1
üö® - Trade your Attention,1
https://t.co/Pp1tP3fZq1,1
WordPress,1
(&gt;80y) w #CLL,1
#preceptorship,1
Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant,1
https://t.co/Fp0QvARF4M,1
https://t.co/IxNrZaDO08,1
#imaginations #,1
https://t.co/UVQM3Ur3Xq,1
Janssen-Cilag and Alexion,1
3 year olds,1
Humpties,1
üê∑ https://t.co/tEQt52QS71,1
Chairs,1
jedena≈õcie lat,1
po chemii...,1
nie,1
tu nie,1
ma,1
tu nic nie ma,1
Niechaj,1
ü§£ https://t.co/pG00WAkzaR,1
Rayen Waaaaw,1
google,1
YA SE,1
Dr Concannon,1
Cancrr,1
CCW,1
An Umbrella Review of Meta,1
Raicriteria,1
https://t.co/2uJ07DDYsk,1
Louise Concannon,1
Amjat Hayat,1
#iBTK #,1
Mar√≠a Jos√© Terol,1
https://t.co/fVXNerW4Uh,1
https://t.co/eZx2Q5WqQn #CLL,1
Idelalisib in Combination,1
‚ö™‚ö´ https://t.co/OmD8OFQnuk,1
‚ö™‚ö´ https://t.co/Sib9j7vXqm,1
treatment.#American Journal of Hematology,1
1266-1287,1
‚ö™‚ö´ https://t.co/8aj0F8Ct1J,1
the Center for Lifelong Learning‚Äôs,1
more than $500,1
Friday to last week,1
the Association of Corporate Counsel,1
The Bitter End Rock &,1
Roll Club,1
CLE,1
#FBF #,1
#COWANLIEBOWITZLATMAN #CLE4GOOD #,1
1691-1696,1
#herbicide,1
#CLLsm #CLL,1
https://t.co/DWDQJfqCeo,1
the Federal Bar Council‚Äôs Intellectual Property Committee,1
the NFL‚Äôs Intellectual Property Counsel,1
#INVESTIGATIONS #,1
#KGH #,1
#BME #,1
#KGP #ESP #,1
Dollar Tree,1
https://t.co/b2WnQwiN2I https://t.co/vhGepCrSij,1
#CSHealthServices #,1
tx &amp,1
Nordic Educational Meeting,1
April 23.-24.2020,1
"Carol Moreno
Adrian Wiestner",1
600k,1
AttentionMining Advertising Platform for Ad,1
https://t.co/LsnXTvC1YB,1
#BRGE #STX #EPG #,1
https://t.co/6i7hghICHM,1
https://t.co/0WvifI5Q1o,1
https://t.co/1eLtiFmfuS https://t.co/8tH6D7o3J8,1
@metamask_io,1
https://t.co/1QbVjoXB6O #CLL #leusm #,1
https://t.co/LdzfMZwJKy,1
Chris Stevick,1
#GroundWarDoc #,1
Monsanto https://t.co/nCA6ct9DBI,1
Hossein Khiabanian,1
$600K,1
https://t.co/5XKOZveKDb,1
https://t.co/RiiDPlNZyg,1
https://t.co/3UW0rNytd9,1
Janssen Announces Health,1
Haematologica https://t.co/zu20DxwI6K,1
Library https://t.co/IsAuHKSpMf,1
"https://t.co/JPLDXTNmA9

#",1
#mm #,1
https://t.co/ugCL3hFhOT,1
Dr Karmali,1
#chicago #,1
‚Å¶@MayoClinic‚Å© #CLLTreatment #,1
ChronicLymphocyticLeukemi  https://t.co/4CdRlYK7d7,1
TPLL,1
@MartinJSDyer,1
30 yr ago,1
#sNDA to #,1
SLL $,1
@PNAS,1
https://t.co/W1CBKqN9wO,1
SOH02019,1
@m_adler7 @MindyHermannRD  &,1
"w 
@nevillesanjana",1
Neville,1
Chimeric Antigen Receptors for Treating B-cell,1
https://t.co/jJ26y7Z9tc,1
EntreChem,1
#QTX #MRCH #EQN #,1
ARR,1
#genetictesting #del11q,1
Supplemental New Drug Application for Ibrutinib,1
Rituximab Combo Submitted,1
https://t.co/OgFIwDABfp,1
https://t.co/kQxRKbFOEn,1
https://t.co/jKQwB4cS1M,1
https://t.co/UNugiCsaNh,1
https://t.co/vOIYJqJ63H,1
Multicenter,1
https://t.co/C9sExrtise,1
https://t.co/FLbKvQ5lZT,1
B-Cell Receptor,1
https://t.co/8kOJJCdfBr,1
All 1st,1
13.5%,1
"Ki67‚â•30%
28%",1
21.4,1
10.6,1
20.6m,1
only 8.3%,1
#ASH19 https://t.co/jBISkiwWbE,1
el ST!,1
‚öΩ Paola Genes,1
Karina Vega x3 y,1
‚ö™‚ö´ https://t.co/zuer2hSymI,1
16 November an afternoon,1
https://t.co/e7roOtN8l5,1
Prolymphocytic Leukemia: Case Report and,1
Therapeutic Forefront,1
https://t.co/5G92KOiL2n #,1
Roeker,1
#ASH19 https://t.co/12tQXSjnXV,1
Genomics England Pilot,1
8-12%,1
CSE,1
"12,22%",1
6√®me,1
"6,95%",1
7√®me,1
#SUD,1
"2,86%",1
8√®me,1
"2,08%",1
"1,66%",1
10√®me,1
6.3mo,1
Richters &,1
1 G5,1
CLLsm https://t.co/ACos6oxCHc,1
Llor√©,1
"llevaron üíï

",1
La Lucha,1
Sobre,1
los de,1
#Wrestling,1
years old,1
#leusm https://t.co/ik3ooVCjiw,1
29%-82%,1
https://t.co/OBUypxZp7b,1
para enfrentarlo juntas,1
‚ö™‚ö´ https://t.co/5Oioa4paKB,1
https://t.co/rmIaElAl0k,1
#CLLsm https://t.co/9kSIfuFnfw,1
Janssen Announces Submission of Supplemental New Drug Application,1
acala-obinutuzimab,1
Lameris,1
2018;132(21):2260-2272,1
https://t.co/jVc3fTmrSx,1
https://t.co/QuNOV5QuCq,1
#BILN,1
#QTX #,1
#BNZL #,1
#TUNG #,1
#AEFS,1
#SUMO #,1
Gastrointestinal Involvement,1
Gemtuzumab,1
Machine Learning of Discriminative Gate Locations,1
Single-Cell,1
MedTweetorial,1
Author,1
#Physiology #,1
#Nephrology #Renal #,1
#pseudohyperkalemia #hyperkalemia #,1
5 miles,1
#SCI #,1
CancerDiet,1
CLL news &,1
Venetoclax Effective Against CLL,1
Court,1
Principal Life Insurance Company,1
Principal,1
the Sunday #,1
RDChat,1
@tarek_turkk,1
PET/Scan,1
only 2,1
326,1
https://t.co/4koEji25DF,1
https://t.co/JngjOKG07s,1
n=44,1
@anthonymatomd Great,1
@LeukemiaMDA Grand Rounds,1
leukEMia https://t.co/sNRuQoCW0Z,1
#publiHUCA Full,1
https://t.co/zwebzqTK4i,1
xenografts,1
#SITC2019 @sitcancer,1
@WICouncil,1
https://t.co/UptDw0H4go,1
#per_cfs,1
@CECAD,1
#ataxiatelangiectasia,1
Robert Weinkove,1
about 5 years,1
Eddie Robinson,1
Cherokee County,1
Cherokee,1
Northside,1
"""Clinical Responce""",1
1.16B,1
Early Evidence of Clinical Response,1
#POG #,1
#SLI #,1
STX,1
#ATY,1
#HYNS,1
BMV,1
#Epilepsy #,1
ImmuneDisorders,1
Chronic Lymphocytic Leukemia',1
#FightFlu #,1
Postgraduate CLL Conference: Kicking,1
@anthonymatomd @HallekMichael https://t.co/e2pvgAqLUD,1
$CELG Phase 2,1
#CSStaffingLLC #,1
Jill Clayburgh,1
age 66,1
Devin Patrick Kelley,1
Sutherland Springs,1
leaflet &,1
#haematology #,1
"over 3,000",1
"another 13,000",1
Forum,1
Henlius,1
Lorenzo-Herrero S,1
Payer √ÅR,1
Gonz√°lez-Rodr√≠guez AP,1
Gonz√°lez-Garc√≠a E,1
P√©rez-Escuredo J,1
Villa-√Ålvarez,1
P450 1A2,1
11/04/2019,1
TGTX @TGTherapeutics,1
A couple of days,1
Postgraduate CLL Conference: Kivking,1
https://t.co/dHTymMh2ru,1
Dr Cohen,1
Health Monitor Magazine,1
Kate,1
#healthmonitornetwork #,1
Hematologists &,1
https://t.co/b6IkGMdYMt,1
https://t.co/Hr5jBaCCRY,1
the CLL Open House,1
Oct. 25,1
the Independence Cafe,1
"n=342
&lt;75",1
"@anthonymatomd 
",1
#lymsm #CLL #,1
Bologna #CLL,1
Nearly 10 years,1
de Marc,1
leuc√©mielympho√Ødechronique,1
https://t.co/tME906RMIg,1
#leusm https://t.co/xBT0vZjRtg,1
UCSC,1
Davide Rossi‚Äòs,1
Cure Magazine,1
Neily Carrasquel,1
"@Paschald 
Please",1
@walls2 @IrishCancerSoc,1
https://t.co/BzCwuhdrQB,1
just months,1
https://t.co/66S4SC2oke #,1
Hazel Thomas,1
the past 19 years,1
Read Hazel's,1
#weekend,1
#SaturdayMotivation #,1
#ColoradoMountains #,1
Wayne Campbell,1
@EFPIA @IISLaFe @TPHLaFe @abbvie,1
Gene,1
Epstein-Barr Virus Associated Chronic Lymphocytic Leukemia,1
Invasive Genitourinary #Aspergillosis,1
https://t.co/AwK6Aw9aFx,1
"Phase I, II",1
Patienter,1
#rettigheder,1
#all #cml,1
#sociale #,1
#kr√¶ftomr√•det #,1
#rehabilitering,1
#stem #,1
ERIC https://t.co/jMTfOpthFi,1
Daniel Addison,1
MACE,1
BCellMalignancies,1
#MantleCellLymphoma #CLL #,1
#iwCLL19,1
van rebre la,1
#prostatecancer,1
#coloncancer &,1
OncoAlert Ibrutinib,1
last September,1
Jewish,1
30 percent,1
Ô∏è mom,1
HAT,1
#bidet #sundon'tshine #,1
#celiac,1
#gluten #,1
the International Workshop on CLL,1
https://t.co/r6bCenrk22,1
Renowned,1
https://t.co/j8xncXysmT,1
#CLL @VHIO,1
#ovariancancer &,1
#HIV,1
#TBC #,1
fungal &,1
#multiresistant,1
#bacteria,1
Living Well,1
@HiddenForcesPod,1
CLLsm https://t.co/8X0nDKADsm,1
ibrutinib+venetoclax,1
https://t.co/yngXoVcns5,1
at  #,1
@USDA,1
@MeatVP  ,1
Tratamiento,1
CLL Dra Baltasar,1
Everything‚Äôs,1
NHANES,1
üì¢Trial,1
PB 53%):https://t.co/cOZVNDtcGu,1
Ghia &,1
ESH Translational Research Conference,1
‚û°Register,1
ein h√∂heres,1
Risiko,1
Krebserkrankung,1
Liegt,1
an der Therapie,1
Registerstudienanalyse,1
Aufkl√§rung,1
DGHO19,1
5/20,1
the Leeds Institute of Medical Research,1
St James's,1
#FNCE #CLL,1
https://t.co/3WRWkTerwJ,1
Venn,1
#fan PS #,1
ESH Scientific Committee,1
Breast Cancer Awareness Month,1
our Center for Lifelong Learning,1
all month,1
John Allan's,1
MemberMondays,1
John Terry's,1
Jeff Neurman,1
AZD1208,1
https://t.co/vE87yHvKqb,1
https://t.co/klB2AhNIXk,1
Microsoft,1
Industrial Engineering,1
#jobs #Stellenangebote #,1
SoftwareIng,1
#CloudComputing #,1
#SystemIng #,1
Dietitians,1
dietitians,1
ag,1
@FCPDPG,1
#fcpdpgpastchair #,1
https://t.co/PiecfCObZk,1
FNCE https://t.co/B2IJERSbUC,1
Targeting,1
@INSERM,1
https://t.co/jCpXvcaR2K https://t.co/rnwzuIliDE,1
Besserung K√∂bi Kuhn,1
Komplikationen m√∂glich,1
Linderung,1
F√§llen,1
https://t.co/5y4BMzdVhG,1
6/6,1
"#multiplemyeloma 
",1
#Cll #mantlecelllymphoma,1
my morning,1
Ibrutinib Improved Progression-Free Survival,1
Compared,1
Ibrutinib Monotherapy $,1
sehhseth2019,1
Myloid Leukemia,1
Independent Review Committee,1
https://t.co/cAHmXFrEIi,1
B Cell Persistent Lymphocytic,1
https://t.co/1xa225A4J3,1
Coping With Cancer (@Coping_Cancer,1
#coping #,1
B Cell Widespread Lymphocytic,1
https://t.co/4LBrUTkxjU,1
B Cell Vitality Lymphocytic Le,1
CLL Treatment Moves Toward Combo Approaches,1
https://t.co/XhKIORqObX,1
the end of August,1
Maria Tsagiopoulou,1
Ublituximab in Co https://t.co/poHNBMxmlH,1
Jen Cassels,1
#talent #,1
Video Article,1
JoVE https://t.co/wL7nyw0I4v,1
African,1
Norah Akinola,1
@OfficialOAU,1
Leukemia https://t.co/qAyqyGtAyH,1
JoVEÎèôÏòÅÏÉÅ]Subcellular Fractionation of Primary Chronic,1
#Ïã§Ìóò #jove #,1
https://t.co/Li8lAzMlI6,1
https://t.co/Mga3M5Vumf,1
LymphomaMyeloma2019,1
B.S. of @MDAndersonNews #Leukemia,1
CLL https://t.co/6yL0nS6E6K,1
Offseason,1
Antworten,1
#CoachesLifeLive #,1
AmericanFootballCoaches https://t.co/fJk3smOI2y https://t.co/RoqRRmu4kP,1
https://t.co/Yzl7eFsja1,1
https://t.co/br86lyZsSX,1
#GHE #,1
#FUL #VLG #,1
44.1 months,1
91%,1
67.7 months,1
#CMC #,1
https://t.co/sUTiLu3sr8,1
Martha Garcia‚Äôs,1
DLL4,1
Post-Appeals EQA Summary Report,1
Individual Laboratory Report,1
@leukemiaMDA @MDAndersonNews,1
2 of this week‚Äôs,1
https://t.co/QS1TRHvvOv,1
üîÑ Yanina Lopez,1
LIZ,1
Journal of Clinical Oncology https://t.co/cKoJ3VCVzy,1
Journal of Clinical Oncology https://t.co/gSSHAzplmS,1
The Roundup Options Legal Center of Minnesota Encourages Users of Roundup Diagnosed,1
Busting Bad Thinking Habits,1
Andrea Miller,1
@UCLA,1
nacada19,1
#sdf,1
#louisville #,1
Easterwood Airport https://t.co/DtLze21NBH,1
10/22,1
Town Meeting,1
Treating Patients With Recurrent or Refractory B-Cell,1
Cefiderocol,1
Termina el,1
Griselda Pe√±a,1
90'+3,1
Se adicionan 4,1
80,1
jugadora menos,1
Grecia Vega,1
Kaira Houser,1
Carina,1
#DesdeLasCanchasEc https://t.co/thlNTSB4PR,1
el campo,1
las desatenciones defensivas de su,1
la diferencia,1
el marcador,1
abajo para marcar la tercera,1
#DesdeLasCanchasEc https://t.co/B68OApkYJV,1
la llev√≥,1
‚ö™‚ö´ https://t.co/p2BKRmkS3j,1
Termina el primer tiempo,1
del √°rea y defini√≥,1
Galeano,1
un costado de C√≥rdoba,1
Houser,1
Zambrano,1
Bailey,1
la arquera,1
estuvo atenta para evitar,1
el tanto,1
al √°rea,1
la pelota en su,1
Ang√©lica V√°squez,1
para evitar la ca√≠da de su arco,1
the Center for Lifelong Learning,1
Open House,1
"Friday, Oct. 25",1
12:30 to 2 p.m.,1
RSVP,1
Kathy Woods,1
kwoods@escnj.us,1
"tomorrow, Oct. 18",1
Cardiology Regional Grand,1
@PHRIresearch,1
"@DarrylLeong
#Cardiology",1
Braley Research Institute Auditorium,1
N of Ham Gen Hospital,1
https://t.co/Rzk4hfLXJz,1
1st Line CLL,1
#BCMA #,1
https://t.co/6gJjz6HRQK,1
Joanne Lee,1
Cancer Immunoengineering,1
BMES2019,1
Mayo CLL,1
Recurrent or Refractory B-Cell Lymphoma,1
https://t.co/w1b350mVXZ https://t.co/yDlW2gpc2H,1
CLLsm https://t.co/3XYqqnmYGC,1
https://t.co/PvWM47fRhD,1
June 3,1
WC,1
a recent #,1
#NIH_Heme_Onc_Fellow,1
Emerging Combinations Shift,1
https://t.co/jX622gQqGy,1
https://t.co/LZ6wt4I7QJ,1
#Lymphoma #Research #,1
#UroSoMe,1
28th Feb,1
SALT,1
https://t.co/p8iq6GbNyD,1
trois,1
Recherche https://t.co/hlEgYN144I,1
ceux de la classe virtuelle,1
Gilda,1
Club Quad Cities,1
"Tuesday, October 22nd",1
Cedar Rapids,1
Davenport,1
Facebook Live Broadcast,1
Role of Rituximab Biosimilar in,1
Obinutuzumab + Chlorambucil in Patients With Untreated and Previously Treated Chronic,1
https://t.co/3mjIYEFo8q,1
Cancer Cell,1
Network Meta-Analysis,1
Aus,1
1996-2016,1
prostatecancer &amp,1
#braincancer &,1
Prof Lichtenberg,1
AmericaDeCali,1
‚ö™‚ö´ https://t.co/5Di4BLmyUz,1
FINAL DEL PRIMER,1
Gol de Am√©rica,1
https://t.co/9GxnXlI3Oc,1
Daniel Persky,1
https://t.co/UDDWQDP7AJ https://t.co/y9wjOjWfmR,1
Transcriptional Modulation,1
https://t.co/NKfLdSBx9I,1
#CD40 #,1
IDIAL_NET,1
‚Ç¨1.15M,1
INTERREG,1
ŸÖÿ≠ŸàŸÑ ŸáŸäÿ≥ÿ™Ÿà,1
ÿ®ÿßŸÇŸä,1
ŸßŸ†,1
ÿßŸÑÿ¨ÿ≥ŸÖ,1
ŸÑŸÖÿ≠ÿßÿ±ÿ®Ÿá ÿßŸÑŸÖŸäŸÉÿ±Ÿàÿ®ÿßÿ™,1
ŸÖÿ≥ÿ™ŸÖÿ±,1
MY,1
Watch @CTOAM's,1
#CancerAwareness #KnowledgeIsPower #,1
23.-24,1
April 2020 #Oslo,1
"#NCLLSG2020

",1
#Manchester 28,1
https://t.co/wwD6gjphXS,1
@drkomanduri @VincentRK @mrinal90151372,1
#GlobaLLC @DrMiguelPerales,1
@garciamanero,1
ü§îü§î @abbvie @JanssenCilag,1
https://t.co/gNPaYqeYNN,1
iwCART19 Saar Gill,1
LEUsm https://t.co/Xq4EhkmCLO,1
Just  ,1
https://t.co/q2zOQ2QBFC,1
#blooddisease #,1
#illness #,1
#fighter #,1
#donate #,1
scRNASeq,1
the Annual Meeting,1
the German,1
Jeffrey Menashe,1
https://t.co/DE34KS5TTJ,1
AimHigher,1
#NeverGiveUp #,1
#ideas #,1
#stepitup,1
Las Gumarelas,1
debutan,1
las colombianas,1
del Am√©rica,1
Libradores Femenina,1
10/10/19,1
Fox &,1
#BSL #,1
hairy cell,1
Nebula Library Update,1
Nebula Explore,1
Douglas Daily,1
https://t.co/WvP1KQCFit,1
Haemtologica Review Article,1
https://t.co/C6eXAuIJ4,1
https://t.co/HsJDBWk6by,1
323,1
#sari #,1
#app ka,1
#use,1
#bnd kr,1
#rha hu,1
3 #sal tk,1
#Agr #,1
#mujhese #,1
#mujhe #,1
#Lekin mujhe,1
#time,1
kre,1
Lymphoma https://t.co/21g2CBQ03K,1
Walthamstow,1
about 2 weeks,1
795,1
Padua University,1
Idelalisib¬† Rituximab,1
Ibrutinib¬† Rituximab,1
#IMI #,1
#BRSC #,1
https://t.co/MY1gn1l6xr,1
Marina Mostafizar,1
#Cancers https://t.co/OWJwKDo1L1,1
CHC WEST 2019,1
Acute Leukemia &,1
Auto-Transplant,1
#SAG #,1
#AMYT #CBOX #,1
#UroSoMe https://t.co/jCwpzJbt7G,1
bien apr√®s la fin de leur,1
la m√©moire,1
Il s‚Äôagit davantage,1
11 AM,1
1300 York Ave,1
C-405,1
1st 806,1
4th month,1
Yakult Honsha,1
Victims &,1
$VSTM Verastem Oncology Announces Dosing,1
Prof Andreas Strasser,1
"Yakult Honsha Co., Ltd.",1
https://t.co/7B6pDDA8DC https://t.co/xYCMIvRhux,1
https://t.co/dXD8tSzhg7 https://t.co/CDzpE7Kzl5,1
üîîStandard,1
SOHO,1
https://t.co/y9HZQIWoyc,1
"VSTM
Verastem Oncology Announces Dosing of",1
Hassan,1
Hassan Almuhanna,1
the last years,1
Leukemia #leusm #,1
CLLsm https://t.co/GEnruo2Pj9,1
https://t.co/tiA6iU7tRl,1
@GeneQuan,1
the same day,1
Dominik,1
Ven-Ibru,1
Saturday 16 November,1
an afternoon,1
Norma Jean Murphy,1
M√•rten,1
vid,1
#l√§sningg√∂rskillnad  ,1
#v√§rldensb√§staskola #,1
Neue Studie,1
Strategien,1
Lesen,1
#OfficialNIHR https://t.co/k0gcfhz8si KRAS,1
Sonali M. Smith,1
Estoril,1
Marc Schegerin,1
breakout year,1
ClinicalActivity of ARQ 531,1
MOSAIC,1
#ProteusSyndrome &,1
PROS,1
OBINUTUZUMAB,1
https://t.co/95LSRaLGfe,1
RSP https://t.co/YZFPWiq1V2,1
Adaptive Immune Cells,1
Hien Nguyen,1
‚Å¶@CologneBonnMsso‚Å© https://t.co/ubuYSlHk3i,1
Non-Hodgkins,1
8am to,1
"Saturday, October 5",1
PatientAdvocates,1
6:15pm,1
#GVCC19 #,1
Manchester &,1
later this month,1
Dan Landau's,1
#ESHLYMPHOID2019  ,1
#Lymphoid #,1
LymphomaAwareness https://t.co/1uxxUe8lQC,1
Microscopic Polyangiitis,1
15/06/2017,1
Professional Practice Portfolio,1
L3,1
15/16,1
#morphology #,1
#microscope,1
https://t.co/kOZhK9O291,1
the 1st year,1
Moving Forward But Not On,1
#ptsd #,1
#blogging,1
https://t.co/qwO5FM4R2G,1
DanaFarber @harvardmed,1
Dana-Farber Cancer Institute Harvard Medical School,1
Toby Eyre,1
3 p.m. EST,1
CLL https://t.co/1FGrExzyG7,1
https://t.co/h50hzcD985,1
https://t.co/eX2ZWag0y5,1
Hemato Oncology eBook,1
https://t.co/96xcuQAe8x,1
Watch and Wait https://t.co/paRx0kxZbk,1
Entre R√≠os,1
jugar,1
vez con la,1
nuevo desafio y,1
Luis Luciano,1
Urdinarrain https://t.co/A8u7NnMWYN,1
CC @cure_magazine,1
#GKP #,1
#TCS #AV.A,1
#RIGD #,1
#DLN #,1
#SGRO #,1
Analysis and Precise Outlook ‚Äì Altor BioScience,1
Aptevo Therapeutics,1
ArQule https://t.co/e8Kaa2d76D https://t.co/RtnX2qgAIp,1
@KristianJack &,1
877,1
4614,1
Watch Susie‚Äôs,1
#StemCellTreatment #,1
https://t.co/W0OBRUyVc4,1
Alice Sperling,1
Broad,1
Cancer Program,1
Genetic Perturbation Platform,1
Proteomics Platform,1
Metabolism Program,1
Departing College Station,1
"#iflyeasterwood

@americanair",1
#flylocal,1
#airport #americanairlines #,1
#photography #,1
#texas #,1
https://t.co/ME52pKY4wb,1
https://t.co/KelhLMNLju,1
Lymphoma - Lymphoma Research Foundation,1
Clinical Trials With,1
Kreftforeningens #Vitensenter,1
sudanese,1
Medically Fit CLL,1
Christoph Plass,1
https://t.co/4OaBeY0psq,1
Nancy M. Nix,1
@chooseSJC,1
AdvancedPractitioner,1
NCT02614508,1
10/2019,1
85 to 89,1
#cllsm #patientpower #,1
"al
Undetectable-MRD",1
27.4%,1
62,1
41% vs 13%,1
0.02,1
Trooper Daniel Jenkins,1
Manta Cell Lymphoma,1
https://t.co/zn0g8KZpdW #,1
Au Qu√©bec,1
https://t.co/wr6tb5MTGW,1
‚ö™‚ö´ https://t.co/cPXtsScA1Y,1
‚ö™‚ö´ https://t.co/UJY1mMKeHU,1
https://t.co/XnozOHsTjZ,1
idelalisib w/Toby Eyre,1
https://t.co/LrE3whyinT,1
https://t.co/UsqXimboxi,1
Marcos Gonz√°lez,1
Jefe del Servicio @HematoCAUSA,1
HematoForum2019,1
Jack Eble,1
https://t.co/HLILWprCBo,1
https://t.co/s4o94Htk3G,1
New Research: New Recurrent Structural Aberrations,1
the Genome of Chronic,1
Exome-Sequencing Data,1
#KNM #,1
#SPSY #,1
BHIB,1
Ibrutinib in the relapse,1
Venetoclax - NKOTB,1
#cholesterol #,1
#cholesterol,1
https://t.co/o2A498ufTj,1
Dr Paoli Ghia,1
https://t.co/baVuQ3ID3j,1
#KAP #,1
#NTV #BATS #,1
Francesca Vittoria Sbrana,1
the San Raffaele Scientific Institute,1
Sbrana,1
#CLL Healthcare,1
3D systems w/Francesca,1
Vittoria Sbrana,1
#medcomms #,1
#CLL #Edinburgh #,1
https://t.co/joWvsHYCQz,1
CLLsm Register,1
Oncology/Hematology &,1
"Leukemia
Ibrutinib Cardiotoxicity: Worse Than With Chemo",1
#BigDataForBloodCancer #,1
BloodCancerAwarenessMonth https://t.co/MtarbMnoeQ,1
Dr Lesley-Ann Surton,1
Shenmiao Yang,1
Peking,1
6y,1
0.148 #,1
13.6m,1
HTN+AF,1
"1+RFs
16%",1
pre-Rx pts+40.6m,1
#lymsm https://t.co/nNIOfTaF7M,1
Carly,1
UniversityHospitalCologne,1
@Roche ‚Å¶@HUNIMED‚Å© ‚Å¶@SanRaffaeleMI‚Å©,1
The Importance of Minimal Residual Disease Negativity @AbbVieUS @abbvie,1
Western Canada - https://t.co/LQvjyr2KMO,1
Western¬†,1
Edinburgh 4th,1
Dr Montillo,1
about #Bcell,1
https://t.co/8Ldx3gFNZX,1
Dr Frey,1
MRDforALL,1
Newbie Dr Gerson,1
Nikhil Kamat,1
last May,1
üëâ https://t.co/zjEfmknb5x,1
https://t.co/ZRvU3xfTrQ https://t.co/FC4g5h1Zk8,1
TGTherapeutics Announces Data Presentations,1
https://t.co/si8zcVR3mz,1
the last week,1
#BloodCancerAwareness month &,1
https://t.co/yaGGi4ncKP,1
Oludola Omoyiola,1
Nigeria,1
@CllSociety https://t.co/TI0pL0fTrC,1
Venetoclax A Review in RelapsedRefractory Chronic,1
Venetoclax Venclyxto,1
lymphoma2,1
"https://t.co/LGm8qNoloP

",1
#Urology #UroSoMe https://t.co/Uvjlh8ftJO,1
Laura Carfang's,1
https://t.co/LNbqByepnW  ,1
#internationaux #CLL #,1
https://t.co/K3QMkJge54,1
SpringerLink #CLL,1
Hartmut D√∂hner,1
Rai Binet,1
Brazilians,1
#iwCLL2019 @CarlosChiattone,1
South America,1
Sep,1
Oppenheimer,1
"12:00 pm ET

1st",1
SAE,1
3rd month,1
Therapeutics Announces Data Presentations,1
obi+ven,1
ven+ibrutinib,1
@AnnaSchuh3 #CLL #,1
Venetoclax-#Rituximab,1
#iwCLL2019 @IreneGhobrial,1
@CRGHaem,1
B Cell Power Lymphocytic Leukem,1
https://t.co/oWOXd6nbEf,1
Donna Gairns,1
LYA,1
Maine,1
@JanRynne https://t.co/MUb3erbL7H,1
Matthew,1
#leuksm #,1
Invest,1
eToro Genmab,1
February 1999,1
Florian Sch√∂nharting,1
DARZALEX Genmab,1
#SOHO2019 |,1
Watchüìπ,1
Natasha Malik,1
@POG_LRC @GUcancersci,1
#E1912 FCR,1
#iwCLL2019 https://t.co/bpqPXVfA4Y,1
22 months,1
1.15p,1
an important day,1
#MedscapeLIVE https://t.co/XOy7PLeOCm,1
MedscapeLIVE https://t.co/m87M50xT9z,1
https://t.co/VvGl3ZlRsU,1
here&gt;&gt;https://t.co/wTL7RaRGPc @iwCLL,1
Martina Seiffert,1
@DKFZ Heidelberg,1
#iwCLL2019 - Adam Linley,1
https://t.co/vD1DHIIckk,1
Martin-Subero,1
#epigenetic marks,1
#iwcll2019,1
https://t.co/SD28UV46Ao,1
Blood Cancer Alert,1
Hairy Cell Multiple Myeloma,1
@CaThompsonMD @JoselleCookMD,1
@AMarshallMD,1
@ChrisWeeMD @WeiDing3,1
@SidYadavMD #,1
Limerick,1
1 and 6 #EYtwittertagteam #,1
#communication,1
https://t.co/ivg1VoseWj,1
https://t.co/bFth78QYdP,1
https://t.co/HxdmBXJP1a,1
Verastem Oncology Pronounces,1
the 18th Annual,1
$VSTM Verastem Oncology Announces,1
iwcll2019,1
Worcester,1
September 20-23,1
"VSTM
Verastem Oncology Announces",1
Verastem Inc.,1
NasdaqVSTM Verastem Oncology,1
TAD,1
CLL Navigator,1
#letstalkaboutbloodcancer https://t.co/OqSSMMvWXw,1
#iwcll,1
#letstalkaboutbloodcancer https://t.co/CAoX2xELbH,1
Kharfan-Dabaja,1
#mayoclinic,1
https://t.co/psfbqGmSUd,1
#CLLHZ19 https://t.co/xmpjwy82Zj,1
University of Oxford,1
clinical sciences day,1
Four days,1
Cristina Scielzo,1
Francesca Sbrana,1
Jennifer Wilson @LLSusa,1
the last 5 years,1
https://t.co/6HFXr1hvUe,1
The Roundup Options Help Center of Illinois Encourages Those Diagnosed,1
about three months,1
Ô∏è. https://t.co/zbLhJmZsDU,1
https://t.co/IPOLK45jHt,1
Higher Melanoma Risk:Melanoma,1
https://t.co/IwBR4VlznR https://t.co/h9COZAnphu,1
bravo les,1
FRQ,1
https://t.co/pAlYMDroCL https://t.co/msS8Ttu0mL,1
https://t.co/H5ObDr2m8V. https://t.co/S7uaESDdy1,1
symptoms &amp,1
Precision‚Äôs Investigational New Drug,1
#lymphoma #bloodcancerawarenessmonth #,1
#CLLHZ19 Brian,1
#bloodcancerawarenessmonth https://t.co/e4Q1b5Swe5,1
Social Media,1
#BloodCancerAwarenessMonth &,1
about #CML,1
https://t.co/A0YwTYcDrE https://t.co/jdOsb7RpCR,1
the next few days,1
cllhz19,1
Three days,1
https://t.co/i4JjobbX9C,1
zwei Drittel,1
#IHR,1
#KLR #,1
https://t.co/Kd1uH9D0Ei,1
#CHAR #,1
#MFX #,1
#UU #,1
https://t.co/n5gxpLsuLV,1
Monsanto &,1
Bayer,1
CLL Causes &,1
Symptoms,1
Engagement-Innovation/Field Medical Team,1
MSL,1
Nurse Educator &,1
Customer Engagement,1
VerastemLightsItRed,1
LightItRed,1
Observational Study,1
CLL/SLL Treatment and Ibrutinib Treatment,1
https://t.co/hcvOjISHbv,1
the MDACC Board Review,1
@MDAndersonNews @UCIrvineHealth @UCIrvine,1
Watch üé•,1
https://t.co/OS0KLYGO6r,1
@JanRynne @LornaWarwick,1
https://t.co/HPcAq3QFqO,1
Network Horizons,1
Really important week,1
#CCJI,1
#calendar #,1
our 20s,1
https://t.co/llB5eVExdm,1
Rituximab Versus FCR @UniBarcelona,1
up to 60%,1
https://t.co/GGXYfwEnGh,1
el @DrRaulCordoba,1
charla,1
el mecanismo de acci√≥n y los resultados de eficacia de #Venetoclax,1
https://t.co/Map1I9C34v,1
d‚Äôopportunit√©s nouvelles,1
kurz reinschauen lohnt,1
Novartis Pharmaceuticals Corporation,1
Juliette,1
La CAC,1
Convenci√≥n Anual de la Asociaci√≥n Latinoamericana de Exportadores de Servicios,1
ALES,1
"Per√∫
Segu√≠",1
#ales #peru #,1
https://t.co/MZWfod1rim,1
NC,1
DHHS,1
#livskvalitet #,1
#nonhodgkins #,1
Del budskabet,1
0.75,1
credit &gt;&gt,1
https://t.co/drF1Z6p9b1,1
https://t.co/UDDWQDP7AJ https://t.co/NaHmqF1rP7,1
#CWR #,1
#ATS #,1
This summer,1
@BoweryMission &,1
almost 300 meals,1
October 17th,1
#bowerymission,1
#cowanliebowitz #,1
https://t.co/Wyip4GiOM1,1
@UniCologne &,1
REGISTERüëâhttps://t.co/esCgNdsZ2q,1
#CLLsm #BCAM https://t.co/CGyfCspMLe,1
Veterinary,1
#nurses &amp,1
@rcgp &,1
Simone Edenhofer,1
the Functionality of Healthy and Malignant Lymphocytes https://t.co/LOMs0bsZDT,1
WorldLymphomaDay,1
#WLAD,1
@LymphomaCanada  @LLSCanada,1
dag,1
LyLe - Patientforeningen,1
Lymfekr√¶ft,1
Leuk√¶mi,1
del budskabet,1
https://t.co/8LTY9iw7VI,1
https://t.co/DKHiEau2Ql,1
IgA,1
MD NitinJainMD,1
üëâüèºhttps://t.co/K9TTapzTnx,1
only 22 months old,1
SignLanguage,1
CHC2019,1
Weistner,1
soho2019 @LeukemiaMDA @MDAndersonNews,1
Tanya Siddiqui @MDAndersonNews,1
soho2019 @SocietyofHemOnc @LeukemiaMDA @MDAndersonNews,1
Ferrajoli @LeukemiaMDA @MDAndersonNews,1
Dr Jennifer R. Brown,1
PFS MRD,1
#SOHO2019 @wwierda,1
MoAb,1
#leusm https://t.co/3PcWjK0rWH,1
https://t.co/OMMIrcOjdS https://t.co/MrmkobEzAh,1
Bavaria,1
Lukas Frenzel,1
https://t.co/SI2Frjd9iL,1
"#HUPO2019
",1
#Immunoproteogenomics #,1
#SOHO2019 üìΩ,1
üî¨Video,1
https://t.co/cJdVHPM3jx,1
Bulian,1
J Clinical Oncology,1
Medimix LiveTracker,1
Meeting https://t.co/ZdTEeJSaoV,1
Prof Corradini,1
https://t.co/P05ohWlcBc,1
#NOTCH1 #,1
https://t.co/qwywADpFqn #EHA24 #CLL,1
Chimeric Antigen,1
#postdoc #,1
#treatment &,1
#ElMejorBotazoDeChile #,1
https://t.co/kqCs9yXCgs,1
https://t.co/IQ6jxMlfW3,1
Safety and Efficacy of Rituximab,1
Mazziotta,1
#SOHO19 #,1
Booth #111,1
https://t.co/vVXfmgM4vp,1
OncoAlert Phase 1,1
CLLsm  https://t.co/XhUJFJnJB6,1
"K
#",1
"https://t.co/D6kGpklvWj
#",1
#doctor #,1
#steinberglawgroup,1
#legalcare #,1
Medimix,1
"more than 2,300",1
HCPS,1
Sept 2018-April 2019,1
about three-quarters,1
https://t.co/2SaPXHZPMB,1
@SigridSkanland about #PrecisionMedicine,1
OncoAlert Distinct,1
Oslo University Hospital,1
Houston @Oslounivsykehus @Kreftforeningen,1
The Lymphoma Hub,1
@DunleavyKieron,1
"308,354",1
ŸÖŸÜ ÿµÿ≠ÿ™Ÿä,1
ÿßŸÖŸä ŸÜŸàÿ±,1
https://t.co/Q9hLImfmtO,1
Register free &gt,1
BloodCancerAwarenessMonth https://t.co/ywkSolHDyQ,1
Robert Negrin,1
https://t.co/2ScFbPRYdx,1
Eric Jacobsen,1
autoimmune hemolytic,1
https://t.co/ARoJ3VpSea,1
#CLL14 Trial Outcomes,1
MSSO,1
"clinicians @qehbham
Register",1
"https://t.co/XJYmuuLvsK
#",1
"#hemeonc 

",1
"Czechrepublic
https://t.co/Aki7IBg7Zo",1
Ikaros,1
https://t.co/Hh1QFBGMHm,1
every penny,1
RoundUp,1
https://t.co/1HDE415x4x,1
https://t.co/ECKnj6BFXV,1
Rituximab Superior to #,1
Oncology Newswatch,1
https://t.co/3PI6OLUFg5,1
#medEd #,1
#mrcp #usmle #fcps #,1
#cancernursing #,1
https://t.co/kT2WHLWydd,1
"3-4 ‚öΩ

#",1
3-3,1
"Carmen Ben√≠tez ‚öΩ

",1
‚ö™‚ö´ https://t.co/wXSoEuyyvA,1
‚ö™‚ö´ https://t.co/VxFtR5KDkx,1
Catherine Wu‚Äôs,1
https://t.co/sRWFoSsMAk,1
Alison Moskowitz,1
the Treatment of Hematological,1
Oncology Times,1
@UTSWNews &,1
#ASHMHM19,1
@WeillCornell #MedscapeLIVE https://t.co/toj8LsBxB2,1
#unity #,1
#Chaldean #,1
the Locus Coeruleus,1
#number #,1
The Mount Sinai Hospital Icahn School of Medicine,1
@JanRynne.,1
Myeloma https://t.co/j5seZak7yU,1
Anaplastic Large-Cell Lymphoma Angioimmunoblastic Lymphoma,1
"@FondazioneTLS
https://t.co/ZtMta7ptsY",1
Pharmacy Week,1
Higher Melanoma Risk https://t.co/VUe9K5aYDl,1
September 6 Week,1
Higher Risk,1
https://t.co/6TAQjm0ngY,1
Melanoma Associated,1
#MSL #,1
"üòÉ

Books &gt",1
https://t.co/zEl9xl5Dvn,1
More than half,1
‚û°Ô∏è https://t.co/jwznvGcIzp https://t.co/vQGo6Mo6vw,1
‚û°Ô∏è https://t.co/hcCg62uxoV https://t.co/c9Q3nghYs1,1
https://t.co/TM4oQhQj4J,1
#chroniclymphocytic,1
https://t.co/7e0POkKehi,1
' generation ages,1
‚öΩ 0-1,1
‚Å¶@huntsmancancer‚Å© ‚Å¶@UUtah‚Å©,1
‚ö™‚ö´ https://t.co/kh3IW11ErA,1
https://t.co/bi2jQK8Cxh,1
Sept 28th,1
Arlington,1
SunAWARE https://t.co/34ODGvQwA1,1
SunAWARE https://t.co/5GxG7GS8QN,1
Trondheim,1
Hayslip,1
Chemoimmunotherapy for Chronic Lymphocytic Leukemia https://t.co/bzJMZ3LJ9X,1
#StudyGraphics #,1
#Temadag,1
https://t.co/cMbZ8l4cHw Kom,1
@SIOGorg: 'Management of Chronic Lymphocytic Leukaemia,1
The Binet Staging System,1
eight years ago,1
a Hall of Famer,1
#NVRQT,1
https://t.co/285lfW4PyG,1
ËØ≠Ë®ÄÂÖÉËÆ§Áü•ÔºöÊñáÂ≠óÊòØË°®ËææÊÑèÊÄùÁöÑÁ¨¶Âè∑Á≥ªÁªüÔºå‰∏çÂêåÁöÑËØ≠Ë®ÄÁî®‰∏çÂêåÁöÑÁ¨¶Âè∑Êù•Ë°®Ëææ„ÄÇÊàë‰ª¨ÁöÑÂèåËØ≠Âπ≥Ë°åËØæÁ®ã‰ªéÂ∞èÂ∞±ÂüπÂÖªÂ≠©Â≠ê‰ª¨ÂØπËØ≠Ë®ÄÁöÑÊÑüÁü•„ÄÇÂõõÂ≤ÅÁè≠ÁöÑ@Judy Zhu@,1
Malu VillafaneËÄÅÂ∏àÁî®Èô∂ÂúüÊù•ËÆ©Â≠©Â≠ê‰ª¨ÊääÊñáÂ≠óÁî®Èô∂ÂúüÂÅöÂá∫Êù•„ÄÇ#learnisb,1
#Chinese #English #,1
#family #,1
DOI https://t.co/02SfCST5iv,1
"Approximately 2,000",1
Cytogenetics,1
CLL - Five Years,1
#VoicesOfExperience #,1
#retweet,1
CLL https://t.co/SdlJJZnKcZ,1
Paul M.Barr MD,1
#RESONATE Trial,1
RaiseAwareness,1
https://t.co/4USMatjKIa,1
https://t.co/1qK7aZedHA,1
https://t.co/XyCzcsG3Ds #,1
"6, 2018",1
Leukemia Research https://t.co/WmDfrEKvWU,1
REGISTERüëâhttps://t.co/69CtWjy1Xa,1
#ADT,1
#JOUL #,1
#CLTV,1
KMK,1
CLL Creates Need for Closer Monitoring https://t.co/7IhRgT4j7k,1
11 years ago,1
Approximately every 3 minute,1
mid September,1
https://t.co/RmNiudcBLt,1
https://t.co/GZTgTSDpFY JR,1
Kim HT,1
"Armand P, Cutler C",1
Fisher DC,1
Ho V,1
@ZuckerSoM &,1
REGISTERüëâhttps://t.co/BIeMUVfpW1,1
#iwCLL2019 https://t.co/VAmUbqLz8v,1
the Society of Hematologic Oncology,1
"September 11-14, 2019",1
https://t.co/PeOdjUNJyP,1
Elephants and Tea Magazine,1
#effectsofchemo #,1
#bloodcancer #cancerneverends,1
Plasma B-Cell Maturation Antigen Levels,1
Bcells https://t.co/xTTXCI4daM,1
https://t.co/9bLReLtw2G,1
@JanRynne https://t.co/hnQykTgzMf,1
"Approximately 4,220",1
#myelodysplastic #,1
Hematologic-Related Malignancy-Induced Eosinophilic Dermatosis,1
Read Jay Connolly's,1
https://t.co/MWi6ACxTxO https://t.co/LX3JNyXcOw,1
#medicine https://t.co/bDNH7T7O7m,1
#LymphomaHub,1
the Light the Night walk.,1
https://t.co/GCaBLmg9BJ,1
‚ö™‚ö´ https://t.co/hKLIYulaKC,1
la segunda,1
Entre,1
Healthcare Resource Utilization,1
Front-Line Ibrutinib,1
Fc,1
https://t.co/s6Vh7TheRO,1
September 17th,1
Poundland,1
Baby Shower,1
#curiosity #,1
The Roundup Options Help Center of Texas Encourages Those Diagnosed,1
@RoswellPark #,1
VENETOCLAX,1
#Califolink #Logistics,1
#Office,1
#CLL Solutions,1
#lka #,1
Ibrutinib +,1
@DrAdamBurns,1
https://t.co/iMDpIZxyDU,1
Clin Oncol,1
2018;15:510‚Äì27.2.Hallek M,1
@UQ_News,1
REGISTERüëâhttps://t.co/huIGiBnrKg,1
New #JITC Research:,1
https://t.co/P2w39rHvGH,1
https://t.co/amOgdCk3a5,1
#obinutuzumab plus,1
https://t.co/n9R8E9sajh,1
#PeerReviewed Medicom,1
#Medicom Conference,1
"https://t.co/6CE9FrAnGd

#",1
Robak T,1
Ghia P,1
Published by Global Markets Direct],1
OncoAlert Obinutuzumab,1
#leukemia https://t.co/PV4fAy3YRu,1
https://t.co/Q2STQ0Oodh https://t.co/4zjvVYNZTR,1
https://t.co/9NYwj1Q1FC,1
Mahadevan,1
https://t.co/2DN1FrpZkV,1
Kaposi,1
Series and Review of the Literature https://t.co/j7FORru3PR #,1
lymSM,1
Hypothesis,1
Subset,1
Á¨¨‰∫åÈÉ®‰ºöÔºöÊúüÂæÖ„ÅÆÂäπËÉΩËøΩÂä†„Äë4Ë£ΩÂìÅÔºã6Ë£ΩÂìÅÔºà2019Âπ¥8Êúà23Êó•,1
"„ÇíÂê´„ÇÄÔºâ„Äç„ÇíÂäπËÉΩ„ÉªÂäπÊûú„Å®„Åô„ÇãÊñ∞ÊúâÂäπÊàêÂàÜÂê´ÊúâÂåªËñ¨ÂìÅ„Äç
",1
Sea Sea,1
ùóïùóπùóºùóºùó± ùóñùóÆùóªùó∞ùó≤ùóø ùóîùóπùó≤ùóøùòÅ,1
KnowledgeIsPower  ,1
88-year old-female,1
this Mayo Clinic PathWays Case Study: https://t.co/Ep0EEDkwCN,1
#clinicalchem #,1
https://t.co/qJ4v1vnByT  ,1
https://t.co/0IDTPGJ5S7,1
only 19%,1
146%,1
#ASHMHM19 https://t.co/leD6kgji1K,1
#BGS #,1
#DPLM #CLL #,1
#BYG #INCH #,1
#PSHD #,1
#BAF #,1
#PSN #,1
ITV #LAND #,1
Plasma Cell Dyscrasias,1
Access to Innovation,1
https://t.co/864CCbBb9Z https://t.co/l6nwD904Kc,1
BCell Date,1
04122016,1
The Roundup Options Help Center Encourages Those Diagnosed,1
https://t.co/LPdxSkpJ9M,1
#roundupweedkiller,1
#weedkillers #,1
#weeds #nonhodgkinslymphoma #nhl #,1
#lawsuit #classaction,1
#law #,1
#lawyers,1
#legal #massaction #,1
#trial #,1
https://t.co/t50A38vv7f,1
CLLsm https://t.co/b8oYscbetg https://t.co/vrXmVMjq2U,1
the one year anniversary,1
#leukemiawarrior #,1
SLL - Hematological Oncology,1
#CLL= Committee for Lifelong Learning,1
"Cancer, Party of One",1
#remission,1
#lonely #,1
https://t.co/0K23ThqbBj,1
15-23,1
@bcmhouston,1
Sravanti Teegavarapu,1
https://t.co/ujfKes62kr,1
54,1
24.3%,1
finnCap - https://t.co/DQaVG0inzc - #,1
Library Tours,1
"@warwickuni

#librarytours #",1
https://t.co/hJLinWh63X,1
Komplette Remission,1
Kombination Ibrutinib,1
rituximab https://t.co/HfGgjrQcp7,1
miR-29b,1
Chinese Uygur,1
#CHRONIC #,1
#RAD2018,1
Nabhan,1
75 y old,1
Binet C,1
WT CLL,1
Model https://t.co/a0guvE6MH0,1
https://t.co/cOV6F2JLFr,1
"#non_Hodgkin_lymphoma
#",1
https://t.co/UbovzIFNWF,1
kick cancer's,1
https://t.co/IdzlK9GHGJ,1
a few years,1
Conimab 100ml,1
2 minutes,1
https://t.co/P6x0Bmnv2f,1
5 #CLL,1
https://t.co/v1N7O9s8oD,1
https://t.co/VM1GFmF68R,1
#OncoAlert #leusm #,1
https://t.co/1eMVtNmpYp,1
https://t.co/XSKYS522Dm @BloodJournal,1
@StJudeMedCenter,1
43',1
DE LA PRIMERA,1
Natasha Mart√≠nez,1
ËÄÅ‰∫∫ÂÆ∂‰ΩìÈáç‰∏ãÈôç„ÄÅÂèçË¶ÜÂèëÁÉßÊÅêÊÖ¢ÊÄßÊ∑ãÂ∑¥ÊÄßÁôΩË°ÄÁóÖhttps://t.co/TMjTDw3EDaÊÖ¢ÊÄßÊ∑ãÂ∑¥ÊÄßÁôΩË°ÄÁóÖÔºàChronic,1
OncoAlert Prognostic Score and Cytogenetic Risk Classification,1
lymphocyte count,1
HCT #bmtsm #leusm #,1
https://t.co/oDsUCbY8Hx,1
Cancer Alert,1
"https://t.co/Bax3wRaDlm
Det handler",1
#apl #cmml #,1
‚û°Ô∏è https://t.co/jwznvGujXZ https://t.co/DrFhk9j1NW,1
https://t.co/ng4ZeF5Cmg,1
CME WEB,1
"https://t.co/3b62a1qmkn

#",1
https://t.co/yK0RAActyt,1
#MRCH #,1
Imbruvica Use Expanded,1
Combo Treatments,1
Waldenstr√∂m‚Äôs Macroglobulinemia https://t.co/V2z7rnVmta,1
https://t.co/f9ljkkzmBA,1
https://t.co/nd0udyGIHK,1
https://t.co/5DIQFWnVLl,1
https://t.co/DlZTheKEhd,1
@QuantiumCast Episode 12,1
QRT,1
SOLG,1
WHAT,1
@Wiley_Health,1
last day,1
FMLA,1
#geriheme  ,1
#EQLS #,1
10.5mln,1
AbbVie‚Äôs Venetoclax Up for Review,1
Aug. 23,1
Tecentriq‚Äôs,1
Biosimilars Also on,1
Agenda AbbVie‚Äôs,1
https://t.co/ojy3tXvrCG,1
Legal and Regulatory,1
"üëç
https://t.co/dQU5T8fiE7",1
6.4,1
4.53 pm,1
https://t.co/htpPtVCZoB,1
#GoGreenGo #,1
TeamCanada,1
@FILO,1
https://t.co/54AA3ss2l2,1
#CBOX #,1
#LRE #,1
CLLsm https://t.co/b8oYscbetg https://t.co/SZhc9BlDfG,1
#OncoAlert Recommendations,1
#gerionc #geriheme #CardioOnc #,1
CLLsm  https://t.co/75KhsAKU3r,1
https://t.co/OLzuWW8iPk,1
#SupremeCourt #,1
https://t.co/FLQAyTSllx,1
lymsm https://t.co/6lNwhcexKd,1
https://t.co/xJUCIkiykF,1
Venclyxto) &amp,1
"Mabthera, Rixathon",1
"https://t.co/v9VL2LIBiJ
",1
https://t.co/2XGQN8GS2z,1
CLL.,1
"Tedeschi et al @Haematologica 
Cross",1
Obin-Chloramb,1
"O-Chl
",1
0.184 30,1
85% vs 40%,1
0.072 30,1
89% vs,1
Mutated,1
‚û°Ô∏è https://t.co/jwznvGujXZ https://t.co/n9KJTsXD0b,1
https://t.co/mfOORbl5Bl,1
https://t.co/bYjkRDzmwV https://t.co/pJDYHzdMN7,1
about #ibrutinib / #rituximab,1
#Heme #Oncology #Research #,1
macroglobulinemia,1
Cirmtuzumab Blocks,1
To Repress Autocrine STAT3-Activation In Chronic,1
@UCSD,1
https://t.co/f7yMuicnB7,1
#Patients Previously #Treated,1
Willima Wierda,1
Roger,1
Anne Boev√©,1
Massey,1
#ASCOdailynews #leusm,1
https://t.co/GG3U7XLa4i,1
#pawcircle &,1
https://t.co/repCTH864F,1
Linda Karlsen,1
#forskerlinje @UniOslo_MED @TaskenLab,1
#kosei„Åô„Åø„Åã #,1
#ÂéöÁîü„Åô„Åø„Åã #,1
#feverfew https://t.co/4R1G78HvHc,1
12.11,1
Ridesharing,1
F. Diop,1
https://t.co/mNEv0WukVn,1
Leukemia https://t.co/Cd3y0ICMhZ https://t.co/usg0mvqCGT,1
nights,1
OncoAlert Chemo-immunotherapy,1
#HemaSphere #geriheme #CLLsm #,1
between #inherited #predisposition,1
‚û°Ô∏è https://t.co/jwznvGujXZ,1
#CLleukemia  ,1
Chronic Lymphocy,1
https://t.co/aofJBOEzOx @NatureComms https://t.co/kEBK5nLXe2,1
Chloramax Tablet,1
a week or so,1
"Open
Speak",1
Susahnya,1
tengok keadaan,1
"58,mama",1
C.L.L,1
Semoga Allah,1
mempermudahkan,1
kami,1
Amin,1
https://t.co/dphamSfeTa,1
Tanja,1
"Jo, &amp",1
https://t.co/8YxB26W1BM,1
@idibaps @hospitalclinic,1
"@NatureComms  
Funding @blueprint_eu @bloodwise_uk",1
#AcuteMyeloidLeukemia,1
https://t.co/UMvCyDC1St,1
#OncoAlert #IGF1R,1
OncoAlert Resolving PI3K-Œ¥,1
HLA-B27 Positivity Did Not Influence CLL,1
https://t.co/6QPHeZvb3P,1
Angela Howes,1
Leukemia Development,1
https://t.co/VEFQWo2mkH,1
versus rituximab,1
#EYtwittertagteam,1
the end of July,1
another three months,1
John Kuruvilla,1
https://t.co/WGMSPA3G7e,1
@NEJM: Drug,1
https://t.co/QIWVVwqmH9,1
@NYPHospital/@ColumbiaMed,1
@MDAndersonNews https://t.co/hwj8lRmXgn,1
#Reading #,1
EYMatters,1
"E.Montserrat.#lymsm
https://t.co/C6wUxjhBWJ",1
https://t.co/S8z8qtLFqR,1
https://t.co/S4VMBTZbBC,1
1hr,1
https://t.co/SIBJ5qMxHw,1
Leukemia Tr,1
https://t.co/dsgFffYA3o @stanfordmed,1
https://t.co/WJ97bGww5c https://t.co/2XdBSsiGWE,1
John Sangwon,1
ABIM MOC-Accredited Audio,1
Video Programs,1
the Institutional Review Board,1
https://t.co/s6Rv8wEwzR https://t.co/FjOIrOJumO,1
Apprenez,1
https://t.co/IAUAfBjAa4 https://t.co/RlpVEgvrh4,1
Debbie Appelwick,1
Metastatic,1
Susan LeClair,1
JCOCCI,1
Weymann,1
https://t.co/IPCUiVIS26,1
https://t.co/XJU7sX4kaV,1
this Day,1
The Answer Appears To Be Unequivocally,1
https://t.co/tZaU2XWO8Y,1
Ÿàÿ®ÿØŸàŸÜ ÿßÿ≥ÿ™ÿÆÿØÿßŸÖ,1
ÿßŸÑŸÉŸäŸÖÿßŸàŸä ÿßŸÑŸÖŸÜÿßÿπŸä,1
https://t.co/9RzhJA94x6,1
https://t.co/U4I8NAhYQK,1
"al
Non-canonical",1
2.2 y,1
287,1
UVA,1
BIRC,1
2.8,1
https://t.co/Tj0zCBfZYp,1
https://t.co/XB7Wbdgr3v,1
#bestmedicalnews #dermatolgy #,1
https://t.co/fK0vRDhWpA https://t.co/gaIOnUTAvs,1
"About 24,688 #",1
https://t.co/18gW3Pphsg,1
#ChronicDisease #,1
Predictive Effect of IGHV Mutational Status and Load,1
https://t.co/81zdFkGoQu,1
Patrick Thornton's,1
carecantwait,1
https://t.co/G7MpWJ3Ah2,1
11.13 pm,1
World,1
The Week,1
#AD4 #,1
#VLX #,1
MERC,1
the University of Birmingham,1
https://t.co/phgSG6Ki0j,1
CLL Waldenstrom's,1
https://t.co/0ialtHcP5F #,1
"Josh Winfield
Age",1
Studio 91,1
üèâüèãüèª‚Äç‚ôÇ,1
Previous Clubs,1
TST,1
127,1
"rituximab
https://t.co/vT7AlrvGDY",1
South American,1
MALT,1
https://t.co/3U3MBXAXs1,1
Therapieergebnisse,1
Palo Alto,1
#cll https://t.co/RCTjKFY46o,1
‚Å¶@HallekMichael‚Å© #leusm #,1
CLLsm  https://t.co/wxyEU0dKCl,1
https://t.co/xj0R5quyan,1
#Chemistry #,1
E1912,1
7.4%,1
14-17%,1
Ricardo Dalla-Favera,1
under 70 years,1
"al
Lower %",1
8.3%,1
59.2%,1
89.4%,1
72.9%,1
Unmut,1
90.7%,1
62.5%,1
0.26,1
87.7%,1
88.0%,1
Mut vs Unmut,1
CLL14+E1912,1
Immunochemo,1
Mut CLL,1
The Logistical Process of Using Oral Oncolytics,1
"rituximab
https://t.co/zj0IyNYFsy",1
August 6th,1
Stanford Medical Center Report,1
#clinicaltrials https://t.co/NgAQnfKaLS,1
https://t.co/XIJGiBTyDi,1
https://t.co/QJJrCbnCQw,1
https://t.co/h1WimbstES,1
https://t.co/EPjsIXzQsU,1
Practice Changing,1
Ibrutinib + Rituxan,1
Chemoimmunotherapy in Chronic Lymphocytic Leukemia,1
ICGS @eps_unibham,1
@LES_UniBham,1
@LJMU @SygnatureDiscov @ApconiXLtd @winterbournehg &,1
https://t.co/qLAJQ2d9eb #,1
1)BP,1
3)fixed,1
4)eosinophilic,1
https://t.co/KDd5NAZh8R https://t.co/DmbPUCVg4,1
Campath Injection,1
RSP https://t.co/PWkFrGhqyl,1
OncoAlert Ibrutinib‚ÄìRituximab or Chemoimmunotherapy for Chronic Lymphocytic,1
https://t.co/i7U31bdXlU,1
NEJM https://t.co/Q6kK31ozrR,1
https://t.co/UwKg3RzPoM https://t.co/ip4b61iIU8,1
https://t.co/fKe0DO888F,1
Chemoimmunotherapy for Chronic Lymphocytic Leukemia  https://t.co/NYPUo17Za3,1
Hem/Onc APPE,1
the month,1
https://t.co/p9TZoItYxs,1
@nejm,1
Watch Jennifer Brown,1
"al
Italian",1
https://t.co/fzzaFLrJ9j,1
Rodrigue,1
BJSTRJournal,1
Braggio,1
https://t.co/7ET4p9gSdh https://t.co/3EPe3ng7Wi,1
"https://t.co/axXMD9hjO3
@RichardFurmanMD",1
HematologicMalignancies,1
just 5%,1
177,1
#RadRes #,1
#NeuroRad #,1
"https://t.co/pWGIVAPE3G

@IURadiology",1
COTD,1
https://t.co/WJ97bGww5c https://t.co/L4tVNiPg8C,1
‚Å¶@WEHI_research,1
https://t.co/oNe4jxFDJ9,1
https://t.co/wimxwSSEoc,1
2pm ET,1
https://t.co/W7q00ntT1c,1
Federal Register,1
SGMO ZF,1
#celltherapy relapse,1
#Kymriah #,1
XVIII International Workshop,1
Nicola 2,1
Nicola,1
#HemOnc Times,1
https://t.co/MimIaJPPmf,1
Over 80 #,1
https://t.co/uknwUDpOT2,1
rituximab-pvvr,1
https://t.co/FDuzPEJeZe,1
https://t.co/uA4hC1j0pW,1
#FDBK #,1
#MER #INCH #,1
#SMP #ADIG #,1
ADT,1
BAB,1
John Theurer,1
Hackensack University Medical Center Hackensack University Medical Center @HackensackUMC,1
#TRT #,1
#HGM #,1
Combination Therapy,1
#northwellhealth,1
https://t.co/WfvANCcI6Y https://t.co/iFYrHIqWDE,1
https://t.co/ldxin33fVe https://t.co/H85fGvZjyr,1
y‚Äôa,1
kikroll sourie,1
MDR,1
the SDMS Leadership Advisory Team,1
#lovethisplace #,1
John Kuruvilla MD,1
https://t.co/r8fMr8MLX9,1
@Sanofi,1
CIS,1
the Middle East,1
BeiGene‚Äôs,1
https://t.co/Vh4HmP4pDP,1
Joshua Brody MD,1
@MountSinai Icahn School of Medicine,1
Mount Sinai,1
Mantel Cell Lymphoma,1
Round Up,1
"about $292,000",1
https://t.co/WxEF7gZ0w2,1
Ansatz,1
Unterst√ºtzung,1
stg/Abb,1
Mertens @DKFZ,1
#leukemia #leuk√§mie #,1
https://t.co/cjd9sPRsgd,1
PML Progressive,1
https://t.co/o5MbqudfvY,1
Ziegler CGK,1
Kim J,1
Oyler-Yaniv A,1
Argyropoulos KV,1
van den Brink MRM,1
Palomba ML,1
Altan-Bonnet N,1
Altan-Bonnet G,1
#yourwarwick #cll,1
https://t.co/hoqEBhPGns,1
Pentostatin Cyclophosphamide,1
rituximab biosimilar,1
https://t.co/86RvyhzTNW,1
https://t.co/YFHjn9PP27 https://t.co/ii9WgtyskL,1
https://t.co/nK0jKerldw,1
https://t.co/0p9udHOw2w https://t.co/BWPyVZ6aw1,1
https://t.co/MhEXdAfGEz,1
FDA Alert,1
"Scott

https://t.co/aGRDKpg2uQ",1
STELLARTrial,1
RandomisedTrial,1
#TrialsAccelerationProgramme #,1
TAP @bloodwise_uk @AnnaSchuh3,1
obinutuzumab plus,1
the Key Drivers of Growth and Challenges of the Key Industry Players,1
Rituximab #Biosimilar üëçRuxience,1
https://t.co/ze6ye60yCU,1
https://t.co/YpyUpmOQoV,1
"RT PhysRelations ""Study",1
Pentostatin,1
Acta Haematologica - Karger Publishers,1
https://t.co/442SUd8FDv,1
https://t.co/D7YJNfIFo8,1
#obesity #,1
"July 23, 2019",1
#biosimilar to,1
B-Cell #,1
Non Hodgkin #,1
"Leukemia, &amp",1
SaveLives,1
https://t.co/fJppQ2SnEE,1
Pfizer Announces FDA,1
Rituximab-Pvvr,1
The Treatment Of Adult Patients With Non-Hodgkin's,1
Granulomatosis With Polyangiiti,1
PFE,1
https://t.co/WJ97bGww5c https://t.co/kMxQyExi4P,1
To Evaluate the Safety and Tolerability,1
Optimize Safety,1
Evaluate Clinical Activity of PBCAR20A in Subjects With Relapsed/Refractory,1
Sudan,1
Summer Graduation Ceremony üéì,1
OncoAlert IgA,1
https://t.co/1J41NaJslp,1
MGH,1
20-23 September,1
Global Industry Analysis,1
Global Industry Analysis &,1
https://t.co/HxOyQDZa5g,1
üè°üè™üè•üèò,1
LOCATION,1
Susan Pierce &,1
@NIAIDNews,1
Mohamed Kharfan-Dabaja,1
Sajil Kumar,1
14th,1
Jeg,1
#knoglemarvstransplantation #,1
#all #mds #,1
Duterte,1
the Nation Address,1
Philippine,1
#ibrutinib /,1
#onetribe #CLL https://t.co/MFD49Veeq1,1
https://t.co/Pn8URuR6Mn,1
August 13th,1
#resistance #,1
https://t.co/J56GIul5rE,1
https://t.co/pjS6Y1LAnX,1
KnowyourSubtype,1
91.5,1
JM3,1
#RMLL #,1
ThrowbackThursday,1
@SunderlandFDN,1
$66 million,1
Cambridge Tower A‚Äôs,1
#KUBloodCancer #,1
Preclinical Research Suggests Role,1
Tenemos,1
de la que creemos o coincidencias que,1
acercan,1
Aptose Biosciences Inc.,1
Therapy For Select Chronic Lymphocytic Leukemia¬†Patients https://t.co/ROZy8OTpsQ,1
CTImaging,1
Joanna M. Rhodes,1
Anthony R. Mato @anthonymatomd,1
https://t.co/6LFFKt1EjO,1
chez oim,1
HARDCORE,1
BOKU,1
MMX,1
PHTM,1
KETL &,1
SRT,1
https://t.co/Ie5yG9778H,1
#MMX #,1
CAR-Ters,1
https://t.co/yakrogDFHk,1
https://t.co/WYN39Jzoxo,1
The Untold Story of the Longest Persisting CAR T Cells,1
#CellTherapy #,1
#Venetoclax #Ibrutinib #CLL #,1
FunctionalPrecisionMedicine,1
Silence is Golden,1
j‚Äôai pas,1
bien r√©agis,1
mon c≈ìur,1
Bcells https://t.co/zTJrpt6qfo,1
Cirug√≠a Oral e Implantolog√≠a,1
Urizar Gorosarri,1
Feliz,1
CienciaEnTuSonrisa,1
#CG806 and,1
#APTO253 $,1
APS,1
#leukemia @ClevelandClinic,1
#TeamDavao #,1
"üëà 

Davao....",1
Visayas,1
Mindanao Real Estate Market Research,1
#SantosKnightFrank #,1
TeamDavao,1
RealEstate,1
https://t.co/qaKq3rIv1n,1
Mansour Alfayez,1
‚Å¶@LeukemiaMDA‚Å© #,1
#MRDNegativity,1
"Tuesday, August 6th",1
Krebstherapie  bei chronisch-lymphatischer,1
langfristig wirksam,1
Chemotherapie,1
Patienten am Leben,1
Chemotherapie-Gruppe,1
Gefunden,1
https://t.co/WJ97bGww5c,1
66mg/m2,1
1st #CLL,1
every 12 hours,1
2-3 weeks,1
Q2,1
1st or,1
PK &,1
IDH1,1
nuestro equipo,1
Carmen Meno,1
de Atenci√≥n al Paciente,1
https://t.co/VzW9ucHIRj,1
"In Clinic"" &",1
#C481S,1
DSMB,1
This afternoon,1
George Follows &,1
Dr Rifca LeDieu,1
Eisai https://t.co/MnHZbi34S9,1
coq,1
11/12,1
District Championship,1
Intermediate Provincial Championship and Junior Provincial Championship,1
CC @TriCityNews,1
@UKKoeln @DKFZ,1
Lianne Palmer #,1
@OxfordHaem @OUHospitals,1
day-to-day,1
#LymphomaMasterclass #,1
#LivingwithandbeyondCancer #,1
#PLCG2 mutations,1
Great,1
Dr Quinquenel,1
1228,1
https://t.co/GT2RWvgkbp,1
8wk,1
53%,1
the past 10 yrs,1
the past 50 years,1
up to 80%,1
https://t.co/xUZTJQkRyz #CLL,1
Thermax,1
SriCity,1
Platinum,1
#Cll-,1
Green Building Council,1
Blood Journal https://t.co/hAaKBk93HQ,1
3pm,1
Tuesday 16 July,1
https://t.co/EEgidQdgDf,1
Venetoclax https://t.co/hG1gLV2jJn,1
https://t.co/59Ul8WzqdG,1
Blood Journal Patients,1
"al

Non",1
204 ibrutinib #,1
predicts-&gt;shorter PFS,1
Raises,1
https://t.co/MYpzhHmCrZ,1
üíöThe,1
Ematoinfo,1
Focus,1
"https://t.co/MpNeGlwGzS 

",1
Durante,1
dati,1
Marco Montillo,1
li hanno commentati,1
https://t.co/9gSKOdcRWR #CLL #,1
@DrTonyLetai,1
#FunctionalPrecisionMedicine #,1
Coaster July 22,1
10:00 ‚Äì 11:00 AM PDT,1
2:00 PM EDT,1
CLLsm https://t.co/s5RyHW6JLg,1
Tuesday 8/6,1
2pm ET https://t.co/t3luBgE8rV,1
Global Drug Report,1
Follicular Lymphoma by Country,1
https://t.co/e4qhHiuDIx,1
https://t.co/LtgZGU50Gc https://t.co/MVLla4f9KB,1
KPTI Phase 1 Selinexor and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic,1
Aggressive Non-Hodgkin,1
NCT02968563,1
Dr Riccardo Dalla-Favera,1
#BON #,1
#BBGI #,1
#ANP #CLL #,1
#POLY #,1
#BRBY #,1
DOM,1
Rafic Farah MD,1
https://t.co/3T02iS4rWM,1
https://t.co/5pxiTApAdN,1
https://t.co/WJ97bGww5c https://t.co/4kNMKMAErY,1
https://t.co/EkaLg6jIrs https://t.co/ab7STwOpaB,1
"Regional Overview, Segmentations",1
Josh Brody MD,1
Moon Shots Program,1
Rituzena,1
Tuxella,1
https://t.co/kiZV21UpzD @BloodJournal,1
https://t.co/0ulJHEsXYV,1
üî¨üß¨,1
#EHA19 #,1
Broadway,1
4moretogo,1
Personalized Outcome Prediction,1
https://t.co/hEW9x2X4tO,1
Gordonsville,1
Broadway Community,1
"https://t.co/YOdyPjlUdT
#",1
Saanich,1
Good Luck,1
GameChanger,1
Adrian Wiestner‚Äôs,1
CD19CD20,1
Jaco A. C. van Bruggen,1
al.,1
#SFE #,1
#ARR #APH #,1
#SOM #,1
#MGR #,1
#FridayThoughts #,1
Francesc Bosch @Sidnavigare @Hemato_Vhebron,1
Maximilian Koch,1
Lyn,1
UDP,1
SFE,1
D√©cadas de investigaci√≥n han,1
los cient√≠ficos,1
comprensi√≥n de la enfermedad,1
Independence Day,1
https://t.co/pw0VHvifNa,1
Breitengraden,1
https://t.co/AukE3fwhtk,1
https://t.co/hA9AP9uZfw,1
the Multidisciplinary Acute Lymphocytic,1
Leukemia Care,1
one-two,1
KOs #CLL,1
79,1
Alexandre Hirayama,1
#CLL14 Trial,1
FANC,1
https://t.co/rYXyOiwWUW,1
#instagram #warwickuni #cll,1
#yourwarwick https://t.co/lbE90LdegT,1
Global Industry Report,1
https://t.co/BWSehs32Fx,1
#pharma #medical #,1
#Opportunities #,1
#Babesia microti,1
"https://t.co/vLU972QGEP
#mm #",1
https://t.co/ZAbtahhyJN,1
‡§Ö‡§¨ ‡§á‡§Æ‡•ç‡§Ø‡•Ç‡§®‡•ã‡§•‡•á‡§∞‡•á‡§™‡•Ä,1
ImmunoTherapy,1
https://t.co/VFyUP7Fez4,1
https://t.co/ys403mnjB8,1
Optimizing Therapeutic Approaches,1
#ACSO,1
#SGM #,1
#RPS #,1
#dermatolgy #,1
#spinesurgery #,1
https://t.co/hqXtLjKOV1,1
@Kuwaiti_Dr @HematologyTweet of,1
https://t.co/7T96qoRimA,1
Summer Reading Challenge,1
"https://t.co/SVrUiS9gbt - 40,000+ Visits per day",1
"9,150",1
"18,336",1
Posts,1
"2,307",1
"3,434,335",1
CLL Points Awarded,1
798,1
https://t.co/tkKmLuDRsD,1
#beatingcancer #,1
https://t.co/szNWc6QNOK,1
https://t.co/Nfy80i1FTZ,1
#HemOnc Fellow,1
50 years ago,1
Graduation month,1
#graduation2019 #,1
Scouts,1
Camp Long Lake,1
camaraderie,1
#happy,1
https://t.co/fCPfQTcC5w,1
384,1
"al
mut",1
mut TP53 &amp,1
Marrow Transplant Research,1
Pagel 2 Update,1
https://t.co/C71fUCt594,1
#LetsCureThis https://t.co/7QZykLqNCI,1
QoL C/W,1
https://t.co/O7Ffnj1PF8,1
Speech,1
Language Difficulties,1
#XPS,1
Incompetence By Design,1
https://t.co/6PTOP9LFl8 https://t.co/4QJnmPs6SV,1
‚Å¶@BloodJournal‚Å© #CLL #,1
JMIR - Mobile #,1
P√©rez-Jover,1
Journal of Medical Internet Research #,1
mmsm  ,1
#FCR + #Ibrutinib,1
Michael Reff,1
Kirollos Hanna,1
clonal dynamics &amp,1
Estrogen Receptors,1
Venclexta + Gazyva Reduces Disease Progression,1
Mom https://t.co/IBePCmn4m3,1
#nuggetsofJOY #,1
https://t.co/0yA3a0za6h,1
FILO,1
https://t.co/HG00lXg5Ee,1
https://t.co/IRfe7iM4d0,1
NCLLSG Educational Meeting,1
April 23.-24,1
Care to Cure,1
StimulusReport,1
LymphoidNeoplasia https://t.co/PIcHQxDv2M,1
Gait Speed Predict Outcomes,1
Older Patients With #BloodCancers,1
transfusion &,1
https://t.co/EyrqUdHpyd https://t.co/Spr8e7FjTj,1
https://t.co/pYGkpZDe9U,1
Little League,1
Sean,1
14 years,1
‚öæ,1
#continentallittleleauge,1
#buenaparkamericanlittleleague #,1
Santa Fe,1
https://t.co/Nvy1i5tTMD,1
#nephrology,1
https://t.co/HIjreuYbMC,1
204 #,1
Ô∏èAge,1
ParadigmMedCom https://t.co/cuXPInUSGl,1
https://t.co/InsSqCKj2c,1
https://t.co/ngWWT60B6V,1
University of Cologne,1
Gm Talk,1
#RackoonMix #,1
#RackoonCiTy #,1
#music #hiphop #beats #,1
#trap #,1
#soundcloud #,1
#studio #musicproducer #,1
https://t.co/bCIwidQdvQ,1
#NCI #,1
@CIHR-IRSC,1
Drs Dawe,1
https://t.co/pt07Zuidqv,1
about #FL #MCL &,1
the @lymphomahub Satellite Symposium #,1
@JanRynne @NYLCandCLL @CllSociety @CLLAdvocates,1
@UKKoeln https://t.co/8JwmL4tZiG,1
212Pb]NNV-003,1
SNMMI19,1
Prof Patrick Thornton,1
National Information Day,1
VSTM BIG MOVES AHEAD,1
https://t.co/YmGMMWj4xb,1
The last 50 years,1
@NCODAorg,1
https://t.co/lsuDi1zyYH,1
https://t.co/22Fp0s31MK,1
aus Lugano,1
Videoberichte,1
Das Kompetenznetz,1
Videoberichten,1
#15-,1
HEDGEHOG signalling &amp,1
#LL,1
Michael Hallek:‚Äã Step,1
Vimeo,1
Jan ‚Äò17,1
the last 3 weeks,1
https://t.co/3imXxmB0oX,1
Clinic,1
Home in Patients,1
Digital Health,1
13:50 ‚Äì,1
OurHealth,1
Eric Wallisa,1
Statin,1
https://t.co/BHYKjjZ28V,1
fluvastatin,1
@Research_MB https://t.co/F1TR1Q7qgK,1
Condoluci,1
#ICML2019 #15ICML https://t.co/ODBfNby7s6,1
icml15 https://t.co/ZD1asHDj1c,1
Delgado J. EBMT,1
#15ICML #Lugano,1
The Beginning of the End,1
68yearold,1
Venclexta (Venetoclax,1
Genetic tp53,1
CKT,1
https://t.co/UNphWYDBK3,1
https://t.co/HAfTTtgCVt #,1
#15ICML #CLL https://t.co/wzMmuKQYTi,1
upcoming years,1
BeiGene Announces Phase 1b Clinical Results of Zanubrutinib in Combination with GAZYVA¬Æ,1
15th,1
International Conference on Malignant L,1
1st ed.,1
$TGTX #15ICML #umbralisib @TGTherapeutics,1
#15ICML -,1
Ph II,1
https://t.co/O814Cnn4NK,1
BeiGene Presents Pivotal Phase 2 Clinical Results of Zanubrutinib,1
Lymph https://t.co/lG88vXwQo8,1
Samstag,1
Videobeitr√§gen,1
ZNSL,1
Gru√üwort von @HallekMichael auf https://t.co/CB4e2y8uCf,1
the Dept: Dissection of Subclonal Evolution by Temporal Mutation Profiling,1
@AczelDora555 @nagakos93,1
#Cytogenetics #,1
https://t.co/O8OZtEdVXD #,1
Jose Carreras,1
https://t.co/02Up8ur8Gq,1
https://t.co/v2vga4jOSM https://t.co/8w8Lv3aPnj,1
escuchar esa voz,1
Session 3 ‚Äì CLL,1
14.15,1
Jos Melenhorst's,1
https://t.co/TeCwYLOnvV,1
#15ICML,1
#15ICML https://t.co/9wgDkF83uF,1
https://t.co/DT7tMMyO4I,1
#Master of,1
Bergen,1
#CLL #JADPROce https://t.co/juJkSTOfY2,1
Bayesian,1
the Phase III MURANO Study,1
üá®üá≠ https://t.co/AdZ0zDB9xU,1
NICR,1
#Cancer #Research #,1
first line &,1
Ibrutinib + Obinutuzumab +,1
#cancerlaughs #,1
#Ibrutinib)/ #,1
GenericImbruvica,1
CancerDrugs,1
#LVCG #,1
#MBH #,1
#CAY #CLL #,1
VGAS,1
https://t.co/7pwaj1vGOd,1
10km #,1
membership@cllsupport.org.uk,1
https://t.co/dAKTxDbl0c,1
#ICML15 #,1
"#radonc  

",1
@Haematologica #lymsm,1
CLLsm  https://t.co/CD1Qpjb9Ua,1
https://t.co/eouXqeLO7u,1
CLLsm @NorthwellHealth @BrookhavenLab,1
Veneclexta,1
@SunesisPharma,1
SunesisPharma,1
#myeloma #leusm #,1
@GreysABC,1
@netflix,1
Pleaseeeeee,1
#amandavscancer @amandavscancer,1
EFS &,1
#leusm https://t.co/g1L1jRiIjo,1
InvestigatorProfile,1
Jennifer #Woyach,1
Nationally-Recognized #Expert,1
#ChronicLymphocytic #,1
Clinical Trials https://t.co/SttJTPsckL,1
#recognized #,1
6/19,1
clinicaldata &amp,1
REGISTERüëâhttps://t.co/8OBkOHexjP,1
JuLƒÅ Creole Cuisine,1
Peter Jaret,1
https://t.co/hzQ475zQin,1
#TRG,1
#EHG #,1
SHED,1
Presse Detail Die,1
KML Videoberichte,1
Darin,1
MultiplesMyelom,1
iNHL,1
aNHL,1
ein Gru√üwort von @HallekMichael,1
Michael Hallek wurde,1
Jos√© Carreras Award,1
Arbeit,1
Bereich,1
Gute News,1
Forschung k√∂nnen,1
Behandlungsmethoden,1
Herzlichen Gl√ºckwunsch,1
https://t.co/MPVuh61Yum,1
BPI,1
https://t.co/TZjDxlLGKI,1
San Francisco,1
#EHA24 @VJHemOnc,1
Ulrich Yager,1
https://t.co/ruAkrVNgOw,1
Six years ago next month,1
https://t.co/Jh0aMGtkjs,1
Ofatumumab - Notable,1
FCR - Study Design,1
7 highlights,1
A. Kater,1
#eha24 #,1
F1,1
https://t.co/SuM7R6ScYD,1
https://t.co/YvYYoflvFb,1
AES,1
fib &,1
Las mejores,1
Noelia Barros,1
FathersDay,1
September 2018,1
https://t.co/ilcvzHIuN9,1
#cll Abbvie,1
"Sept. 20-23, 2019",1
R-Venetoclax,1
3-48,1
#EHA24 https://t.co/oeQh3Yxl4l,1
Francesca Mauro,1
Miguel Quijada-√Ålamo,1
Saskia Rudat,1
https://t.co/KOy3P8vGWp,1
https://t.co/fbrOAoGbhZ,1
CHARLIEBLACKMON,1
Topps Cactus League Legends,1
Insert,1
Rockies,1
‚öæÔ∏è,1
#NORESERVE #,1
CardCollecting https://t.co/krX2FffEjF,1
@eBay,1
#EHA24 https://t.co/Oh5jiiBPgs,1
https://t.co/dIn6DCM46d,1
the next hour,1
this decade,1
#NTFM #,1
SFI,1
FIRE,1
https://t.co/MVaxoeXTbg,1
#C481S &,1
CMLologist,1
more about #CLL,1
https://t.co/FQ5mgT4kZz,1
Houlston,1
"https://t.co/AeQXjvk2V1
Please",1
EPA,1
Sequencing #Monotherapy,1
Northwell Health #,1
Success of Venetoclax,1
Obinutuzumab Use,1
#EHA2019 Amsterdam,1
https://t.co/HQ8MuFVtNC,1
Clemens-Martin Wendtner,1
#EHA24‚ÄîIbrutinib,1
https://t.co/pWSkXgbreb https://t.co/n3OB9DPU0v,1
https://t.co/eM0cdv1s9q #lymsm,1
TCell,1
#immuesynapsis #,1
NewsletterEpignetik,1
#Epigenetik von,1
Das Abo,1
#EHA24 #CLL #,1
CARTcell Maloney #,1
here&gt;&gt,1
#CLLsm #Leusm @VJHemOnc,1
MRD https://t.co/JNO1V8UisP,1
EHA24 Maloney,1
"al
DoNOT",1
Decreases CRS,1
karadimitris,1
LLC1114,1
#gerionc #geriheme https://t.co/w2FdtV84fZ,1
MEDACorp KOLs,1
Jos√© Carreras,1
#Amsterdam #EHA24 #,1
https://t.co/e8No7IhvEY,1
Vision HO141,1
RR CLL,1
Vision wt I+V,1
https://t.co/7590bURLVT,1
#london #,1
karyotpye,1
Cristof Scneider,1
PF360,1
#S149 #EHA24 #,1
@TaylorJ_MD @mjcascio,1
Nuclear Power,1
@CllIreland &,1
#EHA2019 #,1
coming days,1
https://t.co/f9YDs1ccPg,1
Registration,1
#wisdom #cll,1
#patientpower https://t.co/eyLLyonj3x,1
John M. Pagel,1
Eric Anderson Sr,1
US Army,1
#biomarkers #,1
#EHA24 #EHA2019 #,1
de la consagraci√≥n,1
de las gumarelas de #,1
Kari,1
Liza,1
dejar,1
Falta,1
vamos,1
Ulrich J√§ger @MedUni_Wien &,1
David Maloney @fredhutch,1
#HemOnc #CLLsm #Leusm #,1
Lymsm #ImmunoOnc,1
https://t.co/unHHVLO1bJ,1
17/02/2017,1
"bookmarküëâhttps://t.co/O9p0vDBrzwüëà 
",1
seconds,1
Viruses,1
Tolero Pharmaceuticals Announces,1
Griselda Garay ‚öΩ:,1
https://t.co/eyTl0o1PV4,1
#pi3k #,1
https://t.co/4rbH4ym213,1
@lymphoma_connec,1
1 DAY,1
Save,1
Research Projects,1
#CLL #MM,1
@EFPIA @EU_H2020 #,1
RSP https://t.co/MYJKWXDLnN,1
RSP https://t.co/mf2Xa9q3uT,1
#EHA24 Congress,1
Booth 1010,1
https://t.co/Q2W7oscCLI,1
https://t.co/4xaHAhBkEX,1
#chronicillness #,1
https://t.co/SmxuJ6nvAD https://t.co/2VtneaClYr,1
Tenessee Oncology,1
@ASCO #ASCO19,1
#SmallLymphocyticLymphoma #,1
Philip Baldwin,1
"5,000",1
Prof Paul Moss,1
@MossPAH,1
https://t.co/MSyWSl003u,1
#cancersurvivor,1
#cancerawareness,1
#leukemia #leukemiaandlymphomasociety #,1
#smalllymphocyticlymphoma #,1
average 10.5 months,1
https://t.co/I03hewsRas,1
Multidisciplinary Chronic Lymphocytic,1
CLL Folks,1
Patty,1
https://t.co/Kxhlw9by5,1
https://t.co/zzFx2Ng1mN,1
Mercaptopurine,1
RSP https://t.co/jFdDfbB7K3,1
Uygur,1
Xinjiang Uygur Autonomous Region,1
la gran,1
de las gumarelas,1
las deja,1
m√°s de ratificar la supremac√≠a,1
el premio de,1
"@kellyackroyd
",1
https://t.co/SKkdu6hlw4,1
https://t.co/TTGZo7jbWZ,1
6;380(23):2225-2236,1
Floyd Hasenr√ºck @Floydiiii,1
Dept I of Internal Medicine @UKKoeln,1
https://t.co/is3m0CX0YM,1
The Changing Face of CLL Treatment: Moving With the Times,1
#medstudent,1
https://t.co/y4w252AR8M #,1
Venclexta to Gazyva,1
https://t.co/FnwVxmiuax,1
@MichaelRynne1 kicking,1
https://t.co/52r64LM8YP,1
K685ac of STAT3,1
"STAT3
KAT",1
685,1
Malkavian,1
Mayo Clinic Labs',1
Curtis Hanson,1
Cancer as Hobby,1
#laughterasmedicine,1
https://t.co/9If1R6ArU0,1
80th,1
Copyright Guru,1
Richard Dannay,1
50th,1
#happylawyers #,1
#80years #,1
50years,1
Krebsforscher,1
https://t.co/NSjnFs8pry https://t.co/aGCK8Nozvj,1
https://t.co/uqvwCjORck,1
Pan-Canadian Oncology Drug Review Expert Review Committee,1
Rituxuimab As Treatment For Patients With Chronic,1
F,1
CVP,1
4.,1
Illumina,1
Chlorambucil &,1
Goede NEJM 2014,1
#Leukemia #ChronicLymphocyticLeukemia #CLLsm #Leusm #,1
Asco,1
https://t.co/zwP2E6K6bT,1
BertaBoys,1
GoMocs,1
Gnoccchi,1
infinite_c_b_d,1
Rokeer,1
"@CllSociety 
https://t.co/WpnesWOENG",1
https://t.co/q3gaMk7TJw,1
‚ö™‚ö´ https://t.co/y6vuPeH8OS,1
#Venetoclax for Treatment,1
@KebleConference,1
LymphomaManagement &,1
Quick Take,1
Lymphoma Hub Coverage,1
#leukemia #medtwitter #,1
ligne de la LLC,1
New England Journal of Medicine,1
@CytoChromaC,1
CancerEvolution,1
Spanish Guidelines,1
Venclexta in Combination,1
the New England Journal of Medicine $RO,1
P-III CLL14 Study,1
Venclexta in Combination With Gazyva for Chronic Lymphocytic Leukemia Presented,1
#medtwitter https://t.co/V2qOhOADTe,1
Pinilla Ibarz,1
https://t.co/OQkXRhWOCP,1
de Hematolox√≠a,1
Oncternal Therapeutics',1
91.7%,1
#Genetech #,1
#Gazyva #,1
Kombinationstherapie,1
Ver√∂ffentlichung,1
Studie https://t.co/EfI1azcARC,1
#Uniklinik #K√∂ln,1
GCLLSG https://t.co/huZieulosl,1
Optical Illusions,1
https://t.co/SEdyzdZOkG,1
Dr Kanti Rai,1
Rai Staging of Chronic,1
#Dinner #,1
#Raistaging #,1
multicenter #,1
Messi,1
Ronaldo,1
CLLsm https://t.co/sEC88BZlYT,1
Venetoclax-#Obinutuzumab vs Chl-O. 432,1
age 72y,1
CIRS-G 8,1
Rx MRD-ve,1
75.5%,1
56.9%,1
17.1%,1
https://t.co/0tLWlFZboh,1
a full morning,1
Novel Treatment Options,1
https://t.co/YqcwdizLKM,1
#Venetoclax + #Ibrutinib,1
$ROG,1
the New England Journal of¬†Medicine https://t.co/FKiNZwSlfj,1
Venclexta in Combination with Gazyva for Chronic Lymphocytic,1
Venetoclax Chemotherapy-Free,1
"June 04, 11:09:00",1
Nancy Bartlett,1
9:45 am-12:45 pm in,1
Drs Danielle M. Brander &,1
ASCO19| Jacqueline Claudia Barrientos,1
9:45 a.m.,1
Frontline CLL Treatment,1
https://t.co/ZCkal34hEw,1
#EHA19 Demonstrate,1
#LeukemiaResearch #,1
https://t.co/JSIkPHfMfN,1
https://t.co/R7Mnd2XjGQ,1
A year,1
https://t.co/8hWs9qE52B,1
#asco2019 #,1
#asco #janssennews #,1
#chicagoevents  ,1
4:30,1
Nicholas Moore,1
June 4th,1
Jim Harlan,1
https://t.co/GpmXtciTmX,1
Ali McBride,1
#ACCC #,1
#lungcancer https://t.co/Y8ZhOxaEj8,1
#NYP/@WeillCornell‚Äôs,1
Daniel Helbig,1
Helbig,1
278,1
https://t.co/se4kKHer6x,1
https://t.co/xPreR0j5hd,1
Natalia Couto-Francisco,1
six-year,1
First Treatment a New Standard,1
Rapidly Changing Era,1
#CLL #mantlecelllymphoma #,1
277,1
paso,1
el f√∫tbol,1
88,1
0-5|,1
Pancreatitis,1
Rash,1
Gina,1
6 year,1
8am #,1
Krebszellen aus dem,1
Flora,1
#MZL #MCL #,1
#ASCO #UofM #,1
SEQUENTIAL CIT,1
Birgitta,1
Bogota,1
https://t.co/YKu8JpYN8H,1
Advisory Committee,1
#patientcare #,1
about 80%,1
@tomleblancMD,1
https://t.co/NENDxEXLei,1
"https://t.co/AdUtYXGMGM

Editorial: Ibrutinib",1
"@US_FDA
",1
https://t.co/drs4XnDpYP,1
the United States - Kabadi - -,1
Acute Tubular Injury,1
Denver Nephrology,1
#haematology &amp,1
#empower,1
"@NEJM
https://t.co/tThZspKKtz",1
response inc.,1
https://t.co/SDbBkIGams,1
"Monday, June 3rd",1
#lymsm #leusm https://t.co/T6FIwcFDpF,1
https://t.co/ag3l51338,1
https://t.co/5IsAEHcmIU,1
https://t.co/R12BES9BAk,1
CLL @MDAndersonNews @NitinJain,1
https://t.co/ZEjzvkKOYb,1
@eurekalert_org,1
ÂêåÂÆö„Åï„Çå„ÅüÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ„ÅÆÂ¢óÊÆñ„Éë„Çø„Éº„É≥,1
@MGH_RI &,1
CLL https://t.co/01wioEef1A,1
Morgane,1
Nature:,1
Ivana,1
"Cathy Wu
https://t.co/1foMfk7QOm",1
https://t.co/ZTHIrKZhlv,1
CLL @LeukemiaMDA @MDAndersonNews,1
Covaris,1
Mallm,1
#Amsterdam,1
#combo #,1
https://t.co/lMg37OkzNl,1
https://t.co/eGQjh63MwP,1
@WVCancer @UCSDHealth @CompassOncology,1
Liliane Paquette,1
$10M,1
https://t.co/X4MkibhzUh,1
The University of Texas,1
https://t.co/wR0x2aEKo5,1
the Broad Institute of MIT,1
the University of Washington https://t.co/BXielYWgDg,1
https://t.co/4mEZeqf6oX,1
https://t.co/OnwN4V6qIU,1
https://t.co/SArLC1LZJm https://t.co/MtDvF9ca7Q,1
Science daily News,1
SLuque√±o,1
https://t.co/uWY3DauaEr,1
Booth 4063,1
"https://t.co/E9w1GO7PUh

#",1
DoctorPatient,1
@landau_lab @fgaiti @ChaligneRonan,1
#epimutation #,1
B-Cells,1
Latest Research,1
$17.1 billion,1
#pharma #medical #biotechnology #,1
Opportunities https://t.co/IWzikaWhS5,1
https://t.co/lHf3EZxAPl,1
Chl #,1
5y 68.5%,1
61.5%,1
74.5%,1
65.7%,1
CI 58.6%,1
71.9%,1
CHL,1
TN #,1
CLL+comorb,1
VenG.,1
13 G3+,1
EFS+OS,1
2010-15,1
SBP,1
OSA,1
56%,1
SPM 2,1
Quality Hotel Olavsgaard,1
#KLL https://t.co/HUS63GWyRj,1
Pretoria,1
Weltblutkrebstag,1
PatientInnen,1
Diagnose CLL,1
abwarten &amp,1
Erfahren Sie,1
Online-Kurs,1
Belastung,1
selbst aktiv,1
52 Week,1
#clubedosangue #,1
41 years,1
6.3,1
Plasma K,1
7.5,1
3.4,1
Cleveland Clinic Journal of Medicine,1
‚ö™‚ö´ https://t.co/aAE1WJ6TOs,1
53/195,1
23/195,1
Blooducation,1
https://t.co/HnsRsYwPX4,1
Vitale/Ferrajoli et al ‚Å¶@LeukemiaMDA‚Å©  https://t.co/9y5j2unFrG,1
#samenbeslissen #,1
hematon https://t.co/o09sWbeaLp,1
Gisteren,1
Hematondag,1
Samenbeslissen,1
Bekijk,1
#lymfatische #,1
#CONGRATS,1
the Phase III RESONATETM Study of Ibrutinib Vs Ofatumumab,1
Cancer Hospital,1
Solove Research Institute,1
https://t.co/E9w1GO7PUh,1
no Ven-R. #,1
https://t.co/fef7ZydSGM,1
Computer aided Drug Designing,1
#PCIP #,1
@DVVavoulis,1
Jenny K,1
https://t.co/1xbURcVEvZ,1
Sangmin Lee,1
Research Nurse,1
June Greenberg,1
Asst,1
https://t.co/7zKEQvLODZ,1
https://t.co/Ylzkt16bcq,1
the US #FDA,1
#OKCHEM #Disease #UnitedStates #,1
the @CllSociety Patient and Caregiver Education Forum,1
#cancerfatigue #,1
üî¨üîç,1
CLL Guidelines,1
the Hyatt Regency Chicago,1
Wacker,1
Dublin education &amp,1
the Food and Drug Administration‚Äôs,1
https://t.co/oiXSHx6Hzc,1
8 years ago,1
https://t.co/cp8GF16Ope &lt;--READ,1
Joel Schmidt,1
Bill Borchard,1
Mary Kevlin,1
Bob English,1
International Trademark Association,1
https://t.co/ENfo4OdB2x,1
https://t.co/HUnLI3Ns5k,1
Intercambio de datos y conceptos,1
el VHIO,1
Bosch,1
#CLL #VHIO #,1
FORMACIONDELPROFESIONALSANITARIO,1
https://t.co/3dy4XoVbP6 Happy,1
https://t.co/i2x9BucS1,1
https://t.co/4K6DRbVFA3,1
https://t.co/TpgeF1MlVE #,1
https://t.co/MU6ESmDqc0,1
PuntaDiamante,1
los Campeones en Equipo de #XNL,1
Ngen,1
CLL).https://t.co,1
Better or Worse,1
#humorfightscancer,1
#hatecancer #,1
https://t.co/AG8WrPXJ84,1
2)progression,1
3)Richter,1
Venetoclax/Obinutuzumab,1
Jenny Klintman,1
Jenny Taylor,1
#iwCLL2019 Full Agenda,1
#TuesdayNewsDay #,1
17:30 - 19:00,1
Full Agenda,1
https://t.co/kbLvuGULjL,1
Venetoclax + Obinutuzumab,1
#LetsCureThis #,1
https://t.co/evtoPTCAW1,1
https://t.co/aXFohtEeWP   ,1
Jan Joseph Melenhorst,1
https://t.co/AIWDT9tdr0,1
the VI EAFO #,1
Hematology Forum,1
https://t.co/a747RutI8y,1
Venetoclax/#Obinutuzumab Combo,1
https://t.co/wNWAqGMOKQ,1
#Bellechasse,1
https://t.co/zIDa2Yw8Sc,1
#lymsm Less,1
the Patient Power ‚ÄúMaking Sense of CLL,1
#JeffreyMenashe #,1
DavidMaloney,1
Last minute,1
#PAmedtwitter,1
https://t.co/2seOSL9dBC,1
BioTech,1
https://t.co/o4weUH76iK,1
1.40,1
Vetr =&,1
https://t.co/n1J6TkNQIk #Biotechnology,1
#Stock #,1
@RoswellPark #Hematology,1
New CME Event - FDA Approves Venetoclax,1
Venetoclas,1
https://t.co/7ZSQzyQiK9 https://t.co/rS66kj95f7,1
the Utility of Novel Combination Regimens,1
Danielle M. Brander MD,1
-NK &,1
NCCN Guidelines¬Æ,1
https://t.co/Jk6ofVyZgs,1
Drizzy,1
Jacamo,1
148,1
32 #CLL #,1
CaptainMarvel,1
Venclexta-#Gazyva,1
"Real-Life"" Outside of Clinical Trials",1
highlighting &amp,1
Pavlina Janovska,1
#bryjalab,1
https://t.co/VAAUpI8arM,1
@US_FDA #,1
@Roche's,1
Oncology Priority Review Program,1
Vencle,1
https://t.co/H8nPFcCPob,1
#FDAApproval #CLL #,1
Sharp Awardee,1
https://t.co/FYL8ExJ7Wk,1
#obinutuzumab (,1
#VENCLEXTA¬Æ,1
Bavencio,1
Merck KGaA,1
#cll14 #,1
https://t.co/daYoscuFCG,1
CLL-14 v. similar PFS,1
La @US_FDA,1
combinaison avec le,1
healthNews,1
AbbVie‚Äôs Venclexta,1
| https://t.co/VHoFWLxtqN,1
‚Å¶@BloodJournal‚Å© #CLL #CLLsm #,1
https://t.co/mStMbfIUrm,1
LatestComments,1
https://t.co/gSx7DxSrBL,1
https://t.co/oohMPulgzs,1
Venetoclax/Obinutuzumab Combo Approved,1
https://t.co/5HqjqOFiFE @BloodJournal,1
https://t.co/siOlsECVLq,1
#CLL https://t.co/nyKldzyetp,1
Ibr + Gazyva,1
@DrRaulCordoba @anthonymatomd,1
https://t.co/uBFl9x8ufm https://t.co/UygVd82FMA,1
CLL - https://t.co/9ed1I67EYo,1
https://t.co/hlpAMsDKMD,1
Myeloma @ZuckerSoM,1
#epigenetics,1
#evolution,1
@fgaiti,1
@ChaligneRonan,1
Hongcang Gu,1
https://t.co/sQZ6afiuUe https://t.co/JNqIT2bcoB,1
"https://t.co/iFnypfXXYS
#",1
"May 15, 15:19:00:",1
https://t.co/0eNoJetSA7,1
Venclexta Plus Gazyva for People With Previously Untreated Chronic,1
https://t.co/Bph0XUOUDG,1
Venclexta plus Gazyva for People With Previously Untreated,1
roughly 2 months,1
Genentech Announces FDA Approval,1
K9 Barrett's,1
Jon Cleveland,1
Online Format,1
https://t.co/zAKjtE7VHR https://t.co/v3pCmXdgR6,1
Kabouter Funds,1
around 3.7%,1
#leukaemia #acute #,1
#pneumonia #,1
#infection #,1
#liver #,1
Rod A. Humerickhouse,1
https://t.co/uNlXwX5q1G,1
the 15th annual,1
Lyonel G Israels Memorial Lecture,1
@Stanford,1
https://t.co/T0cSSdyOsX,1
https://t.co/68FpX1VAO0,1
12:00 PM EDT Join,1
https://t.co/YlL5BuVimy,1
UniBarcelona,1
Big Words,1
14-15 May,1
#biorxiv,1
Celegans,1
AIN'T HEARD NO BELL!,1
‚öΩ 11-0,1
Kari Vega https://t.co/vTBvc0SJsc,1
INICI√ì EL,1
https://t.co/jqqkdOJTix,1
AstraZeneca Phase 3 Clinical #Trial,1
Pablo El√≠as Morande,1
https://t.co/K99zLrzLs3,1
#Ë°ÄÊ∂≤ÂÜÖÁßë #,1
#ÁúãË≠∑Â∏´,1
Christoph Bock's,1
BoG19,1
BCell Date of authorisation,1
19042010,1
26.5%,1
"$31,773.4 Million",1
Growth Drivers and Business Opportunities:,1
https://t.co/wDxBu9Renr,1
@APSNoletha @AssocSupBattle,1
https://t.co/ZbkW1Qd4qh,1
https://t.co/eYUgKkzkU2 https://t.co/H72Hc4eTbo,1
BSH @VJHemOnc,1
#LEUsm #CLLsm #,1
https://t.co/4yv125OWjA,1
#lymsm #Ibrutinib,1
Alemtuzumab-Ofatumumab,1
Clinical and Laboratory Prognostic Indicators,1
calgary,1
https://t.co/bLSNofk9ct,1
Chronic Lymphocytic Leukemia Treatment Industry Research Report,1
#ricercaalfa #,1
"@MayoLeukemiaMDS @BloodJournal 
https://t.co/SRQf5tUnut",1
Markers as Prognostic Factors,1
Key Takeaways,1
Donnellan @SarahCannonDocs,1
https://t.co/Ynz7vvJRcz #,1
‚ö™‚ö´ https://t.co/w2AQ1fiDQk,1
‚ö™‚ö´ https://t.co/msSG5VsfNB,1
‚ö™‚ö´ https://t.co/AI5txGvCj0,1
‚ö™‚ö´ https://t.co/1xIosOVuOC,1
Transcriptomics,1
https://t.co/trb8ehBA6c,1
12:00 PM EDT,1
Register https://t.co/YlL5BuVimy,1
Mechanism for IL-15,1
https://t.co/OIZYISvWl6 https://t.co/hABNfv7kNw,1
Health Consulting,1
first half https://t.co/UbrHs2Gs7y,1
https://t.co/4ikGZTfWt2,1
JSG,1
KEYS &,1
VTU,1
APP,1
https://t.co/yIfBZsilsH,1
Nadia Khan,1
Elena Gitelson Memorial Lectureship,1
Gitelson,1
Jefferson,1
https://t.co/yXRE5nWtJG,1
https://t.co/X88ftieWIj,1
the University Awards,1
Elaine Moore,1
Steve Gascoigne,1
Emma Craddock,1
Natalie Purnell,1
#staffawards,1
Talha Munir @LeedsHospitals,1
CLL CLARITY,1
Personalized Approach,1
https://t.co/GEHWBRi9Ux,1
Peptide Vaccination With IO103,1
https://t.co/HLCFYHe6kG,1
@LLSusa CLL Treatment Updates,1
Drug Sensitivity Screening,1
June 13-16,1
https://t.co/r5TLd8RBjj,1
https://t.co/hTyC0rqmUy,1
CLL Patient &,1
Carer Information Day,1
Saturday 8 June,1
Spencer Hotel IFSC,1
10am to 4pm.,1
April 10th,1
C.L.L.,1
#CancerSuck #,1
maladie,1
https://t.co/FhaVp0FFhv,1
#leuc√©mie #traitementllc #,1
https://t.co/tnDjKHj4vZ,1
Woohoo,1
https://t.co/SMn6E4bqz9,1
LeukemiaUpdate,1
webcast &,1
12pmEST,1
&gt;10 years,1
#CLL.New,1
"ü§î 
Da chronische lymphatische Leuk√§mie",1
Verwirrung,1
#CLL #leuk√§mie #,1
zum,1
https://t.co/dGQ0D0vCFy,1
Gilead Sciences ‚Äì,1
"https://t.co/apN0Eff5s5
#mm #",1
Roberts/Seymour,1
CR/MRD neg,1
dlbcl https://t.co/VRlWd3W4SC,1
Akershus University Hospital,1
Hoa Tran,1
https://t.co/FhTYoUUKzV,1
Blood Journal Less,1
90Central,1
#IBT,1
IFTA,1
https://t.co/ws5k8LHxSz,1
Lymphoma Update,1
Stanford University's,1
Neel Gupta,1
https://t.co/sMDbEmceG1,1
insights &amp,1
https://t.co/5J4HNQrsay,1
Lymphoma Research Foundation Announces,1
More Than 20,1
Chronic Lymphocytic Leukemia Research Grants,1
May 01 2019,1
p-53,1
https://t.co/8HbBmTC0tD,1
12pm,1
UNMC https://t.co/AMEOLkoagD,1
Miyita,1
Yita,1
https://t.co/EdOQUR78Us,1
https://t.co/szj2wfKnrJ,1
√ÖAS,1
#√∂ppnauniversitetet,1
#√•boakademi #√•a #,1
#CLLsm #lymSM,1
Baa Baa Black Sheep',1
üçÉüé∂üìö#,1
#understandingtheworld,1
#language #cll,1
POSTDOC,1
https://t.co/azxjzRCUOH,1
20 million,1
Peripheral Blood Mononuclear Cells,1
Top Profilers Analysis,1
New Technologies,1
many more years,1
@LLSusa https://t.co/UCudSm4CRu,1
CME ALERT,1
Georgetown Lombardi's,1
https://t.co/VLFHt93rRK,1
https://t.co/coaRxLczMI,1
https://t.co/xwLrcmOkz2,1
#forestschool,1
https://t.co/a6mZHTqTw8 https://t.co/xkGvNd5dyw,1
#ÿßÿ∑ÿ®ÿßÿ°_ÿßŸÑÿπÿßŸÑŸÖ #,1
BOBADILLA,1
STEPHENIE LACOSTE,1
CORTAZA,1
JOHANA GALEANO,1
FABIOLA SANDOVAL,1
LIZA LARREA,1
ANG√âLICA,1
CTLA-4: The Next Target,1
https://t.co/QUDVTLxzN3 #,1
0.79 95%,1
CLLSLL,1
OncologyNews,1
Mayo/CLL Society,1
@WeiDing3 @hemepa_c https://t.co/9SElBHeoMf,1
https://t.co/BrdAcad65D,1
#nickiminaj,1
#remyma #,1
#tekashi69 #,1
#cardib,1
#lilbaby #,1
#haitian #,1
#broward #,1
#50cent #,1
#iheartradio #,1
#rapmusic #,1
"#lit
",1
#juicewrld #,1
https://t.co/YYncZlylcF,1
Catriona Jamieson,1
UC San Diego,1
Dominic LeBlanc's,1
last October,1
North,1
#PLAYR,1
@NWCRCentre,1
05/01,1
UNMC,1
https://t.co/DZ51dvxqbg https://t.co/zdM7g2i7Fj,1
@ChiMarathon,1
over $90K.,1
26th,1
https://t.co/M1dfH0wNKT https://t.co/PlGS9A3j9l,1
the date 18 June 2019,1
t(11;14)(q13;q32)/CCND1,1
Without #,1
t(11;14)(q13;q32)/CCND1‚ÄêIGH,1
https://t.co/adq7z67y5D,1
https://t.co/mjUpwmb7ws Neil E. Kay,1
Bulk,1
https://t.co/CsWgv2bHxW,1
AKA,1
M.D. @ZuckerSoM,1
Christian Poulsen,1
Susanne,1
#ChemoFree?https://t.co/8rzuCQheWF #,1
Haifa,1
‚Å¶@lyle_foreningen‚Å©,1
Washington DC,1
kbh,1
Aspin Ridge Tenderloin,1
Bone Marrow Crumb,1
Horseradish Gel,1
#tastingmenu #,1
#cll https://t.co/pVtbLBnnkV,1
Tanto,1
lymphopenia,1
Kari Vega ‚óÄ,1
‚öΩ Alicia Bobadilla,1
Only 3 days,1
https://t.co/MhPEzs9PGu,1
#ChIP_seq &,1
#epigenetics &amp,1
savoir plus sur l‚Äô#h√©matologie #,1
https://t.co/OkVT6zMEk8,1
ritixumab,1
https://t.co/W2v6R40YCZ #leusm https://t.co/w6MwkuWXxa,1
Stephen Ansell,1
#Lymsm #,1
@anthonymatomd @tobyeyre82 @TheBloodMD @Maryam_Yazdy,1
@AndreGoyMD &amp,1
#pisoton,1
#lenkoDay #,1
#taylorWolfGym #,1
Milwaukee,1
Key Clinical Trials to Know,1
Alessandro Pastore @AbdelWahablab,1
CLL Eradicates Minimal Residual Disease,1
Prolongs Survival:,1
New #JITC Research,1
#free #,1
https://t.co/szj2wfKnrJ https://t.co/IyAwjdT1Cd,1
#ISBTScience #,1
three weeks,1
LYMsm,1
POST-ASH CLL,1
Ken,1
nuevo modelo de abordaje,1
https://t.co/fPsersHm0a,1
.@MarissaZeppieri,1
@markhenick,1
Indolent #,1
"@Novartis 
Download Sample Copy of Report",1
Duelo,1
https://t.co/14iYsk9eLH,1
@IKEAUK,1
nearly 2 years,1
#eyfs,1
https://t.co/5Wv12m54E7,1
Kitty,1
https://t.co/KIkdJzzNHT,1
Myeloma #,1
üëâhttps://t.co/EAkZgVVyKpüëà You,1
üë®‚Äçüî¨üìâ‚èØ,1
Signup &,1
Cancer Center‚Äôs,1
https://t.co/F1wc1VkKrz,1
https://t.co/fOZ82jhu5g,1
https://t.co/2xI1Nz1gIy,1
https://t.co/1GiJ0bYNMh,1
mandarin,1
#rainyday,1
#juanemakerspace #,1
group+creatinine,1
297 #CLL,1
https://t.co/p4G3GDp99S,1
ThePatient,1
De KH,1
lymfatische leukemie,1
@HOVON,1
@Hematon,1
#hematologie #,1
#ehealth #,1
notre solution de gestion de la fid√©lisation des,1
#CLinkLoyalty #,1
#GDPR #,1
Johnson Johnson - Market,1
Annie Fitzgerald,1
Oncological Love,1
https://t.co/1DHSHW4cwN,1
Through Health Canada's,1
https://t.co/3BreTLhteZ,1
the Association for Academic Outreach,1
Annual Conference,1
@uniofeastanglia,1
AITP,1
15/27,1
28.9,1
https://t.co/BxfvaKNDFd,1
https://t.co/iLldX6ldJp,1
https://t.co/5dd10Ri9O8 https://t.co/NnyyCbaxdx,1
@LeukemiaMDA https://t.co/0Kgym6A0To,1
0-15,1
Fiorella Mart√≠nez,1
"https://t.co/ioN4SDP8ib
",1
https://t.co/qK51Hz1sps,1
@lacarral,1
Hem,1
Riu,1
#koat√≠ #,1
#riuamunt #,1
#BBY,1
#XSG #,1
https://t.co/Fc9qpMQaNr,1
Loretta Nastoupil,1
#leusm https://t.co/PgNAuAHYxL,1
https://t.co/IKJByA7LFm,1
Skola,1
Lars Svedberg,1
Tammerfors,1
#skolaiv√§rldsklass #utbildning #,1
#fortbildning #,1
https://t.co/7rL9pOHiwI,1
https://t.co/szj2wfKnrJ https://t.co/T8pvtvnCrr,1
Cells Cycle,1
Cyclin D2,1
K &,1
CpG + IL-15,1
Bcells  https://t.co/IuVp0CwEpE,1
Ô∏è https://t.co/VEjsStIK2V,1
2019-2024,1
#CLL https://t.co/nyKldzPPkX,1
https://t.co/ynjX6k7ycZ,1
#Leukaemia Care,1
#BSH2019,1
Communication,1
WTF,1
Ultmann Chicago Lymphoma Symposium,1
#ultmannsymposium #,1
the University of Chicago,1
Leo Gordon,1
Barbara Pro https://t.co/BiR9jjkARI,1
Choi,1
Menashe,1
May 18th,1
MU380,1
RedefiningBeauty,1
#HealtheVoices19  ,1
https://t.co/JtUJtm6DlV,1
#CLL https://t.co/W6dptRlUFw,1
#CLLsm #Ibrutinib,1
https://t.co/q03xWG6ZAm,1
CSD Board of School Directors,1
Julie Haywood,1
Times Chronicle/Glenside News,1
this past Saturday's,1
Cheltenham Little League,1
#playball #openingday,1
Study to Evaluate the Safety,1
Non Hodgkin,1
the Power of Patients,1
20-23 September 2019,1
https://t.co/icImB31ddF  #CLL,1
PCROWD,1
PromiseStudy,1
15 minutes #,1
Richardson ‚Å¶@OncLiveSOSS‚Å©,1
@ASCO @BloodJournal,1
@Daver_Leukemia  @MDAndersonNews,1
Conex√£o Lado Leste,1
muito Rap,1
https://t.co/XQzORFOibj,1
#TRUXIMA,1
"@TevaUSA 
https://t.co/qsP9RuVI3x

#",1
Teva Canada Announces,1
https://t.co/ja3SVbSbMn,1
2-2|,1
#Ï£ºÏãù #,1
https://t.co/obppIXb42J,1
RareDiseases,1
https://t.co/9TAoANa8Rb https://t.co/M7UlWuvifB,1
https://t.co/j3pZPPWpKV,1
https://t.co/Nx1snw4sXW,1
https://t.co/U7jzOA449q,1
CLL - Capital Markets Event,1
Capital Markets Event,1
https://t.co/81UmWfsMR6,1
New Research Article,1
https://t.co/cSxw9moB8P,1
OutspokenOncology,1
@QUBelfast,1
https://t.co/ziMwLcxE7f,1
#CLLsm #LEUsm #,1
ActiveMonitoringTip,1
https://t.co/uVHgp5l0kk,1
üêñ @COCHON555,1
Billy Michael Chelliah,1
Jebaraj,1
Ulm,1
May 3,1
Bear Dr.,1
Jan Berger,1
@MDAnderson #,1
ARRANC√ì EL SEGUNDO,1
¬°Equipo,1
@JanRynne @CLLSupport,1
https://t.co/mOdczOEhMT,1
üèæ #CLL,1
https://t.co/uZwk2Ku9Yj,1
https://t.co/QjDcsc3Wyh,1
De Novo MDS,1
https://t.co/Q46rYQXnNc,1
https://t.co/pSORxxE4pb,1
the LCE #,1
Advisory Board,1
May 18,1
the Lymphoma Coalition Europe,1
@Guytavori @sscowcroft @BolanosNat,1
Lymphoma Coalition Europe,1
Hematol Oncol,1
Bear Hunt',1
Mrs Seddon,1
#BearHunt #,1
https://t.co/hbMBTAFh86,1
https://t.co/5s0LbsjlCw U.S. FDA Approves,1
First Non-Chemotherapy Combination Regimen for Treatment-Naive,1
David Gambone,1
https://t.co/WK83Z35C2k,1
Venclexta‚Ñ¢,1
Smudge Cell,1
scRNAseq,1
ATACseq,1
Changing Treatment Options,1
"@wwierda
https://t.co/oaYXpcSxC0",1
Leukemia - Pipeline Review,1
"https://t.co/KO7eFyjs5a

#ResearchByMarkets",1
Tomorrow - #,1
https://t.co/OMMIrcOjdS https://t.co/jtnmfpZaXD,1
Combinations with New Agents Evolve,1
Leukemia Landscape - https://t.co/FxuroLalcF,1
https://t.co/Aja2vAYv0h,1
https://t.co/8cPdp2P9Ct Genentech,1
CLL Society/NIH Patient,1
Malignancy,1
Fantastic 2 day,1
m√∏de,1
lyle_dk https://t.co/mA1cCuKFS3,1
CLL Community Advisory Board,1
"rituximab maintenance
",1
#WHO https://t.co/EgSUJ8RErB,1
https://t.co/1VjZlCbfKi,1
Tang et,1
https://t.co/Ti0mJbEl8U,1
Esteban Braggio,1
Koichi Takahashi,1
#AACR19 #,1
SingleCell,1
4/2,1
Sept 2019,1
https://t.co/PKkRYb0ulD #CLL #,1
@JAMADerm,1
https://t.co/scjtOptlCD https://t.co/WxtqXhgEHN,1
LibertadLimpe√±o,1
manera el,1
de Nacional,1
Estaremos,1
la temporada,1
#india #,1
presidentofindia #,1
#deputychairman #jayavarthan #cll,1
#exambazaar #,1
@zpwlf &,1
the Living with #,1
campaigBSH2019ns üé¨üé•,1
#LeuSM #CLL #,1
Lymphoma/CLL Community Advisory Board,1
Inhibiting Bruton‚Äôs Tyrosine Kinase,1
Other B-Cell Malignancies,1
Read Carl's,1
https://t.co/VkUtcZerop,1
#SundayRead #,1
#SundayMorning #,1
Inhibiting Bruton's,1
Other B-Cell #Malignancies,1
https://t.co/WZGSolxcpB,1
https://t.co/ekhizEQvQF,1
rituximab &,1
#hepatitis #,1
#health #cmv #,1
#ai https://t.co/B5Zyim8pcX,1
c/w,1
FCR-&gt;R,1
https://t.co/dg7Q7uUGfT,1
#CLLsm #LetsCureThis https://t.co/TR6oV2fGgI,1
Only 5-10%,1
#leukemia #cll,1
#fever #fatigue #,1
the Florida Blood Cancer Conference @LLSusa,1
5am,1
anxiety &,1
https://t.co/hkGDBrQ2tV,1
@LeukaemiaCareUK‚Äôs,1
SWEET,1
#lectins #,1
https://t.co/q69ZeESdrt,1
#ALQOL #LeuSM #,1
Baseline PET-CT,1
LSC,1
#OpenAccess #,1
May 18th &,1
Sells - #,1
Carfilzomib Dose Escalation Study,1
Hedgehog,1
https://t.co/A2YKMgp0bQ,1
the CLL Society Patient and Caregiver Forum,1
"next Friday, April 5",1
Marie Jos√© Kersten,1
Text World Theory,1
‚Å¶@KentELLyeah‚Å©,1
CALGB,1
70603,1
145p,1
https://t.co/YQ2yImNOPT,1
the City of Hope,1
Duarte,1
an amazing year,1
https://t.co/BQPCeASEh0 https://t.co/6SsgrwUBak,1
https://t.co/gvKVzM7QE8 &lt;&lt,1
#EBMT19 @VJHemOnc,1
#Relationships #,1
@lucyevans84,1
PTRO,1
@AminoTV,1
AMO,1
Segment Analysis,1
https://t.co/ONS6fUjNVu,1
https://t.co/azwPIeQM8i,1
#clinicalTrials,1
Rezvani @MDAndersonNews,1
Obinutuzumab High Response Rates,1
64% and 91%,1
https://t.co/pkoZnnoNuB,1
NCCN #Guidelines Insights:,1
√öltimos,1
medida,1
#mascarasluchalibreraison #,1
luchalibrechilena‚Ä¶ https://t.co/3nKPKzohHN,1
2.75p,1
Watch Christian Gisselbrecht's,1
Genomic Profiling,1
Khalid Asghar,1
Controller,1
Radio Pakistan Lahore,1
Radio Pakistan,1
no Cancer Hospital,1
New Advances in Therapies,1
Paraneswaran Venugopal,1
3/11,1
the Treatment Options for Blood Cancer Patients Conference,1
https://t.co/4ZGxVt7x5K,1
Richard Maziarz,1
EBMT19,1
@IISLaFe @iClinicoMadrid,1
Los investigadores esperan,1
al comprender,1
deteriora la funci√≥n de la m√©dula √≥sea,1
mejorar la funci√≥n de la m√©dula √≥sea,1
Lea,1
https://t.co/zbtaQtSO4G,1
#venetoclax +,1
disrupted)+R,1
64%,1
exposed)+91%,1
Magnus Bj√∂rkholm,1
#leusm https://t.co/j9cL22eru9,1
https://t.co/YzgS4CF8ei #,1
RGL ≈†√°rka Posp√≠≈°ilov√°,1
IMI,1
https://t.co/rc2Nir9vHv,1
International Chronic Lymphocytic Leukemia Treatment Market 2018 Estimation and Forecasts,1
https://t.co/U5KMBCTNva,1
https://t.co/E4BKnOL6we,1
@ASBschool,1
Catalan,1
Call of the Wild,1
more than 20 #,1
"650,000",1
@Unitemps üôÇ,1
19th to 21st SEPTEMBER,1
CLL HORIZONS,1
8th April,1
ResearchHighlight,1
finnCap,1
@Sopheon,1
SPE,1
Journo,1
PMP,1
SPE &,1
https://t.co/kXTLQA4ltB,1
14-year-old,1
African-American,1
inbox &amp,1
#SHRE #,1
#KAPE #VNH #,1
#BOOM #CLL #,1
#AGL #,1
HRI,1
Neil Kay: KRAS,1
https://t.co/lg26sjypRB,1
https://t.co/wI026LW9cq #leusm https://t.co/Q3Dz66s75h,1
#HealtheVoices19 &,1
Sept. 2019,1
#BloodTests https://t.co/L8vM2h4Pcx,1
Their Effectiveness,1
American Airlines,1
#flylocal #,1
#tamu,1
#bryan #,1
#takeoff #,1
#brazosvalley,1
#brazos,1
https://t.co/X9BLCsDG6i,1
O‚ÄôBrien &,1
one-year,1
12PM,1
1PM PST,1
3PM,1
4PM EST,1
NationalBroadcast Grand Rounds,1
lymsm https://t.co/fquYOaPn0e,1
B2M,1
44 months,1
https://t.co/qvwnHa6ppu,1
#YoungEHA #CLL,1
https://t.co/TlXMzelD0d,1
Two Distinct Pathways for the Development of Plasmablastic Lymphoma,1
1-4:30pm,1
Exhibition Hall,1
https://t.co/PQlYByKPcD https://t.co/S1xO1BVIwg,1
https://t.co/Z901cpx0IP https://t.co/eWMIqP43QZ,1
üëâhttps://t.co/O9p0vDBrzw,1
#ALLsm #,1
#CART üìΩ,1
Inicio De Temporada,1
@bodegabaylodge https://t.co/yWsOrp6Rrg,1
Pavlovsky,1
Nicholas,1
2-1 tonight,1
$XBI #,1
https://t.co/QBOX5vWjkr,1
WatchandWait,1
#BGO #,1
#JDG,1
#KAPE #,1
#MER #,1
#CAU #SDL #,1
#SPE,1
XAR,1
https://t.co/1F4UTecLwC,1
#designing #mixingcolours #,1
@MDAndersonNews https://t.co/W1eoI2st8Q,1
NFAT2,1
VDJ,1
https://t.co/Y4nETRyEMO,1
obinutuzumab regimen,1
https://t.co/GVB5ohiJI6,1
Blood Journal https://t.co/s8bhGtZno1,1
Dysregulated Expression,1
Hadadi L,1
Hafezi M,1
Amirzargar AA,1
Sharifian RA,1
Abediankenari S,1
Asgarian,1
NKp30,1
molecule3 Tim3,1
#Maball #,1
https://t.co/jea6qpBOmg,1
https://t.co/eLWXMwr0X4,1
#FOUR #,1
#SOM #GOCO #PMG #LSAI #,1
some day,1
https://t.co/tyU8vDeUH3,1
Kamala Maddali,1
@OMIonc,1
GlobalSummitOnHemMalignancies,1
Dr Christina Westmose Yde,1
https://t.co/sOKG30yc9y,1
https://t.co/i5ZWl4C7y3,1
10.1158/2159-8290.CD-18-1119,1
#medicine https://t.co/RxTgcC3XTH,1
BREXIT,1
IsleofWight,1
#iow,1
the Isle of Wight,1
https://t.co/Stc82DR3Le,1
CLLsm  https://t.co/iRxQPQngbB,1
EricBerry,1
KC,1
recent seasons,1
#PatientPower #,1
@germancancerresearchcenter,1
STAT-3,1
#leukemia https://t.co/yUW0cB7qIO,1
The Importance of Early Comprehensive Testing and Retesting,1
mid-week,1
#WednesdayWisdom üôÇ,1
@IttWarwick @WarwickSocWork  @Warwick_SocSci https://t.co/S0M0hG6JPp,1
earlybird,1
Gene Polymorphisms,1
IgG-Triggered Cytokine Release: Critical Importance of Cell Assay Format',1
@UoS_Medicine @uoscares,1
Joseph Rosenblatt,1
Rosenblatt ‚Å¶@OncLiveSOSS‚Å©,1
https://t.co/119CeNM9ew,1
#MTO,1
#MTC #CLL #,1
#GOCO #,1
#SSE #,1
RWS,1
NationalBroadcast,1
"Tuesday, March 19, 2019",1
12:00 PM ‚Äì 1:00 PM PST,1
3 ‚Äì 4 PM EST,1
EndCancer https://t.co/Szb6UzHDuC,1
Sept.,1
anna,1
# thereforce,1
me2929,1
Chris Pepper,1
S3-Leitlinie,1
erschienen ist,1
https://t.co/GHS39LkTtq #CLL,1
"Experiments, Evolution, Fermentation, Research and Forecasts",1
"300,000",1
@DRGinsights @Roche,1
$CELG Celgene,1
August 2021 to December 2020,1
Best Drug Sequence,1
MedEd https://t.co/JIrkIB2afb,1
Kinase Inhibitors Autoimmune Toxicity,1
"Co-Existing Medical Conditions
https://t.co/oRQRE9JWgr",1
"Duvelisib, &amp",1
Copanlisib https://t.co/7cmnCX5i0M,1
@LLSusa @LeukemiaRF,1
Plenary Paper,1
#CLL CARE,1
https://t.co/qF8UoJi28j https://t.co/Rb4lnNv73o,1
Student Engagement Coordinator,1
Lauren Elmore,1
de la FDA,1
Abbvie / Roche,1
d'extension d'indication,1
Pharma #Update,1
a fifth #BreakthrougTherapyDesignation,1
780 feet,1
Durkan,1
discussions &,1
#NY-#Presbyterian/#Columbia Univ,1
Medical #Center #Investigator,1
#Shorter Treatment,1
hundreds of #,1
Technology Test FISH,1
Society Alerts,1
Venetoclax Will be Paid for,1
"Venetoclax 
https://t.co/lfEPsEbBTz https://t.co/OYxxBVv8oh",1
Venclexta May Save,1
"Saturday, March 16",1
Focus on Acute Myeloid Leukemia,1
#clinicaltrials   https://t.co/n3aZ5flEGa,1
Fiona,1
#Venetoclax/#Obinutuzumab Combo,1
Heroes,1
#ldnont #communitylivinglondon #,1
Newer #Agents Extend #,1
Survival and Reduce #Toxicity,1
Chemotherapy Poised to Have Minor Role,1
#Earlychildhood #,1
2plus2,1
@warwickuni @WarwickEY,1
https://t.co/wI026LW9cq #leusm https://t.co/GlrDOZiNrh,1
https://t.co/Kgzddr5zpy,1
Leptomeningeal Carcinomatosis,1
the Psycho-Oncology Service @ACTcharity,1
Dr George Follows @CUH_NHS &,1
#roche #,1
#newsalert #,1
#medicine #medical #,1
#Venclexta plus,1
https://t.co/DuVYv03lky,1
https://t.co/VuIL39ZQY8,1
BP1002,1
Roche  Holding Ltd,1
#clearlanguagelab #,1
Golden,1
Prof Gibson,1
Co-Existing Medical¬†Conditions https://t.co/PRSIKSvs3K,1
Alex Trebek &,1
Alex,1
Venclexta and Gazyva Combo,1
the Roche Group,1
SIX,1
OTCQX,1
3/7/19,1
the U.S. Food,1
Shanmugapriya Thangavadivel,1
08:46:00,1
AbbVie Announces Multiple Milestones for Phase 3 CLL14 Venetoclax Study of Fixed Duration Treatment,1
Breakthrough Therapy Designation and Real-Time Oncology Review,1
Venclexta Plus Gazyva for Previously Untreated Chroni,1
08:38:00,1
Sequential Multiple Assignment Randomized Trial,1
Leukemia https://t.co/tjewbfmCMz,1
#SIBBMpub,1
#SIBBMpub @unisiena,1
"https://t.co/uyfG7edRSh

Dean",1
a Teaching Fellow,1
https://t.co/pgJoNjcb9e,1
#MPAC #,1
#RMP #,1
KGH,1
#RMP,1
#SMDS #BATS #,1
#CLL #SPX #ALGW #,1
Blood Journal https://t.co/WIBfkKpzkc,1
Older CLL Patients,1
https://t.co/FxgFkbMEFW,1
The CLL Society,1
Barbara Merrill,1
Scott Revers,1
#leusm https://t.co/KJLZANytnH,1
https://t.co/bZ0O1JaI0V  ,1
#OfficialNIHR https://t.co/8wLkmAM5Y5 Elevated IgM,1
JacquelineBarrientos Discusses Emerging #Agents Leading,1
#Extended #,1
#Reduced Toxicity,1
https://t.co/X0Ckc3KGkX,1
New Agents,1
#ICGT #,1
African American,1
https://t.co/mid4gN2maj,1
https://t.co/drF1Z6p9b1 https://t.co/k9Ta8QjcpU,1
"Application, Production, Revenue and Demand Forecast",1
"Arzerra, Gazyva and Imbruvica",1
Upfront Management &,1
https://t.co/oC5Nqebx1p,1
17P Patients https://t.co/NMu97Xb0pZ @MayoClinic @MayoMedEd @CllSociety #,1
https://t.co/OKJbEu1JO2,1
The Changing Paradigm In The Treatment Of CLL,1
#HealthTalk,1
https://t.co/JFi5DVwzUD,1
March 16,1
#SmartPatientsGetSmartCare #,1
#BAT $,1
"over 91,000",1
BAT Holders,1
#BasicAttentionToken #,1
https://t.co/lRQzZ2KLTL,1
#leusm https://t.co/YCk48zgscV,1
#2x2x2 #,1
Elevated IgM,1
Forecast Period‚Ä¶,1
https://t.co/1ngg5WT5gj &gt;&gt;&gt,1
Affiliate Program,1
#attentionmining #,1
#erc20 #CLL #,1
AffiliateMarketing,1
#science #research https://t.co/mCt1GbLPQe,1
JeM,1
Islamabad,1
last six months,1
#MasoodAzhar #MasoodAzharDead,1
https://t.co/QBOX5vWjkr https://t.co/Ni7tWedRxH,1
NCCN Updates Clinical Practice Guideline,1
#CLLsm #CLL #,1
Medical Lab Scientist,1
https://t.co/LJm7R1ATs2,1
Drs Davids,1
‚Å¶@DanaFarber‚Å© https://t.co/ZCPo2ZqS8,1
Cork,1
Fiona Moriarty,1
Article via Cancer - Wiley Online,1
https://t.co/zYdgt5OHjy,1
@MDAndersonNews https://t.co/oLqV8YXA2L,1
Michael Kneba,1
the University of Kiel,1
April 5-6,1
March 6 @ 8am AH,1
https://t.co/Ix0Yq7DC4B,1
2019 - https://t.co/guyiBzPH8C,1
Roller Coasters,1
https://t.co/IviRmrZKRr,1
1e,1
Gestion Agricole #,1
CLL Patient,1
1.30,1
@IrishCancerSoc @IrishCancerReg,1
almost two years ago,1
Rare Disease Day,1
February 2008,1
the age of 28,1
a day three years ago,1
Croydon,1
DiagnosisDay,1
#leusm https://t.co/eBtJvMJUXF,1
March 14,1
#plainlanguage #,1
https://t.co/eG8uGc3oZK,1
"less than 200,000",1
#RareDiseaseDay #,1
April 29,1
PatientDriven,1
"you""re",1
#alloHCT https://t.co/pPD23jt8Sm,1
1912,1
ALLIANCE A041202,1
the the CLL Society,1
rs11614913,1
the last day of,1
https://t.co/DC7RaPtsqC,1
Sharma S* et al,1
el hijo del querido,1
Juan Carlos Landa Carpio,1
The Roll Of Chemotherapy,1
Cancer Research Wales,1
@Laura_em4,1
https://t.co/pXn52SJ2x8,1
El√≠as Campos,1
CaRLoS L√≥PeZ oTiN's,1
Campos,1
GeNoMe,1
International Cancer #GeNoMe Consortium,1
SPaiN,1
https://t.co/jXJpD4s9Gr https://t.co/sAjszQhEiy,1
https://t.co/Xtr5pa0rVK,1
Chlorambucil-Kombinationen,1
Direktvergleich,1
Jennifer L. Crombie,1
08,1
February 2019,1
#joulepowered,1
the Healthcare System,1
#CLLPatients #,1
#leusm https://t.co/QMKyqjQVcv,1
CLL Society Patient and Caregiver Education Forum,1
https://t.co/6OZKh2RJvw https://t.co/RLmGqR9GZ4,1
#ecp #ecp2019 #,1
Leusm @LeukemiaMDA https://t.co/airkm0r53r,1
CME/CNE EXPIRING,1
MB-CART19.1,1
Condition Summary: Acute Lymphoblastic Leukemia Recurrent,1
Lymphoma Recurrent,1
Lymphoma Refractory,1
Lymphocytic Leukemia Recurrent,1
#transplant https://t.co/pojj2vBGyy,1
their Pharmaceutical Benefits Scheme,1
Gov,1
FirstTweet,1
https://t.co/4W1nFYCtpe,1
#womeninstem #,1
#academictwitter https://t.co/jGTemYawOr,1
#CLLPatient #,1
the Swedish Medical Center,1
"https://t.co/Mttsffm0km

",1
https://t.co/DeNzcfUEWh,1
10 percent,1
https://t.co/TS4GL2aXSA,1
"https://t.co/p0zyTsEWNz
",1
#TCTM19 #CLLsm #,1
https://t.co/BD8ZX85mue,1
Strategic Engagement,1
Alignment,1
New year,1
#MakeADifference #,1
"2,000",1
Ethereum Wallet Address,1
#FreeCrypto #,1
the CLL Society Patient Playbook,1
#leusm https://t.co/4e3aXFERSI,1
@HallekMichael #CLL #,1
https://t.co/4Ejepbwbml,1
https://t.co/IXnspkSOY1,1
#GOLDTigers2019 #,1
SocialGenpacter,1
70-80%,1
https://t.co/8b8pJpqDI6,1
#TCTM19 #,1
@fredhutch - #CARTcells + Ibrutinib,1
#TCTM2019 https://t.co/KmylnQAPGO,1
TCTM2019 üóìÔ∏è,1
5:30 p.m.,1
https://t.co/mqngcK9QjQ,1
https://t.co/8Py0fAtrIX,1
https://t.co/Wkg1oUuRXA #,1
@JanRynne &,1
Clinical Research,1
clinicians &,1
https://t.co/MyIi1f8Jnr,1
oxford https://t.co/5ILZEeDpqC,1
AdvancedNursing,1
CAI,1
Kambhampati MD,1
Managing &,1
Philip Thomson,1
https://t.co/Cq1rOYPQ7w @ASH_hematology,1
ASC,1
#CLL Form Biology,1
GlaxoSmithKline,1
"Roche, Teva Pharmaceuticals",1
Johnson &amp;a,1
https://t.co/opDMuTS4sE,1
Angeles Garcia-Pardo,1
CIB https://t.co/VHGmSKYSLW https://t.co/uZWWo5ODCv,1
Heilungschancen,1
Behandlungsm√∂glichkeiten,1
Neue Forschungserfolge,1
Lymphatischer Leuk√§mie,1
https://t.co/DCh4XrR9J8,1
#CancerMoonShot #,1
https://t.co/5W0LArRRTz @ASH_hematology #ASH18 #,1
the CLL Society Expert Access,1
Peter Hillman,1
Doubt,1
https://t.co/OHWwL1j8N1,1
√Ñlteren,1
Progression #,1
Athina,1
Fulbright Scholarship,1
Christoph Rader,1
the Scripps Research Institute,1
@Mackay_Matthews,1
Suman Kambhampati,1
The CLL Society Tribune,1
Juan Sebastian,1
Liselotte Ponce https://t.co/JoPMTzivUJ,1
IciCLLe &amp,1
https://t.co/cwSHJLoCaU @ASH_hematology #ASH18 #leukemia #CLLsm #HemeOnc #,1
https://t.co/Oif3BQDteE,1
The CLL Society Patient Playbook,1
7 year,1
at least the first few years,1
PIK3,1
@chadinabhan &,1
ü§î https://t.co/FBuo0tfSNj,1
"thoughts?@HallekMichael
https://t.co/ayxqH3kbei",1
Mosquera Orgueira,1
Antelo Rodr√≠guez,1
Benda√±a L√≥pez,1
√Ångel D√≠az Arias,1
Nicol√°s D√≠az Varela,1
Marta Sonia,1
weeks,1
#SuperintendentLife #,1
@JulesBordet,1
AML @SSBMT,1
https://t.co/HkicATW5sL https://t.co/5ycyTpMzFf,1
CARTable,1
@ebmt @EHA_Hematology 1st,1
#mdpijcm Psoas Abscess,1
#Chronic_Lymphocytic_LeukemiaÔºçCase Report,1
ÊÄ•ÊÄßÈ™®È´ÑÊÄßÁôΩË°ÄÁóÖ acute,1
ÊÄ•ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ,1
MantleCell,1
EndCancer PhysRelations,1
#MOHC19 #,1
https://t.co/2my2dqf5yk @ASH_hematology #ASH18 #,1
the Technology for Learning Conference,1
https://t.co/uuYhyqDayq,1
CARTmeeting,1
https://t.co/DRap6743NB #CLL #,1
The day,1
#fallinlovewitheducation #,1
ValentinesDay2019,1
Central Nervous System Lymphoma,1
https://t.co/Khrpyi2Yae,1
Kathleen,1
MPC2019,1
@SamHeughan https://t.co/SYljYDQVkP,1
H√§matologen Kongress,1
Video-Interviews,1
Georg Hess,1
Uniklinik Mainz,1
Uniklinik Ulm,1
Related,1
https://t.co/RM9ZyNFz0z,1
https://t.co/6Q3MkPOzDq,1
#CLIN #,1
#FCH,1
#REC #,1
https://t.co/Jgcg7PfA3b,1
https://t.co/tBbPrM7WjC,1
JOUR,1
la journ√©e,1
Tempete,1
HOS,1
UBS,1
professorer och,1
VBL,1
#hashtags #,1
#vara #,1
#bland,1
#ingenmobbning #,1
@livuniITM,1
ProximityLigation,1
PLAYR,1
#flowcytometry and,1
several hours,1
371,1
Forecast- 2025,1
"https://t.co/aQV8oCSAM6

#",1
@WarwickEquality https://t.co/HvzknWdyAu,1
Bonne,1
#tempete,1
#MOR208 plus,1
EMF Paper,1
the Hardell Group,1
https://t.co/1dECyPo1hp,1
TransformationTuesday,1
@IttWarwick,1
Mannheim,1
pueden ayudar,1
difundirlo,1
difundir esto,1
https://t.co/IjSJisXTEI,1
Dr Murphy,1
#POLR #,1
#CTEC #,1
RCP,1
WomenInScience,1
https://t.co/hYuCnveKyU,1
https://t.co/4FZuf0sSM3,1
Con Todo el,1
@THilalMD https://t.co/6HH4eZoqbl,1
#JT26 #,1
5 yrs ago this month,1
#MWG #SAV #,1
#VRP #,1
#FightClub #,1
GlovesOff,1
#PLAYR #,1
@NatureProtocols,1
https://t.co/49tMbQyfaI,1
CLL Program,1
https://t.co/kzVyU4pKwa,1
white  #,1
nearly 100%,1
https://t.co/HeW5WeTY67,1
"https://t.co/AhGFIS3w8I
@IttWarwick https://t.co/lMxQDTt8D9",1
#WorldwideCancer https://t.co/Q5DnSR0mxv,1
Lauren Thurgood,1
proteomics &,1
healthy &amp,1
#award #,1
https://t.co/2DQ0cEsGAL,1
CLL Mascot,1
Gill Principal Teaching Fellow,1
Careers,1
EACCME,1
"@IttWarwick @WarwickEY 

",1
#mascot #,1
https://t.co/H18tRAizNY,1
MD Anderson's,1
MD https://t.co/S0AqiBv0Jq,1
https://t.co/pJbh4zfcFf,1
https://t.co/g7Jg6DCMu7,1
Cohort-Expansion,1
quoteoftheday,1
https://t.co/S2431QphG4,1
Significant Highlights,1
4 @LeukaemiaCareUK morning,1
@NICE,1
next Friday,1
February 8,1
"12.00H. 
#",1
https://t.co/DwGzdDlDRQ,1
#„Ç§„É†„Éñ„É´„Éì„Ç´ #ibrutinib #,1
"obinutuzumab 
https://t.co/bO9Pl9oPw6",1
theor,1
rituximab https://t.co/nMMiWaMrF3,1
Teemu Roos,1
#framtidsdalen #,1
Hanasaari Cultural Centre https://t.co/bdO6Y1NCqB,1
https://t.co/3xukD8O1mC https://t.co/Dqv0VVJ373,1
only 4 years old,1
Nonchemotherapy Combination Regimen for Treatment-na√Øve,1
#IAmAndIWill  ,1
#iwCLL2019   ,1
30 April 2019,1
UK NEQAS LI,1
#all #mm,1
"More than 240,000",1
Manufacturer,1
https://t.co/dyTTCOSBHT,1
$TGTX #umbralisib #ibrutinib $,1
d‚Äôestar,1
el meu granet de sorra en la,1
the Peter MacCallum Cancer Center,1
#GoPats #,1
#SuperBowl #,1
#cryptoinvesting,1
B Cell-Restricted Expression of Sf3b1 Mutation,1
Atm Deletion,1
https://t.co/BwOYehlAIk,1
#Nurses:,1
#follicularlymphoma,1
18th century,1
https://t.co/77hTrvW3je,1
i Ganolfan D≈µr Cilfynydd,1
Cofiwch,1
Gwisgwch esgidiau glaw,1
ysgafn,1
dim bin,1
Sf3b1,1
Atm,1
Cancer News,1
9-11 Responders Report,1
Robert Preidt,1
572,1
https://t.co/kVrsguaxQj,1
Saturday March 2nd,1
Cork Clayton Hotel Silver Springs inc.,1
@CorkARCcancer &,1
Buckeyes,1
https://t.co/tEeHq4TvRf,1
First FDA,1
CLL Combination Therapy,1
https://t.co/MjH7H7ojft,1
Teleconference - Update on,1
https://t.co/pRhz70lYPW https://t.co/sYVdv5z3jP,1
CancerChat,1
#Nurses,1
TCR)+,1
AVHAHOUpdates,1
Nasta,1
@PennCancer‚Äôs,1
#ILLINOISsocialwork Community Learning Lab,1
"40,000 hours",1
1900,1
#dlbcl #mm #,1
https://t.co/65rSjgqp9M,1
https://t.co/BsNjL7eLlc,1
the last 10 minutes,1
@sloan_kettering‚Äôs,1
#MDedgeChats https://t.co/FHwr0fz7et,1
#MDS https://t.co/nelPH7QaKS https://t.co/zn7FyEyv5,1
Mary Ellen Schneider,1
7PMEST,1
@etenhacken,1
#LLSTRP https://t.co/WviHWIXRd7,1
CLLsm  https://t.co/qil4ADMRcK,1
just 4 hours,1
https://t.co/jZfozofjLw,1
#collaboration #,1
#Leukemia @MDAndersonNews,1
https://t.co/IwT8tHj0OS,1
https://t.co/ozAcydcbI7  #liketakingyoursunglassesoff #highintensitysignals #,1
Pelotonia,1
https://t.co/VSoRNpjEXE,1
Incepta Pharma,1
@TalesToolkit,1
TalesToolkit,1
UnmutatedIGHV,1
#CLLPatients https://t.co/obyiqxn3TK,1
#MATE #AMER #,1
#FCCN #,1
https://t.co/JKa19WzHFH,1
Online Exclusive From HemOnc Times,1
FDA Approves Ibrutinib/Obinutuzumab for Treatment-Naive Patients,1
7 p.m. EST,1
ritux,1
postash2019 https://t.co/uHU3nfcRzr,1
https://t.co/i3Wv2XyG7d https://t.co/xVbLF0Hz6r,1
https://t.co/ZZDQDQyRSQ,1
https://t.co/iFBiNKKB0K #,1
PakistanPatients,1
BIRC3 Expression Predicts CLL Progression,1
Defines Treatment Sensitivity,1
https://t.co/9Yq14TwfOC,1
obinutuzumab  (,1
https://t.co/UxoEBd3fWS @ASH_hematology #,1
https://t.co/sKkQSbarXm,1
https://t.co/YOuWoRCnd1,1
a Similar Path to Help Those,1
Krebs-Kombinationstherapie,1
Wissenschaftler,1
Wiener @CeMM_News,1
Methode,1
Kombinationstherapie bei Chronisch Lymphatischer Leuk√§mie,1
#IWillIn #,1
earlier today,1
https://t.co/O6HWSXfPMX https://t.co/2cQtKfFMJ9,1
#ResearchMatters #,1
@eps_unibham,1
@LJMU @SygnatureDiscov @ApconiXLtd &,1
more than 50 years later,1
BcL-2,1
Jan. 31,1
#MDedgeChats https://t.co/bVXWV7XtKX,1
https://t.co/0dxqs389Bw #,1
#ASH18 https://t.co/VfXw1nUuup https://t.co/OY8WVjY1Hc,1
Sur,1
Gazyvo,1
@Roche #,1
XSR362,1
SNA,1
Santa Ana,1
2575,1
70.9,1
181.8mi/h,1
09:42:42,1
#AboveTustin #,1
#CLL/#SLL https://t.co/mgcD7S5cji,1
https://t.co/iDhUaVVv9h,1
https://t.co/y2MRuKWtaZ,1
Roche's Gazyva,1
"#Treg'

https://t.co/LmcYZYURFD",1
Treg FUNCTION,1
@KjetilTasken,1
The PI3K p110Œ¥ Isoform Inhibitor Idelalisib Preferentially Inhibits Human Regulatory T Cell Function',1
@genentech @Pharmacyclics https://t.co/44aXDUvuE9,1
https://t.co/KjdSwhlkG9,1
Chile Lucha,1
Santiago,1
Chile https://t.co/qtAr29b14W,1
DRGOncology,1
HORSHAM,1
"Jan. 28, 2019",1
Previously,1
Watch here&gt,1
NationalStorytellingWeek,1
Westwood Campus,1
Mondaymorning https://t.co/UfHiRfNKps,1
Duvelisib Provides CLL,1
Ya nos encontramos,1
el ambiente veraniego de SummerFest de @chileluchalibre,1
Centro,1
"#MDS
 ",1
https://t.co/j6Dl7Rhghf,1
Ibrutinib-Opdivo Combination,1
just 25%,1
https://t.co/IFABZKn5wM,1
https://t.co/O33ggTR2q5,1
acccardioonc,1
##IVIG,1
#murica https://t.co/wld3pjtOzl,1
https://t.co/QcfSbualZ5,1
January 31,1
the Lymphoma Coalition Europe's,1
Lymphoma Community Advisory Board,1
https://t.co/Win42dLjAv @knowyournodes,1
LymphomaAware,1
Tweet Chat,1
the Alliance North American Intergroup Study A041202 comparing,1
Valeria Spina,1
https://t.co/bqOhB4jWZp https://t.co/XeG0yd8VUt,1
Anne-Sophie Paquet,1
#cll qui,1
avec sa,1
Concours en #entrepreneuriat agricole,1
https://t.co/VSg1QhaYQh,1
Newcastle,1
@NewcastleHosps,1
https://t.co/KM5eLc5f0L,1
De Marr,1
https://t.co/AadWOdqR7n https://t.co/eAPU3o3VLE,1
Gutbacteria,1
Akkermansia,1
https://t.co/soM3Bblsus,1
Jordanian,1
Annals of Diagnostic #Pathology,1
cll https://t.co/mhB9IVMOny,1
#MDedgeChats https://t.co/xLRLwEPn43,1
between #ibrutinib and,1
#bemcentinib #,1
BGBIO https://t.co/tHSBY8s0eJ,1
termine avec une discussion,1
un beau tour d'horizon,1
l'IA,1
https://t.co/rjuALXeEc9,1
CLL Rewards,1
TradingCompetition,1
Airdrop,1
MDedge Hematology &,1
#MDedgeChats https://t.co/Uq949RNZQ2,1
7-8 pm ET,1
#ASH18 https://t.co/VfXw1nUuup,1
ofatumomab,1
l'intelligence artificielle,1
C√©gep de L√©vis-Lauzon,1
#ia https://t.co/YyVoSrd95U,1
Leukemia Child,1
#immunesystem,1
NCIC,1
https://t.co/SAUK4R8zQH,1
https://t.co/pRhz70lYPW,1
#EPIC,1
#DIS #,1
#CLL #AGK #,1
#ANII #,1
MER,1
https://t.co/gUW6xAWcsK https://t.co/ZdNJp1YEjM,1
age 45,1
age 51,1
Indiana,1
Zanubrutinib Versus Ibrutinib,1
https://t.co/OhpWDuBG0Y,1
#ASH18 w,1
Podcast w,1
Le #cll,1
FAT,1
#proteomics #,1
https://t.co/gr5SPUiDVd,1
Propellants,1
https://t.co/7riNkm9XtC,1
i(17q),1
Yayyyy,1
6 day,1
GRATITUDE,1
#Iron #,1
#NFL #,1
ImmuneSystem,1
#DIS,1
FNA,1
SUVmax &gt;10,1
Postdoc Position: Microenvironmental,1
Masaryk University,1
Veronika Bachanova,1
ClinicalGuidelines,1
'excellent,1
https://t.co/L2hEsR30Vz,1
Cello Health Plc,1
"November 18th, 2018",1
#fnb2020,1
Facebook https://t.co/rOOcCPFtIO https://t.co/wwdMDIzxVo,1
User,1
Adspace,1
#CLL #CryptoLiveLeakToken #,1
Healio SAN DIEGO,1
Editorial Board,1
3 - 5 PM EST,1
https://t.co/5vpN8YR4Ob @CllSociety,1
#clinicaltrials https://t.co/nJ6F3Po0FB,1
Jan Rynne,1
tweeteaba ayer,1
el grupo alem√°n tambi√©n lo tiene claro,1
https://t.co/gkUlbqaeOa,1
5+,1
"https://t.co/M5vkhBsiWB
#",1
https://t.co/BNVrWJQxwj,1
Loyola #,1
Scott Smith,1
"this Saturday, Jan. 19",1
https://t.co/5vpN8YR4Ob @CllSociety https://t.co/XPtX5i7KQb,1
#Advertise #Marketing,1
Journal of Clinical Pathways,1
MEK1/2,1
MK2206,1
https://t.co/6cxQEFeyb5,1
ASO,1
@iofinaplc,1
IOF,1
@wealthkw,1
KWG,1
@Synairgenplc,1
SNG,1
https://t.co/bpORnWPfcS,1
a Berlin Office,1
PRV,1
~$125M https://t.co/QDRrKtAKs3,1
Doelgerichte therapie,1
#therapie #,1
https://t.co/r8uY33c9ZS,1
#MDS https://t.co/nelPH7QaKS,1
practice &amp,1
ASCOReadingRoom,1
https://t.co/EYxc9xc8uM,1
#MDedgeChats https://t.co/AadWOdqR7n,1
Primary Healthcare,1
Other Options,1
mono- &,1
https://t.co/ND4BJrSmlw,1
11 May,1
Nov;30(11):564-6,1
Lyme,1
F√§tkenheuer,1
Staib P,1
Reiser M.,1
"#BloodCancerTreatment
",1
Deadline for Expressions of Interest,1
January 2019,1
@LeukemiaLymph explores,1
Nordic,1
"more than 2,500",1
#cllsm https://t.co/aP4uJZuyzM,1
https://t.co/UFC4SeF2kL https://t.co/BhJAk9qKsq,1
New Copay Assistance Program for Individuals Living,1
The Assistance Fund: The Assistance Fund,1
#braincancer #,1
1/2a,1
‚Å¶@TheLancetHaem‚Å© #,1
INTERESTING &,1
IMPORTANT TREATISE @BloodJournal re,1
https://t.co/Y5TQ7Hu7Qq,1
https://t.co/7TCMbc5xNc,1
#DNA #,1
https://t.co/wTPNUB8yeS @ASH_hematology #,1
Loyola Medicine,1
@cancertrials_ie @IrishCancerSoc &,1
the New England Journal of Medicine @NEJM,1
Nordic CLL Study Group,1
SAKK,1
Cancer Trials Ireland,1
Israel CLL Study Group,1
"around 3,500 to 4,000",1
Watch Kate,1
the last 20 years,1
#LymphomaStory #,1
Landmark,1
Prithviraj Bose,1
https://t.co/G26x0QPHKC,1
https://t.co/OpeX8kvBzR https://t.co/o5qmMtT3On,1
@ALLIANCE_org Learn,1
#clinicaltrials  ,1
"@VJHemOnc
https://t.co/0zwD7hyyeB",1
@DrRaulCordoba &,1
Jennifer Woyach‚Äôs,1
https://t.co/t8eGnzLxXU,1
@BiologySexDiff,1
https://t.co/z6xi8OnRVF,1
PERLE,1
https://t.co/WES8LENCOQ,1
#HematoClinicBcn #,1
Jan 2019,1
sintilimab,1
anti-PD-1 &,1
9 year old,1
The Practical Implications of the Rise of Targeted Therapies for,1
https://t.co/aisO90DndQ,1
Villa-√Ålvarez M,1
Gonzalez-Rodriguez AP,1
Payer AR,1
Gonzalez-Garcia E,1
Villa-√Ålvarez MC,1
L√≥pez-Soto A,1
Duvelisib Feasible,1
Pour info,1
https://t.co/C2XXK7qeXU,1
Epigenetics &,1
Chromatin,1
https://t.co/pr7OO179o9,1
ALLIANCE &,1
https://t.co/KE0v8M2ZvG,1
BloodCancer @healthwatchDton @darlingtoncares,1
Catch Optum #,1
https://t.co/97t5faoyDv,1
https://t.co/pcA8Wg4Adh,1
@eaonc Learn,1
https://t.co/GGIc7xa9BU,1
Congratulations Sara,1
@EpigenChromatin https://t.co/MPiwU1tLiG https://t.co/yKm8RfR15s,1
first Sunday of the year,1
Geriatric Assessment in Hematology,1
GAH,1
#MMsm #,1
GeriOnc,1
rituximab‚Ä¶ https://t.co/JMDqBeIeng,1
https://t.co/V7lHJwalxG,1
between #mmsm and #CLL,1
IgL,1
IgK,1
Fixed-Duration #,1
Baliakas,1
5+abn,1
t12+t19+CK,1
https://t.co/nZeAxacLZh,1
https://t.co/G4O2cpVzpO,1
@anthonymatomd CLL,1
#lymsm #lylmm #,1
https://t.co/fYeKtpzsbx,1
https://t.co/6dkJIkqv7,1
https://t.co/hbXRqvlIPF,1
https://t.co/p7sYgLYqeC.,1
OpenAccess https://t.co/DF2T7UJHQ7,1
https://t.co/FrXjNyxt3O,1
"more than 70,000",1
@LBCNZ,1
New Zealanders,1
#NZ,1
Chemotherapy-Free Regimens,1
West Nile,1
https://t.co/JZrst71iag,1
JCI - PI3K p110Œ¥,1
R-Chl-Len,1
FREE Workshop,1
https://t.co/1ixSllNB6O,1
TruthBeToldSeries,1
Plasma Cell Disorders,1
MPN/MDS,1
hematology https://t.co/1UTa47Kvyr,1
#leusm https://t.co/d9DUXO3yPw,1
#health #treatment #,1
https://t.co/9c9uUqqfhH,1
FixedDuration Venetoclax Triplet Active,1
Kerry A. Rogers MD,1
https://t.co/lWhfBxEWKX,1
the last 12 months,1
https://t.co/EScWexprpa @ASH_hematology #ASH18 #Immunotherapy #,1
https://t.co/zNrhSczAPP,1
Bachanova V,1
Weisdorf DJ,1
Wang T,1
Marsh SGE,1
Cer,1
11 percent,1
https://t.co/qWRxOZvwpt,1
Twitter https://t.co/1t3DRAFi7N,1
https://t.co/YLex7Uwq8,1
https://t.co/7mTaP37nms,1
https://t.co/MIcX1zhkSA #leusm,1
MayoCLL,1
https://t.co/Wub5fhuYSW,1
Leventhal,1
2da,1
Harry Potter de @Cajas_CLL,1
#unboxing,1
#harrypotter,1
#kithp #,1
https://t.co/UFC4SeF2kL https://t.co/qRZnT3y5zS,1
MALAT1 lncRNA,1
1 Feb 2019,1
#NAK #,1
SGI,1
#JLT #,1
#MANX #,1
https://t.co/Gw4G8HB3im,1
https://t.co/E8R80VqaTn,1
https://t.co/YuvdKTmkD0,1
https://t.co/bVYl6ita4d,1
Identify Novel NFAT2 Target Genes,1
Jennifer R. Brown's,1
DrBrown #DrBurger  @sloan_kettering @harvardmed,1
"ECM 

https://t.co/LKHF3chb1L",1
https://t.co/4XqLSi1MK0,1
ü§î Yayyyyyy,1
few days,1
MRD Neg https://t.co/2nuz2mNK6u,1
la suivante,1
eu,1
bilan annuel de votre vie,1
MerryChristmas,1
Payroll,1
FREE Resources,1
#1 Solutions,1
https://t.co/Y6no7bGFZG @ASH_hematology,1
https://t.co/FGxcL811Pt,1
Ibrutinib -Associated Atrial Fibrillation,1
CLLsm ‚Å¶CC @TeresaLpezFdez1‚Å©  ,1
https://t.co/w3YBW6yG9G,1
Graft-Versus-Host Disease Are Associated,1
#PEB #,1
#TSTL #AMER #,1
#ENET #,1
#LSAI #,1
https://t.co/avQvtv8Lnq,1
https://t.co/w6LidcfnLG #,1
.@CancerNetwork -,1
#ASH2018 https://t.co/0LPV6lYMrI,1
#Medicine #,1
@LeukaemiaAus @lymphomaOz &amp,1
https://t.co/GVSuNWcYJc,1
Yahya qui,1
365 jours de ton,1
tu,1
la joie,1
tu flirteras,1
tu trinqueras avec la chance,1
3396,1
xplosionoficial presenta desastre total,1
TargetedDrugs,1
#LOOK #,1
#MWG #CAML #,1
TRCS,1
https://t.co/cJTCEbSvNS,1
30-month,1
https://t.co/IfkJpqSCzH,1
#clinicaltrials https://t.co/YWGFEL2OPT,1
https://t.co/wJBfiDl1gO #,1
https://t.co/yfm30ir59S,1
Ham Wasserman Lecture,1
#HRN,1
#PGR #,1
#APH #,1
FX,1
https://t.co/MBpOAsDzfN,1
#JCAR014 and,1
#leusm https://t.co/7CFbXCoN71,1
#KEFI #,1
#TALK #,1
#QFI #,1
AcademicTwitter @UofGMVLS https://t.co/CpWjHXnLEP,1
https://t.co/miXNOI2z7f,1
https://t.co/yG3FEUIF03,1
https://t.co/mYRy9SHH0k,1
5-day,1
NCTN @ALLIANCE_org,1
65 and older,1
1‚Äì1b,1
Curly O'Callaghan,1
Churchill Hospital,1
PostDoc &,1
#PhD #,1
#RNA s,1
https://t.co/MIcX1zhkSA #,1
#CLL Medscape's,1
ClinicalTrend,1
Consensus,1
the Broad Institute,1
Obamacare,1
https://t.co/jFIjxlD4eD,1
All Personal Health - https://t.co/C9YiYYf9GQ,1
Jennifer Woyach's,1
65 and,1
US Government,1
https://t.co/KzqEx8ZoTo,1
https://t.co/rQ85UiA26N,1
https://t.co/Eq0WcvB5eB https://t.co/xem6gGixrL,1
Natalie Grover,1
An Update on CAR T Therapy,1
12/19/18,1
https://t.co/TsT1HKiR4p,1
#mmsm #mbtsm #,1
Medscape,1
https://t.co/6YZiackFZR,1
#„Ç¢„Ç´„É©„Éñ„É´„ÉÅ„Éã„Éñ #MCL #,1
Block Listing Update,1
Ibrutinib/Obinutuzumab,1
przewlek≈Ça bia≈Çaczka,1
nie rozmy≈õlam,1
nie zamartwiam... nie przejmujƒô,1
tylko,1
zobaczysz,1
1700,1
Attention Mining - #,1
BJ Haem,1
16.4 months,1
LargeBcellLymphoma,1
FollicularLymphoma https://t.co/8dtLLa5P1x,1
medical advisers &amp,1
#12daysofLA #,1
CCL4,1
https://t.co/vb3NlSNRfN,1
#ibrutinib #rituximab #ASH18 #,1
#symptoms #,1
monoallelic,1
#leusm https://t.co/DMS8VSVjpK,1
Front-Line Treatment of Older Patients With Chronic,1
Venetoclax/Rituximab,1
@Kreftforeningen,1
obinutuzumab-venetoclax,1
Credit,1
Auden Utengen,1
@symplur,1
https://t.co/wfWL4FSeR2,1
Ask The Expert,1
https://t.co/WvhiKvcPxP - #,1
#Blood_Cancers,1
#CancerScience2019 https://t.co/qwWbegp1mw,1
https://t.co/9R5qENgIVy @ASH_hematology #,1
https://t.co/SpGUYgiPNW @ASH_hematology,1
24 #,1
@parkerici,1
The Data Presented In The #ASH#18 Provide Evidence Of The Benefits Of First-Line Treatment,1
https://t.co/GeiPWO0bxY https://t.co/Unig6QQbbQ,1
https://t.co/qcj1kn3EX7,1
#LLSCDP,1
#LLSSCR #,1
#ASH18 https://t.co/Iyi52uW4lL #ASH18 #LucidQuest #,1
Feature,1
"Ott, Brown",1
https://t.co/aov4cFi76B,1
Erstli,1
https://t.co/jE3dbOGC3e,1
Erstlinienbehandlung,1
mit dem,1
Therapiestandard FCR,1
"DrBrown #DrBurger
https://t.co/T4JAEUEW8z",1
Lisocabtagene,1
81.3%,1
43.8%,1
#ASH18 https://t.co/ysdzf5k22Q,1
pembrolizumab plus umbralisib,1
https://t.co/qNSVX4pe6l,1
@Nninitaa,1
https://t.co/PmUyQ86KKm,1
CancerMutations,1
4.4%,1
https://t.co/TH38p7L573,1
#duvelisib $,1
https://t.co/a8P6btCFQ9,1
https://t.co/uXY7Saub79 @Ericllorg #ERIC18 #,1
InternationalMeeting,1
MedPage Today,1
Complete Coverage:,1
Deborah Simms,1
MURANO #,1
Recent Clinical Trials Highlight Potential of Targeted Therapies for Multiple Myeloma,1
https://t.co/6zTIJeqEQF,1
@Ericllorg #ERIC18,1
https://t.co/OGGzHllxnt,1
@ChelseaFC https://t.co/OcINI4u89L,1
https://t.co/h2PbTfLHMq,1
rituximab - outplays,1
#ASH18 https://t.co/wUsZ8ytj80,1
https://t.co/56kutPnEX8,1
https://t.co/h2J8fvWlxn,1
#endcancer #leusm #,1
#ASH18 #CLL #,1
PTCL - ‚Å¶@VJHemOnc‚Å©  ,1
Medscape Oncology,1
Gly101Val,1
https://t.co/l8i7QJV164 #ASH18,1
#Thrombosis #,1
#CaxTx #,1
FCR PFS,1
@eaonc #ASH18 #ASH2108,1
TargetedOnc,1
PhysRelat,1
Drs Porter,1
https://t.co/pSWtGNWKMG,1
Last night,1
@stjamesdublin,1
#clinicaltrials awareness,1
Only 3%,1
Patrick Kivlehan,1
üá™üá∫,1
@Twitter https://t.co/AODe9gLijX,1
TargetedTreatment,1
last daily,1
Drs Lamanna &,1
https://t.co/PB7ddq9xKl,1
"https://t.co/9X077jKKFu
",1
"LeukemiaMDA 
",1
#endcancer #leusm #ASH18 #,1
BTC Trading Pairs,1
#btc #kanga #kangaexchange #crypto #,1
Chemo-Free Treatment Best Option,1
Desire,1
#One,1
https://t.co/T88onLAXUP,1
https://t.co/UmwFm8c0bk,1
https://t.co/FBudFjAGWT,1
Ibrutinib ÿßŸÑÿØŸàÿßÿ°Ÿè,1
New Study Provides Evidence,1
Docs ü•º,1
https://t.co/kiQjHaVXMp,1
https://t.co/hqB94C3CxF,1
w starszym,1
#bia≈Çaczka #,1
Haematologica Review,1
#CLL https://t.co/qr57CYV6mx,1
@APHP: https://t.co/PMEZ0uk8NY @Ericllorg #,1
F.. https://t.co/1NPZRlP38v,1
#ASH18 @AaronGerds,1
Article: https://t.co/l4gnMOVrPG,1
Ibrutinib Beats Standard Chemoimmunotherapy,1
https://t.co/OzPxgnQGv0,1
Influential,1
Shannon Maude,1
#ASH18 Article,1
venetoclax/rituximab,1
#ASH18 this morning,1
SUPERSTAR,1
TY,1
#sundlivsstil,1
#nyestudierp√•cll #,1
#medicin #,1
#telemedicin #,1
#kronisklymfatiskleuk√¶mi #patienter,1
https://t.co/ubSJefj3EK,1
#ANP #,1
#ARB #,1
#JSG #,1
#SickleCell #CLL #,1
VTE,1
#medics,1
#PACES #,1
EA,1
Late-Breaker,1
JoVE https://t.co/JtCfVoM41s,1
https://t.co/1LGPVrqwpl #ASH18 #,1
#lovemyjob https://t.co/LWwO2d2wDR,1
#Leukemia #ASH18 #,1
#leukemia https://t.co/hpEBi7golx,1
HemOnc Today,1
#leuke mia,1
CLL @Pharmacyclics,1
https://t.co/92Jc87kO9c,1
https://t.co/B7RW95kb9,1
Late Breaking,1
#venetoclax  ,1
TheJames,1
#CLL Hero,1
https://t.co/n8i8OTW9d5 https://t.co/9IYhHVcO9b,1
#ASH18 Piers Blombery,1
Combination Regimen Significantly Improved Survival Versus the Chemoimmunotherapy FCR (,1
less than 70 #ASH18,1
#ASH18 https://t.co/x0corYwFVc https://t.co/0DkU4KpwOC,1
Dr Shanafelt,1
III Ibrutinib-Ritux,1
#ASH18 Shanafelt,1
Bruton's,1
#ASH18 $,1
#ASH18 Tait Shanafelt,1
age 70,1
Stanford U,1
Dr Kater,1
VenR #,1
Relapsed/Refractory Leukemia,1
https://t.co/pJVYojFRXt,1
HallAB,1
7:30am,1
Dave Maloney,1
FHCRC,1
#Blood_Cancers #,1
@Patients_Videos @CRGHaem,1
Phase 3 Combination Data,1
Obinutuzumab Finds Significant Improvement,1
Doctor‚Äôs,1
#ASH18 press,1
TrialWatch,1
#AbbVie‚Äôs,1
IMBRUVICA¬Æ Data,1
7-Years,1
ILLUMINATE,1
del11q,1
#del17p #ASH18 #,1
Watch ‚Å¶@ginacolumbusonc‚Å©,1
@William Wierda,1
@anthonymatomd @UjjaniC &,1
Venetoclax Improves Quality of Life for Patients,1
Tara Cochrane,1
Anderson https://t.co/bvLp9CHvpT,1
@TheRMH,1
Dr. Byrd,1
#CLL #ASH18 #,1
trials‚Äî80 percent,1
#ASH18 Interview,1
Juno,1
the CLL Center of the Division of Hematologic Malignancies,1
https://t.co/O6HWSXfPMX #,1
#ASH18 https://t.co/Ylugyp9S39,1
#ASH18 Inhye Ahn,1
https://t.co/3gMuTCQtxH #ASH18,1
#SoMe #geriheme #,1
@HKlepinMD,1
#geriheme #SoMe #,1
https://t.co/XHtwSwHatQ,1
#ASH18 Kerry Rogers,1
https://t.co/zay2Nf54QY,1
Ballroom 20A,1
1130,1
Thomas Lew,1
4431,1
Ouderen,1
#ASH18 Daily Wrap Ups,1
6 pm PT/9 pm ET,1
https://t.co/aGgfrhhi1X  #,1
@hematosantpau,1
https://t.co/2gc1gQdLDZ,1
https://t.co/UpphK5lyck,1
695,1
Cancer Drug Sensitivity Screening,1
HRU,1
#BTK mutations,1
Ibrutinib-R,1
&gt;65 years,1
https://t.co/U1Tp6xzntW,1
the Triple Combination,1
https://t.co/MNcickV2y5,1
Ibrutinib Increased PFS Vs,1
https://t.co/ToNEBLAPpA #,1
https://t.co/JglRKqZAVq,1
ASHenvy,1
@FWANDROO,1
Emma Frans,1
#skolaiv√§rldsklass #,1
Identified as Drug Target,1
Analyst,1
Mycket,1
deltagarna,1
klura,1
H√§nga Gubbe-program,1
#python,1
#microbit #,1
Lisa R.I.P.,1
#immunotherapy #ASH18 #,1
https://t.co/7TaG9tZo0E,1
@ASH_hematology #ASH18,1
#ASH18 Updates,1
Jordan @drjgauthier,1
#TrialUpdates #,1
SNSS Reveals Preliminary Findings,1
Study Evaluating Vecabrutinib,1
CRTI,1
#Bendamustine Plus,1
https://t.co/7TfbW2mBrW,1
@ALLIANCE_org A041202 #,1
3134,1
the Alliance North American Intergroup,1
#geriatrics #,1
Bendmustine-rituximab,1
87.9%,1
https://t.co/m7yUHiK2Cj,1
RCT Alliance,1
"Ritux + Ibrutinib
&gt;65y",1
547,1
PlenarySession @OSUCCC_James,1
@ALLIANCE_org #leusm https://t.co/lYgOei7JMi,1
https://t.co/vTywfrd3h8,1
#ASH18 Jennifer Woyach @OhioStateMed,1
Armando van Bruggen,1
#rituximab substitute,1
https://t.co/riag4GDjzF,1
6:00PM,1
the Hall GH,1
https://t.co/tgZyZmGEWv,1
David Lesoway,1
7-year,1
https://t.co/in3Z8bgfMV https://t.co/ggYIM6dIaq,1
first 3 years,1
#ASH18 VIDEO,1
Chemoimmunotherapy in Older #Patients,1
Leukemia https://t.co/kKzkaSh8sV,1
#Venetoxlax and,1
Surviv,1
https://t.co/tZIQfreADj,1
https://t.co/HJQH4K4Joi,1
tolerated &amp,1
three months,1
CLL Impressive,1
CAR T Cells in Combination with Ibrutinib,1
#ASH18 https://t.co/6gtnbVoK8,1
#CLL https://t.co/iPJ7Tc0D2b,1
PhysRela,1
#ASH18 https://t.co/LIJlxGM217,1
11:15,1
#ASH18 https://t.co/ZWFU3a4zU6,1
https://t.co/SC4qqw6wlS,1
Scott Armstrong,1
2138,1
#ASH18 üî¨ https://t.co/J18zlEM7XK,1
#ASH18 day 1,1
https://t.co/pBQTuLilLT https://t.co/LKbW7gHrr3 #ASH18 #,1
https://t.co/Fe84Ts76y9,1
the 2nd day,1
Catch,1
@VJHemOnc &,1
https://t.co/qrP5mYSLIq,1
#Lymphoma trials,1
ASH2018 https://t.co/Yxc4pNabtd,1
Ôºü,1
F Haroun,1
@JElkonMD,1
@NEJM https://t.co/g25BzsQanG,1
1928z/41BBL,1
immunoOnc https://t.co/4oYUmYOxZj,1
Maria Joao Baptista,1
4:45 p.m.,1
#ASH18 https://t.co/CHw472ZR46,1
"https://t.co/6RZeYVXnGN 
",1
@ASH_hematology,1
https://t.co/Q5UE3VSJxD https://t.co/c5kOVjFa2R,1
https://t.co/gTNimDNIAR,1
Minne‚Äùsnow‚Äùta,1
#ASH18 John Seymour,1
@Haem_pmcc_rmh,1
https://t.co/z1wQdSRKZm,1
https://t.co/RN1iILHbvC,1
rituximab no,1
"#ASH18 
",1
#microenvironment,1
https://t.co/iqFG21EGaq,1
his 33rd year,1
Ham-Wasserman,1
#ASH18 https://t.co/cyp2xW1GSq,1
the Ham-Wasserman Lecture,1
Micheal Hallek,1
about day 1Ô∏è‚É£,1
‚ùó,1
#milesvanderrohe,1
#michaelhallek #,1
12:30 p.m.,1
Hall AB,1
@VicompcancerCr @PeterMacCC,1
@AcuteLeuk,1
Jennifer Woyach @OhioStateMed,1
Maria Domenica,1
Thalassemia,1
Mayo Approach,1
https://t.co/O6HWSXfPMX,1
https://t.co/lceM118Jke,1
#CARTcells #ASH18 #,1
https://t.co/GxquAJlBg6,1
Ballroom 20,1
184,1
Great discussion &,1
#ASH18 State of,1
Qs,1
#ASH18 Novel,1
COST,1
#ASH18 Nuts n Bolts,1
#CLL https://t.co/D0lMFcfgGT,1
Jen Brown,1
CLL Center,1
6:15PM,1
The Future of Chronic Lymphocytic Leukemia,1
#ASH18 https://t.co/Teel9UMpS8,1
#ASH18 https://t.co/nq4uaQXWpz,1
https://t.co/fiehkUgdti,1
about #ASH18,1
@ALLIANCE_org North American Intergroup Study,1
Plenary Scientific Session,1
https://t.co/c3LmRhz9fy,1
FDAOncology,1
2889,1
Clin Trials,1
Survival Are Associated w/Pretreatment Modified Charlson Score,1
Dec 2 6,1
#ASH18üá∫,1
First Evidence of Dysfunctional Antigen-Specific T Cell Responses in Experimental CLL,1
12/1 3:15P,1
#ASH18 https://t.co/VNYwcTZA0n,1
Aberrations,1
https://t.co/SZLu56BEbU,1
https://t.co/fL8HJrWaAC,1
the Treatment Armamentarium,1
#leuc√©mie @myESMO,1
https://t.co/Gw4G8HSE9U,1
https://t.co/3UQPWD21F0 @Ericllorg #,1
Oncology Program,1
#CancerAwarenessUAE https://t.co/7oII64bvOn,1
1d,1
Zack @ZPWLC,1
CLL Doctors,1
@DrRaulCordoba @chadinabhan @anthonymatomd,1
@wwierda @DrAnasYounes,1
#DrStephanStilgenbauer,1
@uni_ulm @DrMiguelPerales,1
#cancerresearch #,1
Black Box Warning,1
https://t.co/EnazbEFluZ https://t.co/Q6WX1Rlp9B,1
trouverez ci-joint la,1
CE,1
20.11.18,1
"November 29, 2018",1
https://t.co/m2uYs7OeRV,1
64-year-old,1
5 months ago,1
https://t.co/kEEmzqtkwh https://t.co/bYdpwu9yAR,1
December 10th 2018,1
Pikesville,1
https://t.co/gKIcPCv2In,1
#caregiver,1
Dec. 1,1
https://t.co/TC4GX9CBkA,1
Promising Research,1
#Chlorambucil,1
See Chlorambucil,1
here&gt,1
https://t.co/K39btg6irh https://t.co/0UQ6KQaLyG,1
29062018,1
USD $2125,1
#ASH18 kicks,1
Celltrion and $TEVA's,1
ref product,1
#ASH2018 https://t.co/4x6JVAxKvC,1
https://t.co/11JZkC4As9 #,1
#leusm https://t.co/ZKI65dPxKu,1
#TP53 #Mutation,1
Jitka Malcikova,1
https://t.co/tn4FWILSpt @Ericllorg #,1
SSC,1
NguvuMoja,1
https://t.co/w5XBJhqWJU https://t.co/CdZyMSADHF,1
Dinner Event,1
December 2,1
#clinic,1
GlobalData,1
#ImbruvicaCapsules Exporter,1
Del Mar. Breathe,1
DG &,1
Janie Licosati,1
Anthony R Mato,1
Health Central,1
#journalism #,1
Walter Styer,1
https://t.co/jeUHRiyh1F,1
7.7bn,1
7MM,1
National Institute for Health and Care Excellence,1
https://t.co/QXtu0SqsL7,1
https://t.co/GGXHGcrHyu,1
Nadolig Fictorianaidd,1
Pwll Mawr,1
#CLl,1
https://t.co/VTJWHirBqz,1
https://t.co/hFcaF6EoP1 @Ericllorg #,1
Chris Dwyer &,1
Lisa Minkove R.I.P.,1
turtlelab,1
Willamette Valley #,1
Cancer Institute and Research Center,1
https://t.co/AYmbVSvZCA,1
Kan de,1
letterlijk tegen,1
hoofd helaas maken toch,1
Dus ben de ',1
https://t.co/uNBaFIOM3l @Ericllorg #,1
Fwd,1
3.5%,1
https://t.co/7bYhkflr8c,1
Everything You,1
#ASH18 - Targeted Alpha Therapy,1
RIT,1
Sangdun Choi @Sangdun,1
Review @FrontImmunol,1
aprendan enanos,1
#pisoton en,1
https://t.co/XW5gVs3j9X,1
https://t.co/TnaKQI1uVw,1
the Sapienza University of Rome,1
Rome,1
https://t.co/XYDRQ0lWBX,1
https://t.co/4YoFb91FPB,1
GlobOnc,1
11/29,1
#beinformed,1
"Topics Covered
Overview of Chronic",1
"the University of California, Irvine Health",1
https://t.co/rBy2VRbSLC,1
üé• #lymsm #,1
ScientificEducationSupport,1
https://t.co/DlfAUNOD9,1
https://t.co/xZa1E80dEQ,1
Rainham,1
@LymphomaAction‚Äôs,1
LivingWithAndBeyondCancer https://t.co/Q8xmpQaZES,1
Haematologica https://t.co/zuIKYk1kU0,1
https://t.co/qRH7IL1N03 @Ericllorg #ERIC18 #,1
‚Å¶‚Å¶@rule_simon‚Å©,1
ÿ£ÿ∂ŸÅÿ™ ŸÅŸäÿØŸäŸà,1
"Foundations
- Press Coverage",1
"Blockchain
- #",1
Hosting,1
"Speaking

Message",1
https://t.co/KGc9vIBBu3,1
https://t.co/W1jjXDArxP,1
Joki,1
Joki Turku https://t.co/OQt00nc8T5,1
#worldnurseryrhymeweek #roundandround #,1
MMSM,1
FREE Symplur Account,1
Hashtag Search Results,1
https://t.co/WiJ3ZPo6pK,1
#heme #,1
https://t.co/y02tsLlydy,1
#HemeONC #,1
#Globonc #,1
https://t.co/3S9bxwNXiZ,1
the Center of President Trump Spat,1
Battling a Rare Form of Cancer https://t.co/rmZGyKoVc5 #,1
Blood Journal - https://t.co/gJdqQJ5aud #,1
Blood Journal - https://t.co/2GRoIYi0u2 #,1
https://t.co/ToNEBLAPpA #leusm https://t.co/d8LqJFI9rX,1
https://t.co/rHGQJCizYX,1
Human Pathology,1
https://t.co/Y38VPWvuyU,1
Unga,1
Georg Henrik Wrede,1
Biocity Turku,1
2017Kaw100,1
KAW100,1
#KAW100 @karolinskainst,1
over #,1
#SIT #,1
#SLN #,1
#VLTY #DEST #ALM #,1
Better Health Award,1
@CIBERONC @AEMPSGOV @joseluis_pa,1
https://t.co/GNePwFCfMC,1
#eurekamag https://t.co/fYplHIFegq,1
DrBrown https://t.co/NNdI605PXU,1
Ralph,1
&lt;70 y/o,1
CIT (LBA-4,1
Ibrutinib/Rituximab,1
&lt;70 #,1
4ward,1
IMO,1
Managing Bleeding Risk in Patients With Chronic Lymphocytic Leukemia,1
Milton Aranha,1
Ibr/Gazyva &gt,1
"Clb/Gazyva
Ven/Gazyva &gt",1
"Clb /Gazyva

You",1
Ibrutinib + Rituxumab,1
November 27,1
#RealWorld #,1
https://t.co/4JaBvlBIy3 @Ericllorg #,1
#GlobOnc #,1
https://t.co/Gw4G8HB3im https://t.co/vneM6IMPx5,1
#leusm ‚Å¶,1
Darlington,1
9 January,1
#lymphoma inc,1
@bonell_karen @DarloCCG,1
https://t.co/rZkNsc9pYH,1
https://t.co/vWQnxarGp9,1
https://t.co/KMUoKDt8RI,1
Late Breaking Abstract Session,1
FRC,1
https://t.co/z6Y8VOzOEU,1
STUDENTS &,1
"#socialcapital
",1
„Éô„Éç„Éà„ÇØ„É©„ÇØ„Çπ‰ΩµÁî®ÁôÇÊ≥ï„ÄÅCLLÂØæË±°„ÅÆP3Ë©¶È®ì„ÅßÁÑ°Â¢óÊÇ™ÁîüÂ≠òÊúüÈñì„ÇíÈÅîÊàêÔºçÁ±≥„Ç¢„ÉÉ„É¥„Ç£ - QLifePro,1
Nursery Rhyme,1
#worldnurseryrhymeweek #,1
https://t.co/IlCsHD2Ad8,1
https://t.co/ZCeppKYNTM,1
6 mo ago,1
#caseoftheweek #radiology #,1
WTG,1
Bill McRaven,1
@houstonchron,1
War Hero,1
@GOP,1
the last 6 years,1
JCI - PI3K p110Œ¥inactivation,1
A Phoebe Needles Christmas,1
@CaraModisett,1
Condition Summary: Malignant Neoplasm,1
Lung Disease Chronic,1
Liver Failures,1
Renal Insuf,1
https://t.co/kwkavNHIrD,1
50 %,1
Tcellrx,1
Retired Adm. William H. McRaven,1
bin  Laden,1
https://t.co/7CVPq8OQmH,1
pr√≥ximo,1
al t√≠tulo de ngen,1
8 de diciembre,1
9 de diciembre,1
15 de diciembre,1
How I Treat In Brief,1
$ARQL #ASH18 #,1
ARQ531,1
https://t.co/d6eneaWmOS,1
Campo,1
Charity,1
CLL Champions,1
ThankYou,1
#YouMadeItHappen,1
Frank,1
CLLSA Treasurer,1
ThankYou Frank,1
CLLSA #Trustee,1
Nephrotic Syndrome,1
Rupert,1
a half years,1
ThankYou Rupert,1
YouMadeItHappen,1
John Moore,1
May 2011,1
Hillary Clinton,1
Obama,1
bin Laden,1
Combinations or Sequences of Targeted Agents,1
World Nursery Rhyme Week,1
@FeinsteinIMR,1
years ago,1
FAIL,1
https://t.co/E5O8Vx4mPn,1
CLL Treatment Advances,1
#thanksgiving,1
Salamat,1
"idelalisib, &amp",1
"https://t.co/UG6XY2ZJu6
",1
Leukemia Heroes,1
https://t.co/r4GLACL3ee @Ericllorg,1
#ERIC18 #,1
https://t.co/rMzocQLPIn https://t.co/ArOZAaFIe0,1
New Canadian,1
The Gigantic Turnip ü•¨,1
#PowerofReading #,1
SENP2,1
Current and Emerging Treatment Options,1
https://t.co/bqGqvN9JrH,1
Marwan Ghosn,1
Founder,1
Ayg√ºn Sahin,1
the National Chronic Lymphoblastic #Leukemia,1
#prognostic markers,1
https://t.co/BdV52dUccX @Ericllorg #,1
https://t.co/DZIIPG8PMU,1
https://t.co/EQfR9bF0WH,1
#CaGenome #,1
#chroniclymphocyticleukaemia,1
https://t.co/AD3ZXmVDyT,1
Xenograft,1
#LAHL #IRV #,1
#SIS #,1
IVDs,1
@IrishCancerSoc #,1
more about #clinicalresearch #,1
#classroomlearninglab,1
https://t.co/otz9bHb0I6,1
ERIC) International Meetings,1
#melanoma  ,1
ISPORBarcelona,1
#NovartisInternational AG,1
"#GlaxoSmithKline,#Teva https://t.co/FWwb3Ghfeb",1
THE UNITED STATES,1
CD20 &,1
Terry Strawn https://t.co/4q0ElfaDjs,1
https://t.co/XQNz8Ggukx,1
Ann Hewitson,1
Trasanidis,1
Nikolaos,1
#myeloma treatments,1
bloodwiseghd18,1
Prof Tatjana Stankovic,1
#luekemia #,1
#Hope w,1
https://t.co/cGAbgZGsBO,1
#Cellular #,1
Yohannes Gebreselassie,1
MIA,1
https://t.co/gc6ZRET7cX,1
https://t.co/ftFK2OHD1s,1
PD-1/PD-L1,1
https://t.co/cPX3ftAhGL,1
Discover @VerastemOncolog,1
Arnon P Kater,1
https://t.co/sRLNouUa5f,1
https://t.co/i6wGdoN6Nw @Ericllorg #,1
https://t.co/h9tiay3Aen,1
https://t.co/rKG3iRwvxx,1
#luekemia #leusm #Chemo2018,1
Melissa,1
Guard &,1
Frankincense,1
https://t.co/srcKOxI1w4,1
https://t.co/gfdsHkITzG,1
Karyotype,1
Lacrosse League,1
Zagreb Patriots,1
this season,1
#crolax #,1
#croatianlacrosse #growthegame,1
#lax,1
#laxlife #,1
https://t.co/K4XcjvRRbS,1
George Calin,1
19 Nov,1
@BigLotteryFund &amp,1
https://t.co/ehuHryTNy7,1
https://t.co/sRtz7da0ii,1
"Clones
Authors",1
Mehmet Yilmaz,1
https://t.co/50wR8B7xVs,1
@MDAndersonNews Physician,1
Louise O Driscoll,1
https://t.co/2erIwPBbmL,1
1 November 2018,1
Venclyxto¬Æ,1
#zanubrutinib,1
H2H,1
#multistakeholders #,1
#Prognostic #,1
our second day,1
"next Saturday, November 17th",1
https://t.co/KOlr2ocJbJ,1
Consultatant/Haematologist,1
T√©l√©journal Qu√©bec de 18h,1
#nettoyage #,1
CLL Global Research Foundation,1
November 28,1
1 PM CT,1
a 1 hour,1
Dina El-Sharkawi,1
Royal Marsden,1
@RCGP,1
https://t.co/YC4VSbsmiY,1
@scoopit https://t.co/p25kpABu0P,1
CellularTherapies,1
#Transplant to,1
https://t.co/0GjvnaOnXx @Ericllorg #,1
the Nov 19 live #,1
Two days,1
#eventmanagement,1
#meetings,1
Joe Park,1
#ALL &,1
Symposiumin #Madrid,1
@HematoLaFe @HospitalLaFe @TPHLaFe @GVAsanitat @monicaalri,1
@PatLacruz,1
@AEMPSGOB @IISLaFe https://t.co/LLRbdppAzc,1
#OncoPath #,1
DiseasePathways,1
SNAP,1
SUD,1
14h √†,1
Nimes St C√©saire,1
Perpignan San Vicens,1
https://t.co/HaT8bZIv2c,1
Dysfunction https://t.co/Zj4zIrYrMQ,1
George Canellos,1
CFS,1
Myeloma 2018 https://t.co/9KklwGiatK,1
Anaplastic Large-Cell Lymphoma,1
Burkitt‚Äôs Lymphoma,1
https://t.co/WQN7wbycVw @Ericllorg #,1
https://t.co/TaYXdw24J3 https://t.co/wjHtEDxhe7,1
Relapsed/Refractor,1
https://t.co/ot8QmHDqoI @Ericllorg #,1
#Caxtx #,1
https://t.co/HdWf4oUJSv,1
#CLL Biology,1
Ryan Zarychanski,1
Just 24 hours,1
#Yorkshire #,1
#Hodgkin &,1
#DrugTherapy #Leusm #,1
"Oct 11, 2018] Rogers et",1
the last 5 to 10 years,1
https://t.co/XJ0hllWFjp,1
LIH PhD,1
Marina Wierz,1
the XIth International Workshop,1
https://t.co/wC1Eu45W3l https://t.co/ahSlMk2YUl,1
#SYS1 #,1
VCP,1
#DOTD #,1
https://t.co/pdEdMWTLdw #Cancer,1
Catherine Wu's,1
System,1
LLSScholar https://t.co/Zd3msi34UN,1
#tumor_neoantigens #,1
#neoantigen_prediction #,1
Chris Jones,1
November 1,1
Alkoxy,1
PP2A,1
Bad,1
Brunati,1
https://t.co/fia4x8U9to #mitochondria #,1
PP2A @DiBio_UniPD @UniPadova,1
#Microenvironmental,1
SignalingPathways,1
https://t.co/UnqAIIboD4 #Standards #M√∫sicadelatarde #,1
TranscriptionFactors,1
Lymsm #Epigenetics #Genome #,1
@ICOnoticies @UAHes,1
DrugResistance,1
https://t.co/vsEASlQuk1 @Ericllorg #,1
https://t.co/loln6iS3oS,1
Dr Bill Wierda ‚Å¶@wwierda‚Å© | ‚Å¶@LeukemiaMDA‚Å©,1
#leusm  https://t.co/0pDa4xgYzi,1
Ventoclax+Rituximab,1
Andrew Davis,1
#Venetoclax/#Rituximab Combo Approved,1
#Venetoclax Plus,1
EuropeanCommission,1
#rituximab https://t.co/HbCZGA6P2C,1
#Venclyxto #,1
the Abramson Cancer Center of,1
the University of Pennsylvania,1
the Nov 13th,1
plan &amp,1
Heats Up,1
AbbVie/Roche Upbeat,1
AbbVie/Genentech's,1
https://t.co/K2hhnRrOZ5,1
MRD4,1
23/40,1
17/41,1
&gt;65y,1
71y,1
#VEN #,1
@PatLacruz @joseluis_pa @DrMiguelPerales,1
Roche/AbbVie,1
CLL PhIII,1
https://t.co/U3SlxTG4Oh Phase III Data Showed,1
#UBI #,1
https://t.co/OyjjOHt8FK,1
"#ASH18

",1
#HEMO2018 #,1
only 1.9%,1
65y,1
https://t.co/Zmwq9w4fea,1
https://t.co/SDlq6hq4l3,1
#Medicine #Pharma #,1
TrendingNews Today: Combo Therapy,1
https://t.co/wVBG0aawlq,1
https://t.co/JoCcRbja6Z $ROG,1
obinutuzumab outperformed chlorambucil + obinutuzumab,1
#Venclexta Plus,1
AbbVie Receives European Commission Approval,1
#leusm https://t.co/IOYtQSiWHn,1
Ibrutinib Gazyva Combo,1
https://t.co/elKqnQIvT2,1
CMScript,1
#CMScript #,1
Haematological,1
https://t.co/qTKcFFDQMW,1
https://t.co/8W3sDFKGje,1
the Treatment of Patient,1
https://t.co/Z1sXBdLKOh,1
https://t.co/7UNgIjR0oc,1
#MTW #GFIN #UKW #,1
#AOR #,1
#HNR #,1
$17 million,1
dubbed INVAC-1,1
Epigenomics https://t.co/lCQADpRyWs,1
#CLL https://t.co/1EV4WAsEiR,1
https://t.co/L7c8HVY36x,1
@CUCancerCenter,1
"https://t.co/OcoOFJeAYq
",1
Sab√≠as,1
Iniciativa,1
Investigaci√≥n,1
BCN,1
@sehh_es @Hematocat @Hematored,1
Mayo Clinic CLL,1
Spring 2018,1
#discussion #,1
Ronnie,1
#feelinggood,1
around 15yrs,1
the last few weeks,1
Leukemia Fundraiser https://t.co/W7SjaNHi8,1
#EBMT17  ,1
Barosi G,1
Danesi,1
Kanti Rai - a,1
#mentor #,1
"CLL 

Great",1
Moffitt Cancer,1
"anticanc√©reux INVAC-1
Phase II",1
@MDAndersonNews √† Houston (USA,1
https://t.co/kkODV99IQq,1
https://t.co/ebzIzoCqA5,1
"https://t.co/Gdk7sxI4tF 
#",1
https://t.co/2CFL8WAnuy,1
https://t.co/JbEEQxjJUo,1
28102018,1
Malek S.,1
Oct 23,1
Gene Disruption Using,1
CRISPR-Cas9 Technology,1
Hu N,1
Malek SN,1
"https://t.co/Cfox43KHea
#",1
CRISPR/Cas9-Based,1
Wu K.,1
Malek S.N.,1
5 year old,1
"@MediaplanetIE

https://t.co/cSXFuT9GaJ",1
Immunogenetics,1
üôè Blanca Espinet @imimat,1
Florence Cymbalista @HopitalAvicenne,1
Alessandra Tedeschi @nig_onco &,1
üí¨üé¨  ,1
#ERIC18,1
@WilmotCancer,1
https://t.co/4Fwq2IHrZv,1
ASHMHM18,1
Landscape,1
about #InformedConsent,1
Associacao Portuguesa de Leucemias,1
Linfomas APLL,1
Lisbon,1
#CLL https://t.co/Cihc3XoRcl,1
https://t.co/YfBJbHBd8E #,1
less than half,1
@EMA_News,1
November 13,1
John Seymour @PeterMacCC,1
Peter Hillmen @LeedsHospitals &,1
üôèüí¨üé•,1
Andreas Agathangelidis @INAB_CERTH,1
Jikta Malcikova,1
MonoclonalAntibodies,1
üëâ @VJHemOnc,1
#leukemia #AbbVie #,1
#ERIC18 @Ericllorg,1
Elias Campo &,1
#medgenome #genetictestingindia #,1
https://t.co/libTmonMUE,1
B-Cell https://t.co/M4ePeX84lv,1
https://t.co/AO9orVF8Ni,1
https://t.co/c7BRmtiyEP,1
$CELG #,1
‚àí Ph III,1
‚àí Data,1
Kanti Rai @NorthwellHealth üëè,1
@Ericllorg #CLLsm #Leusm,1
https://t.co/VY9I7EEbcf,1
#ERCSyG dotada,1
limf√†tica cr√≤nica,1
FollicularNHL,1
#OS https://t.co/K6K9eoAegJ,1
https://t.co/ORnIeXJZdB,1
https://t.co/LaCKFiOg7a,1
Waldenstr√∂m‚Äôs Macroglobulinemia,1
#IvoGut,1
https://t.co/vvuKIhM8xn,1
rituximab https://t.co/2ctrpWaOGm https://t.co/EzdLsklr3j,1
BeiGene Announces Acceptance,1
Pati,1
SLL https://t.co/tZXxNysbZ4,1
https://t.co/tMsHVA4UGY,1
https://t.co/086NNhx3W1,1
Peter Mac‚Äôs,1
Prof Andrew Roberts,1
Victoria Prize,1
Life Sciences,1
https://t.co/501EAvMSKh,1
https://t.co/rNwBHGPXJN https://t.co/jesEJyCfmA,1
all four,1
World Junior,1
#IvoGut &,1
Synergy Grant,1
#ERCSyG #,1
"BCLLatlas

‚ñ∂",1
Fighter,1
ERC,1
I√±aki Subero-Martin,1
#EliasCampo &,1
YESSSSS,1
#ERC #,1
"100,000 #",1
31 October 2018,1
#Crypto #kangaexchange #,1
https://t.co/TrB3WMchGA,1
https://t.co/Ef6iBJOLso,1
#LeuSM,1
Connie Robinson,1
Mayo Clinic's,1
https://t.co/4Rl97Zl2lR https://t.co/rZ7bCCo3Xx,1
only 3Ô∏è‚É£ days,1
üìΩ üëâ Follow,1
November 13th,1
#blodcancer #patienter,1
#leusm https://t.co/VopX2Z0qFq,1
https://t.co/gegT8yls1L,1
Nirali N. Shah,1
10/25,1
https://t.co/RGi1pUCWha,1
SundayMotivation,1
@GVAsanitat @GEPAC,1
https://t.co/gJiRQ1aR6T,1
14082018,1
This Monday,1
5Ô∏è‚É£ days,1
Treatment,1
#leucemia,1
@HUInfantaElena,1
268,1
#workshops #,1
#edicational #,1
#ESMO2018 #,1
Munich,1
#LymphomaMyeloma2018 ' https://t.co/Eqh49NVks5,1
Oct. 20,1
UnMaskCancer,1
#cancer research,1
Tickets &,1
Mosaad Zaki E,1
Mohamed Zahran,1
Abdelazeem Metwaly A,1
Hafez,1
Hussein S,1
Elaiw Mohammed A,1
@TheBMA,1
Great Day,1
#LymphomaMyeloma2018 Congress - Dr.,1
1142,1
#LymphomaMyeloma2018 #,1
https://t.co/gMengu8SYp,1
Flinn @SarahCannonDocs,1
https://t.co/fnBkwt1JNf,1
Gazyva for Chronic Lymphocytic Leukemia,1
https://t.co/SdkkRFK7Cm,1
#Fast50 #,1
#STVG #,1
https://t.co/aFSWOAQ0ym,1
MedGenome,1
Tallinn https://t.co/1c4DUTRjnF,1
prioritaire la,1
1L de traitement de la #Leuc√©mie lympho√Øde,1
l'#obinutuzumab (Gazyva¬Æ,1
10.1038,1
Gazyva obinutuzumab,1
https://t.co/6d9SqoSCf3,1
AbbVie Announces Supplemental New Drug Application,1
AbbVie Announces Supplemental New Drug Application Accepted for Priority Review,1
https://t.co/gIrZT6CNFQ,1
https://t.co/0S348JliG3,1
ibrutin https://t.co/AXZoOm1efM,1
IMBRUVICA In Combination With Obinutuzumab For Previously Untreated Chronic,1
https://t.co/iQIgA5Vvwe,1
#genetictest #,1
#medgenome #,1
https://t.co/pHxh7bwgaS,1
Love Tanner‚Äôs,1
Tanner,1
ü§îYou,1
https://t.co/KqsnmR3vj6,1
#CLL Center,1
James Cancer,1
#birthday #,1
#gatvol #,1
Venetoclax Plus Ibrutinib,1
los z,1
bƒôdƒô,1
nie daj,1
Bia≈ÇejSuce,1
z lewa czy,1
prawa,1
co≈õ po≈ºytecznego,1
Epocrates,1
#CLL https://t.co/KDhN0zQe8r,1
CLLsm https://t.co/JUxGVjcyM7,1
Oct 17,1
15:30h,1
Multicenter Study,1
Leukemia https://t.co/3SvTua9pGa,1
https://t.co/lh4Kcb8gmW,1
Interesant√≠simo,1
nos escapamos,1
podemos,1
AnneMarie,1
HAI2018,1
@IrishCancerSoc https://t.co/QtGUct3Oq9,1
Novel Agents and Approaches Continue,1
Advance Through #,1
BM Hematopoietic Dysfunction,1
Sameer,1
2018 October 3,1
Kanga Exchange,1
#Trading #Competition #,1
#freecrypto #kangaexchange #ethereum #,1
https://t.co/ry5sLB2b3M,1
Relapsed &,1
SLL @BloodJournal,1
https://t.co/hSxmA2JfHa,1
Token Airdrop,1
Trading Competition - #,1
#CLL https://t.co/MhRmBR6ofP,1
Leukemia https://t.co/A2QVrWJKgV,1
Facebook https://t.co/rVfUxNlgfu,1
Xun Wu,1
22 years ago,1
https://t.co/ccPAmBg4H1,1
"1,000,000",1
#blockchain #kangaexchange @CryptoLiveLeak,1
https://t.co/SMd7PBMwy7,1
Clinical Practice Guidelines,1
NCCN @NCCNnews,1
SLL - https://t.co/AlPKTOgJlR https://t.co/DEEfjJztTL,1
Celltrion's Rituxan,1
Roche‚Äôs Rituxan,1
"RA
https://t.co/kE4auPbFST https://t.co/TZmLah9V9B",1
https://t.co/hP4ntHmzuA,1
https://t.co/lhK7QFGtFS https://t.co/U8H4SfIF4C,1
Dotson et al.,1
https://t.co/o2POTkhYZi,1
https://t.co/15RIwY7wiE,1
"https://t.co/ntPbcpbmhE

#",1
#kangaexchange #,1
#token #,1
#market #,1
Emma Kennedy,1
Friday 28 September,1
Penn Hall,1
#wolverhampton #,1
#digitalwriting #,1
Leukemia Moon Shot,1
#NCCNhem18,1
#PEYS #,1
#SRC #,1
Copiktra for Refractory Chronic,1
https://t.co/yd17xCMNSL #,1
19th Oct,1
Mullingar Park Hotel,1
Villa,1
https://t.co/SGoPXIw5ZO,1
65th,1
#fuckcancer #CLL #,1
Slawek Zawdzki,1
COO,1
Lukas Minkiewicz,1
Tokenfest,1
@CryptoLiveLeak,1
#Kanga #crypto #,1
blockchain https://t.co/A6fpIZVBt4,1
Manso BA,1
Zhang H,1
Mikkelson MG,1
Gwin KA,1
Secreto CR,1
Ding W,1
Medina,1
IRC,1
Stephen #,1
Nobel Prize,1
Jim Allison  @MDAndersonNews,1
Immunotherapy research &amp,1
https://t.co/OJuQunDxup,1
Control of Chronic Lymphocytic Leukemia Development,1
Undergo Functional Exhaustion,1
Tissues @DKFZ,1
Venclexta-AbbVie,1
https://t.co/nGZ3mfYsdc,1
#Mutations #,1
Glenn Sabin https://t.co/TSYf1tolI7 Glenn,1
Tettenhall Wood Special School,1
#leusm https://t.co/NWGbk3l9ms,1
#Myelomysplastic Syndromes,1
https://t.co/HIDgXOqDaM,1
#CLL #LeukLymph2018 #,1
Dubrovnik,1
https://t.co/bDNEifj5Zu,1
#LeukLymph2018 #,1
Dubrovnik https://t.co/9E3koREVfP,1
TwitterHomework @kmirza https://t.co/78nwPFgZQZ,1
https://t.co/N90sWRUhw6,1
https://t.co/LnJ6VhFBrV,1
Dr Dean,1
‚Å¶@ClevelandClinic‚Å©,1
#CLL ‚§¥Ô∏è,1
‚Å¶‚Å¶@ClevelandClinic‚Å©,1
Under 65,1
@CleClinicMD,1
#stateofscience,1
Jakub Svoboda,1
Updates,1
#ASCO18 Meeting,1
#totalhealth #,1
#Cancer Network,1
@ksticcoMD,1
#Pathology #,1
https://t.co/WyeOxkxQ5Q @SocietyofHemOnc #,1
Venetoclax Monotherapy for Patients with,1
Hodgkin/Non-Hodgkin,1
"CA 
- Main",1
kun,1
36 kr,1
#blodkr√¶ft #lymfekr√¶ft #,1
#mds #lyle_dk #,1
#dksund,1
Paul Keane,1
#Hematology/ #,1
https://t.co/kngwirxEIm https://t.co/4qlXbyTdAy,1
https://t.co/hkd6kHACHk,1
Identification of Distinct Unmutated,1
https://t.co/3aH0qP6BTf,1
Token Talks,1
Online Social Blog Platform,1
#Erc20 #,1
Smart #Importers,1
#Experience &,1
CustomsClearingProcess,1
Professionalism,1
Transparency &,1
#Competence,1
IbadanDelivery,1
Ibarz,1
https://t.co/AAiQQ9EJ7J,1
https://t.co/3SvTua9pGa,1
Targeted Alpha Therapy,1
https://t.co/Y4tdoUg1XN,1
Clinical Nurse Specialist,1
CD8s,1
Sk√§rg√•rdshavets,1
Lokala,1
ska,1
nytta av att k√§nna,1
#sk√§rg√•rd #,1
Novartis Pharmaceuticals‚Äô Gleevec,1
https://t.co/Hffai5Vbmb,1
#CANADA https://t.co/I6PL2aDfqW,1
September 24,1
https://t.co/O3Niq3G5Rv,1
$22 million,1
the US Food and Drug Administration,1
Opportunity Analysis,1
the Lavender House,1
RD Weis,1
InstaFloor NA,1
Duracryl,1
BloodCancerMonth https://t.co/dtc40p6oyL,1
Hampshire,1
Cosham,1
#LivingWithAndBeyondCancer,1
@HealthwatchPO,1
Medicine #nobelprize2018,1
https://t.co/zQWvzQbqe5,1
#pinchpunch #,1
vi taler,1
https://t.co/B0AJSXzOid,1
#letstalkaboutbloodcancer #KnowAML #,1
Toretha Corley,1
PIK3CA,1
https://t.co/Pu71CVp24v,1
BLOX,1
F√∏lg s,1
Dr Martin ‚Å¶@OncLiveSOSS‚Å©,1
#SanFrancisco &,1
https://t.co/hsf510Jez5,1
https://t.co/alpYQEHA2O,1
Lisa Chen,1
blood-2018-06-860593,1
https://t.co/termaPiKzC.  Interesting,1
#TTG #,1
GPH,1
https://t.co/OOU0Dk7Qa1,1
#BloodCancerMonth https://t.co/FTx8aHicdd,1
https://t.co/CFLN8DE33m,1
ASCOQLTY18,1
https://t.co/A5LUQLmTtm,1
https://t.co/FcbBMqZxr8,1
Prof Katyoun Rezvani,1
https://t.co/KjYjXVIUWf,1
@bloodwise_uk CLARITY,1
https://t.co/rU64XmdcdF,1
@AACR @CancerResearch,1
#TUNISIE,1
Prof Francis Bosch,1
CDKN2A,1
https://t.co/tzs3WFe8r7,1
Prof Fox,1
https://t.co/p7Em9tpGxr,1
around 65%,1
Chris Fox,1
idelasib,1
Donna Munro,1
SpotLeukaemia https://t.co/m1TO2VDvzS,1
https://t.co/1ZAykI0oPF,1
#CLL https://t.co/roITq9RZFx,1
@Medivizor: Chlorambucil,1
Physicians Earn CPD Credits,1
AskTheExpert Session,1
https://t.co/0oWf5Xg5S3,1
https://t.co/tT0JeQfy6k,1
Information Sheets,1
#playandlearning,1
#Kindergarten #,1
https://t.co/jDIcLKXliP https://t.co/XU7B05QxIU,1
ChronicLymphoblasticLeukemia,1
Harley Hudson,1
@UTAustin,1
https://t.co/ialoCBDwIk,1
#BSH2018 #Biomarkers #,1
#TP54Mutation #ChronicLymphocyticLeukemia #Sanger #,1
https://t.co/nR1wF0uxE3,1
AbbVie Receives Approval from Health Canada,1
Health Canada for The Combination of  VENCLEXTA¬Æ,1
https://t.co/ztU3usjSDb,1
CLL Support Association,1
"https://t.co/V9pbBMfTFO 10,000",1
https://t.co/2HULkQPLf5,1
25 September 2003,1
twelve-year,1
Edward W. Said,1
67 years of age,1
New York City,1
Piyush Gupta,1
Eric Lander,1
Robert Weinberg,1
https://t.co/D7zGuJWWCR,1
this past Saturday,1
@VerastemOncolog #,1
3pm ET https://t.co/TdycwA4RVg,1
https://t.co/p2fAGELzqF,1
https://t.co/JnhArYm3lV https://t.co/u3ShEO5v3N,1
PV,1
Notice of Compliance,1
#CancerDrugs #,1
Health Canada for,1
#MedicalAffairs #,1
https://t.co/QhNbarb6Ae,1
Verastem Oncology's,1
Affiliate Program Open - #,1
https://t.co/3y80GHFOBP,1
#dualinhibitor #,1
https://t.co/h3s69li1xt,1
Food and Drug Administration,1
https://t.co/4h4f6XbPyp,1
9/24/18,1
#Copiktra #,1
SmallLymphocyticLeukemia,1
https://t.co/5sL0G3ZNEg,1
#FDAapproves #,1
Copikra,1
#PROnounce #,1
Copiktrap https://t.co/EgecHdkQiC,1
mkt cap,1
y/e. Strategic,1
https://t.co/IwSb8csLIr,1
https://t.co/Woh0cZC03q,1
#Update #,1
@VerastemOncolog 's,1
SLL - https://t.co/XFIZ9jqZxz,1
#17pdeletion #,1
SLL - https://t.co/BVqALdRlnl,1
Follicular Lymphoma - https://t.co/epYeqtUzwI,1
Linfocitos B tumorales de,1
Imagen de microscopia electr√≥nica de barrido coloreada,1
Possibilities Fund Golf Tournament,1
the @IrishCancerSoc #CancerWeek,1
#CLL https://t.co/bp7GVDevcG,1
Ken¬†Research,1
https://t.co/tl71CWHz5L,1
Ken Research - https://t.co/elSUm4W8Ap https://t.co/GebKvjH2XV,1
#SpotLeukaemia London,1
#Leukaemia #AML #,1
EarlyDiagnosis,1
Zytux,1
Vayan,1
Instagram Nninitaa,1
el 14 de octubre,1
#CONCURSO #,1
1.10p,1
https://t.co/DKWGoGTXaL,1
EU Panel Backs,1
Venetoclax/#Rituximab Combo,1
Paradigm Continues,1
IL-16 &,1
https://t.co/HMwdynwFeh https://t.co/SR8L3Um9k2,1
#thisisleukemia #,1
#nola #allkindsoffriends #,1
#audobonzoo #,1
https://t.co/xHMI5NzzmV,1
@HENZOKENYA,1
cmlday,1
the decade,1
the Power of Both #,1
Bispecific Antibody,1
https://t.co/rkX9CWLptQ https://t.co/vEXo1MwziB,1
https://t.co/eRVJq7eWo1 https://t.co/uLm93Vrvvx,1
#delicate #repTourNewOrleans #,1
https://t.co/BPvwj0VnwC,1
https://t.co/Wdp0ebq8NC,1
https://t.co/TY2velqbnS https://t.co/wzaNJqDOvz,1
at Least One,1
EU Committee Opinion for Combination of VENCLYXTO,1
up to 90%,1
Education and Understanding Help Patients Cope with,1
MCI,1
Mexico,1
#OncobellSymposium18 @idibell_cat,1
https://t.co/q2kf6XNFL4,1
Manel Juan,1
https://t.co/tlKjxMq34n,1
hct,1
Dr Shadmar,1
Dr Radich ‚Å¶@OncLiveSOSS‚Å©,1
#renalpath #,1
https://t.co/jAMkkzQCVq,1
Tokenfest Interview Video,1
#bancor #airswap,1
#kybernetwork #,1
#Organic #,1
AlcoholFree,1
@MDAndersonNews https://t.co/DntxyFLaaQ,1
https://t.co/FNZwJjes3d,1
https://t.co/rddqeFfuqo Watch,1
https://t.co/pRtwtHUc8i,1
#FightingLeukaemia #,1
TMMG,1
ARE &,1
TMMG &amp,1
U of M,1
Post-Doc/Research Associate,1
https://t.co/jOQgRjxeBk https://t.co/8jCejsO4dn,1
#leusm https://t.co/RcWijfyyXh,1
University of Manitoba,1
Winnipeg MB,1
Zachary,1
Targeting Nuclear Export,1
https://t.co/s3scYnESI4,1
https://t.co/Cde0y8oBVK,1
Dr Jennifer Brown,1
Burger &,1
the Outcome of Patients,1
"at least 25,000",1
at least 5,1
Polyphenon,1
journey w #,1
https://t.co/kVNxryq6A5 https://t.co/oC2HFnis3z,1
Biphenotypic/Undifferentiated Leukemia,1
9/27,1
10/19,1
the Pan Pacific Lymphoma Conference,1
Thomas Kipps &,1
Bcells https://t.co/J7i6l0R4Q8,1
https://t.co/mzcWrQ4WDq,1
https://t.co/lkCpFq9gnV,1
Medical News Today,1
R√©sistance https://t.co/i8G3cBM0mm,1
https://t.co/ljxMgef5OE,1
#BSH2018 #,1
September 15th,1
#WorldLymphomaAwarenessDay,1
https://t.co/bvRV36gkIK,1
#EHA23 covering,1
CLLsm @CllSociety https://t.co/CfhL9Oo3il,1
@MDAndersonNews ‚Äî&gt,1
Files New,1
Sept. 11,1
Russell Brooks,1
MD of University of Oxford,1
#leusm https://t.co/j8gQ9yq68v,1
Florencia Cymbalista,1
H√¥pital Avicenne,1
the Art Update,1
#SOHO18 #,1
Anticancer Drug Development,1
The month of September,1
September 15,1
a big month,1
Michael &,1
https://t.co/YwSYFLQqKX,1
@univ_lille,1
8:30 AM - NitinJainMD,1
8:30 AM,1
https://t.co/WH68KsG4mc https://t.co/IWCE2xkMfj,1
DECEMBER,1
#MyHusband #SickDay #,1
Token Fest,1
#celsiusnetwork,1
#leusm https://t.co/wCGbDF5JZA,1
"üò• 
Help",1
https://t.co/gGPABDXZAN,1
Widespread,1
https://t.co/ANvIqLfs8d,1
ATL,1
a Live Video Broadcast,1
Day ONE,1
Day TWO,1
#bitcoinenergy #liquidassets #tokenfestboston #tokenfest #,1
#digitalcurrency #blockchain #,1
https://t.co/iEHSrP747D,1
14 minutes,1
Lucas,1
Easy MINE,1
#easymine,1
#EMT #,1
Zach,1
Warwickshire,1
tonight -info &,1
"2,500",1
#crypto,1
#seaportworldtradecenter #,1
"@TotleCrypto 

#",1
https://t.co/1PaeFNIRWM,1
https://t.co/yt8XB4Wfed,1
https://t.co/g1crIkkLly,1
Pat Conlin,1
Robert Pike,1
#blockchainnews #,1
#onecointolightupafrica #,1
Joshua Suh,1
Operations,1
#crowdcreate #,1
#telegramapp #,1
#cryptonews #tokenfestboston #,1
Sept 22,1
CBCIII Sept,1
#WhyPathologistsMatter https://t.co/vtLvwoTatA,1
Zent - https://t.co/Io07VFg7LH,1
GDC-0853,1
https://t.co/KIhC5p6SuF,1
@CvNieuwenhuizen @HettyKlavers,1
@InaAdema,1
jaar Zuiderzeewet,1
https://t.co/ews0gMTjQc,1
"141,274",1
"210,691",1
https://t.co/kf7GLkqMHG,1
"CART 
@CancerMedMDA 
@PhysRelations",1
Cancer Bio &,1
JAX,1
#CLl #,1
#escapetothrive,1
Individualized Treatment of Chronic,1
https://t.co/bK8OXsoQhV,1
#ABIM #USMLE #,1
NovelDrugs,1
EGI,1
BELSPO - Belgium,1
the Centre for Cancer Biology,1
https://t.co/RaXgzeSBob https://t.co/XMemMwxm4a,1
CELLO GROUP PLC,1
160,1
473%,1
https://t.co/20YX4B80vf,1
Quebec,1
#Qc2018 #,1
https://t.co/OLRRPrtMAn https://t.co/mC9kr8yaZL,1
https://t.co/WfLFhI1N3C https://t.co/lgAkq52CUh,1
VI LEVER MED DET,1
#mds_dk #lyle_dk #,1
kr√¶ft,1
Alison Michie,1
https://t.co/Y7JxJlwkKb,1
#bcl #,1
Spot Leukaemia,1
https://t.co/X5yLUwIHQt https://t.co/IowaE7pSl8,1
https://t.co/ApvZY5ys0f https://t.co/n3L021P5IZ,1
De la belle,1
LAnglicane,1
#CultureL√©vis #,1
C√©gep @ L'Anglicane,1
National Blood Cancer Awareness Month,1
PRIVILEGE,1
SSH,1
"https://t.co/Mos3d0HXib
Join",1
hematology,1
Cancer Support Community,1
May ‚Äò05,1
the past 17 years,1
https://t.co/s3tZyayTuo,1
https://t.co/BfvZgall62,1
https://t.co/c2yh68Fu1l,1
#biorxiv_genomic,1
12 PM PT:  ,1
https://t.co/zZI02OOvsu,1
ICER Standards for Ibrutinib,1
Individualized Lenalidomide + Chlorambucil &,1
rituximab https://t.co/sIZPwkmygt https://t.co/50EQZSRmdv,1
https://t.co/pKFzOBwVeE,1
Leukemia https://t.co/09G52Xx75G https://t.co/HLdCTwFLAu,1
https://t.co/LbSw19EIRx,1
https://t.co/HthqdIRcNY,1
https://t.co/eRQNukjOQJ,1
14 MINUTES,1
#BloodCancerAwareness #,1
7.0,1
@TGTherapeutics Btk,1
TG-1701 @LinearClinical #BloodCancerResearchWA,1
https://t.co/IGC1iVgPRG,1
Ibrutinib Common,1
Clinical Trials - Cancer Network https://t.co/LouvxzmsTU,1
#DWHA #MRL #,1
#FMPI #,1
ANCR,1
Harrogate,1
https://t.co/4Qe6bAkcvb,1
Minimal Residual Disease Testing,1
LabMedicine,1
BioInvent Int,1
the 4th day,1
@MyelomaIreland  &,1
Prof Lars Bullinger,1
University Berlin,1
Dear Haematologists,1
@anyahotinski,1
clinician,1
Leichhardt Oval,1
https://t.co/qa9D3DD81,1
Lymphoma Australia,1
the Sunday Mail,1
Chose Life,1
@KuhleBergit,1
#EU #,1
Balkans,1
Barbara Eichhorst @UKKoeln:,1
#Leukemia #CLLsm #LeuSM #,1
MPNCLL18 KICKS OFF WITH A CAR-T &,1
Prof Tal Minor,1
Leeds UK,1
@CRGHaem @CRGHaem,1
https://t.co/RPRtiz8y3q,1
https://t.co/54mbrC71xQ,1
over 65,1
https://t.co/5EJFIaGpZf,1
&lt;75,1
#geriheme https://t.co/IKGDe0Aqar,1
HOUSE,1
#spotleukaemia kicks,1
First-Line Ibrutinib Treatment,1
RESONATE-2 https://t.co/kvdBWUjmYW,1
Zusia https://t.co/2VoRRi9SLU,1
Nov of 2016,1
https://t.co/fPh66P0Ax5,1
https://t.co/bGFedWrKrU https://t.co/J54WJHoK0K,1
#leusm https://t.co/VpU8tVXYEB,1
Davids Regarding,1
4SC,1
ACEA Biosciences,1
Aeglea BioTherapeutics,1
@IndustryToday,1
the Center for,1
https://t.co/fmylGMho2K #,1
#leusm https://t.co/mKnckWFXmv,1
Dr Talha Munir @LeedsHospitals - We,1
braincancer,1
https://t.co/ytCpdvpuwR,1
CLLsm  #,1
8/9/18,1
#covhour,1
https://t.co/vCLLCQBCUJ,1
#leusm https://t.co/1PZ6aXXTnE,1
#BSH2018,1
https://t.co/uSoFk2xk7,1
Acanthamoeba,1
Voshtina,1
al @MedicalCollege,1
St-Liboire,1
Amebic Encephalitis,1
https://t.co/KG2VVLlqck,1
https://t.co/HSQKVZzrrA,1
Warwick Campus,1
CLLcommunity,1
Myelodysplastic Syndromes,1
Pediatric Mematologic Malignancies,1
https://t.co/ZOouPuvhVZ,1
Wilmslow @Sainsbury 's,1
HSM,1
HCL,1
Damon Runyon,1
https://t.co/eVLo8kVOzq,1
Twist,1
KnowledgeIsPower https://t.co/vWDH1L0eKD,1
https://t.co/ZKL3egFNB7,1
4dayweek,1
https://t.co/ZUQT05tnNU,1
@SolihullCollege @coventrycollege,1
https://t.co/LgOpYOVn3L,1
https://t.co/RniSHSex3K,1
https://t.co/QS1VySBd1c,1
#BSH2018 #CLLsm #,1
TargetedTherapy #,1
9 Supporting Emergent Literacy,1
#Literacyskills #,1
#communication #,1
keystage1,1
#LANGUAGE #,1
#earlyyearseducation,1
#Telomere,1
#BSH2018 #CLLsm #Leusm #,1
ClinicalPractice,1
Sumamos,1
Limpe√±o,1
#LongLiveLow üíé,1
3L,1
https://t.co/Wi2MqJGzk3 https://t.co/cz4jBw3r5j,1
#bendamustine #obinutuzumab #,1
"@anthonymatomd,",1
https://t.co/jwINjInqnx  ,1
#3000researchers #chroniclymphocyticleukemia #,1
https://t.co/n1pKRLIVH6,1
https://t.co/IzyRQ4uyRN,1
Bcells  https://t.co/zvy7WUxuEb,1
Lamanna say?https://t.co/kVPMLkaDPM,1
Sept 22-23,1
Emory Hem,1
mmsm https://t.co/QwshGO1vUs https://t.co/p8JPkr2PV8,1
CheckOrphan https://t.co/drDOGq36ok @leukemia,1
#MeasurableResidualDisease #,1
DiseaseMonitoring,1
OMF,1
Sandi Schussel,1
Dana-Farber 8-22-18,1
8 Sept,1
Dr Alison Michie,1
Silvia Mele,1
@LymphomaAction Glasgow #,1
only ¬£10,1
https://t.co/cbR8ZBHDQS,1
https://t.co/Cca5HiSupx,1
#GoodbyeBCS #UntilWeMeetAgain #Bryan #,1
#Bombardier #,1
#CR7 #,1
The Fans Real Soon,1
https://t.co/gcBVAIUMqk,1
https://t.co/PtxdLSMWsV Watch,1
England‚Äôs National Health Service,1
#healthnews #,1
ICER,1
https://t.co/LPV5qiOa4J,1
Toxicol Appl Pharmacol,1
#melanoma https://t.co/4qJC0iRxEJ  #,1
Coventry City Centre,1
https://t.co/2T5eVKFMz5,1
late 70s,1
https://t.co/IuOVzexnT9,1
Nearly 85 percent,1
Mechanistic Insights,1
IL-15 Synergy,1
https://t.co/HnWHiXp02q,1
https://t.co/aJhq54L1zo https://t.co/mKZpe8kMb3,1
@TimesONeill &amp,1
https://t.co/2d5qS8NR1G,1
https://t.co/yc6TePfLE2,1
https://t.co/AZfVwz3FLL,1
https://t.co/hQGr6D9OzS,1
56.4%,1
54.5%,1
21.0 months,1
Bendamustine Followed by,1
Obinutuzumab Plus #,1
Proliferation Centers,1
Initial Presentation,1
Disruption,1
almost 20-fold,1
Leamington,1
"Sue, Jon",1
earlier this summer,1
https://t.co/ZOhyZuBFAN,1
https://t.co/Pxwv2OGk2M,1
Leukemia https://t.co/qE9ROYZP6z,1
https://t.co/egxVNqkKT3,1
Quoi de mieux,1
la nouvelle,1
de la sant√©,1
Faire,1
l‚Äôactivit√© de la rentr√©e,1
2018-2019,1
https://t.co/n2Fo8cle7N #,1
https://t.co/52gqaX2LLX,1
Detection of Gene Abnormalities,1
Cases of Chronic,1
Fluorescence in Situ Hybridization,1
#DrugAccess #,1
Lymsm #Leusm #,1
Phase 1,1
https://t.co/Hb2JuI2PCv,1
Coventry City Centre Library,1
the 21 August,1
https://t.co/6tFlGjAhbg,1
#anticoagulant #,1
#chroniclymphocyticleukemia  ,1
Lymphocytic Leukemia: Life Expectancy &,1
Stan Kurtz,1
Catalina Channel,1
"over $28,000",1
Stan,1
Blood Journal https://t.co/6B7EdYN7v4,1
Board Changes,1
https://t.co/FWgO6Qegk2,1
https://t.co/YtvNmuD655,1
J.O.B,1
MRD-CLL,1
#teaching #,1
https://t.co/iUT6UlQcy0,1
Sat 8/9/18,1
NCRI CLL,1
WorldCourier Melbourne,1
#bloodcancer multicenter,1
#Journeyofabox #,1
#melanoma &,1
#LSL #,1
NASA,1
#EGL #,1
KIT,1
#MTFB #,1
#PFD #,1
FDP,1
James I. Barnes,1
HealthGuru,1
von Krankheitsstadium,1
Wilmot,1
#eSahai #WheelChairTaxi,1
#Number2remember #,1
https://t.co/krdrhUzeOu,1
https://t.co/iCeegjp0oX,1
Crypto,1
the Introductory Video Here,1
#SocialMediaJobs #,1
Newsocialmedia,1
#nexttwitter #,1
#getpaidtopost #,1
https://t.co/FeO6bB6rQP,1
https://t.co/tyTMABBe8M,1
#fitness #workout #,1
#online,1
#healthandfitness #,1
#weightloss #,1
#self #,1
#exercise #,1
#loss #,1
https://t.co/wGTUW81fhM,1
#ECK #,1
#TOM #,1
Melanoma Linked,1
https://t.co/jr9LPbyxit,1
https://t.co/kkzHyFFW9C,1
https://t.co/PXqxG9kvhm,1
https://t.co/jGOrQ2GBgo,1
Andrew Rawstron https://t.co/hAhlpK4PDn,1
NCT03624036,1
19 October 2018,1
Clinical Psychologist,1
Mullingar Co Westmeath,1
Free/Registration,1
#ImmuneSystem #,1
https://t.co/9cdWRNJMib,1
https://t.co/wnwXm4i9YB #,1
#Leukemia #CLLsm #,1
FGG,1
00,1
#fgg #connector #egg #,1
#receptacle #,1
#push #,1
#circular #,1
#refractory #,1
East Texas,1
Wesley,1
#IGAS #,1
https://t.co/YuQf4le7G5,1
Videos &,1
NHS England,1
https://t.co/YCIzQy3lj5 - https://t.co/SmGmIw0DMQ,1
Obinutuzumab/Chlorambucil,1
781,1
obinutuzumab head,1
https://t.co/KKrrQpsUig,1
"study,,https://t.co/RWjGM0slhR",1
https://t.co/xWERBlXyZr,1
Study https://t.co/frZWJtfA0b,1
Hindustan Times,1
at least 3 months,1
autumn@patientpower.info  #leusm #,1
Safety and Efficacy,1
https://t.co/62dAlfv9Av,1
Dominik Wodarz,1
the University of California,1
Irvine,1
SIAMLS18,1
10.1016/j.humpath.2018.07.030,1
Lebensqualit√§t,1
von Menschen,1
RuderngegenKrebs,1
Informationen z.B. zur chronischen,1
https://t.co/MmCmMZOrYJ,1
Mother,1
internationalcatday,1
@RolfatWarwick,1
worldcatday,1
Kanti R. Rai,1
"the Lyme Disease Connection
Lyme",1
"https://t.co/T719Tm4ciB 
Central",1
CancerProgression,1
@wakehealth,1
General Aviation Terminal,1
#airport #,1
#catering #bcstx #,1
https://t.co/uXnGjR1rlP,1
https://t.co/88SrxJhlIJ,1
Leukaemia https://t.co/6V6kiuuclu,1
Indication of Chronic,1
Zenyaku Kogyo‚Äôs,1
HPA,1
Rai Helped Launch,1
R. Rai MD,1
Giants,1
Novel,1
Brazilian Love Affair,1
1980,1
Monoclonal Antibody RITUXAN,1
Application for Approval of Additional Indication,1
Grace Cherry,1
Barbara Rogers,1
Laura Zitella,1
PER,1
Michael Ball,1
https://t.co/bcRvSEN33e,1
https://t.co/Z29SbXmXT0 https://t.co/CViytll0jW,1
#PatientTreatment #,1
Latest Developments,1
The Ohio State University Comprehensive,1
#ÁöáÂ≠∏È§®Â§ßÂ≠¶ #,1
#Â≠¶ÁîüÈ£üÊóÖ #,1
WarwickHolidayScheme,1
https://t.co/39pDJUYk8G,1
Gumprecht,1
Vimentin,1
#hematopathology,1
Taking Back Control: How I Became an Empowered Patient,1
Patient Cafe¬Æ https://t.co/F0VU6tYgkc,1
#le√≠smo  https://t.co/33CMOvGcNG,1
https://t.co/jRfH2HFIb4,1
643,1
4 weeks,1
#cantstopwontstop #,1
https://t.co/Baf30WGhST,1
https://t.co/07eXmMCJfN,1
NovelTherapies,1
Guy Pratt,1
#Leukemia &,1
#Lymphoma Patient,1
#Research Registry Project,1
"ÿ¨ÿßŸäÿ© ŸÖŸÜ ÿπŸÜÿØ ÿßŸÑÿßÿ≥ÿ™ÿ¥ÿßÿ±Ÿä ÿ® DD
Septicemia Vs",1
#adulted #FriendshipDay #InternationalFriendshipDay https://t.co/pXq6dHn6Le,1
https://t.co/V4l630Xe0C #EHA23 @EHA_Hematology,1
OncoLink https://t.co/f0a1TSZnqE,1
27 May 2010,1
Inc. Medifocus,1
2-Day,1
@LeoNigeria @eurodistl,1
mosaic,1
Leukemia https://t.co/K4lYYXUG9p,1
Marek Mr√°z,1
Signaling Propensity in the Microenvironment of B Cell Chronic Lymphocytic Leukemia,1
#ERCstg #,1
EUfunded,1
28-year-old,1
#radical #,1
#genetic #,1
#camoldx,1
#GeneticTesting #,1
https://t.co/I2N5yhk0HQ,1
https://t.co/CdSOd9UPhr https://t.co/h3jMenrkre,1
bud,1
@CarstarphenMJ https://t.co/Qy7ZmdE5Ya,1
@QMBCI #leusm #,1
Current and Future,1
#TBT 60,1
Minutes,1
https://t.co/MxqtEucx6,1
cll@patientpower.info &,1
https://t.co/V0CTBbRBej,1
Ge H,1
Wu X,1
"Shen J, Chen J, Chen Y",1
Zhang Y,1
Dear Church Family,1
Joe,1
21 yrs ago,1
30 July - 5 August,1
"https://t.co/OFlcfQctQA
#",1
https://t.co/we8onWMetY https://t.co/QdN6Cw93Or,1
#cll2018 #,1
#TuesdayThoughts #leusm #,1
https://t.co/iYgqmpjyWw,1
Review of Anti-CD20,1
the Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia,1
#FAN #,1
FHIB,1
4:30 pm ET/1:30 Pacific,1
https://t.co/W7qUXH0Ynp,1
#LEK #,1
https://t.co/lcRCZPeXjB,1
MeasurableResidualDisease,1
#leusm https://t.co/BVTP1lbRIc,1
Health Care Costs,1
Kameron Anderson,1
Kitchkinet,1
#cll2018 #ordeal #,1
https://t.co/ygv8jmWazP https://t.co/ReTJSTRMCD,1
RelapsedRefractory,1
OpenAccess https://t.co/SuZz17zkvZ,1
MURANOStudy,1
"üëà
#",1
CaGenome https://t.co/41ZTeqDsOA,1
https://t.co/jrDu8W8AQA,1
Brian Koffman‚Äôs,1
https://t.co/u5neZw3bCM,1
https://t.co/UH17Vo1mQk https://t.co/F0nqezvb9w,1
Gail &,1
https://t.co/NYCols2pzv  @ASH_hematology,1
only my first year,1
her 1st year,1
Stephen Man,1
#Charity #,1
Andy Moore &,1
"1,026 mile",1
Goodluck,1
https://t.co/N7y1zVUdVu @ASH_hematology #ASH17 #,1
Andy Moore,1
#fundraising #,1
"1,026 miles",1
13 days,1
#goodluck #,1
El,1
Ram√≥n Amieva,1
El Fantasma,1
presidente de la CLL,1
Lucha Libre,1
Patrimonio Cultural de la Ciudad de M√©xico,1
https://t.co/gAQh17NAoJ,1
https://t.co/pibszIuVGT,1
only 3,1
Asembia Live Webinar,1
July 24 @ 5,1
CLL Symposium,1
Teaneck,1
NJ,1
CLLsm Registration,1
around #CLL,1
#amandavscancer #kickcancerinthedick #leukemiaandlymphomasociety #,1
#leukemia #imbruvica #,1
7Êúà26Êó•ÔºàÊú®ÔºâÂ≠¶È£ü2Èöé„Å´„Å¶„ÄÅ„Åø„ÅàÈ£üÊóÖ„Éë„Çπ„Éù„Éº„Éà„ÇíÊé≤Á§∫„Åó„Å¶„ÅÑ„Åü„Å†„Åè„Å®„ÄÅÁ•ûÈÉΩ„ÅÆÁ•à„Çä„Çí‰Ωø„Å£„Åü„Çπ„Ç§„Éº„ÉÑ„ÇíÊâã„Å´ÂÖ•„Çå„Çã„Åì„Å®„Åå„Åß„Åç„Åæ„ÅôÔºÅ„Åú„Å≤„Åì„ÅÆÊ©ü‰ºö„Å´„ÄÅ„Åø„ÅàÈ£üÊóÖ„Éë„Çπ„Éù„Éº„Éà„Çí„ÇÇ„Å£„Å¶„ÄÅÂ≠¶È£ü2Èöé„Å´„ÅäË∂ä„Åó„Åè„Å†„Åï„ÅÑ,1
#ÁöáÂ≠∏È§® #,1
Florence Cymbalista PhD,1
FCR Chemotherapy,1
"@VJHemOnc
https://t.co/XJdxonJdPB",1
Hodgkin &,1
8 Sept.,1
#Venetoclax #Ibrutinib #,1
#RELEVANCE,1
@OncologyGo,1
A. Acute,1
ELIAS,1
PatientEmpowerment,1
Cancer Immunology Research,1
Trials,1
Derriford,1
Plymouth,1
Wednesday 25th July,1
https://t.co/zX38rasVfL,1
Trading Update,1
https://t.co/vp5SFbmmNB,1
Lawsuit https://t.co/G8IYT6Mzu0,1
#HOTC #,1
#MTU #,1
https://t.co/cO3ezrCX1K,1
https://t.co/sbL8MJSnIA,1
https://t.co/gMbLPSldh1,1
Biolytica,1
@CERTHellas,1
#bigdata #,1
@EU_H2020 @eHealth_EU,1
4 and a half years,1
#InflectionBiosciences #,1
https://t.co/gMjtw7tIof,1
Gail Wiegman,1
+¬£8k,1
Gail,1
Thomas &,1
Benedict,1
Linda &amp,1
Cathy,1
https://t.co/q6zP6wSlnz,1
#worldhematology,1
the Management of Chronic Lymphocytic Leukemia,1
Primeros,1
se van,1
los Onii Chan-Cho,1
zetag_cll,1
"üåπ

#",1
ChanchoFelipe,1
ChileLuchaLibre,1
MSKCC CLL,1
Leukemia https://t.co/F1R2X2Fkwq https://t.co/aAbJWIpK4V,1
Allogenic,1
@MDAndersonNews https://t.co/nkVgT8y7gQ,1
#oncologymeetings,1
Resolution of Eosinophilia,1
Stephen Robinson,1
https://t.co/PiazOdtOXy,1
Exciting Advances,1
10km,1
over ¬£5k,1
#charity #fundraising,1
Nick Rawlings,1
British10k,1
https://t.co/XfE0Wjuvbq,1
"https://t.co/PhMzpO1u9b
#",1
Incepta Pharma ltd,1
OncologyDrugs,1
https://t.co/vaH8GUbGEX,1
#NovelTherapy #,1
Kieran Platt,1
warwickuni,1
#leusm https://t.co/PNsp85y92x,1
August 15th,1
Ohio &gt;&gt,1
#CLL #Leusm #,1
https://t.co/TjsrYM1mAD,1
#CLL https://t.co/UAcApgOvlX,1
@NCIMedia,1
Leukemia Resource Center: Watch,1
Chile,1
"zetag_cll &lt;3

",1
Denny Marchel,1
Juli,1
Bonneville Speedway,1
https://t.co/e8fDykMFdG,1
a morning,1
Gothia,1
#CLL #vierfcn,1
Denmark https://t.co/gJFbQr2090,1
#BSH2018 #BCL2 #Leusm #,1
#HemeOnc,1
Arbona-Haddad &,1
https://t.co/5k6jyfoPRO,1
#cryptococcosis,1
#leukemia #leusm,1
https://t.co/FNU2MAbIyg,1
@JimJUK,1
PGDE,1
@thedirty_duck,1
üéâ,1
@thedirty_duck @CLLWarwick,1
https://t.co/aJhq54L1zo https://t.co/49ZjRdDKHY,1
#EBMT17 #,1
#Tolerability #PatientCare #,1
#British10k @Virgin_Sport,1
"#fundraising
",1
#BSH18 @VJHemOnc @nottmhospitals,1
@VJHemonc,1
#idelalisib @nottmhospitals,1
Robert L. Talley,1
#ordeal #,1
#wagoshagg #cll2018 #bethere #,1
@DrGinaEagle,1
SWATH,1
#bspr2018 #,1
four and a half years,1
1003,1
https://t.co/oAKsFvXmp4 https://t.co/Jmv2m2BTbN,1
Tolerance,1
#Alternative #,1
@Patients_Videos @PatientPower @TargetedOnc @focusblood @CLLWarwick @Lymphoma_LYL,1
BestTherapy,1
Rituximab New Chemotherapy-Free Option,1
https://t.co/E9NbHCmlgA,1
https://t.co/h7iGICiOp5,1
Chronic Fatigue,1
PE,1
Earlier last month,1
MarlenMurillo,1
#4dejulioHN #CLL,1
https://t.co/S0WtHuPDmy,1
#ProstateCancer,1
https://t.co/NVgLc5NzC2,1
DOWNLOAD,1
KinaseInhibitors,1
https://t.co/nS5VxPZVK6,1
#PI3KInhibitors #PFS,1
#PatientCare #TKIs #,1
LET,1
"BABYYYYYY &lt;3
",1
#CLL_EVERYWHERE #,1
#Cytometry #,1
Enrique O'Connor,1
https://t.co/DZ8ny3EYpc,1
IBL‚Äê202,1
BJH- Wiley Online,1
https://t.co/6Ml5IWooTL,1
https://t.co/XeSLbylv59,1
https://t.co/5cyXeX8k2l https://t.co/ksxP3zXbaC,1
Midmark Teammates,1
Mark Thomas,1
Teammates,1
330,1
Midmark,1
#CLL Allstars,1
Rong,1
Clonal Relatedness https://t.co/0FzfdxKCqX,1
Olaparib,1
Andrew Jackson,1
@mrc_hgu,1
https://t.co/IfvEBLNWkl https://t.co/vRispe6DoC,1
only a week,1
#summer #,1
https://t.co/QjYWNpLWGt,1
Blackburn,1
@EastLancsCCG @BwDCCG,1
https://t.co/9cfHS9Py1o,1
Second-Line Chemoimmunotherapy,1
@MDAndersonNews https://t.co/DjhfvE0Jwe,1
#PrimeView #,1
CLL https://t.co/K1BfJWwsLw,1
https://t.co/fJnEFiWVG4 https://t.co/Idhz0Amw1m,1
RT TargetedOnc,1
"Alison, Job Search Adviser",1
#Classof2005 #,1
NovelAgent,1
#bestlemonade,1
#EPO #,1
#londonconference #,1
tonsillectomies &amp,1
Robert Kreitman,1
@IUOPA,1
#lyle_dk d.,1
Kbh,1
S√¶t kryds,1
#sundpol #dksund,1
Laura J. Zitella,1
Samantha,1
https://t.co/BXH7SxalpL,1
üë®üèΩ‚Äç‚öïÔ∏è,1
https://t.co/OjMLqsQ029  #,1
Descansa,1
PredictiveMarker,1
Dr Talley,1
@sumankambhampa1 ‚Å¶@OncLiveSOSS‚Å© #,1
https://t.co/z3sGcudEJd,1
Plasma Cell Malignancies Regional Summit - Minneapolis,1
#DAVAregionals #,1
DAVA,1
OurNHS70,1
#UCH #,1
ShineCancer &,1
@ShineCancerSupp @bloodwise_uk,1
Remission Duration Predicts Long-Term Outcomes,1
Tecfidera,1
https://t.co/Us7Yn1bicU,1
the Global Industry,1
Oreofe Odejide,1
West Brom,1
11 July,1
https://t.co/hWdX0rIP65,1
https://t.co/dFuvkKmEgk @ASCO #,1
Goede,1
#combination #,1
Mercatox Cryptocurrency Exchange,1
https://t.co/pBo8iNzvHa,1
https://t.co/51pncHVfgM,1
Neues Verfahren,1
Tarnkappe von,1
"Blutkrebszellen
Mit",1
Wissenschaftler des #,1
https://t.co/MDnwcIpp8e,1
#hematologymeetings #,1
https://t.co/8alfId6QaS,1
https://t.co/WXHHUblB8l https://t.co/YwipQDQnd5,1
https://t.co/w7AN1MJ8dL https://t.co/8cDouazlK5,1
Venetoclax: Management and Care for Patients With Relapsed or Refractory Chronic Lymphocytic,1
https://t.co/uXPjzAQdrG,1
https://t.co/UjHnpzrprj,1
Stefano Baldoni,1
Chiara Rompietti,1
Franca Falzetti,1
Mauro Di Ianni,1
Paolo Sportoletti,1
Saturday 30th June 2018,1
üèæ,1
Venclexta-Rituxan Combo Extends Undetectable,1
Study Finds https://t.co/Jhi4xC3eLU,1
Clinical Hematology,1
"Lymphoma
Chronic Lymphoma/ Lymphocytic Leukemia",1
AutoImmune Hemolytic,1
https://t.co/xTark13SD8,1
#leusm https://t.co/m2A7A6Y1MW,1
East Tennessee,1
"Saturday, June 30",1
https://t.co/5lo1z8IqoQ,1
Michael Kea,1
KnowledgeIsPower #,1
https://t.co/5AKCkmESvd @ASH_hematology #,1
#cagenome #,1
#mutations #,1
11yrs ago,1
#nhl &,1
BRUTAL,1
#research &,1
Abbvie/Genentech's,1
Al D√≠a,1
https://t.co/rlV8jFFWgQ,1
#ETH #,1
AbbVie Announces New Undetectable Minimal Residual Disease Data,1
FreeCryptocurrency,1
#CLcares #,1
#obinutuzumab #chlorambucil,1
New Website,1
Tokens,1
https://t.co/zQJPXSAeOd,1
1DayLeft,1
https://t.co/J88BEUmQvO EHA_Hematology,1
#CLL #Leusm,1
#LymphomaManagement #,1
#treatments,1
65+ #meded #lymsym @DrElaineVickers https://t.co/sLwAqdh1kR,1
Dr Borczuk,1
icop18,1
2DaysLeft,1
@middletonccnews,1
T20,1
18 and 19 year,1
Towncroft,1
the @lancs_league,1
#memories,1
encantas,1
#ovariancancer #,1
al @NatureMedicine https://t.co/2EaYs49r4S,1
#BEG #,1
#GAN #,1
https://t.co/XDBRSgauX8,1
Semmelweis University,1
@semmelweishu https://t.co/lyCcvMUTjr,1
quedar√© con la primera,1
#mx #,1
#Wrestler #,1
P.D: Est√°n Bkn,1
#ropa,1
#remera #,1
Nat Med,1
Token Store,1
#TokenStore #,1
Betsy Dennison,1
3DaysLeft,1
https://t.co/6x0e5Z0QIv,1
the 1st Edition of Educational Meeting,1
@UIMP,1
@Sidnavigare,1
next year‚Äôs,1
IŒ∫BŒ∂,1
https://t.co/b0jEtrOFJO https://t.co/skm6RkFtNA,1
4DaysLeft,1
"https://t.co/3VKEbfKS7J
#",1
https://t.co/w1rwTS1BL1,1
Dirty Kinase Inhibitor,1
collaboration w @ALLIANCE_org,1
FDA Approves New Treatment Option for Previously Treated Chronic,1
https://t.co/76f8rEyyfz,1
5DaysLeft,1
https://t.co/C6fGNkjseq Treatment,1
https://t.co/icZYDzlLjv,1
over $2500,1
#RWE w,1
https://t.co/HMzdJu007M,1
Melvin,1
6-11pm,1
July 17,1
ClassOf2018,1
Leukemia https://t.co/9upLA7gxB5,1
UC San Diego Health,1
Rituxumab,1
age 65,1
MicroRNA-92a-3p,1
https://t.co/b9QKM8fIHG,1
6DaysLeft,1
#rituximab dans la,1
questions@patientpower.info,1
Deciphering Functional,1
MS/MS &,1
Azacitidine,1
AZA,1
the next 5 years,1
All Personal Health - https://t.co/jZrCwIN9cA,1
Lymphatischer #,1
sogar von einem Ende,1
#lymphocyticleukemia,1
#investigationaldrug #,1
Ella,1
2-year-old,1
Azusa,1
7DaysLeft,1
A South Model For Turtle Of Chronic Lymphocytic Leukemia,1
Viden,1
#lyle_dk @lyleforeningen,1
La Dott.ssa Lydia Scarf√≤,1
$TGTX #EHA23,1
#umbralisib #CLL #,1
https://t.co/oVnZARqdzf,1
#Meatballs #ShoutOut2TheResearchers #,1
#Meatballs #ShoutOut2TheResearchers #GoGoGo,1
Causes &,1
#EHA23  https://t.co/wY4YK3J8RY,1
Ode,1
Demazong,1
Sikkim,1
Caf√© Live and Loud,1
#tedxgangtok #,1
#gangtok #cll https://t.co/WtGO20VTkr,1
@CllIreland 2018 Information Day,1
https://t.co/m1YRgLnKzE,1
Straten,1
The Netherlands,1
Strefford,1
Andrew Wei,1
#EHA23 üá∏,1
#lymsm #leusm #obinutuzumab #,1
AbbVie  Announces U.S. FDA Approval,1
a Fixed Duration Treatment,1
SLL Patients Who Have  Received,1
Swiss,1
Ericllorg,1
#EHA2018 @Ericllorg https://t.co/leTLAjLS0o,1
A busy hour,1
https://t.co/hv2PJb75wW,1
https://t.co/81mnmgRn9b https://t.co/VOgLQQoWOB,1
#BSH18 https://t.co/311koBd9bC,1
Maria Cappellini,1
day 3,1
ClinicalExperts,1
Grace,1
MSKCC presents,1
KI Intolerance,1
#EHA2018 https://t.co/vA4yJIKOxR,1
EHA18  https://t.co/gwjQ6e3wAE,1
https://t.co/AIliksmV3I,1
https://t.co/gNhhhKx79x,1
Nadine Tolman,1
https://t.co/g3eiro052C,1
#OralSessionsAreFull https://t.co/TbYYSOjd4K,1
challanges,1
#Helical #,1
TomoTherapy,1
@Csac_Algerie &,1
‚û°Ô∏è,1
Subbarao Bondada's,1
Chronic Lymphocytic Leukemia's,1
The Journal of Immunology,1
AbbVie Newsroom,1
#MorphoSys Presents,1
obinutuzumab+ritux,1
"@anthonymatomd 
Good",1
Watch Gustaf's,1
339,1
Hall 7,1
@lyle_foreningen,1
https://t.co/vz6N7XLC5L,1
#OxSymp18,1
#STATINS +,1
BCL2 INHIBITION,1
#LEUKEMIA #,1
TWEET TWEET,1
#DLBCL,1
‚Å¶@nature‚Å© CD&amp;D,1
Craig Sinclair,1
https://t.co/USAEvFdnmW,1
Related Articles Circular,1
https://t.co/u2oxLVEzzL,1
@sehh_es https://t.co/Xq2l1ZLFDI,1
@sehh_es https://t.co/wPoPh5yHm0,1
around half,1
EHA18 https://t.co/yHH1Hc4X8B,1
#EHA18,1
Antibody MOR202,1
EHA 2018 Conference,1
https://t.co/xXsKgXPDpD,1
EHA 2018 Conference https://t.co/nAdD97qHk0 https://t.co/J3Mup4mK5R,1
https://t.co/jNmLr5heqL Presents Clinical Data,1
EHA 2018 Conference  https://t.co/aqTSxIOAcG  ,1
MOR MorphoSys Presents Clinical Data,1
more than 20,1
approximately 5,1
https://t.co/aBYjZM3t1H https://t.co/jssNzGAYfZ,1
#aspergillosis #,1
#EHA23 https://t.co/MmW24xqhRy,1
#EHA23 https://t.co/LeooG8D6Ki,1
6:15 PM CEST,1
https://t.co/1gLUYeKmpK,1
#AbbVie am,1
Neue Updates,1
Zukunft,1
FUN,1
#productlaunch,1
#Cryptowatch #,1
#oncorn #,1
https://t.co/Pc0gL8KgYs,1
4:15 PM CEST,1
Hall 6,1
Glen Sabin,1
#leusm https://t.co/P8DPNGHGgq,1
3b,1
#GLE #,1
#VTA #,1
Clonal Relatedness https://t.co/CVbVrU1WFB,1
https://t.co/8yMLxQk2xH,1
https://t.co/k6iYy40GGz,1
https://t.co/0KSXhaMPPP,1
"AML 
https://t.co/2GlPGo7qtg",1
ECM https://t.co/yR1vfqlDHw,1
Ken Research,1
https://t.co/EjGE8yNFiA,1
https://t.co/hjHijzgoS4 #,1
3B,1
https://t.co/0qXIm2PQgY,1
https://t.co/gAGr7zF01b #,1
https://t.co/GYPIQdsj0A,1
Wierda of,1
@MDAndersonNews Stilgenbauer,1
https://t.co/rg0Cp8ZOeW $ROG $,1
#lymsm https://t.co/hPRTrus5It,1
Venclexta-Rituxan Combo Approved,1
https://t.co/WameD2Ls3e,1
Venclexta and Rituxan,1
Venclexta / #,1
@Roche @biogen,1
Venclexta plus Rituxan for People With Previously Treated #,1
Venclexta plus Rituxan,1
AS,1
"Venclexta, Rituxan",1
Pharmaceutical Business Review - #,1
#Venclexta-#rituximab #,1
ROG https://t.co/lpJupYQFVe,1
https://t.co/FfvQ4uzECa,1
Genetherapy,1
a single #CAR #,1
Der Entwurf,1
"Patientenleitlinie """,1
Leitlinienprogramm Onkologie,1
15.06,1
Kommentare zum Entwurf,1
Alle Dokumente gibt's,1
https://t.co/78IJdUiS0v #CLL,1
https://t.co/uPGwbopXdw,1
almost 1150,1
https://t.co/FVFdCEwg0P,1
Approval,1
389,1
Second-Line #,1
@FDA_Drug_Info,1
https://t.co/gJQOzKvvTg,1
June 8,1
Rituxamab,1
https://t.co/Pu7iDYMkB0,1
Over 1000,1
@US_FDA CC @anthonymatomd,1
Leukemia https://t.co/IvYN9qUXjq,1
a Fixed Duration Treatment for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients Who Have Received One Prior Therapy,1
https://t.co/nbhfXI54ju,1
a Fixed Duration Treatment for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients Who Have Received One Prior¬†Therapy https://t.co/WWSkxtpgQM,1
SLL https://t.co/dBFKOB2ZWH,1
Leukemia https://t.co/0eHNprTWhC,1
https://t.co/mCqH0j5NoA,1
https://t.co/CxmycUW67c,1
BreakingNews,1
https://t.co/IZjTTAbSDq,1
https://t.co/FUJ0cAngGd,1
https://t.co/ZEK4tvReTi,1
#leusm https://t.co/F2Y2557Cv3,1
Cheesin,1
#amandavscancer,1
#kickcancerinthedick,1
CLL Patient Advocates,1
"31 August to 2 September, 2018",1
Sign &,1
Chipinge,1
Harare,1
0782408530,1
https://t.co/Z5Xyoh2T4i,1
140 #CLL,1
Outcomes &,1
Collaboration w @anthonymatomd,1
Transcript,1
the House of Lords,1
https://t.co/Cfv59VDNXs,1
@CellStemCell https://t.co/1APa3WqbvY,1
https://t.co/prxXAE7wkQ,1
Non Hopkins Lymphoma,1
@cnag_eu,1
@icgc_news,1
B. Uncontrolled,1
Wierda of @MDAndersonNews,1
#table #tab #ta #,1
#celli #,1
#cce,1
#cca #,1
#dfdd,1
#tfdd #ffg #,1
#ffi #,1
#hhm #hhn #hho #hhp #,1
#hhl,1
#hhs #hhx #,1
#hha #,1
"hhb 
Man...Monster",1
"Destroyer
Paperback",1
2.99,1
GoodVibes,1
Cancer Survivorship Celebration,1
12-year,1
#ELLA,1
BKG,1
K #,1
https://t.co/lYERKm7MHa  #,1
#makerspaceiskolan #,1
PI3kd,1
Blood Cancers and Advances in Treatment,1
Friday 8th June,1
4pm,1
5.30pm,1
Beaumont Hospital Dublin,1
@cancertrials_ie https://t.co/a4sMYmZ6wQ,1
https://t.co/o7Uu2LIoIa,1
Wednesday June 6th @ 11:30,1
WLJN,1
CLLRooted https://t.co/6V3RwhpdL3,1
CLLsm https://t.co/0J6zTohxG9,1
@CancerNetwrk #leusm #,1
#phase1trial,1
Sends TG Therapeutics Stock Soaring,1
https://t.co/SNR1DGOizi,1
https://t.co/a7uh6eqLYN https://t.co/pEGFUIBP8a,1
https://t.co/z4qurAzSsA,1
the Appellate Division's,1
the New Jersey Construction,1
#ConstructionLaw #,1
https://t.co/zeAb35Mx96 https://t.co/zeAb35Mx96,1
ASCO18 Stefan Barta,1
11:30 a.m.,1
Jos Melenhorst,1
Joseph Fraietta,1
the five years,1
282 #CLL,1
#RWE,1
https://t.co/zXrqHRrvQ3,1
Assess the Safety and Efficacy of Umbralisib,1
167,1
#UnlockYourHealth @CLLSupport @BrandcastHealth #bloodcancer #,1
Justine Kahn - Hematologic Malignancies,1
8-11:30 AM,1
Genomics,1
https://t.co/cmz5N2heGf,1
#Krebskongress #,1
Neue #,1
Audio,1
cancerSC,1
https://t.co/CKhfdcPAzJ,1
Current Clinical Issues and Ongoing Research in,1
0.89,1
-0.90%,1
more than 46%,1
52 week,1
StandardofCare,1
BLC2,1
#HistoryOfBloodCancer #,1
https://t.co/rX1g49MPcM,1
7508,1
"Hall E450, 11:57 AM",1
5/5,1
4/5,1
@wwierda https://t.co/X1yzwYWLeO,1
3/5,1
@wwierda https://t.co/pQEpXtJdJw,1
vincente nella,1
leukemia..https://t.co/DWA1NUMfEt,1
MRD kinetics,1
https://t.co/NwCHKtsQmY,1
https://t.co/s3yanvbvgw,1
https://t.co/iaQecqCQas,1
genomes100k,1
the British Journal of,1
https://t.co/N4PwghxvDC,1
Winship,1
Hematologic Malignancies - Lymphoma,1
https://t.co/gvzDFaFMVQ,1
wwierda et,1
Zaprasza,1
https://t.co/qfwcmDtWGd,1
09.45,1
#blood#leukaemia #cll#haematology#10k#Westminster#,1
https://t.co/uct9eoGH2u,1
about #CLL #VictoriesOverCancer #,1
https://t.co/ZdG7m9ZXgG,1
MayReCap,1
„ÄÇ https://t.co/8WGpjDtHc9,1
#ASCO18  ,1
https://t.co/ip4cLAyaU9 https://t.co/sY9NA3toYy,1
ASC018 w @anthonymatomd,1
Excellence in Oncology LWW Journals,1
Oftentimes,1
https://t.co/53mUgOs8WF,1
GLP,1
https://t.co/KLNYhrI70i,1
Science Magazine,1
Only one week,1
@Coventry2021,1
@NuneatonNews https://t.co/Un8hK55Xag,1
IFLScience,1
https://t.co/O2VOFCj4A3,1
lymphocytic_leukemia_(CLL,1
@Sunnybrook with @LLSCanada,1
https://t.co/YTwBSacAcg,1
6/11,1
ASCO https://t.co/JYpPontuIX,1
@CellStemCell,1
https://t.co/t40y3IkllV,1
6/17/18,1
üëâ CG'806,1
"Monday June 4, 2018",1
https://t.co/c0ZGuZCDD4,1
"Blog, News",1
University of California San ...,1
https://t.co/IDoHftYIiu,1
Rose,1
CEIGHE,1
https://t.co/4yzvAMSO3A,1
Only 1,1
#radonc #,1
Two weeks,1
üé•üé§üìã,1
https://t.co/J87x9KnTnP,1
w @anthonymatomd @NitinJainMD &,1
https://t.co/L09jVzytfM,1
the University of Pennsylvania's,1
Abramson,1
MayReCap https://t.co/NbFESRhTZJ,1
Penn #CLL,1
https://t.co/Jax5fcmTV4,1
Science And Tech Top,1
https://t.co/XFSfmqeIKj,1
https://t.co/WfLFhI1N3C https://t.co/aPwKBCRYna,1
Max Gordon,1
Stephen Amrock,1
Five years,1
'71,1
https://t.co/U7QlgNM7OG,1
https://t.co/ITElt9UtGQ https://t.co/Ijexku5zTZ,1
@theJeremyVine @BBCRadio2,1
@theJeremyVine,1
13:00hrs today,1
https://t.co/ZXmTgatbEB,1
CLL https://t.co/0uALbpiMUL,1
#ChronicLymphocyticLeukemia #CLL #Oncology,1
https://t.co/m7V9mOSbWp,1
CLL @LymphomaAction,1
@BrandcastHealth @HealthUnlocked #,1
https://t.co/ngkwZu55gW,1
https://t.co/wr1CZEd32E,1
https://t.co/JlsSGtESTN,1
#WatchWaitWorry https://t.co/sVrxUTayHC,1
"https://t.co/8oTumrpANz
#ChronicLymphocyticLeukemia #",1
https://t.co/Jc6xJCVNhl,1
@NatureMedicine,1
ChronicymphocyticLeukemia,1
https://t.co/wjc1lJG8sQ,1
https://t.co/eETfaR05IE https://t.co/e05vxnbJwS,1
L'√©tude de phase III,1
ligne de traitement de la,1
World Blood Cancer Day,1
IMBRUVICA Plus GAZYVA Phase III iLLUMINATE Trial,1
Accessibility Signatures,1
Chromatin States,1
Leukemia https://t.co/E2IajCW8rZ,1
"@MDAndersonNews
https://t.co/8Qa1oNMO2e",1
#BankHolidayWeekend #CLL #,1
https://t.co/rph2DwJL3M,1
üëÅüëÅüé•,1
Lymphoma #,1
#Frontline #Ibrutinib Plus,1
Aberrant CD8 Expression and Atypical #Morphology,1
"Review
Authors",1
Bowen Li,1
Dominick Amato,1
Chen Wang,1
https://t.co/SJD9TTzK6D,1
https://t.co/siFzpbeoiD,1
Adrianna Janicik,1
$AVVX $,1
BIIB https://t.co/SKJm529KGj,1
https://t.co/q6CZdhL53M,1
Depth &,1
#imatinib #,1
https://t.co/Hevz3l8Ju2,1
MGUS,1
MIRROR,1
#Genomic #,1
https://t.co/Djefu9HrLY,1
Keesha,1
https://t.co/wvllWBDGeL,1
https://t.co/EeM5SKMvKz,1
https://t.co/XZAhF95WHW IMBRUVICA¬Æ,1
Big day,1
https://t.co/ngkDqUGYa3,1
a month ago,1
#amandavscancer #kickcancerinthedick #bonemarrowtransplant,1
Lymp https://t.co/fKG56UEAwc,1
https://t.co/lGOni4GF4C,1
the Expert Perspective Tumor Board,1
#Oncologists #AcuteMyeloidLeukemia #,1
https://t.co/c3fEGAj1Qz,1
Navigatordagar,1
#Navigatordagar2018 #,1
Nadeem-Baker,1
markers &amp,1
The American Journal of Surgical Pathology,1
a good day,1
beachday,1
#longbranch,1
#newjersey #,1
#jerseyshore #,1
https://t.co/zQcUIhGyM4,1
#ProfPeterHillmen,1
https://t.co/VYms4b28eb https://t.co/vd6Y3bYgHS,1
https://t.co/XVouuVlxA4,1
last ASH,1
Dr Crowther,1
https://t.co/mqCiHsvXSM,1
https://t.co/1sdRjaKffE,1
200 #CLL #,1
#Bloodwise,1
#lymphoma Research,1
#familyfirstalways #,1
"https://t.co/7P1AAZA19K
#",1
Infraestructura Cient√≠fica,1
T√©cnica Singular,1
la obtenci√≥n,1
CNAG-CRG,1
a quick minute,1
CD23 &amp,1
@ELShematology #,1
Bcells https://t.co/fyR7xtMn8O,1
#EBMT18,1
WarwickStory,1
Implications in Current Era,1
https://t.co/eOxaW1ar1,1
https://t.co/Iw4WtHaZW5,1
#CLL Fighters,1
https://t.co/ti9rbZ9T6s,1
https://t.co/iejKYeS6rM,1
@CedarsUnion,1
September 12th,1
Creative Lunch + Learn,1
the Alphabet Soup of Evolving Treatments,1
@ciberonc,1
#regulatory #,1
#genetics,1
NatureMedicine,1
deuce‚ÄºÔ∏è#CLL,1
"Chronic
Lymphocytic Leukemia",1
#leukemia #ChronicLymphocyticLeukemia,1
#Treatments,1
the Alphabet Soup,1
#Evolving #Treatments,1
"3,500",1
Zur Kommentierung,1
@idw_online,1
Haimatus Latam,1
Sao Paulo,1
Novel BCL-2 Inhibitor,1
Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Non-Hodgkin Lymphoma,1
https://t.co/3qYxDcGDEM,1
RSP https://t.co/B2VEiTCCwq,1
#umbralisib,1
"https://t.co/rIluhrfxQa
",1
https://t.co/xI5aNxN8gi,1
1147,1
#ASCO18 w,1
May 30,1
6:30 PM,1
Joseph Hofmeister,1
Columbus Oncology,1
Hematology Associates,1
6:30 pm,1
Nursing Management #,1
Scheuermann,1
June 7,1
lymphatischen,1
Leuk√§mie zur Kommentierung,1
Netz,1
√Ñrztliche Zentrum,1
Qualit√§t,1
Medizin,1
https://t.co/GarTjvEJ6c,1
#InternationalClinicalTrialsDay &,1
Thumb Lake,1
more CNS&amp;HNS hours,1
@rachelfox164 @MyelomaIreland,1
Bendamustine Hydrochloride Injection,1
TGTX safety &,1
https://t.co/MGgTJLJzMx,1
Project Update + Upcoming Speaking Event -,1
Highsocietynetworking,1
#electrichaze #,1
https://t.co/wJPvn2n9mo,1
#JuevesDelRecuerdo #,1
BajoCero,1
Campe√≥n Nacional de @chileluchalibre,1
el a√±o,1
Contraataque,1
20-second,1
DevOperation,1
1 x106,1
#EHA2018 CG‚Äô806,1
37.36,1
Alexandra Kosvyra,1
500-milliliter,1
https://t.co/8op77saFuH,1
#follicularlymphoma #,1
https://t.co/BhFTc9eOH5,1
Raleigh,1
24 hours ago 4,1
2morrow,1
#Cuneo #,1
#CenterOfTheUniverse #,1
https://t.co/UTbZV9SFQT,1
https://t.co/3TkRHxAOya #oncology #PFS #BCL2 #,1
Jeremy Hunt,1
@NICEcomms &amp,1
https://t.co/n2q8Q3pC0i,1
#EAD #,1
recent days,1
DENIES,1
@THilalMD @chadinabhan @focusblood,1
New Drug Combination,1
at least 65 years old,1
#believeinyourself #,1
MondayMotivaton,1
Nat Med ‚Üí,1
https://t.co/UPtHkNbfhc,1
Will Respond,1
Kymriah,1
#cartcell,1
https://t.co/FSDA90bMyT,1
ZYDELIGTablet,1
#reds #,1
https://t.co/QkkRdzLXDt,1
Makin Yard,1
https://t.co/t5PPkIcOZP,1
https://t.co/MSraLqQevS,1
https://t.co/EVru0GPv7N,1
üèΩ#BOLO,1
https://t.co/VM2j5tybya,1
https://t.co/TWqSUVXjDX,1
https://t.co/UoNKVJPJ5s,1
https://t.co/3MaxHS5LwZ,1
autumn@patientpower.info https://t.co/AdJiyIPvgJ,1
prinshipesha,1
Whippoorwill,1
#flashbackfriday,1
#theoffice #,1
#igersparis #,1
weldon,1
Reditux 500mg Injection,1
RSP https://t.co/vpIRGDR19g,1
pneumococci,1
https://t.co/193IDMaflA,1
https://t.co/keP8s9lNAE https://t.co/zSHvFpypHz,1
American Society of Hematology Annual Meeting and Exposition,1
https://t.co/xZ7LyMDkuZ,1
@PrideCov June 9,1
https://t.co/Mk2xfeocLs,1
https://t.co/uSfH7psh1Q,1
iPads at Merridale Primary School,1
the Loganberry Trust,1
https://t.co/pqiRaaQJSv,1
https://t.co/q5PjvNQdzC,1
700.000¬†$,1
LymphomaForum,1
@HHFTnhs,1
Basingstoke,1
the 3rd #LymphomaForum,1
#lymsym #,1
#RminiCHOP #,1
@HHFTnhs @OUHospitals @UHSFT,1
https://t.co/l1q3N8roCm,1
EBV Positive Diffuse,1
AGM,1
https://t.co/OZw44V5Byn,1
https://t.co/1Oa6AkcLxu,1
#mdpicancers #,1
#radonc,1
#information #,1
Cathy Burton,1
#TuesdayThoughts,1
12pm EST,1
MRD Flow Panel,1
https://t.co/7GNhadWQZO,1
https://t.co/yOQpLGMaUx  @ASH_hematology,1
RSP https://t.co/ttLfqqudAb,1
RSP https://t.co/XPdCed3Ziq,1
@J_Immunol #CLL #chroniclymphocyticleukemia,1
Dietitian,1
#hematologyconference #,1
conference2018 #,1
https://t.co/NnQKqmIlwt,1
IGIV,1
RSP https://t.co/T1EShHxgvk,1
Capsule,1
https://t.co/e1WE56DHDk,1
Advanced Chronic Lymphocytic,1
Leukemia/Small Lymphocytic Lymphoma Carrying,1
t(14;18,1
TrenchFoot,1
EvenOdds,1
"https://t.co/mVWta8PoXv
",1
LaPrade,1
https://t.co/gNYplVYMVW,1
#Verastem Oncology,1
FirstPerson,1
KGlugni I  wNunn,1
Inytbk,1
chin pktolhknjlg pm nu,1
Anne-Marie,1
Chronic Malignancies,1
@warwickuni https://t.co/EJ7DheK7rz   #,1
Alvarado,1
Martha,1
Mena Zepeda Veronica,1
Ortiz Zepeda Maricela,1
Alvarez Vera Jos√©,1
Espitia R√≠os Maria,1
Jim√©nez Alvarado Rosa,1
CEO  https://t.co/1d80O8zSlG,1
#sun #,1
https://t.co/IInilSFD38,1
RSP https://t.co/oFgY0ow8Cd,1
B-Chronic,1
https://t.co/4q4eT3r7EZ,1
George Follows @CUH_NHS,1
#chroniclymphocyticleukemia #hemeonc #,1
BigPharma,1
about #WatchWaitWorry,1
Colt Egelston,1
TUM.1219,1
#AAI2018 (Research,1
Populations,1
@LymphomaAction national patient &amp,1
next Saturday,1
@CllIreland Information Day,1
@IrishCancerSoc Rachel Fox,1
Eleanor Sweeney @Beaumont_Dublin,1
https://t.co/ZeEqnFtKhU,1
1.70,1
0.009,1
1.57-1.84,1
1.47,1
0.022,1
1.39-1.55,1
#gerionc #geriheme,1
#SIOG18,1
#geriheme  https://t.co/fiSdOJtSMv,1
Intrinsic Potency,1
#Chicago #,1
Controls,1
Wimbledon @KFHproperty,1
SuttonJobs,1
Isaiah,1
26:3,1
NKJV,1
Venetoclax + rituximab,1
LymphomaConf https://t.co/giu4g9OpYI,1
Shoe Looky,1
@warwickuni https://t.co/SuxHC5Ld01  #2+2degrees #parttimedegrees https://t.co/F4HVCHrhSi,1
@compuniguide,1
https://t.co/O49bJl2KhO,1
Lomas,1
last nights,1
#concentration #physicaldevelopment,1
Global Oncology Partnering,1
Pre-Commercial Initiatives,1
Inv,1
https://t.co/TrYU4ZyJOq,1
Analyst and Investor Day,1
Follicular Lymphoma Opportunity Landscape and Advancements in PreCommercial Initiatives,1
"Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial""  https://t.co/Lrm888CWYd",1
.@andrewschorr &,1
5/3,1
4 pm ET/1 pm PT,1
5-2018,1
5 mo,1
@Areejmd,1
HHV6,1
Adult Leukemia Group,1
https://t.co/FzemLdddA0,1
Juhi Ojha,1
Iryna Dyagil,1
Stuart C. Finch,1
Robert F. Reiss,1
Adam J. de Smith,1
Semira Gonseth,1
Mi Zhou,1
Helen M. Hansen,1
Amy L. Sherborne,1
Jean Na,1
@ASCO Educational Book,1
Half,1
https://t.co/FSEn7oIV7j,1
70th,1
#scarymonster #,1
CONFIRMENLAPROXIMAFECHADECLLPORFAVAAR,1
https://t.co/PsCy8RjJh4,1
https://t.co/SbYMgnTGWB,1
https://t.co/ggsDEGVBvh,1
Venetoclax and Ibrutinib in Treating in Participants With Chronic Lymphocytic Leukemia and Ibrutinib Resistance Mutations https://t.co/14qCQOr6vJ,1
Ibrutinib Resistance,1
https://t.co/iz8t15srrq,1
https://t.co/r19w5u9812 https://t.co/gjgTHyTXkS,1
a fantastic morning,1
Nursery at Saint Stephens Primary School,1
#edtech #,1
#technology,1
The Cytogenetic Quality of Chronic Lymphocytic Leukemia,1
a CpG Oligonucleotide Versus,1
Mitogen Cocktail,1
a CpG Oligo,1
https://t.co/vDZJeVAk57 Chronic,1
https://t.co/CyE2ym5HIj,1
Greg Simon,1
@BidenCancer,1
MIGlobal,1
Seek Knowledge,1
https://t.co/84CcOr7m1P,1
https://t.co/zIUqw9KpTr https://t.co/qUQTx28PjC,1
Mondays,1
Lymphocyctic Leukemia,1
CAN'T-MISS,1
Alison Duffy &,1
Current and Emerging Treatment Standards for Patients with Chronic Lymphocytic Leukemia,1
9am,1
#asembia18 https://t.co/lJdQUj0ZYX,1
Wnt5,1
RAC &,1
Kipps Group,1
Bcells https://t.co/Qbey5PinSj,1
A Study of Duvelisib vs Ofatumumab in Relapsed/Refractory CLL,1
Microenvironment-Induced PIM Kinases,1
NHS Health,1
"30,000",1
#lovewatchingthemplay #,1
Directions in Oncology Pharmacy,1
"https://t.co/GML4Q1eZEA 
",1
Toxicities,1
#leusm https://t.co/LKJS71fnwA,1
https://t.co/qamKejdQGl,1
"Hawkes
Idelalisib",1
"https://t.co/qamKejdQGl

#",1
Christopher Oaks,1
https://t.co/Dz9gvjMRJj,1
https://t.co/0kuFcEvUwG #,1
https://t.co/ccJkZkbFlz,1
https://t.co/W1zhr98mwd,1
@THilalMD,1
#Malignant #,1
#Moffitt Cancer Center,1
#rituximab and,1
https://t.co/fNQUH01TRn,1
https://t.co/WEu3HaLSKi,1
#CYC065 #,1
https://t.co/2Nzb3z6F93,1
https://t.co/ECV3EJoba1,1
May Information Day,1
about 1/3,1
Drs Voorhees,1
Bhutani,1
@Carolinas https://t.co/T2EjTf6Yim,1
Focus on Elderly CLL Patients,1
Dr Jacobs,1
@szusmani,1
@Carolinas https://t.co/hCuELjTB07,1
P13K  ,1
06/04,1
https://t.co/f1efIhjEJK,1
https://t.co/DnWwfCihkT,1
the Current and Emerging Treatment Standards,1
836,1
https://t.co/FdZRjMrhEC,1
#leusm https://t.co/gjnMlwIeMB,1
https://t.co/Q80GLKfOvj,1
https://t.co/yOQpLGMaUx @ASH_hematology #leusm #,1
26 April,1
Martin Peifer,1
#CTCL,1
@WMIWMF,1
Mark Bustoros,1
Benjamin Liechty,1
David Zagzag,1
Cynthia Liu,1
Timothy Shepherd,1
Deborah Gruber,1
Dimitris G.‚Ä¶,1
therapy.‚ÄîJohn C. Byrd,1
https://t.co/X3T9Z0FSsu,1
#LymphomaConf inc,1
@BarbaraEAWilson,1
#cutaneouslymphoma #,1
Eileen Parry + #,1
@DrElaineVickers Book,1
John Girbben,1
https://t.co/6XuW3NCtXe,1
https://t.co/jP2ty2vpKz #CLL,1
CIBERESP,1
the InterLymph Consortium,1
Geffen Kleinstern,1
PRS,1
Association of polygenic,1
https://t.co/VEc6JrXxxf,1
https://t.co/ilVpFsdocf,1
3.86,1
https://t.co/MukQLugfIs,1
ZydeligTablet,1
3.14,1
2.25‚Äì4.39,1
3.06,1
#geriheme https://t.co/kchpgfopoa,1
#geriheme https://t.co/BsWqIPrENx,1
https://t.co/uZdSPvehKA,1
Pts&gt;65,1
Ô∏èPFS &,1
Leusm https://t.co/zbZSRrSm6L,1
#nephronpower #,1
Kidney,1
@renalmyeloma @CKJsocial,1
Easter,1
#biosimulation,1
National Volunteer Week,1
The Leukemia &,1
Ann &,1
Chronic Lymphocytic  Leukemia,1
donate).https://t.co/Y7qsZHKf9H,1
RRP,1
AML World Awareness Day,1
Acute Myleoid &,1
@cancertrials_ie @IrishCancerSoc,1
Stem Cells,1
Patrizia Aureli,1
Emanuela Varasano,1
Ambra Di Tommaso,1
Raffaella,1
Facebook to watch &,1
#RWE &,1
Kline,1
True Blue,1
#CG806 #,1
a FB Live,1
LymphomaAction,1
https://t.co/WIdTxs4OgO,1
#FollowFriday - &,1
@LymphomaAction &,1
LymphomaMatters &,1
RUNX1-PDCD6,1
https://t.co/bGfe2HMo1b,1
https://t.co/ItEAnf0XBh https://t.co/NDz7IDIUIY,1
4/19/2018,1
#Youtuber #,1
#Dragonchain #tezos #,1
148k/year,1
Dominik Heim,1
https://t.co/C4SiRKxHeN #,1
w/Chronic Lymphocytic Leukemia,1
Venetoclax Shows Promise,1
Medical Laboratory Scientist,1
Daniel Landau,1
Weill-Cornell NY,1
BRAF K601E,1
Rm W196 https://t.co/DosjsLPCQF,1
https://t.co/kgLqn7oXEC,1
the Living Well,1
ScholarAlerts,1
https://t.co/qrP5mYSLIq üé¨,1
CYC065 CDK Inhibitor Demonstrates Synergy With Venetoclax By Dual Targeting Of Chronic Lymphocytic,1
BSH2018 @CRGHaem,1
day 2,1
ImmunoOnc &,1
ü§óüëè,1
#BleedingDisorders #,1
#transfusion #,1
Treating Chronic Lymphocytic Leukemia,1
#NWF,1
#TAM #,1
https://t.co/M2wJUae516,1
#VENN,1
#FORT #,1
#BOOT #,1
8:59 - 11:30,1
#WatchWaitWorry https://t.co/p089fnXmLj,1
holistic,1
https://t.co/eLUGYfxQQR,1
"50-6,000",1
$apt $,1
Live Well with,1
https://t.co/kZ0yxhie7R,1
#zenchi en,1
Chilena,1
https://t.co/coI8eM2TAr,1
Humalutin,1
NANO $,1
IMHO Watch &,1
- Active Management,1
https://t.co/qrYYkCa2Ka,1
Leukemia https://t.co/F2OlpDEChq,1
XNW1011,1
Just 3 weeks,1
National #CLL Information Day,1
Carers,1
https://t.co/6t1wx5q4PM,1
https://t.co/88039xjepT,1
18.73%,1
Latest Trend,1
Triplet Combination of Ibrutinib,1
Obinutuzumab Effective,1
Initial CLL Treatment,1
#cllsm https://t.co/8QCFcUPBvC,1
@LeukemiaMDA &amp;@ColumbiaMed,1
JIPMER,1
@rcgp @LeukaemiaCareUK https://t.co/WQVwm26hmv,1
#EGAimpact,1
TCGA &,1
ICGC,1
CLLSA/Leukaemia Care,1
12th and 13th,1
https://t.co/0L1hc8CtHk,1
#Review,1
2nd day,1
Diagnostik,1
Kostenloser Download,1
https://t.co/3Pmm8m4p55 https://t.co/ykrmI28kZ4,1
https://t.co/LNHQtozo2Q,1
https://t.co/BRjLkln00n,1
CXCR4 Imaging of Chronic,1
#health #research #,1
https://t.co/R8ITonHSUy,1
https://t.co/JLo1h6PK4v &,1
Kirman,1
Babesia,1
2+2,1
Sheffield,1
https://t.co/lTH6rXPOdr,1
https://t.co/dzanui40PI,1
the Possibilities Fund Golf Tournament,1
SouthCarolina,1
https://t.co/vacLbsPUwG,1
https://t.co/laP8tTUNgo @Pharma_BR,1
"Cancer 

https://t.co/v1ZEEttV9D",1
los resultados y,1
los s√≠ntomas m√°s,1
LeukaemiaCareUK,1
LMC,1
@kdjhaveri,1
@CKJsocial,1
Expert Discusses Novel Treatment Options for Relapsed/Refractory CLL,1
"https://t.co/c9AwHiJM7o 
",1
last year's,1
CLL @CIBERONC,1
@Cambridge_Uni last month,1
@nicoladandridge,1
https://t.co/A1a2vAp0KO,1
Lisa Minokove,1
Instanebel #,1
ERIC Method,1
https://t.co/Pwmx814WsC,1
12 May,1
#FollicularLymphoma #,1
#biopharma #pharma #,1
Company,1
#mds_dk #cml #cll,1
F√∏lg,1
"kr√¶ft
https://t.co/I1vJfQZ8vQ",1
Woken Matt Hardy,1
Bray Wyatt,1
ganan,1
Titus Worldwide,1
al torneo de la semana,1
#RAW #,1
Useless White Blood Cell Supremacists,1
@Trump_ton &,1
April 14th @ 6pm.,1
4 May,1
@IrishCancerSoc https://t.co/0BzXnH3nUT,1
#Myeloid #,1
Prior #Treatment,1
Wrestlemania,1
New Orleans,1
las cosas,1
Brock Lesnar,1
ok...#Wrestlemania #,1
SHIT,1
Daniel Bryan,1
y gana,1
Zayn,1
Owens,1
John Cena,1
#easy #,1
Bludgeon Brothers,1
Usos,1
New Day,1
#normal,1
RondaRousey,1
gana con armbar,1
NUEVO,1
Woman's,1
Battle Royal lo gana NAOMI!,1
lo esperaba,1
Segundo Upset,1
NUEVO campeon de Estados Unidos,1
Wrestlemania #,1
WOOOOW el,1
Charlotte Flair,1
el titulo,1
https://t.co/d1SxmOSMtx,1
@LeukaemiaCareUK  &amp,1
https://t.co/qO63pahX66,1
#PatientsIncluded #,1
minutes,1
2.5 to 6 hours,1
7 to 8 minutes,1
maar erg duur‚Äô,1
https://t.co/2qmeTCZwa7,1
#earlsdon #,1
BCS,1
about 18 years ago,1
@NWSHouston,1
Venetoclax/Rituxan,1
https://t.co/3ryG5jPFGh,1
https://t.co/fPu7NVGrkX,1
"https://t.co/7CAITNpUgw 
",1
https://t.co/dYcQPTBO7J,1
#CART-,1
Sooner,1
SGMO,1
@roche‚Äôs,1
#MS,1
KPTI,1
PeterMacCallumCancerCentre,1
almost 85%,1
@abcnews,1
#CLL https://t.co/Yacg3eXmWE,1
Biotech Daily,1
https://t.co/4E9331THtC,1
https://t.co/YVM3foBtUl,1
since 2015,1
Pittsburgh,1
300lbs,1
18 years,1
https://t.co/45whWY3mt2,1
nice review article,1
https://t.co/RobaSMUIrI,1
#SoundCloud #,1
#va #,1
CR7 Yine Yaptƒ±,1
Helal Olsun,1
#trt #,1
sin QT,1
droga para,1
https://t.co/7Uxx8krUBL,1
https://t.co/wTCyNnOdSz,1
la elaboraci√≥n de la nueva,1
gu√≠a cl√≠nica,1
publica @BloodJournal,1
Limf√†tica Cr√≤nica,1
al @BloodJournal https://t.co/I9Hx766hqr #,1
Reviews,1
Marginal Zone Lymphoma,1
https://t.co/XcpbtPKePU,1
NOS,1
"69
Days",1
185,1
"16,250",1
"16,450",1
"591,981",1
LBS Left,1
"1,778,019",1
Now Trading Live on TokenStore,1
#decentralizedexcahnge,1
#myetherwallet,1
#tokenlisting #list,1
Now Listed as a Default Token,1
#MEW #myetherwallet,1
#tokenlisting,1
#list,1
VitalikButerin,1
AMHH,1
Madrid Association of Hematology,1
Hemotherapy,1
#AMHH #,1
#hire #,1
https://t.co/ygXln4tY16,1
https://t.co/PCw4J2NW2c,1
PI3Ks,1
Bagg,1
https://t.co/IPHWrmTiQY,1
the Winning at Home Family Camp,1
https://t.co/lFDDHwRnMe,1
RSP https://t.co/8x9tilWFco,1
#CLLPatients https://t.co/VKTN1gNCsb,1
m3india,1
https://t.co/JLo1h6PK4v @LLSusa,1
https://t.co/NJ41mWmzUP,1
#EBMT #,1
#cllsm #ibrutinib #idelalisib,1
poster &,1
https://t.co/2x84La1Yn9,1
270,1
$5K,1
Initial Bounty Offering,1
IBO Summary -,1
Cryptoliveleak,1
#BountyProgram #,1
#cryptobounty,1
36.3%,1
84.9%,1
multi billion dollar,1
"SNSS 

#",1
BTK https://t.co/Suz9xtC1wN,1
#ibrutinib https://t.co/0kG1dV9OtM,1
72.5%,1
15.7%,1
7.9%,1
Drivers of Treatment Patterns,1
https://t.co/F4Yv6i4ZGq,1
ECE,1
Speakers of Other Languages,1
@BritishCouncil,1
https://t.co/04enrrvBz9,1
#ECE,1
#CPD #,1
https://t.co/GMzDCbfU8V,1
Myelodysplast,1
Lars Bullinger @ChariteBerlin,1
All Personal Health - https://t.co/cmwiYk8XN0,1
#EZH,1
#AAS #,1
https://t.co/KJJMQe2wSU https://t.co/71PhqcPHS3,1
BSH,1
#ClaremontMinorsPirates #,1
Venclexta-Rituxan Combo Delays Disease Progression in Lymphocytic Leukemia,1
https://t.co/CaAKIudoNz,1
TCellLymphoma,1
Neon Therapeutics,1
P13K,1
https://t.co/1OZKn2m20X $GILD,1
Venclexta-Rituxan Combo Delays Disease Progression,1
WinterHeme Meeting,1
https://t.co/wDx1qaMMKB,1
Drug Combination Improves Outlook,1
Colorectal Cancer Charity - https://t.co/djKXQ3z784,1
https://t.co/g0U6c6ytJv,1
NEJM https://t.co/L5AGRCjAa4,1
1045,1
#CLL https://t.co/tE2RE2lVz9,1
All Personal Health - https://t.co/gvpwLBafTF,1
J. F. Seymour,1
"March 22, 2018",1
N Engl J Med 2018,1
378:1107-1120,1
@OncLiveSOSS #stateofscience #,1
@elcheikhjean,1
#LSMO #,1
encuentras,1
viejos,1
9.8%,1
14.7 months,1
ThyroidCancer,1
CINV,1
Heartfelt,1
#skin #,1
#malignancies #,1
Dr @elcheikhjean,1
LSMO,1
https://t.co/CNOdmMiBQm,1
https://t.co/Z9e2hd89Rs,1
Hillmen &,1
David Buchanan,1
Extreme Morning Challenge,1
#healthcaresystem,1
Aguinaga L,1
Anton-Remirez J,1
Casaj√∫s-Navasal A,1
Nebot-Villacampa MJ,1
Daroca-Fernandez I,1
Dom√≠nguez-Garrido E,1
Rabasa,1
Field,1
#Obinutuzumab #,1
Therapy https://t.co/u5S4Lkwh3,1
https://t.co/w02nkWAqix,1
NEJM https://t.co/mpE0IR0nSP,1
2 and half days,1
https://t.co/4mjkTSTLsp,1
ASH-Kongress,1
Der Thron,1
Hodgkin Lymphom,1
CLL @BloodJournal  https://t.co/rDmAH7dCpb,1
Murano Study,1
#rituximab  https://t.co/kK0wgkfyQW,1
"Seymour, Stilgenbauer",1
"O'Brien, Chiorazzi https://t.co/IgXQfXJNVq",1
https://t.co/O4ecUxp9pk,1
Health Canada Approves RITUXAN Subcutaneous Formulation for Canadians,1
https://t.co/uwThQ2LuNV,1
3/22/18,1
Venetoclax‚ÄìRituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia,1
#BCL2Inhibitor,1
https://t.co/8IqRHo9ksH,1
NCT02005471,1
Honorary Consultant,1
Cello Group plc - Final Results,1
https://t.co/QSypsketuq,1
Venetoclax‚ÄìRituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia |,1
"NEJM https://t.co/ZepzKO6tHO""",1
RFS,1
#leusm https://t.co/LqK0nXNlzv,1
DailyStrength https://t.co/tOLP892yor,1
https://t.co/qwU5AnSQaU,1
https://t.co/EiZGYJYeu8 #,1
https://t.co/0wupQkvTuO Sign,1
@LoriLeslieMD et,1
TCellLymphoma  @JTCancerCenter https://t.co/S5YarwbYxw,1
Dana-Farber #,1
#Research,1
#candida,1
CYC065 + #,1
24hr,1
Blanca Espinet et al,1
Genomic Microarray Techniques,1
#HemePath #,1
RSP https://t.co/rwLq4suoyf,1
CLL Expert Explains Latest Treatment Developments,1
the Field - Neil E. Kay MD,1
https://t.co/Tbhe0RAKJT Photo,1
Casein,1
"around 13,000",1
today &,1
'Watch &,1
RSP https://t.co/q7oHbrBnNv,1
24 years ago,1
A month ago,1
2800,1
#CLL/#SLL https://t.co/xLWCNCwEmF,1
#leusm https://t.co/vGRV2DjJBf,1
Colonial Systems,1
Nathan Simpson,1
EBMT18,1
Multiple MyelomaAplastic Anemia,1
the Oncology Nursing Society‚Äôs Clinical Journal of Oncology Nursing,1
https://t.co/X2ZNlrqfmQ https://t.co/XLQTc70Mo8,1
$GILD $,1
CR &,1
#transplant #hemeonc #,1
23 March,1
@YorkSportsClub https://t.co/WHZ8shd26o @yorkshirepost @BBCYork,1
St. Patrick's,1
P√°draig shona,1
ForkDelta Exchange,1
#forkdelta #decentralized #,1
#eth #,1
erc20 @ForkDelta,1
196,1
Few days,1
Ronan Foley,1
Host,1
next Saturday's,1
@LeukemiaMDA https://t.co/2trarRyCav,1
#money,1
#invest #,1
#leusm https://t.co/zaHtLOXbCR,1
Kinder Camp,1
#ldinsight #,1
Token $,1
"https://t.co/dZwS8zC1yr 

#CLL #",1
March 24,1
https://t.co/44gvaKPrkd &,1
https://t.co/zBNVK0RiMX,1
@LLSTXG,1
Bi,1
National,1
#lymphoid Ca,1
Robert Strair,1
@RutgersCancer,1
https://t.co/XUrkAtjWAu @MDAndersonNews #,1
https://t.co/ybbiHy8CRP,1
Voxtalisib,1
Helper Cells &,1
Their Association,1
#CLL https://t.co/jCwnZ7hsjk,1
https://t.co/6lShwbLIVs,1
$snss,1
https://t.co/qPWGxrNFZz,1
Haematologica Distinct,1
Taiwan,1
Acute Promyelocytic Leukemia,1
the Lymphoma Service @sloan_kettering,1
"lymsm
https://t.co/7svlqkuT4o",1
https://t.co/KMa1o5gPJU,1
Only 58%,1
Collaboration w @anthonymatomd &,1
https://t.co/vDZm1vUJWM,1
the BCell Chroni,1
Carl H June,1
https://t.co/voszmIx5ie #CLL,1
https://t.co/ShjK4OMc5Y #,1
Clinicaltrials,1
the many #CLL,1
19th,1
the World 2018',1
üåé,1
"12:00 
üìç",1
Aula Magna,1
Facultat de Medicina,1
üëçüëçüëç,1
La √∫ltima vez,1
https://t.co/gNHnRZMhkl,1
https://t.co/9TCB0wz5lD,1
CLLX4,1
https://t.co/tCUIMpolBN,1
@ascp_chicago Patient Champions,1
"Deedee, Chronic Lymphocytic Leukemia",1
https://t.co/p0y5cirGuj,1
https://t.co/S9NiOqueYj,1
Condition Su‚Ä¶ https://t.co/WLxEoAu2hq,1
https://t.co/bgO1CAPXZn,1
Deedee,1
Parul Bhargava,1
https://t.co/5cHUexSTMB,1
Angelo Agathanggelou &,1
https://t.co/Vhpke2HwrZ,1
the UK CLL Forum,1
@uhbcomms @heartofengland,1
Funday üìöüí°üìÑ #,1
this Wednesday,1
Enjoy üòä,1
https://t.co/zx5U0aSyA4,1
lolofromparis2018 #,1
#tournage #,1
https://t.co/CcQneJSJcf,1
Toni,1
https://t.co/j4zlTJMZdD #,1
Chicago Lymphoma Workshop,1
https://t.co/HM8UhtsAjP,1
https://t.co/64axgRRDJ6,1
Dr CM Wendtner,1
Hospital,1
Munich üá©üá™,1
Expert Forum,1
https://t.co/oUdoiQSMWz,1
https://t.co/DtxOeu7473,1
Chronic Lymphocytic Leukemia Pipeline Highlights - 2017,1
https://t.co/0dRnMffT9H,1
https://t.co/6y9j5yBvmF,1
Grade Camp,1
NiagaraFalls,1
Ontario,1
https://t.co/RkKH4ZFqMg,1
Specialty Registries,1
https://t.co/rn4msKABln,1
Customs Clearing Activity,1
the Tin Can Island Port,1
Abat,1
International Women's Day,1
Ray,1
‚ô•,1
#MothersDay https://t.co/37DAjnCCF9,1
#leumsm #,1
#GIpath #,1
anti-CLL,1
Meeting Report] 2017,1
#CLL https://t.co/SBKeFFFkZG,1
Constantine L. Tam,1
11.4%,1
the first year,1
53.5%,1
37.2%,1
IFI,1
"LOVE &lt;3
",1
MOVIE &,1
Nurse Practitioner or,1
Chronic Ly... -,1
Get Family Practice Physician,1
@RCPath,1
https://t.co/IbGZ7gyzQ6,1
Saint Stephens Primary School,1
edtech https://t.co/koDw45RufI,1
"#DLBCL
",1
RheumatoidArthritis &,1
Kelly,1
NOLA,1
New Video Review,1
Token + Airdrop Statistics Review #,1
ethereum - https://t.co/IyhMtu3WtV,1
https://t.co/rbb5H9ngI0,1
UK CLARITY,1
Forconi,1
Activity and Safety of Front,1
Pan-Canadian Oncology Drug Review,1
Lorna,1
#MothersDay https://t.co/WsOYeVv7Fz,1
Token Review,1
https://t.co/GqF1hA1dDX,1
#airdrop #,1
#smarteconomy #,1
Leukemia https://t.co/YFnQ4bWbDo,1
DimetSeminars,1
Massimo Degano,1
DimetPhD @UNIMIB,1
https://t.co/i1iniGQzi6,1
Lorraine,1
RSP https://t.co/afWG66HxZE,1
overnight,1
na√Øve https://t.co/HksVHtDFIc #,1
Quand,1
aux autres,1
Cela,1
ce genre de comportement,1
duvelisib versus ofatumumab,1
Only 78%,1
#BH3 #,1
Teisha Helgerson,1
age 42,1
the third day of 22nd,1
Focus on Leukemias,1
@LeukemiaMDA https://t.co/03wH7bbOV5,1
@SaudiLeukemia,1
https://t.co/SlbngdUetj,1
#environmental,1
https://t.co/dbONKizYw8,1
#genetics #,1
CaGenome #,1
Atef Hsini,1
mnawerna,1
":p &lt;3

",1
#FOG,1
#SIOP2018 #,1
https://t.co/asFVDc14js,1
this March day,1
Flinn Highlights,1
Hardtke Baseball,1
#Airdrops #,1
#cryptoliveleak #CLL #,1
#future #,1
#HBV,1
Hepatitis,1
Sarah Hammond,1
#NoHep #,1
#withdraws #,1
FrenchLanguage,1
The first of March,1
a poignant day,1
A day,1
Ibrutinib-Kombinationen,1
Erstlinie,1
https://t.co/gxhuYaQXL7 https://t.co/WEr6mSH6kd,1
Am√©rica,1
Frisco,1
#theyhadonejob #,1
Mission 8,1
"as many as 245,000",1
#PLCG #BCL2 #,1
#drugresistance #hemeonc #,1
cagenome,1
https://t.co/duWE3vdfPW,1
advocates &,1
https://t.co/wSae8qhxSe,1
https://t.co/DyLNqkFZP0 #,1
https://t.co/yvB79hMBcP #,1
the Western World,1
Acute_lymphocytic_leukemia,1
Chronic_myelogenous_leukemia,1
60 years of age,1
#multiplemyeloma and,1
"Leukemia

https://t.co/FWp16UP376",1
https://t.co/So5i62A2SX,1
Mission 5,1
Astronaut Rescue,1
Lucas SA,1
@Genmab $JNJ,1
Daratumumab and Ibrutinib in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia: Status,1
Daratumumab and Ibrutinib in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia Condition,1
PubSaludMurcia Karyotypic,1
Monitoring Patients With Chronic Lymphocytic Leukemia Treated With Venetoclax,1
del eje IL-23R/IL-23,1
IL-23R/IL-23 Axis Overrides Chronic,1
@UniGenova https://t.co/RC22jMI5pM,1
Midlands,1
#uksnow,1
327,1
#SnowWatch #,1
Major Competitors,1
Healthcare Journal,1
nine,1
#Mondaymotivation #,1
Nearly half,1
https://t.co/VTCk1LlJm7,1
https://t.co/sKs0mWOe1n @ASH_hematology #ASH17 #ChronicLymphocyticLeukemia #,1
https://t.co/484IyCyyKC - üöÄ Grow,1
the spring season,1
https://t.co/wvj1TKTqYv,1
üíò https://t.co/ApzYjrsMqT,1
A Pooled Analysis,1
2017 Information Day,1
69 months,1
Asslaber D,1
Reinthaler,1
Hofbauer JP,1
Danne,1
#LEUSM  ,1
https://t.co/AhZhq7WNrT https://t.co/tGSDy7bqTL,1
the CARE Winter #,1
HemeUpdate,1
https://t.co/m07lAG5bh1 @ASH_hematology,1
@DrMichaelChoi,1
8gellc Jae Park,1
Jae Park,1
Spanish Group,1
the JAMA Network: Complete Response to Ibrutinib,1
kinase inhibitor,1
nearly March,1
Global Pipeline Review,1
Lo√Øc Ysebaert,1
first year,1
https://t.co/4b5cRLZHwy,1
https://t.co/VBJedQLeAH,1
"HUUUUUUGE &lt;3
FREE",1
Science Translational Medicine,1
14 Feb 2018,1
REDOX,1
JPathol,1
https://t.co/vKl0kderna,1
MicroRNA-155-5p Overexpression,1
https://t.co/UvmgfS1rhD,1
https://t.co/9NBY6aAHjN,1
https://t.co/3gD91VPn3o,1
https://t.co/lUNhkmBjHA,1
https://t.co/vIwKNUzPVD,1
#Microenvironment,1
https://t.co/RcuMyqyPdW #leusm #hemeonc,1
https://t.co/covH2xFemg,1
v√•ren √§r det,1
Sursik,1
L√§s mer,1
#satellitbilder #,1
#handson #,1
#boost4charity https://t.co/rIuKEmxr5P,1
#lymphoma https://t.co/fe8fy5QA9O,1
#MCL $,1
#boost4charity https://t.co/ctchvGAstB,1
Maintenance Rituximab,1
Umbraslisib,1
https://t.co/4y5zKsPJUs #,1
March 1st 2018,1
#ethereum #,1
Annals of Behavioral Medicine,1
mannou &lt;3,1
#tickets #key #,1
@Roche @NovartisScience,1
gebruik rituximab,1
the next 4 years,1
TcellRx,1
Graft-Versus-Leukemia Responses,1
KIR Immunogenetics,1
los universitarios enfrentan a,1
Herediano en el estadio,1
Eladio Rosabal,1
Costa Rica,1
"Êäó‰Ωì„ÅÆÊäóËÖ´ÁòçÂäπÊûú„ÇíÁ¢∫Ë™çÔºöIRCCS‚ÄêAOU„ÄÇ
https://t.co/FzlrOHbSXO",1
Veratsem,1
NDA app.ication,1
#newtreatmentoption #PI3Kinase #inhibitor #,1
more than 6 years later,1
Azopardi,1
https://t.co/QkScLyGSuR,1
-nejm,1
"@antonymato et al. 
Read",1
https://t.co/DtmwLihiEV,1
Tuesday 27th,1
#gateway #,1
https://t.co/5FX18WO4u4,1
Cortisol,1
https://t.co/XntfvZ84My #,1
#skiing #,1
#europe #,1
https://t.co/ocqbwDQPMJ,1
#spring #,1
#BaseballIsBack #,1
cll https://t.co/QOYyRp6IP4,1
Hila Shaim,1
David Harris,1
Mayra Hernandez Sanabria,1
Zhiming Liu,1
Peter Ruvolo,1
Phillip A. Thompson,1
#chroniclymphocytic #,1
#interleukin #,1
Psychological Intervention,1
https://t.co/TlvLUJtK0,1
#amlsm #CLL #,1
@BBC,1
Current Treatment Strategies,1
Avicenne Hospital,1
https://t.co/e6OUFLH68o,1
2+2 Degree Student,1
Colorectal Cancer,1
https://t.co/lACuuEHgon,1
Ibrutinib/FCR Combo Highlights Significant Findings,1
https://t.co/ocxqC0QXIJ,1
https://t.co/v8jlGfY9Cu,1
Dallas Texas Hospital,1
Non Curable  ,1
Leukemia Cll,1
https://t.co/Lug1Q3DcbY,1
AGBT18,1
Maman Ramsay,1
ÂÆü„ÅØ‰ªäÊúà„ÅÆ12Êó•„Å´„Äé„Åø„Åà„Åæ„Å°„Ç≠„É£„É≥„Éë„ÇπinÁöáÂ≠¶È§®„Äè„Å∏ÈÅä„Å≥„Å´Ë°å„Å£„Åü„Çà,1
‚óã,1
#ÁöáÂ≠¶È§®Â§ßÂ≠¶ #,1
https://t.co/RxIvSQqQ5K,1
https://t.co/Odjgqucw35,1
O'Brien Covers Evolution of Ibrutinib,1
Susan O&amp;rsquo;Brien MD,1
https://t.co/L7Nn0qb2oc,1
van Hoeven V,1
Munneke JM,1
Hazenberg MD,1
Kater AP https://t.co/tPRo4te3bp,1
ÿ•ŸäŸäŸäŸäÿ¨ÿß,1
KEY &,1
24 F√©vrier 2018 -,1
https://t.co/BvbvZpdCtb #,1
ttp://www.asbmb.org/asbmbtoday/201802/News/Bcells/,1
#pembrolizumab +,1
24 month,1
only 6 months,1
Presenter,1
a 13 year old,1
"90,000",1
"https://t.co/sg2jrfuiIh

One",1
Social Workers,1
#socialwork #,1
Calin Lab,1
MD Anderson associates,1
https://t.co/7kfgCPGJsb,1
https://t.co/OOYfeHwLt5,1
Follicular Lymphoma https://t.co/ZusmnWFMZe,1
Simon Cox's,1
#clinicaltrial,1
Digital Radio,1
Find a Cure,1
21:00,1
https://t.co/IakHODSHhh,1
Jean-Marc Hoffmann,1
Maria-Luisa Schubert,1
Lei Wang,1
Angela H√ºckelhoven,1
Leopold Sellner,1
Sophia Stock,1
Amplicon,1
Personalize Lymphoma Management,1
Karen Koehler,1
Parks,1
just 4,1
https://t.co/W0e2sZYaWZ,1
Swindon 21,1
#Bendamustine plus,1
#mAbs #,1
InfinityPharma,1
ProfPeterHillmen,1
Clarity @bloodwise_uk,1
#Cheerlife #,1
#wearecll #cheerlabellangenfeld #,1
#cheerleadinggermany,1
#cheersport,1
https://t.co/CFrt8OTOgI,1
https://t.co/h4Fsauv51A,1
https://t.co/T9nTKpQ7GZ,1
seg Ctm,1
#VamosUnion #,1
#ChronicLymphocyticLeukemia #PrecisionOncology #,1
Stacey Worthy‚Äôs,1
Chronic Lymphocytic Leukemia News,1
https://t.co/q9bgRWYgmo,1
https://t.co/txdujBFMub,1
Preceptorship in #,1
Lymphoma Unit,1
Fundacion Jimenez Diaz University Hospital,1
Assay,1
#VENETOCLAX #,1
"up to 117,000",1
https://t.co/ULyXtrjJuA,1
Outro,1
Amaram,1
@MetroUK,1
@mgapatrick,1
https://t.co/36xTM0Uid1 https://t.co/3x4Potu4UZ,1
https://t.co/CtJifkLhD6,1
VSTM Verastem Submits New Drug Application,1
https://t.co/SI3mtuyaOg,1
Fundraising Dinner,1
BRIEF-Verastem Submits Marketing Application To FDA,1
Duvelisib - *,1
VERASTEM,1
@VJHemOnc - https://t.co/fOPH2RKaW7 https://t.co/xoqz19jXGk,1
https://t.co/cHL6JNRqRx,1
Westwood ‚ùÑÔ∏èThe,1
acute #,1
#bipolairestoornis,1
#bloedtransfusie,1
#AOA #ziekenhuis #,1
acutezorg,1
Never Give In!,1
Hodgkin‚Äôs,1
AEGLE,1
February 22,1
https://t.co/nUX5v3Xf1S #CLL,1
#BBCRadio4 #,1
@BBC https://t.co/EP5WY5Ry6G,1
#FindMeACure #,1
#BBCRadio4 -,1
Article on the CLARITY,1
St James's Hospital,1
#medicine,1
Leukemia  https://t.co/q45sKeXzF1,1
BBC News -,1
https://t.co/klcCbyuSYI,1
saBOA,1
Antarctica,1
https://t.co/C5xqxiFpQP  l,1
#LiveYourLife #,1
@BBCOxford,1
Cooles Bild,1
CLL-Doppelstartern,1
West 2018,1
Woche,1
klein,1
#peewee #,1
#performancecheer,1
#hiphop #,1
https://t.co/mtQp8EU339,1
S.C. Finch,1
I. Dyagil,1
Vol,1
215,1
https://t.co/1pZb77jHkP,1
11q-(ATM,1
#Trisomy12 #,1
Future Implications - LWW Journals https://t.co/6qX4IKHFlf,1
BBC Radio 4) Mon,1
9:00 PM,1
Dr Catherine,1
Leukemia  Acute,1
WeCanICan &,1
#PatientsLivesMatter  ,1
AndrewSchorr,1
https://t.co/fH1uiWcKIa,1
https://t.co/9YEfRijwTn #,1
.@landau_lab &,1
@WCMICB,1
"60""s",1
#WorldCancerDay #,1
Sunday https://t.co/3ckkhmMrWQ,1
seventh,1
Sunday https://t.co/LsZ2eTVqPh,1
Methylation Analysis Using,1
Domain Capture,1
Sundaymorning,1
https://t.co/s369xCo3Ut,1
SundayMorning,1
hundreds,1
https://t.co/0iJDjefjbq,1
@UniofOxford: https://t.co/QUXO5hnY1A,1
#ChronicLymphocyticLeukemia #leusm,1
#CTH #,1
#FDSA #RLE #FAN #,1
https://t.co/dU16PaYy0K,1
https://t.co/yKvgnIIxcf,1
Early morning,1
CampLakeLouise,1
https://t.co/0YUDDMYvQo https://t.co/t9qu4AOwgP,1
https://t.co/BaZ8FuSn1X,1
https://t.co/pnFJ61u094,1
Inspire &,1
Take Action,1
Marijuana,1
Non-Hematologic Adverse Effects https://t.co/evWKLkDgli,1
Richard Carwardine,1
Abraham Lincoln Institute Book Prize,1
#Lincoln #,1
https://t.co/zTFTiZ5K1n,1
"@haematologica 
@anthonymatomd",1
https://t.co/2E2IzYEuGO,1
#leukemia https://t.co/YCLH34UnDv,1
Genmab's,1
Arzerra Off the Market Due to Low Use #ofatumumab #CLL,1
#daratumumab https://t.co/Do2lS8CbZx,1
@labiotech_eu,1
https://t.co/a5bRY2bXmS,1
CCS,1
https://t.co/kXA3JCuL15 @ASH_hematology,1
C.J. Chis,1
https://t.co/UWUYjdnxBk,1
https://t.co/yUvcsQndVe,1
Behalf of the Guidelines Committee of,1
#FTC #,1
CLL https://t.co/rSQBBBSDEj,1
#Leicester #,1
BBC Radio 4,1
11:00 AM,1
1year 2 weeks,1
"7,500",1
https://t.co/hCriJ3VmCO,1
KOL Kathryn Kolibaba,1
Masasaktan,1
Ansell,1
#ultrastable,1
Dawn,1
Wendy Erber,1
https://t.co/46f6cnHei1,1
$snss #,1
https://t.co/BbrurnvaYU,1
immunoflowFISH,1
#discovery,1
https://t.co/CI7k4TBFb8,1
Chimeric Antigen Receptor,1
https://t.co/mKUc6GA4jk,1
Jorge E. Cortes &,1
@MDAndersonNews: Prediction,1
BCR-ABL1,1
https://t.co/J8dvMqcR8M #,1
https://t.co/oehFdg1cg8 #leusm,1
https://t.co/8TAyqOH197,1
Dasatinib Therapy,1
ACRF,1
non-US,1
https://t.co/CluHB7D4Fr,1
@UofCalifornia: https://t.co/eYxcN6NmvA @ASH_hematology #,1
12 Years,1
the Week,1
@LeukemiaMDA https://t.co/6f1Y57rFvM,1
https://t.co/7hORISFNZ2,1
Genetic Landscape,1
Alliance Award for Outstanding CE Outcomes Assessment,1
#Alliance2018 #,1
#PatientOutcomes #,1
Helfen Sie,1
Verst√§ndnis,1
Bed√ºrfnisse,1
erlangen &amp,1
Ihre Erfahrungen,1
$KITE $,1
DBCBL CAR T,1
genetic &amp,1
#tp53 #,1
@NovartisPharma @Genmab,1
#ÁöáÂ≠¶È§®Â§ßÂ≠¶,1
the Transplant Renaissance,1
Relapsed/Refractory CLL - Cancer Network,1
WhatNexter,1
12 year,1
here&gt;&gt;https://t.co/eUT6yAJ7pE,1
Buddy Support Scheme,1
@UpToDate  https://t.co/oVDXhg2T2x,1
https://t.co/gekHKT9s0p,1
Srinivas MD,1
Visible Human Journal of Endosco,1
https://t.co/xqyJtshM3B https://t.co/WDlGBk2uiU,1
CheckpointInhibitors,1
#ImmunOnc #,1
https://t.co/dLv5CRUGKe,1
https://t.co/77pvuI8pQ0,1
over 30%,1
https://t.co/raOkG2z1F0,1
#CLLestoeslucha #,1
https://t.co/r4sDUXA2lr,1
The Studio Venue,1
LS1 4AW,1
10am‚Äì4pm,1
@WVCancer https://t.co/YMJw8E8rvj @LeukemiaMDA,1
MATD,1
#FRAN #,1
#UKML,1
https://t.co/HDutcuJSbY,1
https://t.co/LJltYd6nRY,1
https://t.co/UCCfbUBUIM,1
Nick Yorke,1
https://t.co/Ja7ZIVeOpp,1
Wordoftheday,1
#Vocabulary #,1
#esl #,1
LearnEnglish,1
only 60.3%,1
@APPGBloodCancer report inc.,1
juno .best,1
10 #bloodcancer #,1
#leukemia #precisionmedicine #,1
5 minutes,1
Just 30 minutes,1
#leusm https://t.co/KBnyo8MGTC,1
#Westminster,1
Implications in Current Era..https://t.co/98UucPeeR8,1
Echo Project Management Group,1
Topics,1
cGVHD,1
freeCME,1
https://t.co/xby870EcZw,1
https://t.co/sk2D8Tzwme,1
https://t.co/0eoNQwZpw8,1
#WestminsterHall,1
#TKIs,1
#EBMT17 #leusm #,1
Watch and Wait &gt,1
https://t.co/5lKcAADNoj https://t.co/PkzGagycRF,1
COPD,1
PAH,1
response.‚ÄîWilliam G. Wierda,1
https://t.co/pwXbkgb2CK #CLL,1
South #,1
Wexham,1
Kathryn,1
Kate &,1
Bridget https://t.co/YArLinmISl,1
"https://t.co/LwUFd4TsLW
#",1
CLLRooted https://t.co/MNHUFar77j,1
GIO,1
#Ketogenic #,1
https://t.co/Ikv050rkcr,1
@AgeUKBerks @HWSlough https://t.co/nP7BErYoGf,1
https://t.co/T2jfK9Ansp,1
#ChronicLymphocyticLeukemia #hemeonc #,1
N√§tverkar f√∂r,1
Vasa,1
https://t.co/rXXGmD6wDF,1
https://t.co/y1k7ar6gR0,1
Campbell,1
Digital Journal,1
#Combination #,1
#Improve #,1
Stem Cell Transplants,1
MRD Testing &,1
Myeloma Ireland,1
Risk-Stratifying Factors,1
https://t.co/1eHBGjnNSZ,1
Roundup  Ready,1
https://t.co/uvQ028GH8s https://t.co/nyqBTze1ru,1
PDF Download Available,1
üçûüç¥@Eastfield_EN3 @ChristallaJ,1
Weldon,1
#2k18 #,1
#workhardplayhard #,1
paris,1
Theodoros Moysiadis,1
statistician,1
https://t.co/wzs3hjJOWg,1
Venetoclax-Rituximab Outshines,1
https://t.co/PFG5UfGVE3,1
ChronicLeukemia,1
https://t.co/khWDuv5qtj https://t.co/DEyfcrZiLK,1
ibrutinib &amp,1
1H,1
2Q 2018,1
June 2018,1
619406,1
https://t.co/nP7BEsfZxN @FrimleyHealth @ExpressSeries @HWSlough,1
Watch Molly's,1
√©pisode par,1
Janovska,1
Verner J,1
Kohoutek J,1
Bryjova L,1
Dzimkova M,1
https://t.co/7DybSYLaFp,1
Hematology https://t.co/e0T7Tojncm,1
je pose √ßa l√†...,1
ProjetSecret,1
https://t.co/p1a1YnZpLD,1
Brigitte Voit,1
https://t.co/07fJr1hxtm #,1
#Saxony #,1
less than 40,1
https://t.co/Pb8LpGbSC4,1
"Regions, Type And Application",1
Bob Frasca,1
Watch,1
AbbVie‚Äôs Venclexta for Chronic Lymphocytic Leukemia https://t.co/dMalMEVAfY,1
Casi,1
#chanchofelipe,1
summerfest2018,1
https://t.co/Z86dpP7X1z,1
#CLL https://t.co/odWTkGKmil,1
https://t.co/0UqnWKawNo,1
https://t.co/Ykt5hYAB8O,1
@hemedoc,1
CCS Researchers,1
ZGF,1
Ore.,1
Frasca,1
497,1
CasiHumano,1
Less Effective - https://t.co/ZDXCkw0Woh,1
#NCICancerCurrentsblog https://t.co/FWBjtXdYi6,1
https://t.co/qkY4j7qo6s,1
429 #lymsm #,1
"Less Effective
https://t.co/GZk3P4JQoS https://t.co/6HPZyLqBeK",1
https://t.co/yJRo5bdlt4,1
Less Effective,1
@bioengineers,1
#researcher https://t.co/kM5kGIHc9J -,1
https://t.co/qZuUVogYHU,1
https://t.co/pa4ZtOGn20,1
https://t.co/5eq7yLPoEY,1
https://t.co/7aKqND6SQk https://t.co/rTWkG8MlCc,1
https://t.co/2DsZ2eqBph,1
https://t.co/E0wd0eFJeV,1
https://t.co/BVc3O1ZSEA,1
https://t.co/aPrpdaLRjI,1
Science News https://t.co/XS384fTrov,1
#BOWL #,1
#EDR #,1
PFD,1
Connected Learning Live #ISO9001:2015,1
the Extreme Morning Challenge,1
Revolutionary Southampton,1
Wang WT,1
Wu JZ,1
Wu W,1
Liang JH,1
Fan L,1
Li JY,1
Xu W https://t.co/DagekHhDLl,1
Major Key Growth Analysis,1
Implications in Current Era https://t.co/hQO0nPEekf,1
Aberrant CD8 Expression and Atypical Morphology,1
#Dental #,1
"Francesc Bosch """,1
#Lymphocytic_Leukemia #,1
https://t.co/iabqEONT4x https://t.co/5W7ZbYYtFC,1
Johnston &,1
Erin Streu,1
Hypogammaglobulinemia in,1
gammaglobulin replacement,1
Jan 9 @ 12:00-13:00,1
https://t.co/viUEHoEQ6K @RockUPress @JExpMed,1
"""  Watch",1
Salicylic Acid Market,1
$ 0.46 Billion,1
TIGIT,1
Catakovic K,1
Ratswohl C,1
Rebhandl S,1
Schubert M,1
Steiner M,1
Gutjahr JC,1
Pleyer L,1
Egle A,1
Hartmann TN,1
Greil,1
https://t.co/1i7zeiGHSS,1
#IGLO #,1
"#ŸÖÿÆÿ™ÿ®ÿ±ÿßÿ™
 ",1
https://t.co/HHu6wH9Ca3,1
https://t.co/z3HEeMMRvk,1
Day Three Daily Wrap,1
2018 Camp Registration,1
"https://t.co/K9czZCOgAK 
",1
CLLRooted,1
https://t.co/Za9kXNBWAl,1
2016 &,1
#leukemia #ASH17 https://t.co/okQ1ZbMBFT,1
Angiosarcoma,1
#leusm https://t.co/mukDkbMLSo,1
Omar Abdel-Wahab,1
#ESH2017 @ESHaematology,1
#cagenome,1
https://t.co/khWDuv5qtj https://t.co/q44CS68rIE,1
What You Need to Know About Leukemia,1
Venkatraman Radhakrishnan,1
#Quora #,1
#survival,1
https://t.co/CSl78F94qs,1
SNSS nice year,1
Last summer,1
https://t.co/I8tASPndwp,1
https://t.co/JbK45rXoZ3,1
AFib &,1
https://t.co/cybjAHkeDc,1
https://t.co/U54RUpz5uq,1
Peripheral Blood Mononuclear Cells Isolated,1
Healthy Individuals,1
https://t.co/v5qxdcyDaS https://t.co/1Z0XZxPTe3,1
@OBRtweets,1
"mckesson
https://t.co/SpZYt6AA0",1
Wells Fargo,1
ü§î https://t.co/aZhPmsHeaF,1
#5 Tweet,1
RoundupLawsuit,1
https://t.co/2SKkVyH0Pn,1
Top Stories,1
https://t.co/YRVdvPH3Lj https://t.co/QmP7XDV10d,1
profiles &amp,1
Mansfield,1
https://t.co/BFo0cZRfQp,1
https://t.co/MqADWIVPpK,1
Quality of Life - While,1
https://t.co/yg1kYjiX8,1
The Oncology Journal https://t.co/HDGbFotMfU,1
Onc/Hem Top Stories,1
"Chronic Lymphocytic Leukemia Defeated With PH Balance and Nutritional Therapy

https://t.co/y5Uy5AztzQ

#Balance #",1
#Diet #,1
https://t.co/v5qxdcyDaS https://t.co/q2oQX7vFTK,1
Ibrutinib-Refractory CLL - Cancer Network:,1
@maljurf100 @DrRaulCordoba,1
@hemedoc #,1
North &,1
East #,1
West #Essex,1
UCLH Cancer Collaborative,1
HS,1
banda de #Blues,1
Bonarda,1
Venetoclax Effective,1
Charitable Trust &,1
Product Description,1
Anthony Coles @ Onyx,1
a holiday,1
https://t.co/ztJDvnjgHm,1
Anthony Coles,1
Onyx,1
https://t.co/WqUxXeBBog,1
EpiCast Report,1
2025SummaryChronic,1
https://t.co/LoTZHyOolj,1
https://t.co/pMr3kZSJAg,1
https://t.co/q5T1w49n10,1
EBMT17,1
CLL https://t.co/Nf08d7MJlC,1
Rebecca Harris,1
Cardiff and Vale University Health Board,1
https://t.co/zVlcjMCQdv https://t.co/KkfEUpHDO5,1
@Nature Communications,1
https://t.co/z2vIvBdUaw,1
Terdapat 2,1
‚ñ∂Acute,1
yang kurang,1
matang &amp,1
Sel,1
matang &,1
Kau,1
jenis mana,1
JON https://t.co/vwBpbJZaoR,1
Venetoclax + rituximab looks great,1
Phase III MURANO,1
"ASH17 
Read",1
https://t.co/Cf7lodbcZW #cll,1
#PRV #,1
#RBOD #,1
https://t.co/kp6MFWBoQD,1
Venetoclax in Combination With,1
#Umbralisib,1
Venteoclax,1
#myeloom,1
https://t.co/QTrIsjjruK,1
Wexham Park #Slough,1
17 Jan,1
Venetoclax Improves,1
#ASH17 @ASH_hematology,1
@CLLCANADA,1
@rcgp @theRCN,1
@CLLCANADA @BrandcastHealth @LLSCanada #leukaemia #,1
Easy Read Leukaemia,1
@nih_nhlbi @broadinstitute,1
#lLeukaemia #,1
#NYGC Core Faculty,1
@LeukemiaMDA https://t.co/MXyPkwJn35,1
@PatriciaDaly,1
@DominiKemp,1
https://t.co/7LiO63ZAu6,1
Venetoclax Effective in Ibrutinib-Failed Chronic Lymphocytic Leukemia,1
https://t.co/8DKkMInjQi,1
https://t.co/HCZE0gAyRe https://t.co/7iqvjw0KlB,1
https://t.co/yxzpKQGNqx,1
https://t.co/SehhndUJZy,1
#leusm  https://t.co/U1n2sId3i0,1
our day 3,1
study &amp,1
CLLClinicalTrial,1
Frontline Ibrutinib/Chemoimmunotherapy Induces Deep Response,1
https://t.co/0AIoFgFQgV,1
https://t.co/Fyr6425LHq,1
#mips #,1
https://t.co/UHHxR5YYYW,1
Dana-Farber Cancer Institute: Study Shows,1
Stahl,1
6e,1
Dana-Farber Cancer Institute: Study Shows Combining Chemotherapy with Targeted Drug Boosts,1
https://t.co/PsrSFOdwXy,1
https://t.co/kxCN4Gnapl https://t.co/y4DGtjO4Mw,1
https://t.co/JLYVKg6ilz,1
Organomegaly,1
#usmle #,1
Biologic,1
https://t.co/p899ErdRfQ #ASH17 @ASH_hematology,1
Endongoso,1
NewVibe‚Ä¶ https://t.co/gxg4hcyoML,1
https://t.co/z0WxN3MGiH #myCNSmatters,1
New Developments in Ibrutinib,1
https://t.co/C4KIMgqygG,1
https://t.co/XkhI9bW1Xo,1
https://t.co/DPN9umA1bD,1
https://t.co/VBrhQ9VUzH #,1
the holiday period,1
#thingstodo #,1
https://t.co/kVxYMGRh8j,1
William McRaven,1
https://t.co/SeLTNiEwvO,1
our Day 2 Daily Wrap,1
Curtis Lachowiez,1
Rituximab Failure,1
"A Case Report"" https://t.co/Tw9w68W166",1
https://t.co/rMvIKDt0Nl,1
Dr Cheson,1
FlashbackFriday,1
#Murano,1
https://t.co/X0Z8EDpnTL,1
MALT1 Inhibition Is Efficacious in Both Naive,1
@FiercePharma https://t.co/jhTELBfJl8,1
Watch-,1
https://t.co/qxBpPgkw6B,1
https://t.co/SBu9aTB1Ho,1
https://t.co/ioYGfwUNQB,1
Vietnamese,1
#vietnamstockexchange,1
#GMD #,1
#CCR,1
DXP,1
CLLSA Chair,1
https://t.co/VM7aXqy1q5 https://t.co/WLfK5ieGd4,1
@PatientPower,1
a Clinical Nurse Specialist,1
Nottingham,1
three #CLL,1
#myCNSmatters,1
Histone Deacetylase 6,1
A Therapeutic Target,1
https://t.co/NT0MZOezZb,1
at least 25%,1
#leusm https://t.co/Ce9yzaeJBk,1
Recepy,1
#Hot #,1
#Friendly #,1
#Strong #,1
#No #Sugar #,1
EnJoy,1
#God #,1
https://t.co/YNBXUn5Kp6,1
@drnashawinters,1
The Metabolic Approach,1
#Cancer,1
#lchf #cll https://t.co/eJ1G9MNbYn,1
#SUSE #,1
https://t.co/nOUBh8ukJN,1
#standard,1
#Abbvie #CLL #,1
#treatment,1
https://t.co/QEQ55WIB9z,1
Gary Gordon,1
"$ASH17

https://t.co/KeanrjYcay",1
ISO 13485,1
#ISO13485 #,1
#Venetoclax-,1
92% vs,1
HR 0.48,1
#AshBest #,1
PatientReported,1
7:45 a.m.,1
ET https://t.co/ytwwr0Qcv0,1
https://t.co/JTMIp5fUJu,1
Dr Kerry Rogers,1
"#ASH17 
https://t.co/Rk5wETp81D",1
https://t.co/xqyJtshM3B https://t.co/9dcRif4SdL,1
Stephen K. Woltz,1
Columbus Fire,1
1997 to 2002,1
the State Fire Marshal,1
w @anthonymatomd @DanielleBrander,1
#RWE https://t.co/7h8qiPM3d2,1
View Paper Here,1
A Pilot Study of Lower Doses of Ibrutinib,1
"View Paper Here: https://t.co/VOZ5YmJZrh 
'A Pilot Study of Lower Doses of Ibrutinib",1
#nonHodgkin #,1
#ASH17 https://t.co/7iG2OtRolo https://t.co/9uq93BTuuU,1
4:30 AM - 6:00 PM,1
605,1
Molecular Pharmacology,1
Lymphoid Diseases,1
CONGRATULATIONS,1
Robert O Dillman,1
GURU,1
@Stanford @Baylor https://t.co/7f5RZPhv4C,1
Predicting Mechanisms of Ibrutinib-Resistance in Chronic Lymphocytic Leukemia,1
Leylah Drusbosky,1
6PM-8PM,1
Bldg A,1
Hall A2 - More,1
https://t.co/VqfhC2nF2B,1
https://t.co/AreN4NoS9Q,1
"RESONATE-2
https://t.co/SWLmC0o7Uo&gt",1
Daily Wrap,1
Watch @andrewschorr @estherschorr1 @doctorpemm,1
'Individualizing Therapy,1
https://t.co/TvOnYniqco,1
#stocks $,1
Continental News: Combination,1
7:00 AM - 8:30 AM,1
#nurse,1
#charity #boost4charity #MondayMotivation,1
https://t.co/3sXUMrJtuB,1
Pharma Cos News IMBRUVICA¬Æ,1
4.33 +9.07%,1
4.71 8.78%,1
https://t.co/SWNczCgFc1,1
https://t.co/dqih2ilhg6,1
VIDEO - Results,1
VSTM  Inc.,1
dx‚Äôed,1
David #,1
https://t.co/9rLP6QXVP5,1
VSTM Reveals,1
https://t.co/AlUtA4TqDT,1
VSTM Clinical Data,1
#STEM #,1
#webleedblue #sistersquad @varsity.nor,1
ASH17 https://t.co/dVSf3mNR56,1
#CLL #ASH17,1
391 #,1
#ASH17 w,1
#ash17 https://t.co/q547LL8HjH,1
#ash17 https://t.co/b8Ozsrcxkj,1
ash17 https://t.co/HasF1DE4QD,1
#AHS17 #CLL #,1
ash17,1
7:30 AM - 9:00 PM,1
Day 9 - Honour,1
#honouryourcoaches #,1
Namensvetter Ranger Marketing,1
Jubil√§um,1
#rangermarketing #,1
#Repost,1
RESONATE-2 Trial,1
#leusm https://t.co/GPm4bvOLW2,1
https://t.co/jt3tuOQSlZ,1
#PowerfulPatient Jeff &,1
Olga #CLL #,1
https://t.co/QAAeB4YI33,1
Tomorrow morning,1
https://t.co/IN6NvL5XIa,1
mmsm https://t.co/Z3L5JPG8j0,1
1:15pm EST,1
5:45pm EST,1
Leukemia https://t.co/kM16LIoX0q,1
about #MCL and,1
Hall A2,1
5:30pm,1
https://t.co/X6ELlKDCdh https://t.co/cAhxZC6C1s,1
booth 2515,1
#Autos,1
$TGTX #ASH17,1
Quality  https://t.co/7816mJA9Gn,1
https://t.co/PHsrlpgu6S,1
https://t.co/LU9xCbgfRK,1
"Dec. 9, 2017",1
https://t.co/SyVJ7uPk2M,1
QOL Experience,1
#ASH17  ,1
Qualit,1
üèΩ‚Äç‚ôÇÔ∏è @varsity.nordic,1
https://t.co/dSj55uMGB1,1
Meixiao Long,1
#iwCLL2017 #leusm #,1
Family &,1
magazines &amp,1
https://t.co/khWDuv5qtj https://t.co/ZRCJW1Q0ly,1
@Carolinas https://t.co/HqGUhvwY6S,1
https://t.co/BBdnimzSbj,1
@OHSUKnight &,1
https://t.co/B5yCHcxF95,1
Susan Slager,1
Mayo Clinic Health Sciences,1
Genetic Risk Factors,1
1:05-2:25 pm ET,1
Bldg B,1
Georgia World Congress Center,1
Justin,1
Larry,1
Pivotal Study,1
@WilliamDale_MD #ASH17,1
our morning,1
@LeukemiaMDA https://t.co/O5MOJc3bk1,1
Alberto Montero,1
4-hour,1
#DLBCL https://t.co/IMECVwijyX,1
#CLL #ASH17 https://t.co/FCTSt0jEt6,1
continuum  https://t.co/CkAdDDVFCy,1
15 years,1
Amitkumar Mehta,1
https://t.co/WmxGwLP5Ts,1
#varsitychristmaschallenge #,1
germanche,1
https://t.co/2B1At9nKqD https://t.co/vYcDZ5UpbV,1
#Slough #,1
Tuesday 12 December @VJHemOnc,1
#ASH2017 Congress,1
https://t.co/Jx3GJdk7g7,1
"@Zoomer 
https://t.co/Wyl4afBzrK",1
"https://t.co/y7bEOTu9s1 
#",1
#Lymphoma Relapsing,1
Older Patients With Treatment-Na√Øve Chronic,1
3-Year Follow,1
9-Monday,1
3 pm Pacific,1
5 pm Central,1
the next few months &,1
Liberal,1
https://t.co/0zflIbomzs,1
#NB #,1
Canadian Fisheries,1
spring,1
Cabinet,1
https://t.co/nKPZwySBVb,1
https://t.co/eFACcirBXR,1
Jolene,1
Arusha,1
Oceans Dominic LeBlanc,1
https://t.co/WtcrElEIyZ,1
#cdnpoli,1
https://t.co/qYKJPcTcBL,1
2820,1
the Chronic Lymphocytic Leukemia Society: CRANBURY,1
the Chronic Lymphocytic Leukemia Society https://t.co/u15vZOk9SP,1
CRO CURE Media Group Partners,1
the Chronic Lymphocytic Leukemia Society https://t.co/q8goUP4nkH https://t.co/SxWqhnWmCz,1
Head,1
December 2004,1
White Count,1
115k,1
@LeukemiaMDA https://t.co/yCURKHKd3R,1
Day 5 - Latest Stunt Skill,1
@varsity.nordic,1
#shorties,1
#varsityallstar #cll,1
"#cheerlabellangenfeld
",1
#newbies #,1
#cheerlabellangenfeld,1
December 9,1
https://t.co/blreiDmJMD,1
#ASH17 https://t.co/7o0FkxQAHt,1
#CRO Verastem,1
Small Ly,1
VSTM - Verastem,1
Druggable Target,1
Expression Levels Unrelated,1
P13,1
Toxicity,1
https://t.co/uo7yw9953,1
Interferon Regulatory,1
Diary &,1
Leeds -  ,1
Paul Moss,1
20th July,1
Bristol - Prof.,1
https://t.co/6wiTZuznFC,1
https://t.co/auklhyDZAZ,1
https://t.co/9jxM3LE7Qy,1
@PERSIMUNE,1
Poetic Licence',1
#boost4charity #CLL,1
Cello Group's,1
GBX 135 PT,1
https://t.co/xqyJtshM3B https://t.co/LWeOZ9w7ef,1
#GeriOnc #,1
Pyramid üñ§üíô CLL Rangers,1
German All Level Championship,1
#pyramid #,1
the third day,1
Venetoclax https://t.co/nl0W6afHj0,1
8q24,1
https://t.co/a2ky7xBTI8,1
https://t.co/WzK3lGFj6Q,1
@Oncotarget,1
CD154,1
#CD40L,1
#charity #boost4charity #CLL #,1
the second day,1
Debbie,1
@haematologica  https://t.co/e9FaH0aihE,1
@HospitalLaFe @IISLaFe @sehh_es @DrMiguelPerales @_pethema,1
https://t.co/ek4FejS6F2,1
#Norwich #,1
MCL @NorwichCC @EveningNews,1
Hemmol,1
para conocer,1
v√≠a,1
patrimoine,1
√©crit,1
les √©tablissements de lecture publique,1
c≈ìur du,1
d√©partementales17,1
https://t.co/rx6GOyJ1QE #ASH17,1
https://t.co/YU3x14EUe5,1
https://t.co/OUZjv8JPs3,1
https://t.co/R9y39FkH4X https://t.co/Brv1K9pbAF,1
November 2017,1
Dental,1
#Leukaemia  ,1
Gruffalo,1
#gruffalo #,1
@jonasasouza &,1
JOP,1
https://t.co/WyJ86vsBGS,1
Tomas Reigl,1
https://t.co/UFzveWHFhu,1
@newark_beth,1
Blood Disorders Center,1
ASCO Value Framework,1
Limitations https://t.co/G9G1ElsFUZ,1
#CLL @BloodAdvances,1
11q22.3-23.2,1
Just a few years ago,1
only #,1
Maverick,1
VJHemonc,1
CLL Madrid Group,1
#telomeres,1
#telomerase #,1
Giving,1
2650,1
less than 3 weeks,1
https://t.co/EXCO44fXAa @LeukemiaMDA,1
Bloo,1
@IISLaFe @HospitalLaFe @TPHLaFe,1
@GVAsanitat @EFPIA #,1
https://t.co/eDeqkTN3fT https://t.co/gYeO4aHB22,1
efficacy,1
FISH &,1
016,1
Mutated/Unmutated,1
https://t.co/U7djPl85XN,1
https://t.co/Gda08eeG4X,1
@LeukemiaMDA https://t.co/8s7UnCu0e2,1
Harmony,1
BIG DATA,1
Black Friday,1
Camp Lake Louise Swag,1
Sistematic Review #,1
IGHV-M #CLL,1
#IELSG19 #,1
Chlor-Ritux,1
GALLIUM,1
https://t.co/pgY1mlopE2,1
https://t.co/VVtrg2oRZM,1
Macitentan,1
endothelin,1
Doug Olsen,1
https://t.co/o5tIhPVDlm,1
$arql $,1
https://t.co/lXgOTTietO https://t.co/gq1Mn8q5V9,1
the CLL Molecular Oncology Tumor Board,1
https://t.co/eDeqkTN3fT https://t.co/weLftl2Bsu,1
$ABBV &,1
93.3%,1
8.2%,1
67.7%,1
https://t.co/SSJwMvI627,1
jaar geleden dat,1
mijn broer,1
die gaf op haar,1
mooiste cadeau,1
Biological rituximab  biosilmilar,1
2350,1
Only 167,1
#leukaemia #AML #,1
#survey #,1
#ASH17 Venetoclax,1
Relapsed/ Refractory Chronic,1
the Randomized Phase 3,1
https://t.co/pUagz5Co1R,1
Liga Provincial de Entre R√≠os,1
#patientengagement https://t.co/a9qNtQpqlc,1
SOHO17,1
#NPDROCK #,1
las entradas,1
@MichuDano https://t.co/bqKjqJvgGN,1
entradas para la lucha,1
el HT  ,1
pida y,1
Epa,1
muy cerca,1
la lucha,1
Jajajaja #NPDRock #CLL,1
https://t.co/iUapUXoI4K,1
Molecular Oncology Tumor Board,1
https://t.co/9dvlSipNAJ,1
#prevention #,1
#molpath #,1
"myeloma 
https://t.co/e0DQMEWzN3",1
@ASCO &,1
@MedUni_Vienna,1
Fluorescence,1
344,1
#ASH17 https://t.co/IU2Eun788Q,1
CLL https://t.co/FHQNR2zl9e,1
@ASHClinicalNews https://t.co/LmwDqzh0aB,1
#flu season &,1
@USDOL,1
DOL,1
https://t.co/2VMRbkGTyr https://t.co/dvZ4BySu3b,1
#mpnsm #mmsm #CLL,1
https://t.co/zd7RI8pFZ0,1
Diagrama de flujo MUY,1
@LeukaemiaCareUK #,1
nursesconf,1
Bush,1
Dr E Campo,1
lymphomaleukemiamadrid,1
Determine Optimal Treatment,1
#lchf #,1
https://t.co/BAAWJkra7r,1
Hematologist - Chronic,1
This Friday,1
12 pm Pacific/ 3 pm ET,1
https://t.co/eDeqkTN3fT https://t.co/zgYkzxvLiS,1
https://t.co/7qGvHeqxEN @MDAndersonNews,1
the last few days,1
#myeloma #mds #,1
#mf #,1
CllFighter,1
Gazyva/Obinutuzumab,1
44th,1
the Virtual Journal Club,1
https://t.co/twZ8O5M1Ta,1
@AMPath &,1
a Molecular Oncology Tumor Board,1
https://t.co/B6lEv1Bay1,1
https://t.co/rgayGGpuPw,1
SnapShot,1
CaseManagers,1
4 PM ET/1 PM PT https://t.co/4Z9WzpsiUI,1
300%,1
https://t.co/r3La9mWlNl,1
Carapau,1
Acredito,1
Almost one quarter,1
Real World,1
https://t.co/ITCe67FOuQ,1
#leukemia #steroidtherapy #,1
the Molecular Oncology Tumor Board,1
SM O'Brien,1
https://t.co/t0DXVbsobZ,1
JA Burger,1
LymphomaHub,1
Dr Hillmen,1
Hepatocyte Growth Factor,1
Vamos la banda,1
Bologna,1
Great Co-chairs &,1
#Bologna #CLL #,1
#rm #,1
#coach,1
#routine,1
#lieb #,1
"Familia

#Cll",1
Ponto de equilibrio,1
Coisa,1
Bruce Wright,1
üëçüëç,1
Research Matters,1
#Haematologica Expression,1
7/12,1
@BBCNorfolk @EveningNews,1
Vamos Luciano,1
EnCasaNoSePierde,1
#SIOG17 #,1
https://t.co/6KpMz7qdFl,1
https://t.co/xnCDXGuEv2,1
s√£o,1
https://t.co/i2OCIeYRXH,1
Leukaemia CARE‚Äôs,1
https://t.co/uN8pj0rVfD,1
10102017,1
https://t.co/onqfJ3jZZn,1
Imma,1
gangsta,1
Furman &,1
Sharman https://t.co/MmkXDKm6o1 https://t.co/tYe2Nxn1TJ,1
QualityImprovement,1
https://t.co/FexqW5K357,1
stu,1
https://t.co/HKo7BHe59g,1
https://t.co/WiJWK63yq3,1
Bendamustine + Rituximab,1
Sarah Cannon,1
#SCRI,1
@Curing_CLL,1
#charityTuesday,1
Great Hall,1
https://t.co/wTMPv8rmpX,1
"Over 2,200",1
between #radon &,1
https://t.co/7DaXkV7J45,1
Bagacean C et al,1
essay all night,1
Silicon Valley,1
https://t.co/PBi6tWMikc,1
"A‚ÄôChailleach üèîüèî
#",1
approximately 7%,1
FCR Is Potentially Facing Life Support,1
https://t.co/j1INkl86cp,1
more than 25,1
@salkinstitute,1
Zap-70 protein &amp,1
the micro environment / tumour,1
DrJeffSharman,1
#mpnsm #mmsm #,1
WEBINAR - #ValueBasedCare,1
"glyphosate&amp;diagnosed
w/Hairy Cell Leukemia
Chronic",1
CNE &,1
https://t.co/1vQPFBzXAD,1
#duvelisib #CLL,1
Kinder,1
https://t.co/3Z4T1xf6qe,1
#ror1 #CLL #,1
https://t.co/nl50TEt6Hn,1
a fabulous first week,1
Corebook,1
Dear Zoo,1
#ISentHimBack,1
DearZoo @ChristallaJ @MissNatalie_M,1
OCMchat,1
NPM1,1
#DLBCL &,1
@ASH_hematology w @DrMatasar &,1
@anthonymatomd https://t.co/stQMzw5ZgH,1
Angela,1
FLAIR &gt,1
https://t.co/qHTb2gN5H4,1
#cll https://t.co/3RfbMc7bpA,1
DrJeffSharman-&gt,1
#BIOEurope https://t.co/WVLtbiYgTE,1
–ó–¥–æ—Ä–æ–≤—ã–π,1
faruk@beaconpharma.com.bd https://t.co/HFXWbFU9gn,1
between #ALL #AML #CLL #CML #,1
500 years ago,1
Martin Luther,1
https://t.co/UAvALSSss4,1
https://t.co/KDb2TgOlCY,1
https://t.co/6YSKeZ71pe,1
Webinar] An Introductory Presentation on the Future of Cancer Care Reimbursement,1
#L #CLL,1
#MACRA #,1
MIPS &,1
OncologyCareModel,1
AlbertoMonteroMD,1
the South Bank,1
24 Nov,1
#bennyblanco #,1
#fr #,1
#dilly #,1
monday,1
Inhye Ahn,1
Under:@CiLiBlack,1
Under:@CiLiWhite,1
https://t.co/aj64OuAwnD,1
CLL Register,1
#cne #pharmacology,1
stress &amp,1
#DrJacquelineBarrientos #,1
https://t.co/TDuimXSrHp,1
Terry Hamblin,1
https://t.co/3purhhYu8M https://t.co/xK7vSCll7r,1
Avicenne Hospital:,1
https://t.co/IqhqPe9HWz,1
Webinar] Defining What,1
#CLL https://t.co/fBGfXh5IUf,1
ÿßÿÆÿ± ŸÅŸÑ,1
ŸÖÿ®Ÿáÿ±ÿ©,1
üòÇ https://t.co/YBUtHKxd0E,1
the Future of Value-Based,1
AlbertoMontero,1
"PCBs, dioxin &amp",1
#Ramazzini17 #,1
Webcast-Defining What,1
cme,1
https://t.co/hsYMA711y0,1
https://t.co/n2mW8twJfL,1
f*m*r,1
Tanya,1
de Ben 10,1
Andrea Sitlinger ‚ÄúInsurance Design,1
#CLL 2,1
https://t.co/ezDhF6lrcP,1
https://t.co/lH10HOnaA5,1
Luke,1
7th &,1
CLL https://t.co/RVu5j5crDP,1
@USAMCI,1
FluChat,1
#BigData &,1
#Genetics,1
VPHAwards,1
https://t.co/DqxPNQddzS,1
https://t.co/eMvhwr5o0k,1
Nat Rev Dis Primers,1
@QMBCI https://t.co/9LJyWlZO6S,1
@UNCSON Register,1
therapeutics &amp,1
Symp Mgmnt,1
#2GA2017 https://t.co/hp2LkKqNTm,1
continuum https://t.co/mJlJ2zWtPD,1
CLL - Oncology Care Model,1
@USAMCI https://t.co/lDhGPOHv1U,1
https://t.co/qr00dbVptP https://t.co/q1PCZgNMhh,1
Neurotensin,1
Esanex Reports First,1
SNX5422,1
#HMs,1
Andrew Hore #,1
#GDR #IDP #,1
#PRM #,1
SML,1
#SPO #,1
Highly Tested Topic,1
Quick Review - Few Pointers,1
https://t.co/lG05PNXpjs,1
Club des Logiciels Libres,1
OSSEC,1
https://t.co/woVwlm8mWP,1
Rajan Dewar,1
#NFPath2017 #,1
Femur,1
FMedSci,1
Watch Michael,1
#clibre #jll #,1
el manar,1
#CHCWEST #,1
https://t.co/8b8sIV07qM,1
Bill Wrentz,1
@uamshealth,1
32nd,1
All In,1
#CampLakeLouise,1
#CLLAllIn #,1
HARMONYAlliance,1
#2ndGeneralAssembly,1
https://t.co/IK6UMGs0iw,1
#J_Community_Hosp_Intern_Med_Perspect #,1
Der Gewinner,1
Kategorie Orphan Drugs,1
Behandlung,1
Gl√ºckwunsch,1
@BrownNhsdeb @cr https://t.co/Tdyjsf1EfZ,1
#DevOps,1
Leukemia https://t.co/x9jHA6R2yS,1
Leukemia https://t.co/tZ1DA3EZny  ,1
CCL Feeling,1
MRD-Adapted Therapy Approach Yields Good Results,1
Current and Future Goals,1
#LeuSM https://t.co/uzvDXYWvQN,1
NY Genome Center,1
#scg2017,1
2017-10-21,1
Journ√©e Des Logiciels,1
#fst,1
#jll #,1
"Tuesday, Nov 14",1
https://t.co/HUkaqNQpRj https://t.co/nmkaVtdf6z,1
https://t.co/7H6gkSbL3r,1
"S. Fapetu ""Energy",1
18/10,1
Clipstone,1
1 pm,1
iOnco Analytics - Newsletter,1
Nitin Jain of,1
https://t.co/BHLX7JqkRN,1
Blwyddyn 3Ll,1
Year,1
3Ll,1
the Cantre Gwaelod Workshop,1
https://t.co/UHjzUUr8UC,1
CancerCompass,1
https://t.co/AQ1cSCvc1K,1
fisicas,1
el Capitulo 2 de #Femme,1
Quien,1
speakers üëèüèª@truthaboutbigc LIVE,1
https://t.co/s0abaRWK3y,1
@LeukaemiaCareUK https://t.co/rTODNwGh76,1
"the date &lt;3
",1
FST https://t.co/5d1q7j0dsh,1
Hairy Cell Leukemia &,1
Cymbalista,1
"Kreuzer, &amp",1
next years,1
https://t.co/2GvyBkZxxI,1
@RCGP Annual Conf,1
RCGPAC,1
rituximab  https://t.co/x0hnMrCIAa,1
https://t.co/BTCBgCA1wD,1
Over 400 #CLL #,1
w Rituximab,1
https://t.co/uyILB0JFYo #,1
Ikgdar(Retuximab Injection,1
CLL - https://t.co/jqVuxNHESn #,1
Celebramos el d√≠a del ni√±o,1
los consentidos,1
del hogar,1
de la gran,1
BOPA17,1
#yourbestshot,1
https://t.co/PXRH3njK8q,1
#Canada,1
LCHF,1
"187,000",1
@pole_emploi ce mardi,1
#CGC,1
#FO #CLL #,1
#STC #,1
"ADULTS
Lymphocytes",1
"11q, 17p",1
7:00,1
CME https://t.co/L616nf3CBD,1
DrPatrickThornton üáÆüá™,1
HOA,1
#WeAreRLL #,1
WorldMentalHealthDay,1
1 December,1
https://t.co/iRYqx1DllE https://t.co/9tPwoiFucm,1
@JanssenANZ @bgoodwi6,1
Aus Government,1
$460,1
Janssen's Ibrutinib - @PharmaDispatch #,1
#auspol #,1
CURE Magazine,1
Leah Lee Photography,1
CLL https://t.co/vX9gypdE8K,1
about #physicaldevelopment &,1
"Jack

Coach",1
aspartame &amp,1
the spring,1
https://t.co/phM1p6STJn,1
Pronounce Cln,1
#stella #l #relaxin,1
#slut,1
AL #,1
https://t.co/mOXZJXrLIP,1
PHAGOCYTOSIS,1
CD180,1
https://t.co/jtl5FIp2Xk,1
Light the Night Walk,1
"SpotLeukaemia 
Welcome",1
Family,1
September 2017,1
https://t.co/TAEhbXcV9j #,1
üèΩ‚Äç,1
NewVisuals,1
1000+ #CLL,1
PatientSurvey,1
üë®‚Äçüî¨ SEEDY,1
@J_Immunol #Bcells #,1
https://t.co/pOpJzwqsoT,1
Wow two years ago,1
üÜë #,1
#cl #,1
Ian Flinn @TNONCOLOGY,1
10.10.2017,1
Tx w @anthonymatomd,1
Hayward,1
6:30,1
https://t.co/1eT3EMUfwj,1
Gimnastas Rusos,1
al podio,1
#Montreal2017 #,1
MAG,1
LoEstelardelaGimnasia https://t.co/7QATgDOuMP,1
#lyle,1
#konference #,1
University Hospital Galway',1
PLL,1
#BeingImaginative #Creativity #,1
#UW,1
Coop,1
Cavemom,1
#LoveMyBoys #,1
#GrandpasTie #,1
ClonalEvolution,1
#bloodcancer #bloodcancerawarenessmonth #,1
#HL,1
#CLL https://t.co/RaD6XLVzKi,1
ChronicIllness,1
#ChronicPain #,1
BBC Radio,1
10-10:30am,1
Beauty Remixed,1
Imbruvica https://t.co/4tWutWyeLY,1
+ &,1
Fazem,1
https://t.co/F6uSBirKwz,1
#hjoan23publica #,1
CancerLett,1
https://t.co/eUDbloz40y,1
https://t.co/zbFDmjRXLk,1
@dogrschools,1
Blood Buddy,1
https://t.co/5MfPzUcXUr,1
Venclexta + Rituxan Helped CLL,1
https://t.co/L5Yc1RecLB,1
https://t.co/tTEgCGsRgW,1
#Intersyndicale #,1
#privatisation #,1
Malin,1
EDLD,1
Kanti Rai @NorthwellHealth https://t.co/2lC7cz3ps1,1
BloodCancer &,1
#CLL - Turn,1
Se va,1
de forma pacifica,1
el env√≠o de,1
catalunya,1
@p_sq,1
the end of September,1
https://t.co/WKd3n8SkFY $CLL,1
this past weekend's,1
JH0354,1
https://t.co/PcDPH3KUtW,1
https://t.co/KGcTYjObRd #,1
Ectopic Expression of ILT3,1
Akt Activation,1
Bcells @BloodJournal https://t.co/4kRf3fEPzK https://t.co/FbceoLEOCT,1
https://t.co/YNWVh7sarD,1
@CommLivLondon #,1
365,1
#fanshawepr #,1
Stunts,1
Pathological Findings,1
https://t.co/Vnw0RRrOXj,1
https://t.co/A9IyMJZJVK,1
Nigga kizomba outro aqui √™ kuduro,1
https://t.co/ZwN6Wbmj71,1
Yours,1
#MicroRNA #,1
DanLandau,1
Nora,1
some #PowerfulPatients Tune,1
@WVCancer drs Watch here- https://t.co/yei29cHKmd,1
MRD Negativity Confirmed,1
Amy Goodrich,1
@JADPRO @APSHOorg @KurtinSandra https://t.co/gINbkX76Wq,1
#CLL https://t.co/eGbvoTZ6cs,1
Silvia Deaglio @unito https://t.co/oXRvT8tD2R,1
#AugCom #,1
Colonia,1
Las Liebres,1
organico,1
mendocino,1
nuestro recomendado,1
CLL - https://t.co/YOJ0L6gMQc #Oncology,1
IWasHealthy,1
MAGA,1
https://t.co/uo3QZQROnz,1
https://t.co/NT0IIwSLCI,1
https://t.co/wjOvG6iVkh #,1
Minis,1
#minismonday,1
#minis #cll,1
Repo,1
https://t.co/t8mORYibRr #,1
https://t.co/sh3ZHcyuCc,1
GardenStateProperty,1
TapeComin,1
OTW,1
https://t.co/ibLnbmbrT1,1
https://t.co/gBevdr2nY7,1
https://t.co/r8FGwQjvp9,1
https://t.co/7yWPl3u4DE,1
66%,1
#oncology #boost4charity https://t.co/YyJNuQyYOf,1
https://t.co/TZaecuRfAI,1
#CLL @CelloGroup,1
‚òù,1
#bestie #,1
https://t.co/1ReYmQzgKj,1
KGF,1
DGE,1
SIXH,1
@CelloGroup #CLL &,1
@ScienceinSport #SIS,1
depression &,1
AbbVie/Roche‚Äôs,1
#RT https://t.co/wDf68W3mqD,1
https://t.co/oV30swChtf,1
#psychooncology  ,1
https://t.co/3OEA9xMHht,1
#CpG #,1
#17p #,1
https://t.co/Bol4ldGD8y,1
#SOHO17 - Outcomes &,1
M13,1
https://t.co/rpcGcbcgKL,1
#CLL #pharma #,1
https://t.co/XHvYqbnLjy,1
https://t.co/yuDSptL9gY,1
#mentalhealth #,1
https://t.co/GVhO1S9r5w #,1
https://t.co/BaoOaxYTOp,1
https://t.co/OAQMbgctxE https://t.co/sXTa3CYPj2,1
https://t.co/giz5COOQp2,1
Dr Michael Hallek,1
https://t.co/wUOWB0OXSX $,1
https://t.co/u15jejyxUH,1
the Treatment of Pats,1
#Leukaemia News,1
https://t.co/50xbxx4lPX,1
https://t.co/S0NAsMh5al,1
Becca,1
Hayde,1
#missedyou #,1
yeg https://t.co/T3OXvOuLdg,1
#BCAM @LymphomaAssoc,1
#SOHO17 #leusm https://t.co/h52TW2iavS,1
Dr Jain,1
#SOHO17 #CLL https://t.co/fz1AtBcS11,1
John Seymour @PeterMacCC  https://t.co/pemvG6mRiJ,1
Quando,1
Adicionando Ublituximab,1
Ibrutinib Melhora,1
Taxas de Resposta CLL,1
#SLL Patients Aided,1
https://t.co/ew4bsaNdr0,1
"the season

Sunday",1
#pcl #,1
The #Microenvironment,1
TSUNAGUfilm,1
#ÈéåÂÄâ #,1
https://t.co/ciU0EUi8vt,1
https://t.co/NhkNg6zYIV,1
Rosenbaum,1
#tcellRX #,1
https://t.co/YYY9LYRk17,1
#Ibrutinib,1
FacebookLive,1
@Patient Power - a,1
Julio Delgado &,1
Stephan Stilgenbauer #,1
#cheerleading #,1
UHD,1
#PQ10 #,1
#WorldLymphomaDay #,1
https://t.co/zPsa7pPkiI,1
Maintenance #Lenalidomide,1
https://t.co/wS7eRXMnyy,1
#cheerhair,1
#bow #,1
@LeukemiaLympho #CLL,1
https://t.co/Nei8u5sja6,1
https://t.co/HT0hKZjSYS,1
#XD5S,1
Se homosexualismo,1
David Andrews,1
HCS UGM,1
vitro &,1
@AACR https://t.co/vTXA36kzTl,1
https://t.co/Y0p6KHjB0S,1
@iannaconelab,1
Leopold Sellner @uniklinik_hd https://t.co/gYsmechWek,1
https://t.co/L6NznfXWJM https://t.co/MYLVCqupfu,1
22bln,1
1.3 years,1
https://t.co/fprxPj1hVB,1
Qs &,1
#ContractorLeadershipLIVE,1
335,1
Thomas J. Kipps,1
https://t.co/xZcVqLFWQh,1
Quincy,1
https://t.co/KvMfbDnGsI,1
#TomTam #,1
https://t.co/n8C3JzzDJa,1
Quando Tosse Cai,1
"#Karlynhos_Matecane

#",1
Salmonella,1
#bloodcancer month,1
Arvind Arumainathan &,1
Jan Ablett https://t.co/6IDvwYIEZA,1
https://t.co/6nOLzqtbyO,1
rua,1
Kostas Stamatopoulos @INAB_CERTH,1
https://t.co/m65F9b0zMV,1
CancerTrial,1
Bomben,1
LymphoTrack NGS IGH,1
Edeb√©,1
#idelalisib + #rituximab &,1
3.4 months,1
#verastem,1
#cancerdrugs #,1
Verastem Positive Data,1
Sm,1
https://t.co/6HLk0izg7k,1
CllFighters https://t.co/DfmvHGToDP,1
roughly 20k,1
LuchalibreChilena,1
2ndQ2018,1
https://t.co/riOQxv30Jc Chronic,1
e-pathology.flv,1
https://t.co/JobFcyPiLm,1
TerryHamblin,1
Blog Mutated,1
rituksimab kullanƒ±mƒ±na onay verdi,1
ile ba≈üetmenin yeni,1
yolu,1
#Lenfoma #,1
#London,1
Min Yoongi,1
Park Jimin,1
https://t.co/dzYSzEXWFF,1
SmartBrief,1
https://t.co/3YBlMZsmx6,1
https://t.co/khWDuv5qtj https://t.co/efQJlYnzzJ,1
https://t.co/GsHUzmSZ5G,1
https://t.co/UHpJrTjoyT,1
https://t.co/joCIlPBSoy,1
UnmaskCancer,1
Oct 21 &amp;help fund,1
CureCancer,1
#PatientsLives #,1
#RT https://t.co/Ze6dew2csO,1
#charity #boost4charity https://t.co/2SjdvPRWhi,1
https://t.co/pfgCvcNxRT,1
N8HPC,1
#Leukaemia -,1
#patientengagement #,1
the Cell of Origin,1
Olivier A. Bernard PhD,1
https://t.co/ymgSgpDWNk,1
https://t.co/pFdV8scXMx,1
https://t.co/M1SaGUwImH,1
#clonoseq #,1
mm,1
https://t.co/1XL2F6UJU4,1
VitaminD,1
https://t.co/561x0EeKGi,1
Health Engineer,1
@mercola,1
@BoyleManuela @Connealy_MD,1
https://t.co/fyRTvLetpm,1
https://t.co/9RwA86po43 @MDAndersonNews,1
Didyouknow September,1
#charity #boost4charity https://t.co/hkBtJMfV7f,1
Clinic https://t.co/5qeEYJcGml,1
Clini,1
https://t.co/QpRN40tZNR,1
https://t.co/9NMiwzp828,1
Anna Schuh @UniofOxford,1
https://t.co/51BEBW2nPG,1
Jimenez,1
WWBH,1
14 months ago,1
https://t.co/TJZWSUXKS5,1
summer 2017,1
Cancer Drug Updates: Venetoclax in Patients with Previously Treated Chronic,1
https://t.co/8WrGMWo5q1,1
FREE + NEW,1
Onco-Nephrology,1
Soy de estatura,1
thursday,1
https://t.co/g1o5HA7HQq,1
https://t.co/PkbXarbFpM,1
The Biologics of #,1
"Condition Summary: Leukemia, Lymphocytic,",1
Kostas Stamatopoulos @INAB_CERTH https://t.co/X1wdSumasq,1
Iris de Weerdt,1
NewDrop,1
Bobby Brown - HittaMiz,1
#Belfast #,1
https://t.co/t8AJBKXnRx,1
https://t.co/kq1JiniA0J,1
Realm,1
#intheLab üöÄ,1
intro,1
late summer 2017,1
$tgtx #btk,1
https://t.co/AUrpaoagTX,1
Buteyko &,1
Keto,1
crx-200,1
Andy's Story: How I Manage #CLL,1
https://t.co/CIwLfFyNx6 #MS,1
OutNow,1
Carlo Croce @OhioState https://t.co/DJy2N0mKXi,1
https://t.co/N22wjpJMR0,1
El uso de lenalidomida,1
Days,1
https://t.co/44RL1Rj7ys,1
#Richter #,1
Come &,1
#blooodcancer #,1
https://t.co/HqCc9rONRR,1
los medallistas de la #,1
Taipei2017,1
GAF,1
#ibrutinib  ,1
The American Cancer Society,1
"about 14,600",1
#AUOncology #,1
#screwworkbreakfree,1
20:30 this evening,1
https://t.co/oMWuRyhsdl,1
Paul Henderson‚Äôs,1
https://t.co/t8K12fa4ez,1
#cancer @nottmhospitals,1
FrontImmunol,1
30062017 Pric,1
the Era of Novel Agents https://t.co/5vio4hSZS4,1
Four weeks,1
Ulrich Jager @MedUni_Wien https://t.co/7zkAoJSeWv,1
ICML17,1
30062017,1
https://t.co/XA72aPy6P4,1
Lamin B1,1
Mutational Gate-Keeper,1
#acne #,1
#aerobicscardio #,1
Pronounce Cllr,1
#fiesta #,1
#Clix #,1
manera de reirme,1
pibes jajajaja,1
Hamburguesas,1
#LeuSM https://t.co/46ccE8YjcN,1
@sehh_es https://t.co/wAWrCImw1p,1
@IrishCancerSoc@BloodCancerIRL,1
#CLL Portland Event,1
https://t.co/kiHWiSRIly,1
https://t.co/uVBSbmhYKK,1
https://t.co/Ea2XDQ4P64,1
260,1
Julio Chavez,1
https://t.co/Y9l6MypJ4i,1
Dr Power's,1
S3-LL #,1
30.08,1
Ublituximab / Ibrutinib,1
https://t.co/kOLPNwbA96 https://t.co/TgJXcQ7Pv5,1
#HSTN #,1
#0O7D #CLL,1
#cancer (,1
https://t.co/7RH90qKwvA,1
https://t.co/6IDvwYIEZA https://t.co/Fb2KaxcACM,1
https://t.co/facgKozza1,1
S100,1
#T2D #CLL #,1
https://t.co/IQlBBEafBk,1
Mark Hoffman,1
Binet A,1
#rituximab &,1
https://t.co/umXOja62e5,1
Terraza,1
disfrutemos buenos,1
colegas y,1
https://t.co/6IDvwYIEZA https://t.co/obKx0MHwqp,1
https://t.co/xqyJtshM3B https://t.co/hHBtJhDaHs,1
Venetoclax in Patients with Previously Treated Chronic Lymphocytic Leukemia,1
https://t.co/5xZcFM42YX,1
few weeks ago,1
https://t.co/wEstg79JBc,1
#ChileLuchaLibre #,1
CHILE,1
LUCHA LIBRE,1
"Origenes

La",1
https://t.co/khWDuv5qtj https://t.co/XSfKIMcFYn,1
#ICAHO2017 @btfoundation,1
"October 8th, 2017",1
the Portland Marathon,1
Wendtner C-M,1
Gregor M. Current,1
"üíö
#",1
Global Chronic Lymphocytic Leukemia Therapeutics Report - Market Size,1
#NCIC2017,1
AntiCD20 Therapy Boosts Efficacy,1
18th August 2017,1
#Pipeline Insight,1
Quantitative &,1
Qualitative Analysis,1
Leukemia https://t.co/Z9GahSjnek,1
Sept 23,1
#Clinical Implications of Novel #Genomics Discoveries,1
between two 2nd,1
#treating #,1
#leukaemia #cml,1
https://t.co/XO17rl2PlH,1
https://t.co/WhC6j1LRoS,1
"Scotland 
Great news",1
L√©vis,1
#l√©vis,1
#cin√©ma #,1
S√§chsischer Verdienstorden,1
"Brigitte Voit

Aus",1
Transplant @OncLive @Jasoncology,1
#Hallek #,1
MRD @JAMAOnc w @anthonymatomd,1
Leukemia https://t.co/PKdWz4BbRL https://t.co/wHKWyBWEvz,1
@MadeLiverpoolTV https://t.co/HIVoLZ26ee,1
https://t.co/ULOloxZeor,1
https://t.co/pvgtwVDKAZ,1
@NortheasternCOS,1
https://t.co/Q5GcL1Gwat,1
https://t.co/6IDvwYIEZA https://t.co/yUeGK7d6G3,1
Momento,1
Competitive Trends,1
FREE #Quiz A Man With Chronic Lymphocytic Leukemia,1
Multiple Myeloma(MM,1
#CD19,1
#Therapy Active,1
Combinations Explored to Enhance #CLL Outcomes,1
https://t.co/n5CN4UbcPS,1
#knowaml #,1
Forecast 2022,1
IE,1
Cuban,1
#gvHD #,1
https://t.co/luZ8TsC10P,1
#PDL-1 #,1
https://t.co/EJn9BvnYtt,1
SUPER,1
Alex &,1
Christoph,1
Pingworks,1
ContinuousDevlivery &,1
Docker,1
Flinn @TNONCOLOGY,1
CLL13,1
Market Forecast 2025 Rep,1
AHP &,1
https://t.co/zxIUDv09JV,1
#Exosomes #ncRNAs #noncodingRNA,1
@CCCNHS https://t.co/nEcblNJ4aU,1
@genbio,1
https://t.co/6IDvwYIEZA https://t.co/TG84rArv3P,1
Selina Chen-Kiang,1
@NortheasternCOS #CLL #,1
Carma,1
Dr kipps,1
@BSH_ASM,1
https://t.co/Th7kcoPQlK,1
Dr Campo,1
@UniBarcelona @BSH_ASM,1
https://t.co/SphG0nRuTp,1
https://t.co/MjVUNAFDrI,1
https://t.co/PhkmM4478V,1
seven years,1
"RockFighter

Siguiendo los... https://t.co/t9j0TidM7X",1
"RockFighter

Siguiendo los",1
https://t.co/wd4oMTWeIG,1
#Moonshot #,1
TargetTherapy,1
New Treatments For Chronic Lymphocytic,1
New Treatments For Chronic Lymphocytic Leukemia,1
Ublituximab/Ibrutinib Beneficial in Patients With Chronic Lymphocytic Leukemia,1
@QMBCI https://t.co/4EAyRvK9Yr,1
Kenneth,1
https://t.co/iVmlt1Q6K0 https://t.co/tnwTCzeFQZ,1
the Era of Novel Agents https://t.co/UiBNMCwmDK https://t.co/gsYrMpmEXn,1
https://t.co/5tas1sEv9Z,1
Thanks to @WillieCrawford #,1
More than 17,1
Republicans,1
SPMS,1
https://t.co/khWDuv5qtj https://t.co/adX9XBEaEc,1
PARP1,1
Sophie Laird,1
@wessexGMC Genetics Lab,1
https://t.co/hcgyJPuoIZ,1
https://t.co/Imk1MT014v,1
https://t.co/sNqM3Nd0eH,1
https://t.co/6IDvwYIEZA https://t.co/IUepU88ZCM,1
#RockyMtnCancer https://t.co/YWhTMeQARr,1
S3-LL #CLL,1
30.8,1
Info/Dokumente https://t.co/yn98i21gfM,1
clinicaltr,1
https://t.co/j63OViJFzY,1
#Melbourne #,1
Al aire-&gt,1
#GemeloZ #,1
#generacionVHS #,1
https://t.co/khWDuv5qtj https://t.co/12FXCPN0XB,1
https://t.co/k8tfyX6mT0,1
#AutopiZta,1
cllsm @JCO_ASCO,1
AMPK,1
#leukemia https://t.co/E4vXFhoTmD,1
Clinica,1
#CLL https://t.co/yCPE8WNmkd,1
#fatigue #exercise #,1
working &,1
#14ICML #,1
https://t.co/JZxTEeBNUj,1
review &,1
MYD88 &,1
Mutations Cooperate,1
B-Cell Dysfunction,1
https://t.co/gZA42YojKW #ICML17,1
Soy un,1
#LuchaLibreFemenina #,1
CancerResoures,1
BL,1
Burkittlymphoma,1
https://t.co/AYkLYnLjbf,1
Gina Eagle,1
"Rice Bran Arabinoxylan + 
",1
#CLL News,1
https://t.co/6IDvwYIEZA https://t.co/JZSXLYeQVo,1
USD $1,1
#cll https://t.co/KSiZMgpx9U,1
Merseyside,1
https://t.co/e7DofYxM8E,1
#TreatmentTrends #,1
TCRM,1
Benefits,1
https://t.co/57NInFyLfy,1
AntiCD20 Therapy Boosts Efficacy of Ibrutinib,1
https://t.co/dJNOhOpYCM,1
Living Club Level Life,1
"@NinthFloorFilm 
@ttfilmfestival",1
#ninthfloor,1
#ttfilmfestival #,1
Trinidad,1
#JCAR014,1
Tmrrw,1
#Predictive #,1
#Treatment With,1
#Bendamustine #,1
https://t.co/XQWXzlRo2k,1
#Leukemia Leads,1
Wichtig Nephrology,1
Dr Burke,1
#ibtutinib #,1
$juno https://t.co/IBF2GFqdAt,1
Mark Scott - @CelloGroup,1
4.3%,1
https://t.co/GDHS1ayQOx,1
about @stwater #,1
DRX,1
WIZZ,1
RPC,1
SNS-062,1
5-Year Anniversary,1
#iwCLL17,1
New Rituximab Formulation Approved,1
Bl3LlD yn gwerthuso'r tai crwn,1
5.2%,1
#BCR,1
#BTK #PI3K #CLL,1
https://t.co/DCPb0jBoZ4 $CLL,1
https://t.co/jA5Qm9FkLb,1
Drs Wierda @LeukemiaMDA &,1
Meeting - Update of Recent Scientific Conferences,1
July 18th,1
https://t.co/vl5FXPtLXA,1
Se terminan las mini,1
nuevo #VamosLuciano #,1
#BCL2inhibitor,1
NCT01886872 #,1
https://t.co/KtKhwlztMO,1
Drs Kay,1
Zent https://t.co/48gIbFnKUw,1
https://t.co/KrbBAwM9ZV,1
Bendamustine Combo Shows Encouraging Activity,1
https://t.co/4CmCbE6F8g,1
#CD180 #,1
Campath,1
https://t.co/fqQzfpPVsE,1
#BGB3111 #obinutuzumab #,1
14ICML,1
https://t.co/6IDvwYIEZA https://t.co/ocNFnlQjVR,1
#LymphomaFocus #,1
Leeds Dr,1
https://t.co/nYD7Aofhw1,1
Susan O'brien,1
https://t.co/JMsoCwEFjy,1
https://t.co/1tkjETBMpv,1
"11q,",1
Umbilical &,1
Cord Blood,1
https://t.co/0KUWTkgAdp,1
@OncToday w @anthonymatomd,1
#11q #,1
https://t.co/ApqcmHzqGd #,1
https://t.co/6SOUNzjCSt  #,1
thankyouthursday,1
#urgnt #,1
@OfficeOfRG,1
https://t.co/S9NSLXaiCi,1
#CLL Centres de,1
Susan O'Brien -,1
#Clinical Timeline on,1
#Pharmaceutical #Sciences #Chronic #,1
Efterlyser,1
kontakt rita@lyle.dk,1
https://t.co/GL4lYjtzAV #CLL https://t.co/mmvxYyt5yX,1
https://t.co/2QMShZoC7o,1
CLL https://t.co/lV9bVzra5L @cancertrials_ie,1
https://t.co/ejfYtpNJ0E,1
the Pacific Northwest,1
this fall,1
https://t.co/Ww5QmeBpOj,1
#CLL https://t.co/kxGdWXdg9X,1
Hardcover Book,1
https://t.co/koWCgvWwTS,1
https://t.co/xqyJtshM3B https://t.co/nMfxWUdVbN,1
https://t.co/QFnY3UAqcL,1
July 12,1
https://t.co/zU8l472k6F https://t.co/jxgbWrIOLM,1
https://t.co/PWypxSIwUf $,1
Last evening,1
@Quantunna,1
https://t.co/cdzhDg515M,1
7/10,1
#ROC #,1
Dr Cathy Burton,1
studyday,1
#Canada150Plus https://t.co/UjNU0qJTXL,1
"mid-2017

+ or",1
https://t.co/FqykACb7F7,1
ÿ®ŸäŸÅÿ∂ŸÑ,1
@cancertrials_ie &,1
@IrishCancerSoc https://t.co/BuWOYRtkam,1
al https://t.co/NoK9pytdBf,1
https://t.co/rDR1IY7AO9,1
#CLL https://t.co/5y4G3tROrX,1
#CLL https://t.co/beCLqh02Jr,1
#leusm https://t.co/ch2eeumQPu,1
Starbuck Merdeka Walk,1
#leusm https://t.co/TDfUlG3hcx,1
Haematology CNS,1
Chromosomal Abnormalities &,1
https://t.co/yOqbQnlrjX,1
#Nktcells #,1
#CLL https://t.co/KFskUqsfds,1
#mycapitan #cfc,1
"to~
Non-Hodgkin‚Äôs",1
@TNONCOLOGY,1
cllsm https://t.co/ezoZcuVjje,1
https://t.co/r8RJjO4sW4,1
Efficacy and Safety of BGB-3111,1
CFH,1
rituximab https://t.co/5fgLCncRwI,1
https://t.co/eCXIoTfBTb,1
Seog Kim,1
#RituxanHycela #,1
follicularlymphoma,1
Christian Buske,1
@uni_ulm  https://t.co/PP5F60NjPj,1
https://t.co/MJKhDbh18o,1
#mymomissupermom #,1
https://t.co/T5zKo7lXiD,1
#cllsm https://t.co/VM54aQg2xW,1
#Genentech #,1
https://t.co/2QMShZoC7o https://t.co/M6XwiFNMJR,1
"Multiple Myeloma
Chronic",1
Absolute Lymphocyte Counts Predictive of Survival With,1
CLL Post-FCR - Cancer,1
#GreatLanguage #GreatTeamWork #UW,1
Pharmacyclics√Ç Triggers,1
Treating Chronic Lymphocytic,1
post-FCR https://t.co/KaUefm5OnS #,1
#CARTcells,1
Roche https://t.co/gq1VYhjk5s,1
cuidar su,1
$nvs #,1
https://t.co/bGpUZkVNzz,1
Immunoglobulin Genes,1
https://t.co/DQjMOGft9M,1
BGB-3111 &,1
#obinituzumab https://t.co/jGAUou6HyE,1
https://t.co/SsxxGh3bjG,1
https://t.co/OjrD2KpUiM,1
USD $10,1
AbTedeschi,1
#NHL Heavily,1
S55746,1
U2TheJoshuaTree2017,1
#Purple News,1
Venetoclax Approved,1
More than 20,1
https://t.co/WcRHpQPnCq,1
Maf‚Ä¶,1
https://t.co/JaqLrTLNyL,1
Caligaris Cappio,1
Adding Ublituximab,1
Subcutaneous Rituxan,1
"https://t.co/kNqnfSFsdZ
",1
#approval,1
genentech,1
rituximab plus,1
follicular &,1
https://t.co/GsH0847iiD,1
C Moreno,1
https://t.co/3lss5KZJm9,1
https://t.co/aXVnvluyAm,1
ProWrestling,1
https://t.co/BBwFM9KiKI,1
DSSG Digest,1
rituximab plus hyaluronidase,1
https://t.co/2yAJnZJY3,1
3pm EDT,1
Advocacy Center,1
https://t.co/Z5fqZ1TqtX,1
#eha2017 #,1
92 thousand,1
117 thousand,1
https://t.co/nE6uExWSYN,1
@MOCBrasil https://t.co/gxdQje4BWo,1
#leukemia https://t.co/jIxTIT6bMd,1
Edelmann &,1
Gribben @JOP_ASCO,1
Atrial fibrillation &amp,1
#LauraRobinson #,1
ibrutinib+rituximab,1
https://t.co/w2z0ZemfQ8,1
New Cancer Drug,1
Newsmax,1
https://t.co/FlvjJz0PKs,1
Therapeutic and Drug Pipeline Review H1,1
Innovative Chronic Lymphocytic,1
Jefferies of,1
RRMS,1
NIHRJL,1
https://t.co/cs7WeQRnfM,1
HER2-Negative Breast Cancers,1
0.8%,1
https://t.co/WpZKZNu5BZ,1
https://t.co/FBg1pntVAi $,1
https://t.co/HvE5VFWbT4,1
#AcuteMyeloid #,1
LeukemiaCauses,1
Brady,1
Monte,1
TOC,1
$$$,1
Daventry,1
https://t.co/iCQqGeYuSv,1
How My Father's,1
#Methylation Analysis,1
#MBDseq Method,1
Mantle Cell Ly‚Ä¶,1
June 1 2017,1
https://t.co/VwMsYr05m8,1
CINSIDERED https://t.co/3KbTNP3hdY,1
#Treatment #Paradigm,1
#excellentEnglish #,1
#CLL https://t.co/md7WygejqR,1
Ofatumomab #,1
Wissenschaftsgetriebene,1
Forschung,1
#Uniklinik #,1
Dr Tam,1
@J_Immunol #Bcells #CLL,1
#icml2017 #,1
Nastoupil,1
IBRUTNIB,1
#ICML2017 #CLL #,1
kipps,1
PI3Kd,1
PO QD,1
NHL #,1
North America,1
@DRGinsights https://t.co/OSVuSVJjWv https://t.co/JIifbc2NQs,1
Chemo-Free Treatment,1
Danielle M. Brander,1
Durh,1
https://t.co/khWDuv5qtj https://t.co/zqaqSnJOYm,1
Akt‚Ä¶ https://t.co/JmjHmM4msp #,1
CRO Feinstein Institute Scientist Recognized,1
N.Y.,1
Deutsche Sutidiengruppe CLL,1
Abstracts &,1
22nd,1
the EHA Learning Center,1
80+,1
#ICML2017 #ICML17 #,1
üèÖ‚ö´&,1
Prognosis and Therapeutic Outlooks,1
Microenvironment Signaling,1
#shanghai #,1
Shanghai Pudong International Airport,1
#ICML14 #ICML2017 #leusm #,1
BeiGene Presents Updated Phase 1 Data,1
Sain Ffagan,1
St Fagans,1
https://t.co/AobvZ0mvVp,1
CLL Forschung,1
PatientsMatter,1
#cllsm https://t.co/kd2AVmSFAl,1
105,1
#cllsm #iwCLL2017,1
Data Presentations Covering New Approaches,1
https://t.co/N7QyZGdQ1F,1
https://t.co/sP1YAM19ZD,1
Cheadle Wilmslow Rd Sainsbury's,1
https://t.co/CjJDw7VNnS,1
Infections,1
https://t.co/0sUQzMwP9y,1
9 #CLL,1
https://t.co/Pkx5bElKQ0,1
Henderson,1
Pharmacy Forum: Venetoclax,1
$NVS #,1
PowerPoint Slides - https://t.co/Hd3ypNweNh,1
#CLL $tgtx #,1
#Marrow #,1
#Concurrent #,1
#Resistant #,1
P3 Study of Ibrutinib in Combination,1
#ClanLeaderLife #,1
#cllsm https://t.co/I0YA4Ni5pA,1
Therapeutics Development of,1
Oncology - Merck Manuals Professional Edition,1
#leusm https://t.co/xji5z7h2QB,1
#tcellRx #,1
#antiCD20 #,1
https://t.co/R2AmvbB1Jj,1
https://t.co/EREqGOvsED,1
https://t.co/L6YS7iRwHt,1
a Potentially Safer Alternative Treatment,1
Leukemia https://t.co/tsJpVWKUbk,1
#ZahlDerWoche #,1
Krebs https://t.co/2Ozy4Y9XL7,1
#CARtherapy #,1
lymphoma)„Å®Êõ∏„ÅÑ„Å¶„Çã„Å™„Å§„Åæ„ÇäB-CLL/SLL,1
mgmt &amp,1
#HCPs,1
https://t.co/OZxTmCZ8hD,1
the Phase III GEUINE,1
PennCancer,1
ASCO17 https://t.co/2LCpJTdlJu,1
E354B,1
#ASCO17 https://t.co/J0kyB5O1fD,1
1:15pm,1
Highlights,1
272,1
Dr Park,1
#329 #ASCO17,1
286,1
Hall A. Details,1
Personalized Cell Therapy Combined,1
Phase 3 Trial of TG-1101,1
Gill et al,1
271,1
8-11:30AM,1
Richter‚Äôs Transformation and Relapsed CLL,1
+0.1%,1
Lymp.. https://t.co/NPbkpRwLaQ,1
https://t.co/xqyJtshM3B https://t.co/MQJfTN9OmQ,1
#Lenalidomide #,1
https://t.co/0hK8Qy9975 #,1
https://t.co/qwEjiZt5db,1
14.00,1
CarlJune,1
#CLL https://t.co/Pby5YcD4oO,1
#iwCLL2017 https://t.co/zk9LfnCuEU,1
OncologyTube  https://t.co/uCg2Ij7tvK,1
Lawsuit https://t.co/iKIFs5cD38,1
Tks,1
Nearly 40%,1
Response Rates,1
Therapeutics Announces Positive Data,1
#ASCO17 CC,1
ASCO17  https://t.co/s9WoVBenbX,1
https://t.co/rLkw36cJqm $TGTX,1
NNECOS,1
@TheBloodMD,1
mab UTX+ibrutinib,1
https://t.co/hxrxn6CMuN,1
Michele Nadeem-Baker‚Äôs,1
Ibrutinib + Ublituximab vs Ibrutinib,1
19% vs,1
Inherited &,1
K Americans,1
A,1
VolunteersWeek,1
#Haematology Nurse Specialist,1
https://t.co/fRoMVEm2BE,1
C Pepper,1
Read Brian's,1
https://t.co/2yQcviGUsm,1
https://t.co/3VbIWvHU1F,1
IHI,1
#ASCO2017 #,1
Schiedam,1
https://t.co/ttXBW50IBB #leukemie #CLL,1
Lazarex,1
#CLL #OneMoreDay #,1
https://t.co/3N8enCIcFS,1
Resonancia Magn√©tica,1
la rodilla :(,1
https://t.co/NHcL12PdTc,1
CompleteRemission,1
https://t.co/0DkahEuH65,1
LuchaLibreChilena,1
Clinical Practice Facilitator,1
https://t.co/WgUUWVs6ln #,1
#Canadian #,1
https://t.co/nFuXcbP32j,1
https://t.co/eEhgl361f7,1
#iwCLL2017  https://t.co/DTn5xYHSyS,1
CTL119 &,1
https://t.co/1T6frmXvWW,1
@dukemedicine,1
York Live Your Life Conference,1
https://t.co/ifslM6mWAg Clinical and Molecular Evidence of Atovaquone,1
https://t.co/5sIL8xF0jD Clinical and Molecular Evidence of Atovaquone,1
Humanized CAR-,1
https://t.co/Hz6OCUw9vB #PI3K,1
Personalized Cell Therapy Combined with Ibrutinib Achieves Complete Remission,1
Novartis CAR-T/Imbruvica,1
https://t.co/tJbg1uJnxj,1
Lymphocy.. https://t.co/WBUYary7Ci,1
Aberrancy,1
"residential radon levels @CllSociety
https://t.co/zBqEp2TPrV",1
$tgtx #ibrutinib #,1
https://t.co/sgYLTr58UU,1
https://t.co/JIKUjoqmI0,1
https://t.co/l1Y3JbztBJ #CLL,1
Clin Exp,1
Pathol,1
AlisonEvans,1
https://t.co/PJSR7lzF7k,1
SURVIVAL,1
loco hasta,1
el insta de @chileluchalibre,1
https://t.co/BBC9znwBpJ,1
print @JCO_ASCO w @anthonymatomd,1
Esta buena la lucha,1
@WBCD,1
https://t.co/QQHZ9YpeWE,1
Hiroshima,1
Nagasaki,1
the Progression and Evolution,1
#Next #,1
#Advancing #,1
CLL Subtype Report,1
https://t.co/Cw5ClBylW1 #CLL #,1
#olderadults #,1
E-Newsletter,1
https://t.co/MU4StDoo9e,1
Multiple Sclerosis,1
under 55,1
https://t.co/o7lGhWPuu9,1
Toby,1
Clive James',1
https://t.co/lCxytZzoul,1
Session 1 Replay,1
#RockyMtnCancerCenters &,1
https://t.co/62S2JeNCgC https://t.co/BYww5GI92q,1
https://t.co/RGRDNwyVae,1
https://t.co/7eexAvuHz5,1
#lylcl https://t.co/LpGk3USrnW,1
chemotherapy &amp,1
ONO/GS-4059 https://t.co/tLrRHNV59r,1
Healthcare Professional's,1
CLINICA,1
julio chavez,1
CLLIPI,1
@Ramikomrokji,1
5.75,1
mwynhau.#CLl https://t.co/cSl8pSYZnc,1
https://t.co/6iuQyVKuu3 https://t.co/ixu0oKkoRV,1
Mr Urdd,1
Year 3,1
https://t.co/2epO2DntLH #,1
Assembly,1
Unique Selling Point,1
Tania,1
Ffwrdd,1
year 3!#CLl,1
@UMassD &,1
SNSO62,1
#Denver &,1
a few thousand,1
#RockyMtnCancer &,1
https://t.co/J9hysPQqpd,1
Diagnosis &,1
Initial Treatment of,1
https://t.co/4UW3BGs9Xk,1
#melbourne @WEHI_research,1
#Ventoclax #,1
MindBlown #,1
https://t.co/1iK7gZkjsT,1
2MGH,1
4 #LivingWithCancer #,1
Yoo,1
An Unusual Pattern of Pulmonary Involvement of Chronic Lymphocytic Leukemia in Area B until,1
4:15pm,1
#ATS2017,1
next season,1
#ChelseaChampions #,1
#thankyoujt #,1
Tuberculosis https://t.co/Ytd2b3L87S,1
john terry's,1
FCG,1
Mitternachtssnack #,1
#currywurst,1
#korn #,1
El pr√≥ximo,1
de Mayo,1
https://t.co/Qsji2OOgnZ,1
Over 100,1
https://t.co/GSs2fsChlV,1
6.6,1
1.5‚Äì29.2,1
https://t.co/Uq8HEHVTOc,1
Leptomeningeal Involvement,1
May Be Effective,1
PI3K isoform Inhibitors,1
https://t.co/6JJ93f9ka8 &,1
Prof Brown,1
400 #CLL,1
Venetoclax Plus Rituximab Induces Durable Responses,1
https://t.co/xCJzp8jMbw,1
FC+O,1
#CLL https://t.co/s5Cjkfj1iH,1
LLS Resources &,1
Communities Help You,1
#Essential #,1
Hybrigenics,1
Ubiquitin-Specific Protease 7,1
ALHYG,1
Davide Rossi Interview,1
Comparison of NGS &,1
Sanger Sequencing,1
#leusm https://t.co/LRMo6wihJQ,1
https://t.co/a4jsK8d7j6 https://t.co/iVpQluHfXb,1
UTX,1
Monocytes &,1
NLCs,1
Eureka,1
CXCR4,1
https://t.co/zU39Se2MfL,1
https://t.co/QA5tghK2n2,1
#ÿ®ÿßÿ≥ŸÇÿßÿ™ #baseqat #,1
https://t.co/cLdzOtwlub,1
6.56 km,1
8ÎÖÑ,1
ÎÑ§Ïù¥Î≤Ñ,1
"TVÏó∞Ïòà
https://t.co/dsgQMM3itW",1
#dara #,1
#ÏÇ∞Îã§ÎùºÎ∞ï #,1
"#Í≥µÎØºÏßÄ 
",1
2NE1toINFIN8Y,1
17th https://t.co/R6160fyM4A,1
CLL Undergoing,1
SLL https://t.co/Safbctuo4H,1
Mtb,1
#4dias #,1
#kine #,1
https://t.co/EZYfsIkUXq,1
InyeAhn,1
Free info,1
1800953081,1
WCM,1
Dan Avi Landau,1
Fridays Young Investigators Meeting,1
Noooo,1
https://t.co/qQJ2l672VT,1
#drugaccess #iwcll2017,1
"https://t.co/51YWgH6K8K
#",1
https://t.co/PwG2Ht2Wiz,1
Lesley Ann Sutton,1
Uppsala Univ,1
#iwCLL2017 https://t.co/ZaBWuJ2FMp,1
lymsm https://t.co/I6KEQbp1IV,1
Ann Sutton,1
https://t.co/Ex57A6XmZX,1
https://t.co/6zdPtrAOWY,1
#iwCLL2017 https://t.co/vrnKLhxR97,1
https://t.co/9GkCIsVLvO,1
MRD &,1
#clinicaltrials going,1
#Hodgkin's &,1
https://t.co/OqWOxFJRcW,1
#cll treatment,1
https://t.co/I7WbXiosVf,1
https://t.co/JtYijJnYA0,1
#iwCLL2017  ,1
Michael #Hallek,1
9 years,1
https://t.co/Nr3sG3C0OI,1
#iwCLL2017 https://t.co/z8vUk3JNbd,1
#iwCLL2017 https://t.co/rs5wA9ysZo,1
CIT &,1
https://t.co/gaGhIciAs9,1
https://t.co/dSZ5dQUMJ2,1
1:30 PM,1
Marriott Marquis,1
Dr Pinilla-Ibarz,1
#iwcll2917 #,1
https://t.co/yCmefKBlWJ,1
Dr Jumaa,1
https://t.co/TQ80oAbH4J,1
Klaus Rajewsky,1
#CLL https://t.co/qQAuaMIitP,1
CLL https://t.co/kvKIomsNKs https://t.co/miqnAyfrDm,1
Francesca Arruga,1
Game Day,1
#indians  ,1
MBL &,1
Neutrophils &,1
Wnt5a Induces ROR1 to Complex w/ HS1,1
Enhance Migration of Chronic,1
https://t.co/gjd4TMG8PK,1
Biomarker for Future Relapse,1
fbio,1
More than 300,1
RockyMountainCancerCenters &,1
@LeukemiaMDA - join,1
https://t.co/D6AEEmcXDZ,1
Con Tam @PeterMacCC +,1
https://t.co/SYfixOWBoc,1
Attending International Workshop,1
https://t.co/We0od5nBWN,1
BloodReviews,1
#CLL/#SLL @Blood https://t.co/Jood3VSQI8,1
https://t.co/mD0SeAnFCy,1
@DerbyEarlyYears https://t.co/vLRP3EORal,1
CLL https://t.co/kvKIomsNKs https://t.co/wHjQgK4Ysq,1
May 11th,1
Bicycle Infrastructure,1
06/15,1
https://t.co/KVM2GjvrCS,1
Personalized Drug Analysis,1
Cancer Nurses,1
Joanne,1
almost 300,1
a year ago,1
Disease-Related Mortality,1
2nd Tuesday of every month,1
5/15,1
#NYGC‚Äôs,1
about @WilliamHillPLC #,1
SXS,1
@CelloGroup #,1
Maldita,1
Rodilla,1
https://t.co/f6BCtNCfbU,1
John Terryyyy,1
https://t.co/iv4uUb5I4R,1
Beneficio,1
7 de Mayo,1
"cancer~
Non-Hodgkin Lymphoma",1
Ireland &,1
Ventricular,1
https://t.co/W7z5RRNR9U,1
FanArt  de #DLN -Saga  ,1
llamar el #3 de #CruzandoLosLimites,1
DESAFIANDO LAS NORMAS,1
300k #,1
Immunology &,1
FRS - Huge,1
Max,1
https://t.co/MwCpvDLKJZ,1
mIgD,1
Needed,1
less than a week,1
time &,1
each decade,1
https://t.co/C96xN77F2N,1
https://t.co/WVrZI1UtGY,1
Gorini F,1
Azzimonti,1
Cancer Doctors,1
ahole,1
#MUMC+ https://t.co/kxfA1VMrFw,1
https://t.co/OPfIJROgjX,1
May 20,1
K. Rai,1
Assimos,1
Hofstra Northwell School of Medicine,1
shld heed,1
PatientsInvolved,1
George Follows https://t.co/2ertqFqZ0B,1
Treatment with Ibrutinib &,1
125k,1
#CLLI Info,1
https://t.co/gEwfwilTfb,1
https://t.co/CGjNduUhLh,1
Francesca R. Mauro,1
Tx Benefiting Pts w/Treatment-Resistant Chronic,1
https://t.co/bWi9QXeNas,1
#Complete Response,1
#Chemo #,1
#BGSConf https://t.co/EIViaXsttr,1
#BGSConf https://t.co/MdaPpjZV8,1
#prognostic,1
more @GeriSoc,1
#immunoglobulins @GeriSoc,1
https://t.co/NpRvrYBgTZ #,1
more than 80 %,1
#FBC @GeriSoc,1
Expression of Death Associated Protein Kinase 1,1
"Friday, April 28, 2017",1
Register &,1
https://t.co/xqyJtshM3B https://t.co/1EDwAqy1pQ,1
#Bicycle Infrastructure,1
https://t.co/Gw5H18Qgdg https://t.co/kdCkrJxPna,1
Hodgkin #,1
https://t.co/G10REqeB4F. https://t.co/TeAKwIUZOa,1
few years,1
eric,1
#john terry #cll,1
üì∑ pre entrenamiento,1
Study of Venetoclax,1
St,1
coming &,1
@CNNI,1
Constructing and Maintaining New Athletic Fields,1
4/27/17,1
Much√≠simos,1
el debut,1
cosas,1
corregir por mejorar,1
Espectacular,1
21 de MAYO,1
"Prep√°rense 
üíÄüíÄüé∂üëΩ",1
https://t.co/iligjojhYv,1
"Maipu üëΩ‚úå
üíÄ",1
https://t.co/WYJLukJJAc,1
HOY,1
"las 4
Sala",1
Maipu,1
Parikh,1
#AMC #,1
#SalaPremiumDo #,1
#FACup #,1
PLCG2 C2,1
LA OLA,1
Rumania,1
Maravilloso,1
#EChCluj2017,1
#Cluj https://t.co/Eo8ASbqny1,1
Avslutningsmiddag,1
https://t.co/ren2IUY91v,1
#UQUMed35 - #ŸÑÿ≥ÿ™_Ÿàÿ≠ÿØŸÉ,1
#Ibrutinib #Discontinuation,1
Approaches https://t.co/vTTzbT59SM  ,1
Constructing and Maintaining New Athletic Fields',1
https://t.co/bN1Ehr89Yk,1
sri lanka,1
https://t.co/wgYzWeKmws,1
Binet A.,1
'77-'81 üòÄ #CLL #,1
#radiationtherapy &,1
@UKKoeln https://t.co/j5az9g80t1,1
Gran trabajo de la Dra,1
R. Bosch de @hematosantpau,1
https://t.co/bVfLoO6PtS,1
MYCrelated,1
https://t.co/oBWgbpcNEp,1
RockyMtnCancer,1
https://t.co/RS84eZH1gt,1
https://t.co/8xHSTSyJhb,1
https://t.co/3kJyIvDymX,1
CLL Ireland: New Standards Are Emerging for Follicular Lymphoma,1
MedicBoard https://t.co/OTNZodjvwz,1
#cfc #,1
https://t.co/pv96JLducC,1
#Central_RYS17 #Central_RYS17 #Central_RYS17 #Central_RYS17 #Central_RYS17 #Central_RYS17 #Central_RYS17 #Central_RYS17,1
#Central_RYS17 #,1
https://t.co/xLk9RZg6Ok,1
Customs Clearing,1
May 20 w/ Drs,1
#RockyMtn &,1
Psoriasis,1
Carl,1
Cancer Therapies,1
The Short Of It,1
#Rituximab #CLL #,1
"FDA Adverse Event Reporting System -
 ",1
3150/10,1
PLCG2 C2 &,1
#lymsm https://t.co/jSDumCUniv,1
NHS Scotland,1
Cubs,1
#CD37 #CLL #,1
May 4th,1
New City,1
https://t.co/G7jTfuD14E,1
https://t.co/UB1awq2lw0,1
#Canada &,1
APril 22nd,1
Mark Barnes,1
37 years,1
Ryan Barnes,1
Royton #Champions,1
#1 + #2,1
"Genetically Modified T Cells Obliterate Chronic Lymphocytic Leukemia Tumors"" https://t.co/ueG0qH8ha7",1
Hodgkinlymphoma,1
Leukemia Defeated,1
Ken Miller,1
@TuftsCancerCtr,1
https://t.co/GoR0l3fp29,1
CLL„ÅÆÂãâÂº∑‰ºö,1
Symptoms and Treatment,1
https://t.co/RBIv7vZQI1,1
Kinase,1
https://t.co/oV9qsTj6dN,1
Medical Sciences] https://t.co/ZOj0SoWViO,1
26/4/17,1
#support #Hodgkin #,1
Belle Gibson,1
Cytokine Research:,1
Cancer Centers &,1
#dogsofinstgram #,1
#lakelouise #winterwonderland #,1
#mountainlife,1
Tim Call,1
2686/15,1
BCR &,1
DLBCL &amp,1
https://t.co/cZeOxcjVfs #lymsm,1
RESEARCH STUDY AVAILABLE,1
Burke of RockyMtnCancer &,1
between #SLL &,1
@mdanderson https://t.co/LsJ3RkPNuI,1
https://t.co/37SJVW0zS6,1
https://t.co/DQebJS4P3C,1
√ñzt√ºrk @DKFZ,1
4/7,1
Clin Path Research,1
https://t.co/CrwtpEPiKv,1
https://t.co/ES6eHSQq3O,1
https://t.co/HSTK4FwoQN,1
Checkpoint Inhibitors &,1
#CLL https://t.co/QYC7rPP1as,1
@LeukemiaMDA https://t.co/4jk1dpoIo3,1
154/21,1
Copanlisib,1
#SNS062 #,1
NCCNGuidelines,1
cllsm https://t.co/8J2BfhYd0s,1
2686,1
@LeukemiaMDA  's,1
#Common #,1
748,1
MinION,1
Tremendo,1
‡πÅ‡∏™‡∏á‡∏ï‡∏∞‡∏ß‡∏±‡∏ô‡∏•‡πà‡∏ß‡∏á‡∏•‡∏±‡∏ö‡∏î‡∏±‡∏ö‡∏à‡∏≤‡∏Å‡∏ü‡πâ‡∏≤,1
#‡∏Ñ‡∏≥‡∏û‡πà‡∏≠‡∏™‡∏≠‡∏ô #,1
https://t.co/2FHVg6XWGT,1
@IrishCancerSoc &,1
#Whistler2017 #,1
https://t.co/1EcEdUKDlw,1
Nasty,1
https://t.co/3GMfqxZu36,1
@umanitoba &,1
@CancerCareMB,1
Leukemia and Lymphoma Society https://t.co/1jpH1RhbbC,1
Paul Bunn,1
https://t.co/LcUTWsm4Z4 #CLL #mmsm #,1
@antidote_me,1
up to 3 hours,1
Period,1
BSH2017,1
#tipstuesday #,1
Leukemia https://t.co/Ik0OPGPf4y,1
https://t.co/hccIwqetzC,1
NOTCH1 Mutated,1
https://t.co/sdLV67PzXO,1
#biosimilars &,1
@bloodwise_uk https://t.co/W4NfJEzcOE,1
https://t.co/OiXGYkrbkR,1
John Gribben @QMUL,1
#hematologists,1
Idelalisib &,1
#theGuidanceOfKing #,1
#mfu,1
lamduangame2017,1
https://t.co/xqyJtshM3B https://t.co/3rlh6Wxr6K,1
PhII #,1
Idelalisib/duvelisib,1
Valentin Goede's,1
William G. Wierda @MDAndersonNews,1
First-Line Options,1
UTR,1
Susan J. Leclair,1
1st treatment year,1
52.1%,1
40.8%,1
https://t.co/5FRfnhSPL7,1
@vmwarensx &,1
W @anthonymatomd https://t.co/FTRKoJ4KnD,1
https://t.co/UIE7LgTqaB,1
https://t.co/7jO4PMYlgn,1
Once-Daily Oral Ibrutinib,1
https://t.co/YfCNkvwPJG,1
https://t.co/qlAxSjca9L,1
https://t.co/SONawnSfr1,1
USA - @CelloGroup,1
FCRL6,1
https://t.co/jXkWHsUUMs,1
KGF @Savills,1
XAR &,1
@CelloGroup #CLL,1
an hour,1
Practice &,1
Research Clinical Haematology,1
https://t.co/qrS6cxbOsj,1
Difference,1
PubChase Epigenetic,1
https://t.co/rPBbzZl0vC,1
https://t.co/jIQWPu1SST,1
Everything You Need to Know,1
https://t.co/km6AFMzor7 @anthonymatomd,1
Reborn de @chileluchalibre,1
#luchalibre #rt #,1
Robbins Park - Playground,1
"üíÄüíÄ
üíÄüíÄ
üíÄüá®üá±
",1
https://t.co/t0tCxcEojT,1
https://t.co/ff5WVR7T8D,1
Deciphering #Ibrutinib #Resistance,1
https://t.co/ghksbpIR5u,1
https://t.co/AXvAhcz9Pz,1
Dr N. Johnson,1
Tracy Regimbald,1
https://t.co/67pW7IHVOt,1
@MethodistHosp @ImedexCME,1
LandM2016 https://t.co/eoR5XESkB6,1
#lymphomas https://t.co/aEiRoGiXJI,1
Better w idela,1
Blood Journal $,1
April 22,1
Deciphering Ibrutinib Resistance in Chronic Lymphocytic Leukemia,1
Richter's Syndrome: Update,1
@ImedexCME #CLL #,1
LandM2016 https://t.co/wOsZywSKyf,1
Optimal Approaches for Management of Patients with,1
LandM2016 https://t.co/madAr0sMHW,1
Lymphoma Canada,1
MedicBoard https://t.co/ohQ9XJSYmD,1
April 8,1
#hematologic #,1
#CLL #AL #MM #,1
https://t.co/g3vIi8XBXA,1
9mathweek,1
Thessaloniki,1
21:10-21:30,1
https://t.co/wWdi2MYiPw,1
Leukemia #,1
ChemoProtocols,1
decisions &,1
Monoclonal Antibody Daratumumab Shows Antitumor Activity,1
Economic Modeling of the Cost of Chronic Lymphocytic Leukemia Therapy,1
TrumpCare,1
#pointblankperiod #,1
https://t.co/MGTcufkWdP,1
Resistance-Mechanisms &,1
@ImedexCME @UChicagoMed #,1
https://t.co/4U6tkMtlsv,1
Oxford U Hospt,1
SHM Assay &,1
Bcells https://t.co/hfQwLxSYPd,1
https://t.co/vmCFukjx31,1
Society of Geriatric Oncology,1
Anthony R. Mato,1
Devops,1
CART Cell Therapies,1
@LombardiCancer @ImedexCME #Leukemia #CancerResearch #,1
LandM2016 https://t.co/BOi1DX6brc,1
https://t.co/EtneS8vlWT,1
Clarity,1
Momentum,1
RT https://t.co/0ErERA72RY,1
#bloodcancerconf #,1
The Hill Resource and Reference Guide Book,1
112,1
#Ublituximab/#Ibrutinib #,1
43 years,1
https://t.co/IZQGKlRj3,1
https://t.co/9lgf75GO2e https://t.co/XmZq3IKUoZ,1
@jenniferzarou  #CLL,1
https://t.co/0nvXZe4TNy,1
next 5-10 years,1
duvelisib &,1
Oxford U Hospitals,1
NGS #,1
doi:10.1038/leu.2016.307,1
Alemtuzumab Therapy With,1
"2015-0570
Administration",1
Prev Untreated,1
https://t.co/jDtmggA6GI,1
Cinderella,1
many decades,1
https://t.co/Xkyc02RXii #cll,1
yixlid jailor,1
0 #cll,1
33 months,1
BCR Signaling Pathway,1
#CLL...https://t.co/wxmIEpMoaK https://t.co/B92tbZXxH2,1
#ATTAC2017 #,1
TG Therapeutics ublituximab Effective,1
$TGTX $JNJ $,1
Ibrutinib Safe and Effective for Patients With Relapsed/Refractory,1
v√≠a @onclive,1
https://t.co/wMWx7qOgC9,1
https://t.co/eVnQMxDjRd,1
RTX,1
Late-Stage Trial https://t.co/FTBTMA67LJ,1
https://t.co/tgzVbPLx5q,1
#MultipleMyeloma &amp;follicular #,1
https://t.co/P6eVPdsXuv,1
9.82,1
The Association of #Dyslipidemia With Chronic Lymphocytic,1
TGTX up &gt;60%,1
https://t.co/hdDGM7ZCJs,1
Nice Review,1
https://t.co/k6mXQ4gv0,1
TGTX Positive Topline Data,1
https://t.co/jR1V11xQZU,1
sprida b√§sta,1
Finland,1
Cholesterol Levels,1
las vegas,1
washington,1
83 days,1
Gebbie Hou,1
https://t.co/KCf7GxXCe1 https://t.co/YGSTEE6nwb,1
https://t.co/Laen2DXbK5 #,1
https://t.co/HVCtX3G4Kq,1
#littleleague #,1
OpeningDay,1
#Kapadia2017 #,1
CozyLife,1
GerminalCenter &,1
APWA SME,1
the Public Works World,1
https://t.co/vaSGomqB1w,1
#Emerging #,1
https://t.co/B8vOygotj7,1
https://t.co/0UBbPuKJct,1
https://t.co/p7ZqxDurCp,1
#TGR-1202 $TGTX #lymsm #,1
bmtsm https://t.co/RgbVFzpBNQ,1
32‚Äì38,1
37‚Äì42,1
https://t.co/deseC3JiCQ #,1
Attn #CLL,1
Patient &,1
Carer Info,1
Day 29 April,1
Speakers,1
"about 1,800",1
11 days,1
https://t.co/RwQz1vqgRJ,1
üíöüíô,1
#hornets #,1
Mechanisms,1
APN,1
Mary DiLorenzo,1
Effective Utility Management,1
https://t.co/jIXLljfIOP,1
lymphatische Leuk√§mie,1
Kevin Norris,1
Vincent Yeung,1
#exosome #,1
Therapy of Chronic,1
https://t.co/amNEE6lW7F,1
https://t.co/xF120thLvn https://t.co/VWp7xX0n9W,1
MDAnderson) &,1
David P. Steensma,1
#PlasmaCell #,1
GDHema2017,1
Leukemia https://t.co/ICz4JSxoPQ,1
MyCompany,1
Saiba,1
https://t.co/0ERmsAJJQB https://t.co/DFnJKiGJmG,1
Paw Jensen,1
"an estimated 115,000",1
ROA,1
#explorealberta #winterwonderland #canada #,1
https://t.co/cZ0IS001kr,1
#EMJVideo HELIOS,1
Rookie,1
18.64 km,1
Runkeeper https://t.co/vS6MKYyqnS,1
Oforta,1
A Positive Review of Current &,1
#CLL https://t.co/rdYoZwTbjP,1
https://t.co/ILDg62QwfP,1
Immune System Genes Linked,1
https://t.co/QBxiYhlTLu,1
"#NonHodgkinsLymphoma,",1
RheumatoidArthritis,1
https://t.co/ETScEVeCby,1
2q37.3,1
8q24.21,1
15q21.3,1
16q24.1,1
https://t.co/X95wynI15,1
https://t.co/t2OEzi4zSB,1
Mario,1
Fred Vella,1
Adam Viger,1
#25NOH #,1
#mariovellasvictoryagainstALS #,1
mariovellasfightagainstALS,1
https://t.co/vVBB07U0CL,1
5 Year,1
https://t.co/uGR6yioNOo,1
https://t.co/PnobA03yS5,1
https://t.co/JjKnYVKyb6,1
@oncology_bg,1
#BMTTandem17 https://t.co/JapN8ikJTU,1
Steve Colbourne,1
https://t.co/I8gUC6W5Lu https://t.co/3qRQ8GxBxb,1
Philippe Aftimos,1
BTK C481S-Mediated Resistance,1
https://t.co/jpFQ3oneU8,1
Small Molecule Combinations,1
May Some Day,1
https://t.co/Uy8Hx8bMdl,1
Radiotherapy &,1
Predicting Relapse,1
https://t.co/qBzlCzcPO7,1
8th March,1
#tickets #,1
Lamanna https://t.co/xXIVc4d16i &,1
https://t.co/VA25xho53V,1
https://t.co/lSWula9vH3 #,1
https://t.co/neUJB0u8VE,1
Nteliopoulos,1
as 1st,1
@mjmauroMD,1
S. Deaglio - Tumor-host,1
https://t.co/m7i1n3iFZD S. Deaglio - Tumor,1
https://t.co/tFBiDD7gaJ,1
the date 25,1
Bueno,1
vez m√°s apoyando,1
# debutdelaescuela,1
https://t.co/xRxaE6DfZt,1
https://t.co/OHF8gztJLS https://t.co/hTQ6VttCmy,1
@anthonymatomd https://t.co/QocoaqMZ5p,1
700,1
25 february,1
https://t.co/OHF8gztJLS https://t.co/iEE2QJ0Npw,1
https://t.co/yKSgmLJi8,1
the Right Time w/,1
"@LeukemiaMDA  @power4patients  
",1
Jim√©nez de Hematolog√≠a Experimental,1
VHIO https://t.co/P64ciWydiP,1
600 + pts &,1
Albitar &,1
New &,1
#bcl2 #,1
https://t.co/zTEElZrFzf,1
HaemOnc &,1
Idelalisib Increases Progression-Free Survival,1
CLRB,1
Apapa,1
@Datamonitor_DF https://t.co/8igxRNi5Dc,1
@Naturecomms https://t.co/QEJfzAqjeb,1
#baseballpractice #,1
PLCG2 Mutations Linked,1
https://t.co/qUIlm06Ggv,1
https://t.co/kGDuWfzJFG,1
https://t.co/71TNDIBQtn,1
#cessna #,1
Clinical Implications of Novel Genomic Discoveries,1
https://t.co/agH7sdS2C8 https://t.co/Qcfh5GPaKR,1
"Saturday, Feb. 18th",1
500 #CLL,1
https://t.co/lcNumfzi91,1
https://t.co/gOPmGT3Ncy https://t.co/EFxmg7u5UF,1
@CLLdoc @LeukemiaMDA https://t.co/J8RBqVxORn,1
PTPROt Tyrosine Phosphatase Functions,1
#lylcl https://t.co/kbA2CYPP7m,1
#management #,1
https://t.co/kbA2CYPP7,1
Study Identifies #Potential #Biomarkers,1
lylcl https://t.co/PbXmgKaEF9,1
https://t.co/85EPABOVqr  @UCIrvineHealth #,1
#ASH16 https://t.co/ZQs3vlog5F,1
https://t.co/jTWlEiDeh7 #,1
https://t.co/cebEg88zQx,1
9 fucking years,1
https://t.co/bUg5w4jqX9 #,1
https://t.co/ebsduVTUOR,1
Almost 500,1
Drs Keating &,1
"subiremos el v√≠deo de """,1
VLL,1
Cll &,1
https://t.co/zC5HLYu87l #CLL,1
https://t.co/XRZT3yJSCQ,1
#risk #,1
https://t.co/wzfNoqiZWT,1
https://t.co/JOeRyARXTy,1
https://t.co/62S2JeNCgC https://t.co/rSvBSHjUPG,1
CancerFree,1
https://t.co/m2QXHIuC8Q,1
Peter Hillmen https://t.co/aYmI2nJ8p9,1
May #NYC,1
https://t.co/GrULcCI2p9,1
abexinostat,1
B. Chronic,1
#immunity #,1
Blwyddyn 3LlD,1
Nghanolfan Ddwr,1
Cilfynydd Water Centre,1
https://t.co/nYYC72mPfg,1
EUR814,1
2013-14,1
https://t.co/m0qLs8qT2k,1
Powerpoint Presentations - https://t.co/Hd3ypNweNh,1
#Leukemia https://t.co/qigMr3h6uf,1
NY City,1
https://t.co/EpyonzQCqM,1
https://t.co/1YkgVMVLsm,1
@UCSDHealth Met,1
Santa Barb,1
Gazyva/Imbruvica,1
Only EIGHT,1
https://t.co/hCc7yRwfHt,1
v√≠a @bloodjournal,1
#SeasonStartsNow #,1
https://t.co/CuBR5rKXqW,1
Expression and Variation,1
Leukemia Market-,1
Strategies,1
Booth 1,1
https://t.co/jFZ1KQpO4Q $CLL #,1
Robert,1
https://t.co/rcvGDzbIuO,1
@CRUK_BI https://t.co/EmJbiMTvkJ,1
https://t.co/6i5Z9s1c0S,1
https://t.co/iWXnE0KU61 #,1
#fairmont #lakelouise #,1
#nationalparks,1
#explorealberta #mybackyard #,1
https://t.co/P0tCqmMzsq #,1
Current Research of Drug Treatments,1
https://t.co/9tUgzCjMoT,1
https://t.co/KbVnerdF3O #WorldCancerDay,1
Tumour,1
MCPH1,1
ANGPT2,1
the Right Time w/ @USOResearch,1
@ImedexCME @jmikhaelmd,1
Sayed,1
Megan,1
Next Decade,1
Hagen,1
Bergbesteigung,1
Gipfel,1
TMW,1
#CosmicLoveLaughter,1
Joy,1
APWA March 23,1
https://t.co/w79lIL4VMG,1
Leukemia Leukemia,1
https://t.co/2fZaeLvjPO,1
Janssen‚Äôs Imbruvica - PharmaTimes,1
Idag,1
#leusm https://t.co/BTzOujxsB1,1
What Is The Optimal Sequencing of Novel Agents,1
null https://t.co/jwiFKPfSj2,1
Deborah‚Äôs Story,1
Path https://t.co/qeSlfpX5IW,1
https://t.co/xqyJtshM3B https://t.co/FbPtah0EBU,1
Atezolizumab in Combo,1
@CLLdoc https://t.co/xTdFVxf3WE,1
tonight the night,1
Eldrazi,1
#mtg #,1
#peoplewhohelpus #,1
"McWilliams, Emily",1
Almost 400 #CLL,1
https://t.co/X6DETWVb2P,1
35.4%,1
PPARdelta,1
#NicholasJacob #,1
https://t.co/7NS29BMZW4,1
SOHO 2016,1
#Meded #,1
#AML #MM,1
Letai,1
lylcl https://t.co/YavXqdvFOR,1
Jan 29th,1
11-4pm,1
Scout Hall,1
#Coquitlam #CLL,1
https://t.co/QJPiCkaKxh,1
few %,1
https://t.co/ofNLtgLFAu,1
early 2016,1
F Cavalli,1
ECCOCongress,1
JANSSEN‚Äôs IMBRUVICA,1
https://t.co/ZydWq37auf,1
#ECCO2017 &,1
next 3 days,1
#patient #,1
https://t.co/4wqdP5SL6Y,1
https://t.co/H4PMaiGSqj,1
quando,1
la chimica rischiamo di perderla per sempre,1
CervelloVsIstinto,1
nof1,1
#ECCO2017 #,1
#OhioStateMedicalCenter https://t.co/S3yY5NCfvF,1
"AgingData 
https://t.co/RHyvzJYJUJ",1
#MOR208 #,1
#GrandRounds Highlights,1
#OhioStateMedicalCenter https://t.co/6TyIxiPxJ4,1
#CLL Chemitheraoy,1
@Lankenau Grand Rounds,1
CLL w,1
48yow,1
Consortium,1
MICROSCOPE,1
#ProPath #,1
Dynamic Employees -,1
11 ET/10,1
Fundaci√≥n Jim√©nez D√≠az University Hospital #Hematology,1
https://t.co/ukPOm7AUiw #,1
van de #,1
NKR kan ',1
leveren,1
van #CLL,1
Nederland,1
the Bone Marrow Transplant,1
ASH16  @anthonymatomd,1
Leukemia https://t.co/EHyEZBDKcb,1
Andreas Strasser,1
ICGEBSeminars,1
Tumor Host,1
https://t.co/EpEH9lA5ls https://t.co/G790D08KXi,1
Over 400,1
#obinutuzumab https://t.co/yKwlrQJAZi,1
https://t.co/ziIbXi8knZ #,1
#leusm https://t.co/4Y232uc0mB,1
Jan 30,1
#ToughCompetition $,1
Citylight Lincoln,1
https://t.co/bWG15Z9MJK,1
Over 350,1
PD-1,1
https://t.co/1PLrAMgTpG,1
OncoImmunology,1
Ottawa,1
ASH16 https://t.co/kK4qKmOUzI,1
Venetoclax + Rituximab Studied,1
Primer,1
https://t.co/41ysJ3XrYi,1
https://t.co/TZmZrsgHTd,1
https://t.co/ObgUszYMBi,1
ASH16 https://t.co/2ujjfLbQSj,1
Host Immune Cells,1
https://t.co/mY81GxbMUI,1
over 300,1
Feb 18,1
New Event,1
#Leukemia #ASCO16 https://t.co/S5AbrMn8c1,1
Value Chain Analysis,1
https://t.co/C7tK09eBGA,1
https://t.co/jf74iPPfxh https://t.co/VfZqFdQU1,1
https://t.co/BnK86L3QBC,1
Dan,1
#Cancermoonshot #,1
https://t.co/gkpIu027AN,1
#Venetoclax+ #,1
#MRD #leusm #,1
https://t.co/NhGL9Yzw0X,1
https://t.co/Sgqzd6wd77,1
OS &,1
https://t.co/Y2A1LRmHll https://t.co/rFP9WIQIsq,1
Cerdulatinib,1
#CLL Sufferers,1
Profs Andrew Roberts,1
Doug Hilton,1
$) https://t.co/EFBXjEC1ZR,1
#remission #cll,1
#CLL https://t.co/EbvDvE7m25,1
#Leukemia #ASH15 https://t.co/Xf2plt3v0L,1
The Expression of Toll-Like Receptors,1
#EMJvideo- Evaluating,1
https://t.co/Y2A1LRmHll https://t.co/qdFca8USmm,1
#relentless,1
#tnt https://t.co/smIULquK3a,1
BCL-2 Inhibitor #,1
https://t.co/ph3DemyiHf,1
#CLL @LLSusa,1
rituximab #,1
https://t.co/5A7cDeJDfw,1
https://t.co/7zGOTtw76V https://t.co/SONawnSfr1,1
HDAC,1
BTK expression &,1
https://t.co/Y2A1LRmHll https://t.co/N1GdX2jMPE,1
290,1
Sandra Hurley,1
#stemcelltransplant https://t.co/iVmqnisLWw,1
Chadi Nabhan,1
Clinical Pathways,1
https://t.co/J4QQ2dnB6W https://t.co/W26JwKyxVA https://t.co/PWVj9EdwR1,1
Medical University of Lodz,1
https://t.co/5fIGu7RRo1,1
SaveTheACA,1
https://t.co/anCWnmFcdZ https://t.co/TCDJhrjcIL,1
#Australia https://t.co/OtOmXJKKrS,1
PPAR-Delta Promotes Survival,1
https://t.co/HGI23ZAS5a,1
Dating https://t.co/JA5Tw4gEfE @PatientPower,1
#CancerCare #Leukemia #,1
las 5,1
el Coliseo de Gurabo,1
around 19.16%,1
2020- Key Vendors,1
Trends,1
https://t.co/b0D7fwiEHK https://t.co/N8HM4JrvUD,1
https://t.co/LMvPdPmmuv,1
Gizmodo Australia,1
@ABCNews,1
#STEM #Jobs #,1
Idelalisib-Ofatumumab in Previously Treated,1
https://t.co/sWDXHgmKgc,1
#TG1101 #,1
ANCIENT WORLDS,1
#CLL @FourthChicago,1
MRD Eradication With Alemtuzumab Consolidation Improves,1
#EurekaMag,1
#PowerfulPatient Derek Caine,1
https://t.co/QhW46SlG6i,1
9p13,1
https://t.co/NqUkiI0WZh,1
https://t.co/BeisxcGouB,1
$juno #JPM17 #leusm #,1
TGR-1202 for Treatment of C..,1
23:23(+1,1
#Gphee #CLL,1
@minafifax,1
Company Update,1
Therapeutics Inc,1
https://t.co/S32pscmTvm,1
TGR-1202 for Treatment of Chronic Lymphocytic Leukemia,1
TGR-1202 for Treatment of Chronic,1
Leukemia https://t.co/7oT6Puycsk,1
TGR-1202 for Treatment of...,1
TGR-1202 for Treatment of Chronic Lymphocytic,1
https://t.co/vSJTzBkm6c #,1
dejo autoregalos..,1
friki Elsa,1
Cruzando,1
el 1ro de ella,1
https://t.co/I64qsMUaje,1
#Rituximab #biosimilar #,1
https://t.co/WdfEq74rXT,1
https://t.co/2f5SBWkLzF https://t.co/bkTbZXtWgO,1
miRNA-16,1
mtg &amp,1
ovarian+bladder cancer &amp,1
https://t.co/yZMpmjHxBX,1
#Sequential #,1
#Evolution Anticipated,1
#Indolent #,1
https://t.co/4hkFbn0gCS,1
3rd International Conference on New Concepts,1
Indolent Lymphoma,1
ASH16 @DrRaulCordoba,1
Market Opportunities,1
Market Analysis,1
Investment Feasibility,1
#CLL https://t.co/pTuG5IjHFg,1
Current Status &,1
Issues https://t.co/J2NVJJaadM,1
Lo nuestro,1
CLL Management Expected,1
https://t.co/D7wjKYW7BL https://t.co/EATG6Ka32U,1
#carnivalfantasydancers #,1
https://t.co/bjAz4qyH1,1
#ibrutinib #leusm #,1
CDC_Cancer,1
https://t.co/w2rSpdJnDT,1
@LeukemiaMDA Register,1
https://t.co/mYctmok9ge,1
MedicBoard https://t.co/YMvcHnaq59,1
https://t.co/JJJNYQc6g3,1
3.9 years,1
https://t.co/4ijVlwbO18,1
Nancy Drew,1
5 Year Follow Up https://t.co/OUwaHOw0zl,1
ASH2016 https://t.co/GljBJqZKPY,1
https://t.co/EaQZguMEnu,1
https://t.co/dKxeEGBwZW,1
https://t.co/ULfWsCXuEV,1
"idelalisib
https://t.co/TUcY3SkkPM",1
https://t.co/wPVnNhWiBF,1
#AskTheExpert,1
Nearly 600 Percent,1
Between 2011 &,1
DutyCalculationWednesday,1
https://t.co/Ltz5dHfWtm,1
LAP,1
TeamEXO,1
George Miller,1
https://t.co/5c03vzgZfy #,1
https://t.co/1gX6mYqLT2,1
#hoa17,1
Ochsner Medical Center,1
HemaCare,1
BoneMarrow,1
https://t.co/kwuEPX1NrE #ibrutinib #,1
nearly 600%,1
between 2011 and 2025,1
MSKHMH,1
USD $25,1
#CLL https://t.co/p1RwUxUzA5,1
The CognoNews Journal,1
Brace,1
https://t.co/WXP4VvEZq4,1
Cells,1
Interrupt,1
Blood EBI2,1
"Jan 30, 2017",1
ALLFacts,1
6HN,1
https://t.co/jYGbR0npzo,1
the Best Frontline Treatment,1
Relapsed/ Refractory #,1
#Leukemia #ASH16 #,1
"HCT
https://t.co/Zxb3l98FAS",1
https://t.co/T1QK0Ktfer,1
#7 Tweet,1
Stromal Microenvironment,1
Perhexiline,1
https://t.co/WIzepZtkJa,1
Raul Cordoba,1
#PatExp #,1
PPI-G4 Glycodendrimers Upregulate TRAIL-Induced Apoptosis,1
#Arzerra #CLL Second-Line Use Filing,1
ASH16 https://t.co/R4gakBcHt3,1
the Current and Future Economic Burden,1
29yr,1
https://t.co/MRU5hoXmZ3,1
"FCR

https://t.co/qIofJbTIvE",1
india,1
Forecast Report,1
Ibrutinib in Treatment of,1
https://t.co/KgczLoubRY,1
"Genomics
Evolution",1
https://t.co/NKtuNITDF4,1
ASH16 Idelalisib +BR,1
ASH16‚Äì5-year,1
Phase Ib/II,1
https://t.co/2coEOsQf8h,1
https://t.co/g2dyWU45OW,1
Antithymocyte Globulin Conditioning https://t.co/giVV731myF,1
29-Year Evolution,1
Single Patient https://t.co/bJoSBFocyD,1
#bendamustine,1
ÿ≠ÿßŸÑÿ© ŸÖŸÜ,1
ŸÑŸàŸÉŸäŸÖŸäÿß,1
Ÿàÿ™ÿ®ŸäŸÜ ŸáÿßŸÑÿµŸàÿ±ÿ©,1
#ŸÖÿÆÿ™ÿ®ÿ±ÿßÿ™ #,1
ŸÑŸàŸÉŸäŸÖŸäÿß https://t.co/DSxPiZSkbD,1
ASH16 https://t.co/D158dx5j9u,1
CancerResources,1
ASH16 https://t.co/T4r8qpMp0p,1
65 y old,1
https://t.co/oTOshNZQ44,1
|Clin Epigenetics‚Ä¢Stamatopoulos B https://t.co/SeHlRdLcyG,1
HCT,1
https://t.co/RDHToeZbCw,1
Complete Remission,1
rel/ref del17p chronic,1
#EC #,1
#PersonalizedMedicine #,1
33-year-old,1
Raul Hinojosa,1
@Sidnavigare https://t.co/kNJXV0vbSf,1
Chiorazzi,1
https://t.co/4FjfZDYiIz,1
MRD-negativity &,1
https://t.co/rWtXhDrfbs,1
#AbbVie https://t.co/SjUvVGNZcB,1
PatientCafe - The Impact of,1
https://t.co/7w7zUR6q8K,1
ford,1
#CLL https://t.co/blwusO6dJW,1
ASH16 https://t.co/hsVFAwTA5N,1
https://t.co/GkOFfsAJyq #,1
#YRDSB #,1
ASH16 https://t.co/F8RM5nCfvl,1
https://t.co/9Z37zUH33c,1
ASH16 https://t.co/Mzt51QtGIB,1
#MSKHMH https://t.co/KrKM6XhvN2,1
Market Insight Report,1
https://t.co/bLbEDhO9h1,1
https://t.co/1ZeGRoS5nN #lymsm,1
ASH16 https://t.co/bA9TG9BGxT,1
"Leukemia
https://t.co/fQJVkJfFrj",1
#Champs #,1
#ASH16 https://t.co/qKsyRVGaiV,1
Congrats @Roche $RHBBY &,1
"#ASH16
",1
https://t.co/of9gSwpJWA,1
Vuela vuela,1
Con tu,1
#estoeslucha,1
#ASH16 Expert Panel,1
@MDAndersonNews @WVCancer,1
5 Year Follow,1
ASH16 https://t.co/hJ4T8A90NM,1
9+ yrs,1
#Winning #,1
https://t.co/h97KpbFMCH,1
#BGB-#3111,1
#TGR-1202/#Ibrutinib,1
#Highly #Active,1
5 #Years of Follow-Up,1
Ibrutinib Continues,1
#CLL/#SLL https://t.co/yfhSPQT3SC,1
@haematologica  https://t.co/Rzi7rNcH35 https://t.co/7x0lDkUshO,1
Cirmtuzumab Inhibits,1
https://t.co/tjpca7B4gM https://t.co/aMEI8MdHNn,1
ASH16 https://t.co/purV3CaEj3,1
https://t.co/C9r4pHOjNe,1
@abbvie,1
https://t.co/EkqmdeCSZs #AbbVie https://t.co/XtpwSo5JJ7,1
https://t.co/8HXkvENg3w,1
https://t.co/lHBi4gZuh0,1
#CombinationTherapy #,1
ASH16 https://t.co/YUHqMbo61a,1
https://t.co/mpJhNu195i,1
#knowuabccc #,1
Conditional Marketing Approval,1
VENCLYXTO #,1
https://t.co/Uef5ur69BP,1
Single-Agent #,1
ASH16 https://t.co/avqsXSF83W,1
.@OhioState &,1
1953-2012,1
https://t.co/vNqeqRfjjo,1
European Commission Conditional Marketing Approval,1
https://t.co/vfnRRYAPQG,1
@Roche conditional,1
#Venclyxto,1
https://t.co/LmnzDDpCWM https://t.co/bDFTmnvodC,1
https://t.co/pWUalbceaX https://t.co/4ZRjqEkyyZ,1
ASH16 What,1
https://t.co/EcastBgyKt https://t.co/OiX2t4vl8b,1
ASH16 @LeukemiaMDA‚Äôs,1
ASH16 Once,1
Dating https://t.co/oYlYOr6Q74,1
#Halland #,1
12 #,1
$juno https://t.co/VtHIKPWArS,1
#Med #,1
https://t.co/vj05SFRfR7,1
mwynhau canu yn y,1
Diolch,1
BUPA Home,1
Be≈üikta≈üƒ±mƒ±zƒ±n,1
#nopasaran #,1
Juno Therapeutics Announces Complete,1
Dr Kadri &,1
"#ASH16,introdng #",1
GEN Genetic Engineering,1
https://t.co/SpUrUpX7d2,1
https://t.co/OrkhzQ9BLe https://t.co/fTZC4pH93W,1
BM CLL,1
Hematology https://t.co/gArZZl3xLS,1
https://t.co/MqVltCz4Kq,1
https://t.co/9aSZdbrcoT,1
Murine B1 Cells Exhibit Potential To Develop Into ',1
https://t.co/Px8x9olThZ,1
https://t.co/J6rntfjQyT,1
"PI=@CLLdoc 
",1
#pERC Final Recommendation Issued for,1
https://t.co/61MWXInBBu,1
Leukemia https://t.co/LqfokahPOB,1
Effects,1
https://t.co/2jxBXsNscy,1
Leukemia @DKFZ,1
#ASH16 No Mutations,1
#ASH16 https://t.co/oZH9x8rryX,1
AutopiZta,1
mAb + idelalisib,1
2767,1
Traditional Treatment Options,1
https://t.co/WtmJ6301XD,1
Main Len,1
#ASH16 #CLL #,1
ASH2016 https://t.co/AYOZT4lCv8,1
https://t.co/a9cF5ue3ZF,1
19k,1
https://t.co/RyaZq5zmhY https://t.co/hL7V0LyTg7,1
58th,1
SanDiego,1
10:30 AM,1
ASH16 https://t.co/o25N3SnJPu https://t.co/N7k136DBul,1
#ASH16 https://t.co/yNW8baQUdi,1
Nivolumab + #Ibrutinib/Refractory #,1
#Richter Transformaron,1
CLL)-Mayo¬†Clinic,1
Chlorambucil #,1
gerionc https://t.co/ioet7oaS16,1
2 #CLL,1
CONTNUUM,1
https://t.co/GwVDhAVm5L,1
CLLM1,1
5pm PT,1
5:15pm,1
5AB,1
IMBRUVICA√Ç,1
LongTerm,1
Dec. 3,1
2843,1
ASH16 Barrientos,1
w FCR,1
#ASH16 https://t.co/uybHNbccN0,1
#leukemia #ASH16 https://t.co/G1cVpRX6zL,1
Nivolumab/Ibrutinib Combo Shows Promise,1
#ASH16 Oral,1
MRD-Neg in IGHV-M Pts Portends Pos Outcomes,1
FL Treatment,1
FCR Thompson,1
#ASH16 https://t.co/ixwVMkzAV0,1
ASH16 @UPenn,1
https://t.co/SsH9vf8Mak #ASH16 https://t.co/nUau1xzomL,1
Dr Melenhorst,1
#Juno #ASH16 #,1
#ASH16 https://t.co/i9ZYdypEm6,1
jcar014 update,1
ASH16 Woyach,1
Richter Transfrom:PhII,1
Rm,1
@cardinalhealth @anthonymatomd &,1
#CLL https://t.co/8Swwd94h7,1
MZL &,1
https://t.co/GLDjtDaq8c,1
https://t.co/tSrCd7cPXp https://t.co/8ZoSLlu859,1
the age of 50,1
CLL &lt;3 https://t.co/aQuRsHFfZY,1
https://t.co/qRf9SLg3Fb,1
lymsm w colleagues,1
Ajay Gopal,1
#DHL #,1
https://t.co/IeCRqK9A5y,1
@DrDJPeace,1
@tdhlf #,1
DHL,1
https://t.co/Xo4TaMbH2k,1
https://t.co/cKy54sKmKk,1
https://t.co/bn31YpITTd #,1
#MPNs &,1
Drs Kipps &,1
Costello,1
https://t.co/3x0q5EoZMt,1
Lymphocytic Leukemia || Symptoms and Causes of Cancer,1
CLL Guide,1
Potential Concerns,1
Ventoclax &,1
#JUNO #,1
CD8+:CD4,1
2x105,1
2x106,1
2x107,1
https://t.co/WS2MvBrdFj,1
https://t.co/uRkHyjvJyq,1
last minute,1
2915,1
#AcuteLeukemia https://t.co/n7PXWZnBOs,1
https://t.co/jCOhvd15N8,1
https://t.co/JhUgRzfCqq,1
Geotechnical Site Characterization for Trenchless Construction - #,1
https://t.co/X2Sm08eHYb,1
https://t.co/erSt60JiUx,1
@Oncotargetjrnl,1
#chemoimmunotherapy,1
#bevacizumab #,1
#CD20,1
https://t.co/2hKnbHGKTs,1
U.S. Customs,1
Ibrutinib-Refractory,1
19-28z,1
ASH16 https://t.co/WPHhjBYyeK,1
Phenotype,1
Clinical Outcomes,1
#CLL https://t.co/rVnnwSmtqy,1
ROR1 &,1
#ASH16 - Kipps,1
https://t.co/1pfyIdrGBV,1
@HOPARX,1
https://t.co/yev2DcGJad,1
#amp2016 View,1
#NFkappaB,1
#rstats #,1
@tdhlf #DHL @lymphoma &,1
B Eichhorst,1
2016 Market Research Report,1
Importance of Life Cycle,1
Strict Adherence,1
https://t.co/xWUukOfCWM #FinancialToxicity #,1
https://t.co/nwcKhnSUBd,1
"Alemtuzumab

Uses",1
#HighCoverage,1
antigen &amp,1
FCGR3A-158VV,1
Puente et al Nature 2015,1
NOTCH / SF3B1,1
https://t.co/Z8AIorKXEm,1
#dendritic,1
Fabienne Mackay,1
Langerbeins,1
2/12,1
SD,1
@tdhlf @lymphomahub @lymphoma https://t.co/EQNEh3r2sY,1
https://t.co/2yaJRXznz4,1
https://t.co/26ihUoJPNh,1
"Hairy Cell Leukemia
Chronic",1
Oct. 2016,1
https://t.co/cGpy3z6aoM,1
2;14)(p16;q32,1
A Case Report and Review of the‚Ä¶ https://t.co/7JUl0eP9c3 #,1
Fludarabine Treatment of Patient,1
Digital Ischemia,1
#leukemia https://t.co/vMZe3pCKhB,1
https://t.co/kQDtQLbAXG #,1
Landscape to Change Dramatically Over,1
#be≈üikta≈ü #,1
#uefa #,1
Benfica #,1
Q7,1
"May 12-17, 2017",1
#NICE #,1
Pattern Recognition,1
https://t.co/26FY9a0J9i #,1
https://t.co/Thg8geshXX,1
https://t.co/iGJgaNuYB1,1
TAK659,1
https://t.co/DihixDUa3S,1
‚û°,1
https://t.co/jE1cw2w2fw,1
https://t.co/yi6lDc1Pov,1
https://t.co/XrJyKKyiDf,1
https://t.co/XmF0NqNNl9,1
J von Tresckow,1
#puntcity https://t.co/Y6mQU8LclI,1
https://t.co/F5zaOjRkRI,1
Venetoclax w Obinutuzumab,1
Results  https://t.co/gXAfEdwVqS #,1
#chroniclymphocyticleukemia #ibrutinib #,1
2011-2025,1
@pharmalot,1
https://t.co/QkYxFQ60TH,1
https://t.co/LyJBZgXu43,1
Booking!!Kereta utk disewa,1
Sementara,1
"üëçüëçüëç
",1
sewa kL,1
"#
#",1
#CLL https://t.co/WHuhSNyLj2,1
https://t.co/kXh4PFXCAb,1
11/30,1
Jamieson,1
$5.1 billion,1
Zied,1
Karim,1
Big Pit,1
year 3,1
The Big Pit,1
SLC,1
Terminal,1
SFO,1
TSA,1
https://t.co/DzlyEdMdSG,1
https://t.co/B37NipVK4P,1
https://t.co/MqLruozvuS https://t.co/5RaL4Vi72V,1
Ghia - Ibrutinib,1
SIOG16 P. Ghia,1
https://t.co/k9um9qDEN5,1
https://t.co/Lo8kiwzxZG,1
JC Strefford,1
McWi,1
Dr Ferrajoli,1
Tolerable &,1
Dr Luan,1
"@JulesBordet 
PD-1/PD-L1",1
IV #,1
https://t.co/GEvhYDk8nl,1
Relapsed/Refractory Setting,1
A Study Venetoclax in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia,1
20161117,1
https://t.co/oDNqlP97a4,1
Current &,1
Future Drugs,1
https://t.co/t84OM9YsbU,1
MRD Predicts PFS,1
The Next Generation of Targeted Molecules for the Treatment of Chronic,1
Fri,1
PubPDF - Full Text Article,1
https://t.co/12NC9IyGwo,1
Precision Medicine &,1
Mutation Detection Advances,1
#Leukemia #Mutation,1
#CLL https://t.co/M44BtDiJQy @VJHemOnc,1
#Leukemia #Immunotherapy #,1
#CCHQC17 #,1
Jan 27,1
chile,1
https://t.co/ZzbUs5XtV6,1
https://t.co/ViB4QLfzFK,1
WAF1/CIP1,1
#sport #,1
New Treatments Sought #,1
https://t.co/9oguDaAZUv,1
#SanDiego #mpnsm #,1
18.8%,1
Chronic Lymphocytic Leukemia/Small Lymphocytic,1
https://t.co/msgBdCpdfa,1
https://t.co/2GwNiG0hon,1
https://t.co/QAh5bx9pPX,1
#CLL Advocates,1
mpncll16 https://t.co/T59ehJwtZp,1
SocialMedia,1
#MPNCLL16 #cml #,1
#delivery #,1
#share #,1
CLLHorizons,1
S√°‚Ä¶ https://t.co/eSw3iQkYAj,1
the Lymphoma Coalition @knowyournodes,1
#Positive #,1
MPNCLL16 P. Aumont,1
Pierre Aumont,1
SILLC,1
Prof Croce,1
https://t.co/DH6zmB4Af4,1
Charlotte Roffiaen,1
Lymphoma Coalition @knowyournodes,1
MPN Horizons,1
#MPNCLL16 #mpn #,1
Arnon Kater -,1
Kostas Stamatopoulos - Some,1
mpncll16 https://t.co/NDfXa3DyZ3,1
mpncll16 @AEAL,1
SMP,1
un estudio de sensibilizaci√≥n sobre,1
Manejar,1
Leucemia Linfoc√≠tica Cr√≥nica:,1
Watch &amp;/or,1
ALLOGENEIC HEMATOPOIETIC STEM,1
Christofer Fegan,1
explica,1
Dr Fegan,1
los riesgos,1
mpncll16 https://t.co/alU0Uv4JtJ,1
#CLLHorizons #,1
NL,1
#MPNCLL16 #,1
watchandwait https://t.co/6dDiQoBgLu,1
mpncll16  ,1
https://t.co/ECIkgeEriK,1
N Chiorazzi,1
#ASH16 https://t.co/uZk0CcWZPi,1
Finish 1st day,1
sHLA-E,1
IOS Android,1
Windows #,1
CLL https://t.co/T91uwtLZ0N,1
Advocacy,1
MPNCLL16 Creating,1
Michael Rynne,1
Ireland CLL Support Group,1
mpncll16 https://t.co/6ZkQkWGkvN,1
mpncll16 https://t.co/N0t19mKv83,1
Around 40 #patient #,1
Kennedy,1
#CLL - Stephan Stilgenbauer,1
mpncll16 https://t.co/giUymoXmmU,1
#CLLtimeline #,1
Stamatopoulus,1
#1 CLL,1
#mpncll16 #,1
mpncll16 https://t.co/edbLMYEAUE,1
#MPNCLL16 Horizons 2016,1
#LearnShareGrow #,1
article,1
MPM,1
#advocate #,1
#advocates,1
#LearnShareGrow https://t.co/2FJdfqby6r,1
Cancer Genomics,1
Jonathan Strefford‚Äù,1
University of Southampton,1
#palbociclib,1
Choose Appropriate Agents,1
Focus on PFS Endpoint,1
KB,1
#advocacy,1
#CLL #MPN #,1
#MPNAN https://t.co/m8deRBnVEA,1
Delta One T Cells for Immunotherapy of,1
Antigen Receptor Stereotypy,1
LymHub,1
2 hours,1
#mtgo #,1
‚Ä¶ https://t.co/45TG9NrLvG #,1
Integrin,1
https://t.co/ZyrS7l5iK2,1
the next ten years,1
Bevan Tandon,1
AMP2016,1
H50,1
#CLL https://t.co/vOu9WqlfPC,1
https://t.co/uNjgwq8e08,1
60-min,1
#GCLLSG,1
https://t.co/cmmziMub9f,1
Oncolog√≠a NIGHT SHIFT,1
The Stem Cell Transplant Daily,1
SIOG,1
trabajo da,1
Sin,1
NADA,1
https://t.co/JHHHHvlH7n,1
TargetedTherapies,1
https://t.co/fAwZr5Yh0O,1
üòòDefeat The Ghost For Me,1
# stüÖ∞,1
KIs,1
https://t.co/GrVjlUlx4u,1
#elderly &,1
Leukemia https://t.co/LImcR8MvKf,1
clinicans,1
#EGCG,1
SIO2016,1
#Ibrutinib https://t.co/k9OmR84UXm,1
Tom Kips,1
#CLL https://t.co/xiC0KxeOg8,1
Maintenance Len,1
$$$ Learn,1
https://t.co/2StErbtzdE https://t.co/fIgwRXxYC3,1
#CLL https://t.co/eqjxXm2Lbp,1
HTS,1
https://t.co/JtrjZc7KZ3,1
'New Treatment Options,1
https://t.co/QbX2TZA3AM,1
between #Ibrutinib and chronic medication taken by our #CLL,1
Reactive Oxygen Species,1
#teampride #carnivalcruiselines #,1
#playlistproductions #,1
@BloodJournal w @anthonymatomd &,1
Acute Leukemia https://t.co/mJeYUS941s @VJHemOnc @MDAndersonNews,1
Standard of Care &,1
Importance of Clonal Evolution,1
ChemoImmunotherapy,1
https://t.co/bVqDFA8OJU,1
https://t.co/ysic47sDhq,1
Transcriptomic Characterization of Mutation Reveals Its Pleiotropic Effects,1
Leukemia https://t.co/13Pnw6CSUM,1
.@MayoClinic,1
#InfinityPharmaceuticals #,1
@GENbio #,1
PatientSelection,1
#PMedUSA #,1
PrecisionMedUS,1
Management of Chronic Lymphocytic #,1
the Elderly: Position Paper,1
roughly 3 hours,1
ClinicalTrials &,1
CLL Specialists Online,1
https://t.co/d4FMFJVjOw #,1
CLL International,1
https://t.co/hMxK2n6JQC,1
2015 to,1
Tx for,1
Smart,1
https://t.co/j6ApYGuBLr #,1
cllsm @UKKoeln,1
#CLL https://t.co/mlpSvCrngd,1
#gerionc #CLL #,1
CancerImmunolImmunother Neutrophils,1
https://t.co/pt1EfR2Kg3 #,1
https://t.co/YIUpEz06vl,1
#UlmUniversity #,1
Over 40 years,1
Rai CLL,1
Blood https://t.co/RI4qjby9xI,1
ada,1
Ade acute myeloid,1
Current Research to Overcome,1
Improve Therapies https://t.co/QMmyW1RyM7 @VJOncology,1
Student's &,1
Clinical Fellows' Day,1
mutiplemyeloma,1
Prof Trnƒõn√Ω,1
Prague &,1
Thx Prof Trnƒõn√Ω &,1
Brilliance,1
#CLL #tgtx #,1
https://t.co/PfWXphm71K,1
Focus on apoptotic #,1
CTV Morning Live,1
Western Canada,1
#Ibrutinib:,1
#CAP Template,1
#ZAP70 #,1
https://t.co/HSiXSle8VD,1
https://t.co/HCYRVhvxwG,1
https://t.co/BOIviuBQEU,1
https://t.co/YdvRdduBrJ #,1
1D,1
the last hour,1
https://t.co/IryrdLlfqx,1
https://t.co/qQrbps3cGh,1
Edisi,1
entah,1
kemana,1
Nemunya,1
merasa konyol,1
https://t.co/F8E50kAkNr  #,1
al https://t.co/0J7PpTwI1n,1
CLL @JNCI_Now https://t.co/7tKdi4GOWC,1
#cancerresearch,1
"to~
Acute Myeloid Leukemia",1
Lankenau,1
Anthonymatomd,1
https://t.co/Z2jYXHu9a8,1
https://t.co/Po28coQkxr #GCLLSG,1
MDACC-PI,1
https://t.co/hPTWkGx7QY,1
https://t.co/j6zv9rFWdk,1
CLL Customs Clear,1
Upfront Ibrutinib,1
https://t.co/FpAuYeCAwx,1
Research4ACure,1
https://t.co/T169G1CoBU,1
https://t.co/6Ywl3L2btz,1
https://t.co/pXusU8DlSA,1
this Nov 2016,1
https://t.co/G2ZlUEpByP,1
#lojban #,1
Second-Generation #CLL,1
microRNA and ROR1 &,1
ABIM,1
Clinical Trials Review,1
https://t.co/85EPABxk1R @UCIrvineHealth,1
https://t.co/L8JthdI2Wm,1
#ClinicalTrial #,1
#iwcll2017,1
https://t.co/qTS6nxoDBq,1
Sangha,1
CLB,1
Second-Generation #CLL Inhibitors,1
An Expert Update,1
https://t.co/XZCTWjSTsl,1
‚óà The Association of Dyslipidemia With Chronic Lymphocytic,1
@LeukemiaMDA @ColumbiaMed &,1
https://t.co/YPFEMhSS3K,1
Minimal Residual Disease Predicts Survival,1
https://t.co/ALn1WjYSCM,1
https://t.co/tiWlTkgadZ,1
#rindualam #,1
dr leis,1
turbodepths,1
@JNCI_Now https://t.co/SpjiSUA4CS,1
Technology &,1
Market Analysis Research Report,1
https://t.co/8PVEoLA3QK,1
McMaster,1
#CHC2016 #CLL #,1
La Verne Abe Harris,1
830 PM EST,1
Best Practice Research Clinical Haematology,1
https://t.co/lxTcHNfYQQ,1
ROCHE,1
CMP,1
https://t.co/QrvR0JgpM9,1
#CLL Progression,1
mutations &amp,1
Mastering Clinical Challenges in,1
Oral Agents,1
$FMI #,1
MedicBoard https://t.co/ZOqmhgT1S8,1
CLLers,1
#Genetics #evolution,1
SabiasQue,1
#Leukemia #Oncology,1
#iloveclaremont #,1
https://t.co/DQovhqsIx8,1
https://t.co/CpGBM0qWrm,1
https://t.co/u5Mq77wZv8,1
https://t.co/QX2jiuqBoA,1
https://t.co/InKml5PkZT,1
Noelle,1
LastSpinebender,1
#FirstEver #,1
MuchDeserved,1
$GILD,1
$TGTX #GreatRead,1
10/14,1
Venetoclax Receives Positive CHMP Opinion,1
https://t.co/PNWMqJWv6o #,1
#Flow #,1
https://t.co/Ux26Pkgxlt,1
#cll https://t.co/h2P2BkmRDZ,1
Johnpagel,1
LIH‚Äôs Department of Oncology's,1
https://t.co/l8rK8acZ3r,1
#lih #,1
https://t.co/XW11mYKwvm,1
https://t.co/3JBTGAK7MS,1
https://t.co/nNzD3lbJZX,1
ClinCancerRes Antigen Selection Shapes,1
ab 14:30 Uhr,1
zuk√ºnftige Therapien,1
1 p.m. - @DrGinaEagle,1
@NWCRCentre #,1
the Tumor Microenvironment Is Essential for Progression of Chronic,1
https://t.co/jUPvxUUMkl https://t.co/NojiwKlUTT,1
Sen,1
Sen Zhuang https://t.co/k13TKmJh55,1
Guest Blog,1
Trebuchets,1
Flying Cows and Why You Should Care,1
#pneumocystis #,1
https://t.co/CCvuqiIRaU https://t.co/mnD3j2cjsA,1
https://t.co/J9GEev0aFJ,1
Pos Metro Batam,1
Key‚Ä¶ https://t.co/OU08tTmXrB,1
Key‚Ä¶ https://t.co/6gxLEKOxLA,1
https://t.co/ACusUcgn0b,1
https://t.co/0aSOAf5Srv,1
the Value of Treatments,1
Experiencia,1
#genoma,1
#medicinadeprecision #ISCIII https://t.co/a2A693W6sj,1
St olav Waterway,1
#stolavwaterway #,1
Rainbow,1
Influence of Treatment Modality on Outcomes,1
#longnoncoding,1
Chemoimmunotherapy for Frontline #CLL Management,1
#CLL https://t.co/v3vS2g2sCy,1
#Leukemia #ASH15 https://t.co/t7KjRQ81hx,1
Hallek @UniCologne &,1
https://t.co/wfzQdskHic,1
https://t.co/XULqe16qXW https://t.co/vz43bIctoX https://t.co/HhMNoAXkH8,1
CARRY,1
Medical Imaging of Chronic,1
https://t.co/MEoMMysXFQ,1
#CLL Newsletter,1
#CGI #,1
Healthcare https://t.co/CPiGxDbnlu,1
Diagnostic Testing and Evidence-Based Treatment,1
https://t.co/PLs7OG3PJX,1
the Tumor Microenvironment Is Essential for the Progression of Chronic,1
https://t.co/57jT8ylaZU,1
https://t.co/17o3F9DdNG,1
Acute Market,1
"de exportaci√≥n
https://t.co/x34aPr9JvL https://t.co/1saqljjKqQ",1
Molly,1
https://t.co/JiEpWZzAeP,1
IL-17A,1
IL-22,1
Zap-70,1
‡∏ó‡∏•.‡∏Å‡∏≥‡∏•‡∏±‡∏á‡∏£‡πâ‡∏≠‡∏ô,1
PERNICIOUS ANEMIA,1
https://t.co/4UQxE5ShAr,1
https://t.co/ba2MeeigXH,1
esmo16,1
ny medicin,1
mwahrin xD &lt;3,1
JLL,1
https://t.co/oPEjWMBY7m https://t.co/P5fqrCN3sy,1
@Intakeme https://t.co/HlWQBVlOUb,1
https://t.co/R5pAoUMpqe @power4patients,1
https://t.co/j8QzjaBjQa,1
Debat #Compartir #Opinions,1
#Myeloid Disorders,1
#First-#Line #,1
#AbbVie,1
#Leukemia #ASH15 https://t.co/uQVtjPjwRP,1
"Arrhythmias, Bleeding Higher With Ibrutinib Therapy",1
@UniboMagazine #CLL #,1
#Leukemia #Medicine #,1
unturned!#Cost-Effective Service,1
#SpeedyDelivery #,1
Light of Novel Drugs,1
Less than 24 hours,1
#lysm https://t.co/VHiHr8n6Lg,1
https://t.co/xOhkBgZQVG,1
https://t.co/B7VTwYYH3,1
Hex Depths,1
Colorless Eldrazi,1
P1,1
https://t.co/KxCxNCs69k,1
The Evolving Role of Chemoimmunotherapy,1
"MD 
https://t.co/wXgZT0XgTn @nyphospital",1
PPT Slides - https://t.co/IFv21xwAa1,1
https://t.co/u6XQV7EyH1,1
Anwendungsgebiet,1
https://t.co/mY3bgf3J1r,1
MD Discusses Risk Assessment,1
Combining Evolutionary Perspective,1
https://t.co/3Gdy6JsCFV #NCCNhem16,1
#Leukemia #ChemoImmunotherapy #,1
https://t.co/Hf5JYf78VY,1
https://t.co/i84WKTVjBA,1
https://t.co/lV2MyIH85O #CLL,1
https://t.co/yjqBcNM8zB #,1
@ASBMT,1
https://t.co/6WtWf99SDI,1
Frail Assessment Strategies,1
#fitness #,1
‡∏Ñ‡∏ß‡∏≤‡∏°‡∏õ‡∏≤‡∏Å‡πÄ‡∏´‡∏ß‡∏ô‡∏µ‡πâ,1
C5 Building Mae,1
https://t.co/NKhONelHlD https://t.co/taVmbKkzOK,1
#EAL #,1
#nqt #,1
71-Year-Old Patient,1
Hypoechoic Nodular Spleen,1
https://t.co/uicq2AsXf9,1
https://t.co/SAV7Irau0M,1
NigerianPort,1
https://t.co/Wop8POvVtG,1
sixth,1
Katyal/Johnston,1
Peter MacCallum Cancer Center,1
https://t.co/UTQV0R1h8L,1
https://t.co/zmnqq9WAhF #,1
https://t.co/4trL5fZUxc #,1
CLL Meeting,1
John Gribben @Bartscancer https://t.co/4xYSy3Um2a,1
https://t.co/uwAaJ5jEL3,1
Olmsted County,1
Minnesota,1
1935 through 1989,1
https://t.co/GCDgMDaSsI,1
https://t.co/NEi5SqvOyg,1
About 2 hours,1
8pm,1
#Cy #Oncotarget Cross,1
https://t.co/mRKUgyTSPm,1
Alexander S. Wiener Lecture,1
Wiener,1
Chronic Lymphocytic Leukemia Research,1
https://t.co/OCgcvEgptt,1
Arrhythmia,1
#leusm  https://t.co/PQ9ysmUJRh,1
https://t.co/NMZdin01jn,1
24.5%,1
Customs,1
WeiDing,1
#Leukemia #CancerCare #,1
New Report Available,1
#DYK #,1
Combination with Fludarabine &,1
Dr Wiestner,1
John Gribben @bciqmul,1
https://t.co/v3GU06xqEG,1
https://t.co/K4Pr0XUSYt https://t.co/iR7RdS0ZMC,1
Leukemia https://t.co/33ZTTST9Xh,1
KB https://t.co/Zs2lBJ15M3,1
KB https://t.co/G8YEaRCbxb,1
LawMFU @ Mae Fah Luang University,1
Market,1
#Batam #,1
#NKcells #,1
https://t.co/najM1a7wWK,1
nur langsam,1
und Therapie,1
https://t.co/VhY0oxJkZ4,1
#iwNHL16 #,1
Landau,1
@WeillCornell &amp;@nygenome,1
¬ñ,1
Future,1
MayoCancerCar,1
#CHC2016 https://t.co/teYhbRCqzL,1
Malibu,1
üëë @bazzbarrington,1
https://t.co/dEgNNJE53,1
https://t.co/X7II4Pj5li,1
Prospect &,1
#biosimilars affect,1
350.000,1
ljudi,1
osoba,1
leukemiju https://t.co/Kb4fbGndDi,1
https://t.co/xBuDernylx,1
European Language Portfolio,1
#europeandayoflanguages #26september #,1
#eTwCitizenship16 #,1
cLL,1
"Accurate, Scalable @fettersac @comScore #xAdOnLocation",1
"1,800",1
HELIOS Trials‚ÄîClinical Impact https://t.co/4eeqdzbKOa,1
@SUMedicine,1
#Solid #,1
https://t.co/lBV0uIoKcX,1
https://t.co/tWJDNoBhBy,1
https://t.co/mVZ4kWEYD6,1
@McGillU,1
Sarit Assouline &,1
Lewis #,1
https://t.co/WSo37bNlsm,1
https://t.co/0OImeA5Sog,1
https://t.co/6ca083dxVm,1
"https://t.co/cDwy4Uc8le
#Ibrutinib",1
https://t.co/3WOlTzkfMN,1
9/28/16,1
8:30PM EST,1
#MTG #,1
DE,1
PowerfulIn2016 https://t.co/TTSsOTX1kM,1
71 #,1
Are Cosmetic Procedures Safe,1
https://t.co/PmO6PWZplm,1
https://t.co/OTQ1UsAm6C #,1
Queretarock,1
#Chiquits #,1
#ASCO16 https://t.co/2pFrLArpc4  ,1
@dukemargolis,1
#Recent #,1
#chemotherapy &,1
https://t.co/9xz90GptVC,1
@WinnipegRHA Wave,1
Hematolog√≠a DUAL TORK,1
#ASHMHM16 https://t.co/sAZDW60XIR,1
https://t.co/Aaa1v3lz3f,1
Schuh,1
https://t.co/Ce5uQ1Mfgu,1
Carol Prestnon,1
#DCLLSG16 German CLL,1
https://t.co/LgpmXuOh2q,1
Carsten Niemann @Rigshospitalet,1
cllsm https://t.co/9vHfkCwMQB,1
https://t.co/CCvuqiIRaU,1
https://t.co/eeI19TMuZ4,1
#lawnbowling #,1
100k,1
Infografik zur chronischen,1
JPM,1
https://t.co/AgcsO45syo,1
https://t.co/XkKEj35OO5,1
Symptome,1
730,1
#Friskies #,1
#NewYorkHealthWorks Innovation,1
"Read ""Innovation",1
https://t.co/8PT3A7gU7Y,1
https://t.co/gVWRNqkhrU,1
Adult Chronic Lymphocytic Leukemia,1
https://t.co/BNE2oikw4M #,1
Ofatumumab plus,1
Cenkos Securities Ltd.,1
https://t.co/ZxwFTJwYgL,1
Cello Group - https://t.co/8qhwbBJgGe -,1
#CLL Spurs Development,1
Welche Organe,1
"Event Abstract 

Role of P53",1
#CLL Al,1
Jara,1
el,1
PoliceUnited,1
0-2 #,1
Pachuca,1
#Leukemia @OncoTherapyNet,1
https://t.co/ORALbwYzZk,1
https://t.co/7qsgH6Wq9J,1
https://t.co/qpTO4q2NWm,1
BloodCancerAwarenessMonth https://t.co/gcjKavYz90,1
"AgingData 
https://t.co/r3MAnqOrjA",1
https://t.co/ZyhWJx8fWU #leusm #,1
World Lung,1
Thompson et al #Atrialfibrillation,1
OT,1
Leukemia https://t.co/CuIQgdK6SP,1
Donnerstag,1
CureClick https://t.co/pw87RbWQHh,1
#Chemotherapy https://t.co/Bz2vUfWUqK,1
#Nature #,1
https://t.co/GNrWH1QR52,1
"https://t.co/6HtNawHQk6
Eur J. Haematol",1
NCCN Guidelines for Patients¬Æ,1
Version,1
1.2016,1
#durvalumab #,1
a mere two years,1
@LombardiCancer @ImedexCME #Leukemia #Rituximab #,1
#Venetoclax/#Rituximab #Combo #Active,1
older than 70,1
Michael va Gelder,1
#EBMTITC16 #,1
https://t.co/Ip409D9VKB,1
NOD/SCID IL2RŒ≥-null,1
Uruguayan,1
@Sidnavigare https://t.co/03EUA9pjTB,1
#Leukemia #Treatment #,1
@brendaLKK #CLL,1
Novartis/Genmab‚Äôs,1
https://t.co/Cjsm8ltXaQ https://t.co/hmC2GFWpKd,1
International,1
RESONATE-2 Trial: Discussion,1
Young/Fit #,1
soho_2016 https://t.co/lJu2NhCoSZ,1
https://t.co/xDM3UFfl9V,1
https://t.co/KaAB8zQwEj,1
Cheson Highlights Choices,1
CancerRes,1
#Leukemia #BSH16 #,1
https://t.co/c2QTB2v2IM,1
#cancer drug,1
https://t.co/AUUeelrVzb,1
@ScienceAlert #,1
Novartis Arzerra,1
https://t.co/5z3CYAEHpS,1
@BloodJournal w @anthonymatomd,1
#Realworld,1
"Almost 6,000 #CLL #",1
every week,1
Robert Oblak,1
https://t.co/Zd5HxqJam7,1
https://t.co/65HVN2nlsJ,1
Autoerotische Abenteuer,1
von B-Zell-Klonen,1
nicht,1
Gibt,1
#Medizin #,1
Global Chronic Lymphocytic Leukemia,1
Resource,1
CLL Canada,1
https://t.co/MTseGoaLs3 #,1
9/13/16 $ABBV,1
sNDA 1st Review,1
https://t.co/Xb3SOwPu27,1
#brain,1
combinations &amp,1
https://t.co/sMqcZH713b,1
HechoEnChile,1
"Lucha
Hecho en Chile",1
https://t.co/TAHH2Uha3L #,1
CLL https://t.co/sMqcZH713b https://t.co/LNW8OuaxAn,1
RESONATE-2 Trial:,1
Underlying Mutational Processes,1
Competitive Strategies,1
Sleep Cycle May Be a Causal Factor of Chronic Lymphocytic Leukemia,1
#Troko #,1
#bom #parafussadeira #,1
#leukemiaawareness #leukemiasucks #,1
https://t.co/RMHtma5Bpt,1
#CLL https://t.co/3eROtz3x4S,1
@UniBarcelona https://t.co/KTVxd6W82F #leusm #,1
Scott Walker,1
https://t.co/MPBiyV9BJm,1
CPH,1
#Fludarabine #CF #,1
9/21,1
Arzerra Combination FDA Approved,1
https://t.co/XMG7GzjbdX,1
#Eureka16 Innovation,1
Medical Research Prize,1
https://t.co/vRJgpSR6mj,1
https://t.co/IVWBIIk5pT,1
https://t.co/gxvR3aiYds,1
#biotech co.,1
@NovartisPharma,1
https://t.co/tREHYlmMbu #,1
https://t.co/4Yqhcm8COY,1
https://t.co/JkiNVfoaSU,1
Beckwith,1
@conlinmccabe &,1
Hematolog√≠a DIFFERENT SPECTRA OF RECURRENT GENE MUTATIONS,1
MRD-neg CR,1
https://t.co/fweeqZqnCv,1
Flow Cytometry,1
Minimal Residual Disease Assessment Improves Prediction of Outcome,1
Minimal Residual Disease Provides Treatment Focus for Next Chronic,1
Clinical Trials Actively Recruiting,1
#Aberrant #,1
#Disease #,1
NYGC‚Äôs,1
ASCO Post,1
#ISH #,1
Symptomatic Hypercalcemia,1
https://t.co/6fRm7wxFxl,1
Treakisym Approved In Japan For Additional Indication Of Chronic Lymphocytic,1
sept 3rd,1
Brighton,1
the whole day,1
1:50 #,1
"Leukemia https://t.co/wJWkTUsCKc 
",1
https://t.co/N2uhVeYpzL,1
Additional Indication of,1
https://t.co/5O7xPvvFB2,1
#CLL https://t.co/YNJJviQ0T3,1
undra varf√∂r dom inte,1
IgM &,1
IgD Signaling,1
https://t.co/zexBNeekh7,1
BMF Super-Enhancer,1
Ofatumumab As Single-Agent,1
Sunitinib,1
#CLL https://t.co/whz9PBph8b,1
Fabio Kerbauy - SP,1
#SBTMO2016,1
https://t.co/JBehanxCzh,1
Stock Update,1
Improve the Value of Treatment,1
CLL13Á´†„Å´ÁõÆ„ÇíÈÄö„Åó„Åü,1
https://t.co/BQjd2ZPhQL,1
OncologyTube,1
https://t.co/WjyqM2unLG,1
Novel Agents on Coverage Decisions,1
#ibtrutinib  ,1
https://t.co/Yp2U2IRjLR,1
CLL - Target,1
https://t.co/XCyjRcuZ9I Leukemia,1
https://t.co/FHnSHvABeX,1
Black Swan Intellige,1
#PROVINCIADESANTODOMINGO DEL #,1
#DISTRITODEEDUCACI√ìN #,1
NNA,1
#AM EN,1
StayStrong,1
#Lupus,1
https://t.co/78cvklKafM #,1
https://t.co/IrAsJDjkBH,1
Dr Seymour,1
#Indication of a,1
#non-#quantifiable #additional #,1
662,1
quebrarle la espalda,1
ShonnenJump,1
the TL1A/DR3,1
https://t.co/XCyjRcuZ9I B-Cell,1
Vax,1
https://t.co/rG9qt8Ghuk,1
https://t.co/ZrprX0fucv,1
https://t.co/8qmAdLWqOI,1
#ready #,1
#SystematicReview #,1
Seasonal Influenza Vaccination in Patients With Chronic Lymphocytic Leukemia,1
https://t.co/RICZtm25il #cllsm #,1
https://t.co/O46M39puQV,1
#CML https://t.co/QJB4zd3ldV,1
https://t.co/JFzsbLG97M,1
Edmonton,1
https://t.co/guSCcupaEP,1
https://t.co/iqfoJMbo9y,1
https://t.co/aRYCMaaMhg,1
Priority Review for @Novartis,1
@Genmab #CLL,1
national &,1
BMF Super-Enhancer Polymorphism https://t.co/CwtMPAA9W4,1
Pts w #CLL,1
https://t.co/6EOM3hKcQW,1
#BloodCellsMolDis Cryoglobulinemia,1
Pubmed: Genetic Predisposition,1
#EMJvideo- Venetoclax,1
15q15.1,1
@PS4CoDFAs,1
#myeloma #leusm,1
https://t.co/Xnb0bzipAk,1
3pm Est,1
#bo3,1
"Leukemia
https://t.co/8RJwk1UnFa",1
bo3,1
the Cod Local League,1
VIDE0,1
MOV 0211 - Chronic,1
Leukemia - Peripheral Blood,1
Especial D√≠a del Ni√±o,1
NAGERO5taRegi√≥n,1
#gulp #,1
https://t.co/7139nQlniR,1
Antonio Pagliuca,1
#EBMT2016,1
Derek,1
https://t.co/0ip6frDdLD #CLL #,1
#macrolides,1
https://t.co/Opv5XAG1RY,1
https://t.co/rM6wqxijYU,1
I Need Your Help w/Something,1
#Influenza #,1
some w CLL,1
https://t.co/CzYyJCoDNX,1
"Pneumonia
https://t.co/SsZBkwBWdn",1
Baby Come Back,1
Lamentablemente el Subcampe√≥n Mundial,1
la competencia,1
el Tobillo,1
Maravilloso el,1
Gimnasta,1
15.800,1
Barra Fija,1
los ganadores del ORO,1
PLATA y BRONCE Individual,1
Ryohei Kato #,1
su √∫ltimo,1
de esta gran,1
7.Lugar en la,1
COL,1
los que,1
han apoyado,1
@Verniaiev_GyM y @maxwhitlock1,1
@kohei198913 despu√©s de la tercera,1
https://t.co/uO7y4fCqd6,1
Roche MabThera SC,1
https://t.co/sC9BCZuyhp,1
el #Cll de #,1
duelo con,1
el T√≠tulo Ol√≠mpico Individual,1
Exito,1
#Rio2016,1
UC961 Cirmtuzumab,1
Int J Cancer,1
Your HealthCare Team,1
#AliBshow #,1
Chicago w @JohnPLeonardMD &amp,1
@timfenske  &,1
https://t.co/fEq9eAbCQ3,1
https://t.co/1dUs9xWkkk,1
@LoyolaQuinlan,1
@anthonymatomd  ,1
https://t.co/K7BPUT9llA,1
the Treatment of Chronic Lymphocytic Leukemia: Combination Treatments,1
https://t.co/wfa4ScWrvG,1
https://t.co/vKT8WsncEr,1
2023-https://t.co/XFPSrPX4Hh,1
Leukemia https://t.co/r8MwBpEfy1,1
#2013 #,1
Three years ago,1
Potential Risks that Influence Treatment,1
https://t.co/68kSp60ali,1
https://t.co/21q5t7d7nC https://t.co/xgBLzKylHZ,1
11:59pm,1
https://t.co/UgyP5ZwPza,1
ATTACK,1
SDF-1,1
CLL https://t.co/irhsUWexPG,1
#coauthor,1
https://t.co/e13CjJgjIu,1
#CLL https://t.co/aoc90p46Ps,1
Tech,1
about 2,1
https://t.co/no465yFYez #,1
https://t.co/E0Jglkjnkj,1
the Phase 3 RESO https://t.co/dmf0HpfdAB,1
#APSHO_Experts https://t.co/1mnqRorJdu,1
https://t.co/xww58nrtBe,1
https://t.co/4ianw7TRVB,1
https://t.co/lqfRQ0Qbhx,1
https://t.co/GDPYmzqO2E #leusm #,1
Second IWCCLL Compilat,1
#amchelsinki,1
https://t.co/o7gHhhBrHO,1
#Novel #Treatment #,1
2-Chlorodeoxyadenosine,1
CLL Challenge,1
https://t.co/wEfTofaod1 #,1
https://t.co/4xe3FB2ESq,1
https://t.co/CQzsktnQTj #,1
https://t.co/XbsSHniRTq,1
MarketResearch,1
https://t.co/rpHX5ao85X,1
CureClcik,1
#idelalisib https://t.co/oUF7Y74sbp,1
#lunch menu,1
#rocksteadyjamaicanbistro #,1
5614653167 #bocaraton,1
# https://t.co/imDLEsOeuR,1
https://t.co/sRLmgJq1m5 #,1
Cello Group Plc,1
Expression's Of Interest,1
15 August 16,1
chronische,1
#APSHO_Experts https://t.co/zr4K8pzp1I,1
Ithaca,1
w CD20+ B-cell,1
B-NHL &,1
#Phase II,1
Onclive https://t.co/nMA7ou3cv2,1
Peter Hilmen,1
#voyagercanoe #,1
https://t.co/TjHegqzhXZ #,1
https://t.co/iubCBHf5AP,1
#ibrutinib #idelalisib #,1
@LeukemiaMDA  https://t.co/pusLKQJbxE #,1
Vicki Morrison,1
QOL Essential for Older Patients With,1
KRAS,1
üòè #,1
Ibrut https://t.co/pq80D9RkC2,1
https://t.co/xNXU6ieutg,1
#chemobrain #,1
https://t.co/fDBjgZvKR2 https://t.co/RQsw46UzO5,1
"Patience 
https://t.co/gQe9fTHnFt",1
NYGC Publication-Clonal,1
Gossip,1
PRAC,1
https://t.co/kd2dbnCm5S #CLL #,1
MabThera #,1
https://t.co/0Hqqpser1x,1
JNJ Health Canada Approves,1
HELIOS Trials,1
https://t.co/ki5BeucH2N #,1
https://t.co/6qwRkRnQFQ,1
https://t.co/aY7sFc51j7,1
#company #,1
Classic Loveline,1
pplc16,1
Dr Kahl,1
James Armitage,1
CureClick https://t.co/pBckNjLIKC,1
#pplc16 #,1
Nicole Lamanna &,1
Tina Sapienza,1
OncologySocialWorker,1
#meded #,1
ASH/@US_FDA,1
#rainbow,1
@chileluchalibre #CLL,1
#everstage #,1
Refractory CLL,1
the Grand Hyatt Kauai Resort &,1
#CLL16 #,1
Kll,1
International Staging System,1
https://t.co/zLmrXGpaJj,1
Brosch√ºren,1
#CLL Therapie,1
https://t.co/79VBXlBW43,1
Retiens,1
https://t.co/PAvi7ib2an,1
#ABT199 #,1
https://t.co/aq2pRZqn4,1
https://t.co/5MU1BhbKTR,1
2016-2021,1
Global Chronic Lymphocytic Leukemia Treatment Industry Report,1
https://t.co/tprn1MrvH2,1
https://t.co/lhNv2oJMtD,1
https://t.co/LoCiSyjN7P #,1
Dr Ranjana Advani,1
https://t.co/5l3keifI2W,1
@mountsinainyc,1
PowerfulIn2016 https://t.co/ka5Ft9No3V,1
https://t.co/3rFq02yf0x,1
https://t.co/640eCD3CFF,1
#PLANIFICANDO #,1
https://t.co/cSEUTF8pzK,1
Klaus Okkenhaug,1
https://t.co/O1X3XbTX3v,1
https://t.co/19u0sVV8L6,1
#lymphoma #lymphomahub #,1
Central Little,1
1963,1
PokemoGo,1
#idelalisib #leusm #,1
https://t.co/cM6ObVCD4l,1
Bruno Silva-Santos,1
#CLL https://t.co/HMto6JPWPC,1
https://t.co/K3iNTMHDHl,1
https://t.co/7OcOo9byry,1
Nathan Fowler,1
RBCHpride,1
https://t.co/948yH9Pwxi,1
p53R2,1
hRRM2,1
PBR,1
MedicBoard https://t.co/Nzq83CQjsa,1
#EHA2016:,1
Adherence to Ibrutinib,1
DogLeukemia,1
#ofatumumab https://t.co/tMK5egxDID,1
the 2016 International Workshop,1
Howard Burris,1
https://t.co/9wxHZy2oDJ,1
https://t.co/JGK2ez0qil,1
https://t.co/JEyzxPBZpr https://t.co/K4P6x0HvFv,1
https://t.co/r6FQxZ3nnM,1
PrixGalien 2016,1
https://t.co/lH0e664L5n,1
https://t.co/TT5QbsxIm6,1
https://t.co/a4t78LyKEX,1
https://t.co/qfChKCAfdW,1
#district1champs,1
Goodbye Lake Louise,1
#fairmont #,1
#SFC_Cali #,1
#ChristLikeLiving #,1
https://t.co/vv42BPD23o https://t.co/4xNSp6cVEo,1
https://t.co/K2ol3Ph0RB,1
Rituximab Maintenance Therapy Promising,1
Diagnosis,1
https://t.co/k8Tg1rkhfw #blooducation,1
https://t.co/9ruQhvg0rE,1
Accredited,1
"https://t.co/bOS4zzGOw6 
",1
HRQOL,1
Lymphoc,1
New York State,1
Jan Guillou 6.9,1
Hans Backe,1
Akademiforum,1
Academill,1
Vasabladet #,1
Vasa https://t.co/Ab1YCxoPIS,1
https://t.co/c5WYWIUlKf,1
Hematology Practice Implications,1
#onscongress #,1
Anna Tramontano U,1
ismb2016,1
Chronic Lymphocytic Leukemia- Pipeline Review,1
H1 https://t.co/yXx19aymUB,1
@MDAndersonNews @Daver_Leukemia,1
about #CLL?https://t.co/9wxHZy2oDJ #,1
DIA2016,1
K√∂rper,1
Menos,1
m√†quinas #,1
#CLL https://t.co/AqD37LQHit,1
https://t.co/Qs4f0YFBtY https://t.co/A7V0gzf72a,1
https://t.co/n9I0qXiE9,1
https://t.co/27GSTiopWZ #CLL,1
Arzerra #,1
Kartaganer,1
Colostomy + Urostomy,1
mid 2018,1
#multiple #,1
https://t.co/54FwC5HFZd,1
Campe√≥n de Madrid,1
"üì∏ @pradoyago 
#",1
CHMP Issues Negative Opinion,1
Arzerra for Maintenance Treatment of Relapsed Chronic Lymphocytic,1
https://t.co/vhv1X8QPj2,1
#B-#Cell #,1
#Complex #,1
#European #,1
Associates,1
Breast,1
dikelompokkan,1
https://t.co/6kddKPyBKG - Chronic Lymphocytic Leukemia,1
morefunz,1
Chanchomania #,1
https://t.co/7z2aAqzzUE,1
Auston Matthews,1
Kenali,1
Lebih,1
Dekat,1
Jean Sumner‚Äôs,1
comincia ora il,1
#montidauni #,1
#bottomup #psrpuglia,1
Tg Therapeuticscmn,1
6.72 $TGTX Chronic,1
PR Newswi https://t.co/cQaLPf2Fbw,1
Technavio Announces Top Ten Vendors,1
"Tuesday, July 19",1
@Genmab #,1
https://t.co/cCjKCn4CaL #,1
https://t.co/d5XOZJEgUT https://t.co/njbC0r3U9f,1
https://t.co/0UoBfy5Q2s,1
Peel Hunt - https://t.co/zzZjXbw6eL,1
B-Cell Malignancies - Europe PMC Article - Europe PMC,1
https://t.co/JvQN7tzLTu,1
81 years,1
Leukemia https://t.co/GW1zinXVdm,1
https://t.co/R0fVa4jSpn,1
#Global #,1
@jenniferzarou &,1
https://t.co/3FqhCzbQ9,1
https://t.co/N7gwUt4MPJ,1
Only 165 days,1
#carnivalvista,1
#carnival #CLL #,1
#Cy #Oncotarget Deregulation,1
B12,1
Poverty,1
#fb Update,1
https://t.co/rMoP4FgKAw #,1
https://t.co/xAMVAr6cOd,1
7505,1
SagerStrong,1
üé∂Doctor,1
k light,1
https://t.co/8QbrnHdI3X #lymsm #lymphoma #,1
https://t.co/nXVt2V9bMm #,1
MiRNA‚Ä¶ https://t.co/RgLro9AkXg,1
https://t.co/LTmNGdP9S7,1
#PowerfulIn2016 https://t.co/5mrSzdsnfu,1
#PowerfulIn2016 https://t.co/2nceYUTY6s,1
https://t.co/7E7pxLbK5n,1
https://t.co/4PxwAsKgBg https://t.co/tkSzvcfszC,1
Kuruvilla https://t.co/QAImo923w6,1
2016 - Review,1
https://t.co/6gUhH5qgXi,1
Relapsed/Refractory to Ibrutinib,1
Idelalisib CLL,1
Forecasts Re.. https://t.co/k1p7Lg3oe2,1
$XBI $,1
Cll/64k9,1
#jadprolive,1
#APSHO_Experts https://t.co/LU3BfnNmLj,1
https://t.co/i7lM5ivKW1,1
no-del17p https://t.co/kXGMjDMD0V,1
#Del17p #CLL,1
#Combined #Analysis,1
Alex Smith,1
Cancer Data &,1
Outcomes Conference,1
#myeloma &,1
#cdoc2016,1
Rabbitte,1
Govt u-turn,1
Fianna F√°il,1
#EHA2016 https://t.co/tmuf2eHJBs,1
@TwitterAds,1
TEAM,1
Android,1
#EHA16 https://t.co/lcu1gzT8xt,1
#idelalisib https://t.co/kxU6N4Emqk,1
#EHA2016 #movingforward #,1
https://t.co/LCmIn7HI1C,1
Dr Jones,1
#EHA2016 https://t.co/OHbs0e5SRe,1
Leukemia Awareness,1
Alvocidib,1
https://t.co/qI6bOkNS7w,1
#Owen #,1
#CLL #hopingforarepeat,1
"NHLs
https://t.co/GeQKme0WZu",1
Trend,1
243,1
Clinical Predictors,1
Lymphoma Patients,1
Davide,1
myeloma data,1
the Poster Sessions,1
the 12th,1
45 day old,1
#birdsofprey #cll,1
#alberta,1
@Bannermdandersn https://t.co/qvmlFhv34W,1
https://t.co/MP1MEZafMq,1
#ColonCancer #,1
#glioma #,1
EHA2016 https://t.co/iYmvfvL71g,1
ADHA,1
93rd,1
208,1
W 8-5,1
Eastern #,1
Gordon,1
Stilgenbauer &,1
https://t.co/giCP6Dtqhc,1
https://t.co/DXVXwoxh13,1
#adha,1
41st,1
eha2016,1
√úberblick,1
Lake Park,1
Eastern,1
Phenotype &,1
LN,1
PB #CLL,1
@MDAndersonNews  @power4patients  https://t.co/tuAYi2jnLW,1
#CART Cells,1
Lymphoma https://t.co/ogX8p6yIgj,1
#bonemarrow,1
Sheds Light,1
26-$33,1
"TGTX @TGTherapeutics 
Link",1
#IHaveNotYetBegunToFight #,1
Fraser,1
ORR &,1
400mg/day,1
J. Soumerai @MSKCC_OncoNotes,1
#CLL https://t.co/TmPoLn5PWN,1
N. Lamana,1
idelalisib +,1
#asco16 #CLL #,1
https://t.co/V4YlWCrODy,1
MTP,1
MemeMonday,1
https://t.co/AWViiMnFyB,1
https://t.co/RF1PqNWy7s #CLL #,1
https://t.co/ErNpYsdUCD,1
#CLL/#SLL https://t.co/7oQXhhPqQ6,1
#ibrutinib https://t.co/G8q0RZr4aq,1
RESONATE &,1
Carmen,1
Hollie,1
#MyDad #,1
https://t.co/Knw1uDzNoW,1
CAR Tcells,1
#Ibrutinib #Patient #,1
#CLL https://t.co/7omDDff6kS,1
#PI3K #Inhibitors,1
https://t.co/HNGhhc2uY9 https://t.co/5dtFrZ6t4P,1
John Pagel https://t.co/CeEeYtrJXc,1
#ASCO16 Venetoclax,1
#ASCO16,1
https://t.co/TvlYwnzfAg,1
https://t.co/gbEFwK0hTF,1
#ASCO16 Management,1
CLL https://t.co/rLXaleO4O4,1
Peter Dreger,1
ASCO16 1st,1
Dr Pagel,1
https://t.co/0kUlH1fhUc,1
Mascara,1
CMLL,1
2cPE,1
#Cannabinoids #ChronicLymphocyticLeukemia,1
New Agents to Treat Chronic,1
Leukemia https://t.co/4a7cavf0F1,1
https://t.co/e0P5cXOnVK,1
https://t.co/kBUupwQPvy,1
7097,1
KRAS &,1
Clb,1
#EHA2016 https://t.co/eBWV9Td27i,1
Which Combination,1
https://t.co/djxegNKv2I,1
EHA2016,1
https://t.co/uFZB8JZhF5,1
$111M,1
$47M,1
@Roche for,1
#MabThera #,1
first 3,1
https://t.co/Cwr7g6c7Gy @roche,1
PowerfulIn2016  https://t.co/GAcmHkpyEJ,1
#Fatigue,1
PowerfulIn2016  https://t.co/JFTtkJnuuJ,1
https://t.co/j0tGLFFSqG #,1
https://t.co/zaZcsxgavF,1
https://t.co/DO9NlMhu2y,1
https://t.co/EYrJryqORy,1
Lampson et al re:,1
#ofatumumab https://t.co/yBPkCCPKnB,1
https://t.co/0nhtYgzh48,1
Cancer Drugs Fund,1
https://t.co/3VhYXONZ3,1
AskTheExpert  https://t.co/4jDcLjsZUY,1
PowerfulPatient Barbara,1
@Roche #CLL,1
#AskDRGexperts,1
https://t.co/8Va8s0hemn,1
Lymphocytic Le,1
https://t.co/wQTmPfUH0j,1
https://t.co/HsKXJ2b2GD,1
Approval For IMBRUVICA For Chronic Lymphocytic Leukemia Treatment,1
https://t.co/yqkfmK6FEQ,1
Approval For IMBRUVICA For Chronic Lymphocytic #Leukemia Treatment,1
https://t.co/nXmSTrnm6u,1
Doublet,1
https://t.co/eCJXvWdRkp,1
https://t.co/x3dugHUi6i,1
https://t.co/YV2SXpA89q,1
Approval For IMBRUVICA For Chronic Lymphocytic Leukemia‚Ä¶ https://t.co/IxO4DsgBWN,1
EU Commission,1
$ABBV European Commission,1
First-Line Treatment of Patients‚Ä¶ https://t.co/LAdCJCly6h,1
ManThera,1
Channel News Asia,1
Southeast Asia,1
https://t.co/NZI1Vt6ryG,1
SETD2,1
https://t.co/H6i7BmDJwc,1
iNewsPhoto,1
https://t.co/m74tHKZhfQ,1
https://t.co/69cwPV7IyC,1
https://t.co/XupUdIlEM3,1
https://t.co/kOskUhjPH9,1
https://t.co/a7WLARPtzg,1
https://t.co/Xy9fFvnCxt,1
https://t.co/du2CRgcQtZ https://t.co/XmX9KtBzkh,1
https://t.co/IOHU6NrfHT,1
https://t.co/z5m4URmYIq,1
https://t.co/Kqv0RYfBei,1
https://t.co/7HyoEY8cdM,1
https://t.co/bmxRs6YRCo,1
https://t.co/QK8vmgMiMa,1
Article Roche's,1
https://t.co/LYzfFjqEav,1
https://t.co/WbxzzxcDU4 #,1
navishealth,1
https://t.co/ouI21XgWem Brought,1
https://t.co/wSNiSkfJfN,1
#world #,1
https://t.co/IYNSUaA8gI,1
https://t.co/9y6ZHBytkB,1
https://t.co/5nQZOmtxsB https://t.co/iBU6cP4fh3,1
https://t.co/Y892Upu0fO,1
https://t.co/4IKavCKcf7,1
https://t.co/zZCE2UzE2,1
https://t.co/cA76k2JURQ,1
#health #news #,1
https://t.co/7vJmE7JMDC,1
https://t.co/2P5VNtu3DR,1
https://t.co/CN5qBOPFx2,1
https://t.co/KTAJ2bxYQn,1
Julian Clark,1
https://t.co/HLQlUWK57F,1
#chiquiturris,1
eyfstanglin @infants_TTS,1
Leukemia Receiving Obinutuzumab,1
FDA Approved New Drug,1
Chromosomal Abnor,1
Dodger,1
DreamTeam,1
the council of Islamic Ideology #Cll,1
Prof Leblond‚Äôs,1
WBCD2016 https://t.co/AhFrpdwaOO,1
AskTheExpert  https://t.co/wrHOU4Lj7F,1
#genetics  https://t.co/RAO0Y4py8N,1
@QMUL @MDAndersonNews,1
Kwok M,1
Davies N,1
R-Benda,1
https://t.co/DKsdTKpAlU,1
Ofatumumab &,1
IslamicState,1
Global Chronic Lymphocytic Leukemia Therapeutics Market,1
2016 to 2020,1
Visit https://t.co/hGWwn7QEQO https://t.co/PGoslv3p8x,1
@LLSNYC @MDAndersonNews,1
Dr Thompson,1
#Medcomms #,1
#EHA16 https://t.co/Zi86PVEPa1,1
#ASCO16 https://t.co/07zlsjgIII,1
#ASCO16 https://t.co/0jm50wYF8X,1
https://t.co/XTTo6VCpvw,1
Ô∏è Sags,1
Quinn at Center,1
https://t.co/iKEJ9PGM95,1
@LLSusa @LLSNYC,1
#patientcentricity #,1
Label Expansion for Leukemia Drug,1
https://t.co/tuulKkXYTK,1
Chronic Lymphocytic Leukemia Program,1
Weisman,1
CureClick https://t.co/lCdp1JBsGc https://t.co/HTRzLyqD09,1
https://t.co/lLbKIJO8uN #radiology,1
the Frontline Management of Chronic Lymphocytic Leukemia,1
https://t.co/oONUpE28jy,1
#babytradition,1
Carlos Lopez-Otin,1
#ESHG2016,1
https://t.co/PlyNpiSCZ5,1
fulllength chromogranin,1
https://t.co/7VHDBX9tDI #,1
https://t.co/a18RxqJJ0H,1
https://t.co/thXPn6TzSe,1
https://t.co/RwoCBvndUs,1
Bright Smile Dental,1
Beaverton,1
Iceland,1
Wegener,1
#ASCO2016!,1
https://t.co/ahBDVEKBnB,1
@Genmab's,1
@LLSNYC @LLSusa @MDAndersonNews,1
ATS2016,1
PowerfulIn2016  https://t.co/x0egydIU5S,1
https://t.co/8HVw2hdzMV,1
idelalisib-rituximab discontinuation,1
NEW POST: https://t.co/l6T4ku9ZZD,1
https://t.co/Hr7ZWJqMPg,1
NEW POST,1
SPRY2,1
#InthisIssue #,1
https://t.co/trivw9xRYZ,1
Habitat,1
#masterfeeds,1
#hfh https://t.co/8RThQs7HNE,1
@carlymhumphrey,1
38.3%,1
Peel Hunt - https://t.co/6O9jhWVaDV - #,1
https://t.co/ZEfr5DZgu3,1
four @ #,1
#weatherexpectations #,1
#murphy #,1
#fotoclub #,1
https://t.co/EVO3YXJz3l,1
1033,1
ClinCancerRes,1
Hematol,1
853,1
May 13,1
Affirm Efficacy,1
John Pagel Focus,1
IGF/mTOR,1
Larry &,1
#CLL patients-,1
https://t.co/08NLvP9wHu,1
just 15 minutes,1
Amiens,1
#fotoclub #weekend,1
#lubbeek #,1
#tourisme #,1
https://t.co/SsL7cxx3gV https://t.co/qon7zh65TN,1
https://t.co/Qs4f0YFBtY https://t.co/5sZQ4e6XXO,1
https://t.co/XmzUJYBEZf,1
Terry har,1
Gleder,1
Bergues,1
#clubweekend #,1
#lubbeek https://t.co/t6aaQmVs4,1
Leader Legend,1
Daar,1
#PowerfulPatients #,1
https://t.co/noGwo1mqRS @ImermanAngels,1
@PVReporter @patientslikeme,1
Anne Wanquet,1
https://t.co/Y2gHd60KcD,1
https://t.co/VKastoTSSI,1
5.14,1
maar morgen,1
uitslagen,1
Ma√±ana dura de desplazamientos,1
√öltimo d√≠a de,1
https://t.co/vf2jdkY7d4,1
SMPs &,1
https://t.co/KOuuYYqJLk,1
https://t.co/6qTPIJCZgo,1
Sat and Sun,1
https://t.co/GceD3OjC9v,1
Relapsed/Refractory Del(17p,1
the NEW #Prostate Compass,1
https://t.co/xDe9CkhxTB,1
https://t.co/RYnvBDX3LO,1
@SeattleCCA #,1
https://t.co/CRJUqP7765,1
https://t.co/m38G8aBDgb,1
https://t.co/Xr64jrger4,1
https://t.co/eHXxnGgikj,1
https://t.co/NF8MEnelN0,1
https://t.co/tT8IVTDmGS,1
2016 - @CelloGroup,1
#JCIInsight Chronic,1
#latergram #,1
https://t.co/CQM6R2OnsC,1
SHU,1
CLL Teaching Approaches,1
39.8%,1
Peel Hunt - https://t.co/M4qFpd7iCq - #,1
#EZJ,1
#BVS @CelloGroup,1
Quiero,1
#Cena #,1
Optimizing Treatment for CLL With New Agents,1
https://t.co/ZdpSGweiic,1
Include OS Data,1
https://t.co/k0gu2kUp76 @BloodJournal,1
https://t.co/ZMxIZnjkFg v√≠a,1
clonal &amp,1
NOTCH1 &,1
2016-2020 - Analysis,1
Dr Ana Schuh: Advances,1
#chefandreblanchet #cll,1
#fairmont,1
#chefandreblanchet #,1
canada,1
Bendamustine Rituximab Effective,1
Campe√≥n en el √∫ltimo,1
Buen a√±o,1
#CLL https://t.co/h07ZqD4tPz,1
Mejorada del Campo,1
#LlavaTeam,1
#myeloma https://t.co/3nIrp5lnPq https://t.co/WcfkSHhCr0,1
5/19,1
2016)57(5):1033-43,1
https://t.co/0PLH91s8N7,1
next Sunday's,1
#hemePath,1
https://t.co/jsyuZpO45a,1
#SOHO2015 #Chronic #,1
Ibrutinib increases++,1
#LuchaLibre #,1
https://t.co/8kseO5CTrW #,1
Farooqui,1
#fatigue and,1
https://t.co/mDYqabb19K,1
"May 4, 2016",1
the Food and Drug Adm,1
Venetoclax 4 #Chronic #Lymphocytic #,1
https://t.co/iYQlpupGud,1
about our,1
https://t.co/HxRW4UIDUT,1
TI,1
https://t.co/X3ke9a0fAo,1
#ibtrutinib,1
https://t.co/R9GPP7rQe1,1
https://t.co/4Vm6AAnySX &gt;integrin,1
2016-2020 - Trends,1
Technologies &amp;amp,1
Bendamustine + Rituximab Effective,1
Study https://t.co/wfyAGeWOyo,1
#yvsty,1
https://t.co/SzZaYNyqPq Join,1
@LeukemiaMDA  https://t.co/GJrw5tblH5,1
CLL Patients &,1
https://t.co/cX908BslvD,1
May 14 LIVE,1
üíöüíô -15,1
daystogo https://t.co/GylnAdWUyQ,1
https://t.co/s9kCwoahFg https://t.co/q7CAxksLmQ,1
Xose Puente,1
@MDAndersonNews @QMUL,1
the Living Well w/#CLL Town Meeting,1
WeLeadLearning,1
#TeacherAppreciationWeek,1
#KCTC #,1
https://t.co/TNlgI6nvAL,1
33 days,1
https://t.co/IVXDA3WKjg,1
#CLL https://t.co/AK0dFLVASo,1
Solid Malignancies,1
Leukemia https://t.co/qOPONuzj8,1
#Epigenetics Papers,1
#815 #,1
https://t.co/O20kalLwqj,1
https://t.co/2nphigjFF3,1
Brianna,1
#Lymphoma Blog,1
https://t.co/BvCFvcQAIN,1
https://t.co/IZqFGJDDvG,1
#CHMP #,1
#CLL https://t.co/Gp52QllIre,1
Receives Positive CHMP Opinion for Expanded Use,1
the Treatment of Leukemia,1
@NCRI,1
SomedayIsToday,1
RxWiki https://t.co/2lsPaBWkfy,1
https://t.co/kgji0aNt2c ‚Ä¢ https://t.co/MmJAa7KXeT,1
#CLL https://t.co/Witcm3qnUf,1
BONE MARROW BIOPSY,1
the Treatment of Chronic Lymphocytic,1
#fatigue  ,1
https://t.co/zfMkCzMj2u,1
4 #CLL Pts,1
Venclexta https://t.co/WwuiNB81Z6,1
https://t.co/1gx8J62bA3,1
Joan Justice,1
@Intakeme https://t.co/IFt9fQBmjX https://t.co/3TaZdVS2qo,1
ShelleyWebbRN,1
https://t.co/Eii4wmCcbU,1
#Leukemia Drs,1
#ESPERAMOSTUAPOYO #,1
#immunooncology,1
https://t.co/0qabOQ1rPS,1
https://t.co/FAYZcZn8FX,1
#clincialtrial #PowerfulIn2016 #,1
16 yr #,1
https://t.co/Fphlf2vU77,1
https://t.co/2nm7kiwlI6,1
#gap2016 #,1
Luis Fayad,1
leerlo enterito,1
Cassie y Tyler,1
su historia,1
https://t.co/gTyWoF7tFs,1
AskTheExpert  https://t.co/I59KbEuzvh,1
PHONE,1
Videowalls,1
#security,1
Salimos,1
#vamoslucho,1
https://t.co/xnWZB44vws,1
acutaconference16,1
Kyle Field,1
#tumorimmuno,1
https://t.co/Xh18Yd1gyG,1
https://t.co/VST5dWk4m2,1
https://t.co/oS8enTLKN6,1
Venclexta Now Approved to Treat Chronic Lymphocytic #Leukemia,1
Peak Med Ed,1
Leukemia w,1
#12thMan #,1
#767 #,1
BioSpace] Venetoclax Approved,1
Leukemia https://t.co/2r5xTMTEB7,1
@columbiacancer@WeillCornell  &,1
https://t.co/UPU2iGYcw9,1
https://t.co/fuFuOclbWY #,1
cllsm https://t.co/WEtr405rTt,1
https://t.co/fYCg2yzp7P https://t.co/uL1je4kIWd,1
#haem2016:,1
Ibrutinib for Chronic Lymphocytic Leukemia,1
https://t.co/1HrfbJ5QOG,1
#exosomes #microvesicles https://t.co/3XojmBGxT3,1
https://t.co/gWuEpMxekr,1
Leukemia https://t.co/4SG64EEnUi,1
Ruth,1
"5,100",1
"https://t.co/kMUQYR0H3x - almost 60,000",1
CTS,1
#clinicalresearchtrials,1
The Coachella Valley Takeover,1
#JoinTheSixFigureClub,1
Xose S. Puente,1
#AACR16 #,1
allTheHyphens,1
https://t.co/o6bdg166eb,1
@WeillCornell@MDAndersonNews &,1
https://t.co/KCujptnlHH,1
PowerfulPatient  https://t.co/PwymKQsoWD,1
#SOHO2015 #,1
Diplomat Pharmacy,1
DPLO - Diplomat to Dispense,1
haem2016 https://t.co/afdEKrlYZ8,1
LIM1215,1
#EV,1
#exosomes #microvesicles #,1
#13Uspringflingchamps #2 #,1
#nurseonduty https://t.co/bI6Vwk0cvq,1
https://t.co/CFOvwLiGm4,1
Eastern Little League,1
more than 10 years,1
https://t.co/vRA6nw1vx5,1
#Alabama #,1
KLF,1
@MDAndersonNews @UCSDHealth @CancerTodayMag,1
"April 15, 2016",1
https://t.co/XlGRdTrNtw,1
October 2014,1
@AlaricD_BPI,1
@Roche Venclexta,1
NordicNanovector &,1
@psich_en,1
https://t.co/rO72yqcfaB @PharmTechnology #,1
Just a week,1
Diplomas,1
Constitutively Activated STAT3 Induces Apoptosis,1
1B-$7B,1
@patientpowereu &,1
Richard Stephens,1
@NCRI 1,1
Vysis CLL,1
Probe Kit,1
Venclexta https://t.co/d8AkMemKPE,1
nearly 3 decades,1
https://t.co/swovFgik8,1
Dr Lloyd Damon,1
#Leukemia Patients,1
April 15,1
Bcn,1
Colomer D https://t.co/qfPVHXcDy9,1
@Genentech PRT,1
1st-Line Ibrutinib Improves PFS + OS vs Chlorambucil in Older Patients With Chronic,1
https://t.co/9GSekZXoXt,1
FISHprobe,1
STAT3 &,1
Glada,1
#smurf #,1
#kliniskfarmakologi #,1
#vasa #,1
between #Ibrutinib and,1
Ibrunitb,1
48B,1
#leukemia https://t.co/w8ArBwDJTR,1
https://t.co/X4Y2XYcOso,1
https://t.co/W1TfKYlirh,1
Recurrent Hyperkalemia In A Patient With Chronic Lymphocytic Leukemia,1
w/@andrewschorr,1
HayesNews,1
@Drugscom,1
Signifi,1
https://t.co/1DkJVoRInJ,1
https://t.co/TQtG3a4sry,1
Venclexta Medicine,1
@HECTORYEMMI,1
https://t.co/8aQ3Ew5hHz,1
https://t.co/j0yzS05308,1
Venc,1
https://t.co/TvKm06CMCc,1
Je,1
#delamouralinfini #,1
Venclex... https://t.co/ixcbMITbHS,1
2016-2020 - Research,1
https://t.co/GhilvOXgF5,1
https://t.co/8DY96lLmnk,1
Roche Reports,1
AcceleratedApproval for People with,1
https://t.co/N0qnmggpKH,1
"MD
SOHO 2015",1
https://t.co/3sJdxs4tVh,1
#findcures #1000km2016 #,1
ACS Press Release,1
The US Foo,1
#CancerAwareness,1
https://t.co/BdCUTIg6KU #,1
https://t.co/Nb3lRk7jzN,1
https://t.co/gDmSYWCEqF,1
BCL-2 https://t.co/T2jli371gP,1
https://t.co/l97Ndv2AUz,1
https://t.co/UVHDfi2vrM,1
$ABV #,1
WEHI,1
BCL-2 https://t.co/VPVKKMo06H,1
https://t.co/vezcUjHoZM,1
BCL-2 Inhibi,1
https://t.co/80eoldk5pC,1
Roche ‚Äôs,1
https://t.co/a10Nz30nfk,1
https://t.co/ivhgC3wRB3,1
https://t.co/YPrbdaCTwT,1
@US_FDA FDA,1
https://t.co/NutxL2mmRT,1
https://t.co/6uVUweLP0Y,1
https://t.co/vmrU9d3W1a,1
https://t.co/uUVsIj6DOl,1
@getsocial_io,1
John Terry ',1
Venclexta Tablets,1
https://t.co/75KJXBvDDB https://t.co/Jk0El8Y8L5,1
AbbVies,1
https://t.co/7cgYkVGONM,1
#AbbVies,1
https://t.co/WgXpUVhMwj,1
https://t.co/lxid5rA66U,1
17p Deletion,1
"April 11, 2016",1
https://t.co/SrT6XKPiVx,1
#specific,1
AbbVie https://t.co/jtv0XxUvmd,1
Drug Information Update-FDA,1
https://t.co/7sZcJ7P9qO,1
https://t.co/lCKKgMubYB,1
https://t.co/Lphv9ZkfL8,1
FDA Approves Drug,1
Hooray,1
#venclexta,1
fda  FDA,1
Venclexta (,1
AbbVie &,1
#Leukemia Treatment,1
FDA Green Lights #AbbVie,1
https://t.co/9G6GZivHeS,1
#Vencexta @genentech,1
Abbvie's Caancer,1
https://t.co/twWJKwB1Ox,1
https://t.co/vG7WHADj7e,1
17p- #CLL,1
https://t.co/AQxIJAd84N,1
CLL - FDA,1
https://t.co/HOLmm5Ss9M,1
https://t.co/7u7MhSimAj,1
#apoptosis,1
FDA Press Release,1
"Venclexta 
https://t.co/uA50iOhKhk",1
https://t.co/5DA5gtIFFB #,1
FDA OK's,1
ABBV &,1
#sisters #,1
nationalsiblingday,1
17 years,1
https://t.co/qfD09LdGsy,1
13q14,1
https://t.co/mr1zbx1V6s,1
https://t.co/AD2novCVdc,1
https://t.co/2lyaiI8ijc,1
Prof Wierda,1
https://t.co/NojiwKlUTT,1
#gasolinealley #,1
https://t.co/sRhNBSfVa9,1
#wiunion,1
Bejaia for Champions League,1
Zamalek #,1
Amr Gamal,1
https://t.co/kFwgPkvNSZ,1
Collaboration @MayoClinic &,1
First-Line Ibrutinib Improves PFS,1
#playball #littleleaguebaseball #littleleaguesoftball #,1
#playhardtraveloften #Texas https://t.co/4o1Lnb0nJi,1
Juega,1
https://t.co/O8rcLCYAi4,1
JCI,1
AshevilleHeme,1
Andrew Zelentz,1
EZH2‚Ä¶ https://t.co/z0ctsn5lrp,1
https://t.co/TFjq7XUQFo,1
Epigenetic,1
https://t.co/i15DLLCTt6,1
Bob Dylan,1
4/4/16,1
Feinstein Institute,1
https://t.co/nZnBHanK7i https://t.co/3q7aZFRuLV,1
https://t.co/MGn04YPjEI,1
Journal of Clinical Investigation,1
https://t.co/TQvBvyn5k1,1
https://t.co/Dt6nCDtL01,1
https://t.co/d3Jo2PqkZG,1
w @UCCancerCenter @UChicagoMed &,1
@HematologyNews1,1
https://t.co/7mpF6Yz8ov,1
New Developments Provide Answers,1
Raise New Questions,1
Keating of @MDAndersonNews #CLL,1
@MDAndersonNews @Bannermdandersn,1
NCCN Recommendations for Relapsed Patients,1
https://t.co/9xjfli0xxr https://t.co/2Lp6QWuK7b,1
https://t.co/RlIZuSvWwm,1
https://t.co/odQVznJThn,1
https://t.co/iMVeiYgZ5v,1
https://t.co/HkYdA5YgLE,1
https://t.co/p9U7zssQ47,1
https://t.co/qL3a9nFSbn,1
https://t.co/HD8LgC4Ydp,1
Tweetchat &,1
101 Highlights,1
@Storify #ePatient,1
P. Dreger #,1
https://t.co/hJGPurVC6i,1
First-Line Ibrutinib Improves Progression-Free and Overall Survival vs Chlorambucil in Older Patients With,1
1st-Line Ibrutinib Improves PFS + OS vs Chlorambucil,1
Soy el unico,1
https://t.co/wV67tL3qPu https://t.co/udd8CH3gNY,1
GENE ANALYSIS,1
https://t.co/nul2atI4Jn,1
#WestCancerCenter &,1
expression &amp,1
sIgM,1
NOH2016,1
LdnOnt,1
https://t.co/tbbruRHggk,1
May 14 and 15th,1
Dr Allan,1
#Genmab Discuss Findings,1
https://t.co/1zoKOz4oXt,1
FDA Denies,1
https://t.co/kL1KOvCoZN,1
3 de abril,1
vivir√° un cl√°sico,1
Carfilzomib,1
https://t.co/yJBc0qxI0,1
Form von #,1
#RoteHandBrief #,1
Idelalisib): Einschr√§nkungen bei  ,1
Wrestlemania #CLL,1
@straightgrain &amp,1
https://t.co/MlV7GDonH7,1
https://t.co/Zfxj8lzDXu,1
Ciƒô≈ºko,1
jaki≈õ karny,1
har l√¶rt,1
regi av forskergruppen,1
Child Language and Learning,1
https://t.co/JI5jYOlQH7,1
https://t.co/8DchHgCCUi,1
AskTheExpert  https://t.co/7y46rU5gtF,1
https://t.co/icc1Hiv1kL,1
https://t.co/s3ho1RC94X,1
https://t.co/5oq6fXEGeJ,1
PowerfulIn2016 https://t.co/hw0qrSUY1M,1
Dr Lloyd E. Damon,1
Week 2,1
#epatient,1
#subcutaneous #,1
60 y.o https://t.co/5ChQT80xD4,1
https://t.co/s1Gglc0hO6,1
https://t.co/EOuC2w9Ejo,1
Join Esther,1
Adam Lerner,1
MD @BUMedicine,1
Merrill https://t.co/NxOu4yo1sX,1
April 13,1
Citation Classic,1
https://t.co/JNA9mBjci3 #,1
the next month or so,1
CNBC,1
https://t.co/sHfv3nVHRV,1
Anders √ñsterborg,1
#ibrutinib https://t.co/OHgDoaKP6L,1
16.0 km,1
Geriatric,1
#leusm https://t.co/V0QJJvwVot,1
the Cancer Network - Lymphoma News,1
the NCCN - Lymphoma News,1
https://t.co/885RWgZrwE v√≠a @mitochonnews,1
Enroll,1
Oncolog√≠a INDOLE-3-CARBINOL,1
1st-Line Ibrutinib Improves PFS,1
CurrTopMicrobiolImmunol PI3K,1
#CurrTopMicrobiolImmunol PI3K,1
https://t.co/RSVcu54cFN https://t.co/0NWb0P4Ul3,1
PowerPoint Slides - https://t.co/IFv21xwAa1,1
lymphoidneoplasia,1
Stephen Stilgenbauer,1
#FrascatiScherma #,1
Espa√±aItalia,1
#idelalisib + #,1
OncoTherapy Network,1
https://t.co/Ku09mn8MOp,1
https://t.co/cxbYVMBH0O,1
Cancer Deaths Decline,1
Financial Burden of Surviving Cancer,1
730 #,1
Peel Hunt - https://t.co/O5wfeo8uy8 - #,1
120p,1
130p,1
GBX 130,1
6.54 km,1
group &amp,1
PCODR,1
https://t.co/C7fRA0zIeR #,1
Mayo Clinic - https://t.co/JDcfNfeYcF #,1
the Cancer¬†Network https://t.co/nkp9XIVnnb,1
Hair &,1
#leukemia https://t.co/baNiuBytnp,1
IV rituximab +,1
NH,1
https://t.co/HhhDprfMxJ https://t.co/kxnPdK87jR,1
√öltimo,1
Torneo Nacional de ayer,1
#llavateam #,1
Leukemia https://t.co/PnLrXH3H2i,1
#fingergym #maths,1
ryan Ross,1
the past few days,1
#morethanaclub #,1
Subcutaneous Rituximab May Be Equivalent to Intravenous Formulation https://t.co/58vgtVsu1k,1
@MDAndersonNews @QMBCI,1
#PowerfulPatients https://t.co/woe6bbRMB1,1
Hodgkin Lymphoma https://t.co/yYO771BdG5,1
https://t.co/tM4G55y9UL,1
#patientchat #,1
https://t.co/CA9Y2ZDU5o,1
101 #,1
Dr Sharman's,1
#Idelalisib - Perspective on Breaking News  ,1
https://t.co/qfVkYHKSnK,1
the ePatient Health Academy,1
https://t.co/vENuE7xroq,1
https://t.co/tXXm4nkvZS,1
https://t.co/iFnog03ePR,1
Andrew Zelenetz https://t.co/tUMDJuzJge,1
cllsm https://t.co/io0CIIkdlb,1
GS,1
https://t.co/HmOKkC1v8Q,1
@anthonymatomd and @ASH_hematology &,1
https://t.co/neJoFieJcW,1
https://t.co/jAKB4R0WPt,1
Diagnose Chronische,1
#Leuk√§mie - Welche Ma√ünahmen,1
"Marches√≠n, Izquierdoz",1
Abella,1
Villafa√±a,1
Gonzal√©z,1
"Molina, Calder√≥n",1
D√°vila,1
Mendoza y Bravo,1
Diplomat,1
Castleton,1
#goodmemories 2nd,1
1stXI #1983,1
Abington Hospital,1
News Network,1
FDA Halts,1
https://t.co/SgqJ2myZ4B #,1
https://t.co/RJX4LV6kBK https://t.co/lMtXSU11Bq,1
Adding Targeted Therapy,1
Recommendation,1
Missed Endpoint,1
GBM Study,1
1000+ community service hours,1
https://t.co/SfKqT0gs3B,1
#PowerfulIn2016 https://t.co/0DQJ3S4WKb,1
Adding Targeted Therapy to Chemoimmunotherapy for CLL,1
Bendamustine/Rituximab Improves Outcome,1
#Expanded #,1
Diplomat Now Dispensing IMBRUVICA√Ç,1
FLINT,1
Mich.,1
#lungcancer https://t.co/koNVWIAwNT,1
Syndrome  ,1
dose rituximab,1
Hematology Treatment Center,1
Mayo CLL Group,1
https://t.co/hAeNXFfCKi,1
La Agencia Europea Med Inicia,1
revisi√≥n de un nuevo,1
@MDAndersonNews @QMBCI @PetermacCC &,1
https://t.co/RK5L0x3W3b,1
#SFC/#CLL https://t.co/7FsAN3uVL2,1
https://t.co/tySMZCaNdG https://t.co/d6xPne3Zeg,1
Allele,1
https://t.co/MnJvdH8JNz,1
https://t.co/0I7kAZdZv8 https://t.co/P83NzXElOf,1
AbbVie Inc. &,1
https://t.co/njNoXmwIwk,1
#COORDINANDO #,1
#FORMACI√ìNENCOMPETENCIASPARALAVIDA2016 #,1
https://t.co/n59RyGdsR1 #ibrutinib #,1
Expanded Indication Approved,1
ClinicalThought,1
GreatNews,1
#CHEPSG #,1
cllsm https://t.co/hrEyKaiG8v,1
@MDAndersonNews @UFMedicine,1
March 19,1
https://t.co/UbHlTS0oRK,1
Hodgkin #Lymphoma,1
PATHOGENESIS,1
https://t.co/JEiVCebA0p,1
https://t.co/VgLtIfkAXq,1
Leben Mit Lymphom,1
#wrestling,1
https://t.co/3v3RdCznpw,1
https://t.co/z6R2X6Dddr Learn,1
https://t.co/hnbzXzzW8C #CLL #Ibrutinib,1
#ASH14  ,1
@MDAndersonNews  https://t.co/wZZPiflYZN,1
AskTheExpert  https://t.co/xiU8Sp8kxe,1
https://t.co/134KXsL4iq,1
https://t.co/iT0Dd7N5i7,1
https://t.co/3ZkhrVlRmZ,1
RPh,1
third year in a row,1
The US Food,1
Somos La,1
Del Universo!,1
polera @cba_perez,1
12.0 km,1
Stallone,1
NICE (England,1
https://t.co/L6o064PmtY,1
Firstline Treatment of Chronic Lymphocytic,1
#innovation,1
#jnj #,1
@Mesarg,1
https://t.co/7m16Q0gmAk,1
https://t.co/hEoJUZTM1P,1
https://t.co/Q5MhOJvOmZ,1
JNJ U.S. FDA Approves,1
Leukemia https://t.co/M6UWSGrj2d,1
#Imbruvica FDA,1
https://t.co/NvB7EniuoY,1
Cancer¬†Network https://t.co/phdz2ZvJm3,1
NCCN Patient Education Resources for Patients,1
cllsm @llsusa,1
https://t.co/XoC9QK7h29,1
https://t.co/QdbSM4H8w0,1
PowerfulIn2016  https://t.co/FbVUcXfpol,1
@LeukemiaMDA @wwierda  https://t.co/cFs9rJxTCs,1
#PowerfulIn2016 https://t.co/sJFx7GmI2W,1
Dr Silver,1
#ibrutinib https://t.co/AZNOGxYiDm,1
JNJ Imbruvica,1
https://t.co/Lv3e2lUOdj,1
https://t.co/abjvi3WfIH,1
https://t.co/XCyjRcuZ9I NCCN Publishes New,1
https://t.co/MKkKIuF0cf,1
Curab,1
#coping,1
https://t.co/03NWZH72zG,1
https://t.co/iG3ESuYxVj,1
#PatientCafe #,1
Sheath Biopsy,1
Chronic My,1
https://t.co/RgrVst8zj6,1
https://t.co/WY2KqN8NIb,1
#CLL https://t.co/kVr3WAyM0,1
3/22 #,1
Dr Tam @PeterMacCC https://t.co/yjpcQDPr3O,1
Leukemia https://t.co/mfUip4I9WX,1
@LeukemiaMDA  https://t.co/frO6j80dAD,1
https://t.co/LlOh9x79aj,1
Lamanna ahttp://ow.ly/YnM7s,1
https://t.co/8ECGR2andq,1
#PowerfulIn2016 #CLL #,1
BMT Journal: Transplantation,1
St David's,1
#StDavidsDay #,1
March1st,1
supplements &,1
https://t.co/sbNwQ6ikDb https://t.co/38QowkdfKb,1
Higher Risk for Other Cancers https://t.co/E1aCibUorL,1
#INICIANDOEL2016 #,1
#ofatumumab &,1
cambiar√° el manejo de la LLC,1
2/29/16,1
https://t.co/mGykx1nXpu,1
https://t.co/GPPeG4kl5H,1
#fellowships #,1
EUjobs,1
#HaywardArena #,1
#CLCREFRESHCOMEBACK #,1
#Ïî®ÏóòÏî® #,1
Higher Risk for Other Cancers https://t.co/7ThAT5qy1j,1
#Potential #,1
#Upcoming #Approvals,1
Combinations Will Transform,1
8q24MYC,1
#Hematolog√≠a SPLEEN,1
https://t.co/IudHlspzu2,1
"Jobs,#ŒïœÅŒ≥Œ±œÉŒØŒ±",1
"Higher Risk for Other Cancers 
 ",1
#FirmConference #,1
https://t.co/6ACfYsN4a7,1
@MorphoSys #antibody #,1
MOR208,1
Endcancer,1
RR-CLL Correlation,1
Immune Characteristics,1
CD126 and Targeted Therapy,1
https://t.co/BGnLkPO9Eh,1
#FeelAliveFriday,1
@MoffittNews #,1
@sloan_kettering &,1
Nature Reviews Cancer,1
@LeukemiaMDA @Bannermdandersn  https://t.co/IGwmmDwDWu,1
https://t.co/6igljmnc5m.,1
Anglo,1
Apoptosis and Inhibits Disease Pro,1
ILK,1
TNFalpha,1
#PowerfulIn2016 https://t.co/alUhZ4wfiX,1
https://t.co/WX5wmx8seo,1
MD #,1
Valter Longo,1
#PowerfulIn2016 https://t.co/5xnNUqUrDy,1
Jeff  Sharman,1
SLL https://t.co/p5ttCBkrN7,1
Lamannd,1
P2 Team Member,1
PowerfulIn2016  https://t.co/Cym1tLq0Vm,1
https://t.co/wxkY3fBBR7,1
#PowerfulIn2016 https://t.co/VnozrjiunC,1
#PowerfulPatient Mark,1
Nelia,1
Alfred Mercier,1
#TorneoMcDonaldsENDI,1
Palbociclib,1
PowerfulIn2016 https://t.co/OMnkzZPlow,1
@EstherSchorr1 &amp,1
@UCSDHealth @MDAndersonNews,1
#PowerfulIn2016 https://t.co/jctiTYWbuW,1
READING &,1
BNC105,1
https://t.co/l2nPyKITrR #,1
6.19 km,1
MrClean,1
Ottawa Hospital - General Campus,1
Ottawa Hospital - General,1
Leblond,1
rituximab https://t.co/fVXYBOZE4h,1
PowerfulIn2016  https://t.co/I71t0Fk4Ku,1
https://t.co/V40PJe3O4r,1
https://t.co/avjsEA5xMh,1
#mmsm,1
#Dory,1
Cancer Advances: Promising Advances For Patients With Chronic Lymphocytic,1
#Leuksm #,1
PowerfulIn2016 https://t.co/apPaDvXGy3,1
Apoptosis and Inhibits Disease,1
https://t.co/5b7lEtFnNp,1
#PowerfulIn2016 https://t.co/YiDK813FPC,1
PowerfulIn2016 https://t.co/tZZrIaYOuV,1
PowerfulIn2016  https://t.co/fcmsoddz5E,1
https://t.co/Rro02HrA7y,1
https://t.co/vFJYGzS2l0,1
AskTheExpert  https://t.co/OE25gi5TJO,1
PowerfulIn2016 https://t.co/R5ZmiznrNq,1
PowerfulIn2016 https://t.co/oVAhJTYErn,1
#ROR1 #CLL,1
PowerfulIn2016 https://t.co/h7HDflwobF,1
#PowerfulIn2016 https://t.co/vQBM8MZdkq,1
Civil War,1
3000,1
https://t.co/WB9akKfpuM,1
https://t.co/bqBDrpzKUf,1
https://t.co/jDZBFrAXHx,1
https://t.co/7a3Qj1vcac,1
ÿ±ÿßÿ®ÿπ,1
ÿßÿ≥ÿ®Ÿàÿπ,1
#ÿØÿπŸàŸá_ŸÑ_ŸÖÿ±ÿ∂Ÿä_ÿßŸÑÿ≥ÿ±ÿ∑ÿßŸÜ https://t.co/wfJshrf6If,1
https://t.co/DHgAeYeimy,1
PowerfulIn2016  https://t.co/eScCr3gbne,1
PowerfulIn2016  https://t.co/4L6QPLFvPg,1
watchandwait,1
#PowerfulIn2016 https://t.co/ApFZ5ohb3A,1
PowerfulIn2016 https://t.co/xCHt3ElnQq,1
#ASCO14 #,1
PowerfulIn2016 https://t.co/NqsMOhpT4G,1
Azerra Delays Cancer Progression,1
https://t.co/uKKPN7kyjb,1
"Leukemia
Stephan Stilgenbauer",1
2/18 #,1
#MMRF #,1
#PowerfulIn2016 https://t.co/wAAsk54Kre,1
PowerfulIn2016 https://t.co/OM8xbZRXdi,1
diderita penduduk,1
Barat,1
@Blood4LifeID @YoungOnTop,1
terbagi,1
CME quiz,1
#PowerfulIn2016 https://t.co/irEQ86UHjk,1
PowerfulIn2016 https://t.co/5U7E222XV0,1
PowerfulIn2016  https://t.co/IwF9XRXDUc,1
PowerfulIn2016  https://t.co/xGvHl3ikBV,1
PowerfulIn2016 https://t.co/Zldw5sUQxM,1
@WeillCornell  #ASH15 #,1
Kanti Rai  https://t.co/4nirIKNlmI,1
HEOR,1
https://t.co/nnlVPvHikM #Healthcare #,1
Con Brandon Jara Campe√≥n,1
https://t.co/cdU329yDBn,1
#domingodiferente,1
johndrago‚Ä¶ https://t.co/IkcffAGMIc,1
#drmarcus https://t.co/TiraG3n0VS,1
https://t.co/Ol9faIMMQ9,1
yang,1
Begitu juga,1
yang jenisnya,1
5.45,1
#existing #,1
terdiri atas dua jenis,1
Research and Markets,1
https://t.co/MnjuLzTp96,1
LymphPractic,1
2014 to 2022,1
3.85,1
https://t.co/E1o5l6O4Kq,1
World Cancer Day,1
PowerfulIn2016  https://t.co/WT6v3yqvro,1
https://t.co/18xv6ywsxx,1
#genetictesting,1
PowerfulIn2016  https://t.co/hbpdFzXZRK,1
PowerfulIn2016 https://t.co/GO7EerRUUC,1
Drs Koehrer,1
las 11,1
mis compa√±eros de baile,1
Front-Line,1
#CLL https://t.co/fHaE0cL6kt  ,1
wereldkankerdag,1
Ayyy,1
Chal #,1
Ô∏è https://t.co/m6KoC0BA9H,1
https://t.co/jRNMK5RK6F,1
#lylcl https://t.co/IRc3xUu9bE,1
#Leukemia https://t.co/Zhz0JyjCQY,1
The Oncology Newsletter,1
#oncologynews #,1
https://t.co/WRq4Yqjcio,1
PowerfulIn2016 https://t.co/OsHwBEcopM,1
PowerfulIn2016 https://t.co/4GyC2kDwV9,1
Popular Science https://t.co/JyJAKNaayt,1
TCells,1
normal developm,1
Hematopoietic Stem Cell Transplantation,1
Novel Molecules,1
The Treatment of Relapsed Refractory Chronic Lymphocytic Leukemia  https://t.co/b7s4iicCh0,1
Supportive Treatment,1
#ASH15 https://t.co/nKayAak62U,1
https://t.co/7FJmooWEt3,1
https://t.co/oWSsa9EaiI,1
@DrJitsu,1
Leukemia Jeopardy,1
#illtaketreatmentfor300Alex cc:@whoisalexjacob,1
#NoLoyalty #,1
#Terry #,1
#terry #cll,1
#cfc,1
https://t.co/daDyMC9F4z,1
Powerpoint Templates - https://t.co/Hd3ypNweNh,1
#ppt #powerpoint #,1
‚öæÔ∏è#Coronado,1
#CLL Coaches Clinic,1
https://t.co/Vu2fAedl7,1
Lymphoid Leukaemia,1
https://t.co/37mGAHskz1,1
#PowerfulIn2016 #ASH15 https://t.co/tmCiIeZbI7,1
MD @UCIrvineHealth Update on Chronic Lymphocytic Leukemia,1
Lisa Nodzon,1
ACP196 for,1
#PowerfulIn2016 https://t.co/dQnUr4OTz8,1
ILLINOISsocialwork,1
Community Learning Lab,1
Stevens-JohnsonSyndrome,1
Neutropenie,1
Routine-Check,1
https://t.co/FrZZVwYBMe https://t.co/MRaNMmqk7e,1
#endlymphoma,1
#lymphomahub #,1
https://t.co/arsuGXlZxf,1
pitch,1
Rituximab https://t.co/63dOsagMcB,1
#BREAKING #,1
@DrRuthHadfield,1
Leukemia https://t.co/5ALpcLZcRx,1
https://t.co/ObVoUfbP02,1
https://t.co/BQ1YhEupcX,1
#harmonization,1
#ZAP-70,1
https://t.co/gibLp7w4d6,1
#BCL2  ,1
#CLLMDA,1
#PowerfulIn2016 https://t.co/ZxBqhQVqsl,1
@curemagazine-,1
"https://t.co/48yPBVn4oP
See",1
https://t.co/FhVDlpPvpp,1
Austrlian,1
https://t.co/mVtc52MGIo,1
https://t.co/SHgsr0nBST,1
3.51,1
Targeting BCL2,1
https://t.co/AkzLc3iPcg,1
Idelalisib Improves Progression-Free Survival,1
Markierungen,1
Krebszellen reflektieren das Reifestadium,1
Vorl√§uferzellen,1
MedHu√©rfanos,1
https://t.co/XHMqtKtIZt,1
M.E.,1
Mentions Rituxan,1
https://t.co/ZtyGtLj81x,1
https://t.co/DNbvKMFJjt,1
https://t.co/2VYSao8TGI,1
üèπBruton‚Äôs,1
üíävenetoclax,1
üèπB-cell,1
üëêüèæ https://t.co/FTEdyZjycD,1
Prof Roberts,1
Seymour et al https://t.co/Jzy9Ytz2dk,1
@marrow,1
https://t.co/98gD8evodf,1
11 am ET,1
https://t.co/JjdTrS1vVp,1
5iu0fk0k9wygme2pt2knSxg√Åmhy,1
4E,1
3√Å,1
STORMPATH https://t.co/vqnAlsu4jK,1
Robert Hromas,1
Quiz Page,1
Jan 2016,1
the last 2 yrs,1
https://t.co/qFh5x0HrFb,1
@LeukemiaMDA  https://t.co/ewj3xJkwoF,1
https://t.co/6j6wsry1B7,1
#CLL #relapse #,1
@MDAndersonNews Expert's,1
#PowerfulIn2016 https://t.co/ICCSnzDYCx,1
https://t.co/kcckSK02hw,1
https://t.co/HsfkkuG6iT,1
#PowerfulIn2016 https://t.co/cbu9VDgOG6,1
#CLL https://t.co/jBTzn8KbDY,1
CLL https://t.co/iSy6z4ZMN2,1
Hemoglobin News Clinical,1
https://t.co/NnBJRsmfiZ,1
the Treatment of CLL https://t.co/kWla2psjLj,1
@Roche RT,1
Lacrosse,1
Lacross,1
@PODuff,1
https://t.co/OW0R2Zt4bI,1
https://t.co/E4PscaNt8W,1
@WUSTLmed https://t.co/BjxPKk0rZ5,1
https://t.co/bxOwAe3CxR,1
#PowerfulIn2016 https://t.co/e1wQOfi32A,1
#High-Risk #,1
https://t.co/jbIWlDl5QG https://t.co/9YLHtCstpe,1
#arzerra https://t.co/KRJDil1aMy,1
#progressive #,1
@Roche PRT,1
#Venetoclax/#Rituximab #,1
Combo Gains #,1
https://t.co/uaStHnqp3H,1
"„Åì„Çå„Åæ„ÅüÁ¥†Êïµ„Å™„Éû„Çπ„ÇØ
",1
#njpcll #,1
#Supplements,1
#CLL @Bannermdandersn,1
https://t.co/zyeQwpNrYL,1
#ASH15 Dr.,1
https://t.co/HP4Xv74G6B,1
CFM &,1
#leukemia https://t.co/pLkYbshfG2,1
#US_FDA,1
https://t.co/osra7Xn9De,1
IMAGE 16 ASH.JPG,1
#PowerfulIn2016 https://t.co/gwoqSXSZIS,1
between #CLL and #Infections - with @MDAndersonNews 's Dr. Wierda @wwierda #AskTheExpert  https://t.co/9kcmhDGT5U,1
Leeds University,1
https://t.co/8H8gp7KKnx,1
https://t.co/pPs1qRulVE,1
@Roche https://t.co/6o3jeolRr4,1
#ASH15 https://t.co/mMQdmNRVb9,1
Maintenance Ofatumumab,1
29.4,1
15.2 months,1
https://t.co/xmldeYACcb,1
PubSaludMurcia The,1
https://t.co/PwQDwojGAW,1
#cancer treatment,1
CME Meeting Treatment Challenges,1
5.35 km,1
#CLL https://t.co/bbxxT1RzED,1
Arzerr,1
Arzerra/ofatumumab Rx recurrent/progressive,1
https://t.co/X9diVApVvC,1
https://t.co/sc2JAPddo2,1
https://t.co/Q2nXIrw4UC,1
KPTI 2nd Generation Sine Compound,1
"JPM16
""",1
Promising #,1
https://t.co/Ay7MlwXNpM,1
https://t.co/6rf9kPuNnm #CLL #,1
Oakes,1
WIlliam Wierda,1
https://t.co/4pJH4kjSVA,1
@WeillCornell #ASH15 #ASH2015P2,1
#RichtersSyndrome @MDAndersonNews,1
https://t.co/SUQ0hVetzV,1
Bruton Kinase Inhibitor,1
https://t.co/NqySg3uLdq,1
December 2015,1
https://t.co/wdlr31uGDc,1
a 98th minute,1
#TakeMeBack #,1
Leukemia https://t.co/hR3OpUiLsW,1
https://t.co/Z3pM9TvkZq,1
700th,1
https://t.co/6iuQyVKuu3 https://t.co/ZigHyiVTiT,1
https://t.co/Aq6Gd1mRAq,1
a Black Swan,1
https://t.co/1ohWF59McP #,1
https://t.co/op6O5LpgtT,1
https://t.co/5bnAhKts9q,1
#PowerfulIn2016 https://t.co/OwDF8v19u2,1
EBM Focus,1
https://t.co/tRiWWjGBWb,1
Dr Barrientos @JacquieBarr,1
https://t.co/OW0R2Zbtka,1
#ASH15 - An Expert‚Äôs,1
PowerfulIn2016http://ow.ly/X3Bk5,1
https://t.co/sd3RjCuI6U,1
#1000km2016 #nopotsy,1
5.44 km,1
U.S. &,1
CLL progression &,1
Estov  @LeukemiaMDA &amp;Dr,1
@LeukemiaMDA  https://t.co/AX6YB0zsC6,1
https://t.co/NDqmXnqxJU,1
Dr Tam Constantine,1
about #BGB-3111,1
#breakthrough #,1
#ABT #,1
https://t.co/qSCsA9cbMz,1
#High-#Risk #,1
https://t.co/nydgASm3pi,1
#Venetoclax New Drug Application,1
Zumba w mom,1
#radon,1
https://t.co/Kkl54BTv0N,1
#ASH15 highlights,1
#ASH15 https://t.co/fODo0xalnq,1
https://t.co/kFgCndDRHT,1
https://t.co/38X8SYIsRv,1
@Roche @AbbVie #,1
the second half,1
@LeukemiaMDA  https://t.co/i9oLY8KP8W,1
https://t.co/EdGnozmPSb,1
$RHHBY @Genentech $,1
Titania,1
üëèüëç,1
https://t.co/IYUfiRLQ8k,1
@AthensStateUniversity #CLL,1
TweetDeck,1
https://t.co/RcHCER2wCk,1
#PowerfulIn2016 https://t.co/noxz4PazvS,1
https://t.co/AQ1cdYWbIS,1
5.37 km,1
#nikeplus https://t.co/GPPQMTnHgd,1
Dec üôÅ,1
https://t.co/cn44CwK8q4 @wellcometrust,1
https://t.co/DQ67PDIbPs,1
Generic Imbruvica,1
PowerfulIn2016 https://t.co/BcpU6mwXgy,1
https://t.co/WzKxyWX6Zb,1
#German https://t.co/nphAkeAv14,1
https://t.co/WPA9rrE38D https://t.co/jCJVtkvy1K,1
FunFactFriday,1
#FridayFeeling #York #,1
Leukemia https://t.co/qmkhKbMXI4,1
Your Happy Place,1
Powerfulin2016,1
https://t.co/Eo2w1Su6Ih,1
Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia,1
https://t.co/CTW424NO7p,1
71-Year-Old White Male,1
The Plan Works,1
CLLPatient,1
Sementara itu,1
25%- 50%,1
memiliki,1
gejala,1
the Outcome of Combination Therapy,1
#chronicpain #,1
5.18 km,1
#PowerfulIn2016 https://t.co/vYwWjEZEXs,1
https://t.co/T8b3R4bhTW #,1
#amor #cll,1
#loucos @ Praia,1
Centro - Peru√≠be https://t.co/ikNZgmLdQX,1
https://t.co/Aw4vYev5TI,1
Young,1
https://t.co/rkcmKiLp4Y,1
https://t.co/DodMCG5sSh,1
MDACLL,1
https://t.co/pdCEyiyxMB,1
https://t.co/R7kOR0QK36,1
linf√°tica cr√≥nica &gt,1
Dr Bosch de @hvhebron,1
#llc #,1
https://t.co/yhp5rwMqNM,1
H2¬†2015,1
Ovarian Cancer,1
https://t.co/HnWch0aRiK,1
gejala apapun,1
https://t.co/R65cmhJstA https://t.co/YQ6xcYNLAP,1
semana,1
el debut en la,1
Liga Provincial,1
CLL Updates,1
Leukemia https://t.co/zhXxZTHrF9 https://t.co/vo5nUgXX9,1
https://t.co/v2sJbNViCs,1
ibrutinib(Imbruvica,1
Leukemia  https://t.co/uQhak8nPOG,1
ID,1
26717038,1
A year ago,1
Collab,1
https://t.co/cWkVOHCXM3,1
Familietrek van de Finkers,1
Herman,1
van leukemie,1
"@LeukemiaMDA 
https://t.co/HTR7oyRxzg",1
https://t.co/T2xOuBV8ZR,1
Chronic Lymphocytic Inflammation with,1
https://t.co/RHtyfk0FkF,1
TG-#1101,1
#TG #Therapeutics,1
"https://t.co/MGlvPipwDf
CancerCureNow -",1
https://t.co/ZC9QFP18Sc,1
2 @BloodJournal,1
Upenn,1
Monoclonal Antibody for Chronic Lymphocytic,1
CLL Society Newsletter,1
christmas,1
Please retweet https://t.co/pgI7HCZRIz,1
@QMBCI @PeterMacCC &amp,1
"@LeukemiaMDA 
",1
#ASH15 #KnowledgeIsBestRx #,1
https://t.co/Pel7WK6pEy,1
Isochromosome 17q,1
https://t.co/S47LmIeOdW,1
#ASH15 -,1
Second-Generation BTK Inhibitor Mean,1
https://t.co/htw0h9qhcD,1
#happyclients,1
#uptown #,1
Susan Leclair-,1
https://t.co/tqdOQqlMX5,1
ROR1/ROR2,1
Adding Imbruvica,1
Treanda &,1
#cirmtuzumab,1
https://t.co/VwYvlnopkX,1
https://t.co/eyL7CJNVv3,1
https://t.co/xi5J64j4yJ,1
#lymphoma #leusm #,1
Dr F Bosch,1
ACP-196 Bruton‚Äôs,1
Ibrutinib-Treated #CLL,1
@ItsBayleyWWE,1
#NXT,1
#ASH15 https://t.co/VnLuW3SnPd,1
#lolwehatework #,1
#fromus #,1
#del17p #,1
#Obinutuzumab/#Venetoclax,1
#Combo #Highly #,1
19 de diciembre de,1
Gala artistica,1
"#ASH15 
",1
#KnowledgeIsBestRx https://t.co/4eO9KuNPhJ,1
VandyHOFellows,1
https://t.co/VoPc3uSgA3,1
Clinical Trials and Observations,1
https://t.co/f3MdZbLqnU,1
La banda,1
https://t.co/asqXpgPFc5,1
lo m√°s alto siempre,1
idelalisib+rituxan 4,1
GoogleAlerts Great,1
Elaine Schattner,1
https://t.co/dSWotam2G3,1
ASH201,1
Jeff Forman,1
Italiana,1
el torneo internacional de Tarrasa,1
https://t.co/39xzwg3PUe,1
4L,1
https://t.co/hG6RKFOinm,1
@LeukemiaMDA https://t.co/vleExyfUbw,1
B-Lymphoblastic Leukemia in Patients With Chronic Lymphocytic Leukemia: A Report,1
@TheUSONetwork #ASH15 #,1
#NHL https://t.co/zFxadNlDFn,1
LSS,1
https://t.co/S5uhR72FCk,1
Telephones,1
LuchaLibreChilena‚Ä¶,1
New Drug Combination Improves Outcomes,1
FMNI Student,1
Art Workshop,1
#yrdsb,1
Santa https://t.co/PTL6G4bxD8,1
Leukemia https://t.co/z3SWen95ab,1
#OHTP #KJC #PGA #JSC #,1
#NeverStopLooking,1
"EndCancer
New Drug Combination Improves Outcomes",1
https://t.co/44jKyAHA7x,1
https://t.co/OJD9iMHCG1,1
https://t.co/i2v0DiOxhN,1
#Belgium #,1
https://t.co/JRzDy5lmXV,1
#W2Oclient,1
https://t.co/IvLOSFo4co,1
Expression,1
8 January 2016,1
https://t.co/bN7HNd08zn,1
alpha4,1
Adaptive Biotechnologies,1
Collaborators Present New Data Showing Minimal Residual Disease,1
Veux,1
#mylove #,1
Next-Generation Drug Challenging Imbruvica,1
#CLL https://t.co/VudpzNRaeK,1
#CLL #thankyou,1
https://t.co/6RmH0ImcXw RT https://t.co/NxSRXl2Mqs,1
https://t.co/cE14vz0aQ2,1
https://t.co/jECUdDiiAk,1
#bendamustine https://t.co/Q07vul3ylN #US_FDA,1
#Obinutuzumab #Combo in,1
#iNHL,1
https://t.co/f0OHTHEvJV,1
TOO,1
#CLL https://t.co/cfYXaHTH99,1
Se entrena,1
two-year,1
98 percent,1
#Hospitalist @DrBrettHP,1
https://t.co/Gmpjb2WE9u,1
https://t.co/Y3q199NVHN #,1
#pharma #ibrutinib #,1
https://t.co/PsD2btI8Fr,1
#Phase #,1
https://t.co/Q1y2LQizws,1
Leukemia Mutations Uncovered New Uses of Existing #,1
@LeukemiaMDA @CLLdoc,1
ADV,1
CR=16%;ORR=79%,1
116pts,1
150-1200mg/,1
3/56,1
neutropnia 41%,1
@leukemiaMDA @clldoc,1
@NEJM w 3,1
3novel,1
Banner week,1
Generic #Bendamustine,1
New Cancer Drug Effective,1
@Elaine Schattner,1
#NHL https://t.co/exOBt7Wl4Q,1
https://t.co/8fUrz0mihQ #,1
12/15 #,1
Idelalisib Trial Stopped Because of 'Overwhelming Efficacy',1
Cyclin-Dependent #Kinase #Inhibitor P1446A,1
Leukemia B-Cells,1
https://t.co/erfCg642tu,1
#Leukemia https://t.co/KgsqBfXtrP,1
https://t.co/S4IONFnhpm,1
#Business #News,1
https://t.co/9oIHkTh2YG,1
https://t.co/YAmwV4TaEG,1
https://t.co/F8If52ymBs,1
#Tashify.com #,1
https://t.co/7Zgg7dsRo5,1
https://t.co/OQAKpV7ngS,1
https://t.co/Lfh9cQdJKO,1
#Healthcare #News #,1
249,1
Leukemia https://t.co/YMbLyw1SEK,1
https://t.co/0hnGtmVElp,1
#FutureWorldNews Venetoclax,1
https://t.co/jppdyuPNje,1
This The Real Reason ‚ÄòPrincipled‚Äô Celebrities Fear The Public,1
"Venetoclax Is A Powerful New Kind of Cancer Drug Effective In Chronic Lymphocytic Leukemia""",1
#TCSITWiz,1
Trivia,1
#Tecno Venetoclax,1
#Tech #,1
Tecnolog√≠a,1
@ForbesTech,1
https://t.co/R0cAvjJ6vX #,1
ictafrica,1
#WorldNews Venetoclax,1
#News Venetoclax,1
https://t.co/eKQ0t5BmH4,1
https://t.co/y3tH7ozYnM,1
https://t.co/LfYa5rI3VK #,1
https://t.co/aXwX4dv4ER,1
https://t.co/LoeI39Z5VR,1
TNN,1
#USA #,1
https://t.co/riR4fibm8o,1
Cuba,1
https://t.co/JLlaa5TeE4,1
v√≠a @hubinbiz,1
https://t.co/cK2u8q4i9B,1
#ARsoft #,1
https://t.co/wFhkQ4XSWr,1
https://t.co/BD0GunYuEs #,1
https://t.co/ctGYw8llIC #pharma,1
#Early-#Stage #,1
#Next-#Generation #,1
CIT-Treated #,1
CLL https://t.co/4sWFM1UtG7,1
Short Side of Nothing,1
#ash15 https://t.co/QnygbNsZtM,1
"zydelig,$GILD treanda",1
TEVA,1
Roche;Non-Hodgkins Lymphoma,1
https://t.co/met4PvfyG9,1
https://t.co/162FbSyLQ7 #,1
https://t.co/Fe9DCTmcgk,1
https://t.co/Q6zNPTFYV5 #,1
Better for,1
https://t.co/GScolfpvsm,1
https://t.co/f3QapXFDxY,1
benda rituximab,1
https://t.co/6Fqmi9TDld,1
https://t.co/evZ1KTyEDp,1
TKI Tx,1
https://t.co/Wed4QJ8Kh6,1
kina,1
#/science #,1
https://t.co/xW3OJTG1bY,1
#KnowledgeIsBestRx  ,1
#ASH15@MayoClinic,1
Mazie Tsang's,1
Pure Red Cell Aplasia,1
https://t.co/7NWhXNuCh0,1
"#ASH2015

https://t.co/vkHWdxLVYX",1
Promising,1
https://t.co/Tf6QGJjEi0,1
#ASH15 Ma,1
830,1
' this year,1
https://t.co/BMp6SO5vXF,1
https://t.co/kaqos23IAG,1
1833,1
"June 11, 2011",1
https://t.co/WPfSAUEyYl,1
Ultra,1
https://t.co/CR8TzG0c39,1
EurekAlert,1
https://t.co/K2lbzTzlJB #Roc #,1
Chemotherapy for Treating Cancer,1
https://t.co/kf3tRsmn6w @time #leusm #,1
https://t.co/fazTgZ9gd4,1
https://t.co/os4JDzdVzm,1
Mal,1
#ASH15 https://t.co/7OHxsT8bb0,1
https://t.co/Ue721WFdFh,1
https://t.co/VUdbDVQpgs,1
booth 1833,1
Last full day,1
https://t.co/lfix1S2spX Breast Cancer Site,1
FIVE,1
#bnw #,1
#scl,1
#city #,1
https://t.co/3xl34boUIn,1
Medical Xpress,1
https://t.co/p8RROXLMnA,1
https://t.co/ikkeirhOzi #KVTC #Genetics,1
https://t.co/V2W6Sdpd0L,1
KevinFitts,1
https://t.co/JGeINso0PX,1
MedicalXpress,1
https://t.co/t3ATVYm6kj,1
https://t.co/OWMw63FSBm,1
https://t.co/9hEBriIFuq,1
https://t.co/bCwztHcoKp,1
https://t.co/vAQj1VaTPU,1
https://t.co/w2fWFRgl7i,1
Mini... https://t.co/WPCAeORHb9,1
ABBVIE ANNOUNCES NEW ENGLAND JOURNAL OF,1
https://t.co/b6eWtUiVxj,1
ABBVIE REPORTS PHASE 2,1
https://t.co/zF22Wqo4Hk,1
https://t.co/ueqTbJG8Y2,1
Relapsed/Refracto,1
https://t.co/ymDYpWZyQD,1
https://t.co/fseieWWPaQ,1
https://t.co/RmTE9uqMBj,1
https://t.co/R0BeFQpQJz,1
https://t.co/hHLmDa0wFW,1
https://t.co/5EG7j6Yz5D,1
Andrew Barnett's,1
https://t.co/wPYlW1VR4R,1
https://t.co/R9C1OrIqct #,1
Today Mining the DNA of chronic lymphocytic,1
https://t.co/DDmmeqxJ50,1
#online #,1
Mining the DNA of chronic lymphocytic,1
#US Mining,1
https://t.co/0XE8Y5XiF2,1
Leukemia https://t.co/qlbPndM0yW https://t.co/9bsXqbYGHj,1
https://t.co/uDv91eYuJa,1
https://t.co/88zgHuEwGc,1
https://t.co/BuqIXYaEXw,1
https://t.co/mrEmrPVnkq,1
"8)

#Victoria #",1
The Kind of Cancer That May Not Need #Chemo https://t.co/itD5UBRdiz,1
#ash15 #,1
Reasons for Initiation,1
Early Outcomes for Patients w/Rai 0/1 #CLL,1
https://t.co/IsIDW79MLL,1
Dec 7th,1
ash15 https://t.co/ehz1kEUqmM,1
LIVE Webcast #AmericanSocietyofHematology,1
https://t.co/jBNhe0UmRD,1
https://t.co/GQRer68aBq,1
5:30 pm ET,1
2nd Generation BTK,1
https://t.co/go7yYL1GPe,1
https://t.co/P6pzXz00xb,1
#ASH15 Learn,1
Ibrutinib VS Chlorambucil,1
https://t.co/fy2CaDCDTI,1
https://t.co/3CNToqnAFU,1
https://t.co/YrK0dxyatf,1
https://t.co/d5aa3INYfe,1
NEARLY 80,1
DELETION,1
98%survival,1
#ASH15 Press Program,1
GEN503 #,1
Sharman 12:45 eastern,1
#CLL #ASH15 https://t.co/kvo5davFeN,1
#ASH15 ‚Äú,1
Practice-Changing Trials @ZosiaChustecka,1
5:30PM about #,1
5:30PM EST,1
https://t.co/3gBmRhSiwW,1
Roche ASH,1
#haemophilia,1
RETWEET https://t.co/aQTOjJrbOz,1
#ASH15 plus,1
MPN session,1
https://t.co/DT4V59OW84,1
&gt;20 abstracts,1
https://t.co/lOB2IiGnpC,1
https://t.co/Jl5h3dMlOC,1
https://t.co/UbTuHZbjhO,1
marcap√°ginas cuquis cuquis,1
@Mariet_Martinez de #,1
‚ô•‚ô•‚ô•,1
https://t.co/zyrd5DXxOo,1
Del 17p,1
#RoadToRMT #RMT2016,1
https://t.co/5S9OFbC0NS #EmergingDrugs,1
Del #,1
#understatement #,1
LymphomaClub,1
#CLL Qs,1
Sharman LIVE,1
https://t.co/aQTOjJrbOz,1
Rodney T. Miller,1
#IHC #Immunohistochemistry https://t.co/GfFoMikKZj,1
"JC, Furman RR",1
Coutre SE,1
N Engl J Med 369,1
32-42,1
Saliendo,1
queremos la copa,1
https://t.co/eeuBkEi6gd,1
Morton LM,1
Curtis RE,1
Linet MS,1
#sergio,1
#petsitting #,1
#MOREoncology https://t.co/AZRcsYBlTg,1
https://t.co/WspBhe2hs3,1
https://t.co/ZlBpcSK7kC https://t.co/OKwavuCzwC,1
#KnowledgeIsBestRx #USOncology,1
https://t.co/ACT2ujQ7DJ,1
Powerpoint Templates - https://t.co/IFv21xwAa1,1
The International Cancer Genome Consor,1
IMPPC,1
üíü‚úå,1
CacyBP/SIP,1
#toleropharma #,1
#fairmont #fisheye #CLL #,1
#myeloma #CLL,1
#CLL #Vina #,1
https://t.co/cvf17Wrb8,1
https://t.co/PnBuFHbhlb,1
chronic &amp,1
jaar geleden,1
gaf ze ons broer,1
Arsenal,1
Carzorla,1
https://t.co/YAdzS7roTD,1
https://t.co/o4FGAx2CQY,1
#todosuma #,1
Tolero,1
a lovely weekend,1
#FunFactFriday,1
https://t.co/DnTns9WT2W,1
MYELOID,1
UGH,1
https://t.co/1u4f4ytbSp,1
https://t.co/IUQXIi31um,1
#cll XHyvq64f,1
Neupogen Shot,1
Treanda,1
Rituxan Appears,1
@profcelentyx,1
@LinkedIn,1
#leukemia #lymphoma #,1
Nov. 17,1
https://t.co/5sCpF9X2Kc,1
gelukkig waar,1
https://t.co/wwpJwH8ADh,1
#hotridesintanzania #,1
#bodykit #,1
hotri,1
#Challenges #,1
https://t.co/QbI8SXODTq,1
Zydelig Trial Unblinded Early for Clear Survival Benefit,1
Leukemia https://t.co/nekZOgQZzM,1
https://t.co/UaZIrDo8yX,1
dan,1
#controle #,1
#Positive #Interim #,1
"https://t.co/d7DJ9Fa22D
Love '",1
#ASH15 https://t.co/4xFrpKCD9R,1
Romans,1
21st January https://t.co/3WumIhU8c8,1
üì∞ÿØÿ±ÿßÿ≥ÿ©:,1
https://t.co/tVmMtyvXXF,1
SLL PRT,1
#donor #,1
BAX/BCL-2 RATIO IN,1
https://t.co/CPKimbGGII #,1
ma caisse,1
#GarageNFS et,1
√ßa va marcher,1
a good night,1
https://t.co/a2FUFoqJmS,1
LPL &,1
SLL https://t.co/LLmkDSWoN6,1
https://t.co/k8Tg1rkhfw #,1
#TeamRed #MoffittIMO #,1
https://t.co/R65cmhJstA,1
28th November,1
#school #teaching #learning,1
#KnowledgeIsBestRx #USOncology @TheUSONetwork,1
https://t.co/tf0TuZlhia,1
SEER,1
ISIOG15,1
Eichhorst https://t.co/8nm48Xu4ut,1
https://t.co/HlMAu1VAn7,1
Bauhaus,1
1919-1933,1
#modernart,1
#Bauhaus #,1
CHC 2015,1
Russian,1
Igor Stravinsky,1
https://t.co/SaNgLCORKP #,1
#music #,1
@KathyCollins15 &,1
w Ss #,1
FOIA Update-New Data &,1
CAM https://t.co/9ce6bntaub,1
ABLS16,1
@Nature @univpompeufabra,1
https://t.co/h52p5jduN1 https://t.co/uasaRuU039,1
the Norman Conquest,1
#History #,1
Dandy Highwayman,1
Tuesday 24th November,1
#york #,1
Boa,1
February 2014,1
#WHO #,1
#fiction #,1
Just another day,1
#CanadianRockies #,1
https://t.co/X5YjxDIIyL,1
Blood Clot #,1
Jeremy Abramson MD FACP,1
Dr Abramson,1
https://t.co/QQzL5FNcb2  @ACPMAChapter #,1
Pathway Inhibitors Show Clear Benefit,1
https://t.co/aBHaQ0TuBh,1
Dutcher,1
#bloodjournal #leusm #,1
medicine https://t.co/LgKeSTXyDd,1
Request,1
#expand #,1
Robert Kyle,1
#CLL @DrMiguelPerales,1
https://t.co/QjxweIJl7j #York #Learning #Coins,1
#Pathway #,1
#CLL https://t.co/o2pDJiIqZW,1
Chronology,1
Mutations Linked,1
https://t.co/ldasS7VZbe,1
Bendito,1
la hora y el lugar,1
17/08/2012,1
‚ô° https://t.co/VLN63oslzX,1
Blindness,1
#Mucormycosis #,1
#Splenectomy #,1
Nocardia,1
#killme #,1
#medstudentproblems #,1
https://t.co/nL4hRmqauI,1
https://t.co/k8Tg1rkhfw  #,1
https://t.co/1QcRIRQjY4,1
https://t.co/TSvT8HzkNH,1
vac√≠o mejora,1
tolerabilidad g√°strica,1
Si artralgia,1
https://t.co/euMeItTe2F,1
Leukemia - Cancer Therapy,1
https://t.co/RaYhJkF56y,1
40 thousand miles,1
MissHim,1
#KnowledgeIsBestRx #PowerfulPatients,1
#leukemia #medicine #,1
https://t.co/2MQxhOhiC9,1
miR-3151,1
https://t.co/qGg0VBkGLh,1
MSCs,1
#medical #pdfebook #chronic #,1
d√≠as y el martes,1
Rumbo,1
Tokio,1
https://t.co/x0bqQIVBij,1
Leuke,1
las preliminares,1
el T√≠tulo Absoluto Individual,1
"ASU
https://t.co/KskqhvGdoU",1
https://t.co/ebjVLEJE2e,1
Saw Prof,1
The morning,1
#TESL15 #,1
Seminar 30 Oct,1
The Institute of Applied Bi,1
√Öbo Akademi,1
#aboakademi #,1
nos trajimos,1
Focus on Chronic Lymphocytic Leukemia,1
CLL https://t.co/cn23XbxuVx,1
https://t.co/kawwfYBkc7,1
a beautiful day,1
the Chateau Lake Louise,1
Chateau Lake,1
Forty-four,1
Matthew Kauffman,1
Register for Breakthrough Developments,1
https://t.co/XnymATrfnM,1
FUCKCancer,1
#Promising #,1
https://t.co/3JZEPdOVao,1
#BIOEurope https://t.co/bTV0Ta5r0x,1
19-3-68 #,1
FCR Achieves,1
Brandon #,1
CER,1
https://t.co/a512qA69cu,1
MD Anderson Hospital,1
#foundation,1
Eyad,1
the Hematopathologist: Treatment,1
#Dermatology #,1
https://t.co/3umgMfjztc,1
#digiscoping adapter,1
iPhone6 https://t.co/0kE9xJlzkO,1
@ComunicaSehh,1
Valencia,1
https://t.co/t6qlqruxT0,1
Reverse Pseudohyperkalemia,1
SCANDAT,1
CSTCPD,1
el 90% de las,1
linf√°ticas cr√≥nicas https://t.co/jEnnPEG3yU #,1
only 42 years old,1
God,1
https://t.co/kMZJb5NcFA,1
Drives Global RNA,1
MYC Translation - Potential New Therapies,1
@BloodWise_UK,1
#Fluoxetine + #Bcl2 Inhibitor,1
@WCMNYPJCTO,1
https://t.co/8Y0Lot4L2d https://t.co/0zAC9yfcUf,1
https://t.co/NIDHquZfwI https://t.co/m3SPUL5U08,1
HSMedical,1
Elizabeth Shpall,1
Pelotonia's,1
#OneGoal #,1
A Transplant for the Cure - A Bump in the Road,1
Bryan/College Station,1
Pelotonia's Impact on Treating Chronic Lymphocytic Leukemia,1
Pelotonia https://t.co/aAifO3VEVB,1
Lancashire Lge/Nth Lg,1
#bdca #,1
The Career-Boosting Benefits of,1
Lifelong Learning',1
Arctic,1
Orient,1
#Optimizing #,1
SQ Veltuzumab,1
https://t.co/ZEFMeGFP83,1
31st October,1
https://t.co/FRP4V7iHi7,1
Gene expression &,1
next weekend,1
gchu,1
#LightTheNight Great,1
Vancouver,1
"Almost 4,000",1
Patient Power's,1
https://t.co/kMUQYR0H3x,1
http://t.co/mtbzQLpT4,1
http://t.co/wblfzWsY4O,1
Ma√±ana arrancamos la copa de gchu,1
Learni #,1
Houston #,1
Asymptomatic,1
http://t.co/Wij4c7tJ4w http://t.co/wu20XcM7g9,1
New Clinical Trial for Patients,1
http://t.co/sZiKTXt2LS #,1
#bloodjournal #,1
http://t.co/DcKwetvcbl,1
http://t.co/5tQmQh2u8w,1
http://t.co/w0b9HBLX1,1
http://t.co/TbF5XYGTSf,1
http://t.co/qabuPfFcuO,1
rituximab http://t.co/3NRHlcMUBu,1
http://t.co/R65cmhJstA http://t.co/f2hGfqTh3l,1
PostedToday,1
@Nature,1
JustPosted,1
http://t.co/ob569FhIj7,1
http://t.co/13cqSjdqCP,1
Middle East Molecular Biology Society,1
http://t.co/eGwrFIao0F,1
Black Swan Int,1
Epstein-Barr Virus DNA,1
the last year,1
http://t.co/bgt0x8jNal,1
Potental 4,1
#Mutations driving,1
http://t.co/NVsZARfd4m,1
http://t.co/JG7YE9JSwN,1
BMS,1
lirilumab,1
broccoli,1
InnatePharma,1
$5M,1
http://t.co/j3F8sVqxSX,1
#plays #,1
omega3,1
http://t.co/QRl1cjt1Yf,1
para alguien,1
#MasEnamoradoYmuero #,1
MCH,1
MCHC,1
#MCV,1
MPV,1
http://t.co/Sw8x9vTuTQ,1
#CLL http://t.co/rYMDaCJMyf,1
Brandon en,1
Ac√° apoyando la lucha,1
http://t.co/gyT9qBZWf6,1
LeukemiaLetters http://t.co/WWcLrg8Jfp,1
Dash2015,1
#ConnectedDash #,1
https://t.co/Z48xhbNe4Y,1
Ab Science Paris,1
ABSCF,1
14.2900 $ABSCF,1
#lls #,1
Peter Green,1
#journey #,1
#watch &,1
#wait,1
http://t.co/XjwNsWRTTW,1
http://t.co/w5lDz6pqXF,1
http://t.co/e9kLuzdxY7,1
http://t.co/ZtoaRQr0ND,1
Leukemia http://t.co/9lxRlJ1unC,1
http://t.co/PajvyCwpAd,1
http://t.co/X0iJpmXAK4,1
#CLL Read,1
"Dai, Yuntao",1
B-1acells,1
http://t.co/diEdTQj2JB,1
NationalPoetryDay,1
#poems #,1
SOACloud,1
AMI,1
#bloodjournal #mmsm #,1
http://t.co/zHJXTSeyPU,1
http://t.co/tgAVk7B8Zc,1
KnowledgeIsBest Rx,1
http://t.co/eiJvInvb4V,1
Hematology News Absence,1
C√©gep L√©vis-Lauzon,1
Agenda,1
Myeloma 2015,1
http://t.co/8Zui6YsMKy,1
MAJORS,1
https://t.co/aKvFHISSVm,1
Arpita Shah,1
Abhishek MangaonkarOc,1
http://t.co/2XO0laUFLL,1
TGTX Lugano,1
CHC2015,1
http://t.co/kEzsqIp6xZ,1
http://t.co/2uUUFHM48,1
https://t.co/KIEGpF5vrl,1
Peter Dorfman,1
@Datamonitor_HC,1
Barts,1
Cultural Heritage #Conservation,1
Dr Riddell,1
http://t.co/G9SyMGBaA4 #,1
CLLuster http://t.co/A4nqlFZ1jK,1
#York #,1
PRIMEROSüòç Mas,1
los amo,1
http://t.co/Axx7oSyVzK,1
#GreekPolymaths,1
#MBL #,1
DonateBlood,1
Pipeline Drugs - http://t.co/EsFXtyh3Wz,1
http://t.co/ZHadR6pNdS,1
Entradas,1
http://t.co/3kVMhU3zY7,1
http://t.co/AyOCViUZp3,1
#name #,1
ENTOSPLETINIB,1
#spleen #,1
#Syk #,1
#Gilead #Sciences,1
#name,1
#Anti-#CD20 #,1
#TG #,1
#CLL http://t.co/dopaXBO9DK,1
the Treatment of Untreated,1
@TippinAaron,1
http://t.co/CACZOYAxK6,1
$juno $,1
http://t.co/aUyiwgRA57,1
Paul Henderson - .@hockeycanada,1
#madeinacoustic,1
http://t.co/khnwQzAbi2 http://t.co/ieEUZOxEW3,1
Aggressive NH #,1
http://t.co/q17dRsOZRf,1
Liu  2014  Int J Dermatol http://t.co/qLjy20MEBb,1
üíñüíñüíñ,1
@Gilead's Zydelig,1
England &,1
Ph.1b/2a,1
IPH2201 &,1
Untreated,1
#Relapsed/#Refractory,1
cicon15,1
@IDIBAPS,1
#mAbs #ofatumumab #biosimilars #,1
http://t.co/KwksY2qTpt,1
CEST15,1
cest15 http://t.co/ohASazMYyu,1
CardiacGenomics,1
http://t.co/CPTzXEItPL http://t.co/zbPEmrjTVQ,1
#Wallonie,1
ada ke,1
Myeloid Malignancies,1
#CLL https://t.co/MVMIrX7vy0,1
the Future of Healthcare,1
Big Data,1
Intensive Car,1
$GNMSF $,1
Cholecalciferol,1
Vitamin D Deficiency,1
http://t.co/6lhFqQEriK,1
#ASHMHM15 #,1
http://t.co/DzJVyC4Wp3,1
Powerpoint Presentations - http://t.co/IFv21xwAa1,1
#USMLE #,1
GBX 90 PT,1
http://t.co/hI4ewPNiFL $CLL #,1
4 Years Durable Remission Make,1
Unique,1
@Datamonitor_DP,1
http://t.co/5JlibznXL8,1
https://t.co/vCCdqtwdOA,1
12:10 PM,1
#soho_2015 #leusm #,1
Dr Rawstron,1
11:55 AM,1
Michael J. Keating MB,1
11:40 AM,1
11:25 AM,1
#CLL Dr.,1
11:10 AM,1
Global Chronic Lymphocytic Leukemia Therapeutics Market 2015‚Äì2019 Report,1
10:55 AM,1
Disease Biology',1
Session IV,1
10:25 AM #,1
TG Therapeutics Announces Special,1
Cholecalciferol in Treating Patients With Newly Diagnosed Non-Hodgkin,1
about #CLL @LLSusa,1
the First Phase 3 Clinical Trial for Patients Chronic Lymphocytic #,1
https://t.co/08ScAAGDgL,1
the Management of Patients,1
more than one,1
#Broker Sanlam,1
Medical Sciences,1
+1%,1
Interims,1
+6% &amp,1
+5%,1
AIM @VOXmarkets,1
Leukemia Submitted,1
Drs Fabienne McClanahan,1
@repopter,1
#CLL http://t.co/a12khdY4k6,1
#Supplemental #,1
"360,000",1
"http://t.co/ctENz6M9g8
https://t.co/dVmOepQhic",1
#CLL https://t.co/nu3unGyOtt,1
Point,1
#cancer http://t.co/FClGwRAuQu,1
a Chronic Lymphocytic Leukemia,1
Ofatumumab Superior to Observation,1
Single-Cell Analysis,1
Next-Generation Immuno-Sequencing Show That Multiple Clones Persist,1
Treatment-Na,1
Supplemental New Drug Application for Treatmentnaive,1
Leukemia Submi,1
@celentyx,1
Gros,1
@MarcoIadeluca: Bienvenue au OL,1
Fran√ßois Cot√©,1
Saison,1
#baseball #,1
Colonie Little League https://t.co/Vbag6ncEbx,1
vamos lucho,1
MTL,1
#leaukemia #,1
Krishan Maggon,1
Cluster Marker,1
the last 2 years,1
the last 2 decades,1
1st Group of Patients to,1
Kevin,1
https://t.co/fnwtP2wEtq,1
Chronic Lymphocytic Leukemia Reveals New Molecular Subdivisions http://t.co/P5Be3C0bhk,1
David Miklos,1
Stanford,1
'87,1
http://t.co/Fn3nQy4Kqv,1
http://t.co/x14qjgioAY,1
http://t.co/Dyc82XyNwp,1
Profs Gribben,1
"Hallek, Keating &",1
$1-$7B #,1
0.6B,1
#TG1101 + #ibrutinb,1
TG1303,1
XBI,1
65-74 years old,1
BMB,1
#TGR1202+ #TG1101+ #,1
http://t.co/6dMtSAJPac Pew Research Center,1
Andrew Kohut,1
Baltimore,1
4-plus,1
Watch Geoff,1
YACancer,1
9pm ET,1
#Carcinoma #,1
Prof Vajdic,1
Claire Vajdic,1
F. Ho...,1
SYD,1
Goede-,1
http://t.co/m5XOQmnUZq,1
http://t.co/XdSNSMuyyz,1
2014-2019,1
Global Chronic Lymphocytic Leukemia Therapeutics,1
CLLlive,1
http://t.co/MdH5jqTzFo,1
http://t.co/x7RY8NlMYM,1
#cll @livtartaro,1
Bills,1
Clinical Research Coordinator II III,1
about #ibrutinib #CLL @CancerDrugsAU http://t.co/qWFwGqY60v,1
Journal Geriatric Oncology,1
@SIOGorg http://t.co/KiTh8mJaw9,1
#oneofourown #,1
DTES,1
http://t.co/gdRozi1SR2,1
Leukemia http://t.co/wPqHF5fZDp,1
#KCA #,1
http://t.co/IcF1eqidsM,1
Aaron,1
http://t.co/kyUTGxPNml #,1
#CLL Trials,1
http://t.co/B92lvVJXhH,1
REOLYSIN,1
Targeting Peripheral &,1
Combination Reovirus Therapy,1
Tumorsuppressoren &,1
kann,1
U of Pennsylvania,1
http://t.co/SbbPsELb3B,1
14 #CLL,1
#Pathology,1
http://t.co/LbspKllEqj,1
http://t.co/zGyuSQStv0,1
mijn eerste,1
gaat de controle,1
Brandon Stewart,1
10kBeforeXmasAskMeHow,1
http://t.co/MknYXUgDCZ,1
http://t.co/BSj0vROAQr,1
#cool #,1
#health #grill #,1
http://t.co/37mBRKzmwJ,1
North American,1
Brooklyn,1
The first week,1
KLKB1 #mRNA #,1
#biochemistry #kallikrein #,1
##,1
"4,000",1
GOOD NEWS @genentech &,1
@abbvie &,1
daily workouts &amp,1
BrazilianspiritualistTeixeiradeFaria,1
Cancer Of The Blood &,1
#BoneMarrow -,1
Worthy,1
http://t.co/1MzEgJlaEP,1
the Newest Regional Executive,1
Wayne Dyer,1
WayneDyer,1
NBC,1
PowerfulWords,1
KnowlegeIsBestRx,1
http://t.co/ZBsQKafNMF,1
Semoga darmian &amp,1
dpt poin penuh,1
utk merebut,1
üòπ,1
#FFM #,1
la maison des Faucons de L√©vis-Lauzon,1
#PainAwareness #,1
MakeADifference,1
Knowledge Centre,1
http://t.co/GO4iHW8aD0 #,1
NORD,1
the age 50,1
Just A Man,1
#Exosomes &,1
Safety and Pharmacokinetic Study,1
"Lymphoma
Exosomes and #",1
http://t.co/8rjN1nYJbk,1
Omg Malm√∂,1
Zatans,1
Real Madrid,1
Shaktar,1
http://t.co/81ct0leKZI,1
LYMPHOBLASTIC,1
#Idelalisib,1
Advance #CLL,1
www.arzneimitteltherapie,1
02.10,1
#Onkologie #,1
http://t.co/WItIb7DvJV,1
#Immunophenotyping #,1
http://t.co/YLWP2Xf7XD,1
Dan Rooker,1
Participants With Chronic Lymphocytic Leukemia,1
#frontoffice #retreat,1
2ndplace #,1
http://t.co/aFO6aOJ3IQ,1
#retreat #,1
http://t.co/rhQnaBZJSn,1
The Ottawa Hospital https://t.co/gN8ce3bisq,1
#bloodjournal Dr.,1
@CLLdoc &amp;Dr,1
NCCN Guide,1
The Hill Resource and Reference Guide,1
http://t.co/aBkQcGyvqa,1
supresa da jak ....,1
tia parabens teamo demais,1
Yay,1
Johnterry,1
gracias,1
el regalo,1
101-1,1
Bogot√°,1
https://t.co/O4qnw9YBBo √önica,1
pel√≠cula chilena,1
$8 Trillion Dollar Industry,1
http://t.co/NwabKYCO0R,1
Recognition,1
http://t.co/Bh3aV5U6rW #ClinicalTrials #Pharma #,1
Lymphoma Society Applauds Encouraging Data,1
@urotoday,1
http://t.co/M2wRsZ7Qfa,1
1992,1
Dream in Blue,1
#jackrussel #,1
#doglover #,1
#nature #,1
#music,1
GoingDiamond,1
Christian Chad,1
http://t.co/qC7bDJtdd1,1
5 months old,1
#goldenretriever,1
Leukemia - Cancer,1
http://t.co/kyO4q4RnrV,1
Denmark,1
#CLANdian #,1
American #,1
Managing¬†Options,1
Umaga,1
Hahahaha,1
@MontonSquad #MontonSquad #,1
#Venetoclax #Achieves #Primary #,1
#Pivotal #Phase II,1
Ibrutinin,1
http://t.co/M0SFWZufeS,1
http://t.co/A6EiZC53VG,1
http://t.co/koYzmgYjCh,1
Ph II #pharma #news,1
http://t.co/Byy5t8cC5,1
#Venetoclax http://t.co/dTKxNfx2Dt,1
$PCYC &,1
17p(del,1
Leukemia http://t.co/En0w6C3FYx,1
https://t.co/3mhoO5UuVC,1
Roche) Effective Phase 2 Study Relapsed/Refractory Chronic Lymphocytic Leukemia,1
Deletio,1
http://t.co/0C6VuGu2UB,1
http://t.co/QqFKQyN4Ik,1
Venetoclax Met Primary Endpoint,1
Pan #PI3Kinase inhibitor,1
http://t.co/zHbUZVVrA8,1
http://t.co/zUcSWxP7Pk,1
#Crazy,1
http://t.co/yxadtSRNxH,1
#LAvCFC #,1
Reaaaaal,1
#livelokai #,1
"CLL
Suggesting",1
17p/11p,1
Better prognostic,1
"MOGA15
Ibrutinib #CLL
Analysis",1
"Diarrhoea, Bleeding",1
Mulligan #CLL Oral,1
Mulligan #CLL FCR,1
bendamustine/rituximab,1
#MOGA15,1
the New Business Partners Joining,1
http://t.co/KwHyRzLUQz,1
http://t.co/HksH8xt61w,1
Hetero,1
Maball,1
the Best Frontline Therapy for Younger Patients,1
University of Texas Discuss Findings,1
Lymphocytic L,1
#fun #loveit #,1
#leukemia http://t.co/PXUiNZh0UL,1
http://t.co/RTtQpZEZCR,1
Green Tea Compound,1
VirtualMeetups,1
#Patients,1
#Best #,1
#Yougner #,1
http://t.co/Z9aDGjRkcx,1
#Researcher #,1
Leukaemia Treatment-,1
760,1
http://t.co/jN4iybowbm,1
age 60,1
"Leukemia
Acute Lymphoblastic Leukemia
Acute Myelogenous Leukemia
Chronic",1
Hendrie @SeattleCCA http://t.co/OSVHjcWWjC,1
Perturbation of the normal,1
#motovlog #,1
http://t.co/dmkBEUwQXh,1
http://t.co/YS30y7sXI4,1
Collaboration@UCCancerCenter &,1
#MSKCC http://t.co/pVgwnADCIH,1
http://t.co/FzbkEAaZz9,1
#lymphomahub,1
https://t.co/yK51POJm7K,1
RT conkers3,1
@MedicalCollege Cancer Center,1
Lynn Wang &,1
Gordana Raca,1
#CLL https://t.co/G6JMKorbkM,1
holds.@UChicagoMed,1
2010 - 2014,1
cll http://t.co/txnmU37b3p http://t.co/lC6KkmLzyL,1
http://t.co/9WST0Ew8Jv,1
Muahaha,1
http://t.co/vULEUulTbi,1
Review of Novel Therapeutics,1
Adding #Ibrutinib Is Beneficial in Previously Treated #,1
http://t.co/OOU5uFFv3R,1
William Dameshek Prize,1
http://t.co/N0XblnkfaZ,1
http://t.co/mk0asySB17,1
ASU Alumni Artists Club,1
October 27 - November 19,1
updates &amp,1
CTCAForum http://t.co/UZslhLsi7L,1
KnowledgeIsBestRx @CllSociety http://t.co/O4zVsN3xHD,1
Potential Treatment Strategy,1
üê∑,1
#loveher #,1
#girls #,1
Carlos Lucas,1
11:20am,1
http://t.co/znRVbqU4dW #CancerNews,1
#CLL https://t.co/9XLEnDEG5K,1
#Quiz http://t.co/V13y3RaOJl,1
The New Movement #,1
#CLL Movement,1
the Coachella Valley,1
the Next Meeting Next,1
IWU,1
http://t.co/UwgU4gZbQ2,1
http://t.co/tGYbu5emL5,1
http://t.co/muLEbgl07F,1
GSK News,1
http://t.co/ibURvaNhtt,1
STORMPATH http://t.co/vqnAlsLFbi,1
healthcare marketing,1
the pond - @CelloGroup,1
#rstats &,1
ggplot2 http://t.co/M4FQOoNORe,1
#leukeamia #,1
http://t.co/4r40UPIpCZ,1
30.3%,1
Tuesday 1 September,1
the King's Manor,1
VRS,1
@Augeanplc,1
AUG,1
GBO,1
TheCommission,1
http://t.co/XFniqFKGdY,1
MDACC Hematologic Malignancies Retreat,1
#dallas $,1
60-minute,1
International Parkway,1
Dallasjobs #,1
D.R.A.M. - Cha ChaüíÉ,1
six days ago,1
#KnowledgeIsBestRx http://t.co/cO8bRAaace,1
Breakthroughs Blog,1
FAB ONE,1
TACI,1
#lifelonglearning #learning,1
the Contemporary Era,1
http://t.co/if3EhOu1x3 #,1
http://t.co/9A12ck8jsU,1
Lirilumab,1
Untreated Chronic Lymphocytic Leukemia,1
CRC 2015,1
Prognostic Indicators,1
Standard Early Care for CLL,1
http://t.co/quMUsP5LEc,1
http://t.co/VpSFAHNHHH,1
de novo HL,1
http://t.co/FkRtJBmfbj,1
http://t.co/7920y2rOPY,1
Epstein-Barr #Virus,1
http://t.co/O2M7WxVZl3 http://t.co/AmIZCzcPCu,1
#Yacht #,1
RichGang,1
#boat,1
#yacht #,1
ASCO Post http://t.co/M2qyGZzod9,1
#MIF #,1
Epstein-Barr Virus,1
http://t.co/S3NwakQ2Df,1
the next few years,1
Michelle Priyanka,1
https://t.co/UOAHd7P8cl,1
u &,1
neva argue &,1
1985,1
Montreal,1
this Call Team 9:30 pm Est,1
#seminary #,1
Poitou-Charentes #,1
CLL Poitou-Charentes,1
MeenaSurieWilson - Author,1
CLL India,1
New Leadership,1
July morning,1
Powerpoint Templates - http://t.co/Hd3ypNweNh,1
MECFS,1
http://t.co/OiQg5cmkLB,1
#CLL #THECommission #,1
New Health Hashtag,1
Clinical Research Coordinator,1
Viva #tequila #,1
ATM/13q14,1
http://t.co/QU7MACLzgZ,1
NewVia,1
"Lymphoma
Genomic",1
http://t.co/VgvjquW5xa,1
http://t.co/I77ZDTlVux,1
Different Compartments of Chronic,1
http://t.co/5OhBJ5Pv9k,1
@LymphomaProgram,1
Optimal Partner with Ibrutinib,1
http://t.co/bEeIIBhFjk,1
http://t.co/0i6Q1uN5Gp,1
zwaar opgezette lymfeklieren,1
de warmte,1
#hematon #,1
http://t.co/hond1C2YXD,1
Demasiado,1
hem,1
#Olivia #Max #,1
#elspetsconcert #atope #,1
http://t.co/qwH5yhBLut,1
Individualized Therapies,1
#lymphomahub http://t.co/GIMAaKmsUH,1
http://t.co/x89U7KkpFN Multiplicom,1
PPT Slides - http://t.co/IFv21xwAa1,1
"FelizLunes https://t.co/AszwY1KSkh
#",1
#arte #decoraci√≥n #,1
#hechoenmexico #,1
#ilustraci√≥n #,1
Roche &,1
Biogen MabThera,1
@MontonSquad n',1
Estto De No,1
Sarah Rutherford - stellar,1
http://t.co/y2b8NfrwD8 #,1
MATCH DAY,1
Treatment-#Resis,1
#Treatment-#Resistant #Patients,1
Gianluca Gaidano @AmedeoAvogadroUni,1
UnionyRecreo,1
Establishment and Characterization,1
June 23,1
Anderson Tx,1
#Genasense #Lenalidomid #,1
rokowanie,1
http://t.co/OqFGv0u0Eq,1
Clinical Research Coordinator III - Chronic,1
98194,1
http://t.co/X6PM6h7AjW,1
#Expanded #Idelalisib #,1
Horizon After Positive #Phase #III #Combo #Trial,1
Ofatumumab https://t.co/zhusLBvYdP,1
de julio llega,1
#BRC #,1
#Baxtter #,1
Leukemia http://t.co/L1aCtQYnil,1
the Rock&amp;Roll Review,1
Shakin Shakin Shakes,1
the Pennine League,1
@UCIrvine,1
http://t.co/CwMGR3pwxh,1
.@Novartis,1
http://t.co/uo6gZZ9QyB,1
‚úã #CLL,1
https://t.co/i7vGLyr3EQ,1
La miraba con los ojos entornados y una sonrisa torcida que probablemente habr√≠a derretido el coraz√≥n de cualquier mujer,1
Redbrook,1
#ADHA #,1
Ublituximab Phase II With Ibrutinib Effective,1
Onco,1
The Case for Kinase Inhibitors http://t.co/95Yj02IE5k,1
Cance,1
#givelife #,1
Draft,1
http://t.co/gJxPTM8bXa,1
http://t.co/LiHoVxH4nN,1
Multiplex PCR-Bas,1
http://t.co/n7vN03EbaU,1
PowerPoint Slides - http://t.co/Hd3ypNweNh,1
BFR,1
Dr Khouri @MDAndersonNews,1
J.Bahlo,1
Oncolog√≠a PRECLINICAL ACTIVITY,1
ANTI-CCR7 IMMUNOTHERAPY IN,1
Choice and Development,1
http://t.co/xetbGNlm2y,1
https://t.co/xHcfBqShQB,1
#EHA15 http://t.co/fNqf6IPuXm,1
http://t.co/gPkNfOLyh9 http://t.co/WSoDMOyLrw,1
"13,000",1
"3,200",1
https://t.co/rVd4WKaWJa,1
Monoclones,1
http://t.co/L6mFY7VsDQ,1
The Train Don't Stop Here,1
Pharmacyclics Inc.,1
#FDLI,1
Cascade,1
All-Stars,1
http://t.co/osGWDPs7iy,1
Leukemia / Small Lymphocytic #,1
http://t.co/0lxZXRpJUS #CancerNews,1
#Lugano #,1
disorders...http://t.co/YObB2AtcjP,1
#fb Comprehensive Analysis,1
Multiplex PCR-Ba,1
ASCOU Tumor Board,1
#EHA20,1
#CLL http://t.co/CU3teP8YPk,1
#EHA20 #,1
Dr Tausch,1
#15 #,1
#rookie #,1
New Drugs,1
#austria #,1
#eu #,1
vienna,1
http://t.co/XcnPZvAett,1
kwaliteit van leven,1
Majid A,1
miR106b,1
Itch,1
PP2A - http://t.co/gXPcpng8jo,1
515,1
#EHA2015,1
#Combo Improves #,1
515 #EHA2015 #leusm #,1
20 20 @RoytonCc,1
Whatsapp,1
at  #EHA15 Learn,1
Reuni√≥n #,1
Cantabria,1
hematolog√≠a,1
http://t.co/UMmISz5kq7,1
104,1
Messe Wien,1
#EHA15 http://t.co/aBKxxwF9wz,1
Nitin Jain @CLLdoc &amp;Susan O'Brien,1
Rituximab Shows Clinical‚Ä¶ http://t.co/vL7a1CALfv,1
First Press Conference,1
#Vienna #,1
GNW-News,1
.@Novartis &,1
@Bayer,1
http://t.co/ekIunudWM4,1
Aug 15th,1
Stanley Riddell,1
http://t.co/28DnIj5PKv,1
Radcliffe,1
#GMCL #,1
NKG2D,1
#German Team,1
@Moshcam,1
Canto Veracruz,1
http://t.co/cPC9OgMFUQ,1
NCCN15,1
#ASCO2015 http://t.co/k1jqfecPcs,1
http://t.co/Cv17iVw7w5 http://t.co/UIhtcRS7BR,1
Application,1
Next,1
Stars,1
http://t.co/WxKyzaDQEV,1
BCL,1
Bolton,1
Multiplex PCR-,1
"more than 3,100",1
Leuk√§mie ‚Äì Therapiekonzepte,1
Ein √úbersichtsartikel,1
Holla,1
#caturlifelive #cll #motovlog #,1
#motorcycle http://t.co/eZAffs2r2e,1
http://t.co/LEkfpKGRZg,1
Meet Marian,1
John-mother &amp,1
SurvivorSelfie,1
#carolinaladieslacrosse,1
#overtimewin #,1
https://t.co/d30I5NTYH2,1
http://t.co/CSiZS7OWMh,1
http://t.co/tFfFXjHA5U Catherine J. Wu,1
#marginalgains @MontonSquad http://t.co/fG5yNrbGo3,1
http://t.co/fJRBxI6yJt,1
http://t.co/jrGcborpb1,1
http://t.co/6u15TTD0HS,1
http://t.co/JJyQSx1hHB,1
http://t.co/BLdmCHhf6N,1
http://t.co/4OJxhb1Rmb,1
http://t.co/cZhlbbo4CC,1
http://t.co/1Kj8EHSdc2,1
http://t.co/f73Hf75QQJ,1
http://t.co/RxFp7yZSpI,1
http://t.co/nPrOb2VeVz,1
#cytogenetics,1
http://t.co/JRm5GBWzp1,1
Leukemia and Lymphoma Society http://t.co/lOgqZkkp9z,1
Cancer News Ibrutinib,1
world,1
http://t.co/NwabKYld9j,1
http://t.co/co20hu7EY4,1
Leukemia Patients,1
Phase III RESONATE-2 Trial,1
LCB,1
3rd Team,1
Fantasy,1
Woodstock99 http://t.co/XhW37ldYs3,1
Tuveson &,1
NfKB,1
üîòAbout type &,1
Meet Jay,1
DiplomatDifference,1
Nfkb,1
resolution &,1
http://t.co/KB2Mse5fhX,1
Educational Book,1
Efficacy of Idelalisib/Ofatumumab Combination,1
CLL http://t.co/CF4sScrw8,1
June 11,1
http://t.co/lCvk7zO5lW,1
this friday,1
catalana ci√®ncies m√©diques',1
Wally Yocum,1
#cancersurvivorsmonth,1
Previously-Treated Patients,1
#researchmatters #,1
Dr Furman's,1
Combo Achieves,1
CLL Progress,1
Dale,1
http://t.co/G6C7BqTZyY,1
Imprime PGG-MAb Combination Therapy Achieves,1
Data - Clinical Activity,1
Previously-Treated Patients With Chronic,1
Ponatinib,1
Chronic-Phase Chronic,1
ANDA,1
9 CR,1
http://t.co/WWuDcFfpyO,1
Resul...,1
http://t.co/Q7xQTQMZiN,1
Infinity Reports Phase 1,1
"Chronic
http://t.co/rYnmElZDcY",1
DrPatel,1
#Phase #III #CLL #,1
JWL Wood Cup,1
#ALL_IN #,1
Dr @AsherChananKhan,1
I+BR,1
ORR/CR,1
Asher Chanan-Khan,1
http://t.co/Oq7bksSSIy,1
#ASCO15 Breaking News,1
#ASCO15 #mmsm #,1
http://t.co/Wjlf1CXObR,1
http://t.co/1hHuDWbjA3,1
Leukemia http://t.co/h3qdLwRmDK,1
#ASCO15 #leusm,1
Nicole Lamanna Co‚Ä¶,1
#JohnTerry #,1
#caturlifelive #motovlog #,1
yamaha,1
http://t.co/KHFzBrbc2i,1
$TGTX #EHA2015 http://t.co/NCcQrwHN9,1
#TGR-1202 #,1
Great League,1
#premier #,1
Second Cancers,1
SUV &,1
http://t.co/BufTuCaRw1 http://t.co/58pQ9YlCSK,1
#ASCO15 http://t.co/w6gFlSQQdp,1
http://t.co/rG3yF7dOuO,1
Update on Treatment &,1
#SideEffects Management,1
6/17/15,1
6/11/15,1
Evaluating &,1
Managing Options,1
https://t.co/kOqwQ87NOh,1
Randy,1
PEN Board,1
LungCancer,1
http://t.co/6Lrdu6VMXn,1
Erysipelothrix,1
http://t.co/Viyy1cXeUh,1
Dorwal P,1
Mehra,1
—Å—à–∞,1
Aunt Helen,1
http://t.co/gZ2YlPEG6a,1
The Cancer Experience Registry,1
Humber River Regional Hospital,1
Venez,1
la vid√©o,1
Pan-PI3K Inhibitor,1
747,1
David E Manning,1
üòä,1
CSC,1
Registry,1
the Chronic Lymphocytic Leukemia Center,1
Dana-Farber Cancer,1
http://t.co/gdc2MnYXeG,1
http://t.co/jZ0cUl1vL3,1
Tada,1
#youtube #,1
http://t.co/Vg0W9dLW5V,1
9News,1
#premiercricket #,1
Ûæ†¶ÛæüôÛæ≠û,1
#DiamondRUN #,1
zarejestrowane w,1
FightingCancerTogether,1
#GML #,1
#NfKB #,1
chemosurvi‚Ä¶ http://t.co/P9gv0EpUNP http://t.co/2nKE9UERSt,1
Browning,1
Blue Eyes,1
#lusitano #,1
#eye #,1
Mitchell Smith,1
http://t.co/DYwQpy0nux http://t.co/p3IEKgxQsO,1
Induce Programmed Cell Death in Refractory,1
#cll http://t.co/MjEZeSfvac,1
ya noche,1
Si lo que,1
http://t.co/5ZkCubvkSv,1
Mansouri et al,1
badania leczenie rokowania,1
zarejestrowane w Europie,1
2.2bn,1
4bn,1
Inhibits Proliferation and Induces Apoptosis,1
#PlanB  ,1
DiamondRUN,1
https://t.co/sNA2yJIFZD,1
http://t.co/sprCuiRAHt,1
Oldham,1
cricketfamily,1
Flow,1
"Clinical Review]""",1
http://t.co/yMOyyV9kLU,1
NF-{kappa}B,1
üôá #,1
Yamaha,1
Suzuki,1
Josep,1
Carreras Leukaemia Research Institute,1
TRIL,1
CD-47,1
Ublituximab + #Ibrutinib,1
Opportunities: #,1
"Gout
#Ovariancancer",1
Team,1
Paycations,1
http://t.co/qv8wnxjPrl,1
#lastnight #,1
#yalaextra√±aba #,1
https://t.co/0ziXLlIGSe,1
http://t.co/QMP3fnhioF,1
Moertel Lecture @ALLIANCE_org,1
RR B-non-Hodgkin,1
http://t.co/854Sswa4R2 http://t.co/5frVduzR50,1
http://t.co/44Ly5YwhvL,1
TG Therapeutics Announces Clinical Data,1
New #,1
http://t.co/nr0v6f9RRB #,1
http://t.co/vNdQVx8ajG,1
http://t.co/bbi6tIJalZ,1
Classic Live Lobos,1
Volver Volver,1
Watsonville,1
MT @mtmdphd,1
http://t.co/WmzTCMPYeJ,1
Ibrutinib http://t.co/F8BYoBeEKM,1
#BeyondHSCT  ,1
Manda,1
1827,1
Weill Cornell Clinical Trials,1
Writers,1
GBX 133 PT,1
http://t.co/256Do46MxZ,1
@VOXmarkets,1
ITP - Chronic,1
ASCT,1
http://t.co/CO740VmpMs,1
Guy #Horion,1
"5/12, 12p ET",1
3lymphoma,1
7069,1
#PI3KŒ¥ #,1
#BCell #,1
8548,1
Ayyy Terry,1
CLL http://t.co/JoITFKm3Y8,1
#New_shit_Dans_Les_Bacs #,1
"#Danny_DAN
",1
"Brisno
#PH http://t.co/kfGLwQdCx6",1
Practicaaaa,1
Basquet  ,1
Mati,1
@ArizonaOncology,1
$6 Billion,1
10am #CLL,1
BEYourOwnBoss,1
Leukemia http://t.co/yyiJWmsPEt PRT,1
myeloi,1
@MDAndersonNews #KnowledgeIsBestRx,1
#CLL http://t.co/eLskg061EC,1
"Richter's Transformation After Transplantation Failure
http://t.co/wIR87lCLsI",1
http://t.co/yyTyA9EUhC,1
Jo Ann!,1
#pelotonia15 #hopehighway #teambuckeye #,1
#leukemiasurvivor #,1
#jamescancercenter #hopehighway #,1
pelotonia15,1
Health - Google News,1
http://t.co/t0u9BtfCef,1
Predicting Prognosis,1
http://t.co/1EtcXYND3K,1
http://t.co/8cqqeiIfVe,1
Venet,1
http://t.co/0HtrCSQOrp,1
http://t.co/lUsUWySEjJ,1
http://t.co/1KtfHb2PFf,1
Breakthrough,1
Leukemia http://t.co/eBmKqaZGdG,1
http://t.co/7j1drDfnZk,1
Leukemia http://t.co/yyiJWmsPEt http://t.co/gdNMUSCoDC,1
Angel Dance,1
@US_FDA Breakthrough Therapy Designation,1
http://t.co/5o3PvhFctt,1
http://t.co/kCAyI3Zbkz,1
#health #pharma #,1
http://t.co/UmG5zYKsR5,1
FDA Breakthrough Therapy,1
AbbVie‚Äôs Venetoclax For Chronic Lymphocytic Leukemia,1
$ABBV Venetoclax,1
CLL - Communication &,1
#CLL/ #DLBCL/ #,1
el mejor,1
el m√°s guapo,1
gustas,1
y ya,1
el amor,1
#spring,1
#alberta #hiking #,1
#Club #,1
#10ourjourney #,1
http://t.co/RphXhL2PDq,1
CLL@memortweets,1
http://t.co/TT5RMjGBYQ,1
@ULHS #Renting,1
https://t.co/J9cf0fOfMv Living with,1
#ALW #,1
pensais,1
#CLL http://t.co/DiJq7WTkE4,1
Idelalisib Continue,1
https://t.co/oqoUIFKlEj,1
Combo Delays #Progression,1
CLL @pcnsm http://t.co/u3ZT7EhMZM,1
http://t.co/2IFZ21rBrC,1
Ense√±andole,1
http://t.co/zochnPGCK4,1
http://t.co/Pgpw7TT6g2,1
Fundos de Pens√£o,1
#cassio #,1
http://t.co/zoQxbiyMaW Great,1
https://t.co/ewniiNnYF4,1
Ivanhoe Newswire,1
http://t.co/KbQbn4E7lW,1
healthnews,1
http://t.co/dBEBYOm8YZ,1
http://t.co/2moBKL1gVQ  #pharma #,1
#proteomics + #,1
PubSaludMurcia,1
median 1yr,1
http://t.co/YeaYb7Zaiq,1
Partido  #,1
U17,1
ahcj15,1
Lynn Rich,1
Upstate NY,1
Furnan,1
#Ultmann #,1
2015@JohnPLeonardMD,1
#Partido #,1
Kagami,1
Adrenocortial,1
Rap,1
http://t.co/6P5ipsUiXa Adventures,1
#walks #,1
#snow #,1
Hollie Mueller Hawn - No,1
http://t.co/JhrhHZdzyT,1
Health Beat - Home http://t.co/KtqwDIBlrg,1
Signs &,1
Ekata,1
http://t.co/dk2kpl0Ad7,1
#durable #,1
@Melanie_Falcon,1
#HealthBeat,1
69News,1
10-3:30,1
the Central Lancashire League,1
#MabTheraSC,1
last week's,1
"Come On, Let's Go!",1
ASCOU Molecular Onc TB,1
T2 Blood,1
#abcDrBchat,1
CLL Molecular Oncology Tumor Board,1
#Lymphoma Program,1
#CLL Research Center,1
the Pathophysiology of Chronic Lymphocytic Leukemia,1
http://t.co/hN5p2UHVUk #Immunology,1
#AACR15 #,1
#JCO #,1
cmplt responses w/patients w,1
11 mai 2015,1
#CozyLife #,1
The Leukemia and Lymphoma,1
the season,1
#firstgame,1
https://t.co/WtR5S5yJNj,1
Altas,1
#ultimobrowdepe #cll,1
#s√°bado #,1
Mario House,1
Croce,1
Stem-Cell Transplantation Failure,1
#JCO,1
na√Øve &,1
Leukemia                                                                   ,1
http://t.co/rzG6uGWEbs Virtual,1
the Phase III #,1
http://t.co/Vi3e56d69u Virtual,1
Apprendre le N√©erlandais,1
ImpactPaques,1
http://t.co/zh166U9wal,1
CME Patient-Centered Care,1
ASCOU Molecular Oncology Tumor Board,1
Small-Molecule Inh,1
Geoff &,1
#Paleo #,1
#master #,1
#foamrolling #,1
fitnesstransform,1
pathologist &amp,1
Syk,1
http://t.co/UY73XiqCYZ Virtual,1
Oncolog√≠a LAG TIMES,1
#CLL @TheLancet,1
@Oncoinfo_it,1
@Oncoematologia  https://t.co/6cMg89Ojzq,1
Medical Condition,1
Steve Brown,1
Leukemia Survivor,1
Ultra Athlete - https://t.co/laDBzgJiFy,1
Anselma,1
1983,1
http://t.co/iKvSTI7VZR,1
+ Clb,1
http://t.co/NjuibLZjrK,1
http://t.co/K13nxjH2Wx,1
http://t.co/AEBYrZGMoM,1
Proteomics,1
54.00,1
#MOREoncology http://t.co/QWNZ2cHH2k,1
55y,1
http://t.co/uXmQ1lZ4k0 Virtual,1
OpportunityAnalyzer,1
#stuckinthepast #,1
http://t.co/QeLtp6diaZ Virtual,1
Transgenic #Mice,1
leucl,1
Genetic &,1
PhaSeal 2,1
http://t.co/N7TGzAuYrm http://t.co/nKCVsvC5hk,1
ABResistance,1
http://t.co/Fv2fDvbSrB,1
Woodstock,1
http://t.co/omEz4ABmcQ,1
#QMandM Hay,1
Nodality Unveils PathPro Chronic,1
@MDACC,1
#Cance,1
#KnowledgeIsBestRx @MDACC http://t.co/XMuGcA0SRp,1
Outcomes of Patients With,1
http://t.co/ieTRaDUP1E,1
Richter‚Äôs Transformation After Transplantation Failure,1
la sonrisa cuando escucho su nombre.,1
Atypical Chronic Lymphocytic Leukemia,1
February 2009,1
linda ÛæåßÛæåß  ....,1
finalmente,1
da assist√™ncia,1
38457930278943014614705011606494,1
#cLL #,1
nova,1
#deontem #,1
Little League Opening Day 2015,1
https://t.co/oVAzR1Tkm0,1
Listo,1
http://t.co/DRl00o6l5d,1
http://t.co/pUj970o2nP,1
"Lymphoma
Pharmacological",1
ABT199,1
http://t.co/I1RfnJZ5Ky,1
PMWC11,1
Nodality launches PathPro(TM,1
PathPro,1
http://t.co/RCIagxILCH,1
http://t.co/g26kMbUa7U,1
http://t.co/pwAVCIRqiD,1
#Basquet #CLL,1
969685859,1
ROS Modulation,1
leu,1
'89,1
All Night Long,1
Extremamente,1
#conejo #,1
http://t.co/HceMyXpgRq,1
04,1
de Santiago,1
Susan F.,1
First Connection,1
@LLSAZ,1
Proud @LLSAZ,1
Munoz,1
UWISTA,1
#Nihongonokurasu #,1
pndbrennan,1
Kingston,1
http://t.co/p6gLSYduJm,1
#farm #,1
#Blood Journal,1
JOHN TERRY JOHN TERRY JOHN TERRY,1
Lipoprotein Lipase,1
25-Year,1
noe,1
enn,1
Zlatan,1
3.1 months,1
http://t.co/0Aki2ROUrF #hpm,1
#hpm,1
Deutsche,1
#minis #deutschemeisterschaft #,1
‚ô• http://t.co/K2wmEjWsrS,1
Leiden,1
Dr Skirvin,1
AML-,1
CML-,1
ALL-,1
Christopher,1
Cancer http://t.co/4nRpVCU2VQ,1
#Publications #,1
Peter Chatterton,1
@8am &,1
12:15pm,1
Hematolog√≠a RECURRENT MUTATIONS REFINE PROGNOSIS,1
Ravindra Kolhe,1
SNPmicroarrays,1
Ravi Kolhe @GeorgiaRegents,1
GGC,1
SNParray,1
#USCAP2015 #,1
the City Living London,1
#Newcar #,1
http://t.co/Pb92xdqEfS,1
NRBCs @ University,1
Viendo el gran cl√°sico desde el sal√≥n,1
Borrelia Infection,1
Amanita,1
James with Bernie,1
#openingceremonies,1
#baseballlover #royals #,1
Angels https://t.co/Krf0ImVhVa,1
Bernie,1
#funtimes #,1
https://t.co/axUPamvRFt,1
Royals this year,1
#royals,1
#baseballseason #,1
#dimitri #,1
Hoetrotskunjezijn http://t.co/lhdhjflGcl,1
Doreen te Raa,1
133,1
April 23,1
http://t.co/r9BxCZxPRB,1
#Lymphomahub CLL,1
Foxboro,1
Jerry Garcia &,1
Bob Weir,1
Las chicas del Lucho,1
Practica https://t.co/CWOpohRtHt,1
CANAM CLL,1
Whangarei Hospital,1
mmsm http://t.co/Pp5spb6oid,1
Imbruvica Significantly Delays Disease Progression,1
SLL Study,1
mmsm http://t.co/V7ApsiVopD,1
http://t.co/3nvJLulkmr,1
#Notch #,1
cMyc,1
mmsm http://t.co/VquD0tQ3bw,1
Treanda/Rituxan/Imbruvica,1
ISI,1
Imb,1
mmsm http://t.co/FmrYgsGikK,1
G-FC,1
#DCFS #,1
KFFI,1
Nev,1
@CLLJudge,1
#Imbruvica http://t.co/Ox7UhLxfVz @aboutdotcom,1
#lymsm http://t.co/16ncQlIR55,1
Productividad,1
Recuerden,1
comuna de Maipu,1
https://t.co/cttTqlfWBL,1
General Information,1
Buen,1
http://t.co/OFBqwMrTsc,1
üëç https://t.co/gNG7O94n3g,1
#treat #,1
http://t.co/GOyj0fZ3Wb,1
The Lymphoma Hub Awards,1
Lifeline,1
Addenbrooke,1
9pm or,1
Dercum,1
Fibro &,1
Spoonie,1
Le contrat d'√©dition,1
JE,1
œÄœÅœåŒ≤ŒªŒµœàŒ∑ Œ∫ŒπŒΩŒ¥œçŒΩŒøœÖ œÑŒ∑œÇ œáœÅœåŒΩŒπŒ±œÇ,1
ŒªŒµœÖœáŒ±ŒπŒºŒØŒ±œÇ,1
se la extra√±a,1
Austin,1
TX @LosLobosBand,1
SEDA,1
Change,1
award @balham,1
#digifest15 #,1
#digifest15,1
MD ANDERSON Clinical Trials,1
$XON $,1
#construction #auckland #,1
Push Ups,1
Lol,1
Shirt,1
Honored Teammate,1
@CNC3TV,1
#openhouse2015 #,1
empezamos las,1
#SuperCrazy,1
ECW,1
https://t.co/j2JqLqww6r,1
http://t.co/n0FFbO6hcQ,1
Cancer Trials: Lenalidomide With or,1
Without Rituximab,1
http://t.co/joctUNQrxO,1
http://t.co/gXJFgL5B9d,1
#InsaneLuchador #,1
SuperCrazy,1
@g_ermaan,1
@IslasSupercrazy,1
#SuperCrazy #,1
Esperando esta sea la primera de muchas,1
#Chileluchalibre #,1
#chile,1
http://t.co/gwr2vbUq78,1
$GILD #,1
Derochando,1
üëàüëç,1
Herkenbaar #CLL,1
ben eigenlijk,1
naar de garage,1
HermanFinkers,1
Haemato-Oncology,1
MT @MDAndersonNews #Innovation,1
LeMoyne,1
WNYPE,1
#phins,1
Practica  #,1
Serial Killer,1
Penn Researchers Report,1
http://t.co/yXiHxIiBUX http://t.co/gBXCy7vPKQ,1
anti-LAG-3,1
el upd con la promo,1
Juro amar las,1
tenemos con,1
massspec,1
Serenata Nortena,1
1984,1
Activation: Evidence from M‚Ä¶,1
d√≠as de arrancar las clases,1
GNAC,1
@dhoneysett,1
SB,1
MSU,1
Tengo,1
http://t.co/SAigAqANEZ,1
http://t.co/tMxZgQXZiY,1
ChronischLymphatischeLeuk√§mie,1
aus dem,1
Leben,1
#quote #,1
http://t.co/rYyQL5wKeJ #CancerNews,1
#biltunisia  ,1
#bilfst #,1
igersAriana,1
http://t.co/Hi7KVn0Izk,1
http://t.co/Y5x9CMcFxj,1
Opening Day,1
http://t.co/Y5x9CMugVT,1
Science Codex http://t.co/5BAy0ngUpj,1
#smartsensors.me,1
smartsensors.me,1
Monica,1
http://t.co/vSYAupXm0N,1
BBC News - Leukaemia: Cardiff University,1
Mati ‚úå #,1
Study http://t.co/q8NhR0ycrD,1
http://t.co/R7o0NYURUl,1
http://t.co/hDifeDQw8B #CancerNews,1
http://t.co/jM6zcl1kOq #medical #,1
#pormillonesm√°s,1
@SamHeughan,1
2600,1
1200mm,1
#kiwirail #,1
#construction #engineering #CLL #,1
http://t.co/7rImn6X5Wc,1
Leukemia Moonshot,1
LinkedIn,1
http://t.co/gN8QuCwSUm,1
the NZTA SH 1 Rangiriri Realignment,1
Completed Cliff Stabilisation,1
#civilworks,1
Auckland NZ,1
#Chapter 5,1
@TNT_EPA,1
midnight,1
#biopsy #,1
"https://t.co/32zRA8MbbA

Check",1
Stone Columns,1
Wellington,1
Ryman Healtcare,1
CFA,1
Mangere Countdown,1
250diameter,1
600diamete,1
#Piling #,1
http://t.co/d5zZzCftxC,1
EtherScript,1
http://t.co/hqQ3e72b7K #,1
2/28,1
Campe√≥n Nacional,1
#chileluchalibre #,1
Agents Into #,1
Frontline Setting Continues to,1
Flux,1
http://t.co/2x7KL4c6nl #,1
La conversaci√≥n con,1
tanto,1
http://t.co/cNQ0MtpBEJ,1
19772,1
EUDiseaseLens,1
Autoimmune #Hemolysis Other,1
5days,1
BTK http://t.co/TAvYiYBPP3,1
üê¥,1
#horselover,1
Dia,1
quinta üê¥,1
#horse,1
Discover #,1
Decaudin D,1
Catherine J Wu,1
http://t.co/wVhl6fWtog,1
http://t.co/ojMaHy2SoG,1
http://t.co/B5XiSdjx0B http://t.co/vFSAiIuCC8,1
#EGRX Report,1
#Teva‚Äôs,1
Commercialize Eagle‚Äôs,1
1990,1
Neighborhood,1
Cancer Advance of,1
http://t.co/HukoY5xqI6,1
Alison Michie &,1
Pharmacyclics Inc,1
Global Clinical Trial by,1
http://t.co/M5z2sVDNRR,1
al Miercoles,1
Ayer,1
Global Clinical Trial,1
The Evolving Role of Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia,1
#Selinexor #,1
Agg,1
https://t.co/Nmn9Hib7Y1,1
GBX 133,1
"37,795",1
Cancer Research:,1
http://t.co/iGTzZrDbVp,1
Novel Btk Inhibitor Heads,1
ANY,1
PGG,1
Glucan‚Ä¶,1
http://t.co/Nx9sC3VAZ1,1
http://t.co/D2leTPBqo3 Calling,1
$ZIOP $,1
9.99,1
Zane,1
Cancer Trials,1
Spring Run Elementary,1
flat ¬£310pwk,1
Marylebone,1
#Affordable #,1
http://t.co/1kv8RaZ3jE,1
March 27th,1
Follicul,1
#Buy @CelloGroup,1
#Impressive #,1
#CLL http://t.co/hDBgRsSlbS,1
Carl Miessen,1
Wallonia,1
Derek Trucks,1
Spring Chesterfield Little League season by Feb 15th,1
7 years ago,1
http://t.co/davHvjXWcX,1
http://t.co/anowX9RdAK,1
http://t.co/R67g4T2ifw Calling,1
http://t.co/nqCKjidiwV,1
@Novartis http://t.co/kYt8ynsxt7,1
http://t.co/I4FFjTXdou,1
#IGGYA #,1
"‚ô• Aburrida En Mi Casa‚ô•
",1
http://t.co/yqx0nenOQw,1
http://t.co/0VQFE2lgI1,1
#EMJvideo #,1
Simone Ecker,1
Vera Pancaldi,1
Daniel Ric,1
http://t.co/0fguEPGu5X,1
Ibrutinib http://t.co/a2Ikux7wtY,1
http://t.co/N7TGzAuYrm http://t.co/wQkQrBOw9D,1
Saudi,1
"OT
&gt;Forklift Operator-",1
"1600 + 200 + OT
&gt;HV/Driver SL/DL",1
0771562149,1
necesitamos sociedad,1
TechOffer,1
a fantastic afternoon,1
@northcott_ds,1
SCG,1
CNIOScientis,1
#sweden,1
http://t.co/lmIxJyDlCq,1
http://t.co/9uXxzBcZr9,1
1st-Line Rx,1
XENCOR,1
Xencor,1
#FCANCER #,1
miR-3676,1
about #WorldCancerDay #,1
#publiCHT,1
http://t.co/QZPVDymHov,1
Louie Perez,1
Saint Behind The Glass,1
vox,1
http://t.co/REgxV4oqQI,1
http://t.co/qu10QIDPpr,1
#york,1
http://t.co/TMvWdzcUdp,1
http://t.co/b6JuYORmY5,1
#molecular #,1
Sutton,1
Rosenquist,1
Leukemia http://t.co/bD2orF1ZOU,1
lymphocyte debris,1
http://t.co/VvVYeUkuXY,1
WP1066,1
Crohn‚Äôs,1
#ABI #,1
Cancer Research: Complementary,1
@cperren26 @13oody,1
http://t.co/iYkMIyEpAO #,1
@Alfons_Valencia,1
mpn http://t.co/7wcPNn5flp,1
http://t.co/OE9wd3EybJ,1
mpn,1
Ibrutinib http://t.co/rEkOJL3ZJJ,1
ZIOP,1
a ton,1
#ch≈Çoniaka z,1
#PBL #,1
Gazyva Medoinfo,1
http://t.co/PIZO1LMwdx,1
http://t.co/dyOnRxnUdD,1
#Mabthera #,1
http://t.co/S95KvIcYaR,1
Mutation Analysis,1
Surrey Fusion Festival:,1
Lobos,1
"@Neilyoung ""Cinnamon Girl",1
https://t.co/kR7voFTH4j,1
MD Anderson #Leukemia,1
http://t.co/V8758lQnnx,1
CLL - OncLive,1
Rai @UCCancerCenter,1
Dentistry,1
TG-1101 + Ibrutinib,1
RIP David Schofield,1
Clinical Advances,1
#Muuaxx #,1
http://t.co/nYls22u9CU,1
https://t.co/9Q8xu5rzjd,1
Êàë‰∏çËØ¥‰Ω†‰∏çÈóÆ,1
#MICROSCOPE #,1
Leukemia http://t.co/9O6Js9ysrl,1
http://t.co/4adXUGfZZu,1
#SummerFest2015 #CLL #,1
http://t.co/7AMUUL0iiG,1
ACUTE,1
http://t.co/kwaB8qVjFj,1
Mobile Technology,1
Dutch Hematology Congress 2015,1
#NVVH,1
La Bamba,1
MTV Awards,1
Lobo,1
a 1st,1
a ‚ÄòCancer Advance,1
http://t.co/4M45Y3nOGz,1
http://t.co/tGMVWFXNTz,1
Cancer Advance,1
#LRT #,1
Cancer Advance of the Year,1
the Cancer Advance of the Year,1
Transformation of Treatment for Chronic Lymphocytic Leukemia,1
http://t.co/xX9rlWQcqv,1
va,1
la persona correcta,1
"about 16,000",1
http://t.co/55M64fY1rw,1
Discontinuing Ibrutinib #,1
http://t.co/VYykP1EwGL,1
Garden City Cafe,1
Bill Riddle,1
#cll http://t.co/IA5odSM5Vn,1
http://t.co/gkS0u7QfNH,1
http://t.co/6pYaZNYUv9,1
http://t.co/GDFXDLN3vp,1
#Centennial #,1
seanyb5,1
ShortageOfMedicinesInVenezuela,1
Sold Out http://t.co/dWggUoQ6Bm,1
DonateloPen,1
#loveit #xasco #,1
#me #,1
#instashot #nocrop #,1
#loveit #,1
Carlos Lucas Lopes,1
http://t.co/VuWAuRBNyM,1
City Living London,1
the London Rental Standard,1
#MOREoncology http://t.co/A0J4DZORxs,1
de novo hodgkin,1
=&gt;&gt,1
Drug-Free Macromolecular Therapeutics Induce Apoptosis of Patient Chronic,1
Morpholino,1
#ASH14 #,1
http://t.co/ab8GoXJZkG,1
http://t.co/b7g3XVTzH7,1
http://t.co/WUa32m1N46,1
Aberrations http://t.co/oDdhyTCBj7 #CancerNews,1
Nederlands,1
Eerste,1
#taal #,1
Brussel,1
Alsagaby SA,1
Khann,1
#oa,1
http://t.co/N7TGzAMzzq http://t.co/8cBysH8AQ4,1
OUTCOMES,1
#bloodjournal #Ibrutinib,1
http://t.co/urP7klZEsm,1
NCCN (National Comprehensive Cancer Network,1
Medical News http://t.co/ZLoTorpcEd,1
Treatment- Balancing Efficacy,1
#Safety and #,1
http://t.co/FDijxBGw99,1
Varsha Gandhi,1
http://t.co/l4SBigfcKM,1
http://t.co/OYvkkLHgTb,1
This season,1
the middle of summer,1
http://t.co/Gxgcl6gNFw,1
@ConanOBrien,1
62 year old,1
http://t.co/k1CLpA0x6r,1
@OncoTherapyNet http://t.co/ZffrD01B9U,1
#symax5c #,1
IMBRUVICA Data Demonstrates Efficacy,1
http://t.co/pQf72IvfYU,1
Bestfriend üòç,1
el pasado,1
brindemos,1
las buenas,1
las malas ya vendran,1
Coulter Award,1
Lifetime Achievement,1
the opening day,1
2gen,1
Gerrard,1
#SG8 #,1
Zusatznutzen von #,1
IMMUNOCHEMOTHERAPY OUTCOME IN,1
